Gene	"Gene synonym"	Ensembl	"Gene description"	Uniprot	Chromosome	Position	"Protein class"	"Biological process"	"Molecular function"	"Disease involvement"	Evidence	"HPA evidence"	"UniProt evidence"	"NeXtProt evidence"	"MS evidence"	"RNA tissue specificity"	"RNA tissue distribution"	"RNA tissue specificity score"	"RNA tissue specific NX"	"RNA single cell type specificity"	"RNA single cell type distribution"	"RNA single cell type specificity score"	"RNA single cell type specific NX"	"RNA cancer specificity"	"RNA cancer distribution"	"RNA cancer specificity score"	"RNA cancer specific FPKM"	"RNA brain regional specificity"	"RNA brain regional distribution"	"RNA brain regional specificity score"	"RNA brain regional specific NX"	"RNA blood cell specificity"	"RNA blood cell distribution"	"RNA blood cell specificity score"	"RNA blood cell specific NX"	"RNA blood lineage specificity"	"RNA blood lineage distribution"	"RNA blood lineage specificity score"	"RNA blood lineage specific NX"	"RNA cell line specificity"	"RNA cell line distribution"	"RNA cell line specificity score"	"RNA cell line specific NX"	"RNA mouse brain regional specificity"	"RNA mouse brain regional distribution"	"RNA mouse brain regional specificity score"	"RNA mouse brain regional specific pTPM"	"RNA pig brain regional specificity"	"RNA pig brain regional distribution"	"RNA pig brain regional specificity score"	"RNA pig brain regional specific pTPM"	Antibody	"Reliability (IH)"	"Reliability (Mouse Brain)"	"Reliability (IF)"	"Subcellular location"	"Secretome location"	"CCD Protein"	"CCD Transcript"	"Blood concentration - Conc. blood IM [pg/L]"	"Blood concentration - Conc. blood MS [pg/L]"	"Subcellular main location"	"Subcellular additional location"	"Antibody RRID"	"Pathology prognostics - Breast cancer"	"Pathology prognostics - Cervical cancer"	"Pathology prognostics - Colorectal cancer"	"Pathology prognostics - Endometrial cancer"	"Pathology prognostics - Glioma"	"Pathology prognostics - Head and neck cancer"	"Pathology prognostics - Liver cancer"	"Pathology prognostics - Lung cancer"	"Pathology prognostics - Melanoma"	"Pathology prognostics - Ovarian cancer"	"Pathology prognostics - Pancreatic cancer"	"Pathology prognostics - Prostate cancer"	"Pathology prognostics - Renal cancer"	"Pathology prognostics - Stomach cancer"	"Pathology prognostics - Testis cancer"	"Pathology prognostics - Thyroid cancer"	"Pathology prognostics - Urothelial cancer"	"Tissue RNA - adipose tissue [NX]"	"Tissue RNA - adrenal gland [NX]"	"Tissue RNA - amygdala [NX]"	"Tissue RNA - appendix [NX]"	"Tissue RNA - basal ganglia [NX]"	"Tissue RNA - bone marrow [NX]"	"Tissue RNA - breast [NX]"	"Tissue RNA - cerebellum [NX]"	"Tissue RNA - cerebral cortex [NX]"	"Tissue RNA - cervix, uterine [NX]"	"Tissue RNA - colon [NX]"	"Tissue RNA - corpus callosum [NX]"	"Tissue RNA - ductus deferens [NX]"	"Tissue RNA - duodenum [NX]"	"Tissue RNA - endometrium 1 [NX]"	"Tissue RNA - epididymis [NX]"	"Tissue RNA - esophagus [NX]"	"Tissue RNA - fallopian tube [NX]"	"Tissue RNA - gallbladder [NX]"	"Tissue RNA - heart muscle [NX]"	"Tissue RNA - hippocampal formation [NX]"	"Tissue RNA - hypothalamus [NX]"	"Tissue RNA - kidney [NX]"	"Tissue RNA - liver [NX]"	"Tissue RNA - lung [NX]"	"Tissue RNA - lymph node [NX]"	"Tissue RNA - midbrain [NX]"	"Tissue RNA - olfactory region [NX]"	"Tissue RNA - ovary [NX]"	"Tissue RNA - pancreas [NX]"	"Tissue RNA - parathyroid gland [NX]"	"Tissue RNA - pituitary gland [NX]"	"Tissue RNA - placenta [NX]"	"Tissue RNA - pons and medulla [NX]"	"Tissue RNA - prostate [NX]"	"Tissue RNA - rectum [NX]"	"Tissue RNA - retina [NX]"	"Tissue RNA - salivary gland [NX]"	"Tissue RNA - seminal vesicle [NX]"	"Tissue RNA - skeletal muscle [NX]"	"Tissue RNA - skin 1 [NX]"	"Tissue RNA - small intestine [NX]"	"Tissue RNA - smooth muscle [NX]"	"Tissue RNA - spinal cord [NX]"	"Tissue RNA - spleen [NX]"	"Tissue RNA - stomach 1 [NX]"	"Tissue RNA - testis [NX]"	"Tissue RNA - thalamus [NX]"	"Tissue RNA - thymus [NX]"	"Tissue RNA - thyroid gland [NX]"	"Tissue RNA - tongue [NX]"	"Tissue RNA - tonsil [NX]"	"Tissue RNA - urinary bladder [NX]"	"Tissue RNA - vagina [NX]"	"Tissue RNA - B-cells [NX]"	"Tissue RNA - dendritic cells [NX]"	"Tissue RNA - granulocytes [NX]"	"Tissue RNA - monocytes [NX]"	"Tissue RNA - NK-cells [NX]"	"Tissue RNA - T-cells [NX]"	"Tissue RNA - total PBMC [NX]"	"Cell RNA - A-431 [NX]"	"Cell RNA - A549 [NX]"	"Cell RNA - AF22 [NX]"	"Cell RNA - AN3-CA [NX]"	"Cell RNA - ASC diff [NX]"	"Cell RNA - ASC TERT1 [NX]"	"Cell RNA - BEWO [NX]"	"Cell RNA - BJ [NX]"	"Cell RNA - BJ hTERT+ [NX]"	"Cell RNA - BJ hTERT+ SV40 Large T+ [NX]"	"Cell RNA - BJ hTERT+ SV40 Large T+ RasG12V [NX]"	"Cell RNA - CACO-2 [NX]"	"Cell RNA - CAPAN-2 [NX]"	"Cell RNA - Daudi [NX]"	"Cell RNA - EFO-21 [NX]"	"Cell RNA - fHDF/TERT166 [NX]"	"Cell RNA - GAMG [NX]"	"Cell RNA - HaCaT [NX]"	"Cell RNA - HAP1 [NX]"	"Cell RNA - HBEC3-KT [NX]"	"Cell RNA - HBF TERT88 [NX]"	"Cell RNA - HDLM-2 [NX]"	"Cell RNA - HEK 293 [NX]"	"Cell RNA - HEL [NX]"	"Cell RNA - HeLa [NX]"	"Cell RNA - Hep G2 [NX]"	"Cell RNA - HHSteC [NX]"	"Cell RNA - HL-60 [NX]"	"Cell RNA - HMC-1 [NX]"	"Cell RNA - HSkMC [NX]"	"Cell RNA - hTCEpi [NX]"	"Cell RNA - hTEC/SVTERT24-B [NX]"	"Cell RNA - hTERT-HME1 [NX]"	"Cell RNA - hTERT-RPE1 [NX]"	"Cell RNA - HUVEC TERT2 [NX]"	"Cell RNA - JURKAT [NX]"	"Cell RNA - K-562 [NX]"	"Cell RNA - Karpas-707 [NX]"	"Cell RNA - LHCN-M2 [NX]"	"Cell RNA - MCF7 [NX]"	"Cell RNA - MOLT-4 [NX]"	"Cell RNA - NB-4 [NX]"	"Cell RNA - NTERA-2 [NX]"	"Cell RNA - OE19 [NX]"	"Cell RNA - PC-3 [NX]"	"Cell RNA - REH [NX]"	"Cell RNA - RH-30 [NX]"	"Cell RNA - RPMI-8226 [NX]"	"Cell RNA - RPTEC TERT1 [NX]"	"Cell RNA - RT4 [NX]"	"Cell RNA - SCLC-21H [NX]"	"Cell RNA - SH-SY5Y [NX]"	"Cell RNA - SiHa [NX]"	"Cell RNA - SK-BR-3 [NX]"	"Cell RNA - SK-MEL-30 [NX]"	"Cell RNA - SuSa [NX]"	"Cell RNA - T-47d [NX]"	"Cell RNA - THP-1 [NX]"	"Cell RNA - TIME [NX]"	"Cell RNA - U-138 MG [NX]"	"Cell RNA - U-2 OS [NX]"	"Cell RNA - U-2197 [NX]"	"Cell RNA - U-251 MG [NX]"	"Cell RNA - U-266/70 [NX]"	"Cell RNA - U-266/84 [NX]"	"Cell RNA - U-698 [NX]"	"Cell RNA - U-87 MG [NX]"	"Cell RNA - U-937 [NX]"	"Cell RNA - WM-115 [NX]"	"Blood RNA - basophil [NX]"	"Blood RNA - classical monocyte [NX]"	"Blood RNA - eosinophil [NX]"	"Blood RNA - gdT-cell [NX]"	"Blood RNA - intermediate monocyte [NX]"	"Blood RNA - MAIT T-cell [NX]"	"Blood RNA - memory B-cell [NX]"	"Blood RNA - memory CD4 T-cell [NX]"	"Blood RNA - memory CD8 T-cell [NX]"	"Blood RNA - myeloid DC [NX]"	"Blood RNA - naive B-cell [NX]"	"Blood RNA - naive CD4 T-cell [NX]"	"Blood RNA - naive CD8 T-cell [NX]"	"Blood RNA - neutrophil [NX]"	"Blood RNA - NK-cell [NX]"	"Blood RNA - non-classical monocyte [NX]"	"Blood RNA - plasmacytoid DC [NX]"	"Blood RNA - T-reg [NX]"	"Blood RNA - total PBMC [NX]"	"Brain RNA - amygdala [NX]"	"Brain RNA - basal ganglia [NX]"	"Brain RNA - cerebellum [NX]"	"Brain RNA - cerebral cortex [NX]"	"Brain RNA - hippocampal formation [NX]"	"Brain RNA - hypothalamus [NX]"	"Brain RNA - midbrain [NX]"	"Brain RNA - olfactory region [NX]"	"Brain RNA - pons and medulla [NX]"	"Brain RNA - thalamus [NX]"	"Single Cell Type RNA - Alveolar cells type 1 [NX]"	"Single Cell Type RNA - Alveolar cells type 2 [NX]"	"Single Cell Type RNA - B-cells [NX]"	"Single Cell Type RNA - Basal glandular cells [NX]"	"Single Cell Type RNA - Basal keratinocytes [NX]"	"Single Cell Type RNA - Bipolar cells [NX]"	"Single Cell Type RNA - Cardiomyocytes [NX]"	"Single Cell Type RNA - Cholangiocytes [NX]"	"Single Cell Type RNA - Ciliated cells [NX]"	"Single Cell Type RNA - Club cells [NX]"	"Single Cell Type RNA - Collecting duct cells [NX]"	"Single Cell Type RNA - Cone photoreceptor cells [NX]"	"Single Cell Type RNA - Cytotrophoblasts [NX]"	"Single Cell Type RNA - Distal tubular cells [NX]"	"Single Cell Type RNA - Ductal cells [NX]"	"Single Cell Type RNA - Early spermatids [NX]"	"Single Cell Type RNA - Endothelial cells [NX]"	"Single Cell Type RNA - Enterocytes [NX]"	"Single Cell Type RNA - Erythroid cells [NX]"	"Single Cell Type RNA - Exocrine glandular cells [NX]"	"Single Cell Type RNA - Extravillous trophoblasts [NX]"	"Single Cell Type RNA - Fibroblasts [NX]"	"Single Cell Type RNA - Glandular cells [NX]"	"Single Cell Type RNA - granulocytes [NX]"	"Single Cell Type RNA - Hepatocytes [NX]"	"Single Cell Type RNA - Hofbauer cells [NX]"	"Single Cell Type RNA - Horizontal cells [NX]"	"Single Cell Type RNA - Intestinal endocrine cells [NX]"	"Single Cell Type RNA - Ito cells [NX]"	"Single Cell Type RNA - Kupffer cells [NX]"	"Single Cell Type RNA - Late spermatids [NX]"	"Single Cell Type RNA - Leydig cells [NX]"	"Single Cell Type RNA - Macrophages [NX]"	"Single Cell Type RNA - Melanocytes [NX]"	"Single Cell Type RNA - monocytes [NX]"	"Single Cell Type RNA - Mucus-secreting cells [NX]"	"Single Cell Type RNA - Muller glia cells [NX]"	"Single Cell Type RNA - Pancreatic endocrine cells [NX]"	"Single Cell Type RNA - Paneth cells [NX]"	"Single Cell Type RNA - Peritubular cells [NX]"	"Single Cell Type RNA - Proximal tubular cells [NX]"	"Single Cell Type RNA - Rod photoreceptor cells [NX]"	"Single Cell Type RNA - Sertoli cells [NX]"	"Single Cell Type RNA - Smooth muscle cells [NX]"	"Single Cell Type RNA - Spermatocytes [NX]"	"Single Cell Type RNA - Spermatogonia [NX]"	"Single Cell Type RNA - Suprabasal keratinocytes [NX]"	"Single Cell Type RNA - Syncytiotrophoblasts [NX]"	"Single Cell Type RNA - T-cells [NX]"	"Single Cell Type RNA - Undifferentiated cells [NX]"	"Single Cell Type RNA - Urothelial cells [NX]"
CATSPER1	CATSPER	ENSG00000175294	"Cation channel sperm associated 1"	Q8NEC5	11	66016752-66026517	"Disease related genes, Predicted membrane proteins"	"Calcium transport, Differentiation, Ion transport, Spermatogenesis, Transport"	"Calcium channel, Developmental protein, Ion channel, Voltage-gated channel"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	42	"blood: 12.8;testis: 38.5"	"Cell type enhanced"	"Detected in some"	24	"Early spermatids: 28.9;granulocytes: 99.1;Hofbauer cells: 20.8;Kupffer cells: 18.5;Macrophages: 20.3"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"basophil: 12.8;classical monocyte: 5.9"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"CAPAN-2: 7.2;EFO-21: 6.6;HEL: 4.4;HMC-1: 8.4;U-2 OS: 3.6"					"Low region specificity"	"Detected in many"									NA	NA						"unprognostic (2.21e-2)"	"unprognostic (3.00e-2)"	"unprognostic (2.67e-2)"	"unprognostic (1.91e-1)"	"unprognostic (3.96e-3)"	"unprognostic (1.71e-1)"	"unprognostic (6.09e-3)"	"unprognostic (1.88e-1)"	"unprognostic (3.32e-1)"	"unprognostic (2.44e-3)"	"unprognostic (5.99e-3)"	"unprognostic (1.61e-2)"	"unprognostic (2.12e-8)"	"unprognostic (8.79e-3)"	"unprognostic (9.02e-3)"	"unprognostic (2.18e-2)"	"unprognostic (1.51e-1)"	0.0	0.0	0.0	0.2	0.1	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.2	0.0	38.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	12.8	5.9	3.3	0.2	2.1	1.6	0.7	0.0	0.0	0.0	0.1	0.1	0.3	1.3	0.6	0.5	0.1	7.2	0.0	6.6	1.3	2.4	0.0	0.0	1.4	0.8	0.0	0.0	4.4	0.3	0.1	0.0	0.0	8.4	0.1	0.0	0.5	0.9	1.6	0.4	0.0	0.0	0.1	1.2	0.0	0.0	0.7	0.0	0.0	0.5	0.0	2.4	0.1	2.4	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	1.0	0.3	1.9	3.6	0.2	0.3	0.0	0.0	0.0	1.3	0.5	1.0	12.8	5.9	0.1	0.2	0.8	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.5	3.3	0.0	0.0	0.0	2.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.7	0.0	0.1	0.8	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.4	28.9	0.0	0.0	0.0	0.6	5.3	0.4	0.0	99.1	0.0	20.8	0.0	0.0	1.8	18.5	2.1	0.9	20.3	1.7	0.0	0.0	0.0	2.2	0.0	0.4	0.0	0.0	0.0	0.1	0.5	0.4	0.3	0.3	4.3	0.0	0.3
HIST1H1B	"H1.5, H1b, H1F5, H1s-3"	ENSG00000184357	"Histone cluster 1 H1 family member b"	P16401	6	27866849-27867529	"Plasma proteins, Predicted intracellular proteins"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	19	"lymphoid tissue: 342.6"	"Cell type enhanced"	"Detected in some"	10	"Extravillous trophoblasts: 3.8;Hofbauer cells: 2.6;Kupffer cells: 2.2;Macrophages: 1.8;T-cells: 1.8"	"Cancer enhanced"	"Detected in many"		"colorectal cancer: 4.6"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"B-cells: 13.0;dendritic cells: 12.7;T-cells: 3.4"	"Cell line enhanced"	"Detected in many"		"MOLT-4: 14.0;NB-4: 7.7;U-698: 6.0"									"CAB012241, HPA055907, HPA060331"	Supported		Supported	Nucleoplasm		NA	NA		510000	Nucleoplasm		"CAB012241: , HPA055907: AB_2682966, HPA060331: "	"unprognostic (2.34e-1)"	"unprognostic (3.75e-4)"	"unprognostic (2.12e-2)"	"unprognostic (3.63e-2)"	"unprognostic (1.05e-1)"	"unprognostic (2.37e-2)"	"unprognostic (1.91e-2)"	"unprognostic (4.93e-2)"	"unprognostic (1.20e-1)"	"unprognostic (8.47e-2)"	"unprognostic (6.23e-3)"	"unprognostic (5.85e-2)"		"unprognostic (5.68e-4)"	"unprognostic (2.10e-1)"	"unprognostic (9.79e-2)"	"unprognostic (1.35e-1)"	1.1	0.4	0.4	22.9	0.5	18.2	2.1	0.5	0.4	1.7	7.3	0.0	0.0	0.3	0.5	1.0	10.2	0.3	1.9	0.6	0.5	0.5	0.4	0.6	3.9	10.7	0.5	0.0	0.4	0.4	0.3	0.4	6.4	0.0	0.4	0.5	0.0	0.8	0.3	0.4	1.4	7.0	0.3	1.7	14.4	1.3	1.7	0.0	342.6	0.6	10.5	26.0	2.0	0.7	13.0	12.7	0.7	1.1	1.8	3.4	2.1	2.2	0.0	0.8	0.0	0.0	0.0	1.7	0.7	0.6	1.0	0.6	0.7	1.5	2.7	0.4	0.8	0.7	0.8	0.0	0.0	0.1	0.8	1.0	3.6	0.1	0.0	0.0	0.0	0.8	0.0	0.0	1.2	0.0	0.0	0.9	1.9	2.7	1.9	0.1	0.4	14.0	7.7	2.1	2.1	0.0	4.2	0.0	0.0	0.4	0.0	1.9	1.1	2.4	0.3	0.0	0.8	1.0	2.5	0.8	1.4	0.1	1.4	1.1	2.9	0.0	6.0	2.0	0.9	1.3	0.0	0.9	0.0	3.3	0.9	1.7	4.8	3.1	3.4	5.1	13.0	1.7	1.8	0.7	1.8	1.1	12.7	3.4	2.1	0.4	0.5	0.5	0.4	0.5	0.5	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.5	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.8	0.3	0.1	0.0	0.0	2.6	0.0	0.0	0.6	2.2	0.0	0.3	1.8	0.0	0.0	0.3	0.5	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	1.2	0.0	0.6	1.8	0.9	0.1
FCER1A	FCE1A	ENSG00000179639	"Fc fragment of IgE receptor Ia"	P12319	1	159289714-159308224	"FDA approved drug targets, Predicted membrane proteins"		"IgE-binding protein, Receptor"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	18	"blood: 494.6"	"Group enriched"	"Detected in some"	4	"granulocytes: 258.2;Macrophages: 206.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in some"	7	"basophil: 494.6"	"Lineage enriched"	"Detected in many"	7	"granulocytes: 494.6"	"Cell line enriched"	"Detected in some"	94	"HEL: 100.1"					"Low region specificity"	"Detected in all"			"CAB022102, HPA036051, CAB055526"	Approved					NA	NA					"CAB022102: , CAB055526: , HPA036051: AB_2674919"	"unprognostic (1.78e-2)"	"unprognostic (2.26e-2)"	"unprognostic (7.32e-2)"	"unprognostic (7.51e-2)"	"unprognostic (1.32e-2)"	"unprognostic (1.44e-3)"	"unprognostic (7.19e-2)"	"unprognostic (1.97e-3)"	"unprognostic (2.44e-1)"	"unprognostic (7.20e-2)"	"unprognostic (8.54e-2)"	"unprognostic (2.74e-1)"	"prognostic favorable (1.20e-4)"	"unprognostic (1.68e-2)"	"unprognostic (1.18e-1)"	"unprognostic (2.70e-1)"	"unprognostic (3.39e-2)"	5.8	1.4	1.6	3.6	0.8	6.0	9.2	0.9	1.3	8.0	3.4	1.1	3.4	3.2	10.6	5.6	12.1	2.0	25.4	4.1	4.3	1.3	3.6	2.4	27.8	0.6	1.0	5.3	1.5	2.6	0.5	1.9	0.5	2.7	9.4	5.4	6.5	5.9	4.7	1.2	17.9	4.1	6.0	2.8	3.5	2.3	1.5	6.8	2.4	2.5	19.7	16.2	3.8	4.9	0.0	75.4	494.6	0.3	0.4	0.1	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	100.1	0.0	0.0	0.0	0.1	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	494.6	0.3	0.9	0.0	0.1	0.1	0.0	0.1	0.0	75.4	0.0	0.0	0.1	0.4	0.4	0.2	10.4	0.0	3.0	1.6	0.8	0.9	1.3	4.3	1.3	1.0	5.3	2.7	6.8	6.0	53.5	20.1	0.0	33.5	0.0	0.2	0.0	2.7	3.4	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.0	0.0	0.0	0.0	7.2	0.0	258.2	0.0	6.6	0.0	0.0	0.0	2.5	0.6	0.0	206.7	43.9	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.9	0.6	0.0	0.2	29.7	0.0	0.0	0.0	0.0
ADAMDEC1	M12.219	ENSG00000134028	"ADAM like decysin 1"	O15204	8	24384285-24406013	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"		"Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	17	"intestine: 126.7;lymphoid tissue: 46.3"	"Group enriched"	"Detected in some"	16	"Hofbauer cells: 15.6;Kupffer cells: 10.4;Macrophages: 9.5;monocytes: 9.0"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"eosinophil: 4.5"	"Group enriched"	"Detected in many"	7	"B-cells: 2.7;granulocytes: 4.5;monocytes: 2.1"	"Cell line enriched"	"Detected in some"	4	"U-266/70: 15.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"								"Secreted in other tissues"	NA	NA		22000000				"unprognostic (1.17e-2)"	"unprognostic (1.80e-2)"	"unprognostic (4.15e-3)"	"unprognostic (3.60e-1)"	"unprognostic (6.21e-2)"	"unprognostic (3.84e-3)"	"unprognostic (2.12e-1)"	"unprognostic (2.90e-1)"	"unprognostic (1.61e-1)"	"unprognostic (5.99e-3)"	"unprognostic (2.79e-1)"	"unprognostic (8.80e-2)"	"unprognostic (1.74e-2)"	"unprognostic (2.06e-1)"	"unprognostic (1.35e-2)"	"unprognostic (3.66e-2)"	"unprognostic (8.23e-2)"	0.6	0.6	0.3	46.3	0.3	0.0	0.4	0.3	0.3	0.4	57.4	0.1	0.1	30.4	0.3	0.4	0.6	0.4	0.4	0.4	0.3	0.3	0.5	0.4	1.4	30.0	0.3	0.1	0.4	0.4	0.0	0.4	0.9	0.1	0.4	52.2	0.2	0.8	0.1	0.3	0.5	126.7	1.7	0.4	5.2	0.8	0.4	0.1	1.9	0.5	0.5	5.4	5.0	0.4	2.7	0.4	4.5	2.1	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.1	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.0	0.0	0.6	0.0	15.6	3.6	0.0	0.0	0.0	0.0	0.0	2.0	4.5	0.0	2.1	0.0	2.7	0.0	0.0	0.4	1.6	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.6	0.3	0.3	0.3	0.3	0.3	0.3	0.3	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	15.6	0.0	0.0	0.0	10.4	0.0	0.0	9.5	0.0	9.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0
STAC3	MGC2793	ENSG00000185482	"SH3 and cysteine rich domain 3"	Q96MF2	12	57243453-57251193	"Disease related genes, Predicted intracellular proteins"			"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	16	"skeletal muscle: 222.7;tongue: 107.8"	"Cell type enhanced"	"Detected in many"	11	"Hofbauer cells: 36.5;Kupffer cells: 32.7;Macrophages: 17.2;monocytes: 16.2"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in many"		"intermediate monocyte: 8.0"	"Group enriched"	"Detected in many"	6	"dendritic cells: 4.9;monocytes: 8.0"	"Cell line enriched"	"Detected in some"	23	"RH-30: 230.4"	"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"HPA039285, HPA039527"			Enhanced	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA039285: AB_2676427, HPA039527: AB_10673424"	"unprognostic (6.16e-2)"	"prognostic favorable (2.01e-4)"	"prognostic unfavorable (7.10e-4)"	"unprognostic (1.05e-2)"	"unprognostic (1.31e-1)"	"unprognostic (5.25e-2)"	"unprognostic (1.62e-1)"	"unprognostic (1.19e-1)"	"unprognostic (2.05e-2)"	"unprognostic (1.31e-1)"	"unprognostic (9.12e-2)"	"unprognostic (1.73e-1)"	"prognostic unfavorable (7.11e-6)"	"unprognostic (4.58e-2)"	"unprognostic (3.36e-1)"	"unprognostic (2.09e-1)"	"unprognostic (1.14e-3)"	3.7	0.2	0.1	0.6	0.1	1.6	0.2	0.1	0.1	0.1	0.2	0.0	0.0	0.1	0.1	10.3	3.2	0.2	0.1	0.1	0.1	0.1	0.2	0.4	0.6	0.7	0.2	0.0	0.1	0.1	0.4	0.2	0.2	0.0	2.3	0.2	0.1	5.4	0.0	222.7	0.2	0.3	0.1	0.3	1.1	0.1	1.2	0.0	0.1	1.2	107.8	3.8	0.1	0.1	1.1	4.9	0.5	8.0	0.0	0.3	1.8	0.0	0.0	0.2	0.4	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	5.3	0.1	0.1	0.0	0.1	0.0	0.1	0.0	0.1	0.1	2.7	0.0	0.0	0.0	1.6	9.8	1.0	0.1	0.0	0.0	0.1	0.0	0.6	0.2	0.2	0.7	0.5	0.1	3.5	0.0	0.0	0.1	1.2	230.4	0.2	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	4.7	0.1	0.0	0.0	0.1	0.0	0.2	0.1	0.9	0.1	3.2	0.0	0.0	6.1	0.5	0.0	8.0	0.1	1.1	0.0	0.3	4.9	0.5	0.0	0.1	0.3	0.0	4.0	1.4	0.3	1.8	0.1	0.1	0.1	0.1	0.1	0.1	0.2	0.0	0.0	0.0	0.0	1.1	0.5	0.4	1.3	6.4	0.2	2.5	1.4	0.0	0.0	2.0	0.9	0.0	0.8	9.3	0.0	1.1	0.0	0.9	0.5	0.9	0.6	5.7	0.6	36.5	1.6	2.4	2.5	32.7	7.6	1.1	17.2	0.0	16.2	1.1	2.2	1.0	0.0	0.7	0.5	1.9	0.0	0.3	2.4	1.1	0.3	1.1	1.3	1.1	0.3
LILRA4	"CD85g, ILT7"	ENSG00000239961	"Leukocyte immunoglobulin like receptor A4"	P59901	19	54333185-54339150	"CD markers, Predicted membrane proteins"	"Immunity, Innate immunity"	Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	13	"blood: 49.7;brain: 12.5;lymphoid tissue: 16.8"	"Cell type enhanced"	"Detected in some"	23	"B-cells: 8.5;Hofbauer cells: 3.1;Kupffer cells: 3.2;Macrophages: 2.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	21	"plasmacytoid DC: 49.7"	"Lineage enriched"	"Detected in many"	21	"dendritic cells: 49.7"	"Cell line enriched"	"Detected in single"	31	"RPMI-8226: 3.0"									HPA049418	Approved					NA	NA					"HPA049418: AB_2680756"	"unprognostic (5.11e-2)"	"unprognostic (1.21e-4)"	"unprognostic (2.65e-2)"	"unprognostic (5.94e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.19e-3)"	"unprognostic (7.62e-2)"	"unprognostic (1.36e-3)"	"unprognostic (1.08e-1)"	"unprognostic (9.46e-2)"	"unprognostic (4.90e-2)"	"unprognostic (9.30e-2)"	"unprognostic (8.28e-7)"	"unprognostic (2.12e-2)"	"unprognostic (1.17e-3)"	"unprognostic (4.53e-1)"	"unprognostic (5.86e-2)"	0.7	0.4	2.1	2.3	2.5	0.6	0.7	1.1	4.3	0.4	0.9	12.5	0.0	0.7	0.4	0.4	0.6	0.4	0.8	0.4	3.5	1.4	0.4	0.7	1.4	5.3	12.2	1.2	0.4	0.4	0.4	0.3	0.4	7.6	0.5	0.5	0.0	0.7	0.5	0.4	0.6	2.0	0.6	7.4	16.8	0.5	0.5	6.7	2.3	0.4	0.0	10.1	0.7	0.2	2.4	49.7	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.2	1.2	0.0	0.0	0.0	0.1	0.0	49.7	0.0	0.1	2.1	2.5	1.1	4.3	3.5	1.4	12.2	1.2	7.6	6.7	0.0	1.1	8.5	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.1	0.0	0.0	0.0	3.2	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0
CD1B	CD1	ENSG00000158485	"CD1b molecule"	P29016	1	158327951-158331531	"CD markers, Predicted membrane proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	12	"lymphoid tissue: 188.8"	"Cell type enriched"	"Detected in some"	6	"Macrophages: 17.4"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Cell type enriched"	"Detected in some"	6	"myeloid DC: 16.3"	"Lineage enriched"	"Detected in many"	6	"dendritic cells: 16.3"	"Cell line enriched"	"Detected in some"	5	"MOLT-4: 112.0"									HPA021824	Approved		Approved	"Golgi apparatus,Vesicles,Cytosol"		NA	NA			"Golgi apparatus, Vesicles"	Cytosol	"HPA021824: AB_1846262"	"unprognostic (7.72e-3)"	"unprognostic (1.55e-4)"	"unprognostic (1.66e-5)"	"unprognostic (1.04e-2)"		"unprognostic (1.06e-3)"	"unprognostic (1.81e-1)"	"unprognostic (2.89e-4)"	"unprognostic (2.27e-2)"	"unprognostic (2.19e-1)"	"unprognostic (1.33e-1)"	"unprognostic (9.53e-2)"	"unprognostic (3.23e-1)"	"unprognostic (3.52e-1)"	"unprognostic (1.56e-1)"	"unprognostic (1.89e-1)"	"unprognostic (3.53e-2)"	0.8	0.1	0.2	1.9	0.2	0.0	0.6	0.2	0.2	0.8	0.6	0.3	0.2	0.0	0.3	0.2	0.9	0.7	1.3	0.2	0.2	0.0	0.6	0.3	1.7	4.0	0.2	0.2	0.3	0.3	0.0	0.2	0.2	0.2	0.2	5.6	0.2	0.6	0.2	0.2	6.2	0.8	0.3	0.2	1.9	0.9	0.2	0.2	188.8	0.4	0.4	2.4	0.5	0.8	0.0	16.3	0.0	2.9	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	23.6	0.0	0.0	0.0	0.0	112.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.0	2.3	0.0	0.0	0.0	0.0	16.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.2	0.2	0.2	0.2	0.2	0.0	0.2	0.2	0.2	0.2	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	2.7	0.0	0.0	17.4	1.7	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0
ERMN	"ERMIN, JN, KIAA1189"	ENSG00000136541	Ermin	Q8TAM6	2	157318625-157327713	"Predicted intracellular proteins"		Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	11	"brain: 106.7"	"Cell type enhanced"	"Detected in some"	12	"Alveolar cells type 2: 2.2;Early spermatids: 1.2;Kupffer cells: 1.2;Macrophages: 1.1;T-cells: 1.9"	"Group enriched"	"Detected in some"	12	"endometrial cancer: 2.2;glioma: 9.9"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enriched"	"Detected in some"	6	"HAP1: 21.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038295, HPA038296"	Enhanced		Approved	"Plasma membrane,Cytosol"		NA	NA			"Plasma membrane"	Cytosol	"HPA038295: AB_10805353, HPA038296: AB_10796217"	"unprognostic (7.89e-2)"	"unprognostic (9.06e-3)"	"unprognostic (2.71e-2)"	"prognostic favorable (6.93e-6)"	"unprognostic (1.06e-1)"	"unprognostic (2.02e-2)"	"unprognostic (9.14e-2)"	"unprognostic (1.79e-1)"	"unprognostic (4.57e-2)"	"unprognostic (4.40e-2)"	"unprognostic (1.07e-1)"	"unprognostic (5.49e-2)"	"unprognostic (1.46e-3)"	"unprognostic (2.84e-2)"	"unprognostic (7.96e-2)"	"unprognostic (9.97e-3)"	"unprognostic (5.76e-2)"	1.6	1.4	29.1	2.9	50.5	9.7	1.6	2.7	106.7	1.4	1.8	52.4	0.0	1.8	1.6	1.5	1.7	1.4	1.9	1.6	40.9	21.4	1.5	1.5	2.0	3.1	75.1	18.4	1.5	1.6	1.4	0.1	1.4	54.5	1.5	1.9	4.3	2.4	1.5	1.7	1.9	1.9	1.6	100.9	2.5	2.2	1.7	69.5	0.0	1.6	0.0	2.7	1.7	0.1	1.7	1.3	3.9	1.6	2.4	2.1	0.7	0.1	0.3	0.3	0.2	0.0	0.0	0.1	0.5	0.0	0.0	0.0	0.1	0.2	1.2	0.0	2.0	0.0	0.3	21.3	0.0	0.0	0.0	0.0	0.2	0.2	0.4	0.0	0.7	0.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	2.8	0.4	0.2	0.8	2.3	0.3	0.1	0.5	0.0	0.4	0.5	0.0	1.0	0.4	0.6	0.0	0.1	0.0	0.3	0.7	1.3	0.0	0.2	0.1	0.2	0.6	3.5	2.0	0.6	1.8	1.0	1.0	2.6	1.6	1.1	2.1	1.2	1.0	0.7	0.8	0.6	0.6	1.7	1.5	1.6	3.9	2.4	1.0	1.3	0.9	0.7	29.1	50.5	2.7	27.9	40.9	21.4	75.1	18.4	54.5	69.5	0.0	2.2	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.6	1.2	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.5	1.9	0.0	0.0
CD1E		ENSG00000158488	"CD1e molecule"	P15812	1	158353696-158357553	"CD markers, Predicted intracellular proteins, Predicted membrane proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	10	"lymphoid tissue: 308.0"	"Cell type enriched"	"Detected in some"	9	"Macrophages: 75.9"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enriched"	"Detected in some"	13	"myeloid DC: 29.7"	"Lineage enriched"	"Detected in many"	13	"dendritic cells: 29.7"	"Cell line enriched"	"Detected in some"	42	"MOLT-4: 171.9"					"Not detected"	"Not detected"			HPA057769	Uncertain				"Intracellular and membrane"	NA	NA					"HPA057769: AB_2683522"	"unprognostic (7.94e-3)"	"unprognostic (1.85e-5)"	"unprognostic (1.47e-2)"	"unprognostic (1.64e-2)"	"unprognostic (1.76e-2)"	"unprognostic (1.29e-2)"	"unprognostic (2.33e-1)"	"unprognostic (1.54e-3)"	"unprognostic (1.24e-1)"	"unprognostic (1.74e-1)"	"unprognostic (1.60e-1)"	"unprognostic (8.55e-2)"	"unprognostic (1.69e-2)"	"unprognostic (1.50e-1)"	"unprognostic (2.49e-1)"	"unprognostic (8.50e-2)"	"unprognostic (2.45e-1)"	1.0	0.2	0.7	2.8	0.7	0.0	1.1	0.7	0.7	1.5	1.0	0.7	0.7	1.2	0.9	0.7	7.0	1.9	3.9	0.7	0.7	0.2	2.0	0.7	2.4	4.7	0.7	0.7	0.7	0.8	0.0	0.7	0.7	0.7	1.8	4.8	0.8	1.9	0.8	0.8	11.5	2.1	0.8	0.7	3.8	3.1	0.9	0.7	308.0	1.0	1.3	8.1	2.4	2.7	0.0	29.7	0.0	2.2	0.0	0.1	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.0	0.0	0.0	0.0	0.0	171.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	1.1	0.1	0.0	0.0	0.0	29.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.7	0.7	0.7	0.7	0.7	0.2	0.7	0.7	0.7	0.7	3.0	0.3	0.0	0.0	7.4	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.1	0.0	1.6	0.0	0.0	0.0	6.4	0.0	0.0	75.9	8.5	8.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.2	6.1	0.1	0.0	0.0	0.0
PLD4	C14orf175	ENSG00000166428	"Phospholipase D family member 4"	Q96BZ4	14	104924816-104937790	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Immunity, Inflammatory response, Innate immunity"	"Exonuclease, Hydrolase, Nuclease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	10	"blood: 229.9"	"Group enriched"	"Detected in some"	4	"B-cells: 25.7;Hofbauer cells: 28.1;Macrophages: 25.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	5	"plasmacytoid DC: 229.9"	"Lineage enriched"	"Detected in many"	5	"dendritic cells: 229.9"	"Group enriched"	"Detected in some"	5	"HMC-1: 34.9;RPMI-8226: 25.0;THP-1: 63.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051512	Uncertain					NA	NA		2000000			"HPA051512: AB_2681515"	"unprognostic (4.50e-3)"	"unprognostic (1.78e-4)"	"unprognostic (7.12e-2)"	"unprognostic (5.30e-3)"	"unprognostic (5.54e-2)"	"unprognostic (2.91e-3)"	"unprognostic (2.56e-1)"	"unprognostic (4.76e-3)"	"unprognostic (1.45e-3)"	"unprognostic (1.19e-3)"	"unprognostic (3.45e-3)"	"unprognostic (3.89e-1)"	"unprognostic (6.90e-3)"	"unprognostic (8.94e-2)"	"unprognostic (2.83e-1)"	"unprognostic (1.28e-2)"	"unprognostic (2.41e-1)"	0.7	1.6	8.9	6.7	8.8	15.0	1.9	5.7	10.0	1.5	1.3	23.1	0.1	5.6	1.5	0.5	1.1	2.8	3.5	0.8	8.7	8.4	1.2	0.9	2.6	14.4	14.5	3.4	0.9	1.6	1.0	2.8	1.2	9.0	2.1	0.8	1.5	4.6	2.3	0.5	0.9	5.5	0.9	19.0	11.6	3.5	0.8	9.2	2.7	1.0	0.0	11.2	3.9	0.9	14.7	229.9	43.4	17.7	1.7	0.1	4.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	34.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	3.0	0.0	0.0	0.0	8.8	0.0	25.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	63.3	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.2	2.8	43.4	0.0	11.9	0.1	14.7	0.0	0.0	35.1	12.3	0.1	0.0	0.6	1.7	17.7	229.9	0.0	4.4	8.9	8.8	5.7	9.6	8.7	8.4	14.5	3.4	9.0	9.2	0.0	0.0	25.7	0.1	0.3	0.3	1.4	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.4	0.3	0.0	0.0	0.0	0.3	0.4	0.1	3.5	0.0	28.1	1.6	0.0	0.0	1.3	2.5	0.0	25.2	5.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	6.5	0.4	0.7	0.1	0.4	0.2	0.0	0.0	0.0
CLECL1	DCAL1	ENSG00000184293	"C-type lectin like 1"	Q8IZS7	12	9715860-9733299	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in many"	9	"blood: 42.4;intestine: 11.5;lymphoid tissue: 20.6"	"Group enriched"	"Detected in some"	4	"B-cells: 69.2;Hofbauer cells: 21.8;Kupffer cells: 84.7;Macrophages: 31.4;monocytes: 69.5"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in some"			"Cell type enhanced"	"Detected in many"		"memory B-cell: 42.4"	"Lineage enriched"	"Detected in many"	5	"B-cells: 42.4"	"Group enriched"	"Detected in some"	5	"HEL: 16.0;Karpas-707: 22.2;U-698: 56.8;U-937: 31.2"									HPA063928			Supported	"Plasma membrane,Centriolar satellite"		NA	NA			"Plasma membrane, Centriolar satellite"		"HPA063928: "	"unprognostic (2.18e-2)"	"unprognostic (2.35e-3)"	"unprognostic (2.20e-3)"	"unprognostic (1.90e-3)"	"unprognostic (3.66e-1)"	"unprognostic (1.90e-3)"	"unprognostic (2.83e-1)"	"unprognostic (7.55e-4)"	"unprognostic (5.10e-2)"	"unprognostic (2.82e-1)"	"unprognostic (1.09e-1)"	"unprognostic (2.20e-1)"	"unprognostic (3.91e-5)"	"unprognostic (3.31e-1)"	"unprognostic (2.45e-1)"	"unprognostic (6.10e-2)"	"unprognostic (7.39e-2)"	2.7	1.0	0.8	9.8	1.1	0.9	1.1	0.3	0.9	0.6	1.7	1.3	0.1	1.6	0.7	1.3	2.6	0.9	1.5	2.7	1.0	0.9	1.6	1.4	1.9	15.5	1.3	0.7	0.5	1.7	0.0	0.9	0.5	0.9	0.8	2.8	0.8	1.5	0.1	0.5	0.5	11.5	0.9	2.5	20.5	2.6	0.6	0.3	2.2	0.9	0.5	20.6	2.8	2.4	42.4	8.6	0.7	4.6	0.0	3.5	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.0	0.0	0.0	0.0	5.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	22.2	0.0	0.0	0.0	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.3	56.8	0.0	31.2	0.0	0.7	2.6	0.1	1.7	4.6	0.0	42.4	1.4	3.5	6.1	14.5	0.0	0.5	0.1	0.0	4.6	8.6	0.1	2.1	0.8	1.1	0.3	0.9	1.0	0.9	1.3	0.7	0.9	0.3	0.0	0.0	69.2	0.1	1.8	0.0	0.0	0.0	0.0	3.4	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.2	0.1	0.4	0.0	4.7	0.2	21.8	0.0	0.0	0.6	84.7	1.1	0.3	31.4	11.8	69.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	6.5	0.2	0.0	0.0	1.6	0.2	12.5	0.0	0.1
SIGLEC10	"MGC126774, PRO940, SIGLEC-10, SLG2"	ENSG00000142512	"Sialic acid binding Ig like lectin 10"	Q96LC7	19	51410021-51417803	"Predicted intracellular proteins, Predicted membrane proteins"	"Adaptive immunity, Cell adhesion, Immunity, Innate immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	9	"blood: 99.9;lymphoid tissue: 74.6"	"Group enriched"	"Detected in some"	5	"B-cells: 17.9;granulocytes: 39.2;Kupffer cells: 67.4;Macrophages: 34.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	6	"eosinophil: 99.9;intermediate monocyte: 33.9;non-classical monocyte: 66.7"	"Group enriched"	"Detected in many"	14	"granulocytes: 99.9;monocytes: 66.7"	"Cell line enhanced"	"Detected in some"		"Daudi: 21.3;HDLM-2: 6.5;HEL: 10.9;HMC-1: 8.7;NB-4: 6.7;U-698: 15.7;U-937: 9.0"									"CAB025807, HPA027093"	Enhanced		Supported	"Plasma membrane,Actin filaments,Cytosol"	"Intracellular and membrane"	NA	NA			Cytosol	"Plasma membrane, Actin filaments"	"CAB025807: , HPA027093: AB_1856858"	"unprognostic (7.18e-2)"	"unprognostic (3.90e-3)"	"unprognostic (1.11e-2)"	"unprognostic (3.67e-2)"	"unprognostic (3.95e-2)"	"unprognostic (9.41e-2)"	"unprognostic (8.18e-2)"	"unprognostic (2.11e-1)"	"unprognostic (3.16e-2)"	"unprognostic (1.83e-1)"	"unprognostic (1.63e-1)"	"unprognostic (3.12e-1)"	"prognostic unfavorable (4.74e-5)"	"unprognostic (2.73e-1)"	"unprognostic (1.69e-2)"	"unprognostic (1.39e-1)"	"unprognostic (9.05e-2)"	2.6	6.2	4.5	24.6	9.8	9.1	1.4	0.7	4.9	2.7	3.7	5.7	0.0	5.3	1.3	0.7	2.2	2.7	2.7	1.6	3.3	3.0	2.6	7.2	7.7	74.6	6.6	1.8	1.2	2.4	0.2	2.5	1.1	7.7	2.6	3.3	0.7	2.3	0.7	0.6	0.9	9.6	3.2	7.4	37.0	3.1	0.9	4.8	2.0	1.2	0.2	13.2	4.8	1.3	5.8	5.1	99.9	66.7	0.0	0.1	4.4	0.1	0.0	0.4	0.4	0.0	0.0	0.2	0.1	0.0	0.1	0.0	0.0	1.0	21.3	0.6	0.0	0.3	0.4	0.0	0.1	0.0	6.5	1.6	10.9	0.2	0.1	0.0	4.9	8.7	0.0	0.0	0.1	0.0	0.1	0.0	1.3	0.5	1.1	0.0	0.4	0.1	6.7	0.6	0.5	0.3	1.4	0.1	0.4	0.0	0.2	0.3	0.3	0.3	0.1	0.2	0.4	0.1	4.0	0.5	0.6	1.0	0.4	0.2	1.0	0.2	15.7	0.4	9.0	0.3	1.5	5.6	99.9	0.1	33.9	0.0	5.8	0.0	0.0	5.1	3.6	0.0	0.0	11.5	0.0	66.7	0.2	0.1	4.4	4.5	9.8	0.7	4.9	3.3	3.0	6.6	1.8	7.7	4.8	3.0	2.2	17.9	0.9	0.1	1.4	0.3	0.0	0.0	0.0	1.8	2.0	0.0	0.0	0.0	0.6	0.6	0.0	0.0	0.0	0.1	0.3	1.0	39.2	0.5	7.8	0.0	0.0	0.6	67.4	0.0	0.0	34.5	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.8	0.0	0.2	0.2	0.3	1.1	0.1	2.2	0.0	0.8
BEST1	"BEST, BMD, RP50, VMD2"	ENSG00000167995	"Bestrophin 1"	O76090	11	61949821-61965515	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Sensory transduction, Transport, Vision"	"Chloride channel, Ion channel"	"Disease mutation, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	8	"retina: 218.0"	"Cell type enhanced"	"Detected in many"	5	"granulocytes: 70.9;Macrophages: 85.3"	"Group enriched"	"Detected in some"	6	"glioma: 2.0;melanoma: 6.6"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	8	"neutrophil: 23.3"	"Lineage enriched"	"Detected in many"	8	"granulocytes: 23.3"	"Cell line enhanced"	"Detected in some"		"ASC diff: 9.4;SK-MEL-30: 33.5;U-266/70: 9.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA057464	Enhanced					NA	NA					"HPA057464: AB_2683444"	"unprognostic (2.41e-3)"	"unprognostic (3.67e-2)"	"unprognostic (5.91e-3)"	"unprognostic (1.21e-1)"	"unprognostic (1.25e-1)"	"unprognostic (2.73e-1)"	"unprognostic (1.53e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.23e-1)"	"unprognostic (3.26e-1)"	"unprognostic (1.07e-3)"	"unprognostic (2.06e-1)"	"unprognostic (4.27e-10)"	"unprognostic (1.38e-1)"	"unprognostic (4.93e-2)"	"unprognostic (3.59e-3)"	"unprognostic (2.72e-3)"	5.2	2.9	7.4	9.5	11.8	26.4	2.3	1.6	12.6	2.0	1.4	16.0	0.7	2.1	2.6	9.6	3.0	2.6	6.2	2.5	9.2	5.3	1.4	1.1	4.7	2.5	14.8	6.0	3.7	2.2	0.5	1.4	2.8	9.4	1.6	1.3	218.0	1.2	1.9	0.7	3.0	2.0	2.1	16.9	5.4	1.3	3.9	13.3	0.3	2.3	0.4	0.6	3.9	2.3	0.3	1.6	23.3	2.8	0.1	0.1	0.9	0.5	0.5	0.2	0.4	9.4	2.0	0.9	0.7	1.2	0.2	0.8	0.3	0.3	0.1	1.3	0.6	1.3	0.7	0.0	0.0	0.1	0.1	0.1	0.0	3.6	0.6	2.9	0.1	0.3	2.7	1.1	1.2	2.6	1.2	0.0	0.5	0.5	5.3	1.2	0.3	0.1	0.4	0.0	0.5	1.3	0.0	0.1	0.2	0.0	1.3	0.7	0.5	1.0	0.1	33.5	0.5	0.5	1.3	0.1	0.6	0.4	0.5	0.2	9.0	0.5	0.5	3.4	0.4	1.0	1.5	2.3	2.1	0.1	2.7	0.1	0.3	0.1	0.1	1.6	0.1	0.1	0.0	23.3	0.1	2.8	0.3	0.1	0.9	7.4	11.8	1.6	5.9	9.2	5.3	14.8	6.0	9.4	13.3	23.8	66.0	6.0	5.8	32.3	1.8	3.2	12.7	37.5	62.6	1.8	0.0	12.7	0.0	2.4	6.6	8.3	19.1	0.0	2.9	18.2	15.0	9.1	70.9	4.7	33.7	0.0	9.9	22.7	60.1	1.8	14.1	85.3	52.3	4.6	10.3	6.0	3.0	14.4	6.3	4.8	9.0	6.5	8.3	1.6	2.8	28.5	17.0	10.2	10.9	5.4
CD1C	CD1	ENSG00000158481	"CD1c molecule"	P29017	1	158289786-158293630	"CD markers, Predicted intracellular proteins, Predicted membrane proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	8	"blood: 70.8;lymphoid tissue: 111.4"	"Cell type enhanced"	"Detected in some"	21	"B-cells: 37.2;Macrophages: 73.3;Melanocytes: 18.6"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"memory B-cell: 18.6;myeloid DC: 70.8"	"Group enriched"	"Detected in many"	8	"B-cells: 18.6;dendritic cells: 70.8"	"Group enriched"	"Detected in some"	9	"JURKAT: 11.0;MOLT-4: 34.8"															NA	NA		240000				"unprognostic (2.55e-3)"	"prognostic favorable (1.79e-5)"	"unprognostic (1.75e-5)"	"unprognostic (3.09e-5)"	"unprognostic (3.12e-2)"	"unprognostic (8.13e-3)"	"unprognostic (2.01e-1)"	"unprognostic (3.80e-3)"	"unprognostic (7.11e-3)"	"unprognostic (1.87e-1)"	"unprognostic (7.41e-2)"	"unprognostic (1.93e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.46e-1)"	"unprognostic (1.67e-1)"	"unprognostic (8.05e-2)"	"unprognostic (1.99e-1)"	1.8	0.4	0.5	8.2	0.6	0.0	2.2	0.5	0.5	1.1	1.2	0.5	1.3	0.4	1.4	1.2	1.8	1.6	5.1	0.6	0.5	0.3	1.6	1.5	2.8	13.2	0.6	0.5	0.7	0.7	0.0	0.6	0.7	0.6	1.0	4.8	0.9	3.0	1.0	0.6	5.5	11.7	1.3	0.5	24.6	1.2	0.8	0.5	111.4	1.0	2.4	20.5	1.4	1.3	18.6	70.8	0.2	5.9	0.9	0.1	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.0	0.0	0.0	0.0	0.0	34.8	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.6	0.0	0.1	5.9	0.0	0.0	5.1	0.0	18.6	0.0	0.0	70.8	9.3	0.0	0.0	0.2	0.9	0.6	0.3	0.1	3.3	0.5	0.6	0.5	0.5	0.5	0.3	0.6	0.5	0.6	0.5	0.0	6.9	37.2	0.0	11.6	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.2	0.0	0.0	0.0	0.1	2.3	0.0	3.5	0.0	4.0	0.0	0.0	0.0	5.9	3.3	0.0	73.3	18.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	6.5	0.0	0.0	0.0	0.0
CLEC12A	"CD371, CLL-1, DCAL-2, MICL"	ENSG00000172322	"C-type lectin domain family 12 member A"	Q5QGZ9	12	9951316-9995694	"Predicted intracellular proteins, Predicted membrane proteins"		Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	8	"blood: 46.5;bone marrow: 35.4;lung: 36.2;lymphoid tissue: 22.4"	"Cell type enhanced"	"Detected in some"	18	"granulocytes: 27.9;Kupffer cells: 91.2;Macrophages: 86.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Cell type enhanced"	"Detected in many"		"eosinophil: 46.5"	"Group enriched"	"Detected in many"	38	"dendritic cells: 17.1;granulocytes: 46.5;monocytes: 32.8"	"Group enriched"	"Detected in some"	6	"HL-60: 12.1;U-937: 37.8"									HPA048515	Enhanced					NA	NA					"HPA048515: AB_2680425"	"unprognostic (4.74e-2)"	"unprognostic (6.06e-3)"	"unprognostic (7.76e-2)"	"unprognostic (6.88e-2)"	"unprognostic (2.00e-2)"	"unprognostic (6.66e-2)"	"unprognostic (1.61e-2)"	"unprognostic (1.21e-2)"	"unprognostic (3.29e-1)"	"unprognostic (1.44e-2)"	"unprognostic (1.70e-1)"	"unprognostic (2.74e-2)"	"unprognostic (1.10e-3)"	"unprognostic (9.67e-3)"	"unprognostic (7.43e-2)"	"unprognostic (3.78e-2)"	"prognostic favorable (9.33e-4)"	4.2	1.2	0.3	6.4	1.2	35.4	1.2	0.6	1.1	0.9	1.5	0.3	0.1	0.2	1.9	3.7	0.9	1.3	2.8	3.5	0.3	0.3	1.9	3.4	36.2	9.6	0.5	0.8	1.0	1.4	0.0	0.6	3.4	1.2	1.3	1.3	1.4	1.5	0.1	0.7	1.1	1.9	3.5	1.5	22.4	1.3	0.9	0.3	2.8	0.7	0.1	1.2	2.1	1.0	0.0	17.1	46.5	32.8	0.8	0.1	12.5	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	12.1	1.3	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	4.3	0.0	0.0	0.0	0.0	0.0	0.0	3.6	0.0	0.0	37.8	0.0	4.1	32.8	46.5	0.0	26.4	0.1	0.0	0.0	0.0	17.1	0.0	0.0	0.1	10.2	0.8	28.4	1.5	0.0	12.5	0.3	1.2	0.6	1.1	0.3	0.3	0.5	0.8	1.2	0.3	3.0	5.3	4.2	0.0	0.3	0.0	0.4	0.0	2.7	5.7	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.4	0.0	27.9	0.8	20.0	0.0	0.0	1.3	91.2	0.0	0.0	86.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.6	0.5	1.1	3.2	0.0	0.0
CLEC9A	"CD370, DNGR-1, HEEE9341, UNQ9341"	ENSG00000197992	"C-type lectin domain containing 9A"	Q6UXN8	12	10030677-10066027	"Predicted membrane proteins"	Endocytosis	Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	8	"blood: 17.3;brain: 7.8;lymphoid tissue: 8.9;testis: 21.1"	"Cell type enhanced"	"Detected in some"	22	"Early spermatids: 2.2;Macrophages: 9.3;Spermatocytes: 7.0"	"Cancer enriched"	"Detected in some"	5	"testis cancer: 2.7"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	103	"myeloid DC: 17.3;neutrophil: 6.1"	"Group enriched"	"Detected in many"	103	"dendritic cells: 17.3;granulocytes: 6.1"	"Group enriched"	"Detected in some"	5	"GAMG: 2.1;Karpas-707: 1.2;U-266/84: 3.7"	"Not detected"	"Not detected"													NA	NA						"unprognostic (1.13e-3)"	"unprognostic (1.21e-2)"	"unprognostic (5.00e-3)"	"unprognostic (7.85e-3)"	"unprognostic (1.28e-2)"	"unprognostic (1.56e-5)"	"unprognostic (6.58e-4)"	"unprognostic (4.73e-3)"	"unprognostic (9.65e-2)"	"unprognostic (7.45e-3)"	"unprognostic (8.15e-3)"	"unprognostic (1.24e-1)"	"unprognostic (1.39e-1)"	"unprognostic (2.21e-1)"	"unprognostic (7.93e-2)"	"unprognostic (3.45e-5)"	"unprognostic (2.17e-1)"	0.6	0.0	3.3	1.7	2.5	0.3	0.6	0.6	1.1	0.6	0.6	0.6	0.6	0.9	0.6	0.6	0.6	0.0	1.0	0.6	3.2	3.1	0.6	0.8	0.6	8.9	5.0	0.6	0.8	0.6	0.0	0.6	1.0	0.6	0.6	0.6	0.6	1.2	0.6	0.6	0.0	1.8	0.8	7.8	6.4	0.2	21.1	0.6	0.6	0.6	0.6	2.8	0.8	0.6	0.0	17.3	6.1	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	3.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.3	0.0	0.0	0.0	6.1	0.1	0.0	0.0	0.0	0.3	3.3	2.5	0.6	1.0	3.2	3.1	5.0	0.6	0.6	0.6	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.6	1.4	0.0	9.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.0	0.9	0.0	0.0	0.0	0.0	0.0
MCEMP1	"C19orf59, MGC132456"	ENSG00000183019	"Mast cell expressed membrane protein 1"	Q8IX19	19	7676628-7679826	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	8	"blood: 36.5;bone marrow: 30.9;lung: 66.4;lymphoid tissue: 24.2"	"Cell type enhanced"	"Detected in some"	12	"Alveolar cells type 1: 17.9;Alveolar cells type 2: 34.6;Club cells: 20.5;Hofbauer cells: 30.0;Kupffer cells: 41.3;Macrophages: 51.1"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in single"		"midbrain: 2.9"	"Group enriched"	"Detected in some"	5	"classical monocyte: 36.5;neutrophil: 16.6"	"Group enriched"	"Detected in many"	5	"granulocytes: 16.6;monocytes: 36.5"	"Group enriched"	"Detected in some"	6	"THP-1: 19.2;U-937: 59.8"									HPA014731	Enhanced		Supported	"Plasma membrane"		NA	NA			"Plasma membrane"		"HPA014731: AB_1845619"	"unprognostic (4.84e-2)"	"unprognostic (9.81e-4)"	"unprognostic (2.41e-1)"	"unprognostic (4.36e-2)"	"unprognostic (8.85e-3)"	"unprognostic (2.62e-3)"	"unprognostic (5.57e-3)"	"unprognostic (1.42e-1)"	"unprognostic (2.19e-1)"	"unprognostic (4.36e-2)"	"unprognostic (1.77e-2)"	"unprognostic (3.50e-1)"	"unprognostic (2.69e-5)"	"unprognostic (1.15e-2)"	"unprognostic (7.37e-2)"	"unprognostic (1.93e-2)"	"unprognostic (7.95e-2)"	2.2	0.3	0.3	10.0	0.5	30.9	0.5	0.4	0.9	0.1	0.3	0.0	0.0	0.1	0.1	0.2	0.3	1.2	0.2	4.8	0.2	0.2	0.6	1.3	66.4	11.8	2.9	0.0	0.4	0.4	0.0	0.1	0.8	0.6	0.4	0.0	0.1	0.6	0.0	0.2	0.1	0.3	2.4	0.9	24.2	0.6	0.7	0.3	0.3	0.7	0.0	0.1	0.5	2.9	0.0	5.3	16.6	36.5	0.2	0.1	11.6	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.5	6.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	59.8	0.0	0.0	36.5	0.9	0.1	2.1	0.0	0.0	0.1	0.0	5.3	0.0	0.0	0.1	16.6	0.2	0.1	0.3	0.1	11.6	0.3	0.5	0.4	0.9	0.2	0.2	2.9	0.0	0.6	0.3	17.9	34.6	1.4	0.0	0.0	0.0	0.3	0.0	9.4	20.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	7.0	0.0	30.0	0.0	0.0	0.0	41.3	0.0	0.0	51.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0
CD52	"CDW52, EDDM5, HE5"	ENSG00000169442	"CD52 molecule"	P31358	1	26317957-26320523	"Cancer-related genes, CD markers, FDA approved drug targets, Predicted membrane proteins"			"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in many"	7	"blood: 495.7;epididymis: 978.9"	"Cell type enhanced"	"Detected in many"	13	"B-cells: 1214.9;granulocytes: 550.2;Hofbauer cells: 593.7;Macrophages: 676.6;T-cells: 760.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Group enriched"	"Detected in some"	9	"Daudi: 76.1;REH: 111.3;U-266/84: 111.2;U-698: 123.2"															NA	NA						"prognostic favorable (1.85e-5)"	"unprognostic (3.28e-3)"	"unprognostic (1.93e-2)"	"prognostic favorable (2.06e-4)"	"unprognostic (4.18e-2)"	"prognostic favorable (4.45e-4)"	"unprognostic (9.11e-2)"	"unprognostic (2.98e-2)"	"unprognostic (7.73e-3)"	"unprognostic (6.27e-2)"	"unprognostic (4.58e-1)"	"unprognostic (1.70e-1)"	"prognostic unfavorable (5.85e-4)"	"unprognostic (3.64e-1)"	"unprognostic (6.14e-2)"	"unprognostic (7.95e-2)"	"unprognostic (1.26e-1)"	9.5	0.9	0.8	23.0	1.4	5.7	4.7	0.3	0.8	0.9	3.7	0.3	93.2	1.0	1.1	978.9	2.9	1.5	2.2	1.5	0.6	0.2	3.5	3.2	43.4	54.6	0.8	0.6	0.8	1.0	0.0	0.7	0.7	0.7	1.7	2.5	1.3	5.7	2.9	0.4	1.9	39.6	1.1	1.2	98.7	2.7	5.3	0.4	24.7	3.2	2.1	30.4	4.3	1.7	292.0	87.6	258.4	194.6	94.3	308.1	495.7	0.2	0.0	0.0	0.0	0.0	0.1	1.6	0.0	0.1	0.0	0.0	0.0	0.0	76.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.7	0.0	0.1	0.0	0.7	11.9	0.0	0.0	0.0	0.0	0.0	0.0	4.9	2.5	0.1	0.0	0.5	0.8	6.8	0.3	0.0	0.0	111.3	0.1	1.7	0.0	0.0	0.2	1.0	0.0	0.1	0.1	1.0	0.0	1.3	0.1	0.0	0.2	0.0	0.1	0.3	111.2	123.2	0.0	1.9	0.0	12.4	126.8	258.4	194.7	194.6	155.1	292.0	244.1	190.3	87.6	273.7	166.6	171.2	9.6	94.3	167.6	28.6	308.1	495.7	0.8	1.4	0.3	0.8	0.6	0.2	0.8	0.6	0.7	0.4	62.5	287.6	1214.9	0.7	40.3	0.0	6.0	2.5	32.1	92.1	47.1	0.0	2.7	0.0	0.2	0.7	22.7	0.7	0.0	0.2	4.3	18.8	0.4	550.2	1.5	593.7	0.0	0.0	17.8	203.9	1.3	0.0	676.6	101.3	2.8	1.9	0.0	0.1	2.9	0.0	7.6	0.0	0.0	3.3	0.2	0.2	27.5	4.7	760.6	0.2	0.8
IPCEF1	"KIAA0403, PIP3-E"	ENSG00000074706	"Interaction protein for cytohesin exchange factors 1"	Q8WWN9	6	154154496-154356792	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in many"	7	"blood: 30.1;bone marrow: 15.2;brain: 26.4;lymphoid tissue: 12.4;thyroid gland: 36.9"	"Cell type enhanced"	"Detected in many"	17	"Kupffer cells: 14.6;Macrophages: 9.5;T-cells: 30.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in some"	5	"HMC-1: 19.7;THP-1: 10.0;U-937: 10.5"									"HPA028708, HPA028710"	Enhanced		Approved	"Nucleoli,Nuclear speckles,Plasma membrane,Cytoplasmic bodies"		NA	NA			"Nuclear speckles, Plasma membrane"	"Nucleoli, Cytoplasmic bodies"	"HPA028708: AB_10601916, HPA028710: AB_2732442"	"unprognostic (1.23e-2)"	"unprognostic (8.93e-3)"	"unprognostic (4.18e-2)"	"unprognostic (5.63e-3)"	"unprognostic (2.05e-1)"	"unprognostic (6.55e-3)"	"unprognostic (1.30e-3)"	"unprognostic (2.57e-2)"	"unprognostic (3.87e-1)"	"unprognostic (5.84e-2)"	"unprognostic (3.27e-2)"	"unprognostic (4.87e-2)"	"unprognostic (5.01e-2)"	"unprognostic (8.64e-2)"	"unprognostic (5.45e-2)"	"unprognostic (1.42e-2)"	"unprognostic (1.51e-4)"	1.3	0.7	5.3	6.9	12.9	15.2	1.9	20.0	26.4	3.4	1.6	5.5	0.0	1.1	1.7	1.8	1.9	2.5	3.2	1.0	3.8	4.6	3.4	2.4	2.0	12.4	3.9	14.1	1.3	1.4	0.4	1.3	2.0	5.5	1.3	1.6	0.0	1.4	0.8	0.7	1.2	2.9	1.3	4.2	6.4	2.6	1.5	4.9	10.0	36.9	0.0	11.7	2.4	1.1	0.0	7.1	30.1	6.3	6.0	13.5	5.3	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.4	0.0	0.0	0.0	1.8	0.0	0.0	0.1	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.1	1.4	0.0	0.0	0.0	0.1	19.7	0.1	0.0	0.0	0.0	0.3	0.0	0.6	0.0	0.0	0.0	0.0	2.8	1.1	1.0	0.0	0.5	0.2	0.2	0.5	1.0	2.1	0.3	0.4	0.0	0.1	0.0	0.0	0.0	10.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	10.5	0.0	1.4	6.3	30.1	6.1	2.8	13.1	0.0	7.7	5.8	7.1	0.0	13.5	7.9	19.3	6.0	3.4	0.2	9.9	5.3	5.3	12.9	20.0	26.4	3.8	4.6	3.9	14.1	5.5	4.9	0.0	1.7	0.5	0.4	0.6	0.0	0.9	0.0	1.4	2.3	1.8	0.0	1.4	6.6	0.9	0.7	1.4	0.0	0.0	0.0	0.1	0.8	0.4	0.0	0.8	2.2	3.2	0.0	2.5	14.6	0.0	0.3	9.5	0.0	0.0	0.3	0.3	0.0	0.0	0.4	1.2	0.1	0.0	0.4	0.2	0.1	0.5	2.3	30.5	0.2	1.2
LILRB1	"CD85, CD85j, ILT2, LIR-1, LIR1, MIR-7, PIR-B, PIRB"	ENSG00000104972	"Leukocyte immunoglobulin like receptor B1"		19	54617158-54637528	"Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"				"Group enriched"	"Detected in many"	7	"blood: 26.7;lymphoid tissue: 52.5"	"Group enriched"	"Detected in some"	7	"B-cells: 16.2;Hofbauer cells: 16.3;Kupffer cells: 58.9;Macrophages: 35.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	7	"intermediate monocyte: 19.1;non-classical monocyte: 26.7"	"Lineage enriched"	"Detected in many"	10	"monocytes: 26.7"	"Group enriched"	"Detected in some"	19	"Daudi: 10.6;THP-1: 5.5"														"Intracellular and membrane"	NA	NA						"unprognostic (9.23e-2)"	"unprognostic (4.20e-2)"	"unprognostic (4.95e-2)"	"unprognostic (3.29e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.43e-2)"	"unprognostic (1.24e-1)"	"unprognostic (3.89e-2)"	"unprognostic (3.58e-1)"	"unprognostic (9.64e-2)"	"unprognostic (1.24e-1)"	"unprognostic (5.92e-2)"	"prognostic unfavorable (3.08e-6)"	"unprognostic (6.57e-2)"	"unprognostic (1.62e-2)"	"unprognostic (7.06e-2)"	"unprognostic (8.03e-2)"	2.6	1.5	2.5	11.9	4.5	2.5	0.9	0.4	2.5	1.1	1.8	3.1	0.5	0.6	0.5	1.8	0.8	1.4	0.7	2.5	2.2	1.6	1.5	3.2	5.6	18.7	4.7	0.9	1.7	0.7	0.3	1.1	2.7	3.7	1.4	1.1	0.8	1.2	0.8	0.3	0.3	4.8	5.4	5.8	52.5	1.0	0.5	4.6	0.8	0.8	0.1	3.0	4.9	0.6	1.2	2.5	0.1	26.7	0.0	0.6	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.5	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.4	0.0	0.0	3.1	0.0	0.6	19.1	0.0	1.2	0.0	0.5	2.5	1.1	0.0	0.4	0.1	0.0	26.7	1.0	0.0	1.7	2.5	4.5	0.4	2.5	2.2	1.6	4.7	0.9	3.7	4.6	0.0	2.1	16.2	0.3	0.2	0.0	0.6	2.5	0.0	4.5	0.0	0.0	0.0	0.0	0.0	0.2	0.6	0.0	0.0	0.0	0.1	0.0	0.2	2.3	0.4	16.3	0.0	0.0	3.7	58.9	0.0	0.0	35.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	4.4	0.0	1.4
PLB1	"FLJ30866, PLB"	ENSG00000163803	"Phospholipase B1"	Q6P1J6	2	28457145-28643788	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Lipid metabolism, Phospholipid metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	7	"intestine: 66.7"	"Group enriched"	"Detected in many"	7	"Early spermatids: 22.5;Extravillous trophoblasts: 20.1;granulocytes: 5.7;Hofbauer cells: 10.2;Kupffer cells: 12.3;Late spermatids: 11.8;Macrophages: 8.7;Syncytiotrophoblasts: 6.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Group enriched"	"Detected in many"	14	"classical monocyte: 3.1;eosinophil: 3.3;intermediate monocyte: 4.9;myeloid DC: 6.4;neutrophil: 9.9;non-classical monocyte: 5.2"	"Group enriched"	"Detected in many"	40	"dendritic cells: 6.4;granulocytes: 9.9;monocytes: 5.2"	"Cell line enhanced"	"Detected in some"		"BEWO: 5.8;OE19: 12.0;RT4: 4.3"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in some"									NA	NA						"unprognostic (2.18e-2)"	"unprognostic (2.49e-1)"	"unprognostic (6.58e-2)"	"unprognostic (1.42e-1)"	"unprognostic (2.94e-2)"	"unprognostic (1.25e-1)"	"unprognostic (4.91e-3)"	"unprognostic (4.74e-2)"	"unprognostic (4.48e-2)"	"unprognostic (2.03e-2)"	"unprognostic (1.53e-1)"	"unprognostic (2.17e-1)"	"unprognostic (2.61e-9)"	"unprognostic (2.48e-2)"	"unprognostic (2.19e-2)"	"unprognostic (4.99e-2)"	"unprognostic (8.03e-2)"	0.9	3.3	0.7	1.0	2.1	2.9	1.0	0.6	0.7	0.9	0.8	0.6	0.6	0.2	0.8	1.7	1.3	0.7	0.9	1.4	0.6	0.9	0.8	0.6	0.7	0.6	0.8	0.6	0.6	0.6	0.0	0.7	1.3	0.7	1.0	1.1	0.7	0.6	0.9	0.9	5.2	66.7	1.7	0.8	2.8	0.5	1.2	0.6	0.6	1.2	0.9	0.6	0.9	0.6	0.0	6.4	9.9	5.2	0.0	0.1	1.1	0.6	0.1	3.8	0.1	0.8	0.6	5.8	0.1	1.5	0.4	0.3	3.8	0.4	0.4	0.4	0.6	1.7	0.8	0.0	3.1	0.3	0.2	0.0	0.3	0.6	0.7	1.3	0.7	0.3	0.6	1.8	0.6	1.0	0.7	1.0	0.0	0.0	0.1	1.1	0.0	0.0	0.5	0.1	12.0	0.8	0.0	0.6	0.0	1.7	4.3	1.7	0.3	0.1	0.2	0.3	0.3	0.0	2.0	0.4	0.4	1.1	0.2	0.2	0.8	0.2	0.0	1.3	2.9	0.1	0.0	3.1	3.3	0.0	4.9	0.0	0.0	0.1	0.0	6.4	0.0	0.0	0.0	9.9	0.0	5.2	0.3	0.1	1.1	0.7	2.1	0.6	0.7	0.6	0.9	0.8	0.6	0.7	0.6	0.0	1.1	0.0	0.8	0.3	0.0	1.1	0.0	0.0	1.2	0.0	0.0	0.4	1.7	0.9	22.5	0.3	1.7	0.0	0.8	20.1	0.5	0.3	5.7	0.0	10.2	0.0	1.2	0.6	12.3	11.8	1.1	8.7	0.0	0.0	1.1	0.6	0.9	0.2	0.7	0.0	0.0	0.0	0.0	0.9	0.2	0.4	6.9	0.5	0.3	1.4
SPN	"CD43, GPL115, LSN"	ENSG00000197471	Sialophorin	P16150	16	29662979-29670876	"CD markers, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	7	"blood: 52.1;bone marrow: 33.1;lung: 25.0;lymphoid tissue: 79.7"	"Group enriched"	"Detected in many"	4	"Alveolar cells type 2: 22.9;Erythroid cells: 23.3;granulocytes: 42.7;Hofbauer cells: 27.4;Kupffer cells: 21.5;Macrophages: 52.4;T-cells: 85.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"non-classical monocyte: 52.1"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"HEL: 56.1;HL-60: 49.8;HMC-1: 28.1;K-562: 17.4;MOLT-4: 19.3;REH: 17.4;THP-1: 27.0;U-937: 35.5"									"CAB002666, HPA055244"	Enhanced		Approved	"Plasma membrane"		NA	NA			"Plasma membrane"		"CAB002666: , HPA055244: AB_2682756"	"prognostic favorable (1.40e-4)"	"unprognostic (1.63e-3)"	"unprognostic (3.14e-2)"	"prognostic favorable (3.08e-5)"	"unprognostic (2.68e-2)"	"unprognostic (2.49e-3)"	"unprognostic (4.02e-2)"	"unprognostic (4.17e-2)"	"prognostic favorable (1.88e-4)"	"unprognostic (1.70e-1)"	"unprognostic (4.67e-2)"	"unprognostic (2.68e-1)"	"unprognostic (2.61e-2)"	"unprognostic (4.52e-2)"	"unprognostic (4.14e-2)"	"unprognostic (5.85e-2)"	"unprognostic (4.72e-2)"	5.7	1.0	1.2	12.9	2.7	33.1	1.6	0.7	1.5	1.3	2.8	2.6	0.0	2.3	1.5	0.6	1.9	1.7	2.8	3.9	1.2	1.4	1.8	1.9	25.0	18.3	3.7	0.2	1.0	1.6	0.2	1.0	0.8	2.3	1.6	2.6	1.6	5.0	0.6	0.8	1.6	6.8	1.0	4.6	15.9	2.0	0.6	1.9	79.7	1.6	1.7	17.4	2.6	1.4	1.0	8.8	3.5	52.1	17.5	26.5	10.7	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	56.1	0.0	0.4	0.0	49.8	28.1	0.0	0.0	0.0	0.0	0.0	0.0	10.9	17.4	13.7	0.1	0.0	19.3	12.5	0.0	0.0	0.0	17.4	0.2	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	27.0	0.1	0.0	0.0	0.0	0.0	0.1	1.0	7.3	0.0	35.5	0.0	2.4	5.5	3.5	26.5	24.3	14.5	1.0	10.7	18.1	8.8	0.3	7.6	13.2	0.9	17.5	52.1	7.0	9.1	10.7	1.2	2.7	0.7	1.5	1.2	1.4	3.7	0.2	2.3	1.9	8.9	22.9	9.3	0.5	1.9	0.6	5.1	0.0	2.7	4.5	1.8	0.0	0.2	0.0	0.0	0.0	0.7	0.0	23.3	0.0	0.3	2.6	0.4	42.7	0.9	27.4	1.6	0.0	4.3	21.5	0.0	0.0	52.4	1.7	1.8	0.0	0.4	0.0	0.0	0.0	0.3	1.9	0.0	1.7	0.2	0.6	1.8	0.2	85.3	0.0	0.7
TCHH	THH	ENSG00000159450	Trichohyalin	Q07283	1	152106317-152115454	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	Keratinization			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	7	"skin 1: 28.8;tongue: 40.9"	"Cell type enhanced"	"Detected in many"	10	"Extravillous trophoblasts: 6.4;Kupffer cells: 15.0;Macrophages: 7.1;monocytes: 6.4;Spermatogonia: 10.4"	"Cancer enhanced"	"Detected in some"		"head and neck cancer: 2.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HaCaT: 8.1;SCLC-21H: 2.5;THP-1: 4.4"									HPA028375	Approved					NA	NA					"HPA028375: AB_10601722"	"unprognostic (7.70e-3)"	"unprognostic (3.84e-2)"	"unprognostic (1.14e-3)"	"unprognostic (1.14e-1)"	"unprognostic (2.07e-1)"	"unprognostic (2.30e-2)"	"unprognostic (4.97e-3)"	"unprognostic (2.15e-2)"	"unprognostic (1.84e-2)"	"unprognostic (7.12e-5)"	"unprognostic (2.03e-1)"	"unprognostic (6.55e-2)"	"unprognostic (5.90e-6)"	"unprognostic (5.58e-2)"	"unprognostic (1.12e-1)"	"unprognostic (9.71e-2)"	"unprognostic (9.28e-7)"	0.7	0.4	0.2	0.2	0.2	0.0	1.7	0.2	0.6	0.2	0.2	0.2	0.2	0.5	0.2	0.2	0.2	0.0	0.2	0.2	0.2	0.3	0.2	0.6	0.4	0.2	0.2	0.2	0.2	0.2	0.0	0.2	3.5	0.2	0.2	0.0	0.2	0.7	0.2	0.2	28.8	0.3	0.2	0.2	4.7	0.0	1.9	0.2	0.6	0.2	40.9	0.2	0.2	0.3	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.3	0.4	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.1	0.4	1.5	0.6	0.0	1.6	0.1	0.0	8.1	0.0	0.1	0.0	0.4	0.2	0.4	0.0	0.0	0.0	0.6	2.3	0.0	0.1	0.0	0.0	0.0	0.0	0.6	0.0	1.7	0.2	2.1	0.2	0.3	2.0	0.0	0.4	0.0	0.0	0.0	0.1	0.0	2.5	0.0	0.4	0.7	0.0	0.1	0.6	4.4	0.1	0.2	2.1	0.4	0.2	0.0	0.0	0.0	0.0	2.2	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.2	0.3	0.2	0.3	0.2	0.2	0.2	0.2	0.0	0.0	0.0	0.1	5.7	0.5	1.7	0.0	0.0	0.0	1.8	0.0	0.4	0.0	0.0	0.2	1.4	0.0	0.0	0.2	6.4	0.4	1.5	0.0	0.0	0.5	0.0	1.7	3.1	15.0	0.0	0.3	7.1	0.0	6.4	0.0	0.0	0.2	0.0	0.7	0.0	0.0	0.0	2.0	2.9	10.4	2.0	4.3	0.0	0.0	0.0
UTF1		ENSG00000171794	"Undifferentiated embryonic cell transcription factor 1"	Q5T230	10	133230274-133231558	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	Activator		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	7	"ovary: 22.9;testis: 23.4"	"Group enriched"	"Detected in some"	7	"Kupffer cells: 2.4;Macrophages: 6.9;Spermatogonia: 8.7"	"Cancer enriched"	"Detected in single"	243	"testis cancer: 49.5"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"intermediate monocyte: 1.1;non-classical monocyte: 1.3"	"Low lineage specificity"	"Detected in single"			"Group enriched"	"Detected in some"	18	"NTERA-2: 11.2;RPMI-8226: 4.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			CAB022384	Enhanced					NA	NA					"CAB022384: "					"unprognostic (9.19e-2)"					"unprognostic (1.95e-1)"	"unprognostic (8.57e-2)"		"unprognostic (1.78e-1)"	"unprognostic (2.99e-3)"	"unprognostic (2.88e-1)"	"unprognostic (3.82e-1)"		0.2	0.3	0.4	0.1	0.2	0.5	0.1	0.3	0.3	0.1	0.1	0.0	0.0	0.1	0.3	0.8	0.1	0.7	0.1	0.9	0.2	0.2	0.1	0.2	0.6	1.6	0.1	0.0	22.9	0.1	0.1	0.2	0.1	0.1	0.1	0.2	0.0	0.1	0.2	0.1	0.3	0.1	0.1	0.4	3.1	0.2	23.4	0.0	1.1	0.1	0.1	0.5	0.1	0.0	0.5	0.9	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	11.2	0.0	0.0	0.0	0.0	4.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.9	0.5	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.4	0.2	0.3	0.3	0.2	0.2	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	2.4	0.9	0.3	6.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	8.7	0.9	0.1	0.0	0.0	0.0
ADGRE3	EMR3	ENSG00000131355	"Adhesion G protein-coupled receptor E3"	Q9BY15	19	14619117-14690027	"G-protein coupled receptors, Predicted membrane proteins, Predicted secreted proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"blood: 70.7;lung: 26.3"	"Cell type enhanced"	"Detected in some"	17	"Alveolar cells type 2: 3.7;Ciliated cells: 1.4;granulocytes: 2.3;Macrophages: 4.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	7	"basophil: 36.3;eosinophil: 69.6;neutrophil: 70.7"	"Lineage enriched"	"Detected in many"	9	"granulocytes: 70.7"	"Cell line enriched"	"Detected in single"	38	"HMC-1: 32.5"					"Not detected"	"Not detected"			HPA015638	Uncertain				"Secreted to blood"	NA	NA					"HPA015638: AB_1848039"	"unprognostic (2.11e-4)"	"unprognostic (1.01e-1)"	"unprognostic (1.17e-1)"	"unprognostic (5.69e-2)"	"unprognostic (5.63e-2)"	"unprognostic (4.53e-2)"	"unprognostic (1.14e-1)"	"unprognostic (8.07e-2)"	"unprognostic (9.61e-2)"	"unprognostic (9.11e-4)"	"unprognostic (4.68e-2)"	"unprognostic (2.41e-1)"	"unprognostic (1.13e-1)"	"unprognostic (7.06e-3)"	"unprognostic (1.51e-1)"	"unprognostic (1.20e-1)"	"unprognostic (6.67e-2)"	1.7	0.2	0.3	8.5	0.8	4.0	0.3	0.2	0.7	0.2	0.4	0.3	0.1	2.1	0.2	0.7	0.4	0.6	1.2	0.6	0.3	0.3	0.4	1.1	26.3	5.9	0.4	0.1	0.5	0.3	0.0	0.3	1.7	0.7	0.6	0.5	0.7	6.2	0.1	0.9	0.2	3.2	0.7	0.6	8.1	0.4	0.8	0.3	0.8	0.5	0.9	3.4	2.6	0.4	0.0	0.7	70.7	8.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	32.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	36.3	3.2	69.6	0.0	7.4	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	70.7	0.0	8.0	0.0	0.0	0.9	0.3	0.8	0.2	0.7	0.3	0.3	0.4	0.1	0.7	0.3	0.0	3.7	0.0	0.0	0.0	0.0	0.2	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.1	0.0	0.0	0.0	0.6	0.0	0.0	4.5	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
ARHGDIB	"GDIA2, GDID4, Ly-GDI, RAP1GN1, RhoGDI2"	ENSG00000111348	"Rho GDP dissociation inhibitor beta"	P52566	12	14942017-14961728	"Plasma proteins, Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	6	"blood: 333.1;bone marrow: 150.7;lymphoid tissue: 221.4"	"Cell type enhanced"	"Detected in many"	7	"granulocytes: 669.1;Hofbauer cells: 807.6;Kupffer cells: 661.4;Macrophages: 633.0;T-cells: 892.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HEL: 102.5;HL-60: 119.9;HMC-1: 135.8;JURKAT: 91.1;MOLT-4: 141.9;REH: 119.4;U-698: 109.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB018584, HPA051235"	Enhanced		Supported	Cytosol		NA	NA		120000000	Cytosol		"CAB018584: AB_647972, HPA051235: AB_2681398"	"unprognostic (2.29e-3)"	"unprognostic (8.10e-2)"	"unprognostic (2.09e-1)"	"unprognostic (1.39e-2)"	"unprognostic (9.16e-2)"	"unprognostic (1.90e-2)"	"unprognostic (2.44e-1)"	"unprognostic (1.47e-2)"	"unprognostic (3.46e-1)"	"unprognostic (2.47e-2)"	"unprognostic (2.19e-2)"	"unprognostic (1.10e-1)"	"prognostic unfavorable (1.08e-4)"	"unprognostic (1.74e-1)"	"unprognostic (4.42e-3)"	"unprognostic (4.97e-2)"	"prognostic favorable (3.42e-4)"	40.3	13.4	9.0	66.1	18.4	150.7	27.9	1.8	8.9	14.6	14.5	13.9	3.6	8.5	14.7	13.2	16.9	18.2	18.3	20.5	8.3	7.8	24.5	20.0	41.3	93.9	17.0	3.9	11.7	7.1	3.9	8.1	35.6	11.4	18.0	16.1	20.4	22.4	7.6	13.3	14.7	38.3	15.7	17.9	157.8	11.1	11.2	15.8	221.4	22.7	12.4	108.1	31.2	13.5	114.0	95.5	267.1	151.9	96.3	231.1	333.1	9.4	0.3	0.3	21.0	1.4	1.1	0.1	0.3	0.1	0.1	0.1	1.2	10.4	76.0	4.9	1.7	0.1	10.4	0.0	16.8	1.1	0.1	0.0	102.5	0.2	0.0	0.3	119.9	135.8	0.1	2.1	0.0	1.5	0.3	59.0	91.1	0.5	29.2	1.8	0.0	141.9	86.3	0.4	0.2	0.1	119.4	1.3	34.0	3.3	52.6	0.1	0.0	0.1	13.6	0.1	0.9	0.7	87.3	74.7	0.3	0.7	0.1	2.2	4.8	0.7	109.8	0.3	84.1	0.1	206.0	109.9	267.1	125.6	130.8	123.3	114.0	144.4	140.7	95.5	103.2	141.1	146.5	237.7	96.3	151.9	41.4	231.1	333.1	9.0	18.4	1.8	8.9	8.3	7.8	17.0	3.9	11.4	15.8	56.6	190.4	437.8	45.8	60.7	0.3	8.1	15.3	38.8	80.8	55.8	0.0	51.5	14.9	20.5	1.2	156.9	3.8	23.3	303.9	465.0	49.8	3.3	669.1	4.7	807.6	0.0	1.2	329.0	661.4	2.0	49.5	633.0	86.0	32.5	2.2	1.9	43.8	20.4	55.2	6.1	1.0	239.3	61.4	0.7	1.5	49.1	56.9	892.2	5.7	85.5
CX3CR1	"CCRL1, CMKBRL1, CMKDR1, GPR13, V28"	ENSG00000168329	"C-X3-C motif chemokine receptor 1"	P49238	3	39263494-39281735	"Disease related genes, G-protein coupled receptors, Plasma proteins, Potential drug targets, Predicted membrane proteins"	"Host-virus interaction"	"G-protein coupled receptor, Receptor, Transducer"	"Age-related macular degeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"blood: 69.2;brain: 51.6"	"Cell type enhanced"	"Detected in some"	17	"Kupffer cells: 14.4;Macrophages: 26.4;Sertoli cells: 6.5;T-cells: 15.2"	"Cancer enhanced"	"Detected in many"		"glioma: 21.1"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"non-classical monocyte: 69.2"	"Low lineage specificity"	"Detected in many"			"Cell line enriched"	"Detected in some"	20	"RPMI-8226: 114.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB032478, HPA046587"	Approved		Approved	"Plasma membrane"		NA	NA			"Plasma membrane"		"CAB032478: AB_638830, HPA046587: AB_2679708"	"unprognostic (2.00e-1)"	"unprognostic (5.12e-2)"	"unprognostic (2.65e-1)"	"unprognostic (2.42e-2)"	"unprognostic (6.52e-2)"	"unprognostic (3.01e-3)"	"unprognostic (2.64e-1)"	"unprognostic (1.16e-2)"	"unprognostic (3.98e-2)"	"unprognostic (1.57e-3)"	"unprognostic (1.13e-2)"	"unprognostic (1.04e-1)"	"unprognostic (3.05e-2)"	"unprognostic (1.36e-2)"	"unprognostic (8.59e-2)"	"unprognostic (7.71e-3)"	"unprognostic (1.12e-1)"	2.3	3.8	14.9	6.0	17.3	0.9	4.8	2.5	34.1	2.7	1.2	51.6	0.0	1.2	2.7	4.2	1.4	5.9	2.5	2.2	12.4	11.9	2.5	1.9	9.0	1.8	21.8	7.4	1.8	1.8	5.2	2.5	4.3	21.8	3.7	1.2	3.5	6.4	7.0	5.2	2.4	1.2	3.3	33.5	10.3	1.5	1.8	16.3	0.8	2.4	0.7	4.7	2.8	1.3	0.1	15.7	3.5	69.2	6.5	46.5	29.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	1.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	4.9	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	114.8	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	5.6	0.0	1.2	15.9	0.2	46.5	43.3	0.5	0.1	10.4	25.2	15.7	0.1	3.7	22.7	3.5	6.5	69.2	1.1	0.2	29.8	14.9	17.3	2.5	19.9	12.4	11.9	21.8	7.4	21.8	16.3	0.0	0.3	0.0	0.0	0.5	0.0	0.4	0.0	1.4	1.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	4.7	0.0	3.5	0.0	0.0	0.6	14.4	0.0	0.3	26.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	6.5	0.0	0.7	0.2	0.5	0.0	15.2	0.0	0.0
FCGR2B	"CD32, CD32B, FCG2, FCGR2"	ENSG00000072694	"Fc fragment of IgG receptor IIb"	P31994	1	161663147-161678654	"Cancer-related genes, CD markers, Disease related genes, FDA approved drug targets, Predicted membrane proteins"	"Host-virus interaction"	"IgG-binding protein, Receptor"	"Cancer-related genes, FDA approved drug targets, Proto-oncogene, Systemic lupus erythematosus"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"blood: 53.3;placenta: 83.2"	"Group enriched"	"Detected in many"	5	"Ito cells: 479.4;Macrophages: 138.2"	"Low cancer specificity"	"Detected in many"							"Cell type enhanced"	"Detected in many"		"basophil: 53.3;memory B-cell: 42.2"	"Group enriched"	"Detected in many"	18	"B-cells: 42.2;dendritic cells: 14.5;granulocytes: 53.3"	"Cell line enhanced"	"Detected in some"		"Daudi: 18.7;HMC-1: 23.5;NB-4: 5.2;RPMI-8226: 8.4"									"CAB007796, HPA014730"	Enhanced					NA	NA					"CAB007796: AB_562288, HPA014730: AB_2669074"	"unprognostic (1.58e-1)"	"unprognostic (5.14e-2)"	"unprognostic (3.32e-3)"	"unprognostic (3.12e-2)"	"unprognostic (6.79e-3)"	"unprognostic (4.05e-3)"	"unprognostic (1.27e-1)"	"unprognostic (4.65e-3)"	"unprognostic (1.91e-1)"	"unprognostic (4.72e-2)"	"unprognostic (2.89e-2)"	"unprognostic (3.49e-1)"	"prognostic unfavorable (8.82e-4)"	"unprognostic (3.51e-2)"	"unprognostic (6.36e-2)"	"unprognostic (4.31e-1)"	"unprognostic (3.37e-1)"	11.3	2.4	0.0	2.0	0.2	0.0	4.1	0.0	0.0	1.9	3.4			0.2	0.9	0.2	2.1	2.1	2.3	3.7	0.0	0.2	2.0	9.5	5.6	2.5	0.5		0.8	0.6	0.0	0.3	83.2		0.3	2.0		3.3	0.2	0.5	2.0	4.6	3.1	4.7	6.7	1.5	0.1			1.7		5.6	3.3	1.2	42.2	14.5	53.3	1.9	0.1	0.3	2.4	0.0	0.1	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	18.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	23.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	5.2	0.1	0.0	0.0	0.0	0.0	8.4	0.0	0.0	0.1	0.1	0.0	0.0	1.6	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	2.2	0.0	53.3	1.8	5.4	0.3	1.9	0.1	42.2	0.1	0.2	14.5	34.3	0.0	0.3	11.2	0.1	1.7	0.0	0.0	2.4											0.0	4.6	57.3	0.0	4.7	0.0	1.9	5.1	0.0	2.3	0.0	0.0	0.2	0.0	0.0	4.2	1.4	0.0	23.3	0.0	0.2	2.7	0.0	2.3	2.5	7.6	0.0	0.0	479.4	63.3	2.3	0.6	138.2	21.9	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.7	0.3	0.2	2.8	0.3	4.9	0.0	0.0
FGR	"c-fgr, p55c-fgr, SRC2"	ENSG00000000938	"FGR proto-oncogene, Src family tyrosine kinase"	P09769	1	27612064-27635277	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Immunity, Innate immunity"	"Kinase, Transferase, Tyrosine-protein kinase"	Proto-oncogene	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"adipose tissue: 20.8;blood: 68.0;bone marrow: 73.6;lung: 30.9;lymphoid tissue: 54.3"	"Cell type enhanced"	"Detected in many"	19	"Hofbauer cells: 58.9;Kupffer cells: 187.9;Macrophages: 86.1;T-cells: 45.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Group enriched"	"Detected in some"	4	"Daudi: 30.1;U-266/70: 55.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA002024	Enhanced		Approved	"Plasma membrane,Aggresome"		NA	NA			"Plasma membrane"	Aggresome	"HPA002024: AB_1078503"	"unprognostic (2.66e-2)"	"unprognostic (1.51e-2)"	"unprognostic (6.32e-2)"	"unprognostic (9.74e-3)"	"unprognostic (6.66e-3)"	"unprognostic (6.71e-2)"	"unprognostic (5.77e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.81e-2)"	"unprognostic (7.45e-2)"	"unprognostic (2.79e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.94e-2)"	"unprognostic (6.26e-2)"	"unprognostic (3.93e-2)"	"unprognostic (2.30e-1)"	"unprognostic (8.12e-3)"	20.8	2.6	2.2	23.6	4.5	73.6	5.6	1.1	4.2	2.9	2.8	1.5	4.2	1.6	4.0	2.3	2.2	6.3	5.3	8.5	2.6	2.3	3.0	4.2	30.9	34.1	6.6	1.7	1.9	2.4	0.4	1.2	3.3	4.2	2.5	1.8	2.1	2.9	2.6	4.4	1.7	3.7	6.4	4.8	54.3	2.5	2.6	4.1	1.9	2.9	2.5	7.8	5.1	6.1	13.3	28.9	40.8	68.0	36.3	29.6	55.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	30.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.5	10.7	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	1.3	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.5	0.0	0.0	0.0	0.0	0.0	55.9	0.7	2.3	0.0	6.8	0.0	3.1	52.4	32.3	29.6	68.0	1.7	7.7	2.6	13.6	28.9	13.3	1.3	12.8	40.8	36.3	55.6	1.3	0.1	55.0	2.2	4.5	1.1	4.2	2.6	2.3	6.6	1.7	4.2	4.1	6.0	30.7	12.5	0.5	2.5	0.0	1.6	2.5	2.7	10.3	1.8	0.0	0.4	0.0	0.0	0.2	11.5	0.0	0.0	0.2	0.5	1.4	0.3	12.7	0.9	58.9	0.0	0.0	4.3	187.9	0.4	0.3	86.1	1.7	7.2	0.0	0.1	0.0	0.2	0.0	0.1	0.0	0.0	1.0	0.2	0.5	1.0	0.8	45.8	0.0	0.9
IL3RA	CD123	ENSG00000185291	"Interleukin 3 receptor subunit alpha"	P26951	X	1336616-1382689	"CD markers, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins"		Receptor	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"blood: 163.1;breast: 50.7;vagina: 65.4"	"Group enriched"	"Detected in many"	5	"Endothelial cells: 40.7;Macrophages: 35.6;monocytes: 120.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	16	"basophil: 163.1;plasmacytoid DC: 49.1"	"Group enriched"	"Detected in many"	33	"dendritic cells: 49.1;granulocytes: 163.1"	"Cell line enhanced"	"Detected in some"		"HDLM-2: 49.0;NB-4: 9.4;RPMI-8226: 20.0"									"HPA003539, CAB018374"	Uncertain					NA	NA					"CAB018374: AB_2233620, HPA003539: AB_1078438"	"prognostic favorable (9.78e-4)"	"prognostic favorable (4.27e-4)"	"unprognostic (8.13e-2)"	"unprognostic (9.32e-2)"	"unprognostic (2.09e-1)"	"unprognostic (1.29e-3)"	"unprognostic (1.32e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.38e-1)"	"unprognostic (3.73e-2)"	"unprognostic (5.77e-3)"	"unprognostic (1.43e-1)"	"unprognostic (1.50e-3)"	"unprognostic (9.41e-2)"	"unprognostic (2.85e-3)"	"unprognostic (2.49e-1)"	"unprognostic (1.46e-1)"	14.9	1.2	7.8	7.7	7.8	12.1	50.7	5.0	10.1	9.7	4.6	1.5	1.5	2.4	13.8	1.5	2.8	4.2	5.6	9.2	11.1	2.4	5.4	1.5	15.9	12.3	8.5	3.9	7.6	2.6	0.6	3.7	9.3	10.9	4.4	3.1	1.5	5.6	1.5	5.7	6.8	5.4	6.1	7.6	5.3	4.2	1.5	7.9	1.5	7.0	1.5	6.4	6.8	65.4	0.7	49.1	163.1	3.2	1.1	0.0	0.7	0.1	4.0	1.5	0.5	0.0	0.0	0.5	0.5	0.1	0.0	0.0	0.4	0.6	0.5	2.8	0.0	0.2	3.9	0.0	0.0	0.0	49.0	1.6	0.2	0.7	0.1	0.0	0.3	6.7	0.0	0.0	0.0	0.0	1.7	3.2	0.4	0.1	2.5	0.0	0.6	0.2	9.4	1.2	0.3	0.2	0.6	1.8	20.0	0.0	0.5	0.2	0.2	0.2	0.1	1.1	0.7	0.5	7.5	0.1	0.2	0.6	0.2	0.1	5.3	1.5	0.4	4.4	1.1	0.0	163.1	0.4	6.7	0.0	2.4	0.0	0.2	0.0	0.0	1.1	0.7	0.0	0.0	0.3	1.1	3.2	49.1	0.0	0.7	7.8	7.8	5.0	10.1	11.1	2.4	8.5	3.9	10.9	7.9	3.0	2.6	7.7	0.5	5.3	2.7	2.4	2.5	0.0	1.2	0.0	9.8	0.0	0.0	0.3	0.0	40.7	0.4	0.0	0.2	0.1	2.8	0.4	11.5	0.0	4.4	0.0	0.0	14.1	3.5	0.0	0.3	35.6	8.5	120.0	1.3	0.8	0.1	3.4	0.7	0.0	2.2	0.0	4.1	0.0	0.2	4.8	0.2	0.0	0.2	1.8
MMP9	CLG4B	ENSG00000100985	"Matrix metallopeptidase 9"	P14780	20	46008908-46016561	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted secreted proteins"	"Collagen degradation"	"Hydrolase, Metalloprotease, Protease"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"adipose tissue: 64.0;blood: 63.2;bone marrow: 89.4;lymphoid tissue: 80.1"	"Cell type enhanced"	"Detected in many"	25	"Hofbauer cells: 273.8;Macrophages: 115.1;Melanocytes: 54.0"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	141	"neutrophil: 63.2"	"Lineage enriched"	"Detected in single"	339	"granulocytes: 63.2"	"Cell line enriched"	"Detected in some"	12	"NB-4: 89.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB000348, HPA001238, HPA063909, CAB068199, CAB068200, CAB068201"	Enhanced		Approved	Cytosol	"Secreted to blood"	NA	NA	43300000	57000000	Cytosol		"CAB000348: , CAB068199: AB_2665675, CAB068200: AB_2665676, CAB068201: AB_2665677, HPA001238: AB_1079398, HPA063909: AB_2685150"	"unprognostic (4.62e-2)"	"unprognostic (1.64e-1)"	"unprognostic (2.85e-2)"	"prognostic favorable (2.55e-4)"	"unprognostic (6.65e-3)"	"unprognostic (2.82e-1)"	"prognostic unfavorable (7.19e-4)"	"unprognostic (1.54e-1)"	"unprognostic (8.57e-2)"	"unprognostic (3.21e-2)"	"unprognostic (4.15e-2)"	"unprognostic (1.96e-1)"	"prognostic unfavorable (4.05e-5)"	"unprognostic (4.65e-1)"	"unprognostic (9.85e-3)"	"unprognostic (2.48e-2)"	"unprognostic (2.17e-3)"	64.0	0.5	0.6	38.6	0.7	89.4	4.3	0.4	0.6	0.8	1.2	0.1	0.0	2.8	0.6	0.2	0.9	1.5	0.6	4.0	0.5	0.6	1.4	2.0	13.3	80.1	0.6	0.0	2.7	1.4	0.0	0.8	2.6	0.5	0.6	0.8	0.5	12.5	0.0	1.3	1.3	4.2	0.3	0.5	53.7	2.5	2.7	0.0	23.6	1.3	2.3	44.5	4.5	2.9	0.0	0.0	63.2	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.8	0.0	7.5	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.9	0.0	89.4	0.2	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0	1.0	0.0	0.3	0.0	2.7	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	63.2	0.0	0.0	0.0	0.0	0.0	0.6	0.7	0.4	0.6	0.5	0.6	0.6	0.0	0.5	0.0	0.0	8.5	0.0	0.0	30.5	1.6	0.4	0.0	0.0	0.0	0.0	7.9	0.9	0.0	0.8	0.6	0.5	0.0	0.0	1.5	2.0	1.7	0.1	1.1	0.0	273.8	3.2	0.0	0.0	1.9	0.0	0.0	115.1	54.0	3.6	0.0	0.5	1.6	0.0	0.0	0.3	4.3	0.0	12.3	5.4	5.5	24.6	1.6	0.0	0.0	0.0
SCIMP	"C17orf87, DTFT5783, FLJ32580, MGC163426, MGC163428, UNQ5783"	ENSG00000161929	"SLP adaptor and CSK interacting membrane protein"	Q6UWF3	17	5208961-5234860	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"blood: 49.6;lymphoid tissue: 84.9"	"Group enriched"	"Detected in some"	5	"B-cells: 45.2;Hofbauer cells: 24.0;Kupffer cells: 93.1;Macrophages: 61.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	8	"classical monocyte: 22.3;intermediate monocyte: 47.8;memory B-cell: 30.6;myeloid DC: 16.8;naive B-cell: 23.0;non-classical monocyte: 49.6"	"Group enriched"	"Detected in many"	8	"B-cells: 30.6;dendritic cells: 16.8;monocytes: 49.6"	"Cell line enhanced"	"Detected in many"		"HeLa: 6.9;U-698: 14.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA006117	Enhanced					NA	NA					"HPA006117: AB_1858633"	"unprognostic (2.53e-2)"	"unprognostic (7.88e-3)"	"unprognostic (1.26e-2)"	"unprognostic (5.79e-3)"	"unprognostic (1.10e-1)"	"unprognostic (3.87e-2)"	"unprognostic (7.96e-2)"	"unprognostic (1.73e-2)"	"unprognostic (4.93e-2)"	"unprognostic (2.99e-1)"	"unprognostic (1.35e-1)"	"unprognostic (8.05e-2)"	"unprognostic (3.33e-2)"	"unprognostic (2.07e-1)"	"unprognostic (4.42e-2)"	"unprognostic (1.77e-1)"	"unprognostic (9.95e-2)"	6.1	2.8	1.3	19.5	1.5	1.7	1.7	0.9	1.1	1.5	2.3	3.2	0.2	2.0	1.4	2.2	3.8	2.0	3.1	2.5	1.3	1.5	3.2	10.0	10.8	55.1	2.1	0.2	2.4	1.6	0.0	1.5	2.2	3.6	1.9	1.8	2.2	4.5	0.2	1.4	1.1	9.9	2.3	3.9	84.9	1.8	1.0	1.0	3.0	1.5	0.7	31.9	3.6	1.3	30.6	16.8	4.0	49.6	1.1	0.4	11.1	1.2	2.0	3.2	4.7	0.1	0.0	3.4	1.4	0.0	0.0	0.0	0.9	2.7	6.4	1.3	0.0	2.4	1.5	0.0	0.0	0.0	0.9	2.8	2.5	6.9	0.8	0.0	0.4	1.0	0.0	0.3	0.0	0.3	1.8	0.0	5.6	0.1	1.7	0.0	2.1	3.0	1.0	1.5	0.4	2.0	2.7	0.7	0.7	0.0	0.8	2.5	1.1	2.4	0.8	1.7	1.2	3.4	3.1	0.4	0.5	1.7	1.9	0.8	1.0	0.5	14.2	1.9	0.7	0.9	2.5	22.3	0.5	0.3	47.8	0.3	30.6	0.2	0.2	16.8	23.0	0.4	0.3	4.0	1.1	49.6	0.7	0.2	11.1	1.3	1.5	0.9	1.1	1.3	1.5	2.1	0.2	3.6	1.0	0.0	4.1	45.2	0.3	0.3	2.5	0.4	0.0	2.7	1.2	0.0	11.8	0.2	0.0	0.6	0.9	0.6	0.0	0.0	0.7	0.2	0.8	0.4	1.1	1.0	24.0	1.6	0.0	1.8	93.1	0.6	0.3	61.4	0.0	1.0	0.0	0.8	0.4	0.0	0.4	0.7	4.1	0.0	0.4	0.2	0.6	0.4	0.1	0.0	0.0	0.3
TNFAIP8L2	FLJ23467	ENSG00000163154	"TNF alpha induced protein 8 like 2"	Q6P589	1	151156629-151159749	"Predicted intracellular proteins"	"Immunity, Innate immunity"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"blood: 63.1;lymphoid tissue: 38.7"	"Cell type enhanced"	"Detected in some"	14	"Hofbauer cells: 59.6;Kupffer cells: 56.1;Macrophages: 47.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"HEL: 12.8;HL-60: 7.5;HMC-1: 19.9;NB-4: 10.8;THP-1: 41.5;U-937: 16.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA062742			Approved	Vesicles		NA	NA			Vesicles		"HPA062742: "	"unprognostic (3.19e-3)"	"unprognostic (1.02e-2)"	"unprognostic (6.63e-3)"	"unprognostic (2.27e-2)"	"unprognostic (1.29e-1)"	"unprognostic (6.49e-3)"	"unprognostic (1.05e-1)"	"unprognostic (9.15e-3)"	"prognostic favorable (3.64e-4)"	"unprognostic (9.54e-2)"	"unprognostic (3.32e-2)"	"unprognostic (9.03e-2)"	"prognostic unfavorable (3.53e-7)"	"unprognostic (1.78e-1)"	"unprognostic (3.91e-2)"	"unprognostic (4.87e-2)"	"unprognostic (2.23e-1)"	8.5	4.2	5.7	13.8	8.8	4.1	2.7	1.3	4.5	2.0	3.2	4.0	0.0	3.9	2.0	2.6	2.1	3.0	4.1	2.8	4.1	3.3	2.9	6.0	8.2	20.9	8.2	2.2	1.8	2.0	0.3	1.9	7.0	7.2	2.6	4.6	1.8	6.4	1.4	1.0	2.7	6.9	3.9	8.0	38.7	2.5	1.0	6.9	21.0	1.8	1.2	12.8	7.2	1.9	17.7	56.4	63.1	50.6	47.1	43.9	44.8	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	12.8	0.1	0.0	0.0	7.5	19.9	0.0	0.0	0.0	0.0	0.0	0.1	1.1	0.0	0.0	0.0	0.0	0.1	10.8	0.0	0.0	0.0	2.2	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	41.5	1.1	0.1	0.0	0.0	0.1	0.1	0.0	0.8	0.0	16.3	0.0	53.4	50.6	50.0	23.3	45.4	22.9	15.6	28.8	23.5	56.4	17.7	43.9	31.5	63.1	47.1	41.2	13.3	31.6	44.8	5.7	8.8	1.3	4.5	4.1	3.3	8.2	2.2	7.2	6.9	0.0	1.7	16.4	0.0	0.2	0.2	0.0	5.1	0.0	2.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	4.7	0.2	59.6	0.0	0.0	1.3	56.1	0.0	0.3	47.5	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.1	0.3	0.3	13.8	0.0	0.0
CD1A	CD1	ENSG00000158477	"CD1a molecule"	P06126	1	158254137-158258269	"CD markers, Predicted membrane proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"lymphoid tissue: 105.1"	"Cell type enhanced"	"Detected in some"	17	"Basal keratinocytes: 6.5;Kupffer cells: 1.6;Macrophages: 2.9;Melanocytes: 1.7;Suprabasal keratinocytes: 6.0"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	23	"classical monocyte: 5.9;intermediate monocyte: 3.7;memory B-cell: 6.8;myeloid DC: 10.2;naive B-cell: 5.4"	"Group enriched"	"Detected in many"	35	"B-cells: 6.8;dendritic cells: 10.2;monocytes: 5.9"	"Group enriched"	"Detected in some"	86	"JURKAT: 21.2;MOLT-4: 33.8"									"CAB000009, HPA010734"	Enhanced					NA	NA					"CAB000009: AB_2073290, HPA010734: AB_1078452"	"unprognostic (7.21e-5)"	"prognostic favorable (6.37e-4)"	"unprognostic (1.37e-5)"	"unprognostic (2.55e-2)"	"unprognostic (2.83e-1)"	"unprognostic (1.16e-2)"	"unprognostic (9.93e-4)"	"unprognostic (1.49e-2)"	"unprognostic (3.12e-1)"	"unprognostic (3.86e-2)"	"unprognostic (6.99e-2)"	"unprognostic (5.12e-2)"	"unprognostic (5.49e-5)"	"unprognostic (5.58e-2)"	"unprognostic (1.72e-1)"	"unprognostic (1.76e-1)"	"unprognostic (8.81e-2)"	0.1	0.0	0.1	0.9	0.1	0.0	1.0	0.1	0.1	0.9	0.1	0.1	0.1	0.0	0.2	0.1	8.0	0.0	0.6	0.1	0.1	0.0	0.2	0.1	1.8	1.9	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	1.2	0.1	0.9	0.1	0.1	20.9	0.3	0.1	0.1	1.4	0.3	0.2	0.1	105.1	0.1	1.0	2.7	0.4	1.1	6.8	10.2	0.0	5.9	0.0	0.2	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	21.2	0.0	0.0	0.0	0.0	33.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	5.9	0.0	0.0	3.7	0.2	6.8	0.0	0.0	10.2	5.4	0.1	0.0	0.0	0.0	0.2	0.2	0.0	1.5	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	6.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	1.6	0.0	0.0	2.9	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	6.0	0.0	0.0	0.0	0.0
CD300A	"CMRF-35-H9, CMRF35H, IGSF12, IRC1, IRC2, Irp60"	ENSG00000167851	"CD300a molecule"	Q9UGN4	17	74466416-74484796	"CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion, Immunity"	Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"blood: 81.1;brain: 28.7;lymphoid tissue: 57.8"	"Group enriched"	"Detected in some"	4	"granulocytes: 57.8;Hofbauer cells: 101.1;Kupffer cells: 71.3;Macrophages: 86.9;T-cells: 25.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"HMC-1: 42.2;NB-4: 17.2;RPMI-8226: 33.2"									"HPA010971, HPA011645"	Approved		Approved	"Vesicles,Plasma membrane,Cytosol"	"Intracellular and membrane"	NA	NA		2800000	"Plasma membrane"	"Vesicles, Cytosol"	"HPA010971: , HPA011645: AB_1846988"	"unprognostic (1.99e-1)"	"unprognostic (4.60e-2)"	"unprognostic (3.88e-2)"	"unprognostic (3.30e-2)"	"unprognostic (2.73e-1)"	"unprognostic (2.01e-1)"	"unprognostic (1.04e-2)"	"unprognostic (2.63e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.17e-2)"	"unprognostic (7.87e-2)"	"unprognostic (1.07e-1)"	"prognostic unfavorable (1.91e-5)"	"unprognostic (5.97e-2)"	"unprognostic (5.45e-3)"	"unprognostic (1.36e-1)"	"unprognostic (5.72e-2)"	8.6	4.5	9.8	16.0	17.7	11.9	4.4	2.2	11.5	2.0	4.8	3.7	0.0	6.0	1.9	1.3	2.1	2.1	7.7	3.4	7.3	4.2	3.0	7.5	10.6	19.0	20.1	0.3	1.5	2.1	0.3	3.0	6.9	12.6	2.8	4.7	2.3	3.0	1.3	1.1	2.3	7.4	6.0	28.7	57.8	2.4	1.5	17.4	4.1	1.9	0.5	6.0	5.4	2.1	2.2	19.4	81.1	45.7	52.1	29.5	19.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	3.5	0.0	0.0	0.0	2.0	42.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.5	17.2	0.0	0.0	0.0	0.0	0.0	33.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.9	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	6.4	0.0	81.1	20.4	57.3	29.5	45.7	6.2	2.2	6.1	8.7	19.4	0.6	2.3	7.1	71.6	52.1	44.2	18.1	0.3	19.2	9.8	17.7	2.2	11.5	7.3	4.2	20.1	0.3	12.6	17.4	0.0	11.9	15.7	0.0	0.8	0.0	0.4	2.5	0.0	1.2	0.0	0.0	0.7	0.0	0.1	0.0	0.5	0.0	0.0	0.0	1.0	0.5	0.1	57.8	0.8	101.1	0.0	0.0	3.1	71.3	0.0	0.0	86.9	3.3	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.5	0.2	0.0	0.5	0.5	1.3	25.9	0.0	0.1
CD300LF	"CD300f, CLM1, IGSF13, IREM1, NKIR"	ENSG00000186074	"CD300 molecule like family member f"	Q8TDQ1	17	74694311-74712978	"CD markers, Predicted intracellular proteins, Predicted membrane proteins"	Immunity	Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"blood: 47.8;bone marrow: 18.2;lung: 24.1;lymphoid tissue: 29.1"	"Cell type enhanced"	"Detected in some"	13	"granulocytes: 22.0;Hofbauer cells: 21.0;Kupffer cells: 28.8;Macrophages: 32.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"eosinophil: 47.8"	"Group enriched"	"Detected in many"	46	"dendritic cells: 13.5;granulocytes: 47.8;monocytes: 38.1"	"Group enriched"	"Detected in some"	6	"THP-1: 16.0;U-937: 30.9"									HPA013712	Supported					NA	NA					"HPA013712: AB_2668874"	"unprognostic (6.51e-2)"	"unprognostic (1.49e-3)"	"unprognostic (3.81e-2)"	"unprognostic (4.00e-2)"	"unprognostic (8.51e-2)"	"unprognostic (6.74e-2)"	"unprognostic (1.79e-1)"	"unprognostic (3.17e-3)"	"unprognostic (1.53e-2)"	"unprognostic (1.77e-1)"	"unprognostic (9.81e-2)"	"unprognostic (2.41e-1)"	"unprognostic (1.95e-1)"	"unprognostic (9.60e-2)"	"unprognostic (4.14e-2)"	"unprognostic (7.75e-2)"	"unprognostic (4.79e-2)"	3.3	1.0	1.2	9.8	3.1	18.2	0.9	1.5	1.3	0.8	2.3	3.1	0.0	2.7	0.7	0.7	0.9	1.1	1.9	2.4	1.3	1.2	1.1	1.5	24.1	15.6	3.8	0.5	0.9	0.9	0.0	1.0	2.1	2.6	1.4	2.6	0.8	1.9	0.3	0.5	0.5	3.4	2.3	5.8	29.1	1.0	0.7	2.4	1.1	0.8	0.0	4.2	2.8	0.8	0.0	13.5	47.8	38.1	0.7	0.1	8.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.6	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.6	0.0	1.4	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	30.9	0.0	8.4	20.2	47.8	0.0	34.4	0.1	0.0	0.0	0.0	13.5	0.0	0.0	0.0	15.9	0.7	38.1	1.4	0.0	8.2	1.2	3.1	1.5	1.3	1.3	1.2	3.8	0.5	2.6	2.4	0.0	8.3	0.0	0.0	0.1	0.2	0.1	2.5	0.0	5.7	0.0	2.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	22.0	0.0	21.0	0.0	0.0	1.3	28.8	0.0	0.0	32.3	0.0	4.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1
CEACAM4	CGM7	ENSG00000105352	"Carcinoembryonic antigen related cell adhesion molecule 4"	O75871	19	41618971-41627074	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"blood: 41.5;bone marrow: 22.5;lymphoid tissue: 30.2"	"Group enriched"	"Detected in some"	7	"Kupffer cells: 39.1;Macrophages: 11.5"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in some"			"Cell type enriched"	"Detected in many"	4	"neutrophil: 41.5"	"Lineage enriched"	"Detected in many"	4	"granulocytes: 41.5"	"Cell line enriched"	"Detected in some"	6	"U-937: 9.5"															NA	NA						"unprognostic (1.10e-2)"	"unprognostic (1.52e-2)"	"unprognostic (1.24e-1)"	"unprognostic (4.48e-1)"	"unprognostic (3.20e-2)"	"unprognostic (3.83e-2)"	"unprognostic (9.11e-2)"	"unprognostic (5.59e-2)"	"unprognostic (1.79e-2)"	"unprognostic (1.97e-1)"	"unprognostic (1.04e-1)"	"unprognostic (2.17e-1)"	"unprognostic (2.09e-9)"	"unprognostic (3.65e-2)"	"unprognostic (2.95e-2)"	"unprognostic (1.47e-1)"	"unprognostic (4.34e-1)"	1.8	0.5	0.2	5.5	0.5	22.5	0.5	0.1	1.0	0.4	0.5	0.1	0.2	0.4	0.4	3.3	1.0	1.0	1.6	3.4	0.9	0.3	2.2	1.2	6.4	30.2	1.7	0.1	0.5	1.5	0.0	0.7	1.1	0.9	0.9	0.3	1.6	0.9	0.2	0.3	0.3	1.4	1.2	1.2	27.5	0.8	0.6	0.3	1.0	0.4	0.0	1.4	0.9	0.5	0.1	7.9	41.5	10.3	0.0	3.5	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.5	0.0	0.0	10.3	1.8	0.0	7.5	0.0	0.1	0.4	0.0	7.9	0.0	0.2	0.0	41.5	0.0	3.2	0.0	3.5	3.5	0.2	0.5	0.1	1.0	0.9	0.3	1.7	0.1	0.9	0.3	0.0	3.8	0.5	0.0	0.3	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.6	39.1	0.0	0.0	11.5	1.7	2.8	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CORO1A	"coronin-1, HCORO1, p57"	ENSG00000102879	"Coronin 1A"	P31146	16	30182827-30189076	"Disease related genes, Plasma proteins, Predicted intracellular proteins"		Actin-binding	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"blood: 204.4;bone marrow: 94.9;lymphoid tissue: 99.8"	"Group enriched"	"Detected in many"	5	"B-cells: 445.3;Hofbauer cells: 429.4;Kupffer cells: 429.2;Macrophages: 313.3;monocytes: 310.2;T-cells: 809.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Daudi: 86.3;HL-60: 60.2;HMC-1: 104.2;JURKAT: 54.9;MOLT-4: 58.2;NB-4: 68.9;RPMI-8226: 90.9;U-698: 56.3;U-937: 76.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB046473, HPA051132"	Enhanced		Approved	Cytosol		NA	NA		130000000	Cytosol		"CAB046473: AB_10602363, HPA051132: AB_2681355"	"unprognostic (4.17e-3)"	"unprognostic (3.64e-3)"	"unprognostic (3.86e-2)"	"prognostic favorable (6.91e-4)"	"unprognostic (2.41e-1)"	"prognostic favorable (4.42e-4)"	"unprognostic (1.99e-2)"	"unprognostic (8.27e-3)"	"unprognostic (8.26e-3)"	"unprognostic (4.30e-1)"	"unprognostic (1.54e-1)"	"unprognostic (2.25e-1)"	"prognostic unfavorable (5.74e-7)"	"unprognostic (2.55e-1)"	"unprognostic (2.37e-2)"	"unprognostic (7.16e-2)"	"unprognostic (2.01e-1)"	6.4	4.9	12.7	58.9	10.8	94.9	4.4	7.8	13.6	2.9	5.0	6.0	0.2	8.3	3.0	3.0	4.7	5.9	8.6	4.8	10.4	7.8	4.9	3.8	13.7	99.8	9.6	8.2	2.2	2.7	0.6	3.0	4.8	7.3	3.3	2.9	2.2	12.3	1.6	1.3	3.4	28.7	4.1	9.0	92.0	8.5	1.1	7.5	86.0	3.6	3.2	64.8	15.8	3.1	41.6	67.7	204.4	67.5	39.1	66.4	101.2	0.2	0.3	1.0	2.1	0.0	0.0	0.5	0.2	0.0	0.5	0.2	0.0	0.6	86.3	0.5	0.0	0.1	0.4	0.4	1.0	0.1	27.6	0.2	9.1	0.0	1.3	0.1	60.2	104.2	0.3	0.0	0.4	0.0	0.0	0.1	54.9	0.1	44.4	0.3	7.3	58.2	68.9	0.4	0.2	0.6	31.7	1.6	90.9	0.1	0.4	1.6	1.2	0.2	10.4	0.2	0.0	0.1	35.0	0.1	0.4	0.8	0.2	0.2	34.5	45.5	56.3	0.3	76.3	0.6	52.5	58.3	204.4	53.7	67.5	50.5	41.6	48.4	52.2	67.7	41.6	46.6	48.1	105.8	39.1	66.3	38.2	66.4	101.2	12.7	10.8	7.8	13.6	10.4	7.8	9.6	8.2	7.3	7.5	20.8	52.4	445.3	1.0	10.1	1.2	1.2	17.8	5.3	7.9	1.8	0.0	4.1	0.0	3.5	0.4	3.6	1.1	0.0	0.8	13.9	9.4	0.7	83.0	2.1	429.4	0.0	5.8	20.9	429.2	0.4	0.6	313.3	30.4	310.2	1.7	0.8	6.6	28.8	0.0	3.7	0.7	6.5	7.2	0.0	0.9	8.0	4.1	809.5	1.3	1.0
CRTAM	CD355	ENSG00000109943	"Cytotoxic and regulatory T cell molecule"	O95727	11	122838500-122872639	"CD markers, Predicted membrane proteins"	"Adaptive immunity, Cell adhesion, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"brain: 140.8"	"Cell type enhanced"	"Detected in some"	25	"Hofbauer cells: 6.2;Kupffer cells: 9.1;Macrophages: 7.2;T-cells: 34.1"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in some"	24	"cerebellum: 140.8"	"Cell type enhanced"	"Detected in many"		"NK-cell: 25.7"	"Group enriched"	"Detected in many"	5	"NK-cells: 25.7;T-cells: 16.7"	"Cell line enriched"	"Detected in single"	34	"SCLC-21H: 17.4"	"Region enriched"	"Detected in single"	44	"cerebellum: 115.2"	"Low region specificity"	"Detected in all"									NA	NA		3200000				"unprognostic (3.51e-3)"	"unprognostic (6.73e-4)"	"unprognostic (1.33e-2)"	"unprognostic (3.73e-3)"	"unprognostic (2.40e-2)"	"unprognostic (5.25e-4)"	"unprognostic (1.25e-1)"	"unprognostic (3.66e-2)"	"unprognostic (5.27e-2)"	"unprognostic (1.71e-1)"	"unprognostic (5.49e-3)"	"unprognostic (2.32e-1)"	"unprognostic (1.83e-4)"	"unprognostic (6.01e-2)"	"unprognostic (4.26e-2)"	"unprognostic (3.87e-2)"	"unprognostic (6.59e-2)"	0.4	0.3	0.3	2.7	0.4	1.9	0.4	140.8	0.4	0.3	0.4	0.2	0.1	0.4	0.8	0.4	0.3	0.3	1.8	0.3	0.3	0.3	0.3	1.0	2.2	10.6	0.4	0.1	0.3	0.3	0.0	0.3	0.2	5.8	0.3	0.5	0.3	0.7	0.1	0.3	0.3	1.3	0.2	1.2	4.4	0.7	0.3	0.1	3.3	0.3	0.2	4.3	1.1	0.3	0.1	1.7	0.6	4.4	25.7	16.7	2.8	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.5	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.4	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	2.2	0.2	6.7	2.7	6.5	0.0	0.7	13.5	1.7	0.1	2.2	16.7	0.6	25.7	4.4	0.1	0.0	2.8	0.3	0.4	140.8	0.4	0.3	0.3	0.4	0.1	5.8	0.1	0.0	1.4	0.0	0.4	1.3	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.1	0.1	0.3	1.1	0.0	6.2	0.0	0.0	0.6	9.1	0.6	0.0	7.2	3.3	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.4	0.6	0.1	34.1	0.0	0.3
CXCR2	"CD182, CMKAR2, IL8RB"	ENSG00000180871	"C-X-C motif chemokine receptor 2"	P25025	2	218125289-218137253	"Cancer-related genes, CD markers, G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins"	Chemotaxis	"G-protein coupled receptor, Receptor, Transducer"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"blood: 216.1"	"Cell type enhanced"	"Detected in some"	21	"Alveolar cells type 2: 17.5;Club cells: 3.4;granulocytes: 5.8;Kupffer cells: 5.0;Macrophages: 4.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in many"	59	"neutrophil: 216.1"	"Lineage enriched"	"Detected in many"	109	"granulocytes: 216.1"	"Group enriched"	"Detected in some"	11	"BEWO: 12.4;HL-60: 6.9;HMC-1: 14.4;THP-1: 13.1;U-937: 12.9"	"Low region specificity"	"Detected in single"							"CAB016268, HPA031999, HPA032017"	Enhanced		Supported	"Nucleoplasm,Plasma membrane,Microtubules,Mitotic spindle"		NA	NA			"Plasma membrane"	"Nucleoplasm, Microtubules, Mitotic spindle"	"CAB016268: AB_626893, HPA031999: AB_2674105, HPA032017: AB_2674112"	"unprognostic (4.89e-2)"	"unprognostic (2.01e-1)"	"unprognostic (5.63e-2)"	"unprognostic (1.10e-2)"	"unprognostic (1.58e-1)"	"unprognostic (3.13e-1)"	"unprognostic (1.33e-1)"	"unprognostic (2.13e-1)"	"unprognostic (5.96e-2)"	"unprognostic (1.22e-2)"	"unprognostic (5.67e-2)"	"unprognostic (1.41e-1)"	"unprognostic (7.54e-2)"	"unprognostic (1.04e-1)"	"unprognostic (7.23e-2)"	"unprognostic (8.18e-2)"	"unprognostic (5.48e-2)"	9.3	0.9	1.3	25.6	1.5	4.0	0.6	1.2	1.3	5.2	0.6	0.5	2.5	0.0	0.8	1.1	18.1	3.3	5.2	4.3	1.5	0.6	0.7	4.6	16.7	40.5	6.6	0.0	1.2	1.7	0.0	0.7	4.5	1.7	1.9	0.3	1.8	3.3	2.6	0.6	3.0	0.7	1.4	4.1	30.6	1.0	1.1	0.7	0.6	0.6	4.8	10.1	5.4	6.4	0.0	1.6	216.1	1.9	0.4	1.9	1.0	0.0	0.0	0.1	0.0	0.0	0.0	12.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	6.9	14.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.3	1.1	0.2	0.0	0.0	0.3	0.0	1.0	0.0	0.7	0.0	0.0	0.0	0.1	0.0	0.5	0.0	13.1	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	12.9	0.0	3.6	1.9	3.2	1.9	0.5	0.0	0.0	0.0	0.4	0.8	0.0	0.0	0.7	216.1	0.4	0.2	1.6	0.0	1.0	1.3	1.5	1.2	1.3	1.5	0.6	6.6	0.0	1.7	0.7	0.0	17.5	0.0	0.9	0.0	0.0	0.2	0.0	0.0	3.4	0.0	0.0	0.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.6	0.2	0.2	5.8	0.0	1.6	0.0	0.0	0.0	5.0	0.0	0.0	4.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	1.0	0.0	1.8
DCSTAMP	"DC-STAMP, FIND, TM7SF4"	ENSG00000164935	"Dendrocyte expressed seven transmembrane protein"	Q9H295	8	104339087-104356689	"Predicted membrane proteins, Transporters"	"Differentiation, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	5	"adipose tissue: 28.8;lung: 18.2"	"Group enriched"	"Detected in some"	4	"Hofbauer cells: 7.5;Macrophages: 2.5"	"Cancer enriched"	"Detected in some"	46	"thyroid cancer: 45.3"	"Region enriched"	"Detected in single"	4	"amygdala: 3.5"	"Cell type enriched"	"Detected in single"	8	"non-classical monocyte: 1.5"	"Lineage enriched"	"Detected in single"	16	"monocytes: 1.5"	"Cell line enhanced"	"Detected in some"		"fHDF/TERT166: 1.1;RPMI-8226: 1.2;SuSa: 1.4;U-87 MG: 4.5;U-937: 1.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (1.11e-2)"	"unprognostic (1.22e-2)"	"unprognostic (8.41e-2)"	"unprognostic (2.96e-2)"	"unprognostic (8.48e-4)"	"unprognostic (2.14e-1)"	"unprognostic (5.40e-2)"	"unprognostic (1.51e-2)"	"unprognostic (3.08e-2)"	"unprognostic (1.18e-2)"	"unprognostic (5.26e-2)"	"unprognostic (2.45e-1)"	"unprognostic (1.61e-3)"	"unprognostic (8.84e-2)"	"unprognostic (1.36e-1)"	"unprognostic (8.05e-2)"	"unprognostic (8.34e-3)"	28.8	0.1	3.5	0.3	0.2	0.4	1.2	0.0	0.6	0.6	0.0	0.0	0.0	0.0	0.0	5.0	0.0	0.3	0.3	0.0	0.8	0.2	0.1	1.0	18.2	0.8	0.2	0.0	0.8	0.2	0.0	0.0	0.1	0.2	0.1	0.1	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.6	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.4	1.4	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	4.5	1.6	0.5	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.9	3.5	0.2	0.0	0.6	0.8	0.2	0.2	0.0	0.2	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	7.5	0.0	0.0	0.0	0.6	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
DOK2	"Dok-2, p56dok-2"	ENSG00000147443	"Docking protein 2"	O60496	8	21908873-21913860	"Predicted intracellular proteins"	"Host-virus interaction"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"blood: 138.5"	"Cell type enhanced"	"Detected in many"	12	"Hofbauer cells: 113.3;Kupffer cells: 141.8;Macrophages: 166.3;T-cells: 159.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Cell type enhanced"	"Detected in many"		"eosinophil: 138.5"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"HDLM-2: 10.1;HEL: 21.6;HMC-1: 46.4;JURKAT: 8.4;THP-1: 16.7;U-937: 16.2"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"CAB004379, HPA005507, HPA066571"	Enhanced		Approved	"Nucleoplasm,Nuclear bodies,Golgi apparatus,Cytosol"		NA	NA		1200000	Cytosol	"Nucleoplasm, Nuclear bodies, Golgi apparatus"	"CAB004379: AB_627449, HPA005507: , HPA066571: AB_2732749"	"unprognostic (5.39e-2)"	"unprognostic (8.84e-3)"	"unprognostic (8.72e-3)"	"unprognostic (1.74e-3)"	"unprognostic (2.14e-2)"	"unprognostic (2.30e-3)"	"unprognostic (1.34e-1)"	"unprognostic (7.22e-2)"	"prognostic favorable (4.31e-4)"	"unprognostic (2.22e-1)"	"unprognostic (4.19e-2)"	"unprognostic (1.90e-1)"	"prognostic unfavorable (2.20e-4)"	"unprognostic (1.88e-1)"	"unprognostic (1.24e-2)"	"unprognostic (3.19e-1)"	"unprognostic (2.80e-1)"	13.6	3.3	0.6	14.2	0.6	8.4	3.5	0.5	0.6	2.4	4.4	0.4	2.1	3.5	2.0	5.9	3.8	2.8	4.8	3.8	0.6	0.7	2.7	4.6	14.0	12.3	1.5	0.2	2.4	2.3	0.0	1.5	5.3	1.4	3.9	1.6	2.6	2.9	0.6	1.4	1.8	5.9	3.4	2.2	28.6	3.2	1.9	0.7	17.9	1.8	2.7	13.5	4.4	9.8	1.4	38.9	138.5	55.9	27.1	52.8	60.8	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.1	0.0	21.6	0.0	0.0	0.0	0.1	46.4	0.0	0.0	0.0	0.0	0.0	0.0	8.4	0.3	1.9	0.0	0.0	0.3	3.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.7	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.5	16.2	0.0	44.9	45.1	138.5	39.0	55.9	18.0	1.4	27.4	29.5	38.9	0.6	15.4	19.1	3.4	27.1	49.3	0.7	52.8	60.8	0.6	0.6	0.5	0.6	0.6	0.7	1.5	0.2	1.4	0.7	3.0	27.3	13.0	0.5	10.2	0.0	1.7	0.0	2.7	2.3	3.5	0.0	0.6	0.0	0.0	0.1	1.3	0.0	0.0	0.0	0.9	5.1	0.2	36.8	0.9	113.3	0.0	0.0	4.3	141.8	0.0	0.3	166.3	18.6	8.2	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	3.1	0.3	1.7	7.4	0.8	159.2	0.0	0.9
DOK3	FLJ22570	ENSG00000146094	"Docking protein 3"	Q7L591	5	177501907-177511274	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"blood: 47.5;bone marrow: 51.8;lymphoid tissue: 50.0"	"Cell type enhanced"	"Detected in some"	14	"granulocytes: 17.4;Hofbauer cells: 49.3;Kupffer cells: 45.9;Macrophages: 19.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"neutrophil: 47.5"	"Group enriched"	"Detected in many"	6	"B-cells: 12.7;granulocytes: 47.5;monocytes: 23.2"	"Cell line enhanced"	"Detected in many"		"Daudi: 41.4;HMC-1: 33.7;REH: 51.0;U-698: 40.9;U-937: 29.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			HPA077312	Enhanced		Supported	"Nucleoplasm,Plasma membrane,Cytokinetic bridge,Cytosol"		NA	NA		750000	"Plasma membrane"	"Nucleoplasm, Cytokinetic bridge, Cytosol"	"HPA077312: AB_2732339"	"unprognostic (2.21e-2)"	"unprognostic (1.14e-2)"	"unprognostic (2.05e-2)"	"unprognostic (5.74e-3)"	"unprognostic (2.32e-2)"	"unprognostic (1.34e-3)"	"unprognostic (4.17e-2)"	"unprognostic (2.20e-1)"	"unprognostic (8.00e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.21e-2)"	"unprognostic (1.60e-1)"	"prognostic unfavorable (3.82e-11)"	"unprognostic (1.34e-1)"	"unprognostic (7.25e-2)"	"unprognostic (1.55e-1)"	"unprognostic (3.78e-2)"	6.9	2.4	2.7	22.6	7.1	51.8	4.7	2.7	3.3	1.4	2.4	1.5	0.4	3.6	1.4	2.5	2.4	3.3	2.4	2.2	3.6	2.2	2.3	4.0	10.9	26.3	6.1	0.7	2.0	1.8	0.4	1.4	4.0	4.1	2.1	1.8	2.3	4.1	1.0	1.3	1.0	10.8	2.4	7.6	50.0	2.9	3.1	2.9	1.9	1.7	0.6	21.7	4.8	1.5	12.7	4.8	47.5	23.2	0.1	0.1	7.8	1.4	2.2	1.5	1.8	0.9	0.1	4.0	1.2	0.2	4.0	3.7	3.3	0.6	41.4	0.9	1.0	2.0	2.5	3.4	2.1	1.9	7.5	4.5	6.7	5.2	0.6	0.3	15.6	33.7	0.5	1.3	4.5	0.4	0.4	0.7	3.3	4.6	18.2	1.4	3.8	0.7	19.7	3.8	0.4	3.9	51.0	3.1	0.3	1.2	1.5	2.2	1.4	0.5	0.6	1.8	1.4	3.5	22.1	0.9	3.8	3.6	1.9	1.4	3.7	4.0	40.9	0.8	29.5	0.7	4.7	20.6	19.9	0.1	20.4	0.1	12.7	0.0	0.1	4.8	6.7	0.0	0.0	47.5	0.1	23.2	0.3	0.0	7.8	2.7	7.1	2.7	3.3	3.6	2.2	6.1	0.7	4.1	2.9	0.0	9.3	13.0	0.1	0.2	0.6	0.4	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.2	0.0	0.4	0.0	0.0	0.2	0.5	0.4	0.1	17.4	0.0	49.3	0.0	0.0	8.0	45.9	0.0	0.6	19.8	1.7	1.0	0.1	0.5	0.0	0.0	1.1	0.0	0.6	0.0	0.4	3.0	1.9	0.3	0.8	0.0	0.6	0.1
FPR2	"ALXR, FMLP-R-II, FMLPX, FPR2A, FPRH2, FPRL1, HM63, LXA4R"	ENSG00000171049	"Formyl peptide receptor 2"	P25090	19	51752026-51770526	"G-protein coupled receptors, Predicted membrane proteins"	Chemotaxis	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"blood: 128.2;lymphoid tissue: 32.2"	"Cell type enhanced"	"Detected in some"	13	"Hofbauer cells: 10.2;Kupffer cells: 24.7;Late spermatids: 14.9;Macrophages: 25.4"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in some"	10	"neutrophil: 128.2"	"Lineage enriched"	"Detected in many"	10	"granulocytes: 128.2"	"Cell line enriched"	"Detected in some"	18	"U-937: 26.0"									HPA029154	Approved					NA	NA					"HPA029154: AB_10602133"	"unprognostic (3.11e-1)"	"unprognostic (5.20e-2)"	"unprognostic (1.71e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.65e-1)"	"unprognostic (1.81e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.00e-1)"	"unprognostic (1.23e-1)"	"unprognostic (5.04e-2)"	"unprognostic (3.90e-4)"	"unprognostic (3.41e-5)"	"unprognostic (1.08e-2)"	"unprognostic (4.69e-2)"	"unprognostic (5.10e-2)"	"unprognostic (1.90e-1)"	7.9	1.1	0.6	30.7	2.1	8.7	0.8	0.4	1.9	0.6	0.8	0.8	0.0	0.4	0.6	0.2	1.0	2.6	3.3	5.0	1.9	0.6	1.3	2.4	17.3	32.2	2.8	0.0	1.6	1.1	0.0	1.1	4.4	2.3	0.6	0.1	1.1	1.0	0.0	1.1	0.4	1.1	3.3	3.0	29.1	1.2	2.5	1.6	0.8	1.0	0.9	0.3	4.4	2.2	0.0	1.7	128.2	12.7	0.0	0.0	3.9	0.0	0.0	0.0	0.0	0.0	0.9	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.1	0.0	0.3	0.1	0.1	0.2	0.7	0.0	0.3	0.0	0.3	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.2	0.5	0.2	0.0	0.0	0.0	0.0	0.1	0.0	1.4	0.0	0.1	0.0	0.2	0.0	0.2	0.0	0.0	0.8	26.0	0.0	0.4	12.7	0.6	0.0	11.3	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	128.2	0.0	7.5	0.3	0.0	3.9	0.6	2.1	0.4	1.9	1.9	0.6	2.8	0.0	2.3	1.6	0.0	5.3	0.8	0.0	0.0	0.0	0.2	0.0	2.7	0.0	0.0	0.0	0.1	0.0	0.0	7.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	4.7	0.4	10.2	0.0	0.0	0.6	24.7	14.9	0.0	25.4	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0
GAPT	"C5orf29, FLJ33641"	ENSG00000175857	"GRB2 binding adaptor protein, transmembrane"	Q8N292	5	58491435-58497090	"Predicted intracellular proteins"	"B-cell activation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"blood: 117.8"	"Group enriched"	"Detected in some"	9	"B-cells: 29.7;granulocytes: 52.1;Hofbauer cells: 15.1;Kupffer cells: 25.6;Macrophages: 34.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in many"	5	"eosinophil: 117.8"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 117.8"	"Cell line enhanced"	"Detected in some"		"HEL: 27.4;HL-60: 15.8;NB-4: 16.5;THP-1: 13.0;U-937: 45.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA011048, HPA011070"	Uncertain		Supported	"Golgi apparatus,Vesicles,Plasma membrane"		NA	NA			"Plasma membrane"	"Golgi apparatus, Vesicles"	"HPA011048: , HPA011070: AB_1848887"	"unprognostic (9.79e-2)"	"unprognostic (5.67e-3)"	"unprognostic (2.39e-2)"	"unprognostic (3.26e-2)"	"unprognostic (3.36e-2)"	"unprognostic (8.09e-4)"	"unprognostic (4.32e-1)"	"unprognostic (1.23e-3)"	"unprognostic (4.14e-2)"	"unprognostic (9.47e-3)"	"unprognostic (7.28e-2)"	"unprognostic (2.93e-1)"	"unprognostic (3.52e-3)"	"unprognostic (3.74e-2)"	"unprognostic (2.42e-2)"	"unprognostic (2.33e-2)"	"unprognostic (1.40e-2)"	1.4	0.8	1.4	15.5	2.7	8.5	1.0	0.6	1.2	1.8	1.4	1.6	0.4	1.8	1.3	2.2	3.3	1.2	3.1	1.1	1.5	1.7	1.6	1.0	7.2	19.4	4.5	0.9	0.7	1.2	0.0	1.5	0.8	4.4	2.6	2.0	1.4	2.3	0.4	0.5	0.9	8.2	2.4	5.9	25.8	1.7	0.8	3.2	5.2	1.1	0.5	23.5	5.1	1.2	12.0	25.4	117.8	8.2	0.1	0.0	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	27.4	0.0	0.0	0.0	15.8	4.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	16.5	0.0	0.0	0.0	6.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	45.7	0.0	12.3	8.2	117.8	0.0	5.7	0.0	12.0	0.0	0.0	9.4	11.9	0.0	0.0	10.1	0.1	6.6	25.4	0.0	3.4	1.4	2.7	0.6	1.2	1.5	1.7	4.5	0.9	4.4	3.2	3.0	3.4	29.7	0.0	0.0	0.0	0.2	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	52.1	0.0	15.1	0.0	0.0	0.6	25.6	0.0	0.0	34.5	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.5	0.0	0.0
GMFG		ENSG00000130755	"Glia maturation factor gamma"	O60234	19	39328353-39342372	"Plasma proteins, Predicted intracellular proteins"		"Growth factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	5	"blood: 276.5;bone marrow: 80.9;lymphoid tissue: 109.5"	"Cell type enhanced"	"Detected in many"	8	"B-cells: 303.1;Hofbauer cells: 397.1;Ito cells: 301.4;Kupffer cells: 575.9;Macrophages: 461.8;T-cells: 456.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"HMC-1: 77.0;JURKAT: 55.8;Karpas-707: 59.8;NB-4: 43.6;REH: 49.0;THP-1: 76.8;U-937: 52.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA002954	Uncertain	Approved	Approved	"Nucleoplasm,Nuclear bodies,Cytosol"		NA	NA		1500000	"Nucleoplasm, Cytosol"	"Nuclear bodies"	"HPA002954: AB_1078997"	"unprognostic (1.22e-2)"	"prognostic favorable (7.35e-4)"	"unprognostic (2.37e-2)"	"unprognostic (1.21e-3)"	"unprognostic (9.93e-2)"	"unprognostic (2.14e-2)"	"unprognostic (1.19e-1)"	"unprognostic (4.84e-2)"	"unprognostic (1.00e-1)"	"unprognostic (2.09e-1)"	"unprognostic (3.09e-1)"	"unprognostic (1.15e-1)"	"prognostic unfavorable (9.11e-6)"	"unprognostic (3.01e-1)"	"unprognostic (8.76e-3)"	"unprognostic (1.06e-1)"	"unprognostic (5.27e-3)"	22.6	6.1	7.3	29.6	7.4	80.9	16.8	2.2	4.8	6.0	8.8	4.0	1.7	5.3	4.4	9.4	6.4	7.3	8.7	7.5	6.0	4.9	9.4	9.7	28.5	42.2	8.6	2.3	4.7	3.6	1.1	3.1	18.0	5.8	6.1	7.9	4.9	8.1	2.3	5.4	4.2	17.8	6.8	8.2	86.0	5.9	2.9	5.6	109.5	9.8	7.0	37.1	11.1	7.5	39.1	57.2	276.5	79.4	41.6	88.0	106.7	0.1	0.0	0.2	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	3.8	33.5	0.3	0.0	0.0	0.2	0.0	0.1	0.1	11.3	0.0	36.4	0.0	0.5	0.6	39.0	77.0	0.1	0.0	0.0	0.1	0.1	2.0	55.8	1.3	59.8	0.3	0.0	35.5	43.6	0.0	0.0	0.0	49.0	0.4	21.9	0.0	5.2	0.1	0.0	0.1	0.2	0.2	0.0	0.1	76.8	20.0	0.0	0.4	0.1	0.1	3.4	11.6	38.3	0.2	52.7	0.3	185.2	79.4	178.1	37.7	72.3	40.0	39.1	56.7	46.6	57.2	35.0	55.9	46.4	276.5	41.6	78.9	22.2	88.0	106.7	7.3	7.4	2.2	4.8	6.0	4.9	8.6	2.3	5.8	5.6	26.8	152.0	303.1	2.8	16.6	0.0	3.1	10.2	16.0	31.8	0.0	0.0	3.0	0.0	0.8	9.5	165.1	0.3	23.3	0.6	3.4	16.0	1.1	229.0	5.5	397.1	0.0	0.0	301.4	575.9	18.8	1.7	461.8	70.9	127.2	0.3	0.3	0.3	0.0	0.4	3.9	0.0	45.3	14.6	8.1	3.0	12.9	4.6	456.6	0.3	1.4
GNGT2	GNG9	ENSG00000167083	"G protein subunit gamma transducin 2"	O14610	17	49202791-49210574	"Predicted intracellular proteins, RAS pathway related proteins, Transporters"		Transducer		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in many"	5	"blood: 29.1;lymphoid tissue: 21.1;retina: 46.7"	"Cell type enhanced"	"Detected in many"	18	"Cone photoreceptor cells: 68.7;Kupffer cells: 22.4;Macrophages: 17.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"non-classical monocyte: 29.1"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"Daudi: 36.4;HDLM-2: 31.2;HUVEC TERT2: 9.4;RH-30: 11.6;TIME: 9.1;U-698: 11.2"	"Low region specificity"	"Detected in some"							HPA043381	Enhanced					NA	NA					"HPA043381: AB_2678455"	"unprognostic (9.11e-2)"	"unprognostic (4.09e-3)"	"unprognostic (1.99e-2)"	"unprognostic (4.62e-5)"	"unprognostic (1.34e-1)"	"unprognostic (3.20e-3)"	"unprognostic (1.75e-1)"	"unprognostic (7.37e-2)"	"unprognostic (1.30e-2)"	"unprognostic (2.11e-2)"	"unprognostic (2.08e-1)"	"unprognostic (1.14e-1)"	"prognostic unfavorable (3.11e-4)"	"unprognostic (1.35e-1)"	"unprognostic (1.19e-1)"	"unprognostic (6.92e-2)"	"unprognostic (1.23e-1)"	2.7	2.1	2.7	9.4	3.7	1.3	1.8	0.7	2.2	2.1	2.3	2.0	0.4	2.6	1.6	1.2	1.8	1.7	3.3	2.4	2.5	1.9	3.0	2.6	6.2	12.2	3.2	0.4	1.7	1.2	0.1	1.4	1.9	2.2	2.2	3.3	46.7	1.6	1.1	0.6	0.6	4.9	2.9	4.5	21.1	1.7	0.8	2.5	6.0	2.5	1.4	16.6	3.6	5.1	2.0	9.7	0.9	29.1	10.6	14.4	5.4	0.3	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.7	0.7	0.5	0.0	0.0	36.4	0.3	0.1	0.0	0.0	0.0	0.0	2.1	31.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	9.4	4.5	0.0	0.2	0.8	0.0	2.7	2.2	0.3	0.0	0.0	7.0	11.6	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.1	9.1	0.0	5.8	0.0	0.0	0.1	1.6	11.2	0.1	0.1	0.0	0.0	4.3	0.4	14.4	21.5	12.6	1.9	2.4	10.2	9.7	2.0	1.5	5.9	0.9	10.6	29.1	0.8	1.8	5.4	2.7	3.7	0.7	2.2	2.5	1.9	3.2	0.4	2.2	2.5	0.0	1.4	5.6	0.0	0.3	2.3	0.6	0.0	0.0	1.2	0.0	68.7	0.0	3.3	0.0	0.6	4.7	0.0	0.0	0.0	0.1	0.2	0.1	0.0	0.0	11.1	0.0	0.0	2.5	22.4	6.5	0.6	17.7	0.0	7.2	0.0	3.3	0.0	0.0	0.0	0.0	12.3	6.5	0.0	0.0	0.0	0.1	0.2	14.0	0.0	0.0
JAML	"AMICA, AMICA1, Gm638"	ENSG00000160593	"Junction adhesion molecule like"	Q86YT9	11	118193740-118225094	"Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion, Immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"blood: 202.6"	"Cell type enhanced"	"Detected in some"	19	"Alveolar cells type 2: 48.3;Kupffer cells: 117.5;Macrophages: 185.0;T-cells: 45.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"eosinophil: 202.6"	"Group enriched"	"Detected in many"	4	"dendritic cells: 60.5;granulocytes: 202.6;monocytes: 59.0"	"Cell line enriched"	"Detected in some"	5	"HMC-1: 24.9"	"Region enriched"	"Detected in single"	9	"cerebellum: 7.0"	"Region enriched"	"Detected in many"	12	"cerebellum: 113.6"	"HPA005854, HPA047919"	Approved		Supported	"Nucleoplasm,Plasma membrane"		NA	NA		1400000	"Plasma membrane"	Nucleoplasm	"HPA005854: , HPA047919: AB_2680209"	"unprognostic (3.91e-3)"	"unprognostic (1.55e-3)"	"unprognostic (3.00e-2)"	"unprognostic (1.28e-3)"	"unprognostic (2.87e-3)"	"prognostic favorable (3.11e-4)"	"unprognostic (2.80e-1)"	"prognostic favorable (3.92e-4)"	"unprognostic (1.14e-1)"	"unprognostic (3.17e-1)"	"unprognostic (8.69e-2)"	"unprognostic (5.08e-1)"	"unprognostic (6.43e-3)"	"unprognostic (8.96e-2)"	"unprognostic (3.12e-2)"	"unprognostic (4.10e-2)"	"unprognostic (1.58e-2)"	6.7	2.1	0.9	23.1	1.1	6.6	2.1	5.3	0.8	4.1	8.4	0.7	1.3	6.1	3.8	9.6	4.0	3.1	8.9	3.1	0.9	0.9	3.4	4.3	34.4	43.2	3.7	0.5	2.1	1.8	0.0	2.7	4.2	2.3	3.4	8.3	6.7	6.7	1.1	1.0	2.2	14.0	4.7	1.8	43.4	3.9	1.9	0.6	14.3	2.6	5.9	25.0	9.8	3.0	0.3	60.5	202.6	59.0	1.4	25.2	40.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	5.1	0.0	1.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.6	0.0	0.0	0.0	1.7	0.0	0.0	24.9	0.0	0.0	0.0	0.0	0.0	0.0	4.3	0.0	0.0	0.0	0.0	0.3	2.3	0.3	2.7	0.0	0.0	0.0	0.1	0.0	0.6	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.7	0.0	0.2	0.0	5.8	59.0	202.6	3.9	36.6	25.2	0.3	7.0	7.4	60.5	0.1	8.3	6.7	126.6	1.4	17.1	46.6	11.1	40.1	0.9	1.1	5.3	0.8	0.9	0.9	3.7	0.5	2.3	0.6	6.0	48.3	15.4	0.1	0.0	0.0	0.0	0.0	4.0	10.3	1.8	0.0	0.1	0.0	0.1	0.7	0.0	0.0	0.0	0.3	0.2	0.4	0.1	14.0	2.1	29.9	0.0	0.0	8.0	117.5	0.9	0.0	185.0	0.0	11.8	0.0	0.0	0.1	0.0	0.0	0.6	0.1	0.0	0.0	0.1	1.4	0.0	0.3	45.3	0.0	0.1
LST1	"B144, D6S49E, LST-1"	ENSG00000204482	"Leukocyte specific transcript 1"	O00453	6	31586124-31588909	"Predicted intracellular proteins, Predicted membrane proteins"	"Cell shape, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"blood: 115.3;bone marrow: 60.9;lymphoid tissue: 72.4"	"Group enriched"	"Detected in many"	6	"Hofbauer cells: 354.0;Kupffer cells: 1112.1;Macrophages: 1026.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	9	"classical monocyte: 38.4;eosinophil: 60.8;intermediate monocyte: 95.8;myeloid DC: 34.1;neutrophil: 99.1;non-classical monocyte: 115.3"	"Group enriched"	"Detected in all"	12	"dendritic cells: 34.1;granulocytes: 99.1;monocytes: 115.3"	"Cell line enhanced"	"Detected in some"		"HEL: 11.9;HMC-1: 23.3;MOLT-4: 11.7;NB-4: 24.2;THP-1: 58.1;U-937: 30.9"															NA	NA						"unprognostic (1.08e-2)"	"prognostic favorable (7.89e-4)"	"unprognostic (6.99e-2)"	"unprognostic (4.16e-3)"	"unprognostic (3.13e-1)"	"unprognostic (3.92e-2)"	"unprognostic (3.65e-1)"	"unprognostic (7.06e-3)"	"unprognostic (2.81e-3)"	"unprognostic (2.12e-1)"	"unprognostic (1.70e-1)"	"unprognostic (1.28e-1)"	"prognostic unfavorable (5.97e-5)"	"unprognostic (1.47e-1)"	"prognostic unfavorable (7.62e-4)"	"unprognostic (1.03e-1)"	"unprognostic (1.95e-1)"	4.6	3.1	5.2	14.9	7.3	60.9	2.4	1.0	4.0	1.5	3.3	7.7	0.2	4.2	1.3	3.9	1.9	2.2	2.8	3.2	4.9	5.4	2.8	11.9	16.2	25.7	9.7	1.9	2.3	1.6	0.7	2.2	7.0	6.2	2.7	2.6	2.6	3.0	1.7	1.0	2.3	4.1	4.2	13.6	72.4	2.8	0.9	6.6	12.6	1.5	1.2	5.8	4.1	1.7	1.9	34.1	99.1	115.3	1.6	7.0	35.7	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.7	0.2	0.0	0.0	0.1	0.1	0.1	0.1	3.8	0.0	11.9	0.0	0.0	0.2	8.7	23.3	0.0	0.1	0.0	0.4	0.0	0.3	0.2	0.0	0.0	0.0	0.0	11.7	24.2	0.0	0.0	0.0	5.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	58.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.7	0.0	30.9	0.0	8.6	38.4	60.8	0.8	95.8	7.0	1.9	1.3	1.7	34.1	1.8	0.9	0.8	99.1	1.6	115.3	6.0	0.9	35.7	5.2	7.3	1.0	4.0	4.9	5.4	9.7	1.9	6.2	6.6	32.8	129.2	43.8	0.3	31.3	0.0	1.7	7.6	20.1	23.9	10.4	0.0	2.5	0.0	0.6	0.9	11.7	0.0	0.0	0.2	2.3	12.2	0.3	68.2	2.6	354.0	0.0	0.0	27.0	1112.1	3.2	3.4	1026.6	42.2	27.9	0.0	0.5	0.1	0.0	1.1	2.2	0.2	25.8	3.6	0.6	2.2	24.7	4.5	39.9	0.0	0.3
MSR1	"CD204, SCARA1, SR-A, SR-AI, SR-AII, SR-AIII"	ENSG00000038945	"Macrophage scavenger receptor 1"	P21757	8	16107878-16567490	"Cancer-related genes, CD markers, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	Endocytosis	Receptor	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	5	"adipose tissue: 88.1;lung: 70.4"	"Group enriched"	"Detected in many"	4	"Hofbauer cells: 144.7;Kupffer cells: 246.5;Macrophages: 103.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"intermediate monocyte: 16.0"	"Lineage enriched"	"Detected in many"	5	"monocytes: 16.0"	"Group enriched"	"Detected in many"	7	"BJ hTERT+: 48.2;REH: 18.3"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"HPA000272, CAB032491"	Enhanced					NA	NA		25000			"CAB032491: AB_672722, HPA000272: AB_1846269"	"unprognostic (8.19e-3)"	"unprognostic (4.87e-2)"	"unprognostic (1.93e-2)"	"unprognostic (2.10e-1)"	"unprognostic (9.24e-2)"	"unprognostic (1.32e-2)"	"unprognostic (5.85e-3)"	"unprognostic (2.89e-1)"	"unprognostic (9.70e-2)"	"unprognostic (1.62e-2)"	"unprognostic (7.19e-2)"	"unprognostic (8.82e-2)"	"unprognostic (2.76e-2)"	"unprognostic (9.16e-2)"	"unprognostic (7.39e-2)"	"unprognostic (6.85e-2)"	"unprognostic (4.69e-2)"	88.1	9.0	2.2	6.1	4.5	3.7	6.9	10.4	3.3	4.5	3.1	1.8	1.0	2.1	3.1	6.2	2.4	4.5	11.4	8.0	3.8	3.1	9.5	13.6	70.4	6.9	4.3	0.8	6.7	3.8	1.2	2.6	10.4	7.7	3.2	3.9	4.5	6.2	2.3	3.2	1.6	4.0	6.5	11.9	10.9	2.5	4.9	3.1	1.5	2.2	1.7	0.7	10.8	1.8	1.5	1.0	3.0	16.0	0.3	1.3	0.5	0.6	0.9	1.3	0.6	0.6	0.6	0.6	0.3	48.2	0.1	0.2	1.6	0.1	1.5	2.4	0.4	0.3	0.3	0.3	0.4	0.9	0.2	2.0	2.0	1.8	1.9	0.4	1.0	1.1	0.3	0.4	0.4	0.7	0.8	0.0	0.8	0.7	1.4	0.9	1.9	0.6	0.6	0.2	0.7	0.6	18.3	1.0	0.4	0.9	2.8	1.0	0.5	0.4	1.3	0.1	2.4	0.2	0.5	1.1	1.3	0.5	5.0	1.3	4.9	3.8	3.3	0.5	0.7	1.0	1.1	3.1	0.5	0.9	16.0	0.4	0.9	0.7	0.7	1.0	1.5	1.3	0.9	3.0	0.3	7.8	0.5	0.6	0.5	2.2	4.5	10.4	2.7	3.8	3.1	4.3	0.8	7.7	3.1	20.8	40.5	8.2	0.0	2.4	0.0	1.7	5.1	12.0	14.8	3.5	23.6	0.5	1.7	0.0	2.2	1.3	0.0	0.0	0.0	0.4	0.9	0.0	16.3	0.9	144.7	0.0	0.0	7.4	246.5	2.1	1.7	103.5	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.7	19.4	0.9	3.3	1.4	1.8	0.7	1.3	0.0	0.1
MYO1F		ENSG00000142347	"Myosin IF"	O00160	19	8520790-8577577	"Disease related genes, Plasma proteins, Predicted intracellular proteins"		"Actin-binding, Calmodulin-binding, Motor protein, Myosin"	"Deafness, Disease mutation, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"blood: 64.9;bone marrow: 50.6;lung: 17.1;lymphoid tissue: 56.1"	"Cell type enhanced"	"Detected in many"	12	"Hofbauer cells: 69.4;Kupffer cells: 191.9;Macrophages: 117.9;T-cells: 142.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 64.9"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"HDLM-2: 15.5;HL-60: 15.3;HMC-1: 27.2;NB-4: 60.4;THP-1: 45.0;U-937: 24.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA055242, HPA056036"	Enhanced		Enhanced	Cytosol		NA	NA		8800	Cytosol		"HPA055242: AB_2682754, HPA056036: "	"unprognostic (4.86e-2)"	"unprognostic (5.86e-3)"	"unprognostic (1.39e-2)"	"unprognostic (1.04e-3)"	"unprognostic (1.76e-2)"	"unprognostic (2.12e-3)"	"unprognostic (2.28e-1)"	"unprognostic (2.13e-1)"	"unprognostic (2.10e-2)"	"unprognostic (2.33e-1)"	"unprognostic (7.47e-3)"	"unprognostic (2.86e-1)"	"prognostic unfavorable (3.27e-4)"	"unprognostic (3.23e-1)"	"unprognostic (2.64e-2)"	"unprognostic (1.57e-1)"	"unprognostic (9.35e-2)"	7.6	3.7	4.8	22.9	9.1	50.6	3.6	1.0	4.6	2.2	4.3	7.5	0.4	4.6	2.1	4.7	2.7	5.4	6.5	4.0	5.2	3.1	3.7	6.2	17.1	24.8	9.0	1.7	2.5	2.3	0.6	2.3	4.8	6.9	3.3	2.3	3.5	3.3	1.3	1.2	1.8	8.5	3.9	9.9	56.1	3.9	1.3	7.0	4.2	2.7	1.8	11.1	6.8	2.5	1.5	15.4	64.9	23.7	7.5	14.9	18.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.1	0.0	0.1	0.0	0.0	0.0	15.5	0.0	11.2	0.0	0.0	0.0	15.3	27.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	7.3	0.0	0.0	0.0	60.4	0.0	0.0	0.1	0.3	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	45.0	3.8	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.1	24.8	0.0	14.4	23.7	24.5	14.9	19.6	11.6	1.5	5.9	10.2	15.4	0.7	0.4	4.6	64.9	7.5	22.4	1.9	8.1	18.6	4.8	9.1	1.0	4.6	5.2	3.1	9.0	1.7	6.9	7.0	3.0	20.1	25.2	1.9	3.0	0.7	2.1	7.6	0.0	4.5	1.8	2.0	4.1	1.7	1.2	5.2	2.7	2.1	23.3	0.8	6.0	3.1	1.2	30.1	5.6	69.4	6.4	1.2	14.1	191.9	3.6	2.3	117.9	6.8	53.3	1.7	1.4	1.7	1.9	1.1	2.1	0.3	0.0	2.8	2.7	2.1	4.6	4.2	142.2	2.4	1.4
NCF4	"p40phox, SH3PXD4"	ENSG00000100365	"Neutrophil cytosolic factor 4"	Q15080	22	36860988-36878015	"Disease related genes, Plasma proteins, Predicted intracellular proteins"			"Chronic granulomatous disease, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"blood: 130.3;bone marrow: 69.0;lymphoid tissue: 66.0"	"Cell type enhanced"	"Detected in many"	14	"B-cells: 49.2;granulocytes: 71.7;Hofbauer cells: 162.7;Kupffer cells: 83.9;Macrophages: 82.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"basophil: 58.0;eosinophil: 76.4;neutrophil: 130.3"	"Lineage enriched"	"Detected in many"	7	"granulocytes: 130.3"	"Cell line enhanced"	"Detected in some"		"HEL: 18.6;HMC-1: 88.9;NB-4: 31.5;REH: 16.2;RPMI-8226: 31.3;THP-1: 29.6;U-937: 16.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"CAB010146, HPA036156, HPA057975"	Enhanced		Enhanced	Cytosol		NA	NA			Cytosol		"CAB010146: AB_627989, HPA036156: AB_2674974, HPA057975: AB_2683568"	"unprognostic (3.27e-2)"	"unprognostic (1.55e-2)"	"unprognostic (2.68e-2)"	"unprognostic (1.36e-3)"	"unprognostic (1.35e-1)"	"unprognostic (2.78e-3)"	"unprognostic (4.20e-2)"	"unprognostic (3.69e-2)"	"unprognostic (4.03e-2)"	"unprognostic (2.70e-1)"	"unprognostic (3.27e-2)"	"unprognostic (2.54e-1)"	"prognostic unfavorable (7.06e-8)"	"unprognostic (3.60e-1)"	"unprognostic (2.23e-2)"	"unprognostic (1.19e-1)"	"unprognostic (2.42e-1)"	10.4	5.8	4.4	24.8	5.6	69.0	5.6	0.7	2.8	3.4	7.4	2.5	1.2	5.0	2.2	8.1	4.4	5.9	7.2	8.0	3.9	2.2	4.4	4.2	17.5	21.2	8.0	1.0	3.3	2.1	0.6	2.6	10.3	4.6	5.1	5.3	4.2	6.5	2.2	2.6	2.3	16.0	4.3	7.7	66.0	3.9	3.0	5.4	5.0	3.5	2.8	22.2	9.0	7.1	12.6	10.0	130.3	19.5	0.4	10.8	10.2	0.2	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	7.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	18.6	0.0	0.0	0.0	2.7	88.9	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	5.9	0.0	0.1	0.0	31.5	0.0	0.0	0.0	16.2	0.0	31.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	29.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	5.5	0.0	16.5	0.0	58.0	19.5	76.4	0.2	9.6	1.1	12.6	3.9	0.8	9.1	8.9	0.2	0.2	130.3	0.4	6.4	10.0	10.8	10.2	4.4	5.6	0.7	2.8	3.9	2.2	8.0	1.0	4.6	5.4	3.0	28.4	49.2	2.2	2.5	0.0	0.8	0.0	1.4	9.1	1.8	0.0	2.5	0.0	0.6	0.3	1.4	0.4	0.0	2.7	14.2	2.5	0.3	71.7	0.6	162.7	0.0	0.0	0.6	83.9	1.0	0.6	82.4	13.5	17.2	0.3	0.0	1.2	17.3	0.0	0.2	0.2	0.0	0.4	0.0	0.2	1.9	10.9	17.0	1.2	3.8
RGS19	"GAIP, RGSGAIP"	ENSG00000171700	"Regulator of G protein signaling 19"	P49795	20	64073181-64079988	"Predicted intracellular proteins"	Autophagy	"Signal transduction inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"blood: 95.0;bone marrow: 36.7;lymphoid tissue: 43.1"	"Cell type enhanced"	"Detected in many"	9	"B-cells: 73.1;Hofbauer cells: 121.6;Kupffer cells: 93.5;Macrophages: 101.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HMC-1: 49.8;NB-4: 39.2;THP-1: 33.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA056384, HPA069984"	Enhanced		Supported	"Nucleoli fibrillar center,Cell Junctions"		NA	NA			"Cell Junctions"	"Nucleoli fibrillar center"	"HPA056384: AB_2732602, HPA069984: AB_2732145"	"unprognostic (3.98e-2)"	"unprognostic (2.32e-1)"	"unprognostic (4.26e-3)"	"unprognostic (8.42e-2)"	"unprognostic (2.03e-1)"	"unprognostic (9.94e-2)"	"prognostic unfavorable (2.75e-4)"	"unprognostic (1.25e-2)"	"unprognostic (2.41e-2)"	"unprognostic (3.91e-1)"	"unprognostic (3.22e-1)"	"unprognostic (2.88e-1)"	"prognostic unfavorable (2.06e-9)"	"unprognostic (1.35e-1)"	"unprognostic (2.68e-2)"	"unprognostic (6.77e-2)"	"unprognostic (4.66e-3)"	7.0	4.8	6.0	19.0	7.5	36.7	12.7	2.5	5.0	3.3	3.5	6.8	1.9	5.5	2.9	2.9	4.4	4.1	4.5	5.1	5.4	4.9	4.0	7.2	10.4	27.2	9.1	2.6	2.7	3.9	0.8	2.6	5.6	5.7	3.9	1.8	2.2	6.1	2.2	1.6	4.3	10.6	3.2	7.1	43.1	5.7	2.8	7.2	15.2	3.7	1.2	19.5	6.1	3.6	17.3	29.9	95.0	55.5	9.1	13.8	22.0	4.9	7.5	2.1	3.9	0.9	1.6	3.7	3.1	2.2	6.5	2.7	11.1	6.8	8.7	8.7	1.9	6.9	4.8	2.2	4.0	1.5	4.2	4.1	12.4	3.8	4.5	1.3	25.2	49.8	1.1	2.4	2.7	0.9	1.3	4.2	5.8	4.7	4.6	1.9	8.8	18.6	39.2	2.2	4.2	9.6	15.7	1.3	6.2	1.8	2.4	4.1	3.9	3.2	2.0	4.1	1.1	2.6	33.3	4.4	6.1	3.1	1.0	3.0	2.9	2.2	10.5	3.4	19.3	4.0	33.1	35.5	95.0	13.4	50.4	13.8	17.3	12.7	12.7	29.9	17.1	8.9	9.2	79.6	9.1	55.5	17.1	13.5	22.0	6.0	7.5	2.5	5.0	5.4	4.9	9.1	2.6	5.7	7.2	3.0	5.5	73.1	4.9	8.7	0.0	2.2	0.0	2.7	4.5	1.8	0.0	2.6	0.0	10.2	0.3	15.2	0.0	23.3	12.7	7.2	6.4	7.3	47.4	0.6	121.6	0.0	0.0	12.3	93.5	0.4	4.0	101.1	5.0	24.4	0.5	0.5	12.8	3.4	1.1	1.7	0.0	12.9	7.2	0.2	6.8	7.9	1.5	48.0	0.8	7.5
SIGLEC14		ENSG00000254415	"Sialic acid binding Ig like lectin 14"	Q08ET2	19	51642553-51646801	"Plasma proteins, Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"blood: 48.7;bone marrow: 13.3;lymphoid tissue: 21.6"	"Cell type enhanced"	"Detected in some"	22	"Hofbauer cells: 16.1;Kupffer cells: 31.5;Macrophages: 9.8"	"Low cancer specificity"	"Detected in many"							"Group enriched"	"Detected in many"	6	"classical monocyte: 25.8;intermediate monocyte: 29.7;myeloid DC: 15.9;neutrophil: 48.7;non-classical monocyte: 21.3"	"Group enriched"	"Detected in many"	6	"dendritic cells: 15.9;granulocytes: 48.7;monocytes: 29.7"	"Cell line enriched"	"Detected in some"	4	"HMC-1: 47.5"									"HPA014377, HPA014428"	Uncertain		Uncertain	"Vesicles,Plasma membrane"		NA	NA		18000000	Vesicles	"Plasma membrane"	"HPA014377: AB_2189277, HPA014428: "	"unprognostic (3.05e-1)"	"unprognostic (1.75e-1)"	"unprognostic (6.47e-3)"	"unprognostic (1.60e-1)"	"unprognostic (3.83e-2)"	"unprognostic (1.50e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.46e-1)"	"unprognostic (9.77e-3)"	"unprognostic (9.28e-2)"	"unprognostic (6.73e-2)"	"unprognostic (1.02e-1)"	"unprognostic (4.28e-3)"	"unprognostic (8.38e-2)"	"unprognostic (4.17e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.89e-1)"	1.6	1.6	0.6	13.0	0.5	13.3	0.5	0.0	0.3	0.6	0.6			0.0	0.4	0.0	0.2	1.7	1.0	0.8	0.6	0.6	0.4	1.4	5.1	6.2	1.3		0.1	0.3	0.0	0.1	0.9		0.4	0.4		0.7	0.1	0.0	0.0	4.0	0.9	1.9	21.6	0.7	1.3			0.2		7.0	2.2	0.2	4.9	15.9	48.7	29.7	0.1	0.0	7.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.7	47.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	11.4	0.0	3.6	25.8	0.4	0.0	29.7	0.0	4.9	0.0	0.0	15.9	4.8	0.0	0.0	48.7	0.1	21.3	2.9	0.0	7.6											0.0	1.4	0.9	0.0	0.0	0.0	0.1	2.5	1.4	0.0	0.0	0.0	0.3	0.0	0.0	5.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.2	16.1	0.0	0.0	0.0	31.5	0.0	0.3	9.8	0.0	1.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0
SIGLEC5	"CD170, CD33L2, OB-BP2, SIGLEC-5"	ENSG00000105501	"Sialic acid binding Ig like lectin 5"	O15389	19	51611927-51645545	"CD markers, Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"blood: 46.7;bone marrow: 13.5"	"Group enriched"	"Detected in some"	10	"granulocytes: 8.1;Hofbauer cells: 4.6;Kupffer cells: 8.5;Macrophages: 3.2"	"Cancer enhanced"	"Detected in single"		"urothelial cancer: 1.7"					"Cell type enhanced"	"Detected in many"		"neutrophil: 46.7"	"Group enriched"	"Detected in many"	6	"granulocytes: 46.7;monocytes: 13.7"	"Group enriched"	"Detected in some"	6	"HMC-1: 35.8;U-937: 14.8"									"HPA009085, CAB024900"	Supported					NA	NA					"CAB024900: , HPA009085: AB_1079965"	"unprognostic (1.83e-1)"	"unprognostic (1.94e-1)"	"unprognostic (2.02e-2)"	"unprognostic (1.03e-2)"	"unprognostic (4.39e-2)"	"unprognostic (1.62e-2)"	"unprognostic (1.73e-1)"	"unprognostic (1.01e-1)"	"unprognostic (3.28e-1)"	"unprognostic (7.44e-2)"	"unprognostic (1.01e-1)"	"unprognostic (4.05e-1)"	"unprognostic (3.71e-4)"	"unprognostic (4.37e-2)"	"unprognostic (3.55e-3)"	"unprognostic (4.02e-1)"	"unprognostic (1.95e-1)"	1.2	0.4	0.4	6.4	0.5	13.5	0.2	0.1	0.2	0.1	0.3			0.0	0.2	0.0	0.2	0.1	0.3	0.3	0.3	0.2	0.2	1.2	1.5	2.5	0.5		0.1	0.2	0.0	0.2	0.5		0.2	0.4		0.4	0.0	0.0	0.1	3.4	0.5	0.7	5.9	0.3	0.7			0.2		1.9	0.8	0.1	0.8	4.7	46.7	13.7	0.2	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.7	35.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	4.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.8	0.0	3.6	6.4	0.1	0.0	7.5	0.0	0.8	0.0	0.0	4.7	0.7	0.0	0.0	46.7	0.2	13.7	1.5	0.0	2.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	8.1	0.0	4.6	0.0	0.0	0.0	8.5	0.0	0.3	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0
SNX20	"SLIC-1, SLIC1"	ENSG00000167208	"Sorting nexin 20"	Q7Z614	16	50666300-50681353	"Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"blood: 58.5;lymphoid tissue: 42.5"	"Cell type enhanced"	"Detected in some"	7	"B-cells: 16.1;Cardiomyocytes: 14.3;Hofbauer cells: 16.3;Kupffer cells: 17.3;Macrophages: 22.2;monocytes: 17.2;Sertoli cells: 12.9;T-cells: 22.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"HDLM-2: 13.3;HMC-1: 37.2;NB-4: 21.6;RPMI-8226: 9.2;THP-1: 9.7;U-266/70: 12.1;U-937: 12.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA043649	Uncertain		Uncertain	Nucleoplasm		NA	NA			Nucleoplasm		"HPA043649: AB_10965697"	"unprognostic (1.53e-2)"	"prognostic favorable (9.07e-4)"	"unprognostic (5.58e-2)"	"unprognostic (5.06e-3)"	"unprognostic (9.03e-2)"	"prognostic favorable (6.56e-4)"	"unprognostic (1.97e-1)"	"unprognostic (1.26e-2)"	"unprognostic (1.78e-2)"	"unprognostic (1.04e-1)"	"unprognostic (4.06e-2)"	"unprognostic (1.84e-1)"	"prognostic unfavorable (6.00e-6)"	"unprognostic (3.24e-1)"	"unprognostic (3.37e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.54e-1)"	2.0	1.4	2.5	12.7	5.7	10.7	1.3	1.2	2.7	1.3	1.7	1.4	0.1	1.8	1.2	2.4	1.7	1.7	3.1	2.7	1.5	1.5	1.9	1.5	5.7	21.1	2.6	0.2	1.1	1.0	0.1	1.1	1.8	3.1	1.8	2.3	1.3	3.0	0.2	0.7	1.4	7.4	1.6	3.0	23.6	2.1	0.6	3.3	42.5	1.5	0.8	22.3	4.7	1.2	5.5	27.9	58.5	30.7	11.1	30.1	15.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	13.3	0.0	2.3	0.0	0.0	0.0	3.3	37.2	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	21.6	0.0	0.0	0.0	1.1	0.0	9.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.7	0.1	0.0	0.0	0.0	0.0	12.1	6.3	2.9	0.0	12.9	0.0	58.5	15.1	45.5	10.1	26.6	12.6	5.5	18.0	12.2	27.9	5.2	14.0	9.5	14.1	11.1	30.7	7.7	30.1	15.8	2.5	5.7	1.2	2.7	1.5	1.5	2.6	0.2	3.1	3.3	0.0	0.0	16.1	0.0	0.7	0.0	14.3	2.5	0.0	2.3	0.0	0.0	0.1	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.1	0.4	0.0	4.7	0.0	16.3	1.6	0.0	0.0	17.3	0.0	0.0	22.2	0.0	17.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.9	0.0	0.0	0.0	0.5	0.3	22.4	0.0	0.0
VNN2	"FOAP-4, GPI-80"	ENSG00000112303	"Vanin 2"	O95498	6	132743870-132763459	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"blood: 85.2;lung: 36.4;lymphoid tissue: 43.6"	"Cell type enhanced"	"Detected in many"	11	"Ciliated cells: 17.4;Ductal cells: 36.1;Kupffer cells: 27.8;Macrophages: 17.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in many"	8	"neutrophil: 85.2"	"Lineage enriched"	"Detected in all"	8	"granulocytes: 85.2"	"Cell line enriched"	"Detected in some"	8	"Daudi: 35.7"					"Not detected"	"Not detected"									NA	NA		270000				"unprognostic (2.13e-1)"	"unprognostic (1.15e-1)"	"unprognostic (9.60e-3)"	"unprognostic (5.71e-2)"	"unprognostic (2.14e-1)"	"unprognostic (5.61e-3)"	"unprognostic (1.98e-3)"	"unprognostic (4.38e-1)"	"unprognostic (3.07e-1)"	"unprognostic (3.46e-1)"	"unprognostic (2.84e-1)"	"unprognostic (8.30e-2)"	"prognostic unfavorable (2.72e-7)"	"unprognostic (1.62e-1)"	"unprognostic (8.17e-2)"	"unprognostic (2.01e-1)"	"unprognostic (5.45e-2)"	10.1	1.4	1.1	9.5	1.1	10.8	1.4	1.4	1.4	1.8	1.9	0.8	0.0	0.7	0.9	3.1	2.1	4.3	10.2	10.5	1.1	1.1	2.8	5.6	36.4	39.8	3.8	0.3	2.1	2.4	0.0	1.2	8.6	1.5	2.4	0.9	1.8	1.3	0.2	1.0	0.7	3.6	2.4	2.2	43.6	2.8	3.6	0.6	3.4	1.4	0.7	17.7	7.3	10.9	6.4	2.2	85.2	10.9	5.8	6.7	5.7	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	35.7	0.7	0.0	0.6	0.0	0.0	0.0	0.0	4.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.6	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.6	0.9	0.0	0.0	1.5	10.9	0.0	4.2	2.4	1.7	6.4	1.4	4.9	2.2	5.5	4.5	6.7	85.2	5.8	1.5	0.4	0.9	5.7	1.1	1.1	1.4	1.4	1.1	1.1	3.8	0.3	1.5	0.6	0.0	10.7	0.0	0.0	0.0	0.0	1.2	2.5	17.4	3.4	0.0	0.0	0.6	0.0	36.1	0.0	0.0	0.0	0.0	0.3	0.1	0.5	5.6	4.7	0.0	11.3	0.0	0.0	4.3	27.8	0.0	0.0	17.1	0.0	1.8	0.0	0.0	4.0	0.0	0.0	0.3	0.0	6.5	0.5	0.0	0.0	0.0	1.1	6.1	0.0	8.4
BTK	"AGMX1, ATK, IMD1, PSCTK1, XLA"	ENSG00000010671	"Bruton tyrosine kinase"	Q06187	X	101349447-101390796	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"Adaptive immunity, Apoptosis, Immunity, Innate immunity, Transcription, Transcription regulation"	"Kinase, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Disease mutation, Dwarfism, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"blood: 77.5;lymphoid tissue: 37.0"	"Cell type enhanced"	"Detected in some"	19	"B-cells: 86.8;granulocytes: 203.6;Hofbauer cells: 50.3;Kupffer cells: 53.4;Macrophages: 53.0;monocytes: 52.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"basophil: 77.5"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"Daudi: 29.5;HEL: 40.9;HMC-1: 147.5;U-937: 21.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA001198, HPA002028, CAB016689"	Enhanced		Supported	"Plasma membrane,Cytosol"		NA	NA		610000	"Plasma membrane, Cytosol"		"CAB016689: AB_1611894, HPA001198: AB_1078305, HPA002028: AB_1078306"	"unprognostic (3.19e-2)"	"unprognostic (2.51e-3)"	"unprognostic (1.06e-2)"	"unprognostic (3.66e-2)"	"unprognostic (5.69e-2)"	"unprognostic (3.76e-3)"	"unprognostic (6.55e-2)"	"unprognostic (3.58e-3)"	"unprognostic (6.02e-2)"	"unprognostic (3.12e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.41e-1)"	"unprognostic (2.08e-3)"	"unprognostic (7.80e-2)"	"unprognostic (1.29e-2)"	"unprognostic (1.56e-2)"	"unprognostic (8.14e-2)"	7.3	2.4	3.3	23.5	5.6	14.0	2.6	0.8	3.6	2.3	3.0	4.7	0.3	2.2	1.9	2.6	2.4	2.0	3.7	3.3	3.3	2.5	2.2	2.5	10.7	25.1	5.4	1.2	1.2	1.5	0.2	1.4	3.2	4.1	2.5	4.5	1.5	3.2	1.0	1.0	2.5	12.9	3.3	10.8	37.0	3.1	1.3	6.3	4.0	1.7	1.8	36.7	5.8	2.0	13.7	13.2	77.5	20.7	0.0	0.0	6.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	29.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	40.9	0.0	0.0	0.0	16.4	147.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.6	0.3	0.0	0.0	0.0	11.5	0.2	0.0	0.0	12.3	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	9.8	0.0	0.0	0.0	0.0	0.0	0.3	0.2	14.0	0.0	21.4	0.0	77.5	11.3	19.3	0.0	18.1	0.0	13.7	0.0	0.0	13.2	13.7	0.0	0.0	4.5	0.0	20.7	6.0	0.0	6.1	3.3	5.6	0.8	3.6	3.3	2.5	5.4	1.2	4.1	6.3	3.0	12.8	86.8	0.1	0.9	0.0	0.4	0.0	0.0	1.2	0.0	0.0	1.1	0.0	0.0	0.2	0.6	0.0	23.3	0.0	0.4	0.5	0.0	203.6	0.0	50.3	0.0	0.0	1.3	53.4	0.0	0.3	53.0	3.3	52.3	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.3	0.4	1.6	0.3	1.6	0.8	0.0	0.1
CCL4	"Act-2, AT744.1, LAG1, MIP-1-beta, SCYA4"	ENSG00000275302	"C-C motif chemokine ligand 4"	P13236	17	36103590-36105621	"Cancer-related genes, Predicted secreted proteins"	"Chemotaxis, Inflammatory response"	Cytokine	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in many"	4	"blood: 69.3;lung: 23.1;lymphoid tissue: 20.8"	"Cell type enhanced"	"Detected in many"	16	"Hofbauer cells: 716.7;Macrophages: 396.6;T-cells: 809.7"	"Low cancer specificity"	"Detected in all"							"Group enriched"	"Detected in many"	5	"gdT-cell: 69.3;MAIT T-cell: 21.8;memory CD8 T-cell: 40.6;naive CD8 T-cell: 30.5"	"Lineage enriched"	"Detected in many"	17	"T-cells: 69.3"	"Group enriched"	"Detected in some"	23	"Karpas-707: 5.2;U-266/70: 11.5;U-266/84: 5.5"									CAB007805	Approved				"Secreted to blood"	NA	NA	144000				"CAB007805: AB_598177"	"unprognostic (6.03e-2)"	"unprognostic (2.48e-2)"	"prognostic favorable (3.54e-4)"	"prognostic favorable (1.97e-5)"	"unprognostic (2.06e-1)"	"unprognostic (7.02e-2)"	"unprognostic (9.08e-2)"	"unprognostic (2.69e-1)"	"prognostic favorable (3.97e-4)"	"unprognostic (3.45e-1)"	"unprognostic (8.57e-2)"	"unprognostic (1.61e-1)"	"prognostic unfavorable (1.68e-4)"	"unprognostic (3.71e-1)"	"unprognostic (1.30e-1)"	"unprognostic (1.18e-1)"	"unprognostic (1.18e-2)"	2.3	2.6	0.0	3.7	0.4	9.3	5.7	0.1	3.6	0.9	2.9	1.4	0.5	0.2	1.6	0.8	1.7	1.6	4.4	3.8	0.0		1.3	5.7	23.1	20.8	1.1	0.0	3.4	0.9	0.0	0.2	4.3	0.9	1.1	1.0	3.9	1.6	1.6	0.5	0.0	0.9	1.4	1.5	10.4	2.3	0.3	0.0	1.0	1.6	2.0	4.3	1.9	0.8	1.8	0.4	4.0	0.6	3.0	69.3	11.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.5	5.5	0.3	0.0	0.0	0.0	1.7	0.2	4.0	69.3	0.0	21.8	0.9	7.7	40.6	0.1	1.8	2.3	30.5	1.6	3.0	0.6	0.4	0.0	11.6											0.0	85.1	30.1	1.1	13.9	1.0	10.2	5.1	10.7	12.5	0.0	0.0	7.8	0.0	0.4	21.7	11.3	0.4	0.0	0.3	9.8	13.1	1.2	58.9	4.3	716.7	1.6	1.2	14.7	198.1	23.7	0.9	396.6	49.0	1.8	0.1	1.2	0.1	0.0	0.4	1.8	5.1	0.0	11.3	0.4	0.2	12.7	21.6	809.7	0.0	1.6
CD14		ENSG00000170458	"CD14 molecule"	P08571	5	140631728-140633701	"Cancer-related genes, CD markers, Plasma proteins, Predicted secreted proteins"	"Immunity, Inflammatory response, Innate immunity"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	4	"blood: 189.4;liver: 165.8"	"Cell type enhanced"	"Detected in many"	25	"Hofbauer cells: 2162.9;Ito cells: 448.7;Kupffer cells: 633.7;Macrophages: 438.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"classical monocyte: 189.4"	"Group enriched"	"Detected in many"	5	"granulocytes: 52.3;monocytes: 189.4"	"Cell line enhanced"	"Detected in many"		"A549: 9.1;CACO-2: 13.9;SiHa: 16.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001887, HPA002127, CAB033631, CAB072865, CAB072866"	Enhanced		Approved	Vesicles	"Secreted to blood"	NA	NA	2750000000	15000000000	Vesicles		"CAB033631: AB_781932, CAB072865: AB_2665714, CAB072866: AB_2665715, HPA001887: AB_1078442, HPA002127: AB_1078440"	"unprognostic (1.92e-1)"	"unprognostic (1.68e-1)"	"unprognostic (3.42e-3)"	"unprognostic (3.89e-2)"	"unprognostic (3.29e-2)"	"unprognostic (1.54e-1)"	"unprognostic (4.71e-3)"	"unprognostic (4.88e-2)"	"unprognostic (2.16e-1)"	"unprognostic (1.06e-1)"	"unprognostic (1.83e-1)"	"unprognostic (2.43e-1)"	"prognostic unfavorable (6.80e-5)"	"unprognostic (1.20e-2)"	"unprognostic (6.87e-3)"	"unprognostic (8.12e-2)"	"unprognostic (6.92e-2)"	27.9	44.1	9.0	42.7	25.2	9.8	11.7	3.5	8.9	5.6	10.0	6.0	1.8	5.4	5.6	24.0	4.5	12.0	14.6	18.9	11.7	7.4	12.7	165.8	23.8	34.7	21.6	2.9	14.2	5.3	4.3	10.1	37.3	18.9	8.5	9.2	14.6	28.5	5.8	10.2	3.5	12.1	21.4	18.2	35.5	6.6	6.5	17.3	2.2	7.9	5.8	6.6	15.9	3.8	0.5	23.6	52.3	189.4	0.2	0.4	124.2	0.1	9.1	0.1	0.6	1.3	0.3	0.5	0.9	4.2	1.3	1.6	13.9	2.2	0.4	0.7	5.0	1.1	3.9	0.0	1.7	0.2	0.1	0.9	0.3	0.5	1.8	4.9	1.0	0.4	4.0	0.2	0.2	1.3	0.4	0.0	0.2	0.2	0.2	1.3	0.3	0.0	0.6	0.2	0.2	0.3	0.3	0.4	1.1	0.2	0.0	2.4	1.0	16.7	0.4	0.5	0.2	0.3	1.7	0.6	0.2	0.3	1.5	1.3	0.7	0.9	0.5	0.4	0.4	0.1	0.4	189.4	1.0	0.3	36.6	0.4	0.5	0.2	0.2	23.6	0.1	0.3	0.2	52.3	0.2	4.8	1.3	0.1	124.2	9.0	25.2	3.5	8.9	11.7	7.4	21.6	2.9	18.9	17.3	8.9	44.2	23.9	3.1	4.5	9.5	2.5	28.1	6.7	6.8	1.8	0.0	15.3	1.7	3.3	1.3	13.8	7.9	0.0	1.6	12.6	12.3	2.2	8.1	323.7	2162.9	31.8	6.9	448.7	633.7	3.2	4.6	438.8	8.5	0.0	4.5	36.9	2.3	8.5	4.9	5.4	3.5	32.3	9.2	0.7	0.9	3.8	38.6	5.9	5.1	3.0
CD300LB	"CLM7, TREM5"	ENSG00000178789	"CD300 molecule like family member b"	A8K4G0	17	74521174-74531474	"CD markers, Predicted intracellular proteins, Predicted membrane proteins"	Immunity	Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in many"	4	"adipose tissue: 20.7;blood: 30.7;bone marrow: 8.8;lymphoid tissue: 10.9"	"Group enriched"	"Detected in some"	8	"Hofbauer cells: 6.5;Kupffer cells: 10.1;Macrophages: 10.7"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in some"			"Cell type enhanced"	"Detected in many"		"eosinophil: 30.7"	"Group enriched"	"Detected in many"	52	"dendritic cells: 10.5;granulocytes: 30.7;monocytes: 13.0"	"Group enriched"	"Detected in some"	6	"HL-60: 4.6;NB-4: 6.0;THP-1: 4.7;U-937: 2.8"									HPA060449			Approved	"Plasma membrane"		NA	NA			"Plasma membrane"		"HPA060449: "	"unprognostic (1.39e-1)"	"unprognostic (2.44e-2)"	"unprognostic (1.37e-1)"	"unprognostic (4.39e-2)"	"unprognostic (3.59e-2)"	"unprognostic (1.15e-1)"	"unprognostic (6.41e-2)"	"unprognostic (7.69e-2)"	"unprognostic (2.05e-1)"	"unprognostic (2.95e-2)"	"unprognostic (6.24e-2)"	"unprognostic (3.32e-1)"	"unprognostic (2.49e-4)"	"unprognostic (2.92e-2)"	"unprognostic (1.79e-2)"	"unprognostic (7.08e-2)"	"unprognostic (4.01e-2)"	20.7	0.9	0.2	10.9	0.5	8.8	2.0	0.4	0.5	0.6	0.8	0.3	0.1	0.7	0.7	1.0	1.1	1.2	2.8	1.6	1.5	0.4	1.2	1.0	4.4	6.5	1.2	0.1	2.0	2.3	0.0	0.7	1.1	1.0	0.8	1.1	1.6	1.2	0.1	0.3	0.4	2.0	2.2	0.6	6.6	0.7	0.7	0.1	0.9	0.6	0.1	2.2	2.6	0.7	0.0	10.5	30.7	13.0	0.3	0.1	4.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.6	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.0	0.4	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.7	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.7	2.8	0.0	0.6	13.0	30.7	0.0	5.6	0.1	0.0	0.0	0.0	10.5	0.0	0.0	0.1	13.8	0.3	0.7	6.6	0.0	4.2	0.2	0.5	0.4	0.5	1.5	0.4	1.2	0.1	1.0	0.1	0.0	0.0	0.5	0.0	0.1	0.0	0.3	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	6.5	0.0	0.0	0.6	10.1	0.0	0.0	10.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0
CLEC7A	"CD369, CLECSF12, dectin-1, hDectin-1, SCARE2"	ENSG00000172243	"C-type lectin domain containing 7A"	Q9BXN2	12	10116777-10130258	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Immunity, Inflammatory response, Innate immunity"	Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"blood: 53.9;bone marrow: 43.9;brain: 18.7;lung: 32.8;lymphoid tissue: 28.8"	"Group enriched"	"Detected in many"	11	"Hofbauer cells: 84.0;Kupffer cells: 334.2;Macrophages: 240.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"neutrophil: 53.9"	"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in some"	16	"Karpas-707: 60.8;U-266/84: 47.3"					"Low region specificity"	"Detected in many"									NA	NA						"unprognostic (1.79e-1)"	"unprognostic (1.88e-2)"	"unprognostic (2.98e-2)"	"unprognostic (3.64e-1)"	"unprognostic (3.03e-2)"	"unprognostic (5.49e-2)"	"unprognostic (5.19e-2)"	"unprognostic (5.88e-3)"	"unprognostic (2.10e-1)"	"unprognostic (9.87e-2)"	"unprognostic (7.46e-2)"	"unprognostic (4.40e-1)"	"prognostic unfavorable (1.31e-4)"	"unprognostic (1.83e-2)"	"unprognostic (3.89e-2)"	"unprognostic (5.13e-2)"	"unprognostic (1.14e-1)"	7.1	5.0	6.3	27.7	7.4	43.9	3.7	0.9	3.4	3.9	4.5	9.5	0.5	3.7	3.2	8.9	8.7	5.3	7.4	5.2	6.2	4.2	8.7	6.9	32.8	24.2	8.9	4.3	2.4	2.8	1.6	2.6	7.8	8.6	2.7	5.0	6.4	6.5	2.4	1.2	3.2	6.5	5.7	18.7	28.8	3.1	1.6	7.3	5.1	2.3	3.2	9.1	5.5	3.8	0.1	13.1	53.9	30.1	0.1	0.1	7.4	0.1	0.1	0.0	0.1	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.2	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	60.8	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.2	0.0	1.5	0.1	0.0	0.1	0.1	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.1	0.0	3.4	47.3	0.0	0.1	0.3	0.0	0.2	26.4	0.4	0.0	29.5	0.1	0.0	0.0	0.0	13.1	0.1	0.0	0.0	53.9	0.1	30.1	0.2	0.0	7.4	6.3	7.4	0.9	3.4	6.2	4.2	8.9	4.3	8.6	7.3	11.9	20.4	11.3	0.2	3.3	0.0	0.6	0.0	4.0	13.6	0.0	0.0	1.2	0.0	0.0	1.4	3.1	0.0	0.0	0.0	10.7	2.6	0.1	5.8	2.1	84.0	0.0	0.0	8.0	334.2	1.5	0.3	240.6	3.3	8.2	0.0	0.0	0.0	0.0	0.0	0.8	0.3	12.9	0.1	0.0	0.5	2.6	4.5	1.3	0.0	0.4
DLEU7	FLJ44882	ENSG00000186047	"Deleted in lymphocytic leukemia, 7"	Q6UYE1	13	50711008-50843939	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in some"	4	"brain: 13.2"	"Cell type enhanced"	"Detected in some"	23	"Bipolar cells: 13.2;Hofbauer cells: 6.2;Kupffer cells: 30.1;Macrophages: 7.8"	"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	6	"intermediate monocyte: 1.5;naive B-cell: 1.3;neutrophil: 1.2;T-reg: 1.4"	"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in some"	8	"NTERA-2: 15.4;U-698: 6.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			HPA053750	Uncertain					NA	NA					"HPA053750: AB_2682249"	"unprognostic (3.97e-2)"	"unprognostic (2.53e-1)"	"unprognostic (7.03e-2)"	"unprognostic (9.31e-2)"	"unprognostic (3.08e-1)"	"unprognostic (1.08e-1)"	"unprognostic (4.47e-3)"	"unprognostic (1.09e-1)"	"unprognostic (1.24e-1)"	"unprognostic (8.75e-3)"	"unprognostic (1.23e-1)"	"unprognostic (1.69e-1)"	"unprognostic (5.88e-2)"	"unprognostic (1.59e-1)"	"unprognostic (4.52e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.51e-1)"	0.7	1.0	4.8	0.8	7.8	0.5	0.5	5.8	13.2	0.6	0.7	0.5	0.0	0.6	0.8	3.0	0.5	0.5	0.4	0.5	4.6	5.7	1.4	0.5	0.5	0.4	3.7	4.2	0.6	0.7	0.4	0.1	0.5	4.1	0.7	0.8	0.0	0.4	0.5	0.5	1.0	0.8	0.5	1.2	0.8	0.5	0.9	0.8	1.3	1.9	0.0	0.5	0.4	0.1	1.3	0.0	1.2	1.5	0.0	1.4	0.7	0.0	0.1	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.1	15.4	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.2	0.2	0.1	0.1	0.0	0.1	0.3	0.0	6.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.2	0.0	1.3	0.1	0.0	1.2	0.0	0.0	0.0	1.4	0.7	4.8	7.8	5.8	9.9	4.6	5.7	3.7	4.2	4.1	0.8	0.0	0.3	0.0	0.0	0.0	13.2	0.1	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	6.2	0.0	0.0	0.0	30.1	0.0	0.0	7.8	0.0	1.8	0.0	0.2	0.0	0.0	1.4	0.5	1.8	0.0	0.0	0.0	0.5	0.0	0.2	0.0	0.0	0.0
FCHO1	KIAA0290	ENSG00000130475	"FCH domain only 1"	O14526	19	17747718-17788568	"Predicted intracellular proteins"	Endocytosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"blood: 25.7;bone marrow: 18.9;brain: 30.2;lymphoid tissue: 22.6;skin 1: 13.4"	"Cell type enhanced"	"Detected in many"	6	"B-cells: 10.4;granulocytes: 9.2;Kupffer cells: 12.6;Macrophages: 11.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Daudi: 28.2;RPMI-8226: 19.4;U-937: 17.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041653, HPA062981"	Approved		Enhanced	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA041653: AB_10795641, HPA062981: AB_2684915"	"unprognostic (3.02e-1)"	"unprognostic (9.52e-2)"	"unprognostic (1.80e-1)"	"unprognostic (4.54e-3)"	"unprognostic (3.62e-2)"	"unprognostic (5.63e-2)"	"unprognostic (3.80e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.84e-1)"	"unprognostic (2.16e-1)"	"unprognostic (6.93e-2)"	"unprognostic (5.48e-3)"	"unprognostic (1.72e-9)"	"unprognostic (3.76e-3)"	"unprognostic (1.18e-1)"	"unprognostic (2.21e-1)"	"unprognostic (9.77e-3)"	2.2	2.3	13.6	13.7	18.9	18.9	1.9	11.4	15.2	1.1	2.7	30.2	0.0	3.7	1.8	1.8	1.5	1.9	4.5	1.1	17.8	11.7	1.0	2.7	3.4	22.6	23.0	10.0	2.2	0.9	0.8	2.6	1.4	10.8	1.4	2.6	0.6	2.7	1.2	0.9	13.4	4.0	2.1	15.9	13.7	3.5	4.3	23.3	16.4	1.2	0.0	17.3	5.1	1.0	9.9	10.4	25.7	9.5	4.1	5.7	4.4	0.4	5.4	3.5	2.5	0.1	0.1	3.5	0.5	0.1	0.1	0.2	0.7	0.6	28.2	8.1	0.2	0.6	1.1	1.7	1.0	0.1	12.4	0.9	2.2	0.7	2.8	0.3	6.9	4.8	0.0	0.1	0.1	0.2	0.2	0.7	14.0	11.0	13.5	0.0	7.8	16.0	12.5	1.7	6.6	13.4	13.6	0.1	19.4	0.1	0.5	0.6	1.3	0.1	2.8	0.4	0.4	2.7	7.0	0.5	0.1	2.0	0.5	0.2	8.6	3.9	15.2	0.4	17.4	0.3	6.9	6.6	6.5	5.2	9.5	4.5	8.8	5.7	4.5	9.7	9.9	5.5	4.4	25.7	4.1	7.2	10.4	5.2	4.4	13.6	18.9	11.4	15.2	17.8	11.7	23.0	10.0	10.8	23.3	0.0	1.0	10.4	0.4	0.0	6.7	0.8	2.5	0.0	0.0	1.8	0.0	2.7	0.0	0.4	1.0	0.8	0.8	0.0	0.0	3.7	0.4	0.2	9.2	0.0	6.5	0.0	1.2	3.7	12.6	0.0	2.3	11.9	1.7	4.6	1.4	0.2	1.4	0.0	8.1	0.0	0.7	0.0	0.4	0.7	1.7	0.5	0.7	5.4	1.0	0.1
HCK	JTK9	ENSG00000101336	"HCK proto-oncogene, Src family tyrosine kinase"	P08631	20	32052188-32101856	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Exocytosis, Host-virus interaction, Immunity, Inflammatory response, Innate immunity, Phagocytosis"	"Kinase, Transferase, Tyrosine-protein kinase"	Proto-oncogene	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"blood: 107.1;lymphoid tissue: 72.6"	"Group enriched"	"Detected in many"	8	"Hofbauer cells: 131.2;Kupffer cells: 133.2;Macrophages: 170.5;monocytes: 221.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	15	"classical monocyte: 50.8;eosinophil: 62.5;intermediate monocyte: 96.5;myeloid DC: 31.6;neutrophil: 73.0;non-classical monocyte: 107.1"	"Group enriched"	"Detected in many"	15	"dendritic cells: 31.6;granulocytes: 73.0;monocytes: 107.1"	"Group enriched"	"Detected in some"	8	"THP-1: 23.1;U-937: 66.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB005195, HPA063768"	Approved		Supported	"Vesicles,Plasma membrane"		NA	NA			"Vesicles, Plasma membrane"		"CAB005195: AB_631619, HPA063768: AB_2685118"	"unprognostic (6.22e-2)"	"unprognostic (6.16e-3)"	"unprognostic (2.26e-2)"	"unprognostic (7.98e-2)"	"unprognostic (8.83e-2)"	"unprognostic (5.50e-2)"	"unprognostic (4.09e-2)"	"unprognostic (1.72e-2)"	"unprognostic (4.34e-2)"	"unprognostic (1.59e-1)"	"unprognostic (4.08e-2)"	"unprognostic (1.21e-1)"	"prognostic unfavorable (1.66e-4)"	"unprognostic (4.92e-2)"	"unprognostic (4.42e-2)"	"unprognostic (6.95e-2)"	"unprognostic (1.12e-1)"	12.3	5.8	5.9	40.8	13.1	20.8	4.0	1.8	5.3	3.0	5.8	6.1	0.9	5.9	2.5	5.7	3.1	5.9	6.5	8.8	6.0	3.7	4.0	7.9	20.9	50.3	11.2	1.2	3.4	2.8	0.7	2.9	8.8	8.0	3.8	5.9	3.1	4.1	1.9	3.1	2.8	7.8	10.2	9.1	72.6	3.7	2.6	8.2	5.8	3.3	1.2	16.4	9.4	3.5	4.7	31.6	73.0	107.1	1.1	0.1	40.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.3	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	5.7	0.0	0.0	0.0	1.6	0.1	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.3	0.0	23.1	0.0	0.0	0.1	0.0	0.0	0.7	0.1	3.4	0.0	66.3	0.0	0.5	50.8	62.5	0.1	96.5	0.1	4.7	0.1	0.1	31.6	3.7	0.1	0.0	73.0	1.1	107.1	2.8	0.1	40.2	5.9	13.1	1.8	5.3	6.0	3.7	11.2	1.2	8.0	8.2	6.0	21.8	10.3	3.5	2.7	0.0	1.7	2.5	2.7	6.8	7.0	0.0	0.8	1.7	0.0	0.2	1.4	0.0	0.0	0.5	0.7	1.3	0.0	5.8	0.8	131.2	0.0	1.7	1.8	133.2	0.0	0.0	170.5	1.7	221.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.2	1.0	1.4	0.5	0.0	4.6
IGSF6	DORA	ENSG00000140749	"Immunoglobulin superfamily member 6"	O95976	16	21639537-21652660	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"blood: 96.8;lymphoid tissue: 49.7"	"Group enriched"	"Detected in many"	7	"Hofbauer cells: 183.3;Kupffer cells: 173.4;Macrophages: 302.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"neutrophil: 96.8"	"Lineage enhanced"	"Detected in many"		"granulocytes: 96.8"	"Cell line enhanced"	"Detected in some"		"THP-1: 2.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA041023, HPA041072"	Uncertain					NA	NA					"HPA041023: AB_10794434, HPA041072: AB_10794262"	"unprognostic (7.94e-2)"	"prognostic favorable (4.92e-4)"	"unprognostic (1.18e-2)"	"prognostic favorable (1.54e-5)"	"unprognostic (3.27e-1)"	"unprognostic (4.03e-2)"	"unprognostic (2.31e-1)"	"unprognostic (1.74e-2)"	"unprognostic (1.35e-2)"	"unprognostic (6.76e-2)"	"unprognostic (1.10e-1)"	"unprognostic (6.28e-2)"	"unprognostic (8.12e-2)"	"unprognostic (1.81e-1)"	"unprognostic (4.42e-2)"	"unprognostic (1.52e-1)"	"unprognostic (2.02e-1)"	17.8	3.9	5.0	16.7	7.7	2.0	2.0	0.9	5.1	2.3	5.8	3.8	0.0	4.1	1.1	2.7	1.2	2.1	1.3	3.6	4.7	2.7	1.7	8.5	16.2	30.2	6.5	0.2	3.5	1.4	0.8	1.1	6.5	5.9	2.1	1.6	0.8	3.6	2.1	0.7	0.9	3.5	1.3	10.6	49.7	2.4	0.6	6.2	3.4	1.2	0.9	2.1	1.5	1.0	0.2	18.7	96.8	28.5	0.2	0.1	12.7	0.1	0.3	0.0	0.7	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.6	1.7	0.1	0.1	1.0	0.4	0.1	0.1	0.1	1.0	0.0	0.4	0.0	0.7	0.0	1.6	1.2	0.1	0.0	0.1	0.0	0.2	0.2	0.3	0.5	0.4	0.1	0.5	0.7	0.9	0.6	0.0	0.0	1.7	0.0	0.6	0.3	0.8	0.5	0.3	0.3	0.1	0.2	0.2	0.3	2.0	0.4	1.7	0.1	0.1	0.9	0.8	0.4	1.3	0.6	0.8	0.3	0.0	23.7	3.4	0.0	28.5	0.0	0.2	0.0	0.0	18.7	0.0	0.0	0.1	96.8	0.2	18.6	4.0	0.0	12.7	5.0	7.7	0.9	5.1	4.7	2.7	6.5	0.2	5.9	6.2	3.0	13.5	13.7	0.7	2.9	1.2	1.1	5.1	8.1	9.1	1.8	9.8	0.5	0.0	0.0	0.3	1.5	0.0	0.0	0.0	1.0	2.6	0.4	9.3	0.9	183.3	0.0	0.0	2.5	173.4	0.0	0.9	302.4	8.5	29.7	0.0	0.9	0.0	0.0	0.0	0.3	1.8	0.0	1.2	0.1	0.0	1.8	1.1	2.5	0.0	0.3
LILRA2	"CD85h, ILT1, LIR-7, LIR7"	ENSG00000239998	"Leukocyte immunoglobulin like receptor A2"	Q8N149	19	54572920-54590287	"CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"	"Immunity, Innate immunity"	Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"blood: 21.6;bone marrow: 21.7;lymphoid tissue: 39.9"	"Group enriched"	"Detected in some"	8	"Hofbauer cells: 21.6;Kupffer cells: 82.8;Macrophages: 28.1"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"neutrophil: 21.6"	"Group enriched"	"Detected in many"	7	"granulocytes: 21.6;monocytes: 7.1"	"Cell line enhanced"	"Detected in some"		"NB-4: 2.5;REH: 3.0;THP-1: 6.1;U-937: 13.6"														"Secreted to blood"	NA	NA		130000000				"unprognostic (2.04e-1)"	"unprognostic (7.72e-2)"	"unprognostic (6.94e-2)"	"unprognostic (1.78e-1)"	"unprognostic (1.54e-2)"	"unprognostic (2.65e-2)"	"unprognostic (8.45e-2)"	"unprognostic (3.56e-2)"	"unprognostic (1.22e-1)"	"unprognostic (3.53e-5)"	"unprognostic (2.67e-1)"	"unprognostic (1.12e-1)"	"unprognostic (5.43e-2)"	"unprognostic (5.58e-2)"	"unprognostic (3.30e-4)"	"unprognostic (4.21e-2)"	"unprognostic (6.59e-2)"	2.8	1.5	1.4	4.7	1.1	21.7	0.9	0.1	2.0	0.6	0.8	3.0	0.0	0.6	0.5	1.0	0.5	2.3	1.0	3.7	1.1	1.1	1.2	3.8	6.8	14.6	2.9	0.4	1.1	0.6	0.5	0.4	1.7	1.4	0.6	0.6	1.1	0.8	0.5	0.6	0.7	0.7	1.0	3.7	39.9	0.7	0.7	2.3	0.7	0.6	0.0	0.8	0.9	1.8	0.2	2.1	21.6	7.1	0.3	0.1	3.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.1	0.0	0.4	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.3	0.0	0.0	0.1	2.5	0.0	0.1	0.0	3.0	0.1	1.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.1	0.1	6.1	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.1	0.1	13.6	0.1	2.4	4.9	1.8	0.1	7.1	0.0	0.1	0.1	0.1	2.1	0.2	0.1	0.1	21.6	0.3	6.8	0.4	0.0	3.0	1.4	1.1	0.1	2.0	1.1	1.1	2.9	0.4	1.4	2.3	3.0	4.8	0.0	0.7	0.2	0.4	0.4	2.5	2.7	3.4	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.1	0.3	0.9	5.8	0.0	21.6	0.0	0.0	0.6	82.8	0.0	0.0	28.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.2	0.4	0.1	0.3	0.0	0.0	0.4
MS4A7	"CD20L4, CFFM4, MS4A8"	ENSG00000166927	"Membrane spanning 4-domains A7"	Q9GZW8	11	60378482-60395951	"Predicted intracellular proteins, Predicted membrane proteins"		Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in all"	4	"blood: 132.8;lymphoid tissue: 126.7"	"Group enriched"	"Detected in many"	12	"Hofbauer cells: 291.6;Kupffer cells: 748.0;Macrophages: 338.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"intermediate monocyte: 71.2;non-classical monocyte: 132.8"	"Lineage enriched"	"Detected in many"	11	"monocytes: 132.8"	"Cell line enriched"	"Detected in some"	24	"THP-1: 51.2"					"Low region specificity"	"Detected in all"			"HPA017418, CAB026387"	Approved					NA	NA					"CAB026387: , HPA017418: AB_1854137"	"unprognostic (1.43e-1)"	"unprognostic (2.60e-3)"	"unprognostic (3.24e-2)"	"unprognostic (9.67e-2)"	"unprognostic (2.04e-1)"	"unprognostic (1.81e-1)"	"unprognostic (1.04e-1)"	"unprognostic (9.51e-2)"	"unprognostic (3.02e-2)"	"unprognostic (4.85e-2)"	"unprognostic (5.79e-2)"	"unprognostic (1.90e-1)"	"unprognostic (1.43e-2)"	"unprognostic (4.59e-2)"	"unprognostic (3.90e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.03e-1)"	24.2	11.9	4.4	15.1	4.9	2.0	9.7	1.3	3.5	5.9	7.4	4.2	2.9	5.2	4.2	11.0	4.0	4.8	15.2	11.3	5.1	3.9	6.8	22.3	29.7	19.1	4.6	1.3	3.2	3.4	2.3	6.2	13.3	5.0	5.9	7.5	8.4	5.3	3.4	2.2	2.3	8.1	4.8	9.9	126.7	4.3	6.0	3.5	7.0	3.3	2.3	5.6	9.7	3.9	2.0	11.9	0.9	132.8	0.1	0.1	10.9	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	1.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.5	0.0	0.0	0.0	1.3	0.0	0.1	0.0	0.3	0.2	0.0	0.0	51.2	0.0	0.0	0.0	0.1	0.1	0.1	0.1	1.2	0.0	1.6	0.0	0.5	18.8	0.2	0.1	71.2	0.1	2.0	0.0	0.0	11.9	1.8	0.0	0.0	0.9	0.1	132.8	0.3	0.0	10.9	4.4	4.9	1.3	3.5	5.1	3.9	4.6	1.3	5.0	3.5	11.9	38.5	23.0	0.6	2.4	0.8	1.9	0.0	13.4	6.8	8.7	0.0	1.0	0.0	0.0	2.0	2.1	0.0	0.0	0.2	1.2	3.1	1.2	12.8	0.9	291.6	0.0	0.0	16.0	748.0	0.5	1.1	338.5	1.7	15.4	0.0	0.3	0.1	0.0	0.0	0.6	0.5	19.4	1.2	0.0	0.3	1.6	1.6	4.1	0.0	0.8
NCF1	"NCF1A, NOXO2, p47phox, SH3PXD1A"	ENSG00000158517	"Neutrophil cytosolic factor 1"	P14598	7	74773962-74789315	"Disease related genes, Predicted intracellular proteins"			"Chronic granulomatous disease, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"blood: 166.6;lymphoid tissue: 42.1"	"Cell type enhanced"	"Detected in many"	14	"B-cells: 168.1;Kupffer cells: 142.9;Macrophages: 51.2;monocytes: 81.2"	"Low cancer specificity"	"Detected in many"							"Group enriched"	"Detected in many"	5	"basophil: 75.1;classical monocyte: 49.6;eosinophil: 106.8;neutrophil: 166.6"	"Group enriched"	"Detected in many"	5	"granulocytes: 166.6;monocytes: 49.6"	"Group enriched"	"Detected in some"	6	"Daudi: 36.1;HMC-1: 51.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004524, HPA047836, HPA052095"	Enhanced					NA	NA					"CAB004524: AB_627987, HPA047836: AB_2680173, HPA052095: AB_2681721"	"unprognostic (4.93e-2)"	"unprognostic (8.34e-3)"	"unprognostic (1.23e-1)"	"unprognostic (1.25e-2)"	"unprognostic (8.67e-2)"	"unprognostic (3.55e-3)"	"unprognostic (7.60e-2)"	"unprognostic (4.75e-2)"	"unprognostic (6.23e-3)"	"unprognostic (9.99e-2)"	"unprognostic (6.61e-3)"	"unprognostic (1.06e-1)"	"unprognostic (2.77e-3)"	"unprognostic (3.16e-1)"	"unprognostic (4.17e-2)"	"unprognostic (3.27e-2)"	"unprognostic (2.09e-1)"	2.4	0.9	0.7	11.9	0.5	25.9	0.7	0.0	0.2	0.4	2.0			1.9	0.3	0.0	1.2	1.2	1.2	0.7	0.7	0.8	1.3	1.4	6.6	17.1	1.3		0.2	0.3	0.0	0.4	1.0		0.7	0.9		1.3	0.0	0.1	0.1	10.0	0.7	2.5	42.1	1.4	0.0			0.9		11.8	3.2	0.6	21.2	21.2	166.6	49.6	0.7	1.0	29.3	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	36.1	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.2	1.1	0.3	0.3	0.0	0.3	51.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	6.2	0.1	0.0	0.0	0.5	0.0	1.2	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.9	0.0	0.0	0.1	0.0	0.0	0.2	0.1	6.2	0.1	3.0	0.0	75.1	49.6	106.8	0.3	18.6	0.7	18.2	0.7	0.4	5.9	21.2	1.0	0.6	166.6	0.7	4.1	21.2	0.7	29.3											0.0	3.2	168.1	1.0	2.7	0.0	0.5	7.6	0.0	1.2	3.5	0.0	0.5	0.0	0.9	6.5	1.0	0.0	23.3	0.6	9.6	1.1	0.9	13.9	0.8	34.7	3.2	0.0	4.3	142.9	4.8	0.0	51.2	10.1	81.2	0.2	0.3	0.9	1.1	0.4	1.4	0.3	0.0	0.3	0.0	0.2	1.5	3.8	25.9	0.2	1.6
NCF2	"NOXA2, p67phox"	ENSG00000116701	"Neutrophil cytosolic factor 2"	P19878	1	183555563-183590876	"Disease related genes, Plasma proteins, Predicted intracellular proteins"			"Chronic granulomatous disease, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"blood: 125.2;bone marrow: 53.0;lung: 39.5;lymphoid tissue: 45.4"	"Group enriched"	"Detected in many"	6	"Ductal cells: 59.6;Hofbauer cells: 199.3;Kupffer cells: 138.6;Macrophages: 192.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"eosinophil: 125.2;neutrophil: 80.6"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"A-431: 13.4;HMC-1: 11.7;hTERT-HME1: 28.0;U-2 OS: 27.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA002327, HPA006040, CAB022160"	Enhanced		Supported	Cytosol		NA	NA			Cytosol		"CAB022160: , HPA002327: AB_1079550, HPA006040: AB_1854906"	"unprognostic (4.97e-2)"	"unprognostic (3.48e-2)"	"unprognostic (2.40e-2)"	"unprognostic (1.22e-3)"	"unprognostic (5.83e-3)"	"unprognostic (4.04e-2)"	"prognostic unfavorable (7.91e-6)"	"unprognostic (1.29e-1)"	"unprognostic (2.45e-1)"	"unprognostic (2.33e-1)"	"unprognostic (5.70e-2)"	"unprognostic (2.01e-1)"	"unprognostic (1.57e-2)"	"unprognostic (1.61e-1)"	"unprognostic (1.41e-2)"	"unprognostic (8.24e-2)"	"unprognostic (2.36e-2)"	15.3	3.1	2.0	23.0	4.5	53.0	3.9	0.7	2.8	2.9	2.8	3.7	0.2	2.3	1.8	6.1	4.1	5.2	7.2	6.4	2.0	1.8	2.9	5.4	39.5	42.7	6.8	0.4	3.5	4.2	0.6	1.9	11.5	3.8	3.4	3.7	4.2	4.4	0.8	3.5	7.1	3.8	5.8	5.5	45.4	2.6	3.9	3.2	4.2	2.0	5.6	5.5	7.3	3.5	1.4	24.3	125.2	45.7	0.2	1.0	22.7	13.4	0.4	0.0	0.0	0.0	0.0	0.1	1.0	1.2	1.8	0.8	0.1	0.4	1.6	2.3	0.4	0.3	7.6	0.0	9.9	1.6	8.4	0.0	0.0	3.4	3.1	0.0	1.0	11.7	0.0	2.2	1.8	28.0	1.1	0.0	0.0	0.0	3.0	3.1	0.1	0.1	0.5	0.2	0.8	0.8	3.6	1.2	10.1	0.4	0.1	0.0	0.0	0.1	0.0	0.4	1.0	1.5	4.7	0.6	0.0	27.2	0.0	2.5	0.5	0.7	0.3	0.2	5.4	0.0	15.5	45.7	125.2	0.1	34.4	0.1	1.4	0.4	0.1	24.3	0.8	0.2	0.1	80.6	0.2	29.7	1.3	1.0	22.7	2.0	4.5	0.7	2.8	2.0	1.8	6.8	0.4	3.8	3.2	8.9	17.8	4.8	0.1	4.8	0.4	1.1	10.2	26.8	13.6	0.0	0.0	0.8	3.3	59.6	1.0	0.7	0.0	0.0	3.3	0.8	2.1	0.3	7.0	0.4	199.3	0.0	0.0	4.3	138.6	2.1	0.6	192.4	6.8	20.8	0.0	0.0	18.4	1.1	0.0	0.1	0.6	12.9	3.4	0.0	0.2	3.8	1.6	1.3	0.0	0.8
NLRP12	"CLR19.3, Monarch1, NALP12, PAN6, PYPAF7, RNO2"	ENSG00000142405	"NLR family pyrin domain containing 12"	P59046	19	53793603-53824394	"Disease related genes, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in many"	4	"blood: 22.8;bone marrow: 11.0;lung: 6.5;lymphoid tissue: 13.5"	"Cell type enhanced"	"Detected in some"	10	"Alveolar cells type 1: 6.0;Alveolar cells type 2: 9.0;Club cells: 6.8;granulocytes: 7.0;Kupffer cells: 12.3;Macrophages: 6.1"	"Cancer enriched"	"Detected in single"	5	"testis cancer: 2.4"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in many"		"basophil: 22.8;neutrophil: 15.0"	"Group enriched"	"Detected in many"	4	"granulocytes: 22.8;monocytes: 8.7"	"Group enriched"	"Detected in some"	4	"HMC-1: 7.7;THP-1: 6.7;U-87 MG: 7.3;U-937: 6.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA042099, HPA042981"	Approved		Uncertain	"Nucleoplasm,Nuclear speckles"		NA	NA			Nucleoplasm	"Nuclear speckles"	"HPA042099: , HPA042981: AB_10795712"	"unprognostic (6.92e-2)"	"unprognostic (3.11e-1)"	"unprognostic (6.66e-3)"	"unprognostic (9.82e-2)"	"unprognostic (1.81e-4)"	"unprognostic (3.90e-2)"	"unprognostic (5.79e-2)"	"unprognostic (6.26e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.60e-5)"	"unprognostic (1.63e-1)"	"unprognostic (1.68e-1)"	"unprognostic (3.35e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.20e-1)"	"unprognostic (1.46e-2)"	"unprognostic (4.48e-1)"	1.9	0.3	0.2	4.2	0.6	11.0	0.4	0.2	0.2	0.9	0.3	0.1	0.9	0.3	0.7	0.7	0.6	1.0	0.5	3.3	0.2	0.2	0.5	0.5	6.5	13.5	0.6	0.3	1.0	0.3	0.1	0.2	1.1	0.8	0.3	0.1	0.5	1.7	0.0	0.2	0.2	0.3	1.4	0.5	10.2	0.4	1.0	0.6	0.3	0.3	0.4	0.2	1.1	1.4	0.0	3.6	22.8	8.7	0.0	0.0	2.1	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	1.6	7.7	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.6	0.0	0.0	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	6.7	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	7.3	6.1	0.0	22.8	8.7	11.0	0.0	2.6	0.0	0.0	0.0	0.0	3.6	0.0	0.0	0.0	15.0	0.0	1.5	0.0	0.0	2.1	0.2	0.6	0.2	0.2	0.2	0.2	0.6	0.3	0.8	0.6	6.0	9.0	0.0	0.7	0.3	0.8	0.4	0.0	4.0	6.8	0.0	0.0	0.1	0.0	0.0	0.1	1.4	0.0	0.0	0.0	0.1	0.4	0.7	7.0	0.0	2.4	0.0	0.0	0.0	12.3	0.0	0.3	6.1	1.7	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.6
NLRP3	"AGTAVPRL, AII, AVP, C1orf7, CIAS1, CLR1.1, FCAS, FCU, MWS, NALP3, PYPAF1"	ENSG00000162711	"NLR family pyrin domain containing 3"	Q96P20	1	247416156-247449108	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"	"Immunity, Inflammatory response, Innate immunity, Transcription, Transcription regulation"	Activator	"Amyloidosis, Cancer-related genes, Deafness, Disease mutation, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"blood: 40.3;bone marrow: 38.2"	"Group enriched"	"Detected in some"	11	"Hofbauer cells: 15.0;Kupffer cells: 26.7;Macrophages: 42.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"basophil: 40.3"	"Group enriched"	"Detected in many"	20	"dendritic cells: 13.4;granulocytes: 40.3;monocytes: 12.5"	"Cell line enhanced"	"Detected in some"		"NB-4: 7.2;THP-1: 41.6;U-937: 10.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA012878	Uncertain				"Intracellular and membrane"	NA	NA					"HPA012878: AB_1846752"	"unprognostic (3.56e-2)"	"unprognostic (1.33e-1)"	"unprognostic (6.23e-2)"	"unprognostic (3.96e-2)"	"unprognostic (1.43e-1)"	"unprognostic (2.69e-1)"	"unprognostic (7.86e-2)"	"unprognostic (4.46e-2)"	"unprognostic (3.84e-1)"	"unprognostic (7.39e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.52e-2)"	"unprognostic (4.88e-3)"	"unprognostic (2.17e-4)"	"unprognostic (1.10e-1)"	"unprognostic (6.10e-2)"	7.4	1.4	2.8	8.3	3.3	38.2	3.2	0.7	3.7	1.8	1.5	6.9	1.5	0.8	4.5	0.9	2.4	3.0	8.9	2.0	3.0	3.1	1.3	1.8	8.2	8.9	3.3	0.8	1.3	1.4	1.1	1.2	3.0	5.2	1.0	1.7	2.4	1.5	0.7	0.9	0.8	2.5	4.1	4.9	8.5	1.6	0.6	3.3	1.0	1.0	3.2	2.8	3.3	0.9	0.0	13.4	40.3	12.5	0.0	1.1	3.9	3.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.1	0.2	0.0	0.2	0.0	0.1	0.0	0.3	0.0	0.0	1.3	1.6	0.2	0.0	0.7	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	7.2	0.0	0.0	0.2	0.2	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	41.6	0.0	1.7	1.3	0.0	0.1	0.0	0.0	0.0	4.0	10.4	1.2	40.3	12.5	0.1	0.2	7.7	0.6	0.0	1.1	0.4	13.4	0.0	0.4	0.2	3.0	0.0	3.6	0.6	0.0	3.9	2.8	3.3	0.7	3.7	3.0	3.1	3.3	0.8	5.2	3.3	0.0	0.3	0.5	0.0	0.9	0.1	0.7	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.3	0.8	0.0	2.3	0.0	15.0	0.0	0.0	0.6	26.7	0.0	0.0	42.3	0.0	1.0	0.0	0.5	0.1	0.0	0.4	0.0	0.2	0.0	0.5	0.5	0.2	0.5	1.1	2.5	0.0	0.0
OSCAR		ENSG00000170909	"Osteoclast associated, immunoglobulin-like receptor"	Q8IYS5	19	54094668-54102692	"Predicted intracellular proteins, Predicted membrane proteins"		Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"blood: 20.6;bone marrow: 18.9;lung: 40.4;lymphoid tissue: 20.2"	"Group enriched"	"Detected in some"	5	"Hofbauer cells: 36.7;Kupffer cells: 33.7;Macrophages: 28.2;monocytes: 39.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	34	"classical monocyte: 20.6;eosinophil: 11.7;intermediate monocyte: 12.8;myeloid DC: 9.4;neutrophil: 18.3;non-classical monocyte: 11.2"	"Group enriched"	"Detected in many"	75	"dendritic cells: 9.4;granulocytes: 18.3;monocytes: 20.6"	"Cell line enhanced"	"Detected in some"		"EFO-21: 13.6;HHSteC: 9.3;hTERT-HME1: 4.9;NB-4: 5.4;U-937: 16.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA073996			Approved	"Nucleoplasm,Plasma membrane,Cytosol"	"Intracellular and membrane"	NA	NA		72000000	"Nucleoplasm, Plasma membrane, Cytosol"		"HPA073996: "	"unprognostic (9.09e-2)"	"unprognostic (6.79e-3)"	"unprognostic (8.47e-3)"	"unprognostic (2.14e-1)"	"unprognostic (2.12e-2)"	"unprognostic (9.04e-2)"	"unprognostic (1.39e-1)"	"unprognostic (3.86e-1)"	"unprognostic (8.57e-2)"	"unprognostic (1.15e-1)"	"unprognostic (2.05e-2)"	"unprognostic (3.01e-1)"	"prognostic unfavorable (2.71e-5)"	"unprognostic (1.84e-1)"	"unprognostic (2.88e-2)"	"unprognostic (9.69e-2)"	"unprognostic (4.28e-2)"	4.5	1.0	1.4	3.8	2.8	18.9	1.4	0.4	1.5	1.3	0.9	3.5	0.0	0.4	0.7	1.3	1.2	2.2	2.3	1.1	3.8	1.9	1.0	1.7	40.4	4.7	3.5	0.4	1.2	0.7	0.3	0.5	2.2	4.0	0.8	0.7	1.0	1.3	0.8	0.7	1.9	1.0	2.8	5.6	20.2	1.3	0.6	2.4	1.7	1.0	0.0	1.2	1.7	3.1	0.0	9.4	18.3	20.6	0.0	0.2	7.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.2	0.1	0.4	0.0	13.6	0.2	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	9.3	0.7	0.0	0.0	0.2	0.6	4.9	0.8	0.0	0.1	0.0	0.4	0.1	0.1	0.0	5.4	0.3	0.2	1.0	0.0	0.5	0.3	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	3.9	0.0	0.3	0.7	0.0	0.0	0.0	0.0	0.6	0.5	16.8	0.0	0.0	20.6	11.7	0.1	12.8	0.0	0.0	0.1	0.2	9.4	0.0	0.0	0.0	18.3	0.0	11.2	0.4	0.1	7.0	1.4	2.8	0.4	1.4	3.8	1.9	3.5	0.4	4.0	2.4	3.0	5.1	0.0	0.5	0.7	0.0	0.3	2.5	6.7	3.4	0.0	0.0	0.3	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.3	0.8	0.2	1.1	0.0	36.7	0.0	0.0	0.0	33.7	0.0	0.0	28.2	0.0	39.7	0.0	0.0	0.3	0.0	0.0	0.0	0.3	0.0	0.0	0.5	0.6	0.1	0.2	0.0	0.0	0.3
P2RY13	"FKSG77, GPR86, GPR94, P2Y13"	ENSG00000181631	"Purinergic receptor P2Y13"	Q9BPV8	3	151326312-151329548	"G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"blood: 88.4;lymphoid tissue: 44.1"	"Group enriched"	"Detected in some"	6	"Kupffer cells: 83.1;Macrophages: 40.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 88.4"	"Group enriched"	"Detected in many"	6	"granulocytes: 88.4;monocytes: 26.1"	"Cell line enhanced"	"Detected in some"		"HEK 293: 1.2;U-937: 1.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA049047	Enhanced					NA	NA					"HPA049047: AB_2680611"	"unprognostic (1.09e-3)"	"unprognostic (7.51e-4)"	"unprognostic (1.68e-2)"	"unprognostic (2.37e-3)"	"unprognostic (3.95e-2)"	"unprognostic (8.66e-3)"	"unprognostic (7.66e-2)"	"unprognostic (5.48e-3)"	"unprognostic (2.84e-3)"	"unprognostic (1.83e-1)"	"unprognostic (4.97e-2)"	"unprognostic (1.17e-1)"	"unprognostic (4.05e-1)"	"unprognostic (4.46e-1)"	"unprognostic (5.95e-2)"	"unprognostic (2.21e-3)"	"unprognostic (3.78e-1)"	4.0	2.6	5.1	13.4	6.1	15.1	2.7	1.7	8.2	1.7	2.8	13.8	0.1	3.0	1.5	2.2	2.1	2.1	2.5	1.7	4.9	4.7	1.8	5.1	5.0	35.1	7.1	3.4	1.3	2.1	1.0	1.7	3.2	8.1	2.1	4.2	2.0	1.9	2.1	1.3	1.6	7.4	3.5	8.2	44.1	1.8	1.2	5.1	2.0	1.5	1.1	5.5	3.8	1.5	0.2	10.1	88.4	26.1	0.0	0.0	10.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	1.2	0.2	0.2	0.0	0.0	0.9	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.1	0.4	0.0	0.0	0.1	0.2	0.8	0.0	0.0	0.1	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.1	0.1	1.1	0.1	0.1	23.6	20.3	0.0	23.5	0.0	0.2	0.0	0.0	10.1	0.0	0.0	0.0	88.4	0.0	26.1	0.1	0.0	10.2	5.1	6.1	1.7	8.2	4.9	4.7	7.1	3.4	8.1	5.1	0.0	9.6	3.2	0.1	0.0	0.8	0.4	0.0	1.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	2.3	0.0	6.6	1.6	0.0	0.6	83.1	0.0	0.0	40.1	0.0	6.4	0.0	2.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0
PILRA	FDF03	ENSG00000085514	"Paired immunoglobin like type 2 receptor alpha"	Q9UKJ1	7	100367530-100400099	"Predicted membrane proteins, Predicted secreted proteins"	"Host-virus interaction"	Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	4	"blood: 138.4"	"Cell type enhanced"	"Detected in many"	12	"Hofbauer cells: 82.8;Kupffer cells: 85.3;Leydig cells: 48.6;Macrophages: 111.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 138.4"	"Group enriched"	"Detected in many"	5	"granulocytes: 138.4;monocytes: 87.3"	"Cell line enhanced"	"Detected in some"		"ASC diff: 21.0;HMC-1: 18.8;NB-4: 14.2"									HPA056132	Approved				"Secreted to blood"	NA	NA					"HPA056132: AB_2683048"	"unprognostic (5.53e-2)"	"prognostic favorable (2.99e-4)"	"unprognostic (7.61e-2)"	"unprognostic (2.88e-1)"	"unprognostic (2.20e-1)"	"unprognostic (5.88e-2)"	"unprognostic (1.44e-1)"	"unprognostic (2.85e-1)"	"unprognostic (3.01e-3)"	"unprognostic (9.95e-2)"	"unprognostic (8.57e-2)"	"unprognostic (4.56e-2)"	"prognostic unfavorable (1.61e-4)"	"unprognostic (3.47e-2)"	"unprognostic (3.17e-2)"	"unprognostic (1.99e-1)"	"unprognostic (4.80e-2)"	18.6	5.4	7.2	32.3	7.2	19.4	8.2	15.6	6.2	6.1	4.5	10.6	2.3	3.8	4.8	10.0	2.6	7.5	8.4	6.5	7.7	4.4	8.5	8.0	31.9	30.1	11.0	2.6	5.7	5.1	4.3	9.2	13.2	11.9	6.6	4.9	7.1	3.1	4.1	2.5	2.6	3.9	8.6	18.4	29.5	3.1	6.4	10.7	3.3	5.3	1.1	3.3	9.8	5.4	0.1	24.0	138.4	87.3	0.5	0.2	22.9	0.2	0.3	0.4	0.5	21.0	1.4	0.1	0.1	1.0	0.1	0.3	0.0	0.3	0.4	1.2	0.3	0.2	0.6	0.1	0.1	0.0	1.0	0.7	0.4	0.8	0.1	0.2	0.8	18.8	1.5	0.3	0.1	0.4	0.0	0.2	1.7	0.2	1.2	0.1	0.6	1.4	14.2	0.4	0.3	0.2	0.4	0.0	0.3	0.8	0.4	0.5	0.2	0.0	5.2	0.4	0.1	0.1	4.3	0.4	0.9	0.9	0.6	0.2	1.8	1.4	0.4	0.2	1.6	0.3	21.3	48.4	1.4	0.2	70.2	0.1	0.1	0.0	0.0	24.0	0.0	0.0	0.1	138.4	0.5	87.3	0.4	0.1	22.9	7.2	7.2	15.6	6.2	7.7	4.4	11.0	2.6	11.9	10.7	3.0	14.3	5.9	0.2	1.5	3.3	0.4	5.1	4.0	5.7	1.8	3.9	0.4	23.2	0.1	0.4	1.4	0.0	0.0	0.3	0.6	1.3	0.5	9.3	1.5	82.8	1.6	0.0	3.1	85.3	1.5	48.6	111.8	1.7	19.8	1.1	1.9	0.3	0.0	20.1	0.6	2.4	0.0	0.3	0.5	1.3	0.6	0.7	0.8	0.9	0.2
POU2F2	"OCT2, OTF2"	ENSG00000028277	"POU class 2 homeobox 2"	P09086	19	42086110-42196585	"Cancer-related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"blood: 33.1;brain: 12.0;intestine: 10.8;lymphoid tissue: 43.1"	"Cell type enhanced"	"Detected in many"	13	"B-cells: 158.6;Bipolar cells: 50.4;Kupffer cells: 98.2;Macrophages: 80.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"non-classical monocyte: 33.1"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 18.5;Daudi: 39.0;hTEC/SVTERT24-B: 15.3;U-266/70: 27.1;U-266/84: 26.2;U-698: 30.9;U-87 MG: 15.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002513, HPA049056, HPA062096, HPA064404, HPA073998"	Enhanced		Enhanced	Nucleoplasm,Vesicles		NA	NA			"Nucleoplasm, Vesicles"		"CAB002513: AB_442118, HPA049056: AB_2732550, HPA062096: AB_2684681, HPA064404: AB_2685259, HPA073998: "	"unprognostic (2.07e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.16e-2)"	"unprognostic (8.89e-2)"	"unprognostic (6.77e-2)"	"unprognostic (1.44e-2)"	"unprognostic (1.62e-2)"	"unprognostic (3.34e-1)"	"unprognostic (8.39e-2)"	"unprognostic (2.09e-1)"	"unprognostic (1.52e-1)"	"unprognostic (8.56e-2)"	"prognostic unfavorable (7.57e-11)"	"unprognostic (2.31e-1)"	"unprognostic (1.76e-1)"	"unprognostic (2.61e-2)"	"unprognostic (1.54e-1)"	1.9	2.0	5.6	43.1	7.4	4.8	1.2	12.0	5.7	0.9	3.2	2.5	0.0	2.1	0.9	1.7	1.4	1.5	2.3	4.8	5.7	5.9	1.6	1.4	3.1	31.4	6.8	1.5	0.7	1.6	0.4	2.1	2.5	6.6	2.5	2.1	1.4	2.1	2.3	0.7	1.2	10.8	1.9	6.5	22.7	3.1	6.0	6.2	1.9	1.3	0.6	30.0	4.3	1.0	13.9	8.0	1.7	33.1	0.6	2.7	4.5	0.3	0.5	0.6	0.0	0.0	1.0	0.2	2.8	18.5	1.8	3.6	0.1	0.5	39.0	1.0	1.0	0.3	0.3	0.2	3.0	8.3	0.1	0.1	0.9	0.1	0.0	0.2	0.3	0.8	0.8	0.6	15.3	1.0	0.1	1.1	0.8	0.4	9.0	0.4	0.3	0.1	2.0	0.1	0.0	0.2	0.4	0.0	0.1	0.0	0.2	0.6	0.3	0.1	0.2	0.3	0.2	0.0	4.9	1.5	7.9	0.8	0.0	0.3	27.1	26.2	30.9	15.0	1.0	1.0	1.0	10.7	0.1	1.2	19.3	1.1	11.0	1.8	1.6	8.0	13.9	0.9	1.3	1.7	0.6	33.1	1.3	2.7	4.5	5.6	7.4	12.0	5.7	5.7	5.9	6.8	1.5	6.6	6.2	0.0	9.5	158.6	6.7	6.9	50.4	2.2	5.1	1.4	3.4	0.0	5.9	0.7	0.0	0.9	12.2	1.4	2.7	0.0	2.5	0.8	2.0	2.9	5.8	0.8	41.8	1.6	9.1	4.9	98.2	7.7	0.9	80.0	8.5	1.8	1.1	1.7	2.5	0.0	0.4	0.5	6.9	0.0	2.4	31.0	7.0	7.8	3.1	17.5	0.7	4.7
PTAFR		ENSG00000169403	"Platelet activating factor receptor"	P25105	1	28147166-28193936	"FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins, Transporters"	Chemotaxis	"G-protein coupled receptor, Receptor, Transducer"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"blood: 98.3"	"Group enriched"	"Detected in many"	7	"granulocytes: 73.9;Hofbauer cells: 62.8;Kupffer cells: 70.6;Macrophages: 55.7;Pancreatic endocrine cells: 55.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"classical monocyte: 28.2;eosinophil: 98.3;neutrophil: 85.7"	"Group enriched"	"Detected in many"	5	"granulocytes: 98.3;monocytes: 28.2"	"Group enriched"	"Detected in some"	4	"HBEC3-KT: 14.7;HMC-1: 53.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA027543	Approved		Uncertain	"Nucleoplasm,Vesicles,Plasma membrane"		NA	NA			"Nucleoplasm, Vesicles"	"Plasma membrane"	"HPA027543: AB_10610287"	"unprognostic (2.22e-2)"	"unprognostic (2.59e-2)"	"unprognostic (6.73e-2)"	"unprognostic (1.24e-1)"	"unprognostic (2.75e-1)"	"unprognostic (3.74e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.72e-1)"	"unprognostic (3.35e-1)"	"unprognostic (1.23e-1)"	"unprognostic (2.39e-1)"	"unprognostic (1.60e-1)"	"unprognostic (2.79e-2)"	"unprognostic (3.52e-1)"	"unprognostic (2.59e-2)"	"unprognostic (5.48e-2)"	"unprognostic (1.38e-2)"	5.6	2.3	2.4	16.2	1.9	20.3	2.4	0.6	2.0	6.9	3.4	1.6	3.5	1.8	2.8	1.4	16.8	2.8	7.5	3.5	2.1	2.3	6.4	1.8	9.2	6.1	4.1	1.0	1.5	2.7	0.9	0.7	3.5	1.8	2.6	3.4	0.6	3.4	2.6	1.1	2.8	5.0	3.8	5.1	15.4	2.3	2.2	1.1	2.3	1.4	22.2	21.7	5.9	3.6	1.5	13.2	98.3	28.2	0.0	0.1	10.1	7.7	0.1	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.3	0.1	0.1	2.2	0.5	0.0	0.0	0.1	5.3	0.2	14.7	0.3	0.1	0.2	2.9	0.0	0.3	0.0	0.7	53.6	0.0	2.4	0.2	0.1	0.0	0.0	0.0	0.2	0.2	0.0	0.5	0.0	7.2	0.2	0.2	0.1	0.1	0.0	0.0	3.6	0.8	0.1	0.0	0.0	7.3	0.0	0.2	0.1	2.0	0.0	0.1	0.3	0.0	0.0	0.5	0.4	2.1	0.0	0.9	0.2	5.9	28.2	98.3	0.0	8.9	0.1	1.5	0.0	0.0	13.2	0.7	0.0	0.0	85.7	0.0	3.5	0.1	0.1	10.1	2.4	1.9	0.6	2.0	2.1	2.3	4.1	1.0	1.8	1.1	6.0	7.9	4.3	1.5	5.8	1.2	2.0	2.5	6.7	2.3	1.8	2.0	0.5	0.0	8.8	0.0	5.9	0.2	0.0	4.6	0.4	2.2	0.4	73.9	0.8	62.8	0.0	0.0	1.8	70.6	0.0	0.6	55.7	0.0	4.6	0.0	0.2	55.1	0.0	0.0	0.0	0.8	0.0	0.9	2.1	0.5	2.5	1.3	1.0	0.0	8.6
PTPRC	"CD45, GP180, LCA, T200"	ENSG00000081237	"Protein tyrosine phosphatase, receptor type C"		1	198638457-198757476	"Cancer-related genes, Predicted intracellular proteins, Predicted membrane proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"				"Group enriched"	"Detected in many"	4	"blood: 116.9;lymphoid tissue: 172.5"	"Cell type enhanced"	"Detected in many"	12	"B-cells: 266.4;granulocytes: 232.9;Kupffer cells: 338.8;Macrophages: 290.3;T-cells: 539.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"Daudi: 47.1;HEL: 26.6;HL-60: 24.0;JURKAT: 61.5;MOLT-4: 35.5;THP-1: 19.7;U-266/70: 22.0;U-266/84: 20.0;U-698: 28.2;U-937: 21.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"CAB000052, HPA000440, CAB002800, CAB056154, CAB068221"	Enhanced		Uncertain	Nucleoplasm,Vesicles	"Intracellular and membrane"	NA	NA			"Nucleoplasm, Vesicles"		"CAB000052: AB_2314143, CAB002800: AB_2237910, CAB056154: AB_2665572, CAB068221: AB_2665571, HPA000440: AB_611377"	"unprognostic (1.51e-2)"	"unprognostic (1.24e-2)"	"unprognostic (5.10e-3)"	"unprognostic (2.33e-3)"	"unprognostic (1.30e-1)"	"unprognostic (2.40e-3)"	"unprognostic (1.62e-1)"	"unprognostic (3.17e-2)"	"unprognostic (1.25e-1)"	"unprognostic (3.18e-2)"	"unprognostic (8.08e-2)"	"unprognostic (3.95e-1)"	"prognostic unfavorable (2.42e-4)"	"unprognostic (2.31e-1)"	"unprognostic (3.43e-2)"	"unprognostic (6.41e-2)"	"unprognostic (7.06e-2)"	9.8	2.9	3.4	48.0	6.2	36.1	4.3	1.3	3.5	3.1	5.6	2.8	0.5	4.9	2.9	3.9	4.8	5.6	8.8	4.9	3.9	4.5	4.4	5.2	27.5	93.2	7.9	1.3	2.9	2.1	0.3	2.5	4.5	5.3	4.2	5.8	3.3	10.7	1.0	1.7	2.5	22.2	4.5	13.2	89.3	6.5	2.3	5.3	172.5	4.6	3.9	53.2	13.1	3.7	28.5	42.8	94.7	103.8	53.7	76.1	116.9	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	47.1	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	26.6	0.0	0.0	0.0	24.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	61.5	0.5	0.7	0.0	0.0	35.5	14.5	0.1	0.0	0.0	1.0	0.1	0.0	0.0	0.0	0.3	0.4	0.0	0.1	0.1	0.0	0.0	19.7	0.3	0.0	0.2	0.1	0.1	22.0	20.0	28.2	0.0	21.5	0.1	20.8	52.0	56.3	76.1	99.7	64.5	28.5	52.9	72.7	42.8	26.8	60.2	60.3	94.7	53.7	103.8	6.4	54.6	116.9	3.4	6.2	1.3	3.5	3.9	4.5	7.9	1.3	5.3	5.3	41.7	86.9	266.4	0.7	14.1	0.0	4.1	7.6	21.4	26.1	1.8	0.0	0.4	0.0	0.0	2.0	11.9	0.1	23.3	0.0	0.5	8.9	0.9	232.9	3.0	90.3	0.0	1.2	14.1	338.8	1.5	1.1	290.3	20.3	120.0	0.2	0.0	0.1	0.0	0.0	1.7	0.2	6.5	4.3	0.2	0.2	13.2	0.7	539.1	0.5	0.9
RELT	"FLJ14993, TNFRSF19L"	ENSG00000054967	"RELT, TNF receptor"	Q969Z4	11	73376264-73397474	"Predicted intracellular proteins, Predicted membrane proteins"	Apoptosis	Receptor	"Amelogenesis imperfecta, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"bone marrow: 92.2"	"Cell type enhanced"	"Detected in many"	5	"Macrophages: 37.2;monocytes: 30.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA062824, HPA071518"			Supported	Nucleoplasm		NA	NA			Nucleoplasm		"HPA062824: AB_2684875, HPA071518: AB_2686408"	"unprognostic (3.49e-1)"	"unprognostic (2.43e-1)"	"unprognostic (2.25e-1)"	"unprognostic (1.67e-2)"	"unprognostic (1.80e-3)"	"unprognostic (9.92e-3)"	"unprognostic (1.67e-3)"	"unprognostic (1.17e-1)"	"unprognostic (1.21e-1)"	"unprognostic (2.87e-1)"	"unprognostic (8.42e-2)"	"unprognostic (4.13e-2)"	"prognostic unfavorable (4.07e-11)"	"unprognostic (1.64e-1)"	"unprognostic (3.07e-3)"	"unprognostic (2.01e-2)"	"unprognostic (1.69e-1)"	3.5	2.2	3.5	11.7	8.8	92.2	2.8	3.5	5.7	1.4	2.1	7.4	0.0	2.7	1.9	2.5	3.2	1.6	4.1	5.3	4.0	5.2	2.0	2.0	8.4	18.2	8.3	3.9	1.5	1.6	1.8	3.1	4.1	13.9	1.7	2.0	2.3	4.6	1.3	22.1	2.5	5.6	2.8	14.3	18.1	2.5	3.0	4.6	4.8	1.8	3.9	9.0	3.3	2.1	4.7	6.8	12.1	19.2	0.3	1.1	3.1	5.7	5.8	4.5	4.5	0.5	0.7	5.1	6.4	4.0	7.4	4.5	5.5	2.5	10.6	21.0	4.1	5.9	8.5	2.8	3.1	2.7	6.4	5.4	10.0	7.2	2.0	1.3	9.9	17.6	0.7	1.3	7.8	2.0	1.7	2.6	5.3	7.5	14.1	2.0	5.4	7.1	10.3	4.1	4.5	7.2	14.1	7.9	9.2	1.5	2.5	6.0	5.7	5.4	4.9	6.6	1.1	2.7	8.6	3.6	9.3	6.6	15.4	11.3	4.9	3.9	11.6	5.7	9.8	9.8	0.4	7.0	12.1	0.5	14.3	1.1	4.7	0.6	1.0	6.8	3.7	0.8	0.4	11.6	0.3	19.2	6.8	0.2	3.1	3.5	8.8	3.5	5.7	4.0	5.2	8.3	3.9	13.9	4.6	6.0	2.1	15.9	11.9	23.6	1.9	2.2	0.0	1.4	3.4	0.0	11.8	1.4	0.0	3.5	0.7	2.3	2.1	0.0	0.7	9.4	6.6	7.8	25.3	0.0	20.4	28.6	3.4	0.6	23.5	1.0	0.0	37.2	5.0	30.7	0.6	10.0	4.1	0.6	0.0	0.4	2.0	6.5	7.8	2.7	7.5	15.9	17.6	7.5	1.3	14.8
S100B	S100beta	ENSG00000160307	"S100 calcium binding protein B"	P04271	21	46598962-46605208	"Cancer-related genes, Candidate cardiovascular disease genes, Predicted intracellular proteins, Transporters"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	4	"brain: 342.0"	"Cell type enhanced"	"Detected in some"	16	"Kupffer cells: 25.7;Macrophages: 53.7;Melanocytes: 94.5;monocytes: 55.9"	"Group enriched"	"Detected in all"	58	"glioma: 463.5;melanoma: 495.2"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"gdT-cell: 78.0"	"Lineage enriched"	"Detected in many"	7	"T-cells: 78.0"	"Group enriched"	"Detected in some"	7	"SK-MEL-30: 82.9;WM-115: 163.0"	"Low region specificity"	"Detected in all"							"CAB000073, HPA015768, CAB078196"	Enhanced	Supported	Supported	Nucleoplasm,Vesicles,Cytosol		NA	NA		120000	"Nucleoplasm, Cytosol"	Vesicles	"CAB000073: AB_10013383, CAB078196: AB_2665776, HPA015768: AB_1856538"	"unprognostic (5.67e-3)"	"unprognostic (6.39e-3)"	"unprognostic (2.08e-3)"	"unprognostic (2.08e-2)"	"unprognostic (4.54e-3)"	"unprognostic (1.10e-2)"	"unprognostic (1.01e-1)"	"unprognostic (6.68e-3)"	"unprognostic (2.03e-1)"	"unprognostic (1.37e-1)"	"unprognostic (8.57e-3)"	"unprognostic (6.70e-2)"	"unprognostic (4.41e-7)"	"unprognostic (3.55e-2)"	"unprognostic (7.56e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.74e-1)"	67.7	14.0	60.9	5.6	51.0	2.0	13.2	39.4	151.2	5.2	9.1	101.0	3.0	4.7	1.5	7.6	8.6	2.1	8.3	6.6	74.6	65.4	1.5	1.6	2.9	9.8	152.0	36.5	2.4	3.0	1.1	3.1	1.4	90.3	3.0	8.3	7.4	10.1	15.3	1.3	5.7	7.5	4.3	342.0	5.7	4.3	1.5	46.4	0.0	1.3	1.8	10.8	8.2	1.6	0.1	3.4	0.7	1.9	11.0	78.0	10.6	0.1	0.0	18.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	2.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	82.9	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.5	0.0	0.0	0.0	0.2	1.0	163.0	0.0	0.1	0.0	78.0	1.8	22.4	0.0	0.2	14.5	3.4	0.1	0.6	33.3	0.7	11.0	1.9	0.8	0.0	10.6	60.9	51.0	39.4	37.6	74.6	65.4	152.0	36.5	90.3	46.4	3.0	7.4	0.9	0.2	14.9	0.9	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.5	0.0	0.0	0.0	0.0	3.3	0.1	0.0	0.2	7.6	0.0	0.0	4.9	25.7	0.4	5.2	53.7	94.5	55.9	0.0	9.7	0.1	0.0	0.0	0.0	4.0	0.0	2.1	0.0	0.1	11.0	0.1	0.5	0.0	0.1
SIGLEC12	"S2V, Siglec-12, Siglec-L1, Siglec-XII, SIGLECL1, SLG"	ENSG00000254521	"Sialic acid binding Ig like lectin 12 (gene/pseudogene)"	Q96PQ1	19	51491357-51501789	"Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"		"Group enriched"	"Detected in many"	4	"liver: 13.1;lymphoid tissue: 29.6"	"Group enriched"	"Detected in some"	14	"granulocytes: 2.3;Hofbauer cells: 1.8;Kupffer cells: 2.8;Macrophages: 2.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Cell type enhanced"	"Detected in some"		"classical monocyte: 2.0;eosinophil: 3.0"	"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in some"	10	"HMC-1: 54.1;U-937: 28.9"															NA	NA						"unprognostic (1.46e-1)"	"unprognostic (2.39e-1)"	"unprognostic (3.81e-2)"	"unprognostic (9.13e-2)"	"unprognostic (9.58e-4)"	"unprognostic (1.38e-1)"	"unprognostic (3.21e-1)"	"unprognostic (1.64e-1)"	"unprognostic (1.33e-1)"	"unprognostic (3.73e-1)"	"unprognostic (1.29e-2)"	"unprognostic (6.79e-2)"	"unprognostic (9.21e-5)"	"unprognostic (2.45e-1)"	"unprognostic (1.14e-1)"	"unprognostic (3.64e-1)"	"unprognostic (1.57e-1)"	2.8	1.0	0.2	6.2	1.2	1.3	0.3	0.1	0.3	0.3	1.5	0.2	0.6	0.4	0.4	0.5	0.6	0.4	1.6	0.7	0.2	0.2	0.4	13.1	5.3	3.9	0.2	0.0	0.3	0.3	0.0	0.2	0.0	0.3	0.5	2.6	0.6	1.2	0.0	0.2	0.2	2.5	3.4	0.3	29.6	0.5	1.4	0.0	2.4	0.2	1.0	1.7	0.6	0.3	0.7	0.8	3.0	2.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.0	0.0	0.0	0.0	0.0	54.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	28.9	0.0	0.0	2.0	3.0	0.0	0.9	0.0	0.7	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.2	1.2	0.1	0.3	0.2	0.2	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	1.8	0.0	0.0	0.0	2.8	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SIGLEC7	"CD328, p75/AIRM1, QA79, SIGLEC-7, SIGLEC19P, SIGLECP2"	ENSG00000168995	"Sialic acid binding Ig like lectin 7"	Q9Y286	19	51142299-51153526	"CD markers, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"blood: 51.5;lymphoid tissue: 29.4"	"Group enriched"	"Detected in some"	5	"Hofbauer cells: 29.4;Kupffer cells: 51.3;Macrophages: 24.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"eosinophil: 51.5"	"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in some"	9	"Karpas-707: 31.5;RPMI-8226: 18.3;U-937: 19.4"									HPA075513			Approved	"Vesicles,Plasma membrane"	"Intracellular and membrane"	NA	NA		1100000	"Plasma membrane"	Vesicles	"HPA075513: "	"unprognostic (3.14e-1)"	"unprognostic (5.87e-2)"	"unprognostic (1.03e-1)"	"unprognostic (2.66e-1)"	"unprognostic (3.90e-2)"	"unprognostic (1.85e-1)"	"unprognostic (2.53e-1)"	"unprognostic (2.78e-1)"	"unprognostic (1.69e-1)"	"unprognostic (4.95e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.66e-1)"	"unprognostic (8.27e-2)"	"unprognostic (6.61e-2)"	"unprognostic (1.14e-3)"	"unprognostic (2.58e-1)"	"unprognostic (2.26e-2)"	6.9	3.7	1.6	10.0	5.8	3.7	3.0	0.3	2.2	0.9	1.6	1.0	0.6	1.4	0.9	2.1	1.1	1.8	2.4	1.9	0.8	1.0	2.8	9.8	4.7	18.4	3.3	0.0	1.3	0.9	0.2	0.9	5.9	2.9	1.0	2.3	0.7	2.3	0.2	0.4	0.5	2.3	3.5	3.3	29.4	1.1	1.8	2.5	0.7	1.0	0.0	2.1	3.2	1.7	0.6	14.9	51.5	32.0	20.0	4.4	15.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	31.5	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	18.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.6	0.6	0.0	0.1	19.4	0.0	0.5	32.0	51.5	2.5	23.0	4.4	0.6	0.0	1.1	14.9	0.0	0.0	1.0	26.8	20.0	9.1	0.6	0.0	15.8	1.6	5.8	0.3	2.2	0.8	1.0	3.3	0.0	2.9	2.5	0.0	2.1	1.4	0.0	0.1	0.0	0.0	0.0	1.4	1.2	1.8	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.2	0.0	1.1	0.6	29.4	0.0	0.0	7.4	51.3	0.0	1.4	24.5	0.0	0.0	0.0	0.0	0.1	0.0	1.1	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	2.2	0.0	0.0
SIRPB1	"CD172b, SIRP-BETA-1"	ENSG00000101307	"Signal regulatory protein beta 1"	"O00241, Q5TFQ8"	20	1563521-1620061	"CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"blood: 137.6"	"Cell type enhanced"	"Detected in some"	19	"Hofbauer cells: 14.8;Kupffer cells: 35.5;Macrophages: 18.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"neutrophil: 137.6"	"Group enriched"	"Detected in many"	6	"granulocytes: 137.6;monocytes: 43.6"	"Group enriched"	"Detected in some"	4	"HMC-1: 25.3;NB-4: 33.6;THP-1: 26.0"									HPA047463	Uncertain		Uncertain	Vesicles		NA	NA		33000000	Vesicles		"HPA047463: AB_2680057"	"unprognostic (1.88e-2)"	"unprognostic (6.19e-2)"	"unprognostic (1.50e-1)"	"unprognostic (2.24e-1)"	"unprognostic (5.38e-2)"	"unprognostic (1.60e-1)"	"unprognostic (4.40e-2)"	"unprognostic (7.18e-2)"	"unprognostic (4.11e-3)"	"unprognostic (9.12e-2)"	"unprognostic (6.31e-2)"	"unprognostic (4.57e-2)"	"unprognostic (2.65e-3)"	"unprognostic (5.76e-2)"	"unprognostic (2.39e-3)"	"unprognostic (5.00e-3)"	"unprognostic (1.19e-2)"	23.7	1.8	2.3	18.7	5.4	31.9	1.8	2.7	3.2	1.1	1.4	1.9	0.1	1.0	1.0	0.5	0.9	2.5	7.6	7.2	2.3	1.6	1.5	7.5	19.4	19.5	6.6	0.7	1.9	0.9	0.1	1.5	3.8	3.7	1.2	1.2	1.7	1.8	0.6	0.9	0.9	2.6	2.1	7.2	28.7	1.2	1.2	3.9	2.5	0.9	0.4	2.9	4.1	1.9	0.2	15.2	137.6	43.6	0.7	1.0	19.2	0.1	0.0	0.1	0.0	0.1	0.2	0.1	0.2	0.0	0.1	0.0	0.1	0.0	0.0	0.3	0.1	3.3	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	6.4	25.3	0.0	0.1	0.1	0.0	3.7	0.2	0.5	0.0	0.1	0.2	0.0	0.0	33.6	0.1	0.0	1.5	0.0	0.0	0.0	5.0	0.1	0.0	0.1	0.1	0.0	0.2	0.0	0.0	26.0	0.7	0.3	0.0	0.2	0.1	0.0	0.0	0.0	0.5	6.1	0.1	0.5	43.6	72.5	0.6	36.3	0.9	0.2	0.6	0.5	15.2	0.2	0.8	0.5	137.6	0.7	29.5	14.5	1.0	19.2	2.3	5.4	2.7	3.2	2.3	1.6	6.6	0.7	3.7	3.9	3.0	6.9	0.5	0.0	0.0	0.2	0.4	0.0	1.4	2.3	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	6.9	0.0	14.8	0.0	0.0	3.1	35.5	0.0	0.0	18.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0
SLA	"hSLAP, SLA1, SLAP, SLAP-1"	ENSG00000155926	"Src like adaptor"	Q13239	8	133036724-133103054	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"blood: 61.6;lymphoid tissue: 152.5"	"Cell type enhanced"	"Detected in many"	14	"Hofbauer cells: 59.4;Kupffer cells: 193.1;Macrophages: 141.0;T-cells: 117.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"HMC-1: 14.1;JURKAT: 59.1;Karpas-707: 37.9;U-266/84: 21.3;U-937: 14.9"	"Group enriched"	"Detected in many"	5	"amygdala: 14.8;basal ganglia: 9.9;cerebellum: 44.5;cerebral cortex: 11.2;hippocampal formation: 11.6"	"Low region specificity"	"Detected in all"			"HPA012296, HPA074192"	Enhanced		Approved	"Nuclear membrane,Cytosol"		NA	NA			"Nuclear membrane, Cytosol"		"HPA012296: AB_1856946, HPA074192: AB_2686673"	"unprognostic (1.19e-2)"	"unprognostic (6.29e-3)"	"unprognostic (2.73e-3)"	"unprognostic (6.07e-3)"	"unprognostic (1.66e-2)"	"unprognostic (1.10e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.67e-1)"	"unprognostic (9.25e-2)"	"unprognostic (3.03e-2)"	"unprognostic (2.73e-1)"	"unprognostic (2.80e-3)"	"unprognostic (2.66e-1)"	"unprognostic (3.05e-2)"	"unprognostic (8.60e-2)"	"unprognostic (1.65e-1)"	6.8	3.6	2.5	21.3	2.7	24.0	2.6	1.6	3.3	2.7	2.2	1.5	1.7	1.6	2.1	1.6	2.4	3.2	5.3	2.6	2.8	1.7	3.2	3.5	11.2	18.2	2.5	2.7	1.7	1.4	0.0	1.4	3.4	2.0	2.1	1.7	1.5	4.0	1.4	1.6	1.3	8.4	2.8	4.1	33.3	2.5	1.6	1.4	152.5	9.2	2.1	18.3	4.3	1.6	11.2	18.4	61.6	31.7	29.2	27.5	29.6	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.6	0.0	0.0	0.0	1.7	14.1	0.2	0.0	0.1	0.0	0.0	0.0	59.1	0.0	37.9	0.0	0.0	10.0	2.4	0.0	0.0	0.0	0.0	0.1	2.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.9	0.0	4.6	0.0	0.0	0.1	0.0	0.0	2.0	21.3	0.0	0.2	14.9	0.0	0.1	24.3	45.0	21.2	28.1	26.7	9.5	19.5	21.1	18.4	11.2	18.6	18.9	61.6	29.2	31.7	1.4	27.5	29.6	2.5	2.7	1.6	3.3	2.8	1.7	2.5	2.7	2.0	1.4	8.9	25.0	32.9	0.3	1.9	7.0	2.0	2.5	9.4	19.4	0.0	0.0	0.4	0.0	0.0	0.1	2.2	0.0	0.0	0.0	0.7	2.3	0.1	34.8	1.7	59.4	0.0	0.0	11.1	193.1	0.9	0.3	141.0	5.0	1.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	6.5	0.9	0.0	0.0	2.4	0.1	117.6	0.0	0.1
SLAMF9	"CD2F-10, CD84-H1, SF2001"	ENSG00000162723	"SLAM family member 9"	Q96A28	1	159951492-159954254	"Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in some"	4	"adipose tissue: 20.3;blood: 5.5"	"Group enriched"	"Detected in some"	5	"Early spermatids: 8.9;Hofbauer cells: 7.2;Late spermatids: 22.7;Macrophages: 7.3"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	9	"myeloid DC: 5.5"	"Lineage enriched"	"Detected in single"	9	"dendritic cells: 5.5"	"Cell line enhanced"	"Detected in some"		"HBEC3-KT: 6.7;HEL: 9.1;PC-3: 3.7;SK-MEL-30: 4.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA035153	Uncertain					NA	NA					"HPA035153: AB_10670586"	"unprognostic (1.05e-1)"	"unprognostic (1.54e-5)"	"unprognostic (6.12e-2)"	"unprognostic (2.84e-1)"	"unprognostic (1.58e-1)"	"unprognostic (7.44e-2)"	"unprognostic (1.15e-1)"	"unprognostic (2.22e-2)"	"unprognostic (2.46e-1)"	"unprognostic (3.54e-4)"	"unprognostic (5.27e-4)"	"unprognostic (5.47e-2)"	"unprognostic (6.17e-5)"	"unprognostic (8.97e-3)"	"unprognostic (1.32e-1)"	"unprognostic (1.26e-1)"	"unprognostic (1.37e-1)"	20.3	0.0	0.1	2.3	0.1	1.1	0.9	0.1	0.1	0.4	0.1	0.1	0.1	0.0	0.1	0.1	0.7	1.0	0.1	0.4	0.1	0.0	0.1	2.6	1.2	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.6	0.1	0.2	0.1	0.1	0.5	0.1	0.1	0.1	0.1	0.1	0.2	0.7	0.2	2.9	0.1	0.5	0.1	0.7	0.5	2.9	0.5	0.1	5.5	0.5	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.4	0.0	0.0	0.2	0.0	0.0	0.0	0.8	0.0	0.0	0.0	6.7	0.0	0.0	0.0	9.1	0.1	0.0	0.0	0.2	0.0	0.0	0.4	0.6	0.7	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.8	3.7	0.0	0.0	0.2	0.0	0.0	1.8	0.0	0.0	0.1	4.0	1.0	0.7	1.5	0.0	1.3	1.5	2.2	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.1	0.0	0.0	0.2	0.0	0.1	0.0	0.0	5.5	0.0	0.0	0.0	0.5	0.0	0.1	0.0	0.0	0.2	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.2	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	8.9	0.0	0.0	0.0	0.2	0.0	0.2	0.8	0.0	2.4	7.2	0.0	0.0	0.0	1.8	22.7	0.3	7.3	0.0	1.8	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.0	1.5	0.0	0.0	0.0	0.6
TNFSF13B	"BAFF, BLYS, CD257, TALL-1, TALL1, THANK, TNFSF20"	ENSG00000102524	"TNF superfamily member 13b"	Q9Y275	13	108251240-108308484	"Cancer-related genes, CD markers, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"	Immunity	Cytokine	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"blood: 76.5;lymphoid tissue: 39.6"	"Cell type enhanced"	"Detected in many"	23	"Hofbauer cells: 88.9;Kupffer cells: 144.9;Macrophages: 141.3;monocytes: 457.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 76.5"	"Group enriched"	"Detected in many"	10	"dendritic cells: 31.0;granulocytes: 76.5;monocytes: 53.7"	"Cell line enriched"	"Detected in some"	7	"U-937: 61.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"CAB009188, HPA030526"	Enhanced		Supported	"Vesicles,Plasma membrane,Focal adhesion sites"	"Secreted to blood"	NA	NA	393000	530000	"Plasma membrane"	"Vesicles, Focal adhesion sites"	"CAB009188: , HPA030526: "	"unprognostic (6.48e-2)"	"unprognostic (3.05e-3)"	"unprognostic (1.38e-1)"	"unprognostic (1.90e-1)"	"unprognostic (2.61e-2)"	"unprognostic (7.99e-2)"	"unprognostic (8.19e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.63e-1)"	"unprognostic (1.02e-2)"	"unprognostic (2.64e-2)"	"unprognostic (1.21e-1)"	"prognostic unfavorable (2.53e-11)"	"unprognostic (1.23e-1)"	"unprognostic (4.14e-2)"	"unprognostic (1.88e-1)"	"unprognostic (1.25e-1)"	7.2	8.2	3.0	18.5	8.2	13.2	3.4	1.4	5.2	1.6	4.2	2.1	1.0	7.8	1.2	6.5	3.5	2.9	9.4	9.4	5.7	2.9	3.1	5.0	13.2	39.6	7.2	2.6	2.9	2.7	0.5	2.1	6.4	5.7	3.7	6.4	2.6	5.4	1.8	1.6	1.6	6.8	3.5	11.6	23.5	3.4	1.0	4.9	7.2	5.1	1.7	12.7	8.5	3.8	1.0	31.0	76.5	53.7	0.6	5.3	20.8	0.0	0.1	0.0	0.0	0.2	0.3	0.0	0.1	0.3	0.2	0.8	0.0	0.6	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	4.2	0.0	0.3	0.1	0.0	0.1	3.6	0.1	0.7	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.4	0.0	0.0	1.9	0.0	0.4	0.0	0.0	0.0	0.0	0.2	0.1	0.5	0.1	0.0	0.0	0.1	0.1	0.0	8.1	0.0	0.1	0.0	0.0	0.1	3.8	0.1	0.0	3.9	61.0	0.6	1.2	53.7	14.4	0.8	39.8	5.3	0.6	3.5	0.7	31.0	1.0	1.7	0.5	76.5	0.6	31.7	11.5	2.8	20.8	3.0	8.2	1.4	5.2	5.7	2.9	7.2	2.6	5.7	4.9	14.9	17.5	3.7	0.7	6.4	0.3	0.5	12.7	2.7	5.7	5.2	0.0	0.5	1.7	2.0	1.0	1.3	0.5	0.0	29.2	0.9	13.3	1.6	4.7	1.5	88.9	0.0	1.2	4.9	144.9	0.2	4.9	141.3	8.5	457.1	0.2	0.4	1.9	0.0	1.8	1.0	0.0	6.5	5.0	0.1	0.1	4.1	0.9	6.2	1.2	1.3
ABI3	"NESH, SSH3BP3"	ENSG00000108798	"ABI family member 3"	Q9P2A4	17	49210227-49223225	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 84.6;lymphoid tissue: 50.6"	"Cell type enhanced"	"Detected in many"	10	"Distal tubular cells: 43.1;Hofbauer cells: 46.5;Ito cells: 40.5;Kupffer cells: 104.3;Macrophages: 57.6;T-cells: 86.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"intermediate monocyte: 84.4;non-classical monocyte: 84.6"	"Group enriched"	"Detected in all"	4	"dendritic cells: 29.5;monocytes: 84.6;T-cells: 36.5"	"Cell line enhanced"	"Detected in some"		"Daudi: 19.4;HDLM-2: 11.2;HUVEC TERT2: 33.0;RH-30: 7.6;TIME: 23.3"	"Low region specificity"	"Detected in many"							"HPA017345, HPA064805"	Enhanced					NA	NA					"HPA017345: AB_2669592, HPA064805: "	"unprognostic (1.24e-1)"	"unprognostic (1.23e-2)"	"unprognostic (2.18e-2)"	"prognostic favorable (7.13e-4)"	"unprognostic (1.56e-1)"	"unprognostic (1.16e-3)"	"unprognostic (5.29e-1)"	"unprognostic (8.25e-2)"	"unprognostic (3.63e-2)"	"unprognostic (1.48e-1)"	"unprognostic (3.47e-2)"	"unprognostic (1.82e-1)"	"unprognostic (2.28e-3)"	"unprognostic (1.03e-1)"	"unprognostic (9.24e-3)"	"unprognostic (4.16e-2)"	"unprognostic (2.40e-1)"	6.4	6.1	8.1	16.2	15.7	3.8	5.7	1.1	8.5	4.9	5.4	9.1	1.2	6.9	7.4	2.7	4.0	5.6	6.0	5.7	7.8	3.9	6.4	7.8	12.0	18.7	14.8	1.6	3.5	3.4	1.8	3.7	4.6	12.1	6.0	6.0	3.8	4.3	2.9	2.5	3.5	12.0	6.0	18.0	50.6	5.3	1.4	13.4	9.2	6.7	3.2	21.0	6.4	4.9	4.4	29.5	2.2	84.6	12.5	36.5	22.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.8	1.3	2.1	0.2	0.0	19.4	0.2	0.0	0.0	0.0	0.0	0.0	2.2	11.2	0.0	0.1	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.5	0.0	0.0	33.0	1.1	0.0	0.0	0.2	0.0	3.9	3.0	1.3	0.0	0.0	3.2	7.6	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.1	23.3	0.0	4.6	0.0	0.0	0.3	1.0	3.3	0.0	0.2	0.0	0.1	14.4	0.3	36.5	84.4	17.9	4.4	6.8	23.6	29.5	3.4	4.1	18.5	2.2	12.5	84.6	1.2	3.6	22.5	8.1	15.7	1.1	8.5	7.8	3.9	14.8	1.6	12.1	13.4	0.0	8.3	18.5	0.0	1.6	0.0	1.6	0.0	1.4	0.0	0.0	0.0	0.2	43.1	0.0	0.3	37.3	0.0	0.0	0.2	0.3	1.8	0.1	6.9	0.9	46.5	0.0	1.2	40.5	104.3	0.4	0.3	57.6	1.7	39.7	0.0	0.2	0.0	0.0	0.0	0.5	0.2	0.0	2.2	0.1	0.2	3.8	0.2	86.3	0.0	0.1
ADA2	"ADGF, CECR1, IDGFL"	ENSG00000093072	"Adenosine deaminase 2"	Q9NZK5	22	17178790-17221989	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins"		"Heparin-binding, Hydrolase"	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 63.0"	"Group enriched"	"Detected in some"	5	"Alveolar cells type 2: 22.1;Ciliated cells: 28.1;Club cells: 20.5;Hofbauer cells: 58.5;Macrophages: 37.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 13.2;EFO-21: 11.6;HUVEC TERT2: 12.5;Karpas-707: 22.3;MOLT-4: 20.7;U-266/70: 12.8;U-937: 21.0"					"Low region specificity"	"Detected in all"			HPA007888	Uncertain				"Secreted to blood"	NA	NA		50000000			"HPA007888: AB_1078495"	"unprognostic (1.03e-3)"	"unprognostic (2.00e-3)"	"unprognostic (6.59e-2)"	"unprognostic (2.50e-1)"	"unprognostic (1.48e-2)"	"unprognostic (7.01e-3)"	"unprognostic (4.48e-2)"	"unprognostic (3.09e-3)"	"unprognostic (3.80e-2)"	"prognostic favorable (9.26e-4)"	"prognostic favorable (8.91e-4)"	"unprognostic (1.41e-1)"	"unprognostic (1.49e-1)"	"unprognostic (4.86e-3)"	"unprognostic (1.96e-2)"	"unprognostic (4.83e-2)"	"unprognostic (2.51e-1)"	24.7	6.6	6.9	15.3	7.5	8.7	6.3	9.7	9.2	7.8	9.8	17.3	3.9	7.0	9.6	7.0	6.9	18.2	12.4	15.9	6.4	8.8	15.2	8.5	28.6	24.3	9.2	5.8	8.9	6.7	0.6	13.7	8.4	14.5	7.4	12.3	15.3	6.9	6.3	2.5	2.5	12.6	7.9	18.2	45.0	7.2	9.7	5.3	63.0	7.5	2.9	22.6	18.0	4.1	6.1	29.8	2.6	46.4	9.5	7.9	28.3	0.0	0.0	3.4	0.0	0.0	0.6	0.1	1.2	0.2	0.0	0.0	0.0	13.2	3.0	11.6	3.6	0.0	0.3	0.2	0.1	0.0	0.0	0.0	0.1	0.0	0.0	2.2	0.2	0.1	6.3	0.0	0.1	0.0	0.0	12.5	4.4	0.1	22.3	0.5	0.0	20.7	1.5	10.3	0.0	0.0	0.4	0.0	3.2	0.0	3.9	5.9	0.1	0.0	0.1	0.0	10.6	0.0	5.9	1.4	0.0	0.1	0.1	0.0	12.8	1.1	0.7	0.1	21.0	0.1	2.6	44.1	2.4	7.9	46.4	6.3	6.1	6.4	7.9	29.8	5.0	7.6	7.8	2.1	9.5	35.2	14.7	3.6	28.3	6.9	7.5	9.7	9.2	6.4	8.8	9.2	5.8	14.5	5.3	0.0	22.1	0.0	0.0	0.0	0.0	0.0	0.0	28.1	20.5	5.2	0.0	0.4	6.6	2.3	0.0	0.0	0.0	0.0	4.6	0.6	0.0	0.0	4.7	0.0	58.5	0.0	0.0	0.0	0.0	0.0	0.0	37.4	0.0	1.8	0.0	0.0	1.3	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0
ADAM28	"ADAM23, eMDCII, MDC-Lm, MDC-Ls"	ENSG00000042980	"ADAM metallopeptidase domain 28"	Q9UKQ2	8	24294040-24359018	"Plasma proteins, Predicted membrane proteins, Predicted secreted proteins, Transporters"		"Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"epididymis: 133.1"	"Cell type enhanced"	"Detected in many"	15	"B-cells: 115.5;Club cells: 62.6;Macrophages: 32.1;Pancreatic endocrine cells: 32.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"memory B-cell: 24.9;naive B-cell: 32.2"	"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in some"	5	"CAPAN-2: 24.8;OE19: 7.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA074034	Enhanced		Approved	"Plasma membrane,Mitochondria"	"Secreted to blood"	NA	NA			"Plasma membrane"	Mitochondria	"HPA074034: AB_2686654"	"unprognostic (4.23e-2)"	"unprognostic (1.01e-2)"	"unprognostic (2.06e-2)"	"prognostic favorable (3.17e-4)"	"unprognostic (2.89e-1)"	"unprognostic (2.55e-2)"	"unprognostic (5.59e-2)"	"unprognostic (1.53e-1)"	"unprognostic (4.71e-1)"	"unprognostic (1.35e-2)"	"unprognostic (3.77e-3)"	"unprognostic (7.77e-2)"	"unprognostic (3.97e-3)"	"unprognostic (1.71e-2)"	"unprognostic (1.30e-1)"	"unprognostic (2.60e-1)"	"unprognostic (1.62e-1)"	2.0	1.7	7.7	17.4	8.8	3.5	2.1	0.9	5.8	6.7	5.8	12.7	2.0	3.7	3.1	133.1	2.7	5.1	16.7	1.1	8.9	5.0	3.1	1.1	3.1	10.1	12.4	3.7	1.8	2.7	1.0	22.5	1.9	10.8	3.3	5.0	1.9	12.6	5.1	0.7	1.8	17.9	1.7	26.0	15.5	38.7	0.9	12.1	0.8	1.8	0.4	19.9	7.4	1.6	32.2	7.5	12.5	0.9	0.9	0.0	0.9	0.0	0.4	0.1	0.0	0.0	0.4	0.1	0.1	0.2	0.0	0.0	1.0	24.8	0.2	0.8	0.0	0.8	0.1	0.0	0.8	0.1	0.1	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.2	3.2	0.6	7.6	0.1	0.1	0.0	0.3	0.6	0.7	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.1	0.0	0.5	0.3	0.1	0.1	1.1	2.1	0.1	1.9	0.9	0.2	12.5	0.9	6.4	0.0	0.2	0.0	24.9	0.0	0.0	7.5	32.2	0.0	0.0	1.6	0.9	0.0	0.4	0.0	0.9	7.7	8.8	0.9	5.8	8.9	5.0	12.4	3.7	10.8	12.1	3.0	5.9	115.5	2.2	0.8	0.0	0.9	25.5	17.4	62.6	3.5	0.0	0.3	0.0	7.1	0.9	0.7	0.5	0.0	3.1	8.1	1.1	2.0	2.3	0.0	9.0	0.0	0.0	0.0	12.3	1.8	0.6	32.1	5.0	5.4	0.1	0.0	32.8	0.0	0.4	3.6	0.0	6.5	0.3	0.2	0.1	0.5	0.5	6.9	0.9	6.3
ADAM8	"CD156, CD156a, MS2"	ENSG00000151651	"ADAM metallopeptidase domain 8"	P78325	10	133262403-133276868	"CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 56.8;bone marrow: 37.1;lymphoid tissue: 28.3"	"Cell type enhanced"	"Detected in many"	11	"Extravillous trophoblasts: 82.5;Macrophages: 42.6;monocytes: 115.4;T-cells: 46.3;Urothelial cells: 41.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"basophil: 20.7;eosinophil: 56.8;neutrophil: 32.9"	"Lineage enriched"	"Detected in all"	7	"granulocytes: 56.8"	"Cell line enhanced"	"Detected in some"		"A-431: 22.9;BEWO: 32.9;CAPAN-2: 27.9;HaCaT: 27.4;HDLM-2: 17.6;U-87 MG: 14.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA064637	Approved				"Intracellular and membrane"	NA	NA					"HPA064637: AB_2685306"	"unprognostic (8.24e-2)"	"unprognostic (6.07e-3)"	"unprognostic (1.27e-3)"	"unprognostic (5.18e-2)"	"unprognostic (8.26e-2)"	"unprognostic (6.47e-2)"	"unprognostic (5.59e-2)"	"unprognostic (2.22e-1)"	"unprognostic (2.57e-1)"	"unprognostic (1.94e-3)"	"unprognostic (3.37e-2)"	"unprognostic (5.47e-2)"	"prognostic unfavorable (3.99e-10)"	"unprognostic (1.92e-1)"	"unprognostic (3.02e-2)"	"unprognostic (1.28e-1)"	"unprognostic (9.32e-2)"	4.8	1.0	0.7	18.0	1.6	37.1	3.1	1.7	1.2	3.8	4.8	0.9	0.2	3.5	1.8	1.6	2.8	3.6	10.1	4.1	0.8	1.1	2.8	4.3	13.0	25.0	1.0	0.2	1.7	2.4	0.1	2.0	7.5	1.6	2.9	0.9	2.9	5.5	0.7	1.5	1.9	6.0	1.6	1.5	28.3	6.9	2.3	0.5	6.6	2.0	1.8	19.7	12.0	2.8	2.5	8.6	56.8	5.4	5.5	5.5	4.6	22.9	0.7	0.2	0.3	0.2	0.0	32.9	0.2	0.5	0.1	0.1	1.8	27.9	0.4	0.6	0.0	0.2	27.4	0.0	4.7	0.0	17.6	0.3	0.3	0.1	0.0	0.2	1.3	6.4	0.1	0.4	0.2	0.4	1.5	0.0	0.2	1.2	1.0	0.0	1.8	0.0	7.7	0.1	2.7	0.6	0.1	0.2	2.5	0.3	0.5	0.0	0.3	0.1	0.1	0.4	0.4	0.4	0.7	0.6	0.0	0.6	0.2	0.4	1.4	0.8	0.2	14.0	0.7	0.1	20.7	5.4	56.8	5.5	2.1	4.0	2.5	3.7	5.2	8.6	1.5	1.4	2.0	32.9	5.5	2.0	0.1	3.8	4.6	0.7	1.6	1.7	1.2	0.8	1.1	1.0	0.2	1.6	0.5	3.0	14.6	0.9	1.4	6.9	4.1	2.0	2.5	5.3	5.7	0.0	7.9	4.1	1.7	3.0	0.9	2.2	0.0	0.0	2.3	82.5	2.9	5.5	11.6	2.1	24.1	0.0	0.0	3.1	11.1	0.2	0.9	42.6	6.8	115.4	0.2	0.2	22.9	0.0	0.0	0.3	5.3	0.0	0.8	1.4	0.7	5.6	16.7	46.3	0.4	41.4
ADCY7	"AC7, KIAA0037"	ENSG00000121281	"Adenylate cyclase 7"	P51828	16	50246137-50318135	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"cAMP biosynthesis"	Lyase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	9	"Alveolar cells type 2: 34.7;granulocytes: 48.6;Hofbauer cells: 30.2;Kupffer cells: 61.4;Macrophages: 41.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HEL: 23.3;HMC-1: 65.3;RPMI-8226: 32.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA041218, HPA048241"	Uncertain		Approved	Cytosol		NA	NA			Cytosol		"HPA041218: AB_2677365, HPA048241: AB_2680326"	"unprognostic (1.98e-1)"	"prognostic unfavorable (5.31e-4)"	"unprognostic (1.24e-1)"	"unprognostic (1.78e-1)"	"unprognostic (3.77e-1)"	"unprognostic (2.80e-1)"	"unprognostic (3.90e-2)"	"unprognostic (7.75e-2)"	"unprognostic (1.21e-1)"	"unprognostic (2.56e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.18e-1)"	"unprognostic (5.59e-3)"	"unprognostic (7.34e-2)"	"unprognostic (2.15e-3)"	"unprognostic (2.18e-1)"	"unprognostic (9.52e-4)"	6.3	4.3	7.0	17.4	9.7	14.9	3.9	1.2	5.2	3.7	5.0	9.8	0.8	2.8	3.7	4.8	13.2	5.3	6.9	7.3	5.3	4.2	3.3	3.6	16.4	16.5	8.8	4.4	17.1	3.7	1.0	3.4	9.7	8.6	3.5	5.9	6.2	6.5	1.6	1.8	7.9	10.4	5.0	12.3	26.9	4.9	2.1	9.2	21.8	3.7	3.1	26.0	6.6	6.1	3.6	12.5	6.5	16.7	8.4	7.0	5.0	4.0	5.5	0.2	0.8	0.6	7.1	0.5	2.8	1.3	2.2	2.0	5.2	8.4	1.6	7.6	11.4	0.1	14.7	5.8	2.4	2.7	15.4	2.0	23.3	4.2	1.5	6.5	4.4	65.3	3.8	2.4	1.6	2.6	1.2	0.6	5.3	8.5	3.2	3.1	2.3	1.7	10.4	1.0	1.9	7.9	1.6	2.1	32.4	1.5	0.4	1.0	2.7	1.5	0.6	1.3	1.4	0.1	13.0	5.2	0.3	7.6	0.8	0.8	0.3	0.1	3.5	2.4	9.5	1.0	6.5	7.8	2.9	7.0	11.7	5.1	3.2	2.8	5.0	12.5	3.6	2.6	3.7	4.4	8.4	16.7	6.5	3.9	5.0	7.0	9.7	1.2	5.2	5.3	4.2	8.8	4.4	8.6	9.2	17.9	34.7	6.9	0.3	3.3	1.0	0.6	0.0	0.0	12.5	0.0	5.9	9.3	0.0	1.6	1.3	1.0	1.7	0.0	0.2	0.9	11.4	0.3	48.6	0.2	30.2	0.0	0.0	1.8	61.4	0.5	0.6	41.8	5.0	3.6	0.5	0.9	3.1	7.0	1.1	0.0	0.4	6.5	1.4	0.0	0.7	3.4	3.3	18.5	2.1	1.0
ADGRE2	"CD312, EMR2"	ENSG00000127507	"Adhesion G protein-coupled receptor E2"	Q9UHX3	19	14732393-14778541	"CD markers, Disease related genes, G-protein coupled receptors, Potential drug targets, Predicted membrane proteins"	"Cell adhesion, Inflammatory response"	"G-protein coupled receptor, Receptor, Transducer"	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 28.7;lymphoid tissue: 38.9"	"Cell type enhanced"	"Detected in many"	15	"granulocytes: 44.2;Kupffer cells: 60.1;Macrophages: 39.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"basophil: 19.6;eosinophil: 24.2;intermediate monocyte: 15.7;neutrophil: 19.1;non-classical monocyte: 28.7"	"Group enriched"	"Detected in many"	8	"granulocytes: 24.2;monocytes: 28.7"	"Cell line enhanced"	"Detected in some"		"HEL: 10.3;HMC-1: 16.6;NB-4: 10.1;RPMI-8226: 7.3;U-937: 13.2"									HPA055200			Uncertain	Vesicles,Cytosol		NA	NA			Vesicles	Cytosol	"HPA055200: "	"unprognostic (2.46e-2)"	"unprognostic (3.58e-2)"	"unprognostic (2.21e-1)"	"unprognostic (1.66e-1)"	"unprognostic (9.10e-2)"	"unprognostic (3.58e-2)"	"unprognostic (2.77e-2)"	"unprognostic (3.88e-2)"	"unprognostic (4.28e-1)"	"unprognostic (1.22e-1)"	"unprognostic (2.32e-1)"	"unprognostic (2.70e-2)"	"prognostic unfavorable (4.35e-6)"	"unprognostic (1.46e-1)"	"unprognostic (2.45e-3)"	"unprognostic (2.50e-1)"	"unprognostic (1.01e-1)"	6.3	3.1	1.7	22.9	1.9	7.2	4.4	1.0	1.3	14.9	8.1	2.5	0.9	2.4	12.0	1.0	1.9	2.3	3.3	7.3	2.0	1.8	3.4	4.3	15.6	37.4	2.2	0.0	5.3	3.5	0.7	1.6	10.9	2.4	3.8	2.5	3.2	2.4	3.9	3.5	3.0	3.0	2.0	3.1	38.9	2.0	2.2	1.4	2.8	3.4	5.2	2.8	7.5	2.1	0.1	3.1	24.2	28.7	1.2	0.0	1.8	0.2	1.0	0.1	0.2	0.1	0.3	1.1	0.8	1.1	0.0	0.0	0.2	0.2	0.2	0.1	0.7	2.1	1.7	0.3	0.1	0.0	0.2	0.2	10.3	3.3	0.2	0.5	3.8	16.6	0.8	1.5	3.7	0.6	0.1	0.1	0.9	2.4	0.4	1.2	0.5	1.3	10.1	0.4	0.7	0.2	0.1	1.4	7.3	0.0	0.3	0.1	0.2	2.1	1.8	0.4	0.2	0.3	4.8	0.3	0.3	0.3	0.2	0.1	0.2	0.1	0.2	1.0	13.2	0.6	19.6	4.4	24.2	0.0	15.7	0.0	0.0	0.0	0.0	3.1	0.1	0.0	0.0	19.1	1.2	28.7	0.6	0.0	1.8	1.7	1.9	1.0	1.3	2.0	1.8	2.2	0.0	2.4	1.4	3.0	10.6	5.4	4.4	0.0	0.7	0.6	0.0	4.0	4.5	0.0	0.0	0.1	0.0	0.0	2.0	0.4	0.0	0.0	0.0	0.3	0.3	1.7	44.2	0.4	13.5	0.0	1.2	1.3	60.1	2.0	0.0	39.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.4	0.0	0.2	0.2	0.3	0.0	0.3	0.7	0.0	3.0
AIF1	"AIF-1, Em:AF129756.17, IBA1, IRT-1"	ENSG00000204472	"Allograft inflammatory factor 1"	P55008	6	31615184-31617021	"Predicted intracellular proteins"		Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 119.2;lymphoid tissue: 99.3"	"Group enriched"	"Detected in many"	19	"Hofbauer cells: 1482.8;Kupffer cells: 1886.5;Macrophages: 1383.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	23	"classical monocyte: 67.4;intermediate monocyte: 104.8;myeloid DC: 35.9;neutrophil: 51.7;non-classical monocyte: 119.2"	"Group enriched"	"Detected in many"	33	"dendritic cells: 35.9;granulocytes: 51.7;monocytes: 119.2"	"Cell line enhanced"	"Detected in some"		"HEL: 25.8;HMC-1: 37.2;JURKAT: 15.1;NB-4: 59.1;THP-1: 20.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA049234, HPA062949"	Enhanced		Uncertain	Cytosol		NA	NA			Cytosol		"HPA049234: AB_2680685, HPA062949: AB_2732694"	"unprognostic (3.20e-2)"	"unprognostic (7.21e-3)"	"unprognostic (6.11e-2)"	"unprognostic (2.33e-2)"	"unprognostic (2.46e-1)"	"unprognostic (1.13e-1)"	"unprognostic (6.98e-2)"	"unprognostic (4.83e-2)"	"unprognostic (2.72e-2)"	"unprognostic (7.56e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.94e-1)"	"prognostic unfavorable (2.30e-5)"	"unprognostic (1.29e-1)"	"unprognostic (1.02e-2)"	"unprognostic (9.59e-2)"	"unprognostic (4.89e-2)"	13.5	9.5	13.0	27.7	23.8	39.8	7.8	1.8	10.0	5.2	8.0	17.0	0.1	6.1	3.2	8.3	3.6	5.6	9.8	5.8	10.2	10.2	15.4	12.6	19.9	40.5	16.9	3.1	4.9	3.4	2.0	4.9	17.0	12.8	6.1	9.7	4.6	5.7	4.3	3.5	2.9	10.8	11.1	28.5	99.3	4.8	2.6	16.2	71.7	3.6	1.7	9.8	11.2	3.5	0.7	35.9	51.7	119.2	0.3	2.1	59.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	25.8	0.0	0.0	0.0	1.7	37.2	0.0	0.0	0.0	0.0	0.0	0.0	15.1	0.1	0.0	0.0	0.0	0.2	59.1	0.1	0.0	0.0	9.8	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	20.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	7.3	0.0	0.5	67.4	3.2	0.2	104.8	0.2	0.7	0.3	0.3	35.9	0.1	2.1	1.7	51.7	0.3	119.2	3.3	0.1	59.6	13.0	23.8	1.8	10.0	10.2	10.2	16.9	3.1	12.8	16.2	23.8	84.5	70.4	0.6	28.8	0.0	5.5	25.5	18.7	35.2	40.1	0.0	9.9	0.0	0.0	1.1	13.5	0.4	0.0	0.4	10.9	24.2	0.3	64.9	8.9	1482.8	0.0	1.2	43.0	1886.5	1.5	6.9	1383.0	37.1	40.5	0.0	0.0	0.1	5.8	0.7	3.1	0.0	51.8	17.6	0.3	1.5	24.7	19.0	27.4	0.4	0.0
ALOX5	5-LOX	ENSG00000012779	"Arachidonate 5-lipoxygenase"	P09917	10	45374176-45446119	"Enzymes, FDA approved drug targets, Predicted intracellular proteins"	"Leukotriene biosynthesis"	"Dioxygenase, Hydrolase, Oxidoreductase"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 45.2;bone marrow: 39.9;lymphoid tissue: 41.8"	"Cell type enhanced"	"Detected in many"	13	"granulocytes: 194.3;Hofbauer cells: 78.7;Kupffer cells: 81.6;Macrophages: 81.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"BEWO: 7.9;CAPAN-2: 6.1;Daudi: 22.3;HMC-1: 16.0;Karpas-707: 7.0;RT4: 10.5;U-266/70: 10.5;U-698: 7.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA071285	Enhanced		Supported	Nucleoplasm		NA	NA			Nucleoplasm		"HPA071285: AB_2686379"	"unprognostic (2.57e-2)"	"unprognostic (2.81e-1)"	"unprognostic (4.82e-2)"	"unprognostic (1.75e-2)"	"unprognostic (7.98e-3)"	"unprognostic (1.26e-1)"	"unprognostic (5.32e-2)"	"unprognostic (8.69e-2)"	"unprognostic (1.86e-2)"	"unprognostic (6.91e-2)"	"unprognostic (5.04e-2)"	"unprognostic (3.42e-1)"	"prognostic unfavorable (1.80e-5)"	"unprognostic (5.59e-3)"	"unprognostic (4.22e-2)"	"unprognostic (1.53e-1)"	"prognostic favorable (7.18e-4)"	7.4	3.9	2.9	18.3	7.4	39.9	5.8	13.2	3.2	3.4	6.5	6.4	1.0	4.5	3.2	4.7	4.9	5.4	8.0	6.1	3.9	2.6	4.8	2.6	34.7	36.9	9.0	1.7	2.6	10.0	1.3	1.7	11.2	6.1	7.8	3.4	3.2	6.6	3.4	1.1	2.9	14.4	7.8	8.4	41.8	4.5	2.0	6.2	2.4	3.0	1.4	16.7	27.2	10.5	14.8	11.1	45.2	21.3	0.0	0.5	9.5	0.0	0.0	0.0	0.0	0.0	0.0	7.9	0.0	0.0	0.0	0.0	0.0	6.1	22.3	0.8	0.0	0.0	0.3	0.2	0.0	0.0	0.4	0.2	4.3	0.0	0.0	0.0	0.0	16.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	7.0	0.0	0.0	0.0	0.3	0.0	1.0	0.0	0.1	0.0	0.8	0.3	10.5	0.5	0.0	0.0	0.2	0.0	0.1	0.1	0.5	0.0	0.0	1.2	0.0	0.0	10.5	1.9	7.4	0.0	0.1	0.0	36.7	21.3	27.0	0.0	20.0	0.1	14.8	0.5	0.2	11.1	10.4	0.0	0.0	45.2	0.0	19.6	0.3	0.1	9.5	2.9	7.4	13.2	3.2	3.9	2.6	9.0	1.7	6.1	6.2	14.9	58.3	34.9	5.4	1.0	0.8	2.0	15.3	4.0	12.5	8.7	2.0	0.5	0.0	19.2	0.4	0.7	2.1	0.0	18.9	1.4	0.6	3.3	194.3	0.6	78.7	0.0	6.8	2.5	81.6	1.1	0.3	81.2	0.0	18.0	0.7	0.3	17.8	0.0	0.0	0.0	0.2	12.9	0.7	0.4	0.8	1.3	3.4	1.3	0.4	35.5
ALOX5AP	FLAP	ENSG00000132965	"Arachidonate 5-lipoxygenase activating protein"	P20292	13	30713478-30764426	"Disease related genes, Predicted membrane proteins"	"Leukotriene biosynthesis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 296.2;bone marrow: 121.8"	"Cell type enhanced"	"Detected in many"	12	"granulocytes: 589.5;Hofbauer cells: 445.6;Macrophages: 736.5;monocytes: 250.7;T-cells: 298.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	6	"basophil: 296.2;eosinophil: 148.4;neutrophil: 194.2;plasmacytoid DC: 136.1"	"Group enriched"	"Detected in all"	7	"dendritic cells: 136.1;granulocytes: 296.2"	"Cell line enhanced"	"Detected in some"		"HDLM-2: 80.1;HL-60: 42.6;HMC-1: 137.8;THP-1: 53.6;U-937: 39.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA026592	Enhanced					NA	NA					"HPA026592: AB_10601115"	"unprognostic (1.17e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.83e-1)"	"unprognostic (4.64e-3)"	"unprognostic (7.18e-2)"	"unprognostic (7.10e-2)"	"unprognostic (7.79e-2)"	"unprognostic (1.04e-1)"	"unprognostic (5.33e-2)"	"prognostic unfavorable (6.44e-4)"	"unprognostic (7.83e-2)"	"unprognostic (6.63e-2)"	"prognostic unfavorable (5.68e-4)"	"unprognostic (1.33e-1)"	"unprognostic (3.19e-2)"	"unprognostic (2.72e-2)"	"unprognostic (2.59e-1)"	16.7	12.7	9.6	27.9	17.0	121.8	8.3	1.9	10.7	6.3	7.5	17.1	0.0	6.4	7.7	3.3	6.4	11.5	11.7	10.4	8.0	9.0	10.6	5.8	55.8	33.4	22.0	2.7	5.1	7.9	1.7	3.3	10.6	14.2	5.9	6.6	5.1	9.9	4.9	2.4	2.8	10.9	12.1	23.0	57.6	7.8	5.2	15.5	42.2	4.3	3.7	29.2	11.9	6.5	18.4	136.1	296.2	12.6	3.6	33.2	24.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.9	19.1	0.2	0.0	0.6	0.1	0.0	0.5	0.0	80.1	0.0	2.3	0.0	0.1	0.1	42.6	137.8	0.1	0.0	0.0	4.8	1.0	0.1	4.1	0.0	0.4	0.2	0.0	2.3	1.5	0.0	0.0	0.0	0.3	0.5	1.5	0.1	0.0	1.3	0.0	0.0	0.0	0.1	0.3	0.0	53.6	0.1	0.0	0.4	0.0	0.3	8.5	0.0	12.7	0.1	39.4	0.1	296.2	12.6	148.4	22.3	0.6	33.2	16.9	22.3	18.2	7.6	18.4	11.3	11.1	194.2	3.6	0.4	136.1	30.9	24.1	9.6	17.0	1.9	10.7	8.0	9.0	22.0	2.7	14.2	15.5	38.7	140.9	78.7	2.7	21.1	0.0	2.5	17.8	20.1	43.3	0.0	0.0	2.6	13.3	1.9	4.4	5.6	2.8	0.0	0.9	2.8	8.0	1.1	589.5	1.0	445.6	0.0	25.3	9.2	168.8	3.1	4.4	736.5	40.5	250.7	1.0	0.0	3.7	1.5	3.9	1.4	0.0	32.3	4.3	0.3	1.0	21.7	4.1	298.1	1.2	1.3
ANKRD44	PP6-ARS-B	ENSG00000065413	"Ankyrin repeat domain 44"	Q8N8A2	2	196967017-197311173	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 34.7;lymphoid tissue: 38.2"	"Cell type enhanced"	"Detected in many"	6	"B-cells: 93.2;Macrophages: 60.1;T-cells: 81.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 26.6;HMC-1: 20.7;Karpas-707: 15.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030122, HPA056549"	Approved		Approved	"Nuclear speckles,Mitochondria"		NA	NA			Mitochondria	"Nuclear speckles"	"HPA030122: AB_10600980, HPA056549: AB_2683170"	"unprognostic (3.64e-1)"	"unprognostic (1.70e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.33e-1)"	"unprognostic (2.63e-1)"	"unprognostic (7.04e-5)"	"unprognostic (1.97e-2)"	"unprognostic (1.58e-3)"	"unprognostic (2.27e-1)"	"unprognostic (1.18e-1)"	"unprognostic (8.25e-3)"	"unprognostic (1.33e-1)"	"unprognostic (1.33e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.29e-2)"	"unprognostic (6.94e-2)"	"unprognostic (3.67e-2)"	6.0	6.0	4.9	29.4	8.8	12.5	4.3	3.7	5.1	8.6	6.7	10.8	3.9	3.2	6.5	3.9	4.3	4.9	7.6	6.4	6.4	4.7	5.6	4.5	15.4	36.7	9.4	4.7	5.1	3.5	6.0	6.1	6.4	6.4	5.0	4.8	7.4	8.0	4.7	2.9	3.0	12.6	9.6	8.0	17.8	5.6	7.1	8.9	38.2	5.1	3.0	27.0	9.0	9.8	15.7	9.4	34.7	11.4	12.0	13.4	6.3	1.0	0.6	1.6	1.7	3.9	1.6	0.3	2.5	1.1	1.3	1.2	0.4	0.6	9.0	1.1	2.1	2.3	0.1	0.6	0.5	1.0	26.6	2.3	0.3	3.2	0.1	0.2	6.5	20.7	0.8	0.3	1.3	0.1	1.9	1.7	2.2	1.5	15.0	1.9	1.5	3.1	5.3	0.2	0.3	1.7	5.7	1.9	12.3	3.1	0.8	1.7	7.4	0.8	0.6	7.0	1.3	0.9	6.4	9.3	4.6	2.5	1.3	1.8	3.7	4.4	11.4	3.1	8.2	2.6	21.8	9.5	21.0	13.1	9.8	12.4	11.6	9.8	11.1	9.4	15.7	11.3	13.4	34.7	12.0	11.4	6.2	9.3	6.3	4.9	8.8	3.7	5.1	6.4	4.7	9.4	4.7	6.4	8.9	14.9	19.2	93.2	4.0	3.1	5.0	7.8	25.5	12.0	13.6	10.4	3.9	3.9	1.7	3.0	10.6	6.7	1.1	0.0	4.0	0.7	5.8	3.2	52.0	7.4	16.4	3.2	2.4	44.2	57.8	12.9	14.4	60.1	35.4	19.8	1.1	10.8	3.8	3.5	16.6	1.1	11.1	19.4	6.1	3.0	3.6	3.1	1.1	81.3	0.8	4.3
AOAH		ENSG00000136250	"Acyloxyacyl hydrolase"	P28039	7	36512949-36724549	"Enzymes, Predicted secreted proteins"	"Lipid metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 54.6;lymphoid tissue: 57.4"	"Cell type enhanced"	"Detected in many"	17	"Hofbauer cells: 31.1;Kupffer cells: 110.3;Macrophages: 54.2;T-cells: 51.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"classical monocyte: 54.6"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"GAMG: 4.1;NB-4: 21.3;THP-1: 16.3;U-937: 7.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"HPA021666, HPA026716"	Approved		Uncertain	Vesicles	"Secreted to blood"	NA	NA			Vesicles		"HPA021666: AB_2670799, HPA026716: AB_2671960"	"unprognostic (3.55e-2)"	"unprognostic (4.03e-3)"	"unprognostic (4.45e-2)"	"unprognostic (3.58e-1)"	"unprognostic (6.06e-2)"	"unprognostic (4.78e-2)"	"unprognostic (2.40e-1)"	"unprognostic (3.14e-3)"	"unprognostic (5.42e-2)"	"unprognostic (6.02e-2)"	"unprognostic (3.36e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.46e-3)"	"unprognostic (1.75e-1)"	"unprognostic (1.92e-3)"	"unprognostic (2.38e-1)"	"unprognostic (1.35e-1)"	8.4	3.4	5.2	17.2	4.9	19.3	2.8	1.9	3.6	3.1	5.3	7.4	0.2	4.9	3.9	7.2	2.5	3.1	8.4	3.4	4.8	3.8	3.1	6.8	9.4	23.2	6.9	2.0	2.1	2.3	0.6	2.4	5.7	5.8	3.8	7.3	3.8	4.5	1.4	1.5	1.6	7.6	4.7	12.6	57.4	3.3	1.4	6.8	14.0	2.9	0.4	10.9	7.2	2.8	0.3	34.8	18.7	54.6	19.2	8.8	31.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.1	0.5	0.0	0.0	0.0	2.9	0.0	0.3	0.1	0.0	0.0	1.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.5	21.3	0.1	0.0	0.0	0.4	0.0	0.2	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	16.3	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	7.1	0.0	0.3	54.6	17.6	8.8	47.9	1.8	0.3	0.4	6.1	34.8	0.0	1.0	7.8	18.7	19.2	20.2	0.5	0.1	31.0	5.2	4.9	1.9	3.6	4.8	3.8	6.9	2.0	5.8	6.8	0.0	14.0	8.8	0.0	0.7	0.0	0.4	0.0	1.4	4.5	0.0	0.0	0.2	1.7	0.2	0.4	0.5	5.8	0.0	0.0	0.2	0.5	0.1	4.7	0.6	31.1	0.0	14.9	3.1	110.3	0.4	0.0	54.2	0.0	19.0	0.4	3.2	0.0	1.5	0.4	0.3	0.2	0.0	0.9	0.0	0.0	0.3	0.1	51.7	0.5	0.1
AP1S2	"MRX59, MRXS5, PGS, SIGMA1B"	ENSG00000182287	"Adaptor related protein complex 1 sigma 2 subunit"	P56377	X	15825806-15854931	"Disease related genes, Predicted intracellular proteins"	"Protein transport, Transport"		"Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"epididymis: 218.0"	"Cell type enhanced"	"Detected in all"	8	"Hofbauer cells: 225.7;Kupffer cells: 390.4;Macrophages: 350.3"	"Cancer enhanced"	"Detected in all"		"melanoma: 49.7"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"dendritic cells: 55.2;monocytes: 74.9"	"Cell line enhanced"	"Detected in many"		"Karpas-707: 67.3;SK-MEL-30: 89.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA049894, HPA060945"	Enhanced		Supported	"Golgi apparatus,Vesicles"		NA	NA			"Golgi apparatus, Vesicles"		"HPA049894: AB_2680939, HPA060945: AB_2684393"	"prognostic favorable (9.86e-4)"	"unprognostic (4.62e-2)"	"unprognostic (2.11e-1)"	"unprognostic (1.68e-1)"	"unprognostic (2.47e-3)"	"unprognostic (3.85e-1)"	"unprognostic (2.03e-3)"	"unprognostic (5.76e-2)"	"unprognostic (1.43e-2)"	"prognostic favorable (5.53e-6)"	"unprognostic (1.85e-2)"	"unprognostic (5.61e-2)"	"unprognostic (5.08e-2)"	"unprognostic (6.35e-2)"	"unprognostic (3.13e-1)"	"unprognostic (9.34e-2)"	"unprognostic (6.47e-2)"	10.1	8.2	21.2	11.7	17.9	12.6	9.7	13.0	17.6	12.0	17.3	9.8	12.6	4.8	25.7	218.0	9.8	5.6	7.0	34.2	12.7	19.9	5.2	5.8	8.9	11.6	16.1	11.8	4.5	4.1	8.2	11.7	13.1	39.7	5.5	8.0	13.3	5.1	13.2	41.4	5.0	8.7	24.9	18.5	14.1	9.9	8.6	11.4	9.8	10.7	8.6	9.6	8.5	5.9	8.2	55.2	12.5	74.9	5.5	8.4	44.8	3.4	2.9	32.5	16.0	6.2	4.1	1.1	10.2	4.8	7.9	10.2	2.1	3.6	5.8	45.5	14.9	14.3	4.0	9.0	2.8	13.3	8.3	14.4	3.5	5.1	3.2	5.4	12.9	3.9	2.4	2.9	7.5	7.7	11.2	15.9	4.7	3.2	67.3	14.3	1.8	3.4	6.8	43.3	1.8	10.7	7.3	23.7	11.8	8.9	0.8	4.0	15.8	4.5	1.4	89.0	23.4	15.2	13.3	8.4	13.6	5.1	18.9	9.5	7.8	17.6	12.3	7.2	5.8	32.9	8.2	74.9	8.0	5.6	67.8	5.4	8.2	5.7	4.5	55.2	7.5	4.1	4.0	12.5	5.5	34.7	17.9	8.4	44.8	21.2	17.9	13.0	17.6	12.7	19.9	16.1	11.8	39.7	11.4	3.0	16.2	80.2	10.9	49.0	31.7	178.0	7.6	1.4	3.4	8.7	11.8	4.7	28.2	12.5	3.9	119.9	7.7	23.3	5.6	16.4	51.9	11.0	77.3	6.4	225.7	11.1	25.8	148.0	390.4	8.9	16.1	350.3	141.7	139.7	7.0	19.0	8.6	11.2	6.7	6.6	34.6	38.8	56.7	25.7	19.4	45.0	4.7	51.1	6.4	5.8
APBB1IP	"INAG1, RIAM"	ENSG00000077420	"Amyloid beta precursor protein binding family B member 1 interacting protein"	Q7Z5R6	10	26438203-26567803	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 54.2;lymphoid tissue: 100.5"	"Cell type enhanced"	"Detected in many"	12	"B-cells: 48.4;Hofbauer cells: 56.0;Kupffer cells: 108.6;Macrophages: 52.4;T-cells: 69.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"neutrophil: 54.2"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Daudi: 25.7;MOLT-4: 22.0;REH: 49.7;U-698: 52.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA017009, HPA063903"	Enhanced		Enhanced	"Plasma membrane,Cytosol"		No	NA			"Plasma membrane, Cytosol"		"HPA017009: AB_2669505, HPA063903: AB_2685147"	"unprognostic (1.31e-2)"	"unprognostic (3.26e-2)"	"unprognostic (2.79e-3)"	"prognostic favorable (7.48e-4)"	"unprognostic (3.06e-1)"	"unprognostic (1.07e-2)"	"unprognostic (3.83e-2)"	"unprognostic (3.05e-1)"	"unprognostic (1.62e-2)"	"unprognostic (3.74e-1)"	"unprognostic (5.72e-2)"	"unprognostic (9.75e-2)"	"unprognostic (1.71e-1)"	"unprognostic (7.77e-3)"	"unprognostic (2.68e-2)"	"unprognostic (6.00e-2)"	"unprognostic (2.38e-2)"	18.3	3.9	7.9	27.7	14.2	25.8	10.1	1.2	7.3	2.6	3.9	16.6	0.0	4.5	2.0	1.5	2.9	4.9	7.5	4.8	7.3	4.9	4.8	25.4	11.1	28.2	14.5	3.2	1.5	3.0	1.3	2.7	5.5	11.1	2.5	4.5	1.6	4.0	1.6	1.5	2.8	12.0	4.7	21.9	41.5	5.4	1.3	12.1	100.5	3.0	0.7	26.2	8.0	3.9	11.0	14.8	54.2	10.3	5.3	9.5	3.5	0.0	0.4	0.0	0.0	3.4	5.7	3.0	9.6	1.8	5.5	5.3	0.0	0.0	25.7	0.1	6.4	5.9	0.0	0.0	0.0	7.6	0.0	0.0	18.6	0.0	0.0	0.0	3.5	0.0	8.2	0.0	0.2	0.0	0.6	0.0	10.6	0.0	16.4	0.0	0.0	22.0	4.9	0.0	2.0	0.0	49.7	0.0	18.2	1.5	0.0	0.0	0.0	0.9	0.1	0.0	0.0	0.0	12.1	0.0	0.0	0.1	1.8	0.0	4.5	0.0	52.9	4.5	18.2	0.0	19.0	7.1	16.1	9.5	6.9	7.7	9.5	8.1	7.9	4.4	11.0	9.3	9.0	54.2	5.3	10.3	14.8	7.6	3.5	7.9	14.2	1.2	7.3	7.3	4.9	14.5	3.2	11.1	12.1	0.0	25.9	48.4	0.0	1.0	0.0	0.9	5.1	6.7	4.5	3.5	0.0	2.0	0.0	4.1	0.3	1.7	0.0	0.0	0.0	14.9	4.1	0.1	22.0	21.5	56.0	0.0	0.0	8.6	108.6	0.0	0.0	52.4	3.3	8.2	0.0	0.0	0.1	0.0	0.0	2.7	0.1	0.0	1.0	0.0	0.9	0.1	1.1	69.3	0.0	0.0
ARHGAP30	FLJ00267	ENSG00000186517	"Rho GTPase activating protein 30"	Q7Z6I6	1	161046946-161069970	"Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 27.1;lymphoid tissue: 45.9"	"Cell type enhanced"	"Detected in many"	9	"granulocytes: 64.9;Hofbauer cells: 51.2;Kupffer cells: 65.0;Macrophages: 65.9;monocytes: 85.6;T-cells: 106.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"Daudi: 31.5;HL-60: 24.3;HMC-1: 34.3;Karpas-707: 25.5;MOLT-4: 19.7;THP-1: 24.2;U-266/70: 38.3;U-266/84: 25.3;U-698: 26.9;U-937: 19.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA036300	Enhanced		Supported	Vesicles		NA	NA			Vesicles		"HPA036300: AB_10601117"	"unprognostic (7.31e-2)"	"unprognostic (8.83e-3)"	"unprognostic (7.46e-3)"	"unprognostic (1.77e-3)"	"unprognostic (7.41e-2)"	"unprognostic (1.68e-3)"	"unprognostic (3.05e-1)"	"unprognostic (6.78e-3)"	"unprognostic (1.94e-2)"	"unprognostic (3.89e-2)"	"unprognostic (7.91e-2)"	"unprognostic (3.09e-1)"	"prognostic unfavorable (9.78e-4)"	"unprognostic (1.18e-1)"	"unprognostic (1.08e-2)"	"unprognostic (6.64e-2)"	"unprognostic (2.65e-2)"	6.1	3.0	2.6	23.3	3.9	20.4	3.1	0.6	2.4	2.2	3.9	3.5	1.4	3.5	2.0	3.7	8.0	3.3	5.9	4.1	1.9	1.7	3.0	3.3	11.3	27.9	4.3	0.7	1.8	1.8	0.3	1.5	2.5	3.4	2.3	3.2	2.6	6.1	1.8	0.9	11.2	13.7	2.9	4.3	45.9	4.1	1.4	4.5	38.1	2.0	2.4	33.2	5.6	3.8	8.3	12.3	27.1	24.0	10.2	19.7	14.7	0.2	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.3	31.5	0.1	0.0	0.0	0.6	0.0	0.0	0.0	14.6	0.0	10.5	0.0	0.0	0.0	24.3	34.3	0.0	0.3	0.0	0.0	0.0	0.0	15.3	0.1	25.5	0.0	0.2	19.7	5.6	0.0	0.2	0.0	12.4	0.1	0.4	0.0	0.2	0.1	0.0	0.0	0.2	0.0	0.1	0.1	24.2	0.2	0.0	0.1	0.0	0.1	38.3	25.3	26.9	0.1	19.5	0.0	3.3	15.5	17.6	19.7	18.3	15.1	7.1	13.2	16.1	12.3	8.3	11.0	14.7	27.1	10.2	24.0	8.4	13.2	14.7	2.6	3.9	0.6	2.4	1.9	1.7	4.3	0.7	3.4	4.5	3.0	25.1	39.8	2.9	4.9	0.2	1.2	5.1	9.4	11.4	0.0	3.9	0.5	0.0	2.2	2.1	2.1	0.0	0.0	5.3	1.2	0.9	3.8	64.9	1.5	51.2	0.0	0.0	7.4	65.0	0.4	0.3	65.9	5.0	85.6	0.3	0.2	7.6	0.0	0.0	0.5	3.0	0.0	1.4	0.0	0.1	21.5	3.8	106.6	0.3	13.6
ARHGAP31	CDGAP	ENSG00000031081	"Rho GTPase activating protein 31"	Q2M1Z3	3	119294373-119420714	"Disease related genes, Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Endothelial cells: 35.0;Ito cells: 27.0;Macrophages: 20.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"myeloid DC: 8.2"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HUVEC TERT2: 21.2;TIME: 23.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036380	Approved					NA	NA					"HPA036380: AB_10673129"	"unprognostic (2.22e-2)"	"unprognostic (1.93e-2)"	"unprognostic (9.90e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.09e-2)"	"unprognostic (1.11e-1)"	"unprognostic (8.75e-3)"	"unprognostic (3.22e-2)"	"unprognostic (2.57e-1)"	"unprognostic (7.18e-3)"	"unprognostic (5.86e-2)"	"unprognostic (1.30e-1)"	"prognostic favorable (8.45e-4)"	"unprognostic (3.57e-2)"	"unprognostic (6.32e-2)"	"unprognostic (1.38e-1)"	"unprognostic (7.79e-3)"	24.5	3.7	9.0	9.3	8.0	1.3	15.1	6.3	12.2	10.1	8.3	7.6	5.0	4.1	14.2	6.0	7.9	8.5	11.1	25.6	9.5	6.4	6.8	5.0	24.4	8.5	8.5	5.5	8.9	3.9	7.7	4.2	15.2	7.4	6.4	7.2	11.0	5.4	5.7	5.5	9.2	7.6	15.3	6.8	8.7	5.7	3.4	7.6	11.0	16.7	7.8	8.5	8.4	14.3	2.4	8.2	0.0	4.0	1.5	1.2	1.3	0.2	1.5	3.8	7.4	2.2	1.8	1.1	4.5	5.2	3.6	2.6	0.0	0.3	0.0	5.4	11.6	6.2	0.1	3.6	1.1	4.1	6.4	0.4	1.0	0.5	0.0	3.6	0.2	4.3	4.8	0.1	9.2	1.0	2.8	21.2	0.7	0.0	1.8	7.9	0.1	0.0	0.2	1.3	0.0	4.6	0.0	1.7	0.0	1.0	0.0	0.0	14.0	2.3	0.0	9.7	2.1	0.4	0.4	23.3	9.9	4.0	1.2	3.4	3.1	3.2	3.7	6.7	3.3	9.9	0.0	3.5	0.0	0.6	4.0	1.2	2.4	0.5	0.7	8.2	0.7	0.4	0.3	0.0	1.5	1.5	7.5	1.2	1.3	9.0	8.0	6.3	8.1	9.5	6.4	8.5	5.5	7.4	7.6	17.9	18.2	1.9	0.5	4.6	0.0	15.4	0.0	1.4	4.5	0.0	0.0	0.9	0.0	1.7	0.2	35.0	0.0	0.0	1.8	8.8	3.8	0.6	9.2	0.0	9.2	0.0	0.0	27.0	12.1	0.2	2.6	20.8	10.1	14.4	2.6	3.6	1.4	0.0	2.5	1.8	0.3	0.0	5.2	0.3	0.1	4.4	0.8	1.0	0.4	0.4
ARHGAP4	"C1, KIAA0131, p115, RhoGAP4, SrGAP4"	ENSG00000089820	"Rho GTPase activating protein 4"	P98171	X	153907367-153934999	"Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 44.8;lymphoid tissue: 48.4"	"Cell type enhanced"	"Detected in many"	7	"Hofbauer cells: 71.1;Kupffer cells: 73.8;Macrophages: 43.6;T-cells: 48.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Daudi: 26.2;Karpas-707: 26.9;MOLT-4: 25.3;RPMI-8226: 49.8;THP-1: 24.3;U-698: 23.2;U-937: 21.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA001012, HPA001083"	Enhanced		Approved	"Nucleoplasm,Focal adhesion sites"		NA	NA			"Focal adhesion sites"	Nucleoplasm	"HPA001012: AB_1078201, HPA001083: AB_1078199"	"unprognostic (3.54e-2)"	"prognostic favorable (3.94e-5)"	"prognostic unfavorable (1.97e-5)"	"unprognostic (5.79e-2)"	"unprognostic (9.42e-2)"	"prognostic favorable (3.31e-4)"	"unprognostic (5.72e-3)"	"unprognostic (1.39e-1)"	"unprognostic (3.27e-1)"	"unprognostic (1.37e-1)"	"unprognostic (7.81e-3)"	"unprognostic (1.45e-1)"	"prognostic unfavorable (2.49e-4)"	"unprognostic (8.47e-3)"	"unprognostic (2.01e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.99e-1)"	7.0	4.8	5.3	24.3	5.8	44.8	5.0	4.5	3.2	3.1	6.5	5.2	2.1	6.0	3.9	7.0	4.4	5.2	6.5	4.2	4.5	3.2	7.4	4.9	13.4	29.1	5.2	0.9	2.6	2.3	0.9	3.5	9.0	4.8	4.2	3.0	5.7	7.5	1.8	1.6	1.8	18.0	3.9	5.9	48.4	4.9	3.6	4.2	43.2	4.2	1.6	29.0	7.1	3.6	10.8	17.7	18.7	30.5	8.5	15.7	12.6	0.4	0.1	0.2	1.7	0.0	0.0	0.7	0.2	0.1	0.0	0.0	0.1	12.5	26.2	1.6	0.0	0.2	0.2	1.3	0.0	0.0	7.1	1.0	10.2	0.1	0.5	1.1	18.6	17.3	0.0	0.1	0.0	0.1	0.1	2.6	6.6	0.0	26.9	0.1	1.3	25.3	0.3	0.8	0.1	0.0	12.0	3.5	49.8	0.1	0.2	2.4	3.6	0.2	0.6	0.2	0.3	5.9	24.3	0.5	0.1	0.3	0.2	0.1	16.3	13.9	23.2	0.2	21.7	0.0	5.1	14.1	18.7	15.7	23.1	10.9	10.8	11.2	12.4	14.1	10.4	10.1	10.1	12.0	8.5	30.5	17.7	12.6	12.6	5.3	5.8	4.5	3.2	4.5	3.2	5.2	0.9	4.8	4.2	8.9	33.9	40.2	0.5	3.1	9.8	30.4	2.5	13.4	4.5	17.4	3.9	1.7	5.0	0.7	0.1	10.6	3.9	0.0	0.6	1.2	2.1	0.4	33.5	0.5	71.1	3.2	4.6	4.3	73.8	0.0	0.9	43.6	10.1	12.6	2.1	1.3	0.1	0.0	0.0	0.6	4.4	0.0	0.9	0.5	4.9	1.5	1.1	48.4	3.9	0.4
ARHGAP9	"10C, MGC1295"	ENSG00000123329	"Rho GTPase activating protein 9"	Q9BRR9	12	57472255-57488814	"Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 76.9;bone marrow: 48.1;lymphoid tissue: 50.4"	"Cell type enhanced"	"Detected in many"	13	"Early spermatids: 56.4;Hofbauer cells: 36.3;Kupffer cells: 39.0;Macrophages: 34.2;T-cells: 110.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in all"		"neutrophil: 76.9"	"Lineage enriched"	"Detected in all"	4	"granulocytes: 76.9"	"Cell line enhanced"	"Detected in some"		"HEL: 11.2;HMC-1: 50.1;THP-1: 14.4;U-937: 11.4"					"Low region specificity"	"Detected in some"			HPA078822			Approved	"Plasma membrane,Cell Junctions"		NA	NA			"Plasma membrane"	"Cell Junctions"	"HPA078822: "	"unprognostic (1.02e-2)"	"unprognostic (4.01e-3)"	"unprognostic (1.91e-2)"	"prognostic favorable (6.61e-5)"	"unprognostic (1.24e-1)"	"unprognostic (2.38e-3)"	"unprognostic (4.79e-2)"	"unprognostic (5.56e-3)"	"unprognostic (1.28e-2)"	"unprognostic (2.80e-1)"	"unprognostic (3.05e-2)"	"unprognostic (3.64e-1)"	"prognostic unfavorable (7.90e-9)"	"unprognostic (1.60e-1)"	"unprognostic (6.32e-2)"	"unprognostic (9.13e-2)"	"unprognostic (6.91e-2)"	5.1	2.5	5.1	33.0	8.0	48.1	4.4	3.7	4.8	1.8	5.4	2.5	0.5	3.6	1.6	1.7	2.7	4.4	4.8	2.4	4.2	1.8	3.5	3.8	11.2	24.1	8.1	0.6	1.2	2.2	0.3	1.5	2.3	5.8	2.5	5.1	2.4	6.0	1.3	0.9	1.4	18.6	2.6	8.5	50.4	3.9	8.8	6.4	19.0	2.6	3.2	28.5	4.7	2.2	8.9	18.9	76.9	17.0	13.1	13.3	11.8	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	5.9	0.1	0.1	0.0	0.1	0.1	0.0	0.0	0.3	0.0	11.2	0.0	0.0	0.4	6.5	50.1	0.3	0.0	0.0	0.1	0.0	0.0	5.9	0.2	3.3	0.0	0.0	8.9	8.9	0.4	0.0	0.0	3.7	4.3	1.8	0.0	0.0	1.6	1.4	0.0	0.0	0.1	0.2	0.0	14.4	0.3	0.0	0.1	0.0	0.0	4.0	2.7	5.4	0.1	11.4	0.2	8.4	16.6	45.1	9.0	17.0	6.2	7.1	9.9	8.1	13.9	8.9	13.3	9.6	76.9	13.1	12.8	18.9	12.1	11.8	5.1	8.0	3.7	4.8	4.2	1.8	8.1	0.6	5.8	6.4	0.0	23.5	22.6	0.0	1.3	0.0	1.2	0.0	4.0	2.3	0.0	2.0	0.3	0.0	0.0	56.4	1.8	0.0	0.0	0.0	0.4	1.3	0.2	11.5	1.1	36.3	0.0	0.0	4.3	39.0	28.4	1.7	34.2	0.0	10.0	0.0	0.0	0.2	0.0	0.0	0.3	0.7	0.0	0.5	28.8	8.5	1.3	0.2	110.8	0.1	0.1
ARL11	"ARLTS1, FLJ33930"	ENSG00000152213	"ADP ribosylation factor like GTPase 11"	Q969Q4	13	49628299-49633872	"Disease related genes, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 21.5;lymphoid tissue: 18.3"	"Cell type enhanced"	"Detected in many"	11	"B-cells: 16.7;Hofbauer cells: 27.4;Kupffer cells: 33.0;Macrophages: 18.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"neutrophil: 21.5"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"Daudi: 7.3;HMC-1: 10.2;NB-4: 10.2;THP-1: 13.4;U-698: 6.1;U-937: 5.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA040855, HPA040887"	Uncertain					NA	NA					"HPA040855: AB_10793864, HPA040887: AB_10796229"	"unprognostic (1.19e-2)"	"unprognostic (2.27e-1)"	"unprognostic (2.07e-1)"	"unprognostic (2.82e-1)"	"unprognostic (7.86e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.12e-2)"	"unprognostic (1.83e-1)"	"unprognostic (3.60e-1)"	"unprognostic (1.82e-1)"	"unprognostic (2.72e-2)"	"unprognostic (2.55e-1)"	"unprognostic (2.27e-4)"	"unprognostic (1.72e-2)"	"unprognostic (5.60e-2)"	"unprognostic (1.16e-1)"	"unprognostic (3.14e-2)"	4.8	2.1	1.7	14.9	4.1	5.4	1.5	0.6	2.5	2.1	1.6	2.1	0.0	2.0	1.3	1.4	3.1	1.3	2.0	1.1	1.4	1.1	1.2	1.1	6.1	13.8	2.9	0.2	0.7	3.3	0.4	1.5	3.8	2.5	1.1	2.6	1.5	2.2	0.4	0.7	1.2	4.1	1.2	3.3	18.3	1.1	1.0	2.4	6.4	1.2	0.0	9.6	2.8	2.5	5.7	4.7	21.5	9.7	0.4	0.5	2.3	0.1	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.6	0.0	7.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	1.9	0.1	0.6	0.0	4.7	10.2	0.1	0.1	0.0	0.0	0.0	0.4	4.8	0.2	0.1	0.0	1.2	4.4	10.2	0.1	0.0	0.0	4.8	0.0	2.0	0.0	0.0	0.0	0.0	0.0	4.2	0.0	0.1	3.3	13.4	0.0	0.0	0.0	0.1	0.0	0.1	0.1	6.1	0.0	5.9	0.0	10.6	8.7	8.8	0.1	9.7	0.1	4.4	0.2	0.2	4.5	5.7	0.5	0.2	21.5	0.4	7.0	4.7	0.1	2.3	1.7	4.1	0.6	2.5	1.4	1.1	2.9	0.2	2.5	2.4	0.0	1.4	16.7	0.2	0.2	0.5	0.4	2.5	4.0	0.0	0.0	0.0	4.1	0.0	0.0	1.0	0.7	2.6	0.0	0.0	4.2	0.3	0.1	7.0	0.4	27.4	0.0	1.2	1.8	33.0	0.4	0.3	18.9	0.0	5.4	3.0	0.3	0.1	10.7	0.0	0.0	0.3	0.0	0.0	0.5	0.2	0.0	1.3	0.9	2.4	0.3
ARRB2	"ARR2, BARR2, DKFZp686L0365"	ENSG00000141480	"Arrestin beta 2"	P32121	17	4710489-4721499	"Predicted intracellular proteins"	"Protein transport, Transport"	"Signal transduction inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 102.8;lymphoid tissue: 66.6"	"Cell type enhanced"	"Detected in many"	11	"Hofbauer cells: 226.1;Kupffer cells: 213.1;Macrophages: 203.0;monocytes: 348.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HEL: 42.4;HMC-1: 71.5;NB-4: 43.0;U-937: 61.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA075177			Supported	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Plasma membrane"	"Nucleoplasm, Cytosol"	"HPA075177: "	"unprognostic (1.12e-1)"	"prognostic favorable (2.93e-5)"	"unprognostic (1.09e-1)"	"unprognostic (1.47e-1)"	"unprognostic (7.43e-2)"	"unprognostic (3.37e-2)"	"unprognostic (2.62e-3)"	"unprognostic (3.85e-2)"	"unprognostic (3.05e-2)"	"unprognostic (2.58e-1)"	"unprognostic (1.66e-3)"	"prognostic unfavorable (2.61e-5)"	"unprognostic (1.32e-2)"	"unprognostic (8.61e-2)"	"unprognostic (4.92e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.88e-1)"	21.6	15.6	23.7	47.8	18.3	102.8	10.0	28.1	26.3	8.7	16.1	20.4	1.9	23.0	7.4	7.8	7.1	10.8	14.8	10.2	27.3	20.9	10.5	15.6	35.0	31.3	20.1	19.6	8.7	8.3	6.6	10.2	16.0	19.7	7.4	13.2	10.7	8.7	6.2	5.5	5.8	21.0	13.7	21.7	66.6	12.5	5.0	18.3	23.5	6.4	3.2	17.0	15.7	7.1	2.2	18.0	52.9	32.8	5.9	11.4	16.0	3.7	19.9	7.8	7.5	1.5	2.2	4.1	2.9	4.0	8.7	10.9	6.8	3.1	10.4	2.7	2.2	4.2	6.3	12.9	4.1	9.0	24.8	18.8	42.4	10.1	12.0	2.3	18.8	71.5	2.0	5.3	10.7	4.3	5.7	6.6	19.7	2.8	10.5	1.9	6.6	18.8	43.0	4.2	10.0	4.1	22.2	6.9	11.6	3.0	2.0	8.1	11.2	6.6	11.5	5.1	3.4	5.5	8.9	5.7	3.3	6.6	5.6	11.1	4.4	5.9	5.9	8.7	61.3	4.8	22.6	30.4	52.5	11.0	31.5	7.8	2.2	7.1	11.4	18.0	1.9	6.8	9.0	52.9	5.9	32.8	4.4	6.0	16.0	23.7	18.3	28.1	26.3	27.3	20.9	20.1	19.6	19.7	18.3	20.8	44.9	18.5	7.0	10.2	17.4	8.1	10.2	8.1	18.2	3.5	2.0	4.8	13.3	8.8	0.4	9.2	10.3	0.0	6.2	9.4	8.1	3.9	91.4	12.1	226.1	20.6	8.1	19.6	213.1	1.8	4.6	203.0	10.1	348.1	14.3	4.7	7.6	17.3	4.6	12.9	7.5	19.4	5.4	0.5	11.8	7.3	5.0	76.9	11.9	10.5
ASCL4	"bHLHa44, HASH4"	ENSG00000187855	"Achaete-scute family bHLH transcription factor 4"	Q6XD76	12	107774385-107776644	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"blood: 2.5;parathyroid gland: 3.1"	"Cell type enriched"	"Detected in single"	5	"Macrophages: 1.6"	"Cancer enhanced"	"Detected in single"		"melanoma: 0.7"					"Cell type enhanced"	"Detected in single"		"myeloid DC: 2.5"	"Lineage enriched"	"Detected in single"	25	"dendritic cells: 2.5"	"Cell line enhanced"	"Detected in single"		"SK-BR-3: 1.7"					"Not detected"	"Not detected"			HPA036116	Uncertain					NA	NA					"HPA036116: AB_10671833"	"unprognostic (2.20e-1)"	"unprognostic (1.53e-4)"			"unprognostic (1.86e-2)"	"unprognostic (8.88e-4)"		"unprognostic (2.09e-5)"	"unprognostic (1.40e-1)"		"unprognostic (1.88e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.88e-3)"	"unprognostic (9.25e-2)"	"unprognostic (1.80e-1)"	"unprognostic (2.90e-1)"		0.1	0.0	0.7	0.3	0.2	0.0	0.4	0.0	0.1	0.1	0.0			0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.5	0.3	0.9	0.0	0.0	0.7	0.4		0.0	0.0	3.1	0.0	0.0		0.3	0.0		0.2	0.1	0.0	1.0	0.3	0.0	0.4	0.5	0.4	0.5			0.0		1.4	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0											0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
ATG16L2	"ATG16B, FLJ00012, WDR80"	ENSG00000168010	"Autophagy related 16 like 2"	Q8NAA4	11	72814308-72843674	"Predicted intracellular proteins, Transporters"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 60.9;lymphoid tissue: 52.0"	"Cell type enhanced"	"Detected in many"	5	"Kupffer cells: 45.9;Macrophages: 38.5;Paneth cells: 43.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 28.5"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HMC-1: 31.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA045444, HPA050312"	Approved		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"HPA045444: AB_2679324, HPA050312: AB_2681082"	"unprognostic (7.20e-3)"	"unprognostic (1.16e-1)"	"unprognostic (1.54e-1)"	"unprognostic (4.26e-2)"	"unprognostic (2.12e-1)"	"unprognostic (1.31e-3)"	"unprognostic (1.61e-2)"	"unprognostic (4.74e-3)"	"unprognostic (1.89e-1)"	"unprognostic (1.90e-1)"	"prognostic favorable (7.06e-4)"	"unprognostic (2.49e-2)"	"prognostic unfavorable (3.39e-4)"	"unprognostic (1.74e-1)"	"unprognostic (4.38e-2)"	"unprognostic (1.08e-1)"	"unprognostic (4.83e-2)"	7.8	6.6	7.1	20.7	8.0	60.9	7.2	7.4	6.2	9.5	9.7	10.5	7.6	5.5	11.9	7.5	10.2	8.3	11.6	5.8	7.4	4.8	7.2	6.5	16.3	16.4	10.7	7.0	10.1	8.0	5.7	11.5	5.2	8.6	7.3	8.9	11.3	10.1	5.5	3.6	35.7	13.1	10.4	7.9	52.0	6.6	2.6	8.3	3.2	6.5	8.0	19.6	8.5	8.5	2.0	4.7	28.5	7.1	2.4	2.6	1.4	1.4	1.3	4.1	3.2	4.9	4.0	2.6	3.2	3.2	1.6	2.5	1.6	3.5	9.6	2.1	4.1	2.9	2.9	0.5	10.8	2.8	7.6	1.6	7.5	6.9	2.7	3.6	9.8	31.3	3.9	1.5	3.6	4.5	17.9	4.9	17.6	1.0	13.2	1.8	4.7	11.3	16.9	0.6	6.4	1.5	5.6	2.9	4.2	5.3	4.9	3.1	2.4	1.3	7.2	3.0	3.4	3.6	13.5	6.8	4.4	1.6	7.9	2.5	6.0	1.5	4.2	1.9	8.8	2.4	2.4	7.1	18.1	1.3	3.9	1.3	1.2	1.9	2.6	4.7	2.0	1.0	1.2	28.5	2.4	4.7	0.8	1.7	1.4	7.1	8.0	7.4	6.2	7.4	4.8	10.7	7.0	8.6	8.3	6.0	18.4	16.7	5.1	14.8	2.6	4.4	5.1	6.7	3.4	5.2	2.0	6.8	0.0	3.7	0.5	7.9	8.0	0.0	0.9	3.1	5.6	2.8	23.0	2.9	15.2	4.8	12.6	12.9	45.9	0.4	9.5	38.5	3.3	16.2	9.0	4.0	2.3	43.6	7.4	1.6	3.7	0.0	6.6	1.6	7.7	15.2	10.3	23.5	10.4	4.2
ATP8B4	"ATPIM, KIAA1939"	ENSG00000104043	"ATPase phospholipid transporting 8B4 (putative)"	Q8TF62	15	49858238-50182817	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Lipid transport, Transport"	Translocase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 28.1;cervix, uterine: 26.0;endometrium 1: 18.2"	"Group enriched"	"Detected in many"	4	"Early spermatids: 23.4;granulocytes: 19.6;Hofbauer cells: 12.9;Kupffer cells: 29.9;Late spermatids: 19.9;Macrophages: 17.3;T-cells: 8.6"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"basophil: 6.9;NK-cell: 10.6"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"HMC-1: 19.1;NB-4: 7.3;THP-1: 12.3;U-937: 38.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA040254	Approved		Uncertain	Nucleoplasm,Vesicles,Cytosol		NA	NA			"Nucleoplasm, Vesicles"	Cytosol	"HPA040254: AB_10673028"	"unprognostic (6.45e-3)"	"unprognostic (3.83e-2)"	"unprognostic (5.39e-2)"	"unprognostic (2.96e-3)"	"unprognostic (3.25e-1)"	"unprognostic (6.51e-3)"	"unprognostic (1.03e-1)"	"unprognostic (4.87e-3)"	"unprognostic (1.64e-2)"	"unprognostic (5.11e-2)"	"unprognostic (1.20e-1)"	"unprognostic (3.74e-2)"	"unprognostic (5.99e-2)"	"unprognostic (5.12e-2)"	"unprognostic (1.20e-2)"	"unprognostic (1.53e-1)"	"unprognostic (2.08e-1)"	2.3	1.2	1.6	1.5	2.1	28.1	1.0	0.6	0.9	26.0	1.5	1.7	1.6	0.4	18.2	3.5	0.6	9.5	3.1	0.8	2.5	0.9	1.0	1.2	3.2	0.7	2.7	0.1	3.9	0.4	0.2	1.1	2.9	2.1	0.7	1.2	0.8	0.9	0.6	0.4	0.5	1.1	2.7	3.1	2.3	0.6	0.9	4.6	0.8	0.5	0.8	2.1	1.3	1.5	0.0	2.2	6.9	1.7	10.6	0.5	0.8	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.1	0.1	0.0	0.0	5.2	0.0	3.0	0.6	0.0	0.0	5.3	19.1	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	7.3	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.6	0.0	0.0	0.0	0.0	12.3	0.0	0.0	0.1	0.5	0.0	0.0	0.0	0.0	0.4	38.5	0.0	6.9	1.7	2.4	0.5	0.8	0.0	0.0	0.0	0.1	2.2	0.0	0.0	0.0	0.8	10.6	0.3	0.0	0.0	0.8	1.6	2.1	0.6	0.9	2.5	0.9	2.7	0.1	2.1	4.6	0.0	3.4	1.3	0.1	1.3	0.2	1.2	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.0	23.4	0.5	0.4	0.0	0.0	1.6	3.3	0.5	19.6	2.8	12.9	0.0	0.0	1.8	29.9	19.9	1.7	17.3	1.7	1.0	0.3	0.5	0.0	0.0	0.7	0.8	0.0	0.0	4.3	0.4	0.6	0.3	2.4	8.6	0.0	0.1
BATF3	"JDP1, JUNDM1, SNFT"	ENSG00000123685	"Basic leucine zipper ATF-like transcription factor 3"	Q9NR55	1	212686418-212699985	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 26.8"	"Group enriched"	"Detected in many"	4	"Extravillous trophoblasts: 36.2;Macrophages: 24.9;monocytes: 98.2;Smooth muscle cells: 25.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	5	"intermediate monocyte: 18.0;myeloid DC: 16.5;non-classical monocyte: 26.8"	"Group enriched"	"Detected in many"	36	"dendritic cells: 16.5;monocytes: 26.8"	"Cell line enriched"	"Detected in some"	12	"HDLM-2: 93.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA075858			Supported	Nucleoplasm,Nucleoli,Cytosol		NA	NA			Nucleoli	"Nucleoplasm, Cytosol"	"HPA075858: "	"unprognostic (3.87e-2)"	"unprognostic (2.10e-2)"	"unprognostic (4.29e-2)"	"unprognostic (6.85e-2)"	"unprognostic (6.33e-2)"	"unprognostic (3.15e-2)"	"unprognostic (3.84e-2)"	"unprognostic (6.59e-2)"	"unprognostic (3.08e-1)"	"unprognostic (6.47e-2)"	"unprognostic (1.28e-2)"	"unprognostic (1.75e-1)"	"unprognostic (6.43e-10)"	"unprognostic (9.88e-2)"	"unprognostic (5.19e-2)"	"unprognostic (3.90e-1)"	"unprognostic (7.08e-2)"	10.4	1.3	6.7	6.3	9.4	5.4	3.5	0.4	5.2	2.0	2.4	3.3	0.2	1.4	1.8	0.4	1.8	2.6	3.8	4.1	5.5	2.1	2.6	2.3	7.2	8.7	9.5	2.8	3.1	3.2	1.2	1.3	4.6	4.3	2.3	1.6	0.5	2.2	1.2	1.5	1.1	4.3	3.7	4.7	9.5	3.2	1.1	7.1	5.0	2.1	2.6	4.9	3.0	6.0	0.2	16.5	0.6	26.8	0.3	0.4	2.4	0.3	0.9	0.1	0.0	0.0	0.6	0.7	0.5	1.1	1.1	1.2	0.0	0.3	0.0	0.2	0.0	1.8	0.0	1.1	0.2	0.8	93.1	2.2	0.0	0.3	0.0	0.2	4.2	0.6	0.1	0.0	2.2	0.3	0.1	0.0	7.7	0.1	1.1	0.2	0.0	3.2	1.7	0.4	0.0	1.5	0.6	0.4	0.0	1.0	0.0	0.2	0.1	0.3	0.0	0.0	0.4	0.0	3.0	0.0	0.5	2.1	0.1	2.4	0.1	0.2	0.5	1.5	3.8	1.1	0.0	4.1	0.0	0.0	18.0	0.0	0.2	0.0	0.0	16.5	0.0	0.0	0.0	0.6	0.3	26.8	0.0	0.4	2.4	6.7	9.4	0.4	5.2	5.5	2.1	9.5	2.8	4.3	7.1	3.0	1.1	0.5	2.2	5.0	0.1	0.3	0.0	4.0	2.3	0.0	0.0	0.8	0.0	0.7	0.3	5.8	0.0	0.0	0.3	36.2	8.5	6.6	4.7	0.2	4.6	0.0	0.0	6.2	10.5	0.8	0.9	24.9	1.7	98.2	0.0	0.2	1.3	0.0	0.0	0.5	0.4	0.0	25.8	1.1	4.3	2.5	3.8	1.0	0.0	0.9
BCL2A1	"ACC-1, ACC-2, ACC1, ACC2, BCL2L5, BFL1, GRS, HBPA1"	ENSG00000140379	"BCL2 related protein A1"	Q16548	15	79960889-79971446	"Cancer-related genes, Predicted intracellular proteins"	Apoptosis		"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 72.7;bone marrow: 105.7;lung: 45.6"	"Group enriched"	"Detected in many"	4	"granulocytes: 217.9;Hofbauer cells: 208.5;Macrophages: 391.0;monocytes: 632.2"	"Cancer enhanced"	"Detected in all"		"melanoma: 39.4"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"eosinophil: 37.1;intermediate monocyte: 25.3;neutrophil: 72.7;non-classical monocyte: 47.2"	"Group enriched"	"Detected in all"	6	"granulocytes: 72.7;monocytes: 47.2"	"Cell line enriched"	"Detected in some"	5	"SK-MEL-30: 96.8"															NA	NA						"unprognostic (3.19e-3)"	"unprognostic (2.61e-1)"	"unprognostic (3.99e-2)"	"unprognostic (3.54e-3)"	"unprognostic (9.65e-3)"	"unprognostic (1.47e-1)"	"unprognostic (1.35e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.78e-1)"	"unprognostic (1.78e-2)"	"unprognostic (4.01e-2)"	"unprognostic (2.09e-1)"	"prognostic unfavorable (2.77e-5)"	"unprognostic (4.61e-2)"	"unprognostic (8.96e-2)"	"unprognostic (2.78e-1)"	"unprognostic (1.87e-1)"	21.6	0.9	1.9	22.6	4.0	105.7	1.8	0.5	1.8	1.0	2.0	0.4	0.0	1.0	0.7	1.0	3.0	4.9	3.6	9.8	2.2	1.3	1.8	5.2	45.6	24.9	11.8	0.0	3.7	1.0	0.2	2.2	3.8	3.8	1.6	1.3	0.8	2.3	0.3	1.4	0.6	4.4	2.7	8.2	32.8	1.9	4.6	4.0	4.3	2.3	1.4	11.1	4.8	7.1	9.3	3.4	72.7	47.2	2.8	5.7	5.8	0.0	0.2	0.0	0.0	0.1	0.1	0.0	0.0	1.1	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	2.7	0.7	0.3	0.0	0.0	0.0	0.2	0.4	0.5	20.6	0.3	0.0	1.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	3.4	0.0	0.0	0.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	96.8	0.0	0.0	1.0	0.0	10.5	0.9	0.0	0.2	0.1	0.0	0.7	0.4	6.6	4.9	3.3	5.6	37.1	3.6	25.3	2.0	9.3	4.7	4.7	3.4	5.9	5.7	5.3	72.7	2.8	47.2	0.6	1.0	5.8	1.9	4.0	0.5	1.8	2.2	1.3	11.8	0.0	3.8	4.0	20.8	84.6	34.0	0.8	9.7	0.0	2.5	0.0	16.0	17.0	1.8	0.0	1.6	1.7	1.9	0.9	3.7	0.0	0.0	1.3	2.1	4.1	1.0	217.9	0.2	208.5	0.0	0.0	2.5	63.4	0.8	0.0	391.0	32.1	632.2	0.0	0.1	4.1	0.0	0.0	0.6	0.0	0.0	7.6	0.1	0.2	8.9	3.8	29.4	0.0	1.4
BST1	CD157	ENSG00000109743	"Bone marrow stromal cell antigen 1"	Q10588	4	15702950-15738313	"CD markers, Enzymes, Plasma proteins, Predicted intracellular proteins"		"Hydrolase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 59.5;bone marrow: 54.9;intestine: 61.3"	"Cell type enhanced"	"Detected in many"	6	"Hofbauer cells: 39.0;Kupffer cells: 36.4;Macrophages: 29.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"classical monocyte: 52.7;neutrophil: 59.5"	"Group enriched"	"Detected in many"	105	"dendritic cells: 16.6;granulocytes: 59.5;monocytes: 52.7"	"Cell line enhanced"	"Detected in many"		"THP-1: 37.1;TIME: 20.4;U-937: 24.2;WM-115: 22.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA050121	Uncertain				"Intracellular and membrane"	NA	NA		170000000			"HPA050121: AB_2681025"	"unprognostic (2.95e-1)"	"unprognostic (3.61e-1)"	"unprognostic (1.27e-1)"	"unprognostic (4.00e-2)"	"unprognostic (7.49e-2)"	"unprognostic (2.89e-1)"	"unprognostic (4.55e-2)"	"unprognostic (2.70e-1)"	"unprognostic (1.75e-1)"	"unprognostic (1.84e-1)"	"unprognostic (1.08e-1)"	"unprognostic (4.06e-2)"	"unprognostic (4.83e-3)"	"unprognostic (1.94e-3)"	"unprognostic (3.11e-1)"	"unprognostic (1.57e-2)"	"unprognostic (1.95e-1)"	14.3	2.0	1.1	5.6	2.0	54.9	6.6	0.8	1.5	7.2	33.8	1.5	2.1	20.4	6.4	7.0	4.6	5.6	10.3	14.5	1.8	0.8	6.6	3.7	9.4	9.6	1.3	1.9	5.5	1.0	0.4	1.3	8.0	1.3	7.5	4.0	5.4	2.8	2.2	3.4	3.5	61.3	7.9	1.5	13.6	2.4	2.4	1.2	2.8	3.5	2.9	1.8	7.5	16.1	0.4	16.6	59.5	52.7	0.1	0.3	19.6	0.2	5.5	0.5	0.4	13.5	3.2	0.7	10.5	1.0	9.6	10.8	0.1	5.7	0.3	0.9	5.3	0.2	0.1	1.5	0.2	8.2	0.3	0.2	2.5	0.3	0.2	3.4	3.3	7.3	2.7	0.7	6.1	0.5	0.4	1.5	2.3	0.3	0.2	5.6	0.1	1.0	1.9	1.2	0.4	1.1	0.3	0.7	0.2	0.3	0.3	0.7	2.1	0.2	0.3	7.0	0.5	0.2	37.1	20.4	0.3	0.5	3.7	0.4	0.2	0.0	0.3	1.3	24.2	22.1	7.6	52.7	3.9	0.2	19.8	0.3	0.4	0.1	0.1	16.6	0.2	0.2	0.1	59.5	0.1	13.6	5.5	0.2	19.6	1.1	2.0	0.8	1.5	1.8	0.8	1.3	1.9	1.3	1.2	3.0	3.0	0.0	0.8	4.0	0.2	0.8	5.1	2.7	1.2	1.8	0.0	14.0	1.7	4.1	2.7	2.1	3.2	0.0	2.3	18.7	18.6	0.5	16.1	1.8	39.0	0.0	1.2	3.7	36.4	0.7	2.8	29.9	13.5	0.0	7.0	0.3	0.8	7.0	2.1	6.7	0.0	6.5	10.8	2.3	1.2	2.6	5.9	0.0	16.6	2.7
C10orf128	Em:AC084727.5	ENSG00000204161	"Chromosome 10 open reading frame 128"	Q5T292	10	49154725-49188585	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 61.0"	"Cell type enhanced"	"Detected in many"	13	"granulocytes: 69.2;Hofbauer cells: 64.2;Macrophages: 25.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	7	"eosinophil: 61.0"	"Lineage enriched"	"Detected in many"	7	"granulocytes: 61.0"	"Cell line enhanced"	"Detected in some"		"HDLM-2: 61.2;HEL: 14.8;K-562: 28.5;U-87 MG: 30.8;U-937: 26.5"	"Low region specificity"	"Detected in many"							HPA058166	Approved					NA	NA					"HPA058166: AB_2683627"	"unprognostic (1.33e-1)"	"unprognostic (5.67e-4)"	"unprognostic (1.34e-2)"	"unprognostic (1.21e-1)"	"unprognostic (4.50e-2)"	"unprognostic (4.13e-2)"	"unprognostic (5.86e-3)"	"unprognostic (9.13e-3)"	"unprognostic (2.61e-1)"	"unprognostic (1.25e-1)"	"unprognostic (5.11e-2)"	"unprognostic (2.11e-1)"	"prognostic unfavorable (2.86e-5)"	"unprognostic (2.45e-2)"	"unprognostic (2.22e-2)"	"unprognostic (8.69e-3)"	"unprognostic (1.24e-1)"	21.6	2.6	5.9	12.9	15.0	2.8	19.4	1.7	9.2	13.1	9.9	19.2	4.6	7.0	11.0	10.0	8.6	9.4	14.7	14.2	9.2	6.7	4.1	7.3	21.1	18.7	27.6	6.5	3.7	3.3	10.1	3.0	8.6	15.0	6.8	11.8	9.6	7.6	6.6	6.7	5.6	17.4	16.8	33.7	23.3	6.7	4.7	20.6	1.5	8.0	9.7	18.0	15.3	13.7	9.1	4.6	61.0	0.9	0.0	9.1	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.1	0.0	0.0	0.0	0.0	0.0	0.0	61.2	0.0	14.8	0.0	0.0	0.0	0.1	6.5	0.0	0.0	0.0	0.0	0.0	0.4	0.0	28.5	1.9	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	10.6	0.0	30.8	26.5	0.0	6.0	0.9	61.0	5.5	0.3	9.1	9.1	3.5	5.4	4.6	2.8	0.2	1.6	4.5	0.0	0.1	0.1	2.7	2.3	5.9	15.0	1.7	9.2	9.2	6.7	27.6	6.5	15.0	20.6	3.0	0.3	8.5	0.1	5.5	0.0	0.0	0.0	0.0	3.4	0.0	0.0	0.5	0.0	0.0	0.4	20.1	0.0	0.0	0.0	0.7	1.5	0.1	69.2	0.4	64.2	0.0	0.0	9.2	12.1	0.9	0.3	25.7	1.7	0.0	0.0	2.7	0.0	0.0	0.4	0.0	0.0	19.4	1.4	0.7	0.2	4.8	0.9	13.1	0.0	0.3
C11orf21		ENSG00000110665	"Chromosome 11 open reading frame 21"	Q9P2W6	11	2295645-2303049	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"blood: 29.5;bone marrow: 30.4;lymphoid tissue: 16.0"	"Cell type enhanced"	"Detected in some"	23	"Cardiomyocytes: 60.5;granulocytes: 15.1;Kupffer cells: 14.3;Macrophages: 12.4;T-cells: 17.5"	"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in some"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"HEL: 30.8;HL-60: 11.6;NB-4: 10.7;THP-1: 7.5;U-937: 13.1"									HPA037607	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA037607: AB_10672909"	"unprognostic (5.25e-3)"	"unprognostic (2.65e-4)"	"unprognostic (1.35e-1)"	"unprognostic (4.61e-3)"	"unprognostic (4.32e-2)"	"unprognostic (3.58e-4)"	"unprognostic (8.98e-4)"	"unprognostic (2.37e-3)"	"unprognostic (1.87e-1)"	"unprognostic (1.15e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.22e-1)"	"unprognostic (8.84e-4)"	"unprognostic (8.50e-2)"	"unprognostic (9.54e-2)"	"unprognostic (3.55e-1)"	"unprognostic (4.07e-2)"	1.5	0.4	0.7	8.7	0.5	30.4	0.7	0.2	0.7	1.5	0.8	1.7	0.8	0.2	1.6	1.3	0.7	1.0	5.4	15.6	0.4	0.4	1.0	1.3	5.2	8.5	2.2	0.9	0.7	0.6	0.0	0.8	0.8	1.0	0.8	0.8	1.4	9.3	0.1	0.4	0.8	3.3	0.6	1.4	16.0	2.0	0.9	1.0	6.4	1.1	2.7	11.5	1.0	0.9	2.6	7.3	29.5	23.2	9.5	10.6	6.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	30.8	0.0	0.1	0.3	11.6	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	10.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.2	13.1	0.0	29.5	6.3	18.7	10.6	13.1	7.3	2.0	3.6	8.4	7.3	2.6	5.4	7.5	5.5	9.5	23.2	0.7	2.6	6.4	0.7	0.5	0.2	0.7	0.4	0.4	2.2	0.9	1.0	1.0	0.0	6.2	1.9	0.0	0.3	0.0	60.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.0	15.1	0.0	3.4	0.0	0.0	1.3	14.3	0.0	0.0	12.4	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.4	0.0	17.5	0.0	0.0
C19orf38	HIDE1	ENSG00000214212	"Chromosome 19 open reading frame 38"	A8MVS5	19	10836575-10869790	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 58.7;bone marrow: 54.4"	"Cell type enhanced"	"Detected in many"	18	"Kupffer cells: 101.9;Macrophages: 32.6;monocytes: 24.4;Spermatocytes: 27.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	19	"classical monocyte: 44.3;eosinophil: 26.1;intermediate monocyte: 48.7;myeloid DC: 26.2;neutrophil: 37.3;non-classical monocyte: 58.7"	"Group enriched"	"Detected in many"	19	"dendritic cells: 26.2;granulocytes: 37.3;monocytes: 58.7"	"Cell line enriched"	"Detected in some"	4	"U-937: 32.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA012150, HPA055027"			Uncertain	"Golgi apparatus,Plasma membrane,Cytosol"		No	NA			Cytosol	"Golgi apparatus, Plasma membrane"	"HPA012150: AB_10603448, HPA055027: "	"unprognostic (6.65e-3)"	"prognostic favorable (2.43e-4)"	"unprognostic (6.44e-4)"	"unprognostic (6.98e-2)"	"unprognostic (2.19e-1)"	"unprognostic (5.31e-3)"	"unprognostic (3.56e-1)"	"unprognostic (8.27e-2)"	"unprognostic (5.60e-2)"	"unprognostic (6.02e-2)"	"unprognostic (9.74e-2)"	"unprognostic (3.43e-2)"	"prognostic unfavorable (1.75e-7)"	"unprognostic (2.31e-1)"	"unprognostic (4.00e-2)"	"unprognostic (1.03e-2)"	"unprognostic (2.11e-2)"	2.7	1.2	2.1	6.9	4.0	54.4	1.8	0.7	3.1	2.0	1.3	4.8	0.0	1.3	0.9	4.0	0.9	2.6	2.1	5.6	2.4	2.1	1.4	2.3	12.8	19.6	4.2	0.6	1.6	1.3	0.3	1.0	1.9	3.8	1.6	1.0	1.5	1.0	0.8	2.3	0.6	1.7	2.3	6.3	22.3	1.2	15.0	3.7	4.1	0.7	0.5	2.0	2.8	3.5	2.1	26.2	37.3	58.7	1.2	0.8	20.7	1.5	0.0	0.1	0.3	1.5	0.8	0.1	0.2	0.0	0.3	0.6	0.1	0.2	3.8	0.3	0.0	0.1	0.1	0.2	0.2	0.2	1.7	0.4	0.2	0.0	0.0	1.1	2.5	0.4	4.1	0.4	0.7	0.2	0.1	0.1	0.4	0.2	8.1	0.1	1.4	0.1	5.9	0.3	0.2	0.3	2.8	0.0	1.9	0.0	0.1	0.2	0.1	0.8	0.0	0.6	0.1	0.1	5.6	0.0	0.0	0.0	0.7	0.0	4.9	2.3	1.1	0.0	32.8	0.0	1.2	44.3	26.1	0.1	48.7	0.2	2.1	0.1	0.1	26.2	1.2	0.8	0.2	37.3	1.2	58.7	0.5	0.3	20.7	2.1	4.0	0.7	3.1	2.4	2.1	4.2	0.6	3.8	3.7	0.0	2.6	12.3	0.3	0.7	0.0	0.6	0.0	2.7	1.2	1.8	2.0	0.8	0.0	0.0	2.7	0.0	0.0	0.0	1.1	0.6	1.1	0.4	2.3	0.9	21.2	0.0	0.0	0.0	101.9	5.3	0.9	32.6	1.7	24.4	0.5	2.3	0.2	3.5	0.7	0.4	1.0	6.5	0.1	27.0	15.8	0.6	0.6	0.8	0.3	0.6
C1orf162	MGC24133	ENSG00000143110	"Chromosome 1 open reading frame 162"	Q8NEQ5	1	111473792-111478512	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 119.1;lymphoid tissue: 86.6"	"Cell type enhanced"	"Detected in many"	18	"granulocytes: 175.8;Hofbauer cells: 198.4;Kupffer cells: 675.1;Macrophages: 367.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Group enriched"	"Detected in some"	7	"HDLM-2: 45.4;HL-60: 22.1;NB-4: 12.3;THP-1: 17.5;U-937: 36.7"									HPA026988	Approved		Approved	"Nucleoplasm,Golgi apparatus"		NA	NA			"Nucleoplasm, Golgi apparatus"		"HPA026988: AB_10600887"	"unprognostic (8.79e-2)"	"unprognostic (5.18e-3)"	"unprognostic (1.14e-2)"	"unprognostic (2.11e-1)"	"unprognostic (5.20e-2)"	"unprognostic (5.96e-2)"	"unprognostic (1.61e-1)"	"unprognostic (5.66e-2)"	"unprognostic (1.11e-1)"	"unprognostic (4.69e-2)"	"unprognostic (1.86e-1)"	"unprognostic (1.80e-1)"	"prognostic unfavorable (3.14e-6)"	"unprognostic (1.29e-2)"	"unprognostic (3.15e-2)"	"unprognostic (1.53e-1)"	"unprognostic (2.74e-1)"	39.8	9.3	9.2	25.1	17.9	37.5	20.1	4.6	9.3	5.2	6.3	4.9	0.8	2.7	5.4	7.4	4.9	10.2	11.7	14.8	13.4	4.7	17.3	14.8	40.1	86.6	17.5	1.9	5.8	4.5	1.3	9.7	5.6	15.3	5.0	6.9	5.0	5.9	2.5	7.2	3.6	8.3	13.5	31.0	78.1	5.8	6.1	13.9	10.6	6.2	1.1	20.0	7.2	6.7	24.7	83.3	98.7	119.1	40.1	27.8	74.8	0.1	0.0	0.1	0.3	0.1	0.2	0.2	0.3	0.0	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.2	0.2	0.2	45.4	0.1	0.1	0.1	0.0	0.2	22.1	3.7	0.0	0.9	0.3	0.3	0.3	0.6	0.2	0.2	0.1	0.1	0.1	0.1	12.3	0.0	0.2	0.2	0.0	0.2	0.0	0.1	0.0	0.1	0.0	0.1	0.1	0.2	0.2	0.1	17.5	0.0	0.2	0.3	0.2	0.2	0.2	0.0	0.2	0.1	36.7	0.5	68.4	82.5	98.7	14.2	119.1	4.1	17.5	17.7	8.2	83.3	24.7	27.8	16.8	11.4	40.1	86.3	24.9	5.0	74.8	9.2	17.9	4.6	9.3	13.4	4.7	17.5	1.9	15.3	13.9	20.8	66.7	71.8	0.5	7.0	3.7	3.1	12.7	1.4	7.9	7.0	2.0	1.1	0.0	0.2	33.3	3.7	0.6	0.0	0.2	1.2	5.8	0.7	175.8	6.4	198.4	0.0	1.7	17.8	675.1	60.1	2.6	367.2	11.8	1.0	0.0	0.3	0.2	0.0	0.7	0.6	3.9	32.3	4.2	1.8	1.7	5.6	1.4	95.6	0.6	0.3
C1orf54	FLJ23221	ENSG00000118292	"Chromosome 1 open reading frame 54"	Q8WWF1	1	150268200-150280916	"Predicted secreted proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Kupffer cells: 98.9;Leydig cells: 88.1;Macrophages: 71.5;Peritubular cells: 97.9;Smooth muscle cells: 69.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	5	"myeloid DC: 36.2"	"Lineage enriched"	"Detected in many"	5	"dendritic cells: 36.2"	"Cell line enhanced"	"Detected in many"		"AF22: 20.9;AN3-CA: 31.6;ASC diff: 22.4;ASC TERT1: 37.5;HSkMC: 30.3;HUVEC TERT2: 29.2"	"Low region specificity"	"Detected in all"							"HPA026518, HPA043874"	Approved		Approved	"Plasma membrane"	"Secreted to blood"	NA	NA			"Plasma membrane"		"HPA026518: AB_1845647, HPA043874: AB_2732511"	"unprognostic (4.64e-3)"	"unprognostic (6.81e-3)"	"unprognostic (4.01e-3)"	"unprognostic (5.69e-3)"	"unprognostic (2.22e-1)"	"unprognostic (1.72e-1)"	"unprognostic (1.51e-2)"	"unprognostic (1.88e-1)"	"unprognostic (1.26e-1)"	"unprognostic (1.33e-1)"	"unprognostic (3.45e-1)"	"unprognostic (3.21e-1)"	"prognostic unfavorable (2.43e-4)"	"unprognostic (3.16e-2)"	"unprognostic (8.06e-2)"	"unprognostic (1.33e-2)"	"unprognostic (4.48e-2)"	16.0	8.8	16.4	19.0	19.3	4.5	13.8	5.8	10.5	11.9	14.0	4.5	19.1	5.8	19.8	21.1	11.0	17.1	21.6	13.8	13.7	13.7	12.7	12.0	11.8	21.5	21.8	8.3	8.3	6.8	2.0	6.7	24.4	14.0	15.3	11.1	10.9	9.8	30.4	13.4	4.5	8.1	24.1	20.4	27.3	8.3	5.7	14.8	4.9	8.3	17.1	11.2	22.0	14.3	0.3	36.2	0.4	7.7	0.2	1.5	2.2	0.5	0.1	20.9	31.6	22.4	37.5	0.6	3.4	5.0	0.9	3.0	0.2	0.6	0.2	1.1	3.0	0.4	0.9	0.0	0.1	1.1	0.3	3.7	0.6	0.5	0.3	4.6	1.1	0.8	30.3	1.5	6.3	0.5	3.7	29.2	0.5	0.4	4.1	3.2	1.2	0.2	7.2	1.7	0.0	1.1	5.2	0.5	0.4	0.3	1.6	0.4	0.4	0.4	0.2	2.3	4.2	0.4	15.8	0.2	7.5	0.6	0.2	0.3	1.7	1.4	0.3	16.6	0.9	0.2	0.0	7.7	0.3	0.2	6.8	0.9	0.3	1.5	0.6	36.2	0.3	1.5	0.8	0.4	0.2	1.9	0.7	0.6	2.2	16.4	19.3	5.8	10.5	13.7	13.7	21.8	8.3	14.0	14.8	3.0	5.0	2.4	2.0	5.7	0.8	6.2	2.5	0.0	2.3	21.0	0.0	1.0	64.6	0.5	7.4	64.6	2.1	0.0	2.0	0.7	22.1	1.8	1.1	0.8	45.5	0.0	1.2	49.1	98.9	15.7	88.1	71.5	11.8	20.8	1.1	11.1	1.5	0.8	97.9	2.6	1.3	32.3	69.0	16.6	1.3	4.4	3.0	2.5	1.2	5.5
C1QA		ENSG00000173372	"Complement C1q A chain"	P02745	1	22636506-22639608	"Disease related genes, Plasma proteins, Predicted secreted proteins"	"Complement pathway, Host-virus interaction, Immunity, Innate immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 204.0"	"Cell type enhanced"	"Detected in many"	28	"Hofbauer cells: 1354.3;Kupffer cells: 3186.4;Macrophages: 679.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	34	"intermediate monocyte: 50.3;non-classical monocyte: 37.5"	"Lineage enriched"	"Detected in single"	57	"monocytes: 50.3"	"Cell line enhanced"	"Detected in some"		"HMC-1: 3.9;NB-4: 2.3;RPMI-8226: 11.7;SCLC-21H: 5.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002350, CAB009823"	Supported				"Secreted to blood"	NA	NA		1100000000			"CAB009823: AB_2228238, HPA002350: AB_1078552"	"unprognostic (1.97e-1)"	"unprognostic (1.14e-2)"	"unprognostic (1.98e-3)"	"unprognostic (3.07e-2)"	"unprognostic (6.10e-2)"	"unprognostic (2.60e-1)"	"unprognostic (1.16e-1)"	"unprognostic (2.13e-1)"	"unprognostic (1.67e-2)"	"unprognostic (1.99e-1)"	"unprognostic (4.42e-2)"	"unprognostic (1.86e-1)"	"prognostic unfavorable (1.58e-6)"	"unprognostic (1.54e-1)"	"unprognostic (2.11e-3)"	"unprognostic (2.75e-2)"	"unprognostic (7.30e-2)"	51.4	33.0	12.4	19.3	21.0	5.3	40.6	1.9	10.9	10.8	20.3	8.0	2.1	22.1	8.2	25.9	11.3	15.5	22.6	43.9	9.2	10.4	14.4	27.6	60.7	94.4	17.2	4.6	9.5	11.9	2.4	9.6	33.6	15.8	16.0	15.9	12.2	9.4	7.5	7.9	4.3	24.7	24.8	26.8	204.0	11.6	12.3	16.6	7.5	10.9	5.4	8.4	24.1	12.8	0.0	0.8	0.1	50.3	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	3.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.3	2.3	0.5	0.0	0.0	0.8	0.5	11.7	0.0	0.0	5.2	1.6	0.1	0.0	0.0	0.0	0.9	0.1	0.4	0.0	0.3	0.7	0.2	1.5	0.0	0.1	0.2	0.2	0.1	0.0	1.2	0.0	0.0	50.3	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.1	0.0	37.5	0.0	0.0	2.1	12.4	21.0	1.9	10.9	9.2	10.4	17.2	4.6	15.8	16.6	32.8	68.3	87.4	1.4	16.4	0.4	9.2	53.5	28.1	33.0	0.0	0.0	7.6	0.0	0.0	1.7	7.3	0.0	0.0	0.2	8.7	13.9	1.2	19.8	15.7	1354.3	0.0	1.7	93.3	3186.4	4.5	12.0	679.3	25.3	1.0	0.0	0.0	0.0	0.0	0.4	1.0	0.3	77.6	9.0	0.5	2.0	14.6	15.2	15.8	0.0	1.0
C1QC	C1QG	ENSG00000159189	"Complement C1q C chain"	P02747	1	22643630-22648110	"Disease related genes, Plasma proteins, Predicted secreted proteins"	"Complement pathway, Immunity, Innate immunity"		"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 192.2"	"Group enriched"	"Detected in many"	21	"Hofbauer cells: 1118.0;Kupffer cells: 1266.9;Macrophages: 421.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	6	"intermediate monocyte: 28.4"	"Lineage enriched"	"Detected in single"	284	"monocytes: 28.4"	"Cell line enhanced"	"Detected in some"		"HL-60: 1.8;NB-4: 2.7;RPMI-8226: 6.7;SH-SY5Y: 2.0;U-266/70: 2.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA001471, CAB009828"	Supported				"Secreted to blood"	NA	NA	513000000	1300000000			"CAB009828: AB_2067541, HPA001471: AB_1078553"	"unprognostic (2.97e-1)"	"unprognostic (6.80e-2)"	"unprognostic (2.40e-2)"	"unprognostic (1.84e-1)"	"unprognostic (7.40e-2)"	"unprognostic (2.38e-1)"	"unprognostic (1.98e-1)"	"unprognostic (1.40e-1)"	"unprognostic (1.66e-2)"	"unprognostic (7.44e-2)"	"unprognostic (2.75e-2)"	"unprognostic (1.32e-1)"	"prognostic unfavorable (1.17e-5)"	"unprognostic (1.06e-1)"	"unprognostic (1.63e-3)"	"unprognostic (2.21e-2)"	"unprognostic (3.73e-2)"	50.5	35.7	24.2	24.6	39.2	5.9	15.6	2.5	18.3	9.8	21.8	19.9	1.2	30.0	8.5	23.4	9.7	17.0	26.8	22.6	17.5	13.6	14.4	41.2	48.2	75.1	34.8	6.1	8.5	7.8	2.6	10.2	34.8	30.2	15.0	15.7	14.8	13.2	8.3	8.0	4.6	33.1	27.1	34.5	192.2	15.5	10.3	29.1	10.7	8.3	4.0	9.5	28.3	6.0	0.0	0.0	0.0	28.4	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	1.8	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.0	0.0	0.7	2.7	0.7	0.0	0.0	1.6	0.9	6.7	0.0	0.0	1.2	2.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	1.4	0.3	2.9	0.0	0.3	0.3	0.4	0.0	0.0	0.7	0.0	0.0	28.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.6	0.0	0.0	0.5	24.2	39.2	2.5	18.3	17.5	13.6	34.8	6.1	30.2	29.1	6.0	6.9	29.4	1.1	7.9	0.0	1.4	22.9	1.4	5.7	0.0	0.0	4.9	0.0	0.0	2.1	2.1	0.0	0.0	0.2	7.9	5.3	0.4	4.7	5.1	1118.0	0.0	0.0	29.4	1266.9	1.8	5.8	421.7	6.8	40.5	0.0	0.3	0.0	0.0	1.1	0.2	0.4	45.3	1.8	0.3	0.9	5.6	8.2	12.9	0.0	0.6
C3AR1	"AZ3B, C3AR"	ENSG00000171860	"Complement C3a receptor 1"	Q16581	12	8058302-8066471	"G-protein coupled receptors, Predicted membrane proteins"	Chemotaxis	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 101.1"	"Group enriched"	"Detected in many"	4	"granulocytes: 35.8;Hofbauer cells: 141.5;Kupffer cells: 97.6;Macrophages: 53.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"basophil: 101.1;eosinophil: 56.9;intermediate monocyte: 34.5;non-classical monocyte: 47.0"	"Group enriched"	"Detected in many"	18	"granulocytes: 101.1;monocytes: 47.0"	"Cell line enriched"	"Detected in some"	9	"HMC-1: 67.4"	"Low region specificity"	"Detected in many"							CAB009405	Enhanced					NA	NA					"CAB009405: AB_2066739"	"unprognostic (1.11e-2)"	"unprognostic (5.67e-2)"	"unprognostic (5.06e-2)"	"unprognostic (4.14e-2)"	"unprognostic (6.60e-2)"	"unprognostic (1.50e-1)"	"unprognostic (4.81e-2)"	"unprognostic (2.78e-1)"	"unprognostic (6.10e-2)"	"unprognostic (8.04e-2)"	"unprognostic (1.59e-1)"	"unprognostic (3.50e-2)"	"unprognostic (8.22e-2)"	"unprognostic (4.96e-2)"	"unprognostic (9.24e-3)"	"unprognostic (2.09e-2)"	"unprognostic (8.16e-2)"	34.1	10.0	11.7	35.1	15.5	17.4	10.7	1.9	7.6	7.2	5.8	15.5	0.7	4.9	4.8	6.7	3.8	7.3	15.0	7.3	9.7	7.2	9.2	10.0	21.1	29.7	16.7	3.5	4.9	5.5	2.9	3.5	19.8	13.3	4.8	6.4	5.2	7.8	4.0	3.6	2.7	9.1	13.9	23.4	25.2	4.9	5.8	16.2	1.9	3.2	1.5	4.8	12.9	3.7	0.0	4.0	101.1	47.0	0.5	3.8	7.8	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.9	0.2	1.9	0.0	0.0	0.7	0.0	0.0	1.1	0.0	0.0	0.0	0.1	0.0	0.0	5.9	0.0	0.0	0.6	7.8	67.4	0.3	0.0	0.1	0.2	0.1	0.3	0.5	1.6	3.9	0.2	0.0	0.3	2.8	0.0	0.0	0.0	0.0	1.4	7.6	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	3.6	0.3	0.2	0.2	0.0	0.1	0.1	0.0	0.2	4.3	3.0	0.2	101.1	13.6	56.9	2.9	34.5	3.8	0.0	1.5	2.0	4.0	0.0	0.3	1.2	1.8	0.5	47.0	0.3	1.5	7.8	11.7	15.5	1.9	7.6	9.7	7.2	16.7	3.5	13.3	16.2	0.0	4.8	1.4	0.0	0.5	0.0	0.4	2.5	1.4	4.5	0.0	2.0	0.5	0.0	0.0	1.9	0.3	0.0	0.0	0.2	1.0	0.9	0.0	35.8	0.8	141.5	0.0	0.0	1.8	97.6	2.7	1.1	53.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	19.4	0.7	0.0	0.1	0.5	1.3	11.7	0.0	0.0
C5AR1	"C5A, C5AR, C5R1, CD88"	ENSG00000197405	"Complement C5a receptor 1"	P21730	19	47290023-47322066	"CD markers, G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins"	Chemotaxis	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 75.8"	"Cell type enhanced"	"Detected in many"	15	"Hofbauer cells: 131.1;Kupffer cells: 223.6;Macrophages: 162.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"neutrophil: 75.8"	"Group enriched"	"Detected in many"	42	"granulocytes: 75.8;monocytes: 20.5"	"Cell line enhanced"	"Detected in many"		"CAPAN-2: 6.0;HMC-1: 7.5;U-87 MG: 9.0;U-937: 9.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB002720, HPA014520, HPA048012"	Approved		Approved	"Golgi apparatus,Vesicles"		NA	NA			"Golgi apparatus"	Vesicles	"CAB002720: , HPA014520: AB_1846337, HPA048012: "	"unprognostic (5.95e-2)"	"prognostic favorable (4.71e-4)"	"unprognostic (1.70e-2)"	"unprognostic (1.25e-1)"	"unprognostic (4.08e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.80e-2)"	"unprognostic (4.41e-2)"	"unprognostic (5.45e-2)"	"prognostic unfavorable (9.55e-4)"	"unprognostic (2.02e-1)"	"unprognostic (9.56e-2)"	"prognostic unfavorable (1.16e-4)"	"unprognostic (1.96e-3)"	"prognostic unfavorable (7.99e-4)"	"unprognostic (1.82e-2)"	"unprognostic (6.54e-2)"	33.7	8.0	1.9	34.9	7.0	46.2	8.7	0.7	3.0	5.6	6.0	3.7	1.6	1.0	4.1	4.9	3.5	14.3	16.5	11.7	7.6	3.2	5.3	9.1	38.1	26.9	3.8	1.2	7.6	3.6	1.3	27.9	12.8	10.9	4.2	1.9	7.8	2.9	1.1	7.0	1.1	3.0	11.4	11.2	48.8	4.2	6.3	1.3	2.3	2.5	1.7	3.4	12.2	2.7	0.1	1.1	75.8	20.5	0.1	0.1	2.6	1.4	5.4	0.3	0.5	1.0	0.4	1.1	1.0	0.6	0.3	0.1	0.2	6.0	0.5	1.1	1.2	0.7	2.0	0.7	0.8	0.2	1.0	0.7	0.2	5.0	0.8	0.7	2.7	7.5	0.8	3.0	0.6	0.9	0.9	0.0	0.3	0.3	2.6	0.2	1.5	0.3	3.4	1.9	0.3	0.9	0.3	0.2	0.4	1.8	1.3	0.0	0.1	0.5	0.6	0.8	0.9	0.4	3.1	0.0	0.1	3.2	0.4	0.3	0.4	0.4	0.3	9.0	9.1	0.3	7.0	8.9	6.9	0.1	15.1	0.0	0.0	0.0	0.0	1.1	0.1	0.0	0.0	75.8	0.1	20.5	0.2	0.0	2.6	1.9	7.0	0.7	3.0	7.6	3.2	3.8	1.2	10.9	1.3	3.0	33.4	11.3	0.6	4.5	0.8	2.0	2.5	52.2	26.1	1.8	2.0	0.8	3.3	0.0	0.6	1.7	1.1	0.0	0.0	0.9	2.6	0.5	23.3	3.4	131.1	0.0	0.0	3.1	223.6	0.0	0.6	162.7	5.0	14.4	0.7	0.4	0.1	0.0	0.0	1.1	4.2	12.9	1.7	0.5	1.1	2.6	1.3	0.0	0.9	0.3
C5AR2	"C5L2, GPR77"	ENSG00000134830	"Complement component 5a receptor 2"	Q9P296	19	47332147-47347327	"G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 21.1;lymphoid tissue: 17.3"	"Cell type enhanced"	"Detected in many"	12	"Ito cells: 31.3;Kupffer cells: 30.9;Macrophages: 18.2"	"Cancer enhanced"	"Detected in many"		"breast cancer: 3.3"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"basophil: 9.4;eosinophil: 7.0;neutrophil: 21.1"	"Lineage enriched"	"Detected in many"	8	"granulocytes: 21.1"	"Group enriched"	"Detected in some"	5	"MCF7: 17.1;T-47d: 21.2"	"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			HPA016629	Uncertain					NA	NA					"HPA016629: AB_1849312"	"unprognostic (5.00e-2)"	"unprognostic (2.31e-2)"	"unprognostic (4.33e-2)"	"unprognostic (2.00e-6)"	"unprognostic (2.88e-1)"	"unprognostic (1.13e-2)"	"unprognostic (1.02e-2)"	"unprognostic (2.13e-1)"	"unprognostic (2.25e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.39e-2)"	"unprognostic (6.05e-2)"	"unprognostic (3.73e-5)"	"unprognostic (1.16e-2)"	"unprognostic (7.42e-2)"	"unprognostic (1.34e-1)"	"unprognostic (6.88e-3)"	7.2	1.7	1.1	7.4	1.6	9.2	4.7	0.3	3.5	2.0	1.9	1.7	0.0	0.9	1.5	4.1	3.3	2.8	2.9	3.2	3.6	1.0	2.4	3.1	7.5	6.8	1.3	2.2	2.0	1.4	0.4	1.4	3.9	2.9	0.8	0.9	1.9	1.9	0.6	0.8	2.2	2.0	1.8	4.5	17.3	1.6	3.8	0.3	0.0	1.4	4.4	13.6	5.6	2.0	0.3	0.4	21.1	2.7	0.2	0.4	0.4	0.0	0.2	0.1	0.1	0.0	0.2	0.1	0.1	0.0	0.0	0.0	0.2	0.2	0.2	0.6	0.4	0.2	0.2	0.0	0.0	0.0	0.1	0.1	0.1	4.0	0.1	0.0	0.7	1.3	0.0	0.1	0.1	0.0	0.1	0.0	0.1	0.1	0.4	0.0	17.1	0.0	2.0	0.2	0.0	0.0	0.2	0.2	2.2	0.1	0.3	0.2	0.1	0.1	0.1	0.0	0.1	21.2	0.2	0.1	0.7	0.2	0.4	0.1	0.3	0.2	0.8	0.7	1.2	0.1	9.4	1.7	7.0	0.2	1.5	0.2	0.2	0.1	0.1	0.4	0.3	0.1	0.1	21.1	0.2	2.7	0.2	0.4	0.4	1.1	1.6	0.3	3.5	3.6	1.0	1.3	2.2	2.9	0.3	3.0	3.4	1.9	2.4	0.3	1.1	1.4	0.0	1.4	4.5	1.8	2.0	0.1	0.0	0.0	4.3	0.7	0.0	0.0	0.0	0.1	0.3	1.7	1.1	0.8	7.1	0.0	0.0	31.3	30.9	2.9	0.0	18.2	0.0	0.0	0.0	0.2	0.0	0.0	0.4	0.2	3.8	0.0	0.4	0.2	0.4	0.6	0.1	1.3	0.0	2.0
C9orf72	"DENNL72, MGC23980"	ENSG00000147894	"Chromosome 9 open reading frame 72"	Q96LT7	9	27546545-27573866	"Disease related genes, Predicted intracellular proteins, Predicted secreted proteins"	Autophagy	"Guanine-nucleotide releasing factor"	"Amyotrophic lateral sclerosis, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Ciliated cells: 77.6;Kupffer cells: 86.3;Macrophages: 73.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"basophil: 8.0;classical monocyte: 15.5;intermediate monocyte: 21.8;myeloid DC: 11.7;neutrophil: 15.6;non-classical monocyte: 16.5"	"Group enriched"	"Detected in all"	5	"dendritic cells: 11.7;granulocytes: 15.6;monocytes: 21.8"	"Cell line enhanced"	"Detected in many"		"AF22: 21.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA023873	Uncertain		Supported	"Vesicles,Midbody ring,Cytosol"	"Secreted - unknown location"	NA	NA			"Vesicles, Cytosol"	"Midbody ring"	"HPA023873: AB_1845834"	"unprognostic (1.78e-2)"	"unprognostic (5.01e-2)"	"unprognostic (7.63e-2)"	"unprognostic (9.78e-3)"	"unprognostic (1.46e-1)"	"unprognostic (1.32e-1)"	"unprognostic (1.59e-1)"	"unprognostic (1.99e-3)"	"unprognostic (2.45e-1)"	"unprognostic (2.05e-2)"	"unprognostic (2.16e-2)"	"unprognostic (9.81e-2)"	"unprognostic (1.44e-2)"	"unprognostic (9.29e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.89e-2)"	"unprognostic (9.13e-2)"	10.0	11.2	9.7	14.2	17.6	19.1	8.0	31.2	21.3	7.4	6.0	10.9	6.7	5.8	10.7	10.6	5.8	14.6	8.9	7.4	9.4	14.6	4.2	14.0	13.0	10.7	11.0	10.7	19.5	8.4	6.7	15.3	10.3	20.0	13.3	7.1	9.4	5.3	5.9	11.0	6.2	6.1	7.6	11.5	13.7	6.5	14.8	6.7	8.0	11.0	3.2	7.3	9.7	6.3	1.7	11.7	15.6	21.8	2.9	2.5	4.4	2.8	2.5	21.1	3.2	4.3	5.3	3.2	4.1	3.5	2.6	1.3	0.3	1.0	7.2	2.7	3.6	5.4	2.2	6.0	5.2	1.9	13.1	2.5	3.4	7.5	2.1	6.6	2.3	3.7	5.6	6.4	0.6	11.9	2.5	5.5	7.4	6.5	13.1	3.1	0.5	4.4	3.5	10.2	4.7	11.6	1.7	6.3	3.2	2.0	2.5	7.2	17.7	2.7	3.1	2.6	8.3	2.6	2.0	4.7	0.0	10.6	6.2	2.7	3.4	10.2	4.7	8.0	7.6	2.6	8.0	15.5	1.0	0.9	21.8	1.7	1.7	1.4	1.2	11.7	1.2	2.5	1.5	15.6	2.9	16.5	1.8	1.8	4.4	9.7	17.6	31.2	21.3	9.4	14.6	11.0	10.7	20.0	6.7	14.9	17.1	6.9	37.1	31.9	22.0	12.8	5.1	77.6	12.5	7.0	19.6	18.4	1.7	6.9	1.7	10.8	3.9	0.0	8.3	6.2	12.4	25.8	16.1	7.8	23.9	11.1	10.9	6.7	86.3	3.3	5.8	73.0	18.6	19.8	9.9	46.1	6.4	8.6	3.5	4.1	28.5	0.0	20.6	30.7	19.3	25.5	28.9	10.9	5.2	35.5
CARD16	"COP, COP1, PSEUDO-ICE"	ENSG00000204397	"Caspase recruitment domain family member 16"	Q5EG05	11	105041326-105101431	"Predicted intracellular proteins"		"Protease inhibitor, Thiol protease inhibitor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"blood: 126.3;lymphoid tissue: 52.1"	"Cell type enhanced"	"Detected in many"	8	"Kupffer cells: 242.8;Macrophages: 269.3;monocytes: 172.3;Paneth cells: 336.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 38.8;HHSteC: 68.1;HUVEC TERT2: 31.2;TIME: 28.5"									"HPA053981, HPA062805"	Uncertain		Uncertain	Mitochondria		NA	NA			Mitochondria		"HPA053981: AB_2682332, HPA062805: AB_2684871"	"unprognostic (2.25e-3)"	"unprognostic (6.56e-2)"	"unprognostic (1.49e-1)"	"unprognostic (8.12e-2)"	"unprognostic (4.45e-3)"	"unprognostic (1.76e-1)"	"unprognostic (4.71e-1)"	"unprognostic (8.68e-2)"	"unprognostic (1.56e-1)"	"unprognostic (1.17e-2)"	"unprognostic (5.12e-2)"	"unprognostic (1.04e-1)"	"prognostic unfavorable (6.93e-7)"	"unprognostic (2.81e-1)"	"unprognostic (6.68e-2)"	"unprognostic (1.82e-1)"	"unprognostic (1.19e-1)"	11.4	4.0	3.8	21.9	6.8	20.9	8.1	2.3	4.3	5.5	13.3	1.7	4.2	16.3	4.4	4.9	9.0	5.4	11.1	6.4	4.7	2.6	8.1	7.3	30.2	14.5	6.4	3.0	7.6	7.2	0.0	3.2	28.5	6.2	8.2	11.8	4.1	5.8	4.4	4.1	5.6	20.2	5.6	9.2	52.1	7.5	2.1	6.2	6.2	5.5	7.4	11.5	10.9	12.8	23.4	57.8	126.3	110.3	19.4	47.9	68.9	0.3	0.0	0.0	38.8	1.0	5.3	0.2	0.8	2.7	0.1	0.7	0.3	0.0	4.0	5.4	2.3	5.8	2.7	0.3	5.6	0.0	16.5	0.0	0.8	0.7	0.4	68.1	5.3	0.0	9.6	2.9	3.9	2.7	0.4	31.2	0.2	0.0	0.0	0.0	0.0	1.8	4.6	0.0	0.0	0.1	4.4	0.1	5.1	0.1	2.5	0.0	0.0	6.1	0.8	19.4	1.4	0.8	12.8	28.5	2.7	0.3	1.7	0.1	0.0	0.8	0.0	3.1	17.9	0.6	44.0	85.3	61.6	26.4	110.3	25.1	23.4	24.1	25.3	57.8	17.9	14.3	21.8	126.3	19.4	97.2	6.7	47.9	68.9	3.8	6.8	2.3	4.3	4.7	2.6	6.4	3.0	6.2	6.2	26.8	49.5	67.7	15.9	23.8	0.0	8.7	28.1	18.7	42.1	14.0	0.0	7.7	1.7	5.9	0.2	66.1	70.9	0.0	19.4	3.1	27.9	3.8	59.9	2.1	81.0	0.0	15.7	50.3	242.8	0.7	19.0	269.3	13.5	172.3	70.7	0.0	7.0	336.9	17.0	0.4	0.0	6.5	9.9	0.1	0.6	13.7	10.9	108.6	47.2	28.3
CARD9		ENSG00000187796	"Caspase recruitment domain family member 9"	Q9H257	9	136361903-136373681	"Disease related genes, Predicted intracellular proteins"	"Immunity, Innate immunity"		"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 24.5;bone marrow: 19.4;lymphoid tissue: 15.9"	"Cell type enhanced"	"Detected in many"	7	"Hofbauer cells: 19.6;Horizontal cells: 14.3;Kupffer cells: 14.8;Macrophages: 18.4;monocytes: 11.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"intermediate monocyte: 24.5;non-classical monocyte: 20.5"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"HEL: 9.8;HMC-1: 33.2;NB-4: 24.1;THP-1: 29.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA059502	Enhanced					NA	NA					"HPA059502: AB_2684042"	"unprognostic (7.03e-2)"	"unprognostic (5.61e-2)"	"unprognostic (8.62e-3)"	"unprognostic (2.06e-2)"	"unprognostic (2.75e-1)"	"unprognostic (2.11e-2)"	"unprognostic (3.89e-3)"	"unprognostic (6.36e-2)"	"unprognostic (2.64e-1)"	"unprognostic (1.55e-2)"	"unprognostic (7.68e-3)"	"unprognostic (6.97e-2)"	"unprognostic (2.02e-6)"	"unprognostic (2.52e-1)"	"unprognostic (4.87e-3)"	"unprognostic (3.06e-1)"	"unprognostic (1.06e-1)"	1.7	2.4	3.6	8.8	10.4	19.4	2.2	2.7	6.4	2.1	1.9	5.5	0.3	2.7	1.4	1.9	1.7	3.3	4.2	1.7	4.0	2.4	2.0	2.3	4.8	6.6	8.1	2.0	1.6	1.0	0.6	1.5	2.3	5.0	2.7	1.0	1.5	2.9	2.2	0.8	4.8	3.8	2.0	4.8	15.9	1.7	0.8	6.9	0.9	0.8	1.5	4.6	2.5	1.8	0.0	11.3	4.6	24.5	0.3	0.4	5.1	0.0	0.0	0.3	0.0	0.0	0.0	2.7	5.0	0.1	0.1	0.0	0.5	0.0	0.0	0.1	1.6	0.0	0.0	0.1	0.0	0.0	0.0	0.2	9.8	0.1	3.2	2.4	6.1	33.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.1	0.0	24.1	0.1	0.0	0.0	0.0	0.2	0.1	0.0	0.2	0.2	7.4	0.0	7.9	0.0	0.0	2.3	29.3	0.0	0.0	0.0	0.6	0.0	0.0	0.1	0.0	0.1	7.3	0.1	2.3	14.6	4.6	0.0	24.5	0.4	0.0	0.0	0.0	11.3	0.0	0.0	0.0	1.1	0.3	20.5	0.1	0.3	5.1	3.6	10.4	2.7	6.4	4.0	2.4	8.1	2.0	5.0	6.9	0.0	5.8	0.0	0.6	1.5	0.0	1.7	0.0	0.0	6.8	3.5	0.0	0.3	1.7	0.1	0.7	0.3	0.0	0.0	0.0	0.3	2.0	0.1	10.4	0.0	19.6	14.3	0.0	1.3	14.8	4.6	0.3	18.4	1.7	11.8	0.0	5.7	0.0	0.0	0.0	0.2	1.0	0.0	1.2	0.9	1.3	1.5	0.3	1.3	0.0	0.3
CASP1	"ICE, IL1BC"	ENSG00000137752	"Caspase 1"	P29466	11	105025443-105035250	"Cancer-related genes, Enzymes, Predicted intracellular proteins"	Apoptosis	"Hydrolase, Protease, Thiol protease"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 64.2;lymphoid tissue: 40.7"	"Cell type enhanced"	"Detected in many"	7	"Hofbauer cells: 83.5;Kupffer cells: 119.3;Macrophages: 125.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 38.4;HBEC3-KT: 18.2;HHSteC: 20.6;U-937: 45.4"	"Region enhanced"	"Detected in many"		"olfactory region: 22.8"	"Low region specificity"	"Detected in all"			"CAB002685, HPA003056"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			Cytosol	Nucleoplasm	"CAB002685: , HPA003056: AB_1846037"	"unprognostic (1.21e-3)"	"unprognostic (3.02e-1)"	"unprognostic (9.47e-3)"	"unprognostic (1.43e-1)"	"unprognostic (1.47e-1)"	"unprognostic (1.21e-1)"	"unprognostic (5.24e-2)"	"unprognostic (1.97e-1)"	"unprognostic (1.66e-1)"	"unprognostic (6.67e-2)"	"unprognostic (2.75e-2)"	"unprognostic (1.35e-1)"	"prognostic unfavorable (3.11e-4)"	"unprognostic (9.03e-2)"	"unprognostic (2.30e-2)"	"unprognostic (3.18e-1)"	"unprognostic (5.19e-2)"	7.4	3.9	6.6	15.1	17.0	8.2	6.9	3.5	7.0	4.1	12.8	2.2	2.9	34.0	3.0	4.2	10.6	4.3	7.3	4.9	9.3	3.0	6.4	5.8	20.5	16.2	16.7	2.6	4.4	3.4	0.2	3.7	8.7	13.3	6.1	13.9	3.7	7.0	3.2	1.6	9.9	37.2	5.2	17.4	40.7	5.6	1.5	11.0	4.1	3.7	5.6	9.0	9.7	13.2	7.3	39.6	40.5	64.2	11.1	34.3	31.2	0.4	0.1	0.0	1.8	2.0	4.3	0.3	1.9	38.4	4.8	13.5	0.0	0.2	6.2	0.8	2.2	8.9	2.7	0.0	18.2	1.1	4.0	0.0	0.3	0.2	0.4	20.6	7.2	0.0	7.3	12.9	3.9	10.6	12.6	2.1	0.1	0.0	0.0	1.1	0.0	0.2	10.1	0.0	0.0	0.1	6.0	0.1	4.9	0.1	3.0	0.1	0.1	5.7	0.4	8.4	0.0	0.4	16.7	2.4	4.4	0.2	0.4	0.5	0.0	1.7	0.0	2.8	45.4	0.9	12.3	42.8	23.2	25.4	64.2	34.3	7.3	18.1	22.0	39.6	6.0	9.9	16.4	40.5	11.1	64.0	1.4	22.2	31.2	6.6	17.0	3.5	7.0	9.3	3.0	16.7	2.6	13.3	11.0	17.9	35.4	32.0	33.0	23.1	0.0	2.6	12.7	12.0	11.4	10.4	0.0	1.3	1.7	15.7	0.0	24.1	33.9	0.0	11.7	1.0	13.1	5.7	15.1	1.7	83.5	0.0	5.8	17.8	119.3	0.2	3.1	125.6	5.0	34.3	32.1	0.0	4.7	49.2	3.2	1.0	0.1	0.0	5.4	0.0	0.0	19.4	0.9	48.4	29.9	41.4
CASS4	"C20orf32, HEFL, HEPL"	ENSG00000087589	"Cas scaffolding protein family member 4"	Q9NQ75	20	56412112-56460387	"Plasma proteins, Predicted intracellular proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 33.8;lung: 16.7"	"Cell type enhanced"	"Detected in some"	15	"granulocytes: 13.9;Kupffer cells: 8.0;Macrophages: 6.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	7	"eosinophil: 10.8;neutrophil: 33.8"	"Lineage enriched"	"Detected in many"	10	"granulocytes: 33.8"	"Cell line enhanced"	"Detected in some"		"fHDF/TERT166: 6.6;HEL: 10.7;HMC-1: 32.8;K-562: 13.2"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			CAB034217	Approved					NA	NA		890000			"CAB034217: AB_2071598"	"unprognostic (9.55e-3)"	"unprognostic (2.53e-2)"	"unprognostic (2.44e-2)"	"unprognostic (8.51e-2)"	"unprognostic (3.04e-1)"	"unprognostic (1.56e-3)"	"unprognostic (2.06e-1)"	"unprognostic (1.59e-2)"	"unprognostic (3.20e-1)"	"unprognostic (4.10e-2)"	"unprognostic (5.28e-2)"	"unprognostic (6.19e-2)"	"unprognostic (7.27e-4)"	"unprognostic (5.33e-2)"	"unprognostic (3.65e-2)"	"unprognostic (6.50e-2)"	"unprognostic (8.16e-2)"	3.3	1.7	2.0	13.0	2.2	2.4	1.7	1.3	4.5	1.7	1.4	6.1	0.0	1.8	2.5	0.9	1.4	1.6	3.5	1.6	2.4	1.5	1.6	2.2	16.7	12.1	1.9	3.1	2.4	1.5	0.4	1.3	6.6	3.4	1.4	1.3	2.7	1.8	2.5	1.3	1.5	2.9	1.8	2.9	9.2	1.5	1.1	2.2	4.1	1.3	1.1	4.3	3.0	1.4	0.0	3.4	33.8	1.9	1.4	2.3	1.1	0.0	0.0	0.1	0.1	0.0	0.2	0.1	0.6	0.2	0.1	0.3	0.1	2.3	0.1	0.1	6.6	0.1	0.1	0.1	0.0	0.4	0.1	0.1	10.7	0.1	0.6	0.2	0.3	32.8	0.7	0.2	0.2	0.0	0.3	0.0	0.2	13.2	0.1	0.4	0.1	0.2	4.1	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.3	0.1	0.1	0.0	0.0	0.0	0.1	0.0	1.6	0.3	0.1	0.1	0.1	0.0	0.2	0.2	0.1	0.0	1.4	0.1	0.2	1.9	10.8	0.7	0.4	1.0	0.0	1.2	1.3	3.4	0.0	2.3	2.0	33.8	1.4	0.0	1.2	0.6	1.1	2.0	2.2	1.3	4.5	2.4	1.5	1.9	3.1	3.4	2.2	0.0	1.4	0.0	0.0	0.1	0.0	0.4	0.0	0.0	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.1	13.9	0.9	2.3	0.0	0.0	0.6	8.0	0.0	0.0	6.8	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.1	0.2	3.2	0.0	0.0
CCL3	"G0S19-1, LD78ALPHA, MIP-1-alpha, SCYA3"	ENSG00000277632	"C-C motif chemokine ligand 3"	P10147	17	36088256-36090169	"Cancer-related genes, Predicted secreted proteins"	"Chemotaxis, Inflammatory response"	Cytokine	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 35.7;lymphoid tissue: 18.0"	"Group enriched"	"Detected in many"	5	"Hofbauer cells: 1808.9;Macrophages: 912.4"	"Low cancer specificity"	"Detected in all"							"Cell type enhanced"	"Detected in many"		"gdT-cell: 10.2"	"Group enriched"	"Detected in many"	5	"B-cells: 4.5;granulocytes: 4.0;T-cells: 10.2"	"Cell line enhanced"	"Detected in some"		"Karpas-707: 27.4;U-266/70: 46.9;U-266/84: 118.9"														"Secreted to blood"	NA	NA	138000					"unprognostic (2.41e-1)"	"unprognostic (1.87e-1)"	"unprognostic (1.45e-1)"	"unprognostic (7.44e-3)"	"unprognostic (1.44e-1)"	"unprognostic (1.66e-1)"	"unprognostic (3.54e-1)"	"unprognostic (8.90e-2)"	"unprognostic (7.92e-3)"	"unprognostic (2.00e-1)"	"unprognostic (7.20e-2)"	"unprognostic (2.05e-1)"	"unprognostic (8.92e-3)"	"unprognostic (1.08e-1)"	"unprognostic (9.29e-2)"	"unprognostic (1.55e-2)"	"unprognostic (1.23e-2)"	5.3	4.3	0.0	5.7	1.6	35.7	2.4	0.5	6.0	0.9	0.9	11.6	0.0	0.8	0.7	1.4	0.4	0.4	3.5	3.4	0.0		0.5	7.9	15.1	5.8	0.0	0.0	2.0	0.4	1.8	0.0	5.7	3.7	0.5	0.9	1.7	1.0	0.2	1.2	0.0	0.8	1.1	0.0	18.0	0.2	3.7	0.0	1.8	0.8	0.5	1.8	2.3	0.0	4.5	0.2	4.0	0.8	1.1	10.2	4.6	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	27.4	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	3.5	0.0	0.0	0.1	46.9	118.9	0.0	0.2	0.0	0.0	0.1	0.8	4.0	10.2	0.5	0.3	1.4	0.3	2.8	0.2	4.5	0.0	3.0	4.0	1.1	0.5	0.0	0.0	4.6											0.0	48.5	43.9	1.0	24.7	1.5	1.6	0.0	4.0	7.9	0.0	0.0	15.8	0.0	0.4	1.2	6.7	0.0	0.0	0.2	19.5	26.9	0.9	23.1	3.2	1808.9	0.0	0.0	19.0	262.3	1.3	1.7	912.4	89.4	37.9	0.0	1.9	0.2	0.0	0.0	0.7	3.6	6.5	9.2	0.5	0.2	25.2	45.4	235.3	0.0	1.1
CCL3L1	"CCL3L3, D17S1718, G0S19-2, LD78BETA, MGC12815, SCYA3L, SCYA3L1"	ENSG00000276085	"C-C motif chemokine ligand 3 like 1"	P16619	17	36194869-36196758	"Predicted secreted proteins"	Chemotaxis	Cytokine		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"bone marrow: 17.7;brain: 16.5"	"Group enriched"	"Detected in some"	18	"Hofbauer cells: 308.0;Macrophages: 77.5"	"Low cancer specificity"	"Detected in all"							"Group enriched"	"Detected in some"	5	"eosinophil: 7.7;neutrophil: 2.5"	"Lineage enriched"	"Detected in single"	8	"granulocytes: 7.7"	"Group enriched"	"Detected in some"	38	"U-266/70: 22.8;U-266/84: 45.4"														"Secreted to blood"	NA	NA						"unprognostic (6.30e-2)"	"unprognostic (8.18e-2)"	"unprognostic (5.37e-2)"	"unprognostic (1.46e-1)"	"unprognostic (9.50e-2)"	"unprognostic (2.18e-1)"	"unprognostic (4.36e-2)"	"unprognostic (3.69e-1)"	"unprognostic (5.75e-2)"	"unprognostic (5.55e-2)"	"unprognostic (2.40e-2)"	"unprognostic (3.66e-1)"	"unprognostic (9.08e-2)"	"unprognostic (2.09e-1)"	"unprognostic (3.21e-1)"	"unprognostic (1.90e-2)"	"unprognostic (8.58e-2)"	0.4	0.1	0.0	3.5	2.2	17.7	0.2	0.0	9.0	0.7	0.4	16.5	0.0	0.4	0.6	0.6	0.1	0.2	1.9	0.1	0.0		0.6	2.7	4.0	0.9	0.0	0.1	1.2	0.3	0.1	0.0	3.0	4.4	0.9	0.3	1.9	2.3	0.4	0.1	0.1	0.6	0.3	0.2	2.7	0.3	2.5	0.0	1.3	0.3	0.6	0.7	0.9	0.0	0.0	0.1	7.7	0.1	0.0	0.9	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	22.8	45.4	0.5	0.0	0.0	0.0	0.3	0.1	7.7	0.9	0.0	0.6	0.0	0.0	0.6	0.1	0.0	0.0	0.2	2.5	0.0	0.0	0.0	0.0	0.1											3.0	10.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	4.2	1.0	0.0	2.3	0.0	308.0	0.0	0.0	0.0	0.0	0.0	0.0	77.5	0.0	2.8	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	1.3	11.0	0.0	0.0	0.0
CCR1	"CD191, CKR-1, CMKBR1, MIP1aR, SCYAR1"	ENSG00000163823	"C-C motif chemokine receptor 1"	P32246	3	46201709-46208396	"CD markers, G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 34.0;lymphoid tissue: 40.2"	"Group enriched"	"Detected in many"	17	"Extravillous trophoblasts: 72.1;Hofbauer cells: 97.6;Kupffer cells: 150.1;Macrophages: 66.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"Karpas-707: 78.3;RPMI-8226: 36.0;U-266/70: 13.8;U-266/84: 40.5"					"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (3.95e-1)"	"unprognostic (2.17e-1)"	"unprognostic (1.20e-1)"	"unprognostic (2.16e-1)"	"unprognostic (1.05e-1)"	"unprognostic (6.66e-2)"	"unprognostic (1.16e-1)"	"unprognostic (8.82e-2)"	"unprognostic (4.91e-3)"	"unprognostic (2.20e-3)"	"unprognostic (1.09e-1)"	"unprognostic (9.60e-2)"	"prognostic unfavorable (1.01e-4)"	"unprognostic (1.08e-1)"	"unprognostic (5.52e-3)"	"unprognostic (1.47e-1)"	"unprognostic (2.38e-1)"	21.2	6.0	5.1	23.8	8.4	11.2	4.9	1.0	3.7	1.9	2.9	7.2	0.5	3.9	2.0	5.1	2.0	4.5	6.7	4.1	5.4	3.2	4.4	9.6	11.6	26.3	9.0	1.6	2.8	2.3	1.0	2.6	14.9	6.9	2.3	4.1	2.9	3.3	1.3	1.4	1.4	4.5	8.5	11.6	40.2	2.9	1.2	8.7	2.2	1.8	1.0	5.5	6.9	1.5	0.9	15.3	32.5	34.0	22.1	15.3	11.8	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.1	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	78.3	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.0	0.0	36.0	0.0	1.3	0.0	0.0	0.0	0.1	0.3	0.2	0.0	8.2	0.0	0.2	0.0	0.0	0.0	13.8	40.5	0.0	7.0	6.1	0.1	21.5	34.0	6.8	3.1	21.4	15.3	0.9	0.0	2.5	15.3	0.0	0.0	0.4	32.5	22.1	13.1	5.5	0.0	11.8	5.1	8.4	1.0	3.3	5.4	3.2	9.0	1.6	6.9	8.7	3.0	4.0	5.4	0.0	0.8	0.0	0.4	0.0	2.7	2.3	0.0	0.0	0.6	1.7	0.0	0.2	0.5	0.0	0.0	0.0	72.1	1.5	0.0	3.5	0.8	97.6	0.0	0.0	2.5	150.1	0.0	0.0	66.6	5.0	0.0	0.0	0.4	0.1	0.0	0.0	2.4	0.0	0.0	0.3	0.0	0.0	1.5	2.4	5.7	0.0	0.0
CCR5	"CC-CKR-5, CD195, CKR-5, CKR5, CMKBR5, IDDM22"	ENSG00000160791	"C-C motif chemokine receptor 5 (gene/pseudogene)"	P51681	3	46370854-46376206	"CD markers, Disease related genes, FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins"	"Host-virus interaction"	"G-protein coupled receptor, Host cell receptor for virus entry, Receptor, Transducer"	"Diabetes mellitus, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 24.5"	"Cell type enhanced"	"Detected in some"	17	"Hofbauer cells: 4.9;Kupffer cells: 4.1;Macrophages: 16.2;T-cells: 13.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"MAIT T-cell: 24.5"	"Lineage enriched"	"Detected in many"	4	"T-cells: 24.5"	"Cell line enhanced"	"Detected in some"		"JURKAT: 2.5;Karpas-707: 12.0;U-266/84: 5.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (4.32e-3)"	"unprognostic (1.94e-3)"	"unprognostic (1.89e-3)"	"prognostic favorable (7.42e-5)"	"unprognostic (1.80e-2)"	"prognostic favorable (9.33e-5)"	"unprognostic (3.38e-3)"	"unprognostic (9.90e-3)"	"unprognostic (7.65e-2)"	"unprognostic (6.22e-2)"	"unprognostic (1.36e-1)"	"unprognostic (5.34e-2)"	"unprognostic (1.14e-3)"	"unprognostic (8.34e-2)"	"unprognostic (4.69e-2)"	"unprognostic (3.14e-2)"	"unprognostic (2.42e-2)"	7.1	2.3	3.4	13.8	6.1	0.8	2.1	0.8	2.5	2.3	3.0	3.0	0.8	3.8	3.7	4.0	2.6	2.6	5.0	3.6	1.6	2.0	2.7	3.0	9.3	11.9	8.1	0.5	3.0	2.1	0.4	1.9	1.2	4.0	2.8	3.8	3.5	4.4	2.5	0.8	1.1	7.2	2.9	6.1	14.6	6.0	0.9	5.9	2.0	2.6	1.5	13.9	5.7	2.0	0.3	5.5	5.6	2.1	3.2	24.5	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	12.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.2	0.0	0.0	0.0	0.0	0.4	5.1	0.0	0.0	0.3	0.0	5.6	1.1	0.0	6.7	2.1	24.5	0.3	2.9	9.7	5.5	0.0	0.3	2.6	0.3	3.2	0.0	5.2	4.5	1.5	3.4	6.1	0.8	2.5	1.6	2.0	8.1	0.5	4.0	5.9	0.0	1.7	0.9	0.0	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	1.1	0.2	4.9	0.0	0.0	1.3	4.1	0.0	0.0	16.2	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	13.1	0.0	0.0
CCRL2	"ACKR5, CKRX, CRAM-A, CRAM-B, HCR"	ENSG00000121797	"C-C motif chemokine receptor like 2"	O00421	3	46407163-46412997	"G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 31.4"	"Cell type enhanced"	"Detected in many"	10	"Enterocytes: 16.9;Hofbauer cells: 40.0;Macrophages: 28.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"HEL: 16.5;OE19: 6.6;PC-3: 12.8;TIME: 12.5;U-266/84: 6.7"					"Low region specificity"	"Detected in many"			HPA043238	Approved					NA	NA					"HPA043238: AB_10794924"	"unprognostic (3.94e-1)"	"unprognostic (7.02e-2)"	"prognostic favorable (3.72e-5)"	"unprognostic (1.64e-1)"	"unprognostic (2.67e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.46e-1)"	"unprognostic (1.62e-1)"	"unprognostic (4.10e-2)"	"unprognostic (4.17e-2)"	"unprognostic (9.73e-2)"	"unprognostic (1.98e-2)"	"unprognostic (5.17e-2)"	"unprognostic (1.78e-1)"	"unprognostic (3.04e-2)"	"unprognostic (2.57e-1)"	"prognostic favorable (9.67e-5)"	31.4	1.4	1.3	9.2	1.5	6.0	9.0	0.6	1.2	1.8	9.5	0.9	2.8	9.5	3.5	1.4	1.8	1.3	4.5	2.3	1.5	1.3	2.0	3.4	13.7	4.3	1.9	0.9	2.3	4.8	0.3	1.3	3.9	1.8	2.4	8.8	1.7	1.4	0.7	2.6	1.1	16.9	1.9	2.9	11.2	4.5	2.3	1.2	9.4	1.9	1.3	3.0	3.6	3.5	2.5	7.7	5.6	16.7	5.4	3.9	3.6	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.1	1.0	0.0	0.1	0.0	0.0	2.4	0.0	0.0	0.2	0.5	3.8	0.0	16.5	0.0	0.0	0.0	1.0	0.2	0.0	0.0	4.2	0.2	0.0	5.9	3.5	2.2	0.1	4.2	0.0	1.3	2.1	0.0	6.6	12.8	0.3	0.2	0.0	0.0	6.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	12.5	0.5	0.2	0.6	0.2	0.0	6.7	0.2	6.5	5.1	0.0	5.6	12.1	3.2	2.4	16.7	2.9	1.4	1.4	3.9	7.7	2.5	0.9	2.2	2.0	5.4	7.8	2.4	3.7	3.6	1.3	1.5	0.6	1.2	1.5	1.3	1.9	0.9	1.8	1.2	0.0	6.6	5.1	0.1	1.8	0.0	0.8	2.5	0.0	1.2	0.0	0.0	0.2	0.0	0.5	0.0	9.0	16.9	0.0	7.4	0.9	0.9	0.2	9.2	0.4	40.0	0.0	0.0	5.5	16.4	0.0	0.0	28.2	1.7	7.2	14.9	0.0	7.8	6.8	0.0	0.1	0.0	0.0	0.5	0.0	0.0	1.0	2.1	6.9	7.2	0.9
CD101	"IGSF2, V7"	ENSG00000134256	"CD101 molecule"	Q93033	1	117001750-117036476	"CD markers, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 33.7;lung: 17.5"	"Cell type enhanced"	"Detected in some"	9	"Kupffer cells: 6.2;Macrophages: 7.2;Sertoli cells: 6.5;T-cells: 4.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"eosinophil: 33.7"	"Group enriched"	"Detected in many"	17	"dendritic cells: 12.2;granulocytes: 33.7;monocytes: 17.4"	"Cell line enriched"	"Detected in some"	9	"HMC-1: 25.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"HPA049527, HPA057763"	Approved		Uncertain	Mitochondria		NA	NA		42000	Mitochondria		"HPA049527: , HPA057763: AB_2683519"	"unprognostic (1.25e-1)"	"unprognostic (7.95e-3)"	"unprognostic (5.40e-3)"	"unprognostic (4.10e-3)"	"unprognostic (2.62e-1)"	"unprognostic (4.00e-2)"	"unprognostic (3.03e-2)"	"unprognostic (3.58e-3)"	"unprognostic (3.57e-2)"	"unprognostic (7.29e-3)"	"unprognostic (3.15e-1)"	"unprognostic (4.54e-2)"	"unprognostic (7.15e-6)"	"unprognostic (7.00e-2)"	"unprognostic (8.07e-2)"	"unprognostic (5.05e-2)"	"unprognostic (5.28e-2)"	0.9	1.7	0.8	11.3	1.1	5.7	0.8	0.2	1.1	1.3	5.0	0.6	1.2	4.6	1.7	0.4	1.8	1.5	1.4	2.6	1.1	0.5	1.3	0.8	17.5	4.0	1.3	0.2	1.0	2.3	0.0	0.8	0.5	1.1	1.6	3.2	0.7	2.1	1.3	0.5	1.8	10.9	1.6	2.0	7.8	1.8	0.9	1.2	6.4	0.9	2.4	7.4	2.4	1.8	0.1	12.2	33.7	17.4	0.0	1.2	2.5	0.4	0.0	0.9	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.1	1.2	1.9	0.1	0.0	0.0	1.1	0.1	0.8	0.0	0.0	0.1	25.3	0.3	1.3	0.0	0.1	0.2	0.2	0.5	0.1	0.6	0.1	1.5	0.0	2.9	0.8	0.0	0.0	0.0	0.5	0.0	0.6	0.7	0.4	0.6	0.4	0.5	0.3	0.6	0.9	0.6	0.5	0.1	0.4	0.5	0.2	0.2	0.1	0.0	0.7	1.9	1.5	0.0	7.6	33.7	0.1	10.0	0.7	0.1	0.2	1.2	12.2	0.0	0.3	1.2	0.3	0.0	17.4	0.0	1.1	2.5	0.8	1.1	0.2	1.1	1.1	0.5	1.3	0.2	1.1	1.2	0.0	1.4	0.5	0.1	1.1	0.0	0.6	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.3	1.5	0.0	0.0	0.0	0.5	0.0	0.2	0.1	1.1	0.4	0.7	0.0	1.7	0.0	6.2	1.3	0.3	7.2	0.0	0.0	0.0	0.0	0.1	0.0	1.1	0.0	0.0	6.5	0.2	0.0	0.0	1.4	0.0	4.6	0.1	0.1
CD1D		ENSG00000158473	"CD1d molecule"	P15813	1	158179947-158184896	"Cancer-related genes, CD markers, Predicted membrane proteins"	"Immunity, Innate immunity"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 49.5;lymphoid tissue: 17.8"	"Cell type enhanced"	"Detected in many"	15	"B-cells: 27.5;Kupffer cells: 52.9;Macrophages: 34.3"	"Low cancer specificity"	"Detected in many"							"Group enriched"	"Detected in many"	6	"classical monocyte: 49.5;intermediate monocyte: 22.4;myeloid DC: 49.5"	"Group enriched"	"Detected in many"	8	"dendritic cells: 49.5;monocytes: 49.5"	"Cell line enriched"	"Detected in some"	4	"JURKAT: 45.7"					"Low region specificity"	"Detected in all"			"CAB016107, HPA072662"	Enhanced		Supported	"Endoplasmic reticulum"		NA	NA		720000	"Endoplasmic reticulum"		"CAB016107: AB_626960, HPA072662: AB_2686545"	"unprognostic (8.67e-2)"	"unprognostic (6.99e-2)"	"unprognostic (2.48e-1)"	"unprognostic (1.48e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.42e-1)"	"unprognostic (3.85e-1)"	"unprognostic (9.67e-3)"	"unprognostic (2.37e-1)"	"unprognostic (3.52e-1)"	"unprognostic (2.23e-2)"	"unprognostic (4.46e-2)"	"prognostic unfavorable (2.12e-5)"	"unprognostic (9.31e-3)"	"unprognostic (2.35e-1)"	"unprognostic (2.32e-2)"	"unprognostic (3.38e-1)"	1.5	1.2	0.0	8.6	0.0	2.6	1.2	0.0	0.0	0.8	2.5			9.5	1.5	0.0	0.4	1.4	2.0	1.4	0.0	0.1	1.6	10.5	2.3	5.5	0.2		0.3	0.7	0.0	0.6	0.0		1.4	3.7		0.7	0.3	0.6	0.0	12.2	2.2	0.4	17.8	1.4	1.4			1.8		3.4	1.6	0.5	6.3	49.5	2.5	49.5	0.1	0.1	23.5	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	1.9	0.0	0.0	2.9	0.0	5.5	0.0	0.0	0.0	0.1	0.0	0.0	8.5	0.1	0.0	3.2	0.4	0.0	0.6	0.0	0.0	45.7	0.0	0.0	0.0	0.0	11.2	1.1	0.5	0.0	0.0	0.0	0.0	0.0	0.5	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	6.9	0.0	0.0	1.7	0.0	0.0	0.3	0.0	0.3	0.0	3.1	0.4	0.0	49.5	0.1	0.0	22.4	0.1	6.3	0.0	0.0	49.5	4.7	0.0	0.0	2.5	0.1	3.6	0.5	0.0	23.5											0.0	5.1	27.5	0.4	0.2	0.4	0.8	5.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	4.5	1.2	2.2	0.0	0.0	0.1	0.2	0.0	1.1	5.3	11.3	1.6	2.4	4.3	52.9	0.9	0.0	34.3	0.0	10.0	2.0	0.3	0.0	3.7	0.0	0.0	0.1	0.0	0.5	0.5	0.9	0.1	0.1	0.0	3.9	0.0
CD207	"CLEC4K, Langerin"	ENSG00000116031	"CD207 molecule"	Q9UJ71	2	70830214-70835822	"CD markers, Disease related genes, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 16.5;skin 1: 42.3"	"Cell type enhanced"	"Detected in some"	14	"Basal keratinocytes: 3.5;Macrophages: 1.5;Melanocytes: 5.0;monocytes: 2.8;Suprabasal keratinocytes: 4.5"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	18	"myeloid DC: 4.0"	"Lineage enriched"	"Detected in single"	18	"dendritic cells: 4.0"	"Cell line enriched"	"Detected in some"	4	"AN3-CA: 14.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB002222, HPA011216"	Enhanced		Uncertain	Cytosol		No	NA			Cytosol		"CAB002222: AB_563850, HPA011216: AB_1078453"	"unprognostic (1.45e-2)"	"unprognostic (8.28e-3)"	"unprognostic (9.34e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.38e-1)"	"unprognostic (2.23e-1)"	"unprognostic (3.02e-1)"	"unprognostic (1.27e-3)"	"unprognostic (1.05e-1)"	"unprognostic (4.86e-2)"	"unprognostic (3.45e-1)"	"unprognostic (1.63e-1)"	"unprognostic (7.92e-4)"	"unprognostic (2.13e-2)"	"unprognostic (1.81e-1)"	"unprognostic (1.98e-1)"	"unprognostic (2.46e-2)"	0.5	0.1	0.1	1.8	0.1	0.0	1.4	0.1	0.1	2.4	1.7	0.1	0.1	1.6	1.1	0.4	9.7	0.3	2.9	0.3	0.1	0.1	0.2	0.9	3.7	0.2	0.1	0.1	0.2	0.2	0.0	1.1	0.1	0.1	1.0	1.1	0.4	1.2	0.2	0.1	42.3	2.6	0.1	0.1	1.5	0.4	0.4	0.1	3.3	0.2	11.3	16.5	0.3	1.9	0.0	4.0	0.0	0.2	0.0	0.0	0.5	0.0	0.0	0.0	14.1	0.1	0.0	0.9	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	3.4	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.1	1.9	0.0	0.0	0.0	0.3	2.5	0.0	0.5	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.5	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	1.1	0.0	0.0	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	5.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.5	0.0	0.0	0.0	0.0
CD209	"CDSIGN, CLEC4L, DC-SIGN, DC-SIGN1"	ENSG00000090659	"CD209 molecule"	Q9NNX6	19	7739994-7747564	"CD markers, Predicted intracellular proteins, Predicted membrane proteins"	"Adaptive immunity, Cell adhesion, Endocytosis, Host-virus interaction, Immunity, Innate immunity"	"Host cell receptor for virus entry, Receptor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 47.9"	"Cell type enhanced"	"Detected in some"	25	"Hofbauer cells: 3.0;Kupffer cells: 14.6;Macrophages: 5.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"classical monocyte: 3.7;intermediate monocyte: 3.5;myeloid DC: 3.4"	"Low lineage specificity"	"Detected in many"			"Cell line enriched"	"Detected in single"	14	"THP-1: 8.8"									"CAB032436, CAB033831"	Supported				"Intracellular and membrane"	NA	NA		970000			"CAB032436: AB_639039, CAB033831: AB_1121347"	"unprognostic (2.76e-1)"	"unprognostic (1.15e-2)"	"unprognostic (5.36e-3)"	"unprognostic (1.25e-1)"	"unprognostic (4.43e-2)"	"unprognostic (1.40e-1)"	"unprognostic (5.45e-2)"	"unprognostic (3.83e-2)"	"unprognostic (2.10e-2)"	"unprognostic (1.24e-1)"	"unprognostic (9.65e-2)"	"unprognostic (1.39e-1)"	"prognostic unfavorable (1.15e-5)"	"unprognostic (1.70e-1)"	"unprognostic (5.51e-2)"	"unprognostic (6.17e-2)"	"unprognostic (1.09e-1)"	20.3	4.5	0.5	4.1	1.8	0.0	6.8	4.5	0.9	2.0	5.6	0.7	0.3	7.2	1.1	7.3	2.4	3.3	4.4	7.8	0.4	0.7	2.2	5.0	3.7	47.9	1.1	0.5	1.8	3.8	0.4	1.0	12.1	1.8	3.6	7.4	3.2	3.0	0.7	3.5	1.6	10.1	5.2	0.9	1.4	2.6	2.1	0.3	2.3	2.1	2.1	1.3	6.8	1.6	0.3	3.4	0.9	3.7	0.3	0.2	1.0	0.1	0.0	0.0	0.0	0.1	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.6	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.1	0.0	0.1	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.2	0.2	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.2	0.1	0.1	0.2	0.6	0.0	0.1	0.0	0.1	0.2	8.8	0.1	0.1	0.0	0.2	0.0	0.1	0.0	0.0	0.1	0.1	0.1	0.5	3.7	0.2	0.2	3.5	0.1	0.2	0.1	0.1	3.4	0.3	0.1	0.2	0.9	0.3	0.1	0.3	0.1	1.0	0.5	1.8	4.5	0.9	0.4	0.7	1.1	0.5	1.8	0.3	0.0	0.0	0.5	0.1	0.5	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	1.1	0.0	3.0	0.0	0.0	0.0	14.6	0.0	0.0	5.9	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.3	0.0	0.0	0.6	0.1	0.0	0.0	0.1
CD300C	"CMRF-35A, CMRF35, CMRF35A, IGSF16, LIR"	ENSG00000167850	"CD300c molecule"	Q08708	17	74541108-74546143	"CD markers, Predicted membrane proteins"	Immunity	Receptor		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"blood: 46.8"	"Group enriched"	"Detected in some"	12	"granulocytes: 15.0;Hofbauer cells: 29.5;Kupffer cells: 28.1;Macrophages: 33.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"classical monocyte: 28.6;intermediate monocyte: 46.8;myeloid DC: 32.5;non-classical monocyte: 46.4"	"Group enriched"	"Detected in many"	5	"dendritic cells: 32.5;monocytes: 46.8"	"Cell line enhanced"	"Detected in some"		"HEL: 5.3;HMC-1: 26.2;THP-1: 4.9;U-937: 12.4"									"HPA014523, HPA060349"	Approved		Uncertain	"Golgi apparatus,Vesicles,Mitochondria"		NA	NA			"Golgi apparatus"	"Vesicles, Mitochondria"	"HPA014523: AB_1846293, HPA060349: "	"unprognostic (1.55e-2)"	"unprognostic (2.60e-1)"	"unprognostic (9.99e-3)"	"unprognostic (3.79e-1)"	"unprognostic (1.21e-1)"	"unprognostic (3.47e-2)"	"unprognostic (3.81e-2)"	"unprognostic (2.19e-1)"	"unprognostic (1.68e-2)"	"unprognostic (7.51e-2)"	"unprognostic (6.51e-2)"	"unprognostic (1.50e-2)"	"unprognostic (1.37e-3)"	"unprognostic (6.27e-2)"	"prognostic unfavorable (8.53e-5)"	"unprognostic (1.16e-2)"	"unprognostic (1.09e-1)"	9.8	2.8	3.6	9.0	4.6	10.9	1.8	0.4	2.9	1.2	1.7	2.9	0.0	1.5	1.4	1.9	1.0	1.9	2.8	3.4	2.0	1.7	1.9	2.1	11.2	12.3	5.3	1.3	1.1	1.3	0.5	1.2	3.8	3.9	1.9	1.8	1.8	1.8	0.7	1.1	0.9	2.3	4.1	7.1	14.2	1.6	0.9	2.7	0.1	1.6	0.1	1.4	3.5	1.1	0.4	32.5	8.4	46.8	8.6	0.1	10.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.6	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	5.3	0.0	0.0	0.0	2.4	26.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	2.7	0.0	0.0	0.1	0.0	0.0	3.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	4.9	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.7	12.4	0.0	8.4	28.6	1.4	0.1	46.8	0.1	0.4	0.0	0.0	32.5	0.3	0.0	0.0	1.0	8.6	46.4	2.1	0.0	10.7	3.6	4.6	0.4	2.9	2.0	1.7	5.3	1.3	3.9	2.7	0.0	2.2	0.0	0.0	0.3	0.0	0.0	0.0	1.4	1.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.2	0.0	15.0	0.0	29.5	0.0	0.0	0.0	28.1	0.0	0.0	33.8	1.7	1.8	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.0
CD300E	"CD300LE, CLM2, IREM2"	ENSG00000186407	"CD300e molecule"	Q496F6	17	74609887-74623738	"CD markers, Predicted intracellular proteins, Predicted membrane proteins"	Immunity	Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 36.5;bone marrow: 22.5;lymphoid tissue: 21.0"	"Cell type enhanced"	"Detected in some"	23	"Alveolar cells type 2: 25.2;Club cells: 15.9;Kupffer cells: 69.4;Macrophages: 16.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Group enriched"	"Detected in some"	5	"classical monocyte: 22.7;intermediate monocyte: 36.5;non-classical monocyte: 36.3"	"Lineage enriched"	"Detected in many"	6	"monocytes: 36.5"	"Cell line enhanced"	"Detected in some"		"HeLa: 1.7;SCLC-21H: 1.5"	"Low region specificity"	"Detected in single"							HPA015570	Uncertain					NA	NA					"HPA015570: AB_1846294"	"unprognostic (1.70e-1)"	"unprognostic (6.82e-2)"	"unprognostic (1.76e-1)"	"unprognostic (2.63e-2)"	"unprognostic (1.42e-2)"	"unprognostic (2.12e-1)"	"unprognostic (1.68e-2)"	"unprognostic (7.80e-3)"	"unprognostic (4.51e-1)"	"unprognostic (1.53e-1)"	"unprognostic (2.69e-2)"	"unprognostic (5.15e-2)"	"unprognostic (4.19e-7)"	"unprognostic (1.90e-2)"	"unprognostic (2.00e-4)"	"unprognostic (7.38e-3)"	"unprognostic (1.19e-1)"	8.5	0.7	0.5	21.0	0.6	22.5	0.7	1.2	1.0	0.5	1.2	0.3	0.0	0.0	0.7	3.0	0.9	1.5	1.9	2.0	0.5	0.5	2.5	1.1	14.3	9.4	0.5	0.2	1.0	0.8	0.0	0.5	1.7	0.7	0.6	0.2	1.1	0.6	1.6	1.6	0.6	0.7	5.3	0.9	14.3	0.8	0.7	0.3	0.2	1.2	0.8	0.8	1.8	0.6	0.0	5.9	0.5	36.5	0.0	0.0	11.6	0.2	0.0	1.1	0.1	0.0	0.1	0.2	0.2	0.2	0.0	0.1	1.1	0.0	0.5	0.2	0.3	0.3	0.2	0.0	0.1	0.0	0.1	0.1	0.0	1.7	0.8	0.0	0.9	0.3	0.1	0.3	0.0	0.0	0.5	0.0	0.5	0.2	0.5	0.0	0.9	0.2	0.8	0.5	0.2	0.4	0.2	0.0	0.2	0.1	0.6	1.5	0.5	0.3	0.0	0.1	1.2	0.6	0.0	0.0	0.5	0.7	0.7	0.2	0.9	0.0	0.1	0.0	0.7	0.5	0.0	22.7	0.1	0.0	36.5	0.0	0.0	0.0	0.0	5.9	0.0	0.0	0.0	0.5	0.0	36.3	0.1	0.0	11.6	0.5	0.6	1.2	1.0	0.5	0.5	0.5	0.2	0.7	0.3	6.0	25.2	1.4	0.0	0.6	0.2	0.3	0.0	2.7	15.9	1.8	0.0	0.1	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.0	3.5	0.2	4.1	0.0	0.0	0.6	69.4	0.0	0.0	16.8	1.7	1.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.3	0.0	0.0	0.0
CD33	"FLJ00391, p67, SIGLEC-3, SIGLEC3"	ENSG00000105383	"CD33 molecule"	P20138	19	51225064-51243860	"CD markers, FDA approved drug targets, Plasma proteins, Predicted membrane proteins"	"Cell adhesion"		"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 49.3;lymphoid tissue: 45.4"	"Group enriched"	"Detected in many"	7	"granulocytes: 73.9;Hofbauer cells: 67.4;Kupffer cells: 119.1;Macrophages: 56.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	7	"classical monocyte: 37.6;intermediate monocyte: 27.3;myeloid DC: 49.3;non-classical monocyte: 12.6"	"Group enriched"	"Detected in many"	9	"dendritic cells: 49.3;monocytes: 37.6"	"Cell line enhanced"	"Detected in some"		"HEL: 28.5;HL-60: 37.9;HMC-1: 28.4;NB-4: 18.1;RPMI-8226: 20.5;THP-1: 22.2;U-937: 28.0"									"CAB011442, HPA035832, HPA064807"	Approved		Approved	"Nucleoplasm,Plasma membrane"		NA	NA		1400000	"Nucleoplasm, Plasma membrane"		"CAB011442: , HPA035832: AB_2674808, HPA064807: AB_2685356"	"unprognostic (1.18e-2)"	"unprognostic (1.45e-2)"	"unprognostic (2.80e-2)"	"unprognostic (7.14e-2)"	"unprognostic (3.71e-1)"	"unprognostic (9.43e-2)"	"unprognostic (2.59e-1)"	"unprognostic (5.90e-3)"	"unprognostic (1.76e-1)"	"unprognostic (1.56e-1)"	"unprognostic (2.53e-1)"	"unprognostic (6.28e-2)"	"unprognostic (6.88e-4)"	"unprognostic (7.79e-2)"	"unprognostic (3.35e-2)"	"unprognostic (6.49e-2)"	"unprognostic (1.67e-1)"	10.2	4.3	3.6	8.4	6.0	23.0	6.5	0.8	3.5	2.6	2.7	4.4	0.3	2.5	2.3	5.2	1.7	3.9	5.3	7.5	3.1	2.5	4.1	6.4	11.6	45.4	6.4	1.8	1.9	1.9	0.5	1.7	5.4	5.2	2.6	3.4	2.6	2.9	2.1	1.2	2.5	4.0	5.6	9.9	31.6	2.8	1.5	5.8	2.5	1.7	0.2	2.7	4.7	2.3	0.1	49.3	4.6	37.6	3.3	0.2	14.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	1.7	0.1	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	28.5	0.1	0.0	0.0	37.9	28.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	5.2	7.2	0.0	0.0	0.0	18.1	0.0	0.0	8.7	0.0	1.5	20.5	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	22.2	0.2	4.9	0.4	0.6	0.0	0.1	2.4	0.0	3.3	28.0	0.1	3.3	37.6	2.3	0.0	27.3	0.1	0.0	0.0	0.1	49.3	0.1	0.0	0.0	4.6	3.3	12.6	1.4	0.2	14.7	3.6	6.0	0.8	3.5	3.1	2.5	6.4	1.8	5.2	5.8	0.0	10.7	1.4	0.5	1.5	0.1	0.6	0.0	1.4	1.2	0.0	0.0	0.7	0.0	0.0	0.4	1.5	0.0	0.0	0.0	0.4	1.5	0.3	73.9	0.8	67.4	0.0	0.0	8.6	119.1	1.3	0.3	56.4	1.7	2.8	0.0	0.2	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.7	0.5	0.9	0.7	1.7	0.0	0.3
CD37	TSPAN26	ENSG00000104894	"CD37 molecule"	P11049	19	49335171-49343335	"CD markers, Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 163.4;lymphoid tissue: 109.6"	"Cell type enhanced"	"Detected in many"	18	"B-cells: 979.0;granulocytes: 262.7;Hofbauer cells: 303.3;Kupffer cells: 224.9;Macrophages: 253.6;T-cells: 359.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"Daudi: 67.2;HMC-1: 66.6;RPMI-8226: 23.9;THP-1: 23.9;U-698: 14.8;U-937: 17.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"CAB002492, HPA032120, HPA032121"	Enhanced		Approved	"Golgi apparatus,Plasma membrane"		NA	NA			"Golgi apparatus"	"Plasma membrane"	"CAB002492: AB_563554, HPA032120: AB_2674162, HPA032121: AB_2674163"	"unprognostic (4.30e-3)"	"unprognostic (2.39e-3)"	"unprognostic (8.85e-2)"	"prognostic favorable (4.51e-4)"	"unprognostic (5.46e-2)"	"unprognostic (4.59e-3)"	"unprognostic (1.76e-1)"	"unprognostic (6.23e-2)"	"unprognostic (5.34e-2)"	"unprognostic (2.23e-1)"	"unprognostic (1.22e-1)"	"unprognostic (3.06e-1)"	"unprognostic (2.45e-3)"	"unprognostic (7.12e-2)"	"unprognostic (3.35e-2)"	"unprognostic (7.22e-2)"	"unprognostic (7.71e-2)"	7.3	3.1	3.4	62.9	4.8	48.7	3.7	1.0	3.1	1.9	4.2	8.5	0.0	3.2	2.0	2.2	5.9	2.9	5.2	10.4	3.8	3.8	4.3	2.7	25.3	109.6	6.9	1.7	2.5	1.6	0.5	1.9	5.4	4.7	3.5	1.7	2.7	10.7	1.4	1.1	2.0	39.3	1.7	14.5	88.1	5.1	2.9	5.0	47.9	3.4	1.7	86.8	10.2	2.4	163.4	53.7	84.4	62.8	27.9	43.5	58.8	0.0	0.1	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	67.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	10.7	0.0	11.8	0.0	0.1	0.0	2.0	66.6	0.0	0.0	0.0	0.0	0.0	0.0	4.1	0.6	3.7	0.0	0.0	0.1	1.2	0.0	0.0	0.0	0.6	0.0	23.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	23.9	0.1	0.0	0.2	0.0	0.0	0.0	0.0	14.8	0.0	17.8	0.0	42.8	58.2	71.7	34.3	53.4	34.7	137.2	41.8	36.4	41.1	163.4	43.5	36.3	84.4	27.9	62.8	53.7	40.9	58.8	3.4	4.8	1.0	3.1	3.8	3.8	6.9	1.7	4.7	5.0	8.9	20.5	979.0	1.1	10.4	12.4	1.2	2.5	1.4	4.5	1.8	5.9	1.6	0.0	0.3	98.9	4.3	0.4	0.0	0.0	1.5	5.4	0.5	262.7	2.5	303.3	0.0	1.2	14.1	224.9	158.6	2.6	253.6	27.0	43.3	0.5	1.1	0.0	5.3	0.7	2.5	5.2	0.0	0.5	1.1	0.9	10.3	2.4	359.8	0.4	0.9
CD48	"BCM1, BLAST, hCD48, mCD48, SLAMF2"	ENSG00000117091	"CD48 molecule"	P09326	1	160678746-160711851	"CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 81.3;lymphoid tissue: 86.3"	"Group enriched"	"Detected in many"	5	"B-cells: 233.4;granulocytes: 88.9;Hofbauer cells: 87.6;Kupffer cells: 195.5;Macrophages: 131.8;T-cells: 297.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"Daudi: 38.9;HMC-1: 43.5;U-266/70: 92.1;U-266/84: 61.5"									"CAB002497, HPA055146"	Enhanced		Supported	"Nucleoli fibrillar center,Plasma membrane,Cytosol"	"Intracellular and membrane"	NA	NA		2600000	"Plasma membrane"	"Nucleoli fibrillar center, Cytosol"	"CAB002497: AB_563586, HPA055146: AB_2682716"	"prognostic favorable (3.91e-4)"	"unprognostic (1.72e-3)"	"prognostic favorable (4.17e-4)"	"unprognostic (1.58e-3)"	"unprognostic (2.36e-1)"	"unprognostic (1.71e-3)"	"unprognostic (2.09e-2)"	"unprognostic (2.19e-2)"	"unprognostic (1.92e-1)"	"unprognostic (3.02e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.65e-1)"	"prognostic unfavorable (3.36e-4)"	"unprognostic (3.21e-1)"	"unprognostic (4.69e-2)"	"unprognostic (9.38e-2)"	"unprognostic (8.51e-2)"	5.5	1.4	1.0	44.6	0.9	23.1	2.8	0.6	0.7	3.2	5.0	0.5	1.1	3.2	1.9	2.5	7.3	2.1	4.8	1.8	1.0	1.0	3.6	3.1	15.4	86.3	1.6	0.3	2.3	1.5	0.0	1.3	2.2	0.8	2.8	5.7	2.4	13.9	1.5	1.3	1.2	21.2	1.7	3.8	66.6	5.0	1.3	0.2	50.8	2.9	3.6	58.0	8.6	2.6	34.6	53.6	35.8	74.1	24.9	57.9	81.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	38.9	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.0	0.0	0.3	0.0	0.0	0.0	4.6	43.5	0.0	0.0	0.0	0.0	0.0	0.0	4.1	0.0	14.2	0.0	0.0	13.5	6.7	0.0	0.0	0.0	0.8	0.0	5.9	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	92.1	61.5	15.8	0.0	11.7	0.0	28.2	52.2	35.8	42.4	74.1	57.9	34.6	48.3	48.8	53.6	27.9	49.7	52.5	13.4	24.9	73.5	9.4	36.4	81.3	1.0	0.9	0.6	0.7	1.0	1.0	1.6	0.3	0.8	0.2	0.0	14.8	233.4	0.5	4.8	0.0	0.8	5.1	4.0	2.3	3.5	0.0	0.7	1.7	0.1	0.0	0.7	0.0	23.3	0.2	0.7	3.1	0.2	88.9	1.8	87.6	0.0	1.2	8.6	195.5	0.4	1.7	131.8	37.1	8.2	0.0	0.0	0.1	0.0	0.4	1.5	0.0	0.0	0.7	0.4	0.1	2.6	0.3	297.5	0.0	0.3
CD53	"MOX44, TSPAN25"	ENSG00000143119	"CD53 molecule"	P19397	1	110873154-110899928	"CD markers, Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 146.7;lymphoid tissue: 103.0"	"Group enriched"	"Detected in many"	7	"B-cells: 233.1;granulocytes: 158.2;Hofbauer cells: 322.4;Kupffer cells: 293.3;Macrophages: 340.3;T-cells: 289.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"Daudi: 87.2;HDLM-2: 37.5;HMC-1: 54.9;Karpas-707: 34.2;U-266/70: 47.3;U-698: 27.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA047216	Enhanced					NA	NA					"HPA047216: AB_2679986"	"unprognostic (2.93e-2)"	"unprognostic (1.25e-2)"	"unprognostic (7.45e-3)"	"unprognostic (1.02e-3)"	"unprognostic (8.88e-2)"	"unprognostic (3.78e-2)"	"unprognostic (2.96e-1)"	"unprognostic (6.07e-2)"	"unprognostic (2.83e-2)"	"unprognostic (2.03e-1)"	"unprognostic (5.09e-2)"	"unprognostic (1.62e-1)"	"prognostic unfavorable (2.60e-4)"	"unprognostic (9.58e-2)"	"unprognostic (4.95e-2)"	"unprognostic (1.33e-1)"	"unprognostic (7.72e-2)"	29.7	8.1	6.1	50.6	10.3	20.4	6.6	1.6	5.8	4.5	9.6	7.6	1.2	6.7	4.3	6.0	5.5	9.9	11.0	6.4	6.4	5.9	9.6	8.8	28.9	93.8	13.3	2.7	4.7	3.8	0.8	3.1	10.6	8.5	5.2	10.5	4.5	10.1	2.3	2.3	2.2	35.2	10.0	14.9	103.0	7.5	4.8	10.0	37.2	4.6	4.1	82.1	15.2	4.0	97.5	74.6	138.0	97.0	59.2	91.8	146.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	87.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	37.5	0.0	4.6	0.0	0.0	0.0	10.4	54.9	0.0	0.0	0.0	0.0	0.0	0.0	25.0	1.9	34.2	0.0	0.0	17.7	12.4	0.0	0.0	0.0	17.2	0.1	18.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	15.7	3.1	0.0	0.0	0.0	0.1	47.3	21.4	27.0	0.2	12.1	0.6	138.0	87.0	54.1	91.8	93.3	82.8	97.5	67.5	80.8	74.6	83.3	49.2	70.8	136.2	59.2	97.0	61.4	85.0	146.7	6.1	10.3	1.6	5.8	6.4	5.9	13.3	2.7	8.5	10.0	14.9	35.6	233.1	0.4	6.3	0.0	0.8	5.1	8.1	15.9	1.8	0.0	1.7	0.0	0.0	0.2	7.2	0.0	23.3	0.2	4.2	5.0	0.3	158.2	1.7	322.4	0.0	0.0	15.4	293.3	0.9	2.0	340.3	37.1	39.7	0.0	0.0	0.2	0.0	0.4	1.1	0.6	6.5	0.7	0.1	0.7	4.8	3.4	289.1	0.0	0.3
CD58	LFA3	ENSG00000116815	"CD58 molecule"	P19256	1	116514535-116571039	"CD markers, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	9	"Macrophages: 115.4;monocytes: 225.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"Karpas-707: 46.3"															NA	NA		7100000				"unprognostic (4.48e-3)"	"unprognostic (3.20e-1)"	"unprognostic (2.95e-2)"	"unprognostic (4.03e-2)"	"unprognostic (8.45e-2)"	"unprognostic (1.95e-1)"	"prognostic unfavorable (2.32e-6)"	"unprognostic (9.84e-2)"	"unprognostic (7.17e-2)"	"unprognostic (4.72e-2)"	"prognostic unfavorable (5.60e-4)"	"unprognostic (2.82e-1)"	"unprognostic (1.66e-2)"	"unprognostic (1.86e-1)"	"unprognostic (3.68e-2)"	"unprognostic (2.17e-2)"	"unprognostic (9.66e-2)"	21.5	9.6	5.9	17.6	8.7	29.9	15.2	2.2	7.7	15.8	24.7	5.9	10.4	17.0	12.4	15.3	22.1	11.0	19.2	23.9	7.3	4.8	32.8	11.0	22.4	14.5	9.6	3.7	6.5	6.6	6.5	12.0	10.0	9.3	9.4	17.9	6.4	18.4	15.3	8.8	14.9	48.3	16.3	11.5	23.1	11.1	6.5	8.8	9.3	12.0	22.9	18.2	15.4	16.2	6.0	12.4	47.3	17.1	4.9	17.8	9.5	11.8	6.8	5.0	4.8	8.5	14.3	3.1	6.1	10.6	10.6	10.4	3.0	23.0	2.1	11.3	10.6	12.4	15.4	3.7	10.4	11.3	11.6	4.3	10.7	12.5	4.2	5.4	14.7	14.9	3.9	14.2	8.8	7.9	22.7	6.1	2.8	9.4	46.3	6.4	21.3	6.3	11.2	2.5	17.6	7.5	12.5	17.0	2.8	21.3	9.7	1.7	3.5	12.2	9.1	34.2	5.4	4.7	5.5	11.2	7.7	5.9	10.3	15.5	7.0	12.4	1.4	17.7	7.3	38.0	28.7	14.7	24.4	11.5	14.2	7.9	6.0	10.1	9.5	12.4	2.1	1.4	5.8	47.3	4.9	17.1	1.4	17.8	9.5	5.9	8.7	2.2	7.7	7.3	4.8	9.6	3.7	9.3	8.8	8.9	36.4	11.5	12.8	16.3	0.0	24.6	30.6	33.5	22.7	14.0	0.0	3.6	3.3	34.2	1.7	27.4	41.0	23.3	24.6	1.6	16.2	13.6	49.9	7.8	57.7	1.6	10.4	22.1	34.3	2.1	9.8	115.4	11.8	225.4	14.5	3.9	30.7	42.1	11.0	23.7	0.5	32.3	25.9	3.0	1.4	24.3	1.6	30.5	16.3	33.1
CD68	"DKFZp686M18236, GP110, LAMP4, macrosialin, SCARD1"	ENSG00000129226	"CD68 molecule"	P34810	17	7579467-7582113	"CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 179.1;lymphoid tissue: 139.1"	"Group enriched"	"Detected in many"	6	"Hofbauer cells: 1656.8;Kupffer cells: 486.8;Macrophages: 440.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"classical monocyte: 155.1;intermediate monocyte: 179.1;non-classical monocyte: 170.1"	"Group enriched"	"Detected in many"	11	"dendritic cells: 68.4;monocytes: 179.1"	"Cell line enhanced"	"Detected in many"		"ASC diff: 74.5;U-87 MG: 117.4"	"Low region specificity"	"Detected in all"							"CAB000051, CAB000066, HPA048982, CAB072861, CAB072862"	Enhanced		Supported	"Golgi apparatus,Vesicles"		NA	NA			"Golgi apparatus, Vesicles"		"CAB000051: AB_2314148, CAB000066: AB_2074844, CAB072861: AB_2665705, CAB072862: AB_2665706, HPA048982: AB_2680587"	"unprognostic (2.16e-2)"	"unprognostic (1.47e-2)"	"unprognostic (6.46e-2)"	"unprognostic (1.49e-3)"	"unprognostic (1.78e-2)"	"unprognostic (1.97e-1)"	"unprognostic (4.75e-4)"	"unprognostic (2.83e-2)"	"unprognostic (1.31e-1)"	"unprognostic (6.85e-2)"	"unprognostic (1.04e-1)"	"unprognostic (2.59e-1)"	"prognostic unfavorable (1.14e-5)"	"unprognostic (1.58e-1)"	"unprognostic (8.91e-2)"	"unprognostic (1.61e-1)"	"unprognostic (1.65e-2)"	118.4	28.5	12.5	46.8	21.6	46.8	40.9	2.9	11.2	27.1	38.1	15.5	2.1	57.0	9.6	24.1	26.9	17.3	33.7	39.0	10.1	6.9	20.9	43.1	84.4	102.5	21.1	4.4	15.8	7.5	2.1	8.5	34.7	15.7	12.1	18.5	12.8	22.2	4.4	16.1	9.4	58.3	15.6	26.0	139.1	17.6	9.4	16.3	13.3	8.8	12.3	21.1	31.4	19.1	3.7	68.4	11.0	179.1	0.9	0.5	125.6	35.7	7.3	0.4	0.5	74.5	28.4	0.3	11.4	31.2	15.2	17.7	1.5	10.8	0.4	13.0	33.1	27.0	1.6	0.1	7.2	10.3	0.3	1.3	5.7	1.8	8.6	6.3	2.8	32.2	9.0	1.5	31.7	23.4	25.1	3.9	0.6	2.2	3.7	14.6	0.2	0.2	2.5	0.4	9.3	5.3	0.4	0.6	21.1	3.1	1.6	0.2	0.4	9.5	4.8	11.1	0.3	0.2	21.9	12.4	19.3	1.2	19.3	14.9	0.2	0.3	0.2	117.4	7.0	9.7	10.1	155.1	0.9	0.4	179.1	0.5	3.7	0.2	0.3	40.9	2.0	0.3	0.2	11.0	0.9	170.1	68.4	0.3	125.6	12.5	21.6	2.9	11.2	10.1	6.9	21.1	4.4	15.7	16.3	0.0	22.4	23.8	26.4	14.0	0.0	0.0	7.6	9.4	13.6	5.2	0.0	7.2	5.0	60.6	0.6	16.8	36.0	0.0	137.4	51.8	33.7	27.3	40.6	16.3	1656.8	0.0	4.7	13.5	486.8	1.1	6.1	440.3	37.1	60.5	7.1	0.2	92.4	25.9	1.8	31.1	1.2	25.8	13.3	0.3	0.2	12.5	27.9	12.5	10.2	68.9
CD74	DHLAG	ENSG00000019582	"CD74 molecule"	P04233	5	150401637-150412929	"Cancer-related genes, CD markers, Disease related genes, Predicted membrane proteins"	"Adaptive immunity, Immunity"	Chaperone	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 504.7"	"Cell type enhanced"	"Detected in many"	16	"Hofbauer cells: 4588.2;Macrophages: 7133.7;monocytes: 15196.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"classical monocyte: 191.6;intermediate monocyte: 303.5;memory B-cell: 467.7;myeloid DC: 437.9;naive B-cell: 504.7;non-classical monocyte: 140.0;plasmacytoid DC: 303.2"	"Group enriched"	"Detected in all"	5	"B-cells: 504.7;dendritic cells: 437.9;monocytes: 303.5"	"Cell line enhanced"	"Detected in many"		"CAPAN-2: 118.2;Daudi: 181.9;HDLM-2: 261.1;REH: 157.4;RPMI-8226: 107.2;U-266/70: 87.7;U-698: 100.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB002506, HPA010592"	Enhanced		Supported	"Golgi apparatus"		NA	NA		90000	"Golgi apparatus"		"CAB002506: AB_563630, HPA010592: AB_1078482"	"prognostic favorable (1.06e-4)"	"unprognostic (1.48e-2)"	"unprognostic (4.80e-3)"	"prognostic favorable (6.53e-6)"	"unprognostic (1.41e-1)"	"unprognostic (4.53e-2)"	"unprognostic (2.05e-1)"	"unprognostic (3.69e-3)"	"unprognostic (1.54e-2)"	"unprognostic (3.48e-2)"	"unprognostic (2.20e-2)"	"unprognostic (2.64e-1)"	"unprognostic (5.44e-3)"	"unprognostic (1.73e-1)"	"unprognostic (4.95e-2)"	"unprognostic (2.05e-1)"	"unprognostic (4.24e-2)"	137.8	95.7	53.2	177.0	81.4	40.7	104.2	8.4	43.5	89.6	68.2	79.0	30.0	98.3	60.0	73.9	43.6	68.1	81.3	104.1	46.9	43.5	168.3	60.1	222.5	310.1	78.3	23.1	53.4	34.1	15.1	51.0	27.9	79.8	72.6	63.6	72.9	123.0	55.4	40.5	56.6	182.8	55.1	123.1	372.1	77.3	23.7	68.1	201.1	83.4	45.6	288.2	91.7	47.0	504.7	437.9	76.1	303.5	42.2	41.2	238.1	1.9	0.0	0.0	0.1	0.1	0.1	0.7	0.0	0.0	0.0	0.0	23.6	118.2	181.9	7.3	0.0	0.5	0.5	0.0	0.0	0.0	261.1	0.0	5.9	0.1	14.4	0.3	0.4	0.3	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.4	72.4	0.0	0.0	0.2	0.8	0.3	0.0	0.0	157.4	0.2	107.2	0.5	7.7	0.3	0.5	0.3	0.2	5.2	1.2	4.8	21.8	0.2	0.6	0.5	0.5	0.2	87.7	9.4	100.8	42.2	8.2	38.5	6.3	191.6	76.1	16.8	303.5	18.7	467.7	14.8	24.8	437.9	504.7	7.8	13.5	16.8	42.2	140.0	303.2	41.2	238.1	53.2	81.4	8.4	43.5	46.9	43.5	78.3	23.1	79.8	68.1	390.1	2012.6	3694.0	133.2	635.9	0.3	57.9	405.1	591.6	683.6	476.3	0.0	29.1	99.5	571.4	6.9	1116.8	170.9	23.3	476.1	19.5	234.4	182.3	395.1	56.2	4588.2	1.6	233.2	353.6	3259.2	11.0	108.4	7133.7	1135.4	15196.0	331.4	14.5	306.9	131.5	16.6	759.6	8.0	161.7	171.2	2.3	7.6	503.4	34.8	370.6	168.2	195.9
CD83	"BL11, HB15"	ENSG00000112149	"CD83 molecule"	Q01151	6	14117256-14136918	"CD markers, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 70.0;lymphoid tissue: 64.5"	"Cell type enhanced"	"Detected in many"	22	"granulocytes: 239.5;Macrophages: 184.4;monocytes: 891.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Daudi: 29.2;HDLM-2: 26.2;U-698: 44.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB002509, HPA041454"	Enhanced					NA	NA					"CAB002509: AB_563641, HPA041454: AB_2677489"	"unprognostic (2.22e-3)"	"unprognostic (1.92e-2)"	"unprognostic (1.22e-1)"	"unprognostic (6.39e-2)"	"unprognostic (5.83e-2)"	"unprognostic (3.02e-2)"	"unprognostic (1.00e-2)"	"unprognostic (9.05e-3)"	"unprognostic (9.05e-2)"	"unprognostic (3.91e-2)"	"unprognostic (7.37e-2)"	"unprognostic (6.68e-2)"	"prognostic favorable (3.49e-4)"	"unprognostic (2.30e-1)"	"unprognostic (7.07e-2)"	"unprognostic (1.40e-2)"	"unprognostic (2.46e-2)"	14.0	8.3	6.1	64.5	5.7	70.0	7.5	14.2	11.8	17.0	2.0	24.7	3.4	1.8	3.7	8.3	3.6	1.8	9.9	2.6	7.3	12.7	9.7	6.0	29.0	19.5	7.8	2.2	9.7	1.6	2.2	4.1	3.4	10.8	5.2	3.8	3.5	16.4	7.8	1.8	2.6	6.9	2.7	11.1	16.5	2.2	4.0	2.8	33.8	2.3	6.2	57.5	16.4	9.8	19.1	5.2	1.3	15.4	2.6	3.6	2.3	6.6	0.3	5.0	6.9	7.3	1.7	0.1	1.8	6.8	3.2	5.7	0.5	4.4	29.2	5.6	0.5	6.7	0.7	1.9	2.1	10.8	26.2	2.8	4.0	8.6	0.8	0.2	5.8	6.4	1.9	0.9	3.1	1.0	1.0	0.1	10.1	0.8	0.0	0.3	2.4	4.6	11.0	2.0	1.2	1.3	4.5	10.9	4.1	2.3	6.6	1.1	2.0	0.4	0.2	5.0	3.0	1.2	4.7	0.1	5.0	3.1	0.7	4.5	0.3	0.0	44.9	1.1	8.0	7.5	0.0	1.7	1.1	2.7	10.7	2.9	11.5	2.5	2.2	5.2	19.1	1.8	2.1	1.3	2.6	15.4	1.8	3.6	2.3	6.1	5.7	14.2	11.8	7.3	12.7	7.8	2.2	10.8	2.8	17.9	74.6	42.7	9.5	44.0	3.5	25.4	2.5	5.3	9.1	10.4	5.9	1.4	3.3	0.6	0.4	16.9	2.6	0.0	1.3	2.2	18.7	12.7	239.5	0.8	140.3	1.6	23.1	3.1	66.8	1.1	0.3	184.4	42.2	891.9	3.3	3.1	1.6	0.0	0.0	15.8	2.6	0.0	26.8	0.9	12.1	33.6	2.3	13.8	3.5	2.8
CD84	"hCD84, mCD84, SLAMF5"	ENSG00000066294	"CD84 molecule"	Q9UIB8	1	160541095-160579516	"CD markers, Predicted membrane proteins"	"Adaptive immunity, Autophagy, Cell adhesion, Immunity, Innate immunity"	Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 26.0"	"Cell type enhanced"	"Detected in many"	14	"granulocytes: 177.3;Hofbauer cells: 84.2;Kupffer cells: 123.8;Macrophages: 52.0;monocytes: 78.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"Daudi: 12.6;HEL: 24.3;HL-60: 6.8;HMC-1: 27.7;MOLT-4: 6.7;U-698: 17.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA063316, HPA068020, HPA070502"	Enhanced		Enhanced	"Vesicles,Plasma membrane"		NA	NA		36000000	"Plasma membrane"	Vesicles	"HPA063316: , HPA068020: , HPA070502: AB_2686274"	"unprognostic (4.38e-2)"	"unprognostic (6.16e-3)"	"unprognostic (1.00e-2)"	"unprognostic (8.16e-2)"	"unprognostic (2.35e-1)"	"unprognostic (2.00e-2)"	"unprognostic (3.84e-1)"	"unprognostic (2.54e-2)"	"unprognostic (8.60e-2)"	"unprognostic (1.80e-1)"	"unprognostic (8.26e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.30e-2)"	"unprognostic (2.15e-1)"	"unprognostic (4.14e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.08e-1)"	15.9	4.8	3.8	18.5	4.5	6.7	3.7	1.3	3.4	3.3	3.2	7.9	7.7	2.5	2.5	4.3	2.7	3.1	6.4	5.0	3.8	3.0	3.1	5.1	9.2	26.0	6.0	2.2	1.8	4.3	0.9	1.9	7.1	5.3	3.7	4.7	2.4	4.3	9.8	1.6	2.7	9.6	4.1	11.1	25.6	3.5	2.8	5.9	13.8	2.9	2.3	16.3	5.8	2.7	5.1	5.4	21.0	7.3	1.0	8.2	6.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	24.3	0.0	0.0	0.0	6.8	27.7	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.4	0.1	0.0	0.0	6.7	5.1	0.0	0.0	0.0	0.2	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.1	0.0	1.5	0.0	21.0	7.3	11.0	6.9	6.3	5.2	5.1	5.9	8.2	5.4	4.7	3.5	6.3	1.0	1.0	2.4	3.2	7.9	6.1	3.8	4.5	1.3	3.4	3.8	3.0	6.0	2.2	5.3	5.9	0.0	8.3	23.1	0.7	2.2	0.2	1.2	5.1	1.4	2.3	0.0	0.0	0.4	0.0	0.0	0.6	2.6	0.0	0.0	0.2	0.3	0.8	0.6	177.3	0.9	84.2	0.0	0.0	5.5	123.8	0.5	0.6	52.0	5.0	78.5	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	1.0	0.0	0.0	2.0	0.8	42.4	0.0	0.7
CD93	"C1qR(P), C1QR1, C1qRP, CDw93, dJ737E23.1, ECSM3, MXRA4"	ENSG00000125810	"CD93 molecule"	Q9NPY3	20	23079349-23086340	"CD markers, Plasma proteins, Predicted membrane proteins"	"Cell adhesion, Host-virus interaction"	Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	6	"Endothelial cells: 232.0;Ito cells: 170.6;Kupffer cells: 149.3;Macrophages: 59.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"classical monocyte: 14.4;neutrophil: 17.4"	"Group enriched"	"Detected in many"	40	"dendritic cells: 5.5;granulocytes: 17.4;monocytes: 14.4"	"Group enriched"	"Detected in some"	4	"HUVEC TERT2: 58.4;TIME: 73.9;U-937: 98.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA009300, HPA012368"	Enhanced		Approved	"Vesicles,Plasma membrane"		NA	NA		440000000	"Vesicles, Plasma membrane"		"HPA009300: AB_1846342, HPA012368: AB_1846341"	"unprognostic (2.05e-1)"	"unprognostic (2.85e-1)"	"unprognostic (1.07e-1)"	"unprognostic (4.83e-2)"	"unprognostic (2.31e-1)"	"unprognostic (2.66e-2)"	"unprognostic (6.45e-2)"	"unprognostic (2.77e-1)"	"unprognostic (4.51e-1)"	"unprognostic (3.74e-2)"	"unprognostic (2.61e-1)"	"unprognostic (1.81e-1)"	"prognostic unfavorable (2.74e-4)"	"unprognostic (8.81e-3)"	"unprognostic (6.13e-2)"	"unprognostic (4.49e-2)"	"unprognostic (3.11e-2)"	50.5	6.1	2.4	15.0	3.4	4.7	31.4	1.0	3.0	13.6	8.1	1.7	3.9	3.2	14.3	12.5	10.0	13.6	14.2	33.3	2.4	2.2	10.8	10.9	34.8	25.3	4.1	1.2	11.6	5.9	5.1	4.3	48.9	5.3	9.7	4.3	4.9	5.9	3.9	16.2	6.8	7.7	15.4	4.3	17.5	7.5	6.9	3.3	6.9	12.3	9.3	4.5	15.6	12.2	0.0	5.5	17.4	14.4	0.0	0.3	4.7	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	58.4	0.0	0.1	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.1	0.0	4.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.4	73.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	98.9	0.0	0.0	14.4	0.2	0.2	10.3	0.0	0.0	0.1	0.0	5.5	0.0	0.0	0.0	17.4	0.0	4.2	0.7	0.3	4.7	2.4	3.4	1.0	3.0	2.4	2.2	4.1	1.2	5.3	3.3	3.0	11.9	3.7	0.6	13.4	0.0	7.3	10.2	5.3	6.8	0.0	0.0	0.2	0.0	0.2	0.4	232.0	0.0	0.0	0.0	0.4	6.5	2.9	4.7	1.3	16.2	0.0	0.0	170.6	149.3	0.2	1.7	59.8	8.5	0.0	0.0	0.1	0.1	0.0	26.2	0.2	0.0	19.4	15.3	0.0	0.2	8.8	0.3	2.9	0.0	0.9
CEACAM21	"FLJ13540, R29124_1"	ENSG00000007129	"Carcinoembryonic antigen related cell adhesion molecule 21"	Q3KPI0	19	41549518-41586844	"Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"blood: 19.1;bone marrow: 21.1;lymphoid tissue: 22.7"	"Group enriched"	"Detected in some"	4	"B-cells: 4.4;Early spermatids: 5.3;granulocytes: 4.6;Hofbauer cells: 7.6;Ito cells: 14.1;Kupffer cells: 6.9;Late spermatids: 7.8;Macrophages: 4.6;T-cells: 10.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"HMC-1: 9.8;Karpas-707: 7.8;U-266/70: 8.6;U-937: 6.5"									HPA043411	Uncertain					NA	NA					"HPA043411: AB_10794886"	"unprognostic (2.55e-1)"	"unprognostic (1.61e-3)"	"unprognostic (5.73e-2)"	"prognostic favorable (1.89e-5)"	"unprognostic (2.57e-1)"	"unprognostic (8.02e-4)"	"unprognostic (3.04e-1)"	"unprognostic (2.05e-3)"	"unprognostic (1.51e-2)"	"unprognostic (2.63e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.66e-1)"	"unprognostic (3.37e-6)"	"unprognostic (2.09e-1)"	"unprognostic (3.67e-1)"	"unprognostic (1.12e-3)"	"unprognostic (1.37e-1)"	1.8	1.2	1.6	18.5	1.7	21.1	1.3	1.0	1.4	3.5	3.8	2.4	0.0	1.2	3.9	1.4	1.5	1.4	1.1	2.1	2.0	7.2	1.4	1.8	7.2	19.2	8.4	0.5	1.1	0.7	0.3	1.0	2.4	1.9	1.2	1.2	2.0	4.3	6.2	0.5	0.6	5.0	0.9	3.3	22.7	1.4	1.5	1.6	11.1	1.2	0.7	22.4	2.9	0.8	6.9	7.0	13.0	4.6	10.3	19.1	10.1	0.0	0.0	1.6	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.4	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	9.8	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	7.8	0.0	0.1	0.1	0.1	0.1	0.0	0.0	1.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.1	0.0	0.0	0.0	0.0	8.6	1.5	1.6	0.0	6.5	0.0	0.0	2.6	10.8	19.1	4.6	12.8	6.7	16.5	13.1	2.8	6.9	14.2	13.8	13.0	10.3	2.8	7.0	14.6	10.1	1.6	1.7	1.0	1.4	2.0	7.2	8.4	0.5	1.9	1.6	0.0	0.0	4.4	0.2	0.0	0.0	0.6	0.0	0.0	1.2	1.8	0.0	0.0	0.0	0.0	5.3	1.3	0.0	0.0	0.0	0.1	0.0	0.0	4.6	0.0	7.6	0.0	0.0	14.1	6.9	7.8	0.0	4.6	1.7	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.4	0.4	0.0	0.2	10.0	0.0	0.0
CFP	PFC	ENSG00000126759	"Complement factor properdin"	P27918	X	47623172-47630305	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Complement alternate pathway, Immunity, Innate immunity"		"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 106.7;bone marrow: 39.4;lymphoid tissue: 41.3"	"Group enriched"	"Detected in many"	17	"Ito cells: 122.2;Kupffer cells: 303.6;Macrophages: 129.1;monocytes: 486.9"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	9	"classical monocyte: 102.4;intermediate monocyte: 106.7;myeloid DC: 86.2;neutrophil: 64.3;non-classical monocyte: 70.6"	"Group enriched"	"Detected in many"	40	"dendritic cells: 86.2;granulocytes: 64.3;monocytes: 106.7"	"Cell line enhanced"	"Detected in some"		"EFO-21: 21.2;HEL: 4.6;HMC-1: 5.3;NB-4: 10.1;U-937: 7.0"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			HPA072644			Approved	Vesicles	"Secreted to blood"	NA	NA		8500000000	Vesicles		"HPA072644: "	"unprognostic (2.77e-3)"	"unprognostic (2.21e-3)"	"unprognostic (1.00e-1)"	"unprognostic (2.15e-2)"	"unprognostic (4.15e-2)"	"unprognostic (9.66e-5)"	"unprognostic (9.90e-3)"	"unprognostic (1.30e-2)"	"unprognostic (5.37e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.08e-2)"	"unprognostic (2.70e-1)"	"unprognostic (1.97e-2)"	"unprognostic (2.58e-1)"	"unprognostic (1.32e-1)"	"unprognostic (4.62e-2)"	"unprognostic (2.17e-1)"	3.3	1.0	0.7	10.3	0.9	39.4	1.6	0.7	0.6	0.6	2.0	0.2	0.6	0.5	0.7	3.1	1.8	2.5	2.1	4.3	0.6	0.6	1.3	21.6	8.7	41.3	0.4	0.0	0.7	0.4	0.0	0.7	1.6	0.3	0.8	0.4	1.2	3.1	0.6	1.4	1.0	2.1	2.6	0.4	39.3	1.1	0.8	0.0	6.0	0.9	1.3	5.6	2.1	0.9	0.4	86.2	64.3	106.7	1.1	2.1	70.7	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	21.2	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.2	4.6	0.1	0.0	0.1	1.1	5.3	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.1	0.1	0.0	0.2	0.0	10.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	3.2	0.9	0.0	0.0	0.5	0.1	0.4	0.3	0.1	0.1	7.0	0.0	9.0	102.4	3.2	0.2	106.7	0.2	0.4	1.4	0.1	86.2	0.1	2.1	0.7	64.3	1.1	70.6	2.7	1.1	70.7	0.7	0.9	0.7	0.6	0.6	0.6	0.4	0.0	0.3	0.0	0.0	14.5	8.5	0.1	3.5	3.2	0.8	2.5	4.0	4.5	0.0	0.0	0.3	0.0	0.2	0.1	1.0	0.0	0.0	0.6	0.4	1.6	0.2	1.1	1.7	15.7	1.6	0.0	122.2	303.6	0.0	0.9	129.1	5.0	486.9	0.0	0.2	0.4	0.0	1.1	0.4	1.7	0.0	0.9	0.0	0.2	2.6	0.3	3.3	0.6	0.0
CIITA	"C2TA, MHC2TA, NLRA"	ENSG00000179583	"Class II major histocompatibility complex transactivator"	P33076	16	10866222-10943021	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Activator, Acyltransferase, Kinase, Transferase"	"Cancer-related genes, Disease mutation, SCID"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 67.2"	"Cell type enhanced"	"Detected in many"	14	"Alveolar cells type 2: 17.9;Macrophages: 36.9;monocytes: 58.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"HDLM-2: 23.3;REH: 40.9;U-266/70: 8.6;U-698: 12.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB016084, HPA054757"	Enhanced		Supported	Nucleoplasm		NA	NA			Nucleoplasm		"CAB016084: AB_627261, HPA054757: "	"unprognostic (1.45e-3)"	"unprognostic (1.38e-2)"	"unprognostic (8.22e-3)"	"unprognostic (1.12e-2)"	"unprognostic (5.66e-2)"	"unprognostic (2.88e-3)"	"unprognostic (2.92e-2)"	"unprognostic (1.55e-2)"	"unprognostic (1.15e-2)"	"unprognostic (1.85e-1)"	"unprognostic (1.23e-1)"	"unprognostic (3.72e-1)"	"unprognostic (1.64e-2)"	"unprognostic (2.72e-2)"	"unprognostic (6.33e-3)"	"unprognostic (2.74e-1)"	"unprognostic (1.05e-2)"	8.0	5.9	4.6	47.7	7.1	4.3	6.8	1.5	5.5	6.3	3.7	10.6	4.2	10.4	8.1	10.4	4.8	5.2	8.1	4.9	4.7	3.5	8.8	2.9	15.0	27.0	9.4	1.1	2.5	3.5	1.9	4.0	1.2	6.6	5.5	4.3	5.5	13.3	4.3	2.9	4.4	17.4	3.7	15.6	25.9	6.2	1.5	7.4	12.6	6.1	5.2	67.2	6.3	6.8	27.3	19.0	6.5	11.9	0.7	0.5	1.7	0.1	0.2	0.3	0.3	0.1	0.0	0.2	0.1	0.0	0.1	0.1	0.3	5.6	5.1	0.8	0.0	0.9	0.9	0.0	0.0	0.1	23.3	0.3	2.9	1.1	0.6	0.0	0.5	0.4	1.0	0.0	0.1	0.0	0.9	0.0	0.3	0.3	2.0	0.1	0.3	0.2	0.4	0.1	0.2	0.1	40.9	0.3	3.6	0.0	1.7	0.9	0.1	0.9	0.3	0.9	0.3	0.5	1.7	0.3	2.1	0.3	0.6	0.2	8.6	0.6	12.1	7.7	0.5	6.9	0.2	11.9	6.5	0.3	9.5	0.1	17.9	0.1	0.5	17.7	27.3	0.1	0.2	2.8	0.7	10.0	19.0	0.4	1.7	4.6	7.1	1.5	5.5	4.7	3.5	9.4	1.1	6.6	7.4	6.0	17.9	12.3	0.3	2.1	0.6	2.8	2.5	2.7	1.2	3.5	0.0	0.1	0.0	2.5	0.6	4.2	3.4	0.0	1.7	0.2	1.0	0.3	10.4	1.0	9.1	0.0	2.4	2.5	15.6	0.0	0.6	36.9	6.8	58.7	0.7	0.4	1.7	0.0	0.0	3.3	0.9	0.0	0.9	0.0	0.0	2.5	0.1	1.0	0.4	0.3
CKLF	"C32, CKLF1, CKLF3, CKLF4, HSPC224, UCK-1"	ENSG00000217555	"Chemokine like factor"	Q9UBR5	16	66552563-66566251	"Predicted membrane proteins, Predicted secreted proteins"	Chemotaxis	Cytokine		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 142.0"	"Cell type enhanced"	"Detected in many"	5	"granulocytes: 334.0;Macrophages: 289.2;Spermatocytes: 349.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"neutrophil: 142.0"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			HPA062779			Approved	Vesicles	"Secreted to blood"	NA	NA			Vesicles		"HPA062779: AB_2684867"	"unprognostic (1.64e-2)"	"unprognostic (2.17e-2)"	"unprognostic (1.88e-1)"	"unprognostic (4.97e-2)"	"unprognostic (3.06e-1)"	"unprognostic (1.76e-1)"	"prognostic unfavorable (5.67e-5)"	"unprognostic (2.72e-1)"	"unprognostic (3.35e-1)"	"unprognostic (1.79e-2)"	"unprognostic (8.05e-3)"	"unprognostic (1.48e-1)"	"prognostic unfavorable (1.06e-9)"	"unprognostic (2.36e-1)"	"unprognostic (2.65e-1)"	"prognostic favorable (2.22e-4)"	"unprognostic (1.07e-1)"	18.8	21.1	16.1	27.7	16.9	29.9	18.8	19.0	14.9	14.8	20.6	11.0	9.1	15.7	14.8	15.2	12.5	16.4	22.8	11.0	14.9	13.4	15.0	14.6	28.9	41.2	23.1	11.0	14.5	12.0	11.4	13.5	14.6	15.0	14.6	22.0	10.9	13.0	9.7	6.8	9.0	26.5	16.9	20.8	44.4	12.2	42.5	18.6	40.2	12.3	11.7	24.6	17.6	13.0	9.4	32.2	142.0	39.6	17.7	25.6	34.2	35.7	31.9	6.7	19.3	18.1	14.8	4.9	17.9	13.6	19.6	29.3	29.7	43.9	14.1	22.7	15.3	20.5	19.3	13.3	10.7	27.6	17.4	6.7	10.3	28.4	36.3	10.9	32.0	27.8	10.1	8.7	24.4	8.7	23.5	23.3	43.6	16.4	40.7	24.4	11.9	30.9	31.8	2.2	21.1	51.8	53.1	35.4	39.2	65.4	19.9	9.4	11.4	54.8	3.6	16.6	4.7	10.6	21.7	14.2	28.4	25.7	9.8	21.0	19.3	39.7	71.8	23.9	28.2	22.9	64.6	39.6	74.8	20.6	19.8	25.6	9.4	19.2	20.0	32.2	8.8	10.2	14.1	142.0	17.7	18.6	16.3	22.9	34.2	16.1	16.9	19.0	14.9	14.9	13.4	23.1	11.0	15.0	18.6	17.9	66.2	46.2	20.8	24.3	8.2	0.8	101.9	65.6	35.2	54.1	0.0	40.5	14.9	120.7	24.7	44.8	58.0	23.3	113.2	92.3	41.3	13.1	334.0	34.2	227.1	1.6	31.7	66.9	154.7	20.5	45.8	289.2	38.8	30.7	61.5	19.0	153.7	40.3	28.3	75.1	6.4	32.3	33.5	349.8	69.4	20.1	14.5	215.8	65.0	23.3
CLEC10A	"CD301, CLECSF13, CLECSF14, HML, HML2"	ENSG00000132514	"C-type lectin domain containing 10A"	Q8IUN9	17	7074537-7080307	"CD markers, Predicted intracellular proteins, Predicted membrane proteins"	"Adaptive immunity, Endocytosis, Immunity, Innate immunity"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 81.1;lymphoid tissue: 49.3"	"Group enriched"	"Detected in some"	6	"Kupffer cells: 53.6;Macrophages: 176.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Cell type enriched"	"Detected in some"	12	"myeloid DC: 81.1"	"Lineage enriched"	"Detected in many"	12	"dendritic cells: 81.1"	"Cell line enhanced"	"Detected in some"		"HUVEC TERT2: 1.6;NB-4: 4.0"									HPA021937	Approved					NA	NA					"HPA021937: AB_1846905"	"unprognostic (3.96e-3)"	"unprognostic (1.71e-3)"	"unprognostic (2.95e-2)"	"unprognostic (2.04e-3)"	"unprognostic (4.54e-2)"	"prognostic favorable (1.26e-5)"	"unprognostic (1.07e-1)"	"prognostic favorable (9.24e-4)"	"unprognostic (2.70e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.12e-1)"	"unprognostic (2.30e-1)"	"unprognostic (6.12e-2)"	"unprognostic (1.43e-1)"	"prognostic unfavorable (4.22e-4)"	"unprognostic (3.23e-1)"	"unprognostic (3.65e-1)"	12.7	4.0	0.4	14.3	0.5	0.6	6.6	0.4	0.6	4.9	9.7	0.8	1.7	7.9	6.4	31.3	6.9	6.1	12.2	17.5	0.4	0.4	4.4	6.2	22.0	49.3	0.6	0.6	4.1	3.3	0.4	2.0	1.3	2.0	7.2	9.7	3.8	5.0	5.9	6.1	5.1	14.3	9.6	0.9	10.2	4.4	3.7	0.5	5.4	4.7	9.9	10.4	9.8	4.6	0.0	81.1	0.3	6.6	0.3	0.0	3.3	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.3	0.3	0.0	0.0	0.0	4.0	0.0	0.0	0.2	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.3	0.3	0.6	0.0	0.0	0.1	0.0	0.1	0.0	5.5	0.0	0.0	6.6	0.0	0.0	0.0	0.0	81.1	0.0	0.0	0.0	0.3	0.3	0.0	1.6	0.0	3.3	0.4	0.5	0.4	0.6	0.4	0.4	0.6	0.6	2.0	0.5	3.0	3.8	2.2	0.0	11.7	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	1.5	0.0	1.1	0.9	17.9	0.0	0.0	0.6	53.6	0.7	0.3	176.8	20.3	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.0	6.5	3.9	0.0	2.1	10.3	0.1	0.0	0.0	0.0
CLEC2B	"AICL, CLECSF2, HP10085"	ENSG00000110852	"C-type lectin domain family 2 member B"	Q92478	12	9852984-9870136	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 58.7;lymphoid tissue: 56.6"	"Cell type enhanced"	"Detected in many"	6	"Basal keratinocytes: 179.2;Macrophages: 186.4;Suprabasal keratinocytes: 210.5;T-cells: 224.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"neutrophil: 58.7"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC diff: 17.2;ASC TERT1: 27.2;HSkMC: 14.9;U-937: 62.1"									HPA008194	Enhanced				"Intracellular and membrane"	NA	NA					"HPA008194: AB_1078533"	"unprognostic (3.14e-2)"	"unprognostic (4.27e-2)"	"unprognostic (2.14e-2)"	"unprognostic (9.69e-3)"	"unprognostic (4.83e-2)"	"unprognostic (2.51e-1)"	"unprognostic (5.99e-2)"	"unprognostic (4.45e-1)"	"unprognostic (1.79e-1)"	"unprognostic (3.58e-1)"	"unprognostic (1.15e-3)"	"unprognostic (3.50e-1)"	"prognostic unfavorable (5.64e-13)"	"unprognostic (8.09e-2)"	"unprognostic (7.12e-3)"	"unprognostic (5.70e-2)"	"unprognostic (2.79e-1)"	10.8	1.8	2.0	9.1	2.8	29.8	8.2	2.4	3.0	6.3	3.9	2.7	3.4	1.5	7.2	4.4	6.1	3.6	6.0	4.8	2.0	1.3	2.7	4.5	13.1	8.9	3.0	2.0	12.9	2.0	0.2	2.0	4.8	3.2	4.9	3.7	3.4	4.5	2.0	5.7	24.5	4.9	4.0	3.3	12.6	2.2	3.6	2.4	56.6	3.4	3.6	7.6	5.3	7.9	5.6	9.3	58.7	17.3	17.1	19.1	18.6	0.0	0.8	0.0	0.0	17.2	27.2	0.1	0.4	3.3	0.2	0.9	0.0	0.6	0.3	0.2	13.7	10.3	5.1	2.8	0.0	0.1	0.7	0.0	0.9	0.0	0.0	5.7	0.6	0.1	14.9	5.1	0.6	0.1	0.8	8.6	3.6	0.0	2.3	4.0	0.0	5.3	1.2	0.1	0.0	0.5	7.9	0.1	0.0	0.0	5.5	0.0	0.0	0.2	0.0	3.5	0.0	1.3	0.1	11.4	0.1	3.2	0.4	1.6	4.1	0.3	0.6	3.5	62.1	5.0	9.6	10.3	3.7	18.4	14.7	14.6	3.1	11.6	19.1	9.3	5.6	11.1	16.8	58.7	17.1	17.3	3.5	9.3	18.6	2.0	2.8	2.4	3.0	2.0	1.3	3.0	2.0	3.2	2.4	3.0	33.4	35.1	68.5	179.2	0.0	3.1	12.7	4.0	26.1	0.0	0.0	0.7	0.0	3.8	0.2	130.0	0.2	23.3	0.7	1.4	28.8	14.5	52.1	2.6	77.5	0.0	1.7	145.5	124.7	0.7	46.1	186.4	75.9	10.8	0.0	0.4	1.8	0.0	16.6	0.7	0.2	6.5	37.7	0.2	0.5	210.5	1.6	224.3	0.0	126.6
CLEC4A	"CD367, CLECSF6, DCIR, DDB27"	ENSG00000111729	"C-type lectin domain family 4 member A"	Q9UMR7	12	8123632-8138607	"Predicted intracellular proteins, Predicted membrane proteins"	"Adaptive immunity, Host-virus interaction, Immunity, Innate immunity"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 54.6;lung: 30.0"	"Cell type enhanced"	"Detected in many"	18	"Hofbauer cells: 22.3;Kupffer cells: 81.7;Macrophages: 93.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"basophil: 29.2;classical monocyte: 54.6;intermediate monocyte: 31.2;myeloid DC: 53.2;neutrophil: 48.8;non-classical monocyte: 19.6"	"Group enriched"	"Detected in many"	12	"dendritic cells: 53.2;granulocytes: 48.8;monocytes: 54.6"	"Cell line enhanced"	"Detected in many"		"ASC TERT1: 8.4"									HPA007842	Uncertain					NA	NA					"HPA007842: AB_1078534"	"unprognostic (9.13e-2)"	"unprognostic (2.11e-2)"	"unprognostic (1.41e-2)"	"unprognostic (3.13e-2)"	"unprognostic (2.69e-1)"	"unprognostic (9.34e-2)"	"unprognostic (5.49e-2)"	"unprognostic (8.22e-2)"	"unprognostic (1.62e-1)"	"unprognostic (7.84e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.90e-1)"	"unprognostic (1.42e-3)"	"unprognostic (1.42e-1)"	"unprognostic (1.35e-2)"	"unprognostic (3.05e-1)"	"unprognostic (9.79e-2)"	8.3	2.0	2.7	20.1	4.0	14.6	3.3	2.2	2.6	3.7	3.1	3.5	0.6	3.6	2.7	5.2	2.1	2.9	5.6	3.4	2.5	2.5	5.4	4.1	30.0	25.1	2.8	2.4	5.5	2.5	0.5	3.3	6.0	3.2	4.1	4.6	4.0	2.6	2.2	2.2	3.8	4.7	3.3	8.1	16.3	2.0	2.8	3.7	5.7	2.8	3.2	7.4	6.0	3.1	4.5	53.2	48.8	54.6	0.5	0.2	23.7	0.3	0.0	0.7	1.8	3.3	8.4	1.1	2.2	0.9	1.8	2.5	3.0	1.4	1.3	0.3	1.2	0.7	0.4	1.9	0.4	1.1	2.2	2.2	1.4	1.5	0.8	4.1	4.2	5.6	4.2	1.9	0.7	2.3	5.2	0.4	3.0	0.7	1.2	2.3	1.0	1.2	3.1	1.3	1.1	0.8	0.8	1.4	2.1	1.2	2.0	0.3	0.7	0.5	1.6	0.0	2.9	0.2	0.3	0.5	3.1	1.9	1.2	1.4	1.4	0.2	1.7	0.4	1.6	0.1	29.2	54.6	0.1	0.1	31.2	0.1	2.0	0.1	0.2	53.2	4.5	0.1	0.1	48.8	0.5	19.6	7.3	0.1	23.7	2.7	4.0	2.2	2.6	2.5	2.5	2.8	2.4	3.2	3.7	0.0	5.8	5.0	0.6	3.8	0.5	0.8	0.0	4.0	3.4	0.0	3.9	0.2	1.7	0.1	4.1	1.4	0.0	0.0	0.4	0.2	2.2	0.8	2.3	0.9	22.3	0.0	1.7	1.3	81.7	0.9	2.3	93.5	6.8	1.0	0.0	0.4	0.5	0.3	1.4	0.2	0.6	0.0	1.2	0.2	0.5	2.9	0.2	0.5	0.0	0.7
CLEC4E	"CLECSF9, mincle"	ENSG00000166523	"C-type lectin domain family 4 member E"	Q9ULY5	12	8533305-8540963	"Predicted intracellular proteins, Predicted membrane proteins"	"Immunity, Innate immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 81.7;bone marrow: 37.7;lymphoid tissue: 41.2"	"Group enriched"	"Detected in some"	8	"Kupffer cells: 144.8;Macrophages: 65.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	16	"classical monocyte: 22.8;neutrophil: 81.7"	"Group enriched"	"Detected in many"	17	"granulocytes: 81.7;monocytes: 22.8"	"Group enriched"	"Detected in some"	4	"NB-4: 5.8;RPTEC TERT1: 16.3"	"Not detected"	"Not detected"							HPA004935	Uncertain		Uncertain	Cytosol		NA	NA			Cytosol		"HPA004935: AB_2667299"	"unprognostic (3.05e-2)"	"unprognostic (2.01e-2)"	"unprognostic (8.91e-2)"	"unprognostic (3.76e-1)"	"unprognostic (1.76e-1)"	"unprognostic (9.71e-3)"	"unprognostic (1.77e-1)"	"unprognostic (1.24e-1)"	"unprognostic (9.29e-2)"	"unprognostic (1.83e-1)"	"unprognostic (1.16e-1)"	"unprognostic (2.11e-2)"	"unprognostic (7.65e-3)"	"unprognostic (1.62e-1)"	"unprognostic (1.51e-1)"	"unprognostic (8.44e-2)"	"unprognostic (2.29e-1)"	8.4	3.0	1.1	20.9	2.4	37.7	17.5	1.2	2.2	3.4	1.4	0.0	1.1	0.1	1.2	1.6	1.7	4.2	6.7	5.9	1.3	1.2	6.2	3.5	25.6	41.2	2.8	0.6	1.0	3.3	0.0	1.7	1.7	9.0	1.6	0.5	1.1	1.2	0.6	2.7	0.7	1.9	3.2	5.3	34.2	1.8	3.3	0.8	0.7	12.8	0.9	1.1	2.2	2.2	0.0	2.9	81.7	22.8	0.0	0.0	4.5	0.1	0.6	0.4	0.0	0.1	0.2	0.3	0.2	0.0	0.0	0.0	0.2	0.0	0.1	2.0	0.1	0.2	2.6	0.0	0.2	0.1	0.2	0.2	0.0	0.3	0.3	0.3	0.0	0.7	0.1	0.0	1.7	0.1	0.6	0.7	0.1	0.2	0.1	0.0	0.1	0.0	5.8	0.5	0.0	0.1	0.1	0.2	0.1	16.3	0.0	0.0	0.2	0.1	0.0	0.1	0.5	0.0	0.5	1.3	0.6	0.1	1.1	0.1	0.2	0.1	0.1	1.6	0.5	0.1	0.0	22.8	0.0	0.0	3.2	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.0	81.7	0.0	0.1	0.1	0.0	4.5	1.1	2.4	1.2	2.2	1.3	1.2	2.8	0.6	9.0	0.8	0.0	6.6	1.4	0.0	0.0	0.0	0.3	7.6	1.4	3.4	1.8	0.0	0.0	0.0	4.5	0.3	0.4	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.8	5.8	0.0	0.0	11.6	144.8	1.1	0.9	65.6	0.0	0.0	0.0	0.0	0.4	0.0	0.4	0.0	0.0	12.9	0.0	0.2	0.2	0.0	0.1	0.0	0.0	0.0
CLEC5A	"CLECSF5, MDL-1"	ENSG00000258227	"C-type lectin domain containing 5A"	Q9NY25	7	141927357-141947007	"Predicted intracellular proteins, Predicted membrane proteins"	"Host-virus interaction, Immunity, Innate immunity"	"Host cell receptor for virus entry, Receptor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 35.8"	"Group enriched"	"Detected in some"	4	"Hofbauer cells: 18.6;Macrophages: 57.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in some"	8	"classical monocyte: 11.5"	"Lineage enriched"	"Detected in many"	8	"monocytes: 11.5"	"Group enriched"	"Detected in some"	23	"HL-60: 15.2;U-937: 58.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA054137			Supported	"Plasma membrane,Cytosol"		NA	NA			"Plasma membrane, Cytosol"		"HPA054137: AB_2732582"	"unprognostic (6.89e-2)"	"unprognostic (1.07e-1)"	"unprognostic (5.01e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.69e-2)"	"unprognostic (4.56e-2)"	"unprognostic (1.33e-5)"	"unprognostic (4.57e-1)"	"unprognostic (2.59e-1)"	"prognostic unfavorable (2.21e-4)"	"unprognostic (6.58e-3)"	"unprognostic (1.06e-1)"	"unprognostic (1.73e-2)"	"unprognostic (3.00e-2)"	"unprognostic (2.82e-1)"	"unprognostic (7.23e-2)"	"unprognostic (1.64e-1)"	1.4	3.2	1.8	7.3	2.4	35.8	0.8	0.8	2.5	1.7	0.4	1.9	0.6	0.4	0.8	0.5	1.4	1.2	2.0	3.8	7.6	3.1	2.9	2.1	13.9	0.3	2.4	0.5	2.7	2.6	1.4	1.1	2.7	8.2	0.9	0.5	0.8	2.7	0.8	0.3	2.7	0.3	1.5	4.8	2.1	0.4	0.9	4.8	1.1	1.4	4.9	1.4	1.9	1.1	0.0	0.5	1.4	11.5	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	58.7	0.0	0.0	11.5	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	1.4	0.0	0.0	0.3	0.0	1.9	1.8	2.4	0.8	2.5	7.6	3.1	2.4	0.5	8.2	4.8	0.0	7.4	0.0	0.0	1.6	0.0	0.3	2.5	5.3	9.1	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.6	0.0	2.3	0.0	18.6	0.0	0.0	0.0	3.8	0.2	0.0	57.4	1.7	1.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1	1.3	0.2	0.0	0.0	0.0
CMKLR1	RVER1	ENSG00000174600	"Chemerin chemokine-like receptor 1"	Q99788	12	108288044-108339341	"G-protein coupled receptors, Predicted membrane proteins, Transporters"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 42.6"	"Cell type enhanced"	"Detected in some"	20	"Hofbauer cells: 25.9;Kupffer cells: 51.2;Macrophages: 10.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"intermediate monocyte: 11.9;plasmacytoid DC: 15.2"	"Group enriched"	"Detected in many"	31	"dendritic cells: 15.2;monocytes: 11.9;T-cells: 6.3"	"Cell line enhanced"	"Detected in some"		"ASC diff: 7.9;ASC TERT1: 33.3;BJ hTERT+: 23.7;hTERT-RPE1: 8.0;LHCN-M2: 7.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA047865	Uncertain					NA	NA					"HPA047865: AB_2680191"	"unprognostic (1.78e-1)"	"unprognostic (2.61e-2)"	"unprognostic (8.83e-3)"	"unprognostic (7.39e-2)"	"unprognostic (2.44e-1)"	"unprognostic (3.49e-3)"	"unprognostic (1.69e-1)"	"unprognostic (2.94e-2)"	"unprognostic (1.69e-1)"	"unprognostic (6.83e-2)"	"unprognostic (1.06e-1)"	"unprognostic (8.72e-2)"	"unprognostic (2.96e-2)"	"unprognostic (1.77e-1)"	"unprognostic (1.83e-2)"	"unprognostic (5.19e-2)"	"unprognostic (1.14e-1)"	11.3	6.3	2.5	8.5	3.5	0.3	5.1	0.9	3.6	6.7	5.2	5.1	1.7	3.1	9.6	12.0	4.1	5.4	6.4	9.3	2.9	2.3	4.3	7.1	10.5	17.2	5.6	1.5	3.9	3.2	1.6	4.1	18.9	4.0	5.3	6.5	10.7	5.6	3.7	2.9	4.6	5.4	12.1	5.1	42.6	3.4	4.6	4.8	3.2	9.9	5.9	5.8	6.9	3.2	0.0	15.2	0.2	11.9	0.3	6.3	3.1	0.0	0.0	0.1	0.0	7.9	33.3	0.1	0.0	23.7	0.0	0.0	0.0	0.0	0.1	0.8	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.2	0.0	0.0	0.1	8.0	0.4	0.0	0.0	0.0	7.3	0.0	0.0	0.6	0.0	0.0	0.0	0.0	1.0	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.4	0.0	0.2	0.0	0.0	0.0	0.0	0.5	0.0	0.1	0.0	3.2	0.0	6.3	11.9	0.0	0.0	1.0	4.2	0.8	0.0	0.4	3.4	0.2	0.3	2.0	15.2	0.3	3.1	2.5	3.5	0.9	2.6	2.9	2.3	5.6	1.5	4.0	4.8	0.0	0.0	0.9	0.0	0.8	0.0	1.2	0.0	1.4	1.2	0.0	0.0	0.4	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.4	6.2	0.0	0.0	0.0	25.9	0.0	0.0	5.5	51.2	0.0	0.3	10.6	3.3	1.8	0.0	0.0	0.0	0.0	4.9	0.0	0.0	6.5	5.3	0.0	0.0	0.5	0.5	0.0	0.0	0.0
CMTM7	"CKLFSF7, FLJ30992"	ENSG00000153551	"CKLF like MARVEL transmembrane domain containing 7"	Q96FZ5	3	32391671-32483067	"Predicted membrane proteins, Transporters"	Chemotaxis	Cytokine		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	6	"Hofbauer cells: 104.7;Kupffer cells: 102.2;Macrophages: 86.9;monocytes: 120.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 39.8;hTERT-RPE1: 41.0"	"Low region specificity"	"Detected in all"							HPA077409			Approved	"Plasma membrane"		NA	NA			"Plasma membrane"		"HPA077409: AB_2686838"	"unprognostic (2.27e-3)"	"unprognostic (3.16e-2)"	"unprognostic (3.98e-2)"	"unprognostic (1.15e-1)"	"unprognostic (5.42e-2)"	"unprognostic (3.16e-2)"	"prognostic unfavorable (3.21e-4)"	"unprognostic (3.03e-2)"	"unprognostic (3.92e-2)"	"unprognostic (2.60e-1)"	"unprognostic (6.55e-3)"	"unprognostic (1.64e-1)"	"prognostic unfavorable (1.00e-6)"	"unprognostic (5.86e-2)"	"unprognostic (2.51e-1)"	"unprognostic (3.79e-1)"	"unprognostic (3.12e-2)"	14.5	6.5	3.3	18.9	5.7	23.8	43.1	4.5	2.2	10.0	6.2	4.3	11.0	3.1	7.7	12.3	4.8	24.5	14.6	8.3	2.8	2.8	14.8	5.9	25.1	47.5	5.9	1.0	9.3	27.6	0.9	2.8	11.4	4.7	12.8	5.9	6.1	8.7	17.6	4.0	6.4	10.9	7.0	10.3	32.4	8.2	5.8	4.6	45.9	24.5	3.3	23.1	16.5	12.4	10.0	24.8	24.4	47.0	4.9	36.2	22.1	0.1	4.5	9.8	11.9	9.2	9.1	27.9	4.4	5.3	8.0	7.4	5.0	39.8	0.0	13.8	5.3	9.9	5.0	12.1	20.5	7.1	0.0	9.6	5.3	0.0	11.6	37.6	1.3	8.5	9.6	2.7	8.2	13.1	41.0	18.0	0.0	4.4	12.0	5.9	0.1	0.0	12.3	11.8	2.0	20.9	25.6	3.7	24.4	11.3	8.8	0.5	10.2	0.6	0.7	22.8	4.4	6.2	13.8	10.3	7.6	7.6	8.3	15.4	3.4	1.2	0.0	2.7	16.7	15.9	5.5	47.0	24.4	5.3	44.1	3.2	10.0	17.9	10.9	24.8	7.0	19.5	13.5	18.0	4.9	37.2	10.5	36.2	22.1	3.3	5.7	4.5	2.2	2.8	2.8	5.9	1.0	4.7	4.6	23.8	14.7	40.7	17.6	8.8	0.2	1.5	15.3	14.7	23.9	17.4	0.0	19.8	0.0	83.6	0.1	15.7	1.3	23.3	13.6	6.7	16.0	11.2	28.9	1.0	104.7	1.6	16.6	18.4	102.2	1.0	1.4	86.9	23.6	120.0	3.4	1.3	59.3	8.6	1.1	24.0	0.2	6.5	14.5	1.2	7.2	4.8	5.7	43.6	3.0	10.2
COTL1	CLP	ENSG00000103187	"Coactosin like F-actin binding protein 1"	Q14019	16	84565594-84618077	"Plasma proteins, Predicted intracellular proteins"		"Actin-binding, Chaperone"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 206.6;lymphoid tissue: 103.0"	"Cell type enhanced"	"Detected in many"	10	"Extravillous trophoblasts: 1310.7;Hofbauer cells: 547.8;Kupffer cells: 920.9;Macrophages: 713.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"classical monocyte: 110.8;eosinophil: 160.2;intermediate monocyte: 190.1;myeloid DC: 117.3;neutrophil: 86.8;non-classical monocyte: 206.6"	"Group enriched"	"Detected in all"	5	"dendritic cells: 117.3;granulocytes: 160.2;monocytes: 206.6"	"Cell line enhanced"	"Detected in many"		"WM-115: 130.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008918, CAB062328"	Enhanced		Supported	Cytosol		NA	NA		28000000	Cytosol		"CAB062328: AB_2084785, HPA008918: AB_2668176"	"unprognostic (2.93e-2)"	"unprognostic (1.11e-1)"	"unprognostic (3.27e-2)"	"unprognostic (2.38e-1)"	"unprognostic (3.21e-3)"	"unprognostic (8.95e-2)"	"unprognostic (2.43e-1)"	"unprognostic (1.14e-1)"	"unprognostic (7.70e-2)"	"unprognostic (5.99e-2)"	"unprognostic (5.43e-3)"	"unprognostic (1.47e-2)"	"prognostic unfavorable (5.51e-4)"	"unprognostic (1.26e-1)"	"unprognostic (5.48e-2)"	"unprognostic (7.73e-2)"	"unprognostic (3.35e-3)"	28.6	9.9	20.4	68.1	19.5	57.7	13.7	12.4	18.1	7.6	16.5	25.3	2.4	22.0	13.2	8.4	8.2	13.2	18.7	7.2	19.6	24.9	34.3	12.4	26.6	103.0	28.9	8.1	10.8	7.5	5.1	13.1	29.4	23.2	11.8	16.7	30.8	7.7	7.6	5.1	5.1	26.1	16.2	27.8	92.3	29.6	8.0	13.4	33.0	10.1	5.2	62.0	29.3	7.6	28.5	117.3	160.2	206.6	30.8	32.5	108.3	53.9	45.1	103.2	108.9	11.8	32.7	31.1	47.0	30.4	37.1	14.4	61.2	83.8	15.0	14.4	35.3	22.1	27.2	6.3	37.0	37.4	0.1	7.9	28.1	9.5	16.1	33.5	31.5	111.6	26.1	5.9	35.7	32.0	23.3	17.6	33.3	2.6	6.2	22.0	8.7	9.7	19.0	12.7	17.8	46.1	1.0	3.5	0.9	54.4	23.0	16.3	0.8	43.8	10.5	23.4	12.7	7.9	25.7	45.3	53.5	30.4	17.1	34.2	1.2	5.6	12.2	41.8	15.4	130.2	29.6	110.8	160.2	3.6	190.1	4.8	28.5	23.0	21.7	117.3	13.2	10.3	12.1	86.8	30.8	206.6	6.0	32.5	108.3	20.4	19.5	12.4	18.1	19.6	24.9	28.9	8.1	23.2	13.4	3.0	13.5	259.5	72.9	56.3	9.5	4.4	17.8	2.7	6.8	73.3	229.7	114.0	33.2	49.7	5.6	83.4	40.6	0.0	29.3	1310.7	47.3	43.2	143.7	4.2	547.8	23.8	139.8	242.5	920.9	6.9	7.5	713.2	91.1	125.4	65.3	16.9	70.8	14.4	15.2	238.6	41.0	6.5	62.8	2.9	18.1	33.4	144.5	177.7	122.8	153.6
CPVL		ENSG00000106066	"Carboxypeptidase, vitellogenic like"	Q9H3G5	7	28995231-29195451	"Enzymes, Predicted intracellular proteins"		"Carboxypeptidase, Hydrolase, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 111.9;lymphoid tissue: 84.0"	"Cell type enhanced"	"Detected in many"	9	"Hofbauer cells: 263.6;Kupffer cells: 230.2;Macrophages: 292.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"classical monocyte: 95.8;intermediate monocyte: 81.6;myeloid DC: 111.9"	"Group enriched"	"Detected in many"	52	"dendritic cells: 111.9;monocytes: 95.8"	"Cell line enriched"	"Detected in many"	4	"RPTEC TERT1: 131.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB003697, HPA045715, HPA056466"	Enhanced		Supported	"Endoplasmic reticulum"	"Intracellular and membrane"	NA	NA		510000	"Endoplasmic reticulum"		"CAB003697: AB_425990, HPA045715: AB_2679429, HPA056466: AB_2683140"	"unprognostic (4.72e-2)"	"unprognostic (7.08e-2)"	"unprognostic (5.96e-2)"	"prognostic unfavorable (8.56e-6)"	"unprognostic (1.63e-1)"	"unprognostic (2.49e-2)"	"unprognostic (6.85e-3)"	"unprognostic (7.01e-2)"	"unprognostic (1.49e-1)"	"unprognostic (4.98e-2)"	"unprognostic (3.07e-1)"	"unprognostic (4.25e-2)"	"unprognostic (1.56e-2)"	"unprognostic (1.79e-3)"	"unprognostic (2.21e-1)"	"unprognostic (7.46e-3)"	"prognostic unfavorable (4.99e-4)"	19.0	6.2	4.0	15.0	9.1	11.9	7.7	11.6	3.4	9.1	10.0	7.7	4.2	7.6	6.9	20.4	6.4	7.2	10.2	30.2	6.1	4.4	39.1	12.3	13.5	30.5	6.6	2.3	10.1	8.5	0.2	6.1	31.3	20.1	8.4	6.0	15.8	3.5	5.2	7.9	5.1	13.3	8.1	9.7	84.0	4.7	10.6	4.2	29.7	51.9	5.0	8.1	11.0	15.7	0.1	111.9	1.9	95.8	0.5	0.3	74.4	0.2	0.0	3.3	0.0	0.0	0.0	31.5	0.0	0.0	0.3	0.0	9.5	0.0	0.0	15.0	0.1	15.6	0.5	8.4	0.6	0.1	0.0	7.8	10.6	0.1	22.8	0.0	0.0	0.0	0.0	0.9	0.1	0.2	0.0	0.1	4.4	7.1	0.0	0.2	0.0	9.8	0.0	5.2	0.0	2.6	0.0	0.0	0.0	131.9	3.6	1.9	1.5	8.6	20.6	15.9	16.8	2.4	7.9	0.0	0.0	0.1	0.0	1.9	2.9	31.7	0.1	0.0	3.9	3.3	1.0	95.8	0.4	0.2	81.6	0.3	0.1	0.1	0.1	111.9	0.1	0.1	0.1	1.9	0.5	26.0	2.9	0.1	74.4	4.0	9.1	11.6	3.4	6.1	4.4	6.6	2.3	20.1	4.2	6.0	20.2	17.9	1.1	11.1	0.0	63.1	7.6	2.7	4.5	68.0	0.0	103.1	29.9	0.5	15.2	12.6	0.0	0.0	14.2	103.4	14.2	0.2	4.7	0.5	263.6	0.0	1.7	6.7	230.2	6.4	8.6	292.5	10.1	4.6	0.8	0.2	1.2	0.0	2.8	23.9	0.3	0.0	5.7	15.2	103.9	7.8	99.1	0.9	0.9	0.9
CR1	"CD35, KN"	ENSG00000203710	"Complement C3b/C4b receptor 1 (Knops blood group)"	P17927	1	207496147-207641765	"Blood group antigen proteins, CD markers, Plasma proteins, Predicted membrane proteins"	"Complement pathway, Host-virus interaction, Immunity, Innate immunity"	"Blood group antigen, Host cell receptor for virus entry, Receptor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 23.2;lymphoid tissue: 42.3"	"Group enriched"	"Detected in some"	4	"B-cells: 23.8;Erythroid cells: 46.7;Kupffer cells: 50.8;Macrophages: 12.9"	"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in single"			"Group enriched"	"Detected in many"	5	"basophil: 23.2;eosinophil: 9.4;neutrophil: 9.1"	"Lineage enriched"	"Detected in many"	8	"granulocytes: 23.2"	"Group enriched"	"Detected in some"	9	"HL-60: 9.0;HMC-1: 21.1;NB-4: 8.4"									"CAB002491, CAB016271, HPA042455, HPA043579, HPA049348"	Enhanced					NA	NA		27000000			"CAB002491: AB_563553, CAB016271: AB_627040, HPA042455: AB_2678006, HPA043579: AB_2678564, HPA049348: AB_2680723"	"unprognostic (1.74e-1)"	"unprognostic (3.16e-2)"	"unprognostic (2.75e-2)"	"unprognostic (6.12e-2)"	"unprognostic (1.58e-2)"	"unprognostic (7.14e-2)"	"unprognostic (2.84e-1)"	"unprognostic (3.86e-2)"	"unprognostic (2.02e-1)"	"unprognostic (2.80e-1)"	"unprognostic (1.32e-1)"	"unprognostic (1.84e-1)"	"unprognostic (2.29e-3)"	"unprognostic (4.38e-2)"	"unprognostic (3.32e-2)"	"unprognostic (6.45e-2)"	"unprognostic (3.50e-3)"	9.0	1.1	0.6	17.0	0.6	5.8	1.5	0.4	0.5	0.6	1.7	0.2	0.0	0.5	0.7	5.6	1.4	2.2	1.1	8.0	0.6	0.5	2.3	3.8	4.0	42.3	0.6	0.0	1.7	1.2	0.0	0.6	5.5	1.0	1.7	0.7	0.5	1.9	0.0	0.8	0.5	5.1	3.6	0.7	42.0	1.1	0.9	0.1	1.3	0.7	0.0	11.1	3.2	1.3	2.8	0.2	23.2	2.3	0.0	0.6	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	9.0	21.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	8.4	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	23.2	2.3	9.4	0.0	1.4	0.4	2.8	0.6	0.3	0.2	1.4	0.1	0.1	9.1	0.0	1.2	0.0	0.0	0.6	0.6	0.6	0.4	0.5	0.6	0.5	0.6	0.0	1.0	0.1	0.0	6.2	23.8	0.0	0.0	0.0	0.8	0.0	1.4	2.3	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	46.7	0.0	0.1	0.2	0.0	1.1	0.0	8.0	0.0	0.0	0.0	50.8	0.0	0.0	12.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0
CREB5	"CRE-BPA, H_GS165L15.1"	ENSG00000146592	"CAMP responsive element binding protein 5"	Q02930	7	28299321-28825894	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 53.3;brain: 38.0"	"Cell type enhanced"	"Detected in many"	7	"Basal glandular cells: 116.6;Macrophages: 74.2;monocytes: 74.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	7	"neutrophil: 53.3"	"Lineage enriched"	"Detected in many"	7	"granulocytes: 53.3"	"Cell line enhanced"	"Detected in many"		"HL-60: 32.2;Karpas-707: 13.5;U-2 OS: 14.2;U-2197: 15.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA050020, HPA061622"			Approved	"Nucleoplasm,Vesicles,Plasma membrane"		NA	Yes			Nucleoplasm	"Vesicles, Plasma membrane"	"HPA050020: AB_2680993, HPA061622: AB_2684569"	"unprognostic (3.59e-2)"	"unprognostic (3.80e-1)"	"unprognostic (1.06e-1)"	"unprognostic (6.46e-2)"	"unprognostic (1.01e-1)"	"unprognostic (4.90e-3)"	"unprognostic (2.01e-3)"	"unprognostic (2.87e-1)"	"unprognostic (3.31e-1)"	"unprognostic (1.04e-1)"	"unprognostic (3.49e-1)"	"unprognostic (2.67e-1)"	"unprognostic (4.91e-3)"	"unprognostic (6.61e-2)"	"unprognostic (3.95e-1)"	"unprognostic (1.60e-1)"	"unprognostic (1.52e-3)"	20.0	3.6	12.1	15.4	19.5	11.5	9.0	10.4	17.8	4.6	5.6	38.0	0.9	2.8	16.3	6.9	7.7	4.7	23.1	10.4	16.7	8.7	6.6	4.6	9.5	6.1	17.9	12.1	2.4	7.0	1.5	2.8	19.5	18.3	3.1	4.3	1.1	6.5	3.0	6.2	5.5	4.2	9.8	14.6	12.6	3.2	2.3	22.7	0.0	3.8	7.0	2.5	5.5	5.0	0.3	4.8	53.3	7.8	0.0	0.0	1.5	0.0	0.3	3.9	0.2	0.2	5.7	0.1	0.3	0.8	2.4	3.6	2.2	1.4	9.9	0.7	0.9	2.4	0.4	0.1	3.4	7.6	0.0	2.7	10.7	2.1	0.2	0.2	32.2	0.4	0.7	0.7	10.2	11.0	0.5	1.6	0.0	1.2	13.5	0.8	0.0	0.0	0.0	4.9	0.0	3.9	0.2	3.7	0.2	4.9	1.0	0.4	2.8	0.1	0.2	1.1	5.7	0.1	0.7	0.4	4.7	14.2	15.5	4.5	0.8	2.2	0.1	5.2	0.2	8.0	0.0	7.8	0.0	0.0	2.7	0.0	0.3	0.0	0.0	4.8	0.0	0.0	0.0	53.3	0.0	0.8	0.0	0.0	1.5	12.1	19.5	10.4	15.6	16.7	8.7	17.9	12.1	18.3	22.7	6.0	11.1	4.5	116.6	19.5	0.0	14.1	22.9	5.3	6.8	12.2	0.0	2.5	1.7	61.9	0.4	14.9	0.0	0.0	23.7	9.2	31.3	32.4	13.9	0.5	8.1	4.8	0.0	7.4	46.4	1.1	5.5	74.2	28.7	74.9	0.0	16.6	30.3	0.0	0.4	18.3	0.6	19.4	10.7	12.5	3.3	11.5	20.7	1.3	0.0	28.7
CSF1R	"C-FMS, CD115, CSFR, FMS"	ENSG00000182578	"Colony stimulating factor 1 receptor"	P07333	5	150053291-150113372	"Cancer-related genes, CD markers, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, RAS pathway related proteins"	"Immunity, Inflammatory response, Innate immunity"	"Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Disease mutation, FDA approved drug targets, Neurodegeneration, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 82.5;lymphoid tissue: 82.6"	"Group enriched"	"Detected in many"	8	"Extravillous trophoblasts: 97.9;Hofbauer cells: 277.3;Kupffer cells: 200.7;Macrophages: 125.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"intermediate monocyte: 60.7;non-classical monocyte: 82.5"	"Lineage enriched"	"Detected in many"	4	"monocytes: 82.5"	"Group enriched"	"Detected in some"	5	"BEWO: 51.8;SK-BR-3: 19.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB008970, HPA012323"	Uncertain		Supported	"Vesicles,Plasma membrane"	"Intracellular and membrane"	NA	NA		1500000000	"Vesicles, Plasma membrane"		"CAB008970: , HPA012323: AB_1848977"	"unprognostic (3.82e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.86e-3)"	"unprognostic (9.83e-2)"	"unprognostic (1.20e-1)"	"unprognostic (7.33e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.45e-1)"	"unprognostic (9.37e-2)"	"unprognostic (1.11e-2)"	"unprognostic (2.49e-1)"	"unprognostic (1.65e-1)"	"prognostic unfavorable (1.08e-4)"	"unprognostic (3.67e-2)"	"prognostic unfavorable (4.92e-4)"	"unprognostic (1.72e-2)"	"unprognostic (4.61e-2)"	20.9	12.4	18.2	28.1	18.9	1.8	7.7	2.8	13.5	9.3	8.3	25.4	1.1	9.2	5.9	13.1	8.4	7.9	16.1	8.7	16.4	13.7	7.8	15.1	13.7	25.4	21.3	6.0	5.3	5.2	5.9	6.4	52.1	17.1	8.5	8.4	16.8	8.0	8.7	3.0	5.8	14.5	16.2	25.8	82.6	9.0	4.9	23.0	3.1	4.2	2.9	8.2	16.4	4.7	0.0	19.1	2.9	82.5	0.0	0.1	13.9	1.7	0.0	0.0	0.0	0.8	0.2	51.8	0.1	0.0	0.0	0.0	1.5	0.0	2.4	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	1.1	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.7	0.2	0.0	0.0	0.0	0.1	0.0	19.8	0.0	0.8	0.0	7.4	0.0	0.3	0.0	0.0	1.3	0.0	0.1	0.0	2.6	0.9	0.0	0.4	18.1	0.5	0.1	60.7	0.0	0.0	0.0	0.0	19.1	0.0	0.0	0.0	2.9	0.0	82.5	1.4	0.0	13.9	18.2	18.9	2.8	13.4	16.4	13.7	21.3	6.0	17.1	23.0	0.0	6.7	0.5	0.0	2.5	0.0	2.8	5.1	1.4	0.0	0.0	0.0	2.9	0.0	0.0	3.7	2.2	0.0	0.0	0.0	97.9	3.3	0.0	2.3	0.8	277.3	0.0	0.0	4.9	200.7	3.5	1.7	125.7	3.3	1.8	0.0	0.0	0.1	0.0	0.0	0.0	0.4	12.9	1.3	0.5	0.2	1.1	22.1	2.2	0.0	0.0
CSF2RB	"betaGMR, CD131, IL3RB, IL5RB"	ENSG00000100368	"Colony stimulating factor 2 receptor beta common subunit"	P32927	22	36913628-36940449	"CD markers, Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		Receptor	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 53.1;placenta: 73.6"	"Cell type enhanced"	"Detected in many"	12	"Extravillous trophoblasts: 32.6;granulocytes: 87.9;Macrophages: 41.6;monocytes: 29.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	6	"basophil: 53.1;neutrophil: 20.1"	"Lineage enriched"	"Detected in many"	14	"granulocytes: 53.1"	"Group enriched"	"Detected in some"	6	"HEL: 27.0;HMC-1: 84.6"					"Low region specificity"	"Detected in all"			HPA078677			Approved	"Golgi apparatus"		NA	NA			"Golgi apparatus"		"HPA078677: AB_2732389"	"unprognostic (1.67e-2)"	"unprognostic (9.44e-3)"	"unprognostic (1.03e-2)"	"unprognostic (6.66e-3)"	"unprognostic (1.51e-1)"	"prognostic favorable (7.47e-5)"	"unprognostic (1.86e-1)"	"unprognostic (1.94e-2)"	"unprognostic (4.38e-1)"	"unprognostic (9.57e-2)"	"unprognostic (1.33e-1)"	"unprognostic (3.21e-1)"	"unprognostic (1.82e-3)"	"unprognostic (5.76e-2)"	"unprognostic (3.65e-2)"	"unprognostic (1.95e-1)"	"unprognostic (8.52e-2)"	8.5	1.8	1.5	28.9	1.5	21.7	6.0	0.6	1.0	3.0	5.9	2.0	0.4	4.5	2.2	2.8	4.0	3.6	5.5	4.2	1.4	1.4	2.4	3.5	12.6	34.1	2.9	0.2	2.5	1.9	0.3	1.2	73.6	2.4	3.5	3.8	2.8	9.7	1.0	2.6	3.8	10.2	3.0	2.9	25.2	3.9	2.1	1.9	8.2	3.4	4.8	30.5	8.2	4.3	0.4	3.8	53.1	2.1	0.0	0.6	1.8	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	6.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.0	0.0	27.0	0.0	0.0	0.0	0.4	84.6	0.0	0.0	0.0	0.0	0.0	4.8	0.0	0.0	3.2	0.0	0.0	0.0	2.8	0.0	0.0	0.0	2.7	0.0	10.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	2.4	0.1	0.2	0.0	0.0	0.0	0.4	0.2	1.7	0.0	3.9	0.0	53.1	1.9	5.8	0.0	2.1	0.0	0.4	0.0	0.0	1.2	0.3	0.0	0.0	20.1	0.0	1.7	3.8	0.6	1.8	1.5	1.5	0.6	1.0	1.4	1.4	2.9	0.2	2.4	1.9	0.0	14.5	8.2	0.0	6.4	0.0	0.8	5.1	5.3	3.4	0.0	0.0	2.2	0.0	0.0	11.1	9.0	0.0	0.0	0.2	32.6	4.1	0.0	87.9	0.0	16.8	0.0	0.0	4.3	26.0	26.5	0.0	41.6	11.8	29.7	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.5	0.0	0.0	5.5	13.8	1.3	0.0	0.0
CSGALNACT2	"GALNACT-2, GALNACT2, MGC40204, PRO0082"	ENSG00000169826	"Chondroitin sulfate N-acetylgalactosaminyltransferase 2"	Q8N6G5	10	43138486-43185308	"Enzymes, Predicted intracellular proteins"		Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 80.6"	"Cell type enhanced"	"Detected in many"	5	"Kupffer cells: 62.0;Macrophages: 59.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"hTERT-HME1: 37.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA031540	Approved		Approved	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"HPA031540: AB_10599943"	"unprognostic (1.65e-1)"	"unprognostic (2.70e-2)"	"unprognostic (9.10e-2)"	"unprognostic (6.41e-2)"	"unprognostic (1.95e-1)"	"unprognostic (8.28e-3)"	"unprognostic (2.85e-3)"	"unprognostic (4.95e-2)"	"unprognostic (2.96e-1)"	"unprognostic (3.43e-3)"	"unprognostic (7.65e-2)"	"unprognostic (1.90e-1)"	"prognostic unfavorable (3.53e-7)"	"unprognostic (2.68e-2)"	"unprognostic (1.40e-1)"	"unprognostic (2.47e-1)"	"unprognostic (4.05e-3)"	18.3	8.2	9.0	16.4	13.0	80.6	11.5	10.0	10.9	11.4	12.5	17.6	4.8	6.8	14.7	7.5	9.8	12.8	18.4	11.5	10.0	9.0	8.2	11.3	24.0	25.7	11.0	6.2	16.2	6.3	7.8	15.0	18.3	11.5	10.4	8.9	19.8	7.9	8.6	12.5	8.1	9.6	15.7	14.4	21.1	8.7	6.7	9.6	24.3	9.2	6.6	12.2	17.8	11.0	2.5	11.6	15.2	16.3	8.7	6.3	5.1	4.9	3.3	6.2	5.9	9.7	16.4	1.5	18.1	24.4	8.0	12.5	1.1	5.1	8.2	4.5	16.3	3.8	4.6	5.1	6.8	13.1	9.8	3.8	4.3	3.1	3.4	21.2	9.9	9.0	16.3	7.5	17.8	37.3	10.1	10.2	12.5	1.8	24.7	16.3	2.6	7.5	5.9	2.7	1.7	4.3	4.7	6.2	3.4	7.1	2.6	5.6	11.1	4.7	4.8	11.3	5.6	6.4	8.2	15.0	6.9	10.9	21.5	12.1	6.4	8.9	4.4	14.6	24.3	3.2	10.7	9.8	15.2	6.3	11.4	5.5	2.5	4.9	4.9	11.6	2.2	5.8	4.8	9.0	8.7	16.3	3.4	5.6	5.1	9.0	13.0	10.0	10.9	10.0	9.0	11.0	6.2	11.5	9.6	14.9	16.0	7.2	10.1	15.8	11.9	9.2	2.5	6.7	14.8	10.4	9.8	1.9	0.0	5.4	2.1	14.0	1.4	0.0	6.0	5.6	26.7	10.2	46.2	10.4	15.8	7.9	8.6	14.1	62.0	0.4	15.8	59.7	8.5	7.2	2.1	4.4	9.8	1.7	11.7	3.4	8.3	25.8	25.1	11.7	17.2	10.7	1.3	32.8	1.6	6.0
CST3		ENSG00000101439	"Cystatin C"	P01034	20	23626706-23638473	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted secreted proteins"		"Protease inhibitor, Thiol protease inhibitor"	"Age-related macular degeneration, Amyloidosis, Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	5	"Kupffer cells: 3433.6;Macrophages: 4110.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	7	"classical monocyte: 163.9;intermediate monocyte: 211.0;myeloid DC: 269.6;non-classical monocyte: 135.1;plasmacytoid DC: 153.5"	"Group enriched"	"Detected in many"	9	"dendritic cells: 269.6;monocytes: 211.0"	"Cell line enhanced"	"Detected in many"		"ASC diff: 163.2;ASC TERT1: 111.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000118, HPA013143"	Enhanced		Supported	"Golgi apparatus,Vesicles"	"Secreted to blood"	NA	NA	1040000000	4100000000	"Golgi apparatus, Vesicles"		"CAB000118: , HPA013143: AB_1847417"	"unprognostic (3.89e-2)"	"unprognostic (1.63e-1)"	"unprognostic (1.45e-1)"	"prognostic favorable (1.83e-4)"	"unprognostic (8.53e-2)"	"unprognostic (4.06e-2)"	"unprognostic (2.10e-2)"	"unprognostic (2.18e-2)"	"unprognostic (3.46e-2)"	"unprognostic (3.72e-1)"	"unprognostic (2.29e-3)"	"unprognostic (3.51e-2)"	"unprognostic (1.85e-1)"	"unprognostic (1.16e-1)"	"unprognostic (2.97e-1)"	"unprognostic (5.01e-2)"	"prognostic favorable (8.77e-4)"	95.8	72.6	229.0	37.9	254.7	22.2	68.6	61.4	196.7	76.6	78.2	75.4	39.5	59.4	47.6	143.6	73.8	64.9	89.4	79.7	157.4	96.2	35.9	67.3	58.0	91.2	148.3	90.6	51.4	142.1	34.5	45.6	25.8	69.9	55.2	66.1	195.0	338.2	74.2	44.2	44.9	77.9	57.3	73.3	85.5	105.5	57.4	68.4	40.7	43.2	40.1	31.9	49.4	50.2	0.6	269.6	27.4	211.0	6.4	2.4	106.7	12.9	29.3	6.9	15.8	163.2	111.7	12.8	22.5	31.4	15.5	12.6	55.8	20.0	0.0	21.2	30.7	20.1	43.9	6.3	45.0	4.8	0.0	21.7	13.3	5.8	94.7	58.4	0.6	22.3	86.4	37.9	20.8	22.3	32.8	24.2	1.6	12.1	0.3	21.5	20.6	0.1	14.0	9.2	41.0	64.4	0.5	8.4	17.8	63.6	29.3	7.5	8.6	16.4	4.9	28.0	10.4	13.9	48.7	60.9	14.7	10.6	20.5	8.4	13.9	0.5	0.1	12.5	29.1	16.5	1.4	163.9	1.0	2.4	211.0	0.9	0.6	0.6	1.6	269.6	0.5	0.6	1.2	27.4	6.4	135.1	153.5	0.4	106.7	229.0	254.7	61.4	196.7	157.4	96.2	148.3	90.6	69.9	68.4	107.2	165.4	122.1	459.0	837.5	35.4	213.0	1645.8	65.6	135.4	608.9	27.5	429.7	351.5	407.3	34.7	720.9	2161.2	23.3	692.7	269.5	1051.9	864.5	358.3	2073.4	1660.2	46.1	847.5	528.5	3433.6	95.9	1974.8	4110.2	1482.9	256.1	1276.0	130.5	997.4	2367.2	1683.0	939.5	34.6	2160.2	727.9	82.7	461.4	718.5	392.2	90.0	866.3	802.3
CTSC	"DPP1, PALS, PLS"	ENSG00000109861	"Cathepsin C"	P53634	11	88293592-88337787	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"Hydrolase, Protease, Thiol protease"	"Disease mutation, Palmoplantar keratoderma"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 218.6"	"Cell type enhanced"	"Detected in many"	11	"Cytotrophoblasts: 362.7;Hofbauer cells: 897.2;Macrophages: 364.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"BJ hTERT+: 111.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"CAB025364, HPA066610, HPA068434"	Enhanced		Supported	Vesicles	"Intracellular and membrane"	No	No		19000000	Vesicles		"CAB025364: , HPA066610: AB_2685694, HPA068434: AB_2685989"	"unprognostic (4.05e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.50e-1)"	"unprognostic (1.10e-1)"	"unprognostic (3.70e-2)"	"unprognostic (1.45e-2)"	"prognostic unfavorable (9.30e-5)"	"unprognostic (1.62e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.56e-2)"	"unprognostic (3.11e-2)"	"unprognostic (3.35e-1)"	"prognostic favorable (4.80e-4)"	"unprognostic (2.93e-1)"	"unprognostic (4.35e-2)"	"unprognostic (8.10e-2)"	"unprognostic (4.07e-2)"	40.7	20.5	6.7	44.5	10.6	12.0	35.3	1.5	5.6	14.0	25.3	7.1	6.2	20.4	16.1	24.0	21.8	16.7	36.6	53.3	6.8	6.5	62.7	18.1	110.1	218.6	12.5	3.6	11.0	24.8	3.8	17.3	43.4	9.4	13.8	33.1	27.0	35.1	5.8	10.0	11.7	28.5	14.2	14.6	86.6	13.5	10.8	9.2	19.5	17.7	25.3	30.0	30.2	16.9	8.5	75.9	52.5	92.6	34.7	42.4	31.2	11.1	11.5	4.5	9.4	12.1	32.9	30.1	76.8	111.7	43.9	31.7	31.1	51.7	17.4	40.9	41.7	10.1	18.1	7.0	32.5	35.0	30.7	12.7	22.7	31.8	35.0	16.2	28.9	15.4	45.8	23.0	33.8	69.4	37.0	43.1	16.9	20.6	21.1	5.3	2.1	13.0	39.9	23.5	75.5	35.6	17.0	4.7	30.9	56.4	18.8	1.2	9.4	12.9	17.1	10.0	27.9	3.8	19.8	20.9	3.0	27.2	20.9	48.8	8.9	12.8	17.7	7.9	60.9	16.6	12.5	32.5	52.5	42.4	69.3	36.5	8.5	19.5	37.8	35.1	4.6	9.9	23.8	37.2	34.7	92.6	75.9	28.4	31.2	6.7	10.6	1.5	5.6	6.8	6.5	12.5	3.6	9.4	9.2	20.8	83.9	64.9	5.0	26.8	1.0	2.5	56.0	80.3	93.3	38.4	0.0	362.7	24.9	14.0	1.2	41.8	29.0	0.0	79.6	130.7	85.3	3.1	72.8	14.0	897.2	0.0	10.9	24.5	290.2	4.0	183.8	364.2	45.5	139.7	15.7	0.6	35.1	69.1	24.1	150.6	0.6	58.2	183.3	3.0	11.5	23.7	190.1	167.5	36.3	14.2
CTSS		ENSG00000163131	"Cathepsin S"	P25774	1	150730196-150765957	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 171.4;lymphoid tissue: 111.4"	"Cell type enhanced"	"Detected in many"	13	"Hofbauer cells: 672.3;Kupffer cells: 1992.4;Macrophages: 1161.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	7	"classical monocyte: 171.4;intermediate monocyte: 151.2;myeloid DC: 43.5;neutrophil: 94.5;non-classical monocyte: 138.5"	"Group enriched"	"Detected in all"	9	"dendritic cells: 43.5;granulocytes: 94.5;monocytes: 171.4"	"Cell line enhanced"	"Detected in many"		"CAPAN-2: 21.6;HMC-1: 51.4;U-698: 109.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000460, HPA002988"	Supported		Approved	Vesicles	"Intracellular and membrane"	NA	NA		19000000	Vesicles		"CAB000460: , HPA002988: AB_1078409"	"unprognostic (7.81e-2)"	"unprognostic (9.04e-2)"	"unprognostic (3.23e-2)"	"unprognostic (3.93e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.12e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.59e-1)"	"unprognostic (6.00e-3)"	"unprognostic (1.46e-1)"	"unprognostic (3.89e-1)"	"unprognostic (6.24e-2)"	"unprognostic (7.50e-2)"	"unprognostic (4.14e-2)"	"unprognostic (2.13e-1)"	"unprognostic (2.47e-3)"	41.6	9.3	6.8	32.3	10.3	30.3	9.7	1.9	6.2	4.7	32.9	6.6	5.6	19.6	3.7	12.9	8.8	10.7	15.9	17.3	6.4	5.1	9.6	21.5	55.8	99.5	12.6	2.3	7.6	6.4	0.4	3.4	14.4	9.3	7.5	33.4	6.5	12.9	3.3	3.5	3.8	38.0	6.8	17.1	111.4	13.8	3.8	9.5	12.9	7.6	4.6	22.8	21.5	5.3	11.1	43.5	94.5	171.4	3.3	5.6	145.4	1.0	3.3	0.0	0.0	0.4	0.3	0.3	0.0	3.3	0.2	0.6	0.0	21.6	14.9	1.6	0.1	6.1	0.4	0.0	0.1	0.0	8.3	0.0	6.5	0.1	0.0	0.0	8.9	51.4	0.6	0.0	1.9	0.1	0.1	1.2	0.0	0.6	13.0	0.4	0.0	0.0	6.3	0.0	0.0	0.0	3.7	1.2	18.2	4.0	3.2	0.0	0.1	0.2	0.9	0.3	0.0	0.0	18.2	1.8	1.3	0.2	0.0	0.3	9.0	0.8	109.3	7.6	9.6	0.8	1.2	171.4	16.5	3.2	151.2	3.9	11.1	3.9	3.8	43.5	10.2	3.9	3.6	94.5	3.3	138.5	9.4	5.6	145.4	6.8	10.3	1.9	6.2	6.4	5.1	12.6	2.3	9.3	9.5	101.3	167.2	252.8	20.8	15.0	2.0	3.0	84.1	518.0	134.2	40.1	11.8	3.1	0.0	145.4	5.3	35.1	277.5	0.0	157.6	3.9	26.3	16.7	100.8	19.5	672.3	0.0	40.9	64.4	1992.4	1.7	4.9	1161.7	54.0	251.5	198.9	0.3	150.7	378.7	2.1	4.2	4.1	19.4	7.6	0.2	0.4	13.6	5.1	117.4	149.8	109.8
CTSZ	CTSX	ENSG00000101160	"Cathepsin Z"	Q9UBR2	20	58995185-59007247	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	11	"Hofbauer cells: 945.4;Macrophages: 462.5;monocytes: 1072.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"classical monocyte: 3.2;intermediate monocyte: 2.7;memory B-cell: 1.0;myeloid DC: 3.9;naive B-cell: 1.9;neutrophil: 3.5;non-classical monocyte: 2.9;plasmacytoid DC: 2.2"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"fHDF/TERT166: 119.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"CAB025114, HPA049876, HPA053504"	Supported		Supported	Vesicles	"Intracellular and membrane"	NA	NA		85000000	Vesicles		"CAB025114: , HPA049876: AB_2680927, HPA053504: AB_2682172"	"unprognostic (7.30e-2)"	"unprognostic (3.98e-2)"	"unprognostic (4.07e-2)"	"unprognostic (1.11e-3)"	"unprognostic (8.25e-3)"	"unprognostic (1.15e-1)"	"unprognostic (4.12e-2)"	"unprognostic (6.59e-2)"	"unprognostic (1.59e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.33e-1)"	"unprognostic (5.33e-2)"	"prognostic unfavorable (5.72e-5)"	"unprognostic (1.96e-1)"	"unprognostic (6.92e-2)"	"unprognostic (1.19e-1)"	"unprognostic (2.04e-1)"	70.7	27.9	12.4	40.8	20.4	20.7	51.2	14.6	13.5	25.4	52.8	16.0	19.9	40.8	20.6	25.5	20.1	20.7	22.3	50.1	9.8	13.3	34.9	83.7	54.3	61.2	18.8	10.5	29.7	29.0	30.6	27.6	38.6	19.2	28.8	37.8	31.5	40.3	17.7	20.7	12.9	63.6	26.4	22.1	56.5	19.2	13.8	14.9	18.4	42.4	17.5	35.8	29.8	21.5	1.9	3.9	3.5	3.2	0.3	0.6	0.8	27.6	21.5	0.0	0.0	25.4	29.2	15.2	45.5	50.4	34.9	31.2	41.5	46.5	15.2	30.2	119.6	0.0	22.1	13.7	43.1	23.9	48.6	1.8	13.9	34.8	0.0	26.6	1.6	48.4	24.8	26.0	15.2	18.2	11.6	55.2	0.0	10.0	7.7	23.3	0.0	0.1	15.0	1.7	12.1	21.5	0.3	0.1	18.2	25.5	6.5	0.4	0.3	35.4	41.0	0.1	14.2	18.9	23.6	60.6	0.0	23.6	30.7	0.2	36.7	22.3	2.9	0.4	33.5	0.0	0.0	3.2	0.3	0.6	2.7	0.0	1.0	0.4	0.1	3.9	1.9	0.4	0.1	3.5	0.3	2.9	2.2	0.2	0.8	12.4	20.4	14.6	13.5	9.8	13.3	18.8	10.5	19.2	14.9	14.9	4.0	130.0	51.2	44.8	4.6	17.5	53.5	8.1	5.7	68.0	0.0	34.5	19.9	168.0	2.8	62.8	285.7	23.3	37.2	91.0	58.0	41.9	10.4	307.7	945.4	11.1	26.0	44.2	260.7	3.3	12.0	462.5	96.2	1072.2	50.0	45.9	72.3	98.2	13.1	68.2	4.9	45.3	59.0	1.7	4.5	36.3	34.6	29.9	76.8	46.2
CXCL10	"C7, crg-2, gIP-10, IFI10, INP10, IP-10, mob-1, SCYB10"	ENSG00000169245	"C-X-C motif chemokine ligand 10"	P02778	4	76021117-76023497	"Cancer-related genes, Plasma proteins, Predicted secreted proteins"	"Chemotaxis, Inflammatory response"	Cytokine	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 36.2;lymphoid tissue: 34.8;prostate: 34.6"	"Cell type enhanced"	"Detected in some"	12	"Basal glandular cells: 9.7;Glandular cells: 10.1;Hofbauer cells: 18.2;Macrophages: 18.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	10	"classical monocyte: 10.6;intermediate monocyte: 25.5;non-classical monocyte: 15.9"	"Lineage enriched"	"Detected in many"	15	"monocytes: 25.5"	"Cell line enhanced"	"Detected in some"		"BJ hTERT+: 9.2;BJ hTERT+ SV40 Large T+: 3.4;BJ hTERT+ SV40 Large T+ RasG12V: 3.4;GAMG: 7.9;RPMI-8226: 6.3;RT4: 3.6;THP-1: 4.4"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"								"Secreted to blood"	NA	NA	253000					"unprognostic (1.94e-1)"	"unprognostic (5.32e-2)"	"unprognostic (9.98e-3)"	"unprognostic (6.30e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.35e-2)"	"unprognostic (1.02e-1)"	"unprognostic (2.51e-1)"	"unprognostic (7.59e-2)"	"prognostic favorable (1.12e-5)"	"prognostic unfavorable (4.61e-4)"	"unprognostic (2.75e-1)"	"prognostic unfavorable (1.16e-6)"	"unprognostic (1.03e-1)"	"unprognostic (4.95e-2)"	"unprognostic (1.73e-2)"	"unprognostic (1.66e-2)"	4.3	2.1	2.7	34.8	2.5	0.0	7.3	1.8	4.8	8.1	3.5	0.9	0.2	3.8	2.3	6.7	4.7	1.2	3.8	7.6	1.2	1.2	7.5	10.6	36.2	21.7	3.2	1.6	3.9	1.2	0.0	2.3	5.6	3.0	34.6	6.0	2.6	9.1	2.1	7.3	2.1	4.1	5.5	11.3	15.8	6.4	1.3	0.9	15.0	25.7	5.4	9.2	9.2	2.2	0.5	1.6	0.6	25.5	0.0	0.1	3.7	0.7	0.0	0.0	0.3	0.0	0.2	0.0	0.0	9.2	3.4	3.4	0.3	0.1	3.0	0.3	0.0	7.9	0.0	0.0	0.2	0.2	2.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.6	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	6.3	0.1	3.6	0.0	0.0	0.0	0.7	2.0	0.0	0.2	4.4	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.5	0.0	0.8	0.0	0.0	10.6	0.0	0.0	25.5	0.0	0.5	0.1	0.0	1.6	0.0	0.0	0.0	0.6	0.0	15.9	0.0	0.0	3.7	2.7	2.5	1.8	4.8	1.2	1.2	3.2	1.6	3.0	0.9	0.0	2.1	0.5	9.7	0.8	0.0	0.3	0.0	1.4	0.0	0.0	0.0	0.1	0.0	0.0	1.9	0.0	1.1	0.0	0.0	0.0	0.8	10.1	1.1	0.0	18.2	0.0	0.0	0.0	5.6	3.5	0.3	18.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	1.4
CXCL3	"CINC-2b, GRO3, GROg, MIP-2b, SCYB3"	ENSG00000163734	"C-X-C motif chemokine ligand 3"	P19876	4	74036589-74038807	"Plasma proteins, Predicted secreted proteins"	"Chemotaxis, Inflammatory response"	Cytokine		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 28.5"	"Cell type enhanced"	"Detected in many"	12	"Macrophages: 757.6"	"Cancer enhanced"	"Detected in many"		"colorectal cancer: 23.4"	"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in single"		"non-classical monocyte: 1.0"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"BJ hTERT+: 23.2;hTEC/SVTERT24-B: 36.5;RPTEC TERT1: 21.0"														"Secreted to blood"	NA	NA	28700					"unprognostic (2.12e-3)"	"prognostic unfavorable (2.33e-4)"	"unprognostic (1.08e-3)"	"unprognostic (6.97e-3)"	"unprognostic (2.41e-2)"	"unprognostic (2.74e-1)"	"unprognostic (5.80e-4)"	"unprognostic (2.45e-2)"	"unprognostic (2.24e-1)"	"unprognostic (2.68e-1)"	"unprognostic (9.69e-2)"	"unprognostic (1.81e-1)"	"unprognostic (2.89e-6)"	"unprognostic (2.61e-3)"	"unprognostic (1.31e-1)"	"unprognostic (1.13e-2)"	"unprognostic (1.20e-1)"	18.8	0.6	1.7	16.5	1.2	10.3	4.3	0.2	1.2	19.6	3.3	1.0	0.4	0.5	0.7	2.2	1.3	1.7	9.2	7.2	1.3	0.8	1.7	3.2	28.5	1.8	2.0	1.0	4.9	3.1	0.0	0.6	1.5	3.0	2.3	7.9	0.8	4.4	0.9	2.3	0.6	2.8	1.2	2.2	5.3	10.3	1.6	0.6	2.7	0.8	2.7	1.9	11.7	0.5	0.0	0.5	0.4	1.0	0.0	0.4	2.4	0.2	1.7	0.7	0.0	0.4	0.7	0.0	2.5	23.2	0.6	1.4	0.0	2.8	0.0	2.5	0.0	8.6	0.1	0.1	0.8	5.1	0.0	0.0	1.9	0.2	0.0	2.8	0.2	0.0	0.5	0.6	36.5	3.6	0.6	0.5	0.4	0.4	0.0	1.0	0.0	0.5	0.1	0.3	3.3	0.7	0.0	0.8	0.0	21.0	0.6	0.0	0.0	0.2	0.0	0.5	0.3	0.1	0.0	0.9	5.2	0.2	2.6	6.4	0.0	0.0	0.0	5.8	0.1	0.3	0.0	0.2	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.4	0.0	1.0	0.5	0.0	2.4	1.7	1.2	0.2	1.2	1.3	0.8	2.0	1.0	3.0	0.6	92.3	203.1	5.1	105.8	203.0	0.0	6.1	33.1	87.0	40.9	5.2	0.0	0.5	0.0	138.2	0.4	32.1	49.7	0.0	85.9	1.0	32.9	154.6	26.5	1.1	74.4	0.0	50.8	10.4	119.3	0.9	13.0	757.6	178.8	48.7	41.4	0.0	148.4	28.8	0.4	0.0	0.0	38.8	169.7	0.7	3.1	129.9	6.8	2.5	59.8	50.3
CXCL9	"CMK, crg-10, Humig, MIG, SCYB9"	ENSG00000138755	"C-X-C motif chemokine ligand 9"	Q07325	4	76001275-76007488	"Cancer-related genes, Plasma proteins, Predicted secreted proteins"	"Inflammatory response"	Cytokine	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 70.6;thyroid gland: 28.6"	"Cell type enhanced"	"Detected in some"	15	"Hofbauer cells: 6.6;Kupffer cells: 11.9;Macrophages: 9.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Cell type enhanced"	"Detected in some"		"intermediate monocyte: 1.2;non-classical monocyte: 2.6"	"Lineage enriched"	"Detected in single"	27	"monocytes: 2.6"	"Cell line enriched"	"Detected in single"	8	"RPMI-8226: 4.9"	"Region enhanced"	"Detected in single"		"olfactory region: 0.6"	"Low region specificity"	"Detected in some"								"Secreted to blood"	NA	NA	902000					"prognostic favorable (6.36e-4)"	"unprognostic (6.86e-3)"	"unprognostic (1.25e-2)"	"prognostic favorable (2.07e-4)"	"unprognostic (2.97e-1)"	"unprognostic (3.78e-3)"	"unprognostic (8.79e-2)"	"unprognostic (4.93e-2)"	"unprognostic (1.46e-2)"	"prognostic favorable (8.06e-4)"	"unprognostic (2.18e-3)"	"unprognostic (1.88e-1)"	"prognostic unfavorable (5.15e-6)"	"unprognostic (4.76e-2)"	"unprognostic (4.14e-2)"	"unprognostic (1.57e-2)"	"unprognostic (6.54e-2)"	6.3	0.4	0.5	30.8	0.8	0.0	4.4	0.4	0.4	6.0	2.4	0.4	1.0	0.5	1.1	3.6	2.5	0.5	2.1	5.3	0.5	0.4	9.9	5.9	16.4	70.6	0.3	0.5	4.5	1.0	0.0	1.5	2.1	1.3	5.0	7.3	2.9	4.9	0.6	7.0	2.2	6.6	3.4	2.6	18.6	4.1	1.9	0.4	17.3	28.6	3.5	15.7	4.3	1.6	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.3	4.9	0.0	0.0	0.1	0.2	0.1	0.1	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.5	0.1	0.0	0.5	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.5	0.8	0.4	0.4	0.5	0.4	0.3	0.5	1.3	0.4	0.0	1.7	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.6	0.5	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.8	6.6	0.0	0.0	0.0	11.9	1.4	0.6	9.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.4	2.7	0.3	0.1	0.0	0.0	0.1
CXCR4	"CD184, D2S201E, fusin, HM89, HSY3RR, LESTR, NPY3R, NPYR, NPYY3R"	ENSG00000121966	"C-X-C motif chemokine receptor 4"	P61073	2	136114349-136118165	"Cancer-related genes, CD markers, Disease related genes, FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins, Transporters"	"Host-virus interaction"	"G-protein coupled receptor, Host cell receptor for virus entry, Receptor, Transducer"	"Cancer-related genes, Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 149.9;lymphoid tissue: 186.3"	"Cell type enhanced"	"Detected in many"	14	"B-cells: 772.9;Macrophages: 299.5;monocytes: 255.1;T-cells: 588.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Daudi: 76.4;JURKAT: 43.5;Karpas-707: 41.0;MOLT-4: 69.2;REH: 36.7;U-266/70: 88.9;U-698: 89.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (1.19e-1)"	"unprognostic (1.46e-2)"	"unprognostic (2.69e-1)"	"unprognostic (5.97e-2)"	"unprognostic (1.29e-2)"	"unprognostic (1.12e-2)"	"unprognostic (4.99e-2)"	"unprognostic (9.25e-2)"	"unprognostic (6.06e-2)"	"prognostic favorable (2.05e-4)"	"unprognostic (1.23e-1)"	"unprognostic (2.66e-1)"	"prognostic unfavorable (1.41e-7)"	"prognostic unfavorable (5.67e-4)"	"unprognostic (1.57e-1)"	"unprognostic (3.47e-2)"	"unprognostic (9.33e-2)"	15.4	26.5	3.0	39.1	3.4	149.9	9.7	0.8	2.1	7.7	8.7	6.8	1.5	1.6	8.3	3.8	16.4	9.1	12.0	5.4	4.1	4.7	8.2	7.1	29.3	94.5	6.5	1.3	6.3	3.1	0.7	8.1	7.8	6.1	6.8	7.0	10.0	10.6	2.2	3.2	2.3	57.8	3.8	22.9	82.4	8.0	7.2	3.4	186.3	9.2	4.6	97.5	50.0	6.6	47.3	16.8	37.8	7.2	4.0	32.0	11.9	0.1	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	76.4	0.2	0.0	0.0	0.0	0.2	0.0	0.0	3.8	0.9	4.6	12.1	0.0	0.0	10.5	8.3	0.0	0.0	0.0	0.0	0.0	7.3	43.5	0.1	41.0	0.0	0.2	69.2	9.4	1.2	5.9	0.4	36.7	8.5	13.3	0.6	0.0	4.2	3.5	0.0	0.2	0.0	0.4	0.0	20.7	1.0	0.0	0.2	0.0	0.0	88.9	15.0	89.4	0.0	17.4	0.0	17.9	7.2	29.6	22.9	3.8	18.7	30.1	21.1	21.7	6.6	47.3	32.0	30.1	37.8	4.0	2.1	16.8	18.9	11.9	3.0	3.4	0.8	2.1	4.1	4.7	6.5	1.3	6.1	3.4	14.9	64.2	772.9	4.0	36.5	4.4	3.6	2.5	4.0	6.8	3.5	0.0	1.4	11.6	3.6	0.9	19.0	0.0	46.7	0.8	2.2	30.2	4.8	11.6	5.5	168.4	0.0	1.7	22.7	175.5	1.7	1.4	299.5	108.0	255.1	0.1	1.0	1.6	0.0	2.5	2.1	0.6	45.3	16.3	0.5	5.5	31.1	5.3	588.4	0.4	3.2
CXorf21	FLJ11577	ENSG00000120280	"Chromosome X open reading frame 21"	Q9HAI6	X	30558824-30577844	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 21.9;bone marrow: 16.0;lymphoid tissue: 16.7"	"Cell type enhanced"	"Detected in some"	13	"B-cells: 25.2;granulocytes: 15.0;Hofbauer cells: 20.5;Kupffer cells: 21.1;Macrophages: 39.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enriched"	"Detected in some"	7	"THP-1: 59.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA001185	Uncertain		Approved	Nucleoplasm,Vesicles		NA	NA			Nucleoplasm	Vesicles	"HPA001185: AB_1078591"	"unprognostic (1.37e-1)"	"unprognostic (2.52e-2)"	"unprognostic (4.37e-2)"	"unprognostic (2.27e-2)"	"unprognostic (3.47e-2)"	"unprognostic (5.25e-3)"	"unprognostic (9.07e-3)"	"unprognostic (5.94e-3)"	"unprognostic (1.15e-1)"	"unprognostic (1.40e-1)"	"unprognostic (3.43e-1)"	"unprognostic (3.60e-1)"	"unprognostic (1.66e-3)"	"unprognostic (8.99e-2)"	"unprognostic (1.98e-2)"	"unprognostic (3.45e-2)"	"unprognostic (3.23e-2)"	6.5	2.1	4.6	9.8	4.0	16.0	2.0	0.8	4.4	1.4	3.0	2.3	0.2	4.3	1.2	2.4	1.4	1.5	3.6	1.5	5.0	2.1	1.9	2.8	6.1	12.9	6.3	0.0	1.0	2.0	0.7	1.5	2.7	5.1	1.5	3.1	1.1	3.3	0.5	0.8	1.1	5.3	1.8	9.9	16.7	3.1	0.8	5.2	9.1	1.4	1.2	9.3	4.8	1.4	11.1	21.9	14.9	18.9	3.2	1.6	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	4.8	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.1	0.0	0.0	0.0	7.6	0.0	0.0	0.0	7.2	0.0	7.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	59.1	0.0	0.0	0.0	0.0	0.0	5.6	0.5	2.7	0.0	8.5	0.0	3.4	10.3	11.4	0.8	9.6	0.1	11.1	1.0	0.5	12.0	10.8	1.0	0.7	14.9	3.2	18.9	21.9	1.6	3.5	4.6	4.0	0.8	4.4	5.0	2.1	6.3	0.0	5.1	5.2	0.0	2.2	25.2	0.2	0.5	0.0	0.2	0.0	2.7	2.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.2	15.0	0.0	20.5	0.0	0.0	0.6	21.1	0.0	0.0	39.3	8.5	5.4	0.0	2.0	0.0	0.0	0.0	0.8	0.0	0.0	0.1	0.0	0.0	0.4	0.2	1.3	0.0	0.1
CYBA	p22-PHOX	ENSG00000051523	"Cytochrome b-245 alpha chain"	P13498	16	88643283-88651152	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Electron transport, Transport"	Oxidoreductase	"Chronic granulomatous disease, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 116.7;lymphoid tissue: 129.2"	"Cell type enhanced"	"Detected in many"	6	"Hofbauer cells: 1995.7;Kupffer cells: 1785.0;Macrophages: 1690.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"eosinophil: 94.1"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"RPMI-8226: 141.2;THP-1: 117.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB009492	Enhanced					NA	NA					"CAB009492: AB_2090309"	"prognostic favorable (8.19e-4)"	"unprognostic (1.05e-1)"	"unprognostic (8.32e-2)"	"prognostic favorable (4.75e-5)"	"unprognostic (2.42e-1)"	"unprognostic (4.77e-2)"	"unprognostic (4.88e-2)"	"unprognostic (9.16e-2)"	"unprognostic (1.72e-1)"	"unprognostic (1.11e-1)"	"unprognostic (3.08e-2)"	"unprognostic (2.68e-1)"	"prognostic unfavorable (1.83e-4)"	"unprognostic (1.91e-1)"	"unprognostic (5.22e-2)"	"unprognostic (2.57e-2)"	"unprognostic (1.63e-2)"	31.4	12.6	9.7	60.1	14.9	116.7	16.5	2.0	8.6	16.1	40.5	11.5	25.8	35.7	11.4	20.0	19.6	19.2	43.6	18.0	7.8	8.0	49.3	19.8	46.7	120.1	15.7	3.4	14.8	37.4	0.9	8.2	19.3	11.8	14.7	15.2	15.1	21.7	22.5	6.7	7.1	41.0	9.0	16.7	129.2	41.1	7.4	12.7	31.0	25.6	14.0	60.4	27.0	13.6	15.3	28.4	94.1	20.7	5.2	11.9	5.7	0.2	55.2	0.2	0.1	0.1	0.0	29.8	13.5	7.4	3.9	2.2	36.8	78.7	42.3	40.1	5.6	0.0	23.0	2.1	0.0	0.5	13.4	45.6	8.3	20.7	58.7	7.4	14.0	37.5	7.8	0.0	0.1	0.0	0.1	2.1	9.6	23.7	57.8	0.3	85.6	13.6	66.7	10.1	23.9	0.1	39.7	0.1	141.2	32.1	46.3	7.9	7.0	40.4	7.9	12.7	6.4	0.1	117.9	11.2	0.1	0.5	0.1	0.2	34.5	41.4	46.5	19.2	40.2	5.1	15.9	14.7	94.1	11.9	20.7	8.7	14.5	5.8	11.0	15.7	15.3	4.6	5.7	28.5	5.2	19.3	28.4	5.8	5.7	9.7	14.9	2.0	8.6	7.8	8.0	15.7	3.4	11.8	12.7	14.9	14.3	1206.4	193.9	106.1	0.0	11.3	382.1	38.8	34.2	270.4	2.0	56.0	107.8	589.8	3.5	108.2	700.4	256.9	138.1	250.5	228.6	131.9	281.8	17.4	1995.7	0.0	221.3	360.3	1785.0	7.4	46.3	1690.4	1093.2	1012.7	382.5	1.5	573.4	1045.1	20.1	714.0	2.1	58.2	83.9	0.6	17.7	74.9	98.9	597.7	722.2	321.4
CYBB	"CGD, GP91-PHOX, NOX2"	ENSG00000165168	"Cytochrome b-245 beta chain"	P04839	X	37780011-37813461	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Electron transport, Ion transport, Transport"	"Ion channel, Oxidoreductase, Voltage-gated channel"	"Chronic granulomatous disease, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 50.3;lung: 49.4;lymphoid tissue: 74.5"	"Group enriched"	"Detected in many"	6	"Hofbauer cells: 133.2;Kupffer cells: 479.9;Macrophages: 227.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"intermediate monocyte: 50.3"	"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in some"	5	"Daudi: 16.5;NB-4: 19.8;REH: 16.9;RPMI-8226: 65.1"	"Not detected"	"Not detected"							HPA051227	Enhanced					NA	NA		640000			"HPA051227: AB_2681395"	"unprognostic (5.83e-2)"	"unprognostic (1.77e-2)"	"unprognostic (2.15e-3)"	"unprognostic (1.48e-2)"	"unprognostic (1.27e-1)"	"unprognostic (5.65e-2)"	"unprognostic (2.29e-2)"	"unprognostic (4.45e-2)"	"unprognostic (9.14e-2)"	"unprognostic (2.32e-2)"	"unprognostic (5.73e-2)"	"unprognostic (5.18e-2)"	"unprognostic (5.92e-2)"	"unprognostic (3.02e-1)"	"unprognostic (2.48e-2)"	"unprognostic (1.32e-1)"	"unprognostic (9.72e-2)"	16.4	11.0	9.7	44.2	13.2	42.6	8.1	2.5	6.7	3.7	6.0	10.4	0.2	5.2	3.4	6.3	3.2	6.0	7.5	10.1	6.8	6.5	6.2	11.8	49.4	74.5	12.6	2.9	5.3	4.5	1.4	4.9	16.1	10.3	4.8	8.9	4.5	6.0	2.7	2.5	2.2	16.1	15.3	20.3	49.9	4.9	2.3	10.3	5.4	3.4	3.5	20.2	13.9	3.1	8.1	17.5	20.0	50.3	0.1	0.1	22.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	16.5	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	1.1	0.1	0.0	0.0	1.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.0	19.8	0.0	0.0	0.1	16.9	0.0	65.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	6.3	0.0	0.0	0.0	0.0	0.0	0.1	0.4	1.0	0.0	2.8	0.0	0.3	45.5	20.0	0.0	50.3	0.1	8.1	0.0	0.0	12.1	7.2	0.0	0.0	3.7	0.1	42.7	17.5	0.1	22.0	9.7	13.2	2.5	6.7	6.8	6.5	12.6	2.9	10.3	10.3	23.8	33.4	47.7	0.1	0.9	0.0	9.6	2.5	13.4	23.9	1.8	0.0	0.9	0.0	0.0	0.1	1.6	0.9	0.0	0.3	0.9	4.3	0.0	7.0	2.1	133.2	1.6	0.0	7.4	479.9	0.4	0.6	227.9	1.7	3.6	0.7	0.1	0.2	0.0	0.0	0.5	0.5	12.9	0.9	0.0	0.3	1.1	1.5	2.5	1.2	0.0
CYSLTR2	"CysLT(2), CYSLT2R"	ENSG00000152207	"Cysteinyl leukotriene receptor 2"	Q9NS75	13	48653711-48711226	"FDA approved drug targets, G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"blood: 37.2;ductus deferens: 25.1;placenta: 22.6;seminal vesicle: 22.4"	"Cell type enhanced"	"Detected in some"	12	"Macrophages: 4.3;Melanocytes: 5.0;Sertoli cells: 12.9;Smooth muscle cells: 5.1"	"Group enriched"	"Detected in many"	6	"melanoma: 1.8;renal cancer: 6.6;thyroid cancer: 7.7"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	12	"eosinophil: 37.2"	"Lineage enriched"	"Detected in many"	12	"granulocytes: 37.2"	"Cell line enriched"	"Detected in some"	43	"HDLM-2: 44.7"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			HPA046528	Approved					NA	NA					"HPA046528: AB_2679687"	"unprognostic (9.83e-3)"	"unprognostic (2.72e-3)"	"unprognostic (1.05e-2)"	"unprognostic (6.81e-2)"	"unprognostic (2.94e-2)"	"unprognostic (3.11e-2)"	"unprognostic (1.11e-1)"	"unprognostic (7.41e-3)"	"unprognostic (8.33e-2)"	"unprognostic (1.83e-1)"	"unprognostic (5.44e-2)"	"unprognostic (5.93e-2)"	"unprognostic (1.88e-3)"	"unprognostic (3.79e-2)"	"unprognostic (4.44e-2)"	"unprognostic (2.35e-2)"	"unprognostic (1.18e-2)"	2.0	11.4	3.4	3.9	4.2	0.7	1.0	1.6	8.0	0.9	1.0	1.1	25.1	2.1	1.3	1.7	0.7	3.4	1.6	11.5	4.1	3.4	1.8	1.0	1.5	4.4	3.3	1.5	5.4	0.5	0.7	2.3	22.6	3.7	3.4	1.1	2.9	0.7	22.4	0.5	1.3	2.5	0.7	2.3	6.9	1.1	1.0	2.9	1.0	1.1	0.5	1.5	1.0	1.2	0.0	0.9	37.2	3.2	0.4	0.5	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	44.7	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.0	1.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	2.2	1.0	37.2	0.2	3.2	0.0	0.0	0.4	0.0	0.9	0.0	0.5	0.1	0.1	0.4	2.0	0.0	0.3	0.4	3.4	4.2	1.6	8.0	4.1	3.4	3.3	1.5	3.7	2.9	0.0	1.4	0.5	0.1	0.5	0.0	0.8	0.0	0.0	0.0	3.5	0.0	0.3	0.0	0.0	0.2	0.8	0.0	0.0	0.0	1.0	4.1	0.0	1.1	0.0	0.6	0.0	0.0	3.1	2.1	0.0	0.3	4.3	5.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.9	5.1	0.0	0.1	0.0	2.4	1.9	0.0	0.0
CYTH4	"CYT4, cytohesin-4, PSCD4"	ENSG00000100055	"Cytohesin 4"	Q9UIA0	22	37282027-37315345	"Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 52.3;lymphoid tissue: 53.9"	"Cell type enhanced"	"Detected in some"	11	"granulocytes: 55.4;Hofbauer cells: 64.0;Kupffer cells: 57.8;Macrophages: 83.4;T-cells: 48.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"HL-60: 12.1;HMC-1: 50.8;THP-1: 33.3;U-266/70: 10.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004065, HPA071573"	Approved		Supported	"Plasma membrane,Cytokinetic bridge,Centriolar satellite,Cytosol"		NA	NA			"Plasma membrane"	"Cytokinetic bridge, Centriolar satellite, Cytosol"	"HPA004065: , HPA071573: AB_2686418"	"unprognostic (4.30e-3)"	"unprognostic (1.65e-2)"	"unprognostic (3.03e-2)"	"unprognostic (9.28e-3)"	"unprognostic (9.25e-2)"	"unprognostic (1.69e-2)"	"unprognostic (1.50e-1)"	"unprognostic (5.84e-2)"	"unprognostic (3.30e-3)"	"unprognostic (1.23e-1)"	"unprognostic (3.31e-2)"	"unprognostic (8.42e-2)"	"prognostic unfavorable (2.41e-8)"	"unprognostic (3.70e-2)"	"unprognostic (1.92e-2)"	"unprognostic (5.56e-2)"	"unprognostic (2.07e-1)"	13.6	6.6	7.0	32.0	9.2	24.2	7.6	1.5	4.2	2.9	5.0	7.0	0.9	4.1	3.9	6.5	3.2	5.5	8.3	9.2	4.7	3.7	5.1	4.5	14.8	27.4	10.3	2.6	2.5	3.1	1.1	3.7	13.5	6.9	4.0	4.8	4.6	10.3	2.1	2.1	3.0	13.2	6.0	9.9	53.9	5.4	2.3	7.5	12.9	3.6	2.9	22.9	12.0	3.2	8.0	27.2	52.3	31.4	11.4	15.1	16.1	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	3.2	0.1	0.0	0.8	0.0	0.0	0.2	0.0	1.8	0.0	3.5	0.0	0.0	0.0	12.1	50.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.5	0.0	0.0	0.1	4.5	0.0	0.0	0.3	0.4	0.1	6.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	33.3	0.1	0.0	0.0	0.0	0.0	10.3	1.3	1.6	6.9	4.1	0.1	3.7	15.6	21.6	15.1	26.4	10.6	7.8	8.3	11.9	12.4	8.0	8.0	10.6	52.3	11.4	31.4	27.2	7.5	16.1	7.0	9.2	1.5	4.2	4.7	3.7	10.3	2.6	6.9	7.5	3.0	12.5	18.1	0.7	2.2	0.0	1.6	0.0	0.0	3.4	0.0	0.0	0.5	0.0	0.0	0.0	0.5	0.0	0.0	0.2	0.6	2.1	0.3	55.4	0.8	64.0	0.0	0.0	2.5	57.8	0.0	0.6	83.4	6.8	1.0	0.0	0.0	0.5	0.0	0.0	0.5	0.0	0.0	0.8	0.0	0.1	1.9	0.8	48.9	0.0	0.6
CYTL1	"C17, C4orf4"	ENSG00000170891	"Cytokine like 1"	Q9NRR1	4	5014586-5019472	"Plasma proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 42.2"	"Cell type enhanced"	"Detected in some"	12	"Endothelial cells: 8.3;Fibroblasts: 15.8;granulocytes: 9.2;Hofbauer cells: 12.7;Macrophages: 5.9;Melanocytes: 8.5"	"Cancer enhanced"	"Detected in many"		"glioma: 21.0;melanoma: 20.4"	"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in some"	10	"NK-cell: 18.8"	"Lineage enriched"	"Detected in many"	10	"NK-cells: 18.8"	"Cell line enhanced"	"Detected in some"		"HEL: 42.6;HUVEC TERT2: 34.2;NB-4: 83.4;WM-115: 20.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA067201			Supported	"Nuclear membrane,Endoplasmic reticulum"	"Secreted in other tissues"	NA	NA			"Nuclear membrane, Endoplasmic reticulum"		"HPA067201: AB_2732760"	"unprognostic (2.35e-2)"	"unprognostic (9.01e-3)"	"unprognostic (3.56e-1)"	"unprognostic (3.76e-2)"	"unprognostic (1.14e-1)"	"unprognostic (2.71e-1)"	"unprognostic (2.09e-2)"	"unprognostic (1.44e-1)"	"unprognostic (7.10e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.54e-1)"	"unprognostic (4.78e-2)"	"prognostic unfavorable (7.43e-4)"	"prognostic unfavorable (3.00e-5)"	"unprognostic (2.18e-1)"	"unprognostic (3.07e-2)"	"prognostic unfavorable (1.25e-4)"	5.2	2.3	6.5	2.0	6.0	10.8	6.4	0.7	4.2	11.0	4.9	9.2	4.9	1.0	10.1	2.8	5.3	7.3	4.6	4.4	5.4	4.4	1.2	0.8	17.1	9.4	6.2	2.1	2.5	1.1	1.7	1.6	42.2	4.7	10.5	1.8	4.5	4.0	14.2	0.8	3.3	2.1	4.2	11.0	1.1	4.9	2.2	8.4	0.5	5.7	3.6	4.8	13.2	7.4	0.0	0.3	1.9	1.0	18.8	0.6	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	42.6	0.0	0.0	0.2	0.0	0.0	1.1	0.0	0.6	0.0	0.0	34.2	0.0	0.0	1.7	0.0	0.0	0.0	83.4	0.1	0.0	0.0	1.2	1.7	0.0	0.0	0.0	0.0	2.0	0.0	0.0	5.2	0.0	0.0	0.0	11.7	0.0	8.1	0.0	0.0	0.2	0.0	0.0	0.0	1.0	20.2	1.9	1.0	0.0	0.0	0.2	0.0	0.0	0.0	0.5	0.2	0.0	0.0	0.6	0.1	18.8	0.0	0.3	0.0	0.6	6.5	6.0	0.7	4.2	5.4	4.4	6.2	2.1	4.7	8.4	0.0	0.3	0.5	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.2	8.3	0.0	0.0	0.0	0.1	15.8	0.5	9.2	0.0	12.7	0.0	0.0	1.3	0.0	0.0	0.0	5.9	8.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	1.4	0.5	0.0	0.0	0.6
DOCK10	"KIAA0694, ZIZ3"	ENSG00000135905	"Dedicator of cytokinesis 10"	Q96BY6	2	224765090-225042445	"Plasma proteins, Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 37.7;lymphoid tissue: 27.6"	"Cell type enhanced"	"Detected in many"	11	"granulocytes: 34.8;Horizontal cells: 92.2;Kupffer cells: 46.3;Macrophages: 38.8;monocytes: 40.5;T-cells: 37.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"GAMG: 31.6;HDLM-2: 21.5;TIME: 20.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA058106	Enhanced	Supported	Supported	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA058106: AB_2683606"	"unprognostic (6.95e-2)"	"unprognostic (1.41e-2)"	"unprognostic (1.05e-2)"	"unprognostic (2.03e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.55e-3)"	"unprognostic (1.19e-1)"	"unprognostic (6.92e-2)"	"unprognostic (3.44e-2)"	"unprognostic (3.80e-1)"	"unprognostic (3.22e-3)"	"unprognostic (3.39e-1)"	"unprognostic (1.24e-2)"	"unprognostic (1.01e-1)"	"unprognostic (2.99e-2)"	"unprognostic (2.54e-1)"	"unprognostic (7.72e-2)"	4.2	7.6	17.1	16.7	28.8	8.8	4.0	3.0	18.4	9.5	5.9	27.6	0.0	4.1	3.4	1.4	3.4	2.5	6.4	1.8	24.3	14.7	2.9	5.4	7.3	23.9	33.3	9.6	15.9	1.8	1.9	1.4	2.5	23.2	2.0	6.7	1.1	4.1	2.0	1.3	5.0	8.5	4.4	37.7	26.5	6.1	2.3	35.5	27.6	2.7	1.3	18.4	6.6	3.7	6.8	6.2	2.6	9.6	12.8	10.5	4.0	0.0	8.9	2.8	0.0	3.7	7.9	0.0	19.0	15.5	9.1	6.8	0.0	0.0	0.2	0.0	12.0	31.6	0.2	0.0	0.0	7.3	21.5	0.0	0.2	1.9	0.0	0.1	1.8	0.9	1.8	0.2	13.2	5.2	3.6	9.0	2.9	0.0	17.9	15.3	0.8	3.2	2.5	1.1	0.0	2.1	4.3	4.1	2.6	0.4	0.0	0.1	2.3	0.0	0.0	1.9	0.5	0.6	8.2	20.1	9.9	2.4	4.7	6.4	0.0	0.0	0.0	14.0	12.2	4.2	2.6	2.8	0.2	6.2	8.2	6.4	6.8	10.5	8.8	6.2	3.8	10.4	9.0	0.1	12.8	9.6	2.6	7.5	4.0	17.1	28.8	3.0	18.4	24.3	14.7	33.3	9.6	23.2	35.5	3.0	10.8	18.5	0.5	4.1	5.6	0.8	0.0	4.0	4.5	5.2	0.0	0.2	1.7	0.1	1.7	2.2	0.0	0.0	0.0	0.1	2.3	0.5	34.8	0.9	29.1	92.2	2.4	2.5	46.3	2.2	0.6	38.8	8.5	40.5	2.7	1.3	0.3	0.0	0.0	0.2	2.0	12.9	8.6	0.1	0.2	3.6	0.7	37.4	3.3	0.6
DOCK2	KIAA0209	ENSG00000134516	"Dedicator of cytokinesis 2"	Q92608	5	169637247-170083382	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"	"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 31.0;bone marrow: 29.8;lymphoid tissue: 50.3"	"Group enriched"	"Detected in many"	4	"B-cells: 35.0;granulocytes: 32.4;Hofbauer cells: 37.5;Kupffer cells: 86.2;Macrophages: 45.8;T-cells: 34.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"Daudi: 32.4;HDLM-2: 40.7;HL-60: 32.3;HMC-1: 37.5;MOLT-4: 24.6;U-698: 28.6;U-937: 22.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA036469	Enhanced					NA	NA					"HPA036469: AB_2675140"	"unprognostic (3.45e-2)"	"unprognostic (1.84e-2)"	"unprognostic (3.90e-3)"	"unprognostic (2.04e-2)"	"unprognostic (1.03e-1)"	"unprognostic (5.92e-3)"	"unprognostic (3.47e-1)"	"unprognostic (1.61e-2)"	"unprognostic (1.34e-1)"	"unprognostic (2.10e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.31e-1)"	"unprognostic (2.03e-3)"	"unprognostic (1.47e-1)"	"unprognostic (2.22e-2)"	"unprognostic (6.95e-2)"	"unprognostic (7.24e-2)"	7.3	3.1	2.9	30.7	4.8	29.8	4.1	1.0	2.7	2.2	3.5	5.8	1.2	2.6	2.9	2.7	2.4	2.9	4.9	2.7	3.4	2.5	3.1	2.9	12.6	22.6	4.8	1.3	1.9	1.9	0.7	2.2	3.8	4.1	3.3	4.5	2.6	6.6	1.2	1.3	2.0	13.7	3.6	8.5	28.0	3.6	1.8	3.7	50.3	2.8	1.7	31.5	6.2	2.5	6.4	14.0	12.7	31.0	6.6	6.6	9.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	1.6	3.3	0.0	0.0	32.4	0.6	2.5	0.3	0.0	0.0	0.0	4.1	40.7	0.0	18.0	0.3	0.0	0.0	32.3	37.5	0.0	0.0	0.7	0.0	0.7	0.0	17.3	0.3	16.3	0.8	0.0	24.6	8.3	0.0	0.0	0.0	15.3	0.5	12.9	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.1	0.1	0.3	1.0	0.4	0.7	5.1	7.9	28.6	0.6	22.5	0.0	6.2	12.7	10.0	6.4	23.0	6.6	6.4	5.9	6.3	14.0	5.3	4.3	5.0	12.7	6.6	31.0	4.8	5.3	9.4	2.9	4.8	1.0	2.7	3.4	2.5	4.8	1.3	4.1	3.7	0.0	3.8	35.0	0.2	0.8	0.0	1.2	0.0	1.4	4.5	0.0	0.0	0.3	0.0	0.0	4.2	0.5	0.0	0.0	0.0	0.4	0.9	0.0	32.4	0.9	37.5	0.0	0.0	1.3	86.2	4.1	0.3	45.8	5.0	10.8	0.0	0.0	0.2	0.0	0.0	0.0	0.0	6.5	0.3	1.7	1.5	1.8	0.7	34.6	0.0	0.1
DOCK8	"FLJ00026, FLJ00152, FLJ00346, ZIR8"	ENSG00000107099	"Dedicator of cytokinesis 8"	Q8NF50	9	214854-465259	"Disease related genes, Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"	"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 40.5;lymphoid tissue: 61.0"	"Cell type enhanced"	"Detected in many"	6	"B-cells: 83.1;Cone photoreceptor cells: 72.6;Kupffer cells: 113.9;Macrophages: 79.1;monocytes: 79.4;T-cells: 76.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"Daudi: 17.3;HL-60: 17.2;MOLT-4: 16.1;NB-4: 27.2;REH: 20.2;RT4: 17.9;THP-1: 51.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA003218, HPA073349"	Enhanced		Approved	Nucleoplasm,Centrosome,Mitochondria,Cytosol		NA	NA			Centrosome	"Nucleoplasm, Mitochondria, Cytosol"	"HPA003218: AB_1078695, HPA073349: "	"unprognostic (1.56e-1)"	"unprognostic (5.90e-2)"	"unprognostic (7.75e-2)"	"unprognostic (7.55e-3)"	"unprognostic (3.31e-1)"	"unprognostic (6.28e-3)"	"unprognostic (1.79e-1)"	"unprognostic (8.12e-2)"	"unprognostic (2.72e-2)"	"unprognostic (6.72e-2)"	"unprognostic (1.90e-1)"	"unprognostic (3.89e-2)"	"prognostic favorable (9.21e-6)"	"unprognostic (2.91e-1)"	"unprognostic (3.91e-2)"	"unprognostic (3.91e-1)"	"prognostic favorable (6.89e-6)"	6.7	12.9	5.6	27.4	8.4	20.8	6.1	1.2	4.1	3.1	3.9	9.2	0.9	3.9	3.0	4.3	6.0	4.1	8.2	2.9	6.3	3.3	7.5	3.9	16.8	35.3	10.2	2.3	2.5	6.4	7.6	3.5	10.4	8.1	4.9	4.1	4.4	10.5	2.4	1.7	3.3	15.0	3.4	13.6	43.5	4.9	7.2	8.9	61.0	5.1	3.0	27.1	10.5	4.0	7.3	15.4	40.5	21.5	6.6	5.5	6.4	0.0	0.0	0.0	0.0	0.0	0.0	3.4	0.0	0.0	0.0	0.0	0.5	0.4	17.3	1.2	0.0	0.0	0.7	0.2	0.1	0.0	5.9	0.6	0.0	0.0	0.0	0.0	17.2	2.3	0.1	3.2	0.0	0.0	0.0	0.0	0.0	3.7	8.7	0.0	1.0	16.1	27.2	0.1	0.0	0.2	20.2	0.0	6.7	0.0	17.9	0.0	0.0	0.0	0.2	1.2	0.3	0.4	51.7	3.4	0.0	0.1	0.2	0.0	3.5	0.0	0.0	0.0	10.9	0.3	14.2	14.7	16.7	4.6	15.1	3.8	7.3	5.5	4.8	15.4	6.8	4.4	4.2	40.5	6.6	21.5	4.4	5.3	6.4	5.6	8.4	1.2	4.1	6.3	3.3	10.2	2.3	8.1	8.9	8.9	31.0	83.1	1.5	5.7	0.2	2.0	22.9	1.4	3.4	7.0	72.6	44.4	1.7	0.8	24.2	4.8	0.5	0.0	5.9	3.1	2.9	1.1	23.2	2.5	50.8	0.0	8.1	3.1	113.9	11.5	2.8	79.1	8.5	79.4	8.9	1.0	1.4	17.5	0.4	8.7	3.8	12.9	14.4	15.4	4.1	3.3	35.7	76.2	1.0	3.0
DOK1	p62dok	ENSG00000115325	"Docking protein 1"	Q99704	2	74549026-74557554	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"granulocytes: 36.8;Hofbauer cells: 43.1;Macrophages: 32.0;monocytes: 47.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 31.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"CAB004224, HPA048561"	Approved		Supported	Cytosol		NA	NA		74000	Cytosol		"CAB004224: AB_627447, HPA048561: AB_2680443"	"unprognostic (2.40e-2)"	"unprognostic (2.07e-2)"	"unprognostic (2.60e-1)"	"prognostic favorable (8.42e-4)"	"unprognostic (9.86e-3)"	"unprognostic (1.28e-1)"	"unprognostic (7.10e-2)"	"prognostic favorable (4.64e-4)"	"unprognostic (7.57e-2)"	"unprognostic (1.85e-2)"	"unprognostic (1.89e-2)"	"unprognostic (3.15e-2)"	"prognostic unfavorable (3.16e-6)"	"unprognostic (8.65e-2)"	"unprognostic (2.40e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.20e-2)"	13.2	4.9	4.7	11.2	6.0	15.7	13.3	1.3	3.3	6.2	5.9	5.3	2.6	4.3	7.0	3.6	3.4	5.5	8.0	5.0	4.9	4.2	4.7	2.3	8.0	9.5	6.9	2.8	6.7	10.9	5.5	3.1	5.0	5.4	5.6	5.1	3.1	4.1	5.0	2.0	2.2	7.2	4.7	6.7	15.5	6.6	4.5	5.2	14.5	8.8	1.3	10.8	5.0	7.7	6.9	13.9	17.9	16.1	7.4	5.6	9.9	2.1	0.7	2.0	1.6	4.4	4.8	1.9	4.3	2.7	1.3	2.1	0.7	2.3	1.0	6.9	4.2	3.4	0.3	2.9	1.2	0.8	31.8	3.0	13.6	1.9	0.1	3.7	7.8	14.6	4.6	0.0	10.9	5.0	6.8	1.8	5.1	4.2	2.9	3.2	2.3	6.2	17.0	4.2	3.3	0.9	5.0	4.0	1.6	1.0	1.9	0.9	3.8	1.4	0.2	3.4	0.9	1.5	11.4	3.5	10.7	6.2	5.8	1.0	4.5	3.3	0.0	10.3	11.1	1.8	10.8	15.1	11.3	4.9	14.3	4.1	6.7	3.9	4.2	13.9	6.9	3.6	3.6	17.9	7.4	16.1	2.9	5.6	9.9	4.7	6.0	1.3	2.8	4.9	4.2	6.9	2.8	5.4	5.2	8.9	12.0	9.9	0.9	1.8	0.2	1.7	7.6	1.4	2.3	5.2	0.0	1.8	0.0	10.7	0.2	6.2	5.4	0.0	7.9	3.7	7.3	2.8	36.8	0.5	43.1	1.6	2.9	12.9	28.1	0.0	4.6	32.0	3.3	47.7	5.6	9.1	8.8	7.2	5.6	3.4	0.5	6.5	6.2	0.5	1.7	1.4	1.9	15.2	6.9	1.4
DPEP2		ENSG00000167261	"Dipeptidase 2"	Q9H4A9	16	67987394-68000586	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Lipid metabolism"	"Dipeptidase, Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 105.1"	"Cell type enhanced"	"Detected in many"	9	"Hofbauer cells: 29.3;Kupffer cells: 40.0;Macrophages: 33.7;Syncytiotrophoblasts: 45.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"basophil: 43.5;eosinophil: 105.1;neutrophil: 47.3"	"Lineage enriched"	"Detected in all"	7	"granulocytes: 105.1"	"Cell line enhanced"	"Detected in some"		"HEL: 4.4;HMC-1: 19.9;NB-4: 4.3;U-937: 6.6"					"Low region specificity"	"Detected in many"			HPA035644	Approved					NA	NA		260000000			"HPA035644: AB_10670164"	"unprognostic (8.81e-2)"	"unprognostic (7.84e-5)"	"unprognostic (1.35e-1)"	"unprognostic (1.42e-2)"	"unprognostic (1.92e-1)"	"unprognostic (6.66e-3)"	"unprognostic (1.03e-1)"	"unprognostic (5.47e-2)"	"unprognostic (3.69e-2)"	"unprognostic (1.68e-1)"	"unprognostic (6.01e-2)"	"unprognostic (1.46e-1)"	"unprognostic (3.91e-2)"	"unprognostic (5.75e-2)"	"prognostic unfavorable (8.47e-4)"	"unprognostic (7.78e-3)"	"unprognostic (3.91e-2)"	7.8	0.9	1.3	7.1	2.4	13.0	3.5	0.7	2.5	1.5	2.6	2.4	1.1	1.7	4.1	4.1	1.8	2.0	6.8	2.4	1.6	1.3	2.0	2.0	11.4	10.4	2.1	2.0	0.7	0.9	0.1	0.9	19.4	2.7	2.4	2.4	5.1	2.8	0.4	1.6	1.2	10.1	2.3	3.3	26.4	1.6	2.5	1.6	3.5	2.5	3.8	11.1	6.3	1.5	5.0	4.3	105.1	15.3	5.6	4.9	5.7	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.4	0.0	0.0	0.0	1.4	0.4	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.5	0.0	4.4	0.0	0.1	0.0	0.1	19.9	0.0	0.1	0.0	0.0	0.1	0.1	1.4	0.3	0.1	0.0	0.0	0.1	4.3	0.0	0.0	0.2	0.2	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	1.1	0.6	0.0	0.0	0.0	0.0	1.1	0.5	0.3	0.0	6.6	0.0	43.5	10.7	105.1	2.3	13.0	2.7	4.1	4.0	1.9	4.3	5.0	4.9	2.5	47.3	5.6	15.3	0.6	4.0	5.7	1.3	2.4	0.7	2.5	1.6	1.3	2.1	2.0	2.7	1.6	0.0	12.2	15.6	0.0	1.8	0.0	1.1	0.0	2.7	2.3	0.0	0.0	7.7	0.0	0.0	0.3	2.2	0.0	0.0	0.0	0.6	1.6	0.0	2.3	0.0	29.3	0.0	0.0	17.2	40.0	0.9	0.0	33.7	3.3	1.8	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.2	6.5	6.1	1.1	45.2	13.8	0.0	0.1
DSE	"DS-Epi1, DSEPI, SART2"	ENSG00000111817	"Dermatan sulfate epimerase"	Q9UL01	6	116254173-116444860	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		Isomerase	"Disease mutation, Ehlers-Danlos syndrome"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Kupffer cells: 85.3;Macrophages: 81.1;monocytes: 97.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"myeloid DC: 8.9"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							"HPA014764, HPA052151"	Uncertain		Approved	Nucleoplasm,Cytosol	"Intracellular and membrane"	NA	NA			Nucleoplasm	Cytosol	"HPA014764: AB_1856587, HPA052151: AB_2681746"	"unprognostic (1.28e-1)"	"prognostic unfavorable (3.36e-4)"	"unprognostic (1.38e-1)"	"unprognostic (3.23e-3)"	"unprognostic (1.21e-1)"	"unprognostic (1.48e-2)"	"unprognostic (6.76e-2)"	"unprognostic (1.02e-2)"	"unprognostic (7.81e-2)"	"prognostic unfavorable (6.34e-4)"	"unprognostic (5.11e-2)"	"unprognostic (1.54e-1)"	"prognostic unfavorable (1.50e-4)"	"unprognostic (6.19e-3)"	"unprognostic (2.54e-2)"	"unprognostic (2.06e-1)"	"unprognostic (1.10e-2)"	32.3	10.6	7.4	22.3	10.7	13.1	34.8	5.4	7.7	16.0	12.8	4.9	9.9	5.3	11.7	18.5	13.5	15.3	12.9	16.1	8.1	4.3	11.2	10.4	17.7	13.1	9.8	4.5	21.0	4.0	15.4	20.9	21.7	13.1	13.0	7.1	14.3	9.3	9.4	8.5	16.9	10.7	12.8	16.1	24.9	7.6	10.9	9.0	8.3	8.7	10.9	8.3	14.6	29.4	3.6	8.9	2.5	3.9	0.2	1.1	1.2	10.5	2.3	7.9	7.4	21.5	14.2	9.0	12.5	29.4	15.7	23.1	0.0	3.0	0.3	1.1	21.8	15.8	20.3	1.1	29.4	20.6	10.9	4.8	0.7	3.4	0.1	24.0	0.5	0.5	30.1	12.7	17.4	17.1	8.2	9.2	2.7	0.2	4.8	7.5	0.3	1.4	0.6	4.2	0.0	0.6	1.8	7.3	5.0	10.4	0.7	2.6	2.0	12.1	0.0	0.3	5.7	0.1	1.2	3.4	15.9	4.6	3.9	10.0	1.0	0.3	0.5	8.4	1.3	1.8	0.7	3.1	0.1	1.0	3.9	0.6	3.2	0.9	0.4	8.9	3.6	1.1	0.4	2.5	0.2	2.2	4.2	0.2	1.2	7.4	10.7	5.4	7.7	8.1	4.3	9.8	4.5	13.1	9.0	14.9	2.6	18.6	20.6	46.1	4.1	7.0	5.1	18.7	18.2	3.5	0.0	2.0	6.6	4.0	39.9	11.9	0.0	0.0	7.5	3.7	35.5	14.2	22.0	3.8	39.5	1.6	1.2	57.7	85.3	19.2	50.9	81.1	10.1	97.4	0.7	3.9	9.5	0.0	28.3	6.1	3.0	32.3	29.2	2.6	5.1	34.9	4.1	6.5	1.0	42.4
EGR2	KROX20	ENSG00000122877	"Early growth response 2"	P11161	10	62811996-62919900	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation, Ubl conjugation pathway"	"Activator, DNA-binding, Transferase"	"Charcot-Marie-Tooth disease, Dejerine-Sottas syndrome, Disease mutation, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"thyroid gland: 57.1"	"Cell type enhanced"	"Detected in many"	10	"Intestinal endocrine cells: 70.2;Macrophages: 30.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"intermediate monocyte: 5.5;non-classical monocyte: 5.3"	"Low lineage specificity"	"Detected in many"			"Cell line enriched"	"Detected in some"	6	"U-87 MG: 22.9"	"Group enriched"	"Detected in many"	10	"amygdala: 2.5;basal ganglia: 3.8;cerebral cortex: 4.9;hippocampal formation: 4.1;olfactory region: 3.0"	"Group enriched"	"Detected in many"	4	"basal ganglia: 3.7;cerebral cortex: 6.6;hippocampal formation: 5.1;midbrain: 3.0;olfactory region: 9.8"	HPA031165			Supported	Nucleoplasm		NA	NA			Nucleoplasm		"HPA031165: AB_2673768"	"prognostic favorable (7.30e-5)"	"unprognostic (1.86e-3)"	"unprognostic (1.45e-2)"	"unprognostic (8.72e-2)"	"unprognostic (2.92e-2)"	"unprognostic (1.29e-1)"	"unprognostic (2.70e-1)"	"unprognostic (1.75e-1)"	"unprognostic (9.79e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.18e-1)"	"unprognostic (1.27e-1)"	"unprognostic (2.47e-3)"	"unprognostic (6.54e-2)"	"unprognostic (1.74e-2)"	"unprognostic (3.46e-1)"	"unprognostic (1.11e-3)"	9.4	4.7	1.8	8.3	9.2	2.7	7.8	1.2	9.9	8.5	2.9	18.7	0.5	0.7	5.8	25.5	3.5	6.1	13.1	16.1	3.3	1.6	3.0	5.2	15.7	5.3	6.0	1.2	7.6	2.2	3.9	10.6	4.9	7.5	7.6	1.5	7.8	3.1	1.3	1.2	15.9	3.1	6.7	3.1	3.6	3.0	4.3	0.7	22.7	57.1	5.0	11.5	8.2	2.4	1.2	1.1	1.5	5.5	0.5	0.4	0.6	0.0	0.2	2.5	1.0	1.8	2.5	0.4	0.5	0.2	0.6	0.8	0.0	0.3	0.6	0.0	0.6	0.7	0.3	0.2	0.0	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.6	3.9	0.3	0.6	1.3	0.2	0.8	0.1	0.3	0.2	0.8	0.1	1.2	0.0	1.7	0.2	0.1	1.3	0.1	0.3	0.4	0.0	0.2	0.1	0.3	0.2	0.8	4.0	0.5	0.0	0.5	0.1	0.6	0.4	0.2	0.3	1.4	0.6	0.3	22.9	0.5	0.4	0.0	1.1	0.4	0.4	5.5	0.0	1.0	0.0	0.2	1.1	1.2	0.0	0.4	1.5	0.5	5.3	0.0	0.0	0.6	1.8	9.2	1.2	9.9	3.3	1.6	6.0	1.2	7.5	0.7	0.0	18.8	0.5	8.5	18.9	0.9	4.8	0.0	4.0	0.0	0.0	0.0	1.3	0.0	0.9	6.3	2.1	6.9	0.0	0.6	1.1	14.4	7.8	19.7	1.5	22.6	0.0	70.2	5.5	12.4	3.1	1.7	30.3	8.5	1.0	16.6	1.7	0.8	5.8	6.7	0.0	0.5	6.5	4.4	0.1	1.1	10.9	0.9	4.4	14.3	0.8
EMILIN2	"FLJ33200, FOAP-10"	ENSG00000132205	"Elastin microfibril interfacer 2"	Q9BXX0	18	2847030-2915993	"Plasma proteins, Predicted secreted proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"parathyroid gland: 83.7"	"Cell type enhanced"	"Detected in many"	8	"granulocytes: 45.1;Hofbauer cells: 53.4;Kupffer cells: 51.7;Macrophages: 73.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"basophil: 8.0"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"ASC diff: 22.6;BEWO: 17.4;HL-60: 16.4;HMC-1: 27.9;HSkMC: 12.3;SuSa: 12.3;THP-1: 16.3;U-2197: 21.4"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	7	"midbrain: 9.1;pons and medulla: 16.9;thalamus: 6.3"	HPA064576	Supported				"Secreted to extracellular matrix"	NA	NA		600000			"HPA064576: AB_2732717"	"unprognostic (1.31e-1)"	"unprognostic (1.05e-1)"	"unprognostic (7.91e-3)"	"unprognostic (1.11e-2)"	"unprognostic (3.98e-3)"	"unprognostic (9.91e-3)"	"prognostic unfavorable (6.30e-4)"	"unprognostic (2.01e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.61e-1)"	"unprognostic (2.89e-1)"	"prognostic unfavorable (1.62e-4)"	"unprognostic (1.49e-1)"	"unprognostic (3.15e-3)"	"unprognostic (3.72e-2)"	"unprognostic (2.96e-1)"	32.3	1.4	0.9	8.4	0.7	4.9	14.5	0.3	0.8	5.8	3.9	1.1	2.2	1.1	6.8	6.7	3.9	5.2	4.3	9.6	1.0	1.1	2.0	1.3	10.9	24.4	3.1	0.0	11.0	1.8	83.7	0.6	34.9	3.7	4.6	2.0	2.4	2.9	1.0	3.9	3.0	2.4	5.7	16.4	6.9	1.9	2.8	0.3	2.8	3.0	4.1	1.8	7.9	6.6	0.5	2.1	8.0	2.3	3.1	0.9	0.6	0.1	0.1	1.3	0.0	22.6	9.4	17.4	3.5	0.0	0.6	1.1	2.5	0.0	0.0	0.2	8.6	0.2	0.0	0.4	0.0	1.2	0.0	1.2	0.2	0.1	0.1	0.8	16.4	27.9	12.3	0.0	0.6	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	4.5	2.2	0.1	0.0	0.0	1.1	0.0	0.0	0.1	0.2	0.0	0.1	0.1	0.6	12.3	0.0	16.3	0.2	0.0	2.4	21.4	0.2	0.0	0.0	0.0	1.4	4.1	0.4	8.0	2.3	0.6	0.9	1.6	0.7	0.4	0.9	0.6	2.1	0.5	0.5	0.9	2.3	3.1	1.4	1.4	0.6	0.6	0.9	0.7	0.3	0.8	1.0	1.1	3.1	0.0	3.7	0.3	3.0	7.9	13.7	4.1	5.0	0.0	14.9	2.5	6.7	9.1	3.5	0.0	3.6	1.7	2.4	1.6	8.0	1.1	0.0	1.0	8.1	19.7	2.5	45.1	0.0	53.4	0.0	2.9	3.1	51.7	2.1	14.1	73.7	5.0	24.4	3.9	0.0	1.8	8.0	1.1	1.1	0.3	0.0	8.5	4.7	3.5	3.4	2.4	4.9	4.5	1.7
EMP3	YMP	ENSG00000142227	"Epithelial membrane protein 3"	P54852	19	48321509-48330553	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 165.9"	"Cell type enhanced"	"Detected in many"	8	"Fibroblasts: 530.6;Hofbauer cells: 548.3;Kupffer cells: 540.8;Macrophages: 782.1;Melanocytes: 1059.5"	"Cancer enhanced"	"Detected in all"		"melanoma: 195.4"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"NB-4: 116.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA062030			Approved	"Vesicles,Plasma membrane"		NA	NA			"Vesicles, Plasma membrane"		"HPA062030: "	"unprognostic (5.06e-3)"	"unprognostic (4.41e-1)"	"unprognostic (1.83e-1)"	"unprognostic (9.28e-3)"	"unprognostic (1.33e-2)"	"unprognostic (4.83e-3)"	"unprognostic (1.49e-2)"	"unprognostic (1.02e-1)"	"unprognostic (9.31e-2)"	"unprognostic (4.72e-2)"	"unprognostic (3.41e-2)"	"unprognostic (1.79e-1)"	"prognostic unfavorable (2.31e-7)"	"prognostic unfavorable (3.13e-4)"	"unprognostic (1.16e-1)"	"unprognostic (2.41e-1)"	"unprognostic (2.90e-3)"	27.6	23.4	10.4	26.5	12.6	66.2	28.7	7.2	8.4	50.6	40.3	9.2	14.6	8.4	45.9	22.6	26.9	26.1	21.1	37.9	10.8	6.9	15.6	7.0	36.1	48.0	15.2	6.7	41.4	6.4	2.2	6.1	29.9	12.7	30.7	15.4	24.7	11.3	23.1	13.2	16.3	20.8	46.7	19.1	27.8	19.2	18.2	8.2	16.2	11.6	13.4	25.6	36.8	30.6	44.9	54.8	165.9	91.0	59.7	119.1	124.8	5.6	63.2	3.5	10.1	56.2	87.8	0.1	39.0	71.1	51.7	45.8	6.1	20.4	0.7	8.8	86.6	26.7	1.0	3.7	4.2	31.8	18.6	1.6	27.0	16.6	3.7	47.2	13.3	28.3	47.6	0.8	53.0	36.6	38.4	22.1	6.1	17.8	46.4	79.0	0.9	2.0	116.0	4.7	1.2	16.0	1.6	12.2	27.4	44.3	0.0	0.1	0.2	17.7	0.1	10.1	6.8	0.2	20.4	36.4	46.8	20.3	36.9	30.6	24.5	30.4	1.7	27.7	17.6	31.7	165.9	77.2	105.6	109.2	91.0	90.4	44.9	114.8	106.6	54.8	35.4	65.7	78.2	85.7	59.7	86.6	40.8	119.1	124.8	10.4	12.6	7.2	8.4	10.8	6.9	15.2	6.7	12.7	8.2	0.0	5.0	254.5	67.7	246.9	2.2	3.9	15.3	5.3	11.4	31.4	0.0	10.5	5.0	62.4	5.0	137.6	1.3	0.0	9.8	19.7	530.6	38.3	254.8	4.7	548.3	0.0	5.8	114.8	540.8	9.1	310.7	782.1	1059.5	206.4	2.9	65.0	72.6	17.3	204.0	6.5	3.3	103.5	237.6	9.8	4.5	166.0	16.9	200.3	2.6	22.6
ENTPD1	"ATPDase, CD39, NTPDase-1, SPG64"	ENSG00000138185	"Ectonucleoside triphosphate diphosphohydrolase 1"	P49961	10	95711779-95869695	"CD markers, Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins"		Hydrolase	"Disease mutation, Hereditary spastic paraplegia, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"endometrium 1: 59.4"	"Cell type enhanced"	"Detected in many"	8	"B-cells: 45.3;Endothelial cells: 46.6;Kupffer cells: 77.1;Macrophages: 80.4;monocytes: 46.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"eosinophil: 37.4"	"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in some"	7	"HDLM-2: 57.3;Karpas-707: 47.1"									"CAB002494, HPA014067"	Enhanced		Uncertain	Microtubules		NA	NA			Microtubules		"CAB002494: AB_563557, HPA014067: AB_1848178"	"unprognostic (1.14e-1)"	"unprognostic (1.01e-2)"	"unprognostic (3.11e-1)"	"unprognostic (5.67e-2)"	"unprognostic (9.68e-3)"	"unprognostic (3.45e-3)"	"unprognostic (6.31e-2)"	"unprognostic (5.26e-3)"	"unprognostic (2.73e-1)"	"unprognostic (1.28e-2)"	"unprognostic (6.40e-2)"	"unprognostic (1.41e-1)"	"prognostic unfavorable (5.33e-5)"	"unprognostic (9.79e-2)"	"unprognostic (2.30e-1)"	"prognostic favorable (7.89e-4)"	"unprognostic (5.09e-2)"	10.4	7.5	7.4	16.2	8.4	15.6	8.8	7.6	6.9	18.9	12.7	13.1	8.7	5.8	59.4	12.8	13.2	15.6	22.2	6.8	7.4	7.4	6.2	3.9	14.8	14.5	8.5	4.9	10.3	2.8	3.0	4.3	24.0	9.9	14.7	9.1	10.8	6.7	12.7	3.3	5.5	12.2	37.2	17.9	25.3	7.5	5.4	7.2	3.5	13.4	12.5	21.1	25.2	12.4	6.0	11.8	37.4	15.2	0.5	5.1	4.6	0.1	0.3	0.9	0.8	0.0	0.0	0.5	0.5	0.4	0.0	0.0	0.5	0.1	1.0	0.6	0.0	1.4	0.3	0.0	0.0	0.0	57.3	0.7	0.6	0.4	0.7	0.0	1.5	0.2	0.0	0.0	0.2	0.0	0.3	7.5	0.3	0.6	47.1	0.0	0.6	0.4	1.5	0.6	0.6	0.2	2.4	0.4	0.7	0.5	0.2	0.7	1.1	0.3	1.1	0.8	0.6	0.5	1.6	0.8	0.4	0.2	0.6	0.6	6.7	0.9	0.0	0.6	3.1	0.2	0.1	15.2	37.4	0.1	10.7	0.3	6.0	0.6	0.3	11.8	4.6	0.1	0.1	26.7	0.5	2.4	0.7	5.1	4.6	7.4	8.4	7.6	6.9	7.4	7.4	8.5	4.9	9.9	7.2	0.0	1.4	45.3	0.3	7.9	1.4	8.5	0.0	1.4	1.2	1.8	2.0	0.4	1.7	0.0	5.9	46.6	0.0	0.0	1.8	1.7	8.7	0.4	3.5	0.0	23.2	0.0	0.0	11.6	77.1	6.1	0.6	80.4	15.1	46.9	0.0	0.7	0.2	0.2	2.8	0.3	0.7	6.5	32.0	6.2	4.3	9.8	13.2	14.6	0.4	0.2
EREG	ER	ENSG00000124882	Epiregulin	O14944	4	74365143-74388751	"Predicted membrane proteins, Predicted secreted proteins"	"Angiogenesis, Differentiation"	"Developmental protein, Growth factor, Mitogen"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 52.1;tongue: 44.0"	"Cell type enhanced"	"Detected in many"	13	"Enterocytes: 44.2;Kupffer cells: 56.9;Macrophages: 122.8"	"Cancer enhanced"	"Detected in many"		"colorectal cancer: 11.3"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"BJ hTERT+: 60.3;CAPAN-2: 17.1;hTEC/SVTERT24-B: 19.0;U-2197: 41.1;U-87 MG: 70.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA054373			Approved	Vesicles	"Secreted to blood"	NA	NA	46000		Vesicles		"HPA054373: "	"unprognostic (1.26e-2)"	"prognostic unfavorable (1.67e-7)"	"unprognostic (4.56e-3)"	"unprognostic (3.94e-2)"	"unprognostic (2.24e-3)"	"unprognostic (1.00e-1)"	"unprognostic (1.06e-2)"	"prognostic unfavorable (1.45e-5)"	"unprognostic (1.07e-1)"	"unprognostic (7.34e-2)"	"prognostic unfavorable (6.57e-5)"	"unprognostic (2.94e-1)"	"unprognostic (1.70e-6)"	"unprognostic (2.42e-2)"	"unprognostic (1.13e-2)"	"unprognostic (6.59e-3)"	"unprognostic (3.16e-3)"	2.2	0.0	0.1	4.6	0.3	52.1	1.2	0.0	0.1	5.0	1.2	0.1	0.0	0.0	0.1	0.5	15.3	1.2	7.3	0.8	0.0	0.0	0.4	0.2	6.7	1.1	0.0	0.2	0.5	0.1	0.0	0.0	2.0	0.3	0.2	1.6	0.1	1.6	0.0	0.5	10.7	1.0	1.3	0.1	1.9	0.3	0.3	0.0	0.2	0.0	44.0	7.2	4.1	4.6	0.6	1.3	2.6	1.2	0.4	0.3	0.3	0.3	9.1	0.0	0.0	0.9	1.5	0.0	2.0	60.3	0.6	0.3	7.1	17.1	0.0	10.1	0.0	4.6	0.5	0.0	13.1	0.6	0.0	0.0	0.2	0.3	0.2	0.2	0.0	0.0	0.9	4.6	19.0	10.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.3	0.0	0.0	6.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	41.1	0.0	0.0	0.0	0.0	70.5	0.0	0.0	1.9	1.2	2.6	0.3	1.0	0.2	0.2	0.2	0.2	1.3	0.6	0.3	0.2	1.0	0.4	0.2	0.4	0.2	0.3	0.1	0.3	0.0	0.1	0.0	0.0	0.0	0.2	0.3	0.0	6.0	11.1	1.9	4.9	4.7	0.0	15.7	2.5	4.0	29.6	0.0	0.0	0.5	0.0	0.0	3.1	2.2	44.2	0.0	0.2	0.7	6.1	2.0	6.9	0.0	28.2	0.0	3.5	0.6	56.9	0.4	0.3	122.8	6.8	29.7	24.7	0.0	0.4	17.5	0.0	0.1	0.0	0.0	2.2	0.5	0.2	8.2	0.6	1.0	27.7	6.7
EVI2A	"EVDA, EVI2"	ENSG00000126860	"Ecotropic viral integration site 2A"	P22794	17	31317560-31321884	"Predicted membrane proteins"			Proto-oncogene	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 51.7;brain: 74.0"	"Group enriched"	"Detected in many"	4	"granulocytes: 75.5;Hofbauer cells: 100.8;Kupffer cells: 231.8;Macrophages: 127.6;T-cells: 130.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HHSteC: 20.2;Karpas-707: 33.4;RPMI-8226: 51.6"									"HPA045033, HPA057051"	Uncertain		Approved	"Nucleoplasm,Nuclear bodies"		NA	NA			Nucleoplasm	"Nuclear bodies"	"HPA045033: AB_2679191, HPA057051: AB_2683321"	"unprognostic (7.75e-2)"	"unprognostic (1.54e-2)"	"unprognostic (3.48e-2)"	"unprognostic (1.39e-2)"	"unprognostic (8.49e-2)"	"unprognostic (4.89e-2)"	"unprognostic (1.88e-1)"	"unprognostic (1.05e-1)"	"prognostic unfavorable (7.55e-4)"	"unprognostic (1.90e-1)"	"unprognostic (3.54e-2)"	"unprognostic (3.15e-2)"	"prognostic unfavorable (2.63e-6)"	"unprognostic (7.64e-2)"	"unprognostic (4.95e-2)"	"unprognostic (5.87e-2)"	"unprognostic (2.90e-2)"	6.4	4.7	26.8	25.8	36.0	15.1	4.7	3.8	30.0	5.2	6.2	16.5	0.0	6.3	2.2	1.6	3.5	2.1	10.6	2.6	42.5	21.8	2.2	5.3	12.5	27.4	64.7	13.9	1.6	1.6	1.0	1.6	11.6	33.7	2.4	8.2	0.0	3.0	2.0	1.2	1.5	6.8	4.1	74.0	20.4	6.9	1.2	59.7	32.1	2.0	0.6	22.6	14.2	2.2	8.6	17.9	51.7	26.5	8.9	19.2	23.9	0.0	0.0	0.0	0.0	1.7	10.6	0.0	1.3	2.2	1.7	6.1	0.0	0.5	9.0	0.0	1.7	9.9	0.0	0.0	0.1	4.9	0.0	0.0	0.0	0.0	0.0	20.2	10.4	11.4	13.1	0.0	2.4	7.0	2.6	0.6	8.3	0.3	33.4	13.2	0.1	7.4	11.4	0.0	0.0	0.0	7.8	1.3	51.6	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	11.4	4.3	7.3	0.2	0.3	4.8	15.0	0.0	10.1	5.9	7.6	6.0	1.3	26.5	1.0	11.3	12.7	13.7	8.6	16.1	13.1	17.9	4.2	19.2	16.8	51.7	8.9	9.6	5.9	17.1	23.9	26.8	36.0	3.8	24.0	42.5	21.8	64.7	13.9	33.7	59.7	0.0	6.4	31.5	0.3	3.5	0.2	0.3	0.0	2.7	2.3	0.0	0.0	0.6	0.0	0.0	2.0	1.3	0.0	0.0	0.0	0.5	2.6	0.2	75.5	0.8	100.8	0.0	0.0	7.4	231.8	0.0	0.3	127.6	13.5	0.0	0.0	0.5	0.0	0.0	0.0	0.6	0.7	0.0	1.6	0.1	0.2	2.8	1.1	130.3	0.0	0.3
EVI2B	"CD361, D17S376, EVDB"	ENSG00000185862	"Ecotropic viral integration site 2B"	P34910	17	31303766-31314112	"CD markers, Predicted membrane proteins"			Proto-oncogene	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 133.6;lymphoid tissue: 72.8"	"Cell type enhanced"	"Detected in many"	16	"B-cells: 217.4;Kupffer cells: 447.5;Macrophages: 274.7;T-cells: 178.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"neutrophil: 133.6"	"Group enriched"	"Detected in all"	4	"granulocytes: 133.6;monocytes: 34.3"	"Cell line enhanced"	"Detected in many"		"Daudi: 24.2;HHSteC: 19.9;HL-60: 27.3;HMC-1: 38.5;Karpas-707: 27.3;NB-4: 21.6;RPMI-8226: 39.9;THP-1: 34.4"					"Low region specificity"	"Detected in all"			HPA007436	Enhanced		Approved	"Nucleoplasm,Plasma membrane,Focal adhesion sites"		NA	NA			Nucleoplasm	"Plasma membrane, Focal adhesion sites"	"HPA007436: AB_1848307"	"unprognostic (1.07e-2)"	"unprognostic (1.20e-2)"	"unprognostic (5.97e-2)"	"unprognostic (4.09e-3)"	"unprognostic (2.99e-2)"	"unprognostic (1.41e-2)"	"unprognostic (3.06e-1)"	"unprognostic (3.36e-2)"	"unprognostic (1.93e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.78e-2)"	"unprognostic (2.34e-1)"	"prognostic unfavorable (2.05e-4)"	"unprognostic (1.56e-2)"	"unprognostic (3.32e-2)"	"unprognostic (8.64e-2)"	"unprognostic (2.73e-2)"	15.0	3.6	4.4	37.7	5.8	44.0	4.2	1.7	4.4	3.7	10.7	6.5	0.3	6.0	2.8	4.8	7.1	4.7	8.1	6.7	6.4	4.4	7.8	7.1	38.5	37.5	10.2	2.6	3.8	2.7	0.4	2.1	4.8	7.8	5.3	8.1	2.5	6.6	1.5	2.3	2.4	23.3	4.2	22.0	72.8	8.0	3.7	6.7	26.1	4.0	3.0	43.0	13.0	7.6	18.6	14.6	133.6	34.3	4.1	16.4	19.8	0.1	0.1	0.0	0.0	1.9	2.5	0.0	0.2	1.7	2.0	3.7	0.0	0.9	24.2	0.0	1.5	7.5	0.1	0.0	0.3	2.2	0.0	0.0	0.5	0.0	0.0	19.9	27.3	38.5	4.6	0.0	1.1	1.5	0.6	1.9	2.0	0.3	27.3	5.7	0.0	7.9	21.6	0.0	0.0	0.0	13.9	0.1	39.9	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	34.4	2.1	0.5	0.0	0.2	1.9	5.3	0.2	5.3	2.5	9.4	0.6	78.9	30.5	74.5	8.2	23.2	7.9	18.6	12.6	10.6	14.6	14.3	9.7	9.1	133.6	4.1	34.3	8.4	16.4	19.8	4.4	5.8	1.7	4.4	6.4	4.4	10.2	2.6	7.8	6.7	0.0	17.9	217.4	0.6	4.7	0.2	0.4	2.5	4.0	11.4	1.8	0.0	0.5	0.0	0.0	5.3	2.7	0.2	0.0	0.0	0.5	2.8	0.3	78.7	1.7	88.8	0.0	0.0	9.8	447.5	4.7	0.0	274.7	35.4	10.8	0.0	0.0	0.7	0.0	0.4	0.7	0.8	19.4	4.1	0.3	0.5	3.1	0.2	178.5	0.0	1.1
FCER1G		ENSG00000158869	"Fc fragment of IgE receptor Ig"	P30273	1	161215234-161220699	"FDA approved drug targets, Predicted membrane proteins"	"Immunity, Innate immunity"	"IgE-binding protein, Receptor"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 262.7;lymphoid tissue: 176.3"	"Group enriched"	"Detected in many"	6	"granulocytes: 677.9;Hofbauer cells: 2071.1;Kupffer cells: 1979.2;Macrophages: 2000.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"non-classical monocyte: 262.7"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"HEL: 17.5;HMC-1: 71.6;THP-1: 63.0;U-266/84: 19.4;U-937: 19.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB022108, HPA026872"	Supported					NA	NA		9800000			"CAB022108: , HPA026872: AB_1848473"	"unprognostic (3.71e-2)"	"unprognostic (2.52e-2)"	"unprognostic (2.40e-2)"	"unprognostic (8.73e-3)"	"unprognostic (1.46e-1)"	"unprognostic (4.28e-2)"	"unprognostic (3.10e-3)"	"unprognostic (1.84e-1)"	"unprognostic (3.25e-1)"	"unprognostic (9.63e-2)"	"unprognostic (2.28e-2)"	"unprognostic (5.67e-2)"	"prognostic unfavorable (1.83e-6)"	"unprognostic (1.99e-1)"	"unprognostic (6.28e-2)"	"unprognostic (2.04e-2)"	"unprognostic (7.87e-2)"	62.6	20.5	12.1	49.5	22.4	71.5	17.6	2.4	10.8	10.6	14.6	14.1	1.3	8.0	7.2	15.9	6.9	20.5	18.8	21.2	15.3	11.2	18.9	35.9	71.2	124.8	23.4	4.5	11.4	7.4	2.9	7.9	38.1	17.0	9.7	21.3	9.7	12.8	7.4	11.9	5.7	13.6	28.5	33.3	176.3	10.9	11.6	16.0	6.5	11.5	6.7	14.7	22.4	10.5	0.9	135.4	73.5	262.7	66.6	2.0	132.1	0.0	0.0	0.1	0.3	0.4	0.1	0.0	0.1	0.0	0.1	0.2	0.5	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.3	17.5	0.1	3.3	0.0	3.6	71.6	1.4	0.7	0.5	0.0	0.1	0.1	0.4	0.0	1.7	0.5	0.1	0.3	8.5	0.3	0.0	0.0	0.0	1.5	0.1	0.1	0.0	0.0	0.2	0.1	0.0	0.6	0.3	0.0	63.0	0.1	0.4	0.1	0.2	0.2	0.7	19.4	0.2	0.4	19.7	0.1	64.3	129.8	12.1	0.5	210.3	0.6	0.9	0.4	0.4	97.1	0.3	0.7	2.0	73.5	66.6	262.7	135.4	0.8	132.1	12.1	22.4	2.4	10.8	15.3	11.2	23.4	4.5	17.0	16.0	80.4	219.7	81.8	1.4	35.1	0.0	4.0	20.4	28.1	50.0	17.4	0.0	11.9	0.0	0.5	1.4	15.7	0.6	46.7	0.8	13.5	26.5	1.8	677.9	7.6	2071.1	0.0	1.7	49.7	1979.2	4.7	4.9	2000.4	75.9	55.9	0.0	0.2	0.7	0.9	1.1	3.9	2.6	71.1	23.6	0.9	2.6	31.5	19.8	270.2	0.2	1.6
FCGR1A	"CD64, CD64A"	ENSG00000150337	"Fc fragment of IgG receptor Ia"	P12314	1	149782671-149792518	"CD markers, FDA approved drug targets, Predicted membrane proteins"	"Immunity, Innate immunity"	"IgG-binding protein, Receptor"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 35.6;epididymis: 33.2"	"Cell type enhanced"	"Detected in many"	21	"Hofbauer cells: 235.7;Kupffer cells: 121.8;Late spermatids: 48.6;Macrophages: 101.0"	"Cancer enhanced"	"Detected in many"		"glioma: 10.3"					"Group enriched"	"Detected in some"	7	"classical monocyte: 35.6;intermediate monocyte: 14.0;myeloid DC: 9.5;neutrophil: 25.5"	"Group enriched"	"Detected in many"	80	"dendritic cells: 9.5;granulocytes: 25.5;monocytes: 35.6"	"Cell line enriched"	"Detected in some"	5	"THP-1: 61.0"									HPA026910			Uncertain	"Golgi apparatus,Vesicles,Plasma membrane"		NA	NA			Vesicles	"Golgi apparatus, Plasma membrane"	"HPA026910: "	"unprognostic (5.27e-2)"	"unprognostic (2.89e-2)"	"unprognostic (2.34e-2)"	"unprognostic (7.97e-2)"	"unprognostic (8.44e-3)"	"unprognostic (1.73e-1)"	"unprognostic (7.69e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.88e-2)"	"unprognostic (1.72e-1)"	"unprognostic (1.98e-2)"	"unprognostic (6.18e-2)"	"prognostic unfavorable (4.83e-8)"	"unprognostic (1.28e-1)"	"unprognostic (4.51e-2)"	"unprognostic (9.99e-2)"	"unprognostic (9.03e-2)"	3.9	2.4	6.7	14.1	4.4	5.0	0.7	0.3	3.5	1.1	0.3			0.0	0.1	33.2	0.3	0.7	2.4	0.7	5.3	4.9	1.0	1.1	8.9	3.4	10.1		0.3	1.0	0.5	1.2	10.8		0.4	0.3		0.7	0.2	0.0	0.0	0.1	5.5	14.3	7.0	0.3	0.9			0.3		0.0	3.3	0.0	0.2	9.5	25.5	35.6	0.0	0.2	11.2	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	12.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.4	61.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.3	0.0	0.5	35.6	0.4	0.0	14.0	0.2	0.2	0.0	0.1	9.5	0.0	0.0	0.0	25.5	0.0	2.8	0.2	0.1	11.2											0.0	1.9	3.5	0.0	0.1	1.5	1.2	2.5	1.4	2.3	0.0	2.0	2.1	0.0	0.0	28.2	0.1	0.0	0.0	0.0	1.1	0.6	0.0	0.0	0.0	235.7	0.0	0.0	1.3	121.8	48.6	0.3	101.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.1	0.7	6.5	0.0	0.7	0.4	0.0	3.4	0.0	0.0	0.0
FCGR1B	CD64b	ENSG00000198019	"Fc fragment of IgG receptor Ib"	Q92637	1	121087345-121096310	"FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Adaptive immunity, Immunity"	"IgG-binding protein, Receptor"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 21.8;epididymis: 36.9"	"Group enriched"	"Detected in some"	5	"Hofbauer cells: 68.7;Kupffer cells: 38.3;Macrophages: 36.3;Sertoli cells: 19.4"	"Cancer enhanced"	"Detected in single"		"glioma: 1.6"	"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"classical monocyte: 19.2;neutrophil: 21.8"	"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in some"	6	"NB-4: 10.7;THP-1: 40.9"									HPA026910			Uncertain	"Golgi apparatus,Vesicles,Plasma membrane"	"Intracellular and membrane"	NA	NA			Vesicles	"Golgi apparatus, Plasma membrane"	"HPA026910: "	"unprognostic (3.21e-2)"	"unprognostic (4.35e-2)"	"unprognostic (1.13e-2)"	"unprognostic (2.84e-1)"	"unprognostic (1.85e-1)"	"unprognostic (9.60e-2)"	"unprognostic (1.56e-2)"	"unprognostic (6.42e-2)"	"unprognostic (3.10e-2)"	"unprognostic (8.17e-2)"	"unprognostic (1.91e-1)"	"unprognostic (3.65e-1)"	"unprognostic (3.24e-10)"	"unprognostic (8.99e-2)"	"unprognostic (2.85e-2)"	"unprognostic (7.86e-3)"	"unprognostic (8.93e-2)"	4.2	2.3	6.6	13.2	6.2	3.9	1.3	0.8	3.2	0.8	0.5	3.0	0.2	0.5	0.9	36.9	0.5	0.8	1.5	7.4	5.0	4.2	1.0	1.1	4.8	7.9	8.9	0.2	1.1	1.9	0.4	1.5	8.1	6.4	0.6	0.6	0.4	1.3	0.5	0.2	0.0	0.4	4.2	11.3	6.8	0.5	0.5	6.2	0.4	1.8	0.2	0.4	1.5	0.2	0.0	5.2	21.8	19.2	0.0	0.0	5.3	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	3.1	4.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	10.7	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.2	40.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.0	0.0	0.0	19.2	0.2	0.0	11.3	0.0	0.0	0.0	0.0	5.2	0.0	0.0	0.0	21.8	0.0	6.2	0.1	0.0	5.3	6.6	6.2	0.8	3.0	5.0	4.2	8.9	0.2	6.4	6.2	0.0	1.3	0.8	0.0	0.0	0.8	2.0	0.0	0.0	1.2	0.0	2.0	0.5	0.0	0.0	6.6	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	68.7	3.2	0.0	0.0	38.3	8.2	1.1	36.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	19.4	0.0	0.4	0.2	0.0	0.3	0.0	0.0	0.0
FCGR2A	"CD32, CD32A, CDw32, FCG2, FCGR2, FCGR2A1, IGFR2"	ENSG00000143226	"Fc fragment of IgG receptor IIa"	P12318	1	161505430-161524013	"CD markers, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	Immunity	"IgG-binding protein, Receptor"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 182.8"	"Cell type enhanced"	"Detected in many"	17	"Hofbauer cells: 145.9;Kupffer cells: 155.0;Macrophages: 311.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	6	"neutrophil: 182.8"	"Lineage enriched"	"Detected in many"	7	"granulocytes: 182.8"	"Cell line enhanced"	"Detected in some"		"HEL: 14.3;HMC-1: 28.9;K-562: 8.4;NB-4: 8.1;THP-1: 30.7;U-937: 13.2"									"HPA010718, HPA010776, HPA014730"	Enhanced		Supported	"Golgi apparatus,Plasma membrane"		NA	NA		55000000	"Plasma membrane"	"Golgi apparatus"	"HPA010718: AB_1078463, HPA010776: , HPA014730: AB_2669074"	"unprognostic (2.57e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.48e-2)"	"unprognostic (4.12e-2)"	"unprognostic (5.89e-2)"	"unprognostic (6.17e-2)"	"unprognostic (1.24e-2)"	"unprognostic (1.17e-1)"	"unprognostic (7.63e-2)"	"unprognostic (1.17e-3)"	"unprognostic (2.43e-2)"	"unprognostic (2.91e-1)"	"prognostic unfavorable (6.49e-7)"	"unprognostic (8.85e-3)"	"unprognostic (6.47e-3)"	"unprognostic (1.54e-1)"	"unprognostic (3.42e-2)"	36.8	12.6	13.2	44.6	19.2	18.6	8.2	2.2	10.1	9.1	7.1	10.0	0.0	3.8	4.7	6.6	5.5	11.6	17.0	11.3	17.0	8.9	11.5	7.1	44.1	50.0	25.9	1.7	8.0	5.8	2.8	6.1	47.5	19.6	7.0	9.9	10.8	8.3	4.8	7.3	3.0	7.3	17.6	30.9	43.4	5.9	4.8	19.2	3.2	6.3	2.5	4.4	19.3	4.5	0.2	7.0	182.8	27.2	0.0	0.0	10.6	0.0	0.0	0.0	1.2	0.0	0.2	0.0	0.0	0.3	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	14.3	0.2	0.0	0.3	4.1	28.9	0.3	0.0	0.0	0.0	0.4	0.0	0.0	8.4	0.2	0.0	0.0	0.2	8.1	0.0	0.0	0.6	0.1	0.6	3.9	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	30.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.2	13.2	3.6	0.1	27.2	31.6	0.0	20.7	0.0	0.2	0.0	0.0	7.0	0.1	0.0	0.0	182.8	0.0	16.7	0.2	0.0	10.6	13.2	19.2	2.2	10.1	17.0	8.9	25.9	1.7	19.6	19.2	20.8	63.3	13.7	0.4	7.7	0.0	1.2	5.1	6.7	21.6	0.0	0.0	0.8	8.3	0.2	37.5	2.6	0.0	0.0	0.5	1.1	5.8	0.3	29.0	0.8	145.9	0.0	0.0	4.3	155.0	35.2	1.4	311.2	16.9	1.8	0.0	0.3	0.7	0.0	0.0	7.9	0.1	6.5	5.8	0.3	0.4	6.8	1.4	4.1	0.0	0.3
FCGR3A	"CD16, CD16a, FCG3, FCGR3"	ENSG00000203747	"Fc fragment of IgG receptor IIIa"	P08637	1	161541759-161550737	"CD markers, Disease related genes, FDA approved drug targets, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins"		"IgG-binding protein, Receptor"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 223.6;lymphoid tissue: 60.8"	"Cell type enhanced"	"Detected in many"	22	"Hofbauer cells: 191.4;Kupffer cells: 556.1;Macrophages: 266.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"intermediate monocyte: 109.4;non-classical monocyte: 223.6"	"Group enriched"	"Detected in many"	4	"granulocytes: 73.0;monocytes: 223.6"	"Cell line enhanced"	"Detected in some"		"BEWO: 1.0;HaCaT: 1.7;SH-SY5Y: 1.3;U-2197: 1.1;U-266/70: 1.8"									"CAB032435, HPA055431"	Supported				"Secreted to blood"	NA	NA		2500000000			"CAB032435: AB_626925, HPA055431: AB_2682815"	"unprognostic (5.27e-2)"	"unprognostic (9.95e-2)"	"unprognostic (2.37e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.39e-1)"	"unprognostic (1.82e-1)"	"unprognostic (2.24e-2)"	"unprognostic (6.06e-2)"	"unprognostic (2.41e-1)"	"unprognostic (1.64e-1)"	"unprognostic (1.98e-2)"	"unprognostic (7.52e-2)"	"prognostic unfavorable (3.22e-6)"	"unprognostic (1.14e-1)"	"unprognostic (4.66e-2)"	"unprognostic (1.03e-2)"	"unprognostic (7.51e-2)"	11.9	9.7	7.5	20.5	12.4	4.4	4.1	1.6	7.0	1.9	2.1	5.5	0.8	0.8	1.1	2.4	1.0	2.4	5.1	6.4	6.3	7.3	2.6	22.5	43.2	8.0	12.7	1.9	1.4	2.9	1.8	3.9	14.6	6.8	2.6	2.3	2.2	2.7	1.3	1.3	0.3	1.2	14.3	25.7	60.8	1.3	1.2	8.0	1.4	1.8	1.3	1.3	6.3	2.3	0.1	11.7	73.0	223.6	7.9	33.9	35.8	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.1	0.0	0.5	1.7	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.3	0.8	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.1	0.0	0.0	0.3	0.5	0.5	0.0	0.0	0.8	0.5	0.4	0.0	0.0	0.5	1.3	0.4	0.2	0.0	0.5	0.0	0.1	0.0	0.0	0.1	1.1	0.0	1.8	0.0	0.4	0.0	0.0	0.0	0.3	1.6	0.5	33.9	109.4	0.3	0.1	0.3	13.2	11.7	0.0	0.2	12.2	73.0	7.9	223.6	0.2	0.1	35.8	7.5	12.4	1.6	7.0	6.3	7.3	12.7	1.9	6.8	8.0	20.8	30.6	13.0	0.0	0.5	0.1	0.4	7.6	10.7	19.4	3.5	2.0	1.1	0.0	0.0	0.9	0.8	0.0	0.0	0.0	1.1	0.3	0.0	17.4	3.4	191.4	0.0	0.0	9.2	556.1	1.5	0.3	266.3	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.6	1.3	19.4	0.0	0.0	0.5	0.0	1.7	99.7	0.0	0.1
FERMT3	"KIND3, MGC10966, MIG-2, MIG2B, UNC112C, URP2"	ENSG00000149781	"Fermitin family member 3"	Q86UX7	11	64206678-64223886	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell adhesion"		"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 59.4;bone marrow: 57.6;lymphoid tissue: 52.7"	"Cell type enhanced"	"Detected in many"	10	"granulocytes: 94.6;Hofbauer cells: 174.8;Kupffer cells: 81.3;Macrophages: 95.8;monocytes: 155.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HEL: 62.7;HL-60: 27.4;HMC-1: 67.1;Karpas-707: 27.0;NB-4: 35.3;U-937: 28.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA065231			Approved	Vesicles		NA	NA		450000000	Vesicles		"HPA065231: AB_2685439"	"unprognostic (1.96e-2)"	"unprognostic (1.07e-2)"	"unprognostic (3.38e-3)"	"prognostic favorable (9.89e-4)"	"unprognostic (8.77e-2)"	"unprognostic (1.83e-2)"	"unprognostic (3.56e-2)"	"unprognostic (2.46e-1)"	"unprognostic (4.20e-1)"	"unprognostic (3.98e-1)"	"unprognostic (2.70e-1)"	"unprognostic (3.88e-1)"	"prognostic unfavorable (2.12e-5)"	"unprognostic (3.08e-3)"	"unprognostic (5.25e-2)"	"unprognostic (4.97e-2)"	"unprognostic (1.75e-1)"	20.0	5.6	3.1	29.4	5.5	57.6	5.6	0.9	3.2	3.4	8.8	3.4	0.7	8.1	3.4	6.0	3.6	5.8	6.5	7.2	2.2	2.4	5.3	5.5	17.8	39.1	6.3	0.8	4.9	2.8	0.2	2.6	7.5	3.7	4.2	3.0	5.6	8.9	2.9	3.2	2.8	12.4	3.3	4.8	52.7	10.6	2.5	4.3	51.2	4.0	2.4	29.6	6.2	2.9	13.7	47.3	54.7	49.5	22.6	30.6	59.4	0.2	0.3	0.1	0.1	0.0	0.1	0.4	0.2	0.0	0.0	0.0	0.5	0.4	6.6	0.6	1.3	0.1	0.5	0.2	0.1	0.1	17.0	0.1	62.7	0.2	0.0	2.3	27.4	67.1	0.2	0.2	1.1	0.0	0.1	17.0	16.0	1.4	27.0	1.8	0.7	24.4	35.3	0.2	0.2	0.4	14.7	1.8	0.1	0.0	0.1	0.4	0.1	0.1	0.9	0.3	0.1	0.4	19.1	1.6	0.2	0.5	0.4	0.1	0.3	0.6	12.0	4.1	28.4	18.1	40.6	49.5	54.7	30.6	46.3	29.4	13.7	24.4	28.4	39.0	13.4	16.1	21.1	45.0	22.6	33.5	47.3	28.3	59.4	3.1	5.5	0.9	3.2	2.2	2.4	6.3	0.8	3.7	4.3	8.9	17.1	42.2	0.6	4.1	0.6	2.0	5.1	1.4	6.8	0.0	0.0	0.9	0.0	0.6	0.1	3.6	5.9	23.3	2.2	1.1	5.3	0.9	94.6	1.7	174.8	0.0	0.0	17.2	81.3	0.8	0.9	95.8	16.9	155.9	22.4	0.1	2.8	10.5	2.5	0.2	0.2	6.5	6.1	1.1	0.7	4.0	2.2	69.2	13.9	0.7
FES	FPS	ENSG00000182511	"FES proto-oncogene, tyrosine kinase"	P07332	15	90883695-90895776	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		"Kinase, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Proto-oncogene, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 60.8;lymphoid tissue: 49.7"	"Cell type enhanced"	"Detected in many"	11	"Hofbauer cells: 40.6;Kupffer cells: 93.1;Macrophages: 37.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"eosinophil: 60.8"	"Group enriched"	"Detected in many"	4	"dendritic cells: 32.6;granulocytes: 60.8;monocytes: 30.5"	"Cell line enhanced"	"Detected in many"		"HEL: 21.3;HL-60: 19.0;HMC-1: 40.7;NB-4: 24.9;THP-1: 37.4;U-937: 16.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA001376	Approved		Approved	Nucleoplasm,Vesicles,Cytosol		NA	NA			"Nucleoplasm, Cytosol"	Vesicles	"HPA001376: AB_1078847"	"unprognostic (1.07e-2)"	"unprognostic (2.54e-2)"	"prognostic unfavorable (5.78e-4)"	"unprognostic (2.31e-2)"	"unprognostic (4.05e-3)"	"unprognostic (7.33e-2)"	"unprognostic (1.74e-1)"	"unprognostic (2.22e-1)"	"unprognostic (1.58e-3)"	"unprognostic (1.35e-1)"	"unprognostic (4.66e-2)"	"unprognostic (5.15e-3)"	"unprognostic (1.78e-3)"	"unprognostic (2.53e-3)"	"unprognostic (6.08e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.40e-1)"	14.9	3.4	4.8	9.7	4.1	38.3	12.7	2.4	5.7	6.8	5.4	3.2	4.7	3.0	7.4	5.6	4.9	7.6	7.3	7.9	4.2	2.2	5.2	11.8	12.7	23.3	3.7	0.9	6.4	3.7	1.8	2.7	8.1	7.2	7.7	2.4	5.3	33.8	6.3	3.4	3.5	5.2	5.4	6.9	49.7	4.3	3.2	4.7	3.1	7.2	4.1	4.5	7.2	9.4	1.1	32.6	60.8	30.5	9.3	0.1	13.8	0.1	0.2	0.3	3.6	1.0	3.1	6.1	0.9	0.0	1.8	1.0	0.9	0.0	2.3	0.1	2.0	0.0	0.5	0.6	0.1	0.5	1.2	0.3	21.3	0.0	3.8	2.1	19.0	40.7	3.1	0.0	2.6	0.0	0.0	10.8	3.2	0.6	0.0	0.0	6.9	0.6	24.9	1.0	0.8	0.0	2.8	0.0	0.0	0.0	0.1	0.1	0.0	0.0	1.0	0.9	1.1	0.0	37.4	8.4	0.0	3.7	0.1	0.0	0.0	2.7	0.8	0.1	16.1	0.8	10.4	30.5	60.8	0.1	17.6	0.0	1.1	0.0	0.0	32.6	0.9	0.0	0.0	20.0	9.3	7.3	12.9	0.0	13.8	4.8	4.1	2.4	5.7	4.2	2.2	3.7	0.9	7.2	4.7	3.0	8.0	6.4	4.7	3.4	0.0	2.5	5.1	0.0	0.0	1.8	0.0	4.5	3.3	4.8	1.1	24.5	0.4	0.0	3.9	3.8	6.2	4.0	28.8	8.2	40.6	0.0	2.9	22.7	93.1	4.7	8.3	37.3	6.8	27.1	2.1	2.3	2.0	0.0	9.6	1.3	1.9	12.9	7.2	3.5	9.1	2.5	3.8	10.2	2.6	5.2
FFAR3	"FFA3R, GPR41"	ENSG00000185897	"Free fatty acid receptor 3"	O14843	19	35358460-35360485	"G-protein coupled receptors, Predicted membrane proteins"	"Immunity, Inflammatory response"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"adipose tissue: 6.5;blood: 5.6;lymphoid tissue: 6.1"	"Cell type enhanced"	"Detected in single"	19	"Macrophages: 1.2"	"Not detected"	"Not detected"							"Group enriched"	"Detected in some"	5	"eosinophil: 4.7;neutrophil: 5.6"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 5.6"	"Group enriched"	"Detected in some"	5	"ASC diff: 1.2;HHSteC: 3.9;HSkMC: 3.4;U-937: 1.5"									HPA044681	Uncertain					NA	NA					"HPA044681: AB_2679043"	"unprognostic (1.15e-1)"		"unprognostic (5.16e-3)"		"unprognostic (1.45e-1)"	"unprognostic (3.08e-2)"	"unprognostic (1.03e-3)"	"unprognostic (2.21e-2)"	"unprognostic (4.46e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.92e-4)"	"unprognostic (3.80e-1)"	"unprognostic (1.11e-3)"	"unprognostic (1.04e-3)"	"unprognostic (2.18e-2)"	"unprognostic (3.41e-1)"	"unprognostic (3.22e-2)"	6.5	0.0	0.1	6.1	0.3	1.7	3.8	0.0	0.2	0.0	2.1			0.7	0.0	0.0	0.0	0.5	1.1	0.2	0.4	0.2	0.0	0.5	0.6	0.4	0.5		0.3	1.0	0.4	0.5	0.9		0.2	0.1		0.0	0.0	0.0	0.0	0.9	3.7	1.5	2.4	1.3	0.0			0.9		0.0	0.7	0.0	0.0	0.1	5.6	1.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.9	0.0	0.1	3.4	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	1.5	0.4	0.0	0.1	4.7	0.0	1.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	5.6	0.0	0.3	0.0	0.0	0.2											0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.9	0.0	0.0	0.6	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
FGD2	ZFYVE4	ENSG00000146192	"FYVE, RhoGEF and PH domain containing 2"	Q7Z6J4	6	37005646-37029070	"Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 25.5;lymphoid tissue: 43.1"	"Cell type enhanced"	"Detected in many"	15	"B-cells: 36.5;Kupffer cells: 86.8;Macrophages: 49.3;monocytes: 32.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	17	"classical monocyte: 8.8;intermediate monocyte: 25.4;memory B-cell: 9.3;myeloid DC: 13.7;naive B-cell: 7.8;non-classical monocyte: 25.5;plasmacytoid DC: 10.8"	"Group enriched"	"Detected in many"	19	"B-cells: 9.3;dendritic cells: 13.7;monocytes: 25.5"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 3.1;Daudi: 12.7;HDLM-2: 12.4;U-698: 10.2"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"HPA029145, HPA049692"	Approved					NA	NA					"HPA029145: AB_10601321, HPA049692: AB_2680852"	"unprognostic (3.54e-2)"	"unprognostic (1.40e-4)"	"unprognostic (5.69e-3)"	"unprognostic (2.29e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.67e-4)"	"unprognostic (7.97e-2)"	"unprognostic (1.58e-2)"	"unprognostic (2.47e-2)"	"unprognostic (2.78e-1)"	"unprognostic (3.39e-2)"	"unprognostic (2.82e-1)"	"unprognostic (1.15e-2)"	"unprognostic (3.91e-1)"	"unprognostic (1.02e-2)"	"unprognostic (3.88e-1)"	"unprognostic (7.10e-2)"	11.3	4.3	6.7	21.8	10.3	5.4	3.3	1.0	4.6	2.4	3.4	5.9	1.3	3.8	2.2	7.6	3.0	4.1	4.3	2.6	7.2	2.4	3.0	3.3	8.7	21.7	10.3	1.4	1.8	2.3	0.3	2.1	2.8	7.4	2.4	2.9	2.5	4.2	2.2	1.5	3.0	11.2	4.6	8.3	43.1	3.8	1.2	9.2	3.0	3.5	1.8	18.9	5.1	2.5	9.3	13.7	0.8	25.5	0.1	0.0	2.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	3.1	12.7	0.0	0.0	0.0	0.4	0.0	0.0	0.3	12.4	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.6	0.0	1.8	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.2	0.0	0.0	0.0	0.0	8.8	0.8	0.0	25.4	0.0	9.3	0.0	0.0	13.7	7.8	0.0	0.0	0.1	0.1	25.5	10.8	0.0	2.1	6.7	10.3	1.0	4.6	7.2	2.4	10.3	1.4	7.4	9.2	6.0	11.9	36.5	2.9	1.8	0.4	2.5	0.0	4.0	0.0	0.0	0.0	0.2	0.0	1.7	10.9	0.7	0.0	0.0	0.8	0.2	1.0	1.2	7.0	0.2	15.5	0.0	0.0	3.1	86.8	1.9	1.4	49.3	1.7	32.5	0.0	0.3	0.8	0.3	0.0	0.0	0.1	0.0	0.8	0.0	0.0	1.9	0.3	2.2	0.2	4.6
FGL2	"pT49, T49"	ENSG00000127951	"Fibrinogen like 2"	Q14314	7	77193371-77199848	"Plasma proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 82.0"	"Group enriched"	"Detected in many"	5	"Kupffer cells: 431.4;Macrophages: 384.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	50	"classical monocyte: 59.3;eosinophil: 52.6;intermediate monocyte: 82.0;myeloid DC: 38.1;neutrophil: 68.4;non-classical monocyte: 73.5"	"Group enriched"	"Detected in many"	56	"dendritic cells: 38.1;granulocytes: 68.4;monocytes: 82.0"	"Cell line enhanced"	"Detected in some"		"ASC diff: 4.1;Karpas-707: 3.8;LHCN-M2: 4.2;NB-4: 4.6;RPTEC TERT1: 8.0;U-937: 8.4;WM-115: 9.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA021011, HPA026682"	Enhanced				"Secreted to blood"	NA	NA	38800000	6400000			"HPA021011: AB_1848532, HPA026682: AB_1848533"	"unprognostic (9.80e-3)"	"unprognostic (4.70e-3)"	"unprognostic (1.19e-1)"	"unprognostic (3.51e-3)"	"unprognostic (1.62e-1)"	"unprognostic (1.00e-2)"	"unprognostic (1.44e-2)"	"unprognostic (1.23e-2)"	"unprognostic (3.49e-1)"	"unprognostic (2.70e-1)"	"unprognostic (3.19e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.19e-1)"	"unprognostic (5.00e-2)"	"unprognostic (1.91e-2)"	"unprognostic (2.33e-1)"	"unprognostic (7.01e-2)"	30.0	8.7	6.0	28.7	10.7	1.5	18.0	5.7	4.7	8.0	29.5	5.0	7.7	14.2	7.6	18.4	41.4	13.8	16.2	17.8	5.1	5.5	23.3	14.3	17.0	28.1	10.3	4.1	6.4	3.0	1.8	8.0	7.0	11.4	17.9	20.3	6.8	11.7	4.4	6.2	8.6	40.9	73.7	18.4	63.4	16.9	3.4	8.6	12.0	19.2	18.3	9.1	55.8	7.7	1.0	38.1	68.4	82.0	0.7	1.1	34.6	0.0	0.0	0.0	0.0	4.1	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.3	0.3	0.1	0.0	0.0	0.1	0.1	0.0	0.1	0.1	0.0	3.8	4.2	0.1	0.0	4.6	0.3	0.0	0.2	0.2	0.5	0.4	8.0	1.1	0.1	0.3	0.1	0.0	0.0	0.0	0.0	3.0	0.0	0.2	0.0	0.2	0.0	0.1	0.0	0.0	0.3	8.4	9.0	0.6	59.3	52.6	1.1	82.0	0.5	1.0	0.7	1.0	38.1	0.5	0.4	0.8	68.4	0.7	73.5	1.2	1.1	34.6	6.0	10.7	5.7	4.7	5.1	5.5	10.3	4.1	11.4	8.6	6.0	18.4	34.2	1.0	33.9	1.1	3.2	0.0	4.0	9.1	83.7	9.8	1.1	5.0	0.2	7.0	45.8	11.9	0.0	0.0	1.0	69.5	0.8	9.3	4.2	36.4	1.6	0.0	56.4	431.4	7.1	25.6	384.4	47.2	1.0	0.3	11.3	0.1	2.8	18.4	5.4	7.7	0.0	9.5	0.5	0.3	27.4	3.1	19.2	0.3	1.4
FLI1	"EWSR2, SIC-1"	ENSG00000151702	"Fli-1 proto-oncogene, ETS transcription factor"	Q01543	11	128686535-128813267	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"	"Cancer-related genes, Disease mutation, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 40.2"	"Group enriched"	"Detected in many"	6	"B-cells: 32.3;Endothelial cells: 76.4;granulocytes: 22.0;Hofbauer cells: 36.1;Ito cells: 49.7;Kupffer cells: 85.1;Macrophages: 24.6;T-cells: 47.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HEL: 41.0;HUVEC TERT2: 22.8;REH: 19.2;TIME: 23.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA065030, HPA073099"	Approved		Supported	"Nucleoplasm,Nuclear bodies"		Yes	NA			"Nucleoplasm, Nuclear bodies"		"HPA065030: , HPA073099: AB_2686572"	"unprognostic (1.38e-2)"	"unprognostic (7.46e-2)"	"unprognostic (6.16e-2)"	"unprognostic (3.74e-2)"	"unprognostic (6.22e-2)"	"unprognostic (4.26e-3)"	"unprognostic (1.33e-1)"	"unprognostic (8.32e-3)"	"unprognostic (2.97e-1)"	"unprognostic (9.91e-2)"	"unprognostic (1.60e-2)"	"unprognostic (1.42e-1)"	"prognostic unfavorable (4.60e-4)"	"unprognostic (4.79e-2)"	"unprognostic (2.07e-2)"	"unprognostic (2.62e-1)"	"unprognostic (4.79e-2)"	14.7	2.5	3.5	15.8	4.4	10.6	9.9	1.4	3.2	6.7	5.1	3.8	2.1	3.3	7.8	6.5	4.8	5.3	6.0	7.5	3.8	3.1	4.2	3.6	17.4	24.4	6.2	1.6	4.0	3.2	2.5	2.0	11.4	3.8	4.3	3.1	4.8	4.2	3.3	5.2	3.2	6.9	5.7	6.6	40.2	4.1	2.7	4.6	26.8	5.7	2.8	17.9	6.2	6.7	4.5	13.1	20.1	12.0	7.8	8.8	11.6	0.0	0.0	2.1	0.0	0.2	0.4	0.0	1.2	3.4	1.4	1.2	0.0	0.0	7.0	12.5	4.1	0.4	0.0	0.3	5.1	1.6	3.2	0.1	41.0	0.2	0.0	2.4	4.9	5.8	0.3	0.4	3.0	6.9	4.3	22.8	9.8	0.0	9.0	0.3	0.0	4.9	2.8	0.6	0.0	1.2	19.2	0.0	7.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	2.0	0.0	7.9	23.6	0.2	0.0	0.1	1.3	2.9	6.0	6.0	0.0	11.9	1.9	20.1	9.5	16.1	7.2	10.3	8.8	4.5	6.2	5.8	13.1	3.6	2.6	5.6	7.8	7.8	12.0	2.2	7.4	11.6	3.5	4.4	1.4	3.2	3.8	3.1	6.2	1.6	3.8	4.6	6.0	7.7	32.3	0.2	4.5	0.0	5.0	5.1	1.4	0.0	1.8	0.0	0.3	0.0	0.0	0.5	76.4	0.0	0.0	0.0	0.2	5.6	0.3	22.0	1.0	36.1	0.0	0.0	49.7	85.1	0.0	1.7	24.6	6.8	6.4	0.0	0.1	0.0	0.0	0.7	0.3	0.0	6.5	2.8	0.3	0.1	3.6	0.2	47.8	0.0	0.4
FLT3	"CD135, FLK2, STK1"	ENSG00000122025	"Fms related tyrosine kinase 3"	P36888	13	28003274-28100592	"Cancer-related genes, CD markers, Disease related genes, Enzymes, FDA approved drug targets, Predicted membrane proteins, RAS pathway related proteins"	"Host-virus interaction"	"Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Disease mutation, FDA approved drug targets, Proto-oncogene"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 29.9;brain: 19.3;lymphoid tissue: 15.0"	"Cell type enhanced"	"Detected in some"	25	"Kupffer cells: 29.6;Macrophages: 12.4;monocytes: 55.9"	"Cancer enhanced"	"Detected in some"		"breast cancer: 1.8"	"Region enhanced"	"Detected in many"		"cerebellum: 19.3"	"Group enriched"	"Detected in some"	11	"myeloid DC: 29.9;plasmacytoid DC: 12.1"	"Lineage enriched"	"Detected in many"	16	"dendritic cells: 29.9"	"Group enriched"	"Detected in some"	11	"REH: 28.5;THP-1: 17.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA047539			Approved	"Endoplasmic reticulum"		NA	NA		180000	"Endoplasmic reticulum"		"HPA047539: AB_2680080"	"unprognostic (2.19e-3)"	"unprognostic (3.16e-3)"	"unprognostic (6.54e-3)"	"unprognostic (9.96e-2)"	"unprognostic (3.88e-1)"	"unprognostic (3.96e-7)"	"unprognostic (7.99e-3)"	"unprognostic (1.65e-2)"	"unprognostic (5.37e-2)"	"unprognostic (1.01e-2)"	"unprognostic (1.96e-1)"	"unprognostic (1.03e-1)"	"unprognostic (4.56e-2)"	"unprognostic (3.65e-1)"	"unprognostic (3.91e-2)"	"unprognostic (2.51e-1)"	"unprognostic (2.22e-1)"	0.9	0.6	0.6	7.2	1.1	7.5	2.6	19.3	3.5	0.9	1.2	0.1	0.1	0.4	0.8	0.8	1.0	1.2	4.6	0.5	0.9	1.7	2.8	0.7	2.7	15.0	1.8	1.1	0.5	5.7	0.0	0.4	0.0	7.4	0.6	1.4	0.1	2.3	0.6	0.4	1.2	3.0	1.3	4.4	8.8	0.9	1.2	0.0	8.2	0.6	0.0	5.8	2.4	0.7	0.1	29.9	1.4	1.8	0.8	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	2.1	0.5	0.0	0.0	28.5	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	17.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	1.8	1.4	0.0	0.3	0.0	0.1	0.0	0.0	29.9	0.0	0.0	0.0	0.0	0.8	0.0	12.1	0.0	1.2	0.6	1.1	19.3	3.5	0.9	1.7	1.8	1.1	7.4	0.0	0.0	0.0	0.8	0.0	0.2	0.0	0.3	2.5	0.0	0.0	0.0	0.0	0.0	0.0	2.2	3.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.5	0.0	0.0	1.3	29.6	1.6	0.0	12.4	1.7	55.9	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.5	0.5	0.0	0.0	0.0	0.0
FMNL1	"C17orf1, C17orf1B, FMNL"	ENSG00000184922	"Formin like 1"	O95466	17	45221444-45247320	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 107.4;lymphoid tissue: 56.6"	"Cell type enhanced"	"Detected in many"	10	"B-cells: 52.5;Kupffer cells: 54.4;Macrophages: 116.9;monocytes: 95.6;T-cells: 97.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Karpas-707: 50.4;MOLT-4: 34.6;U-266/70: 42.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008129, HPA028288"	Enhanced		Approved	Cytosol		NA	NA			Cytosol		"HPA008129: AB_1848963, HPA028288: AB_10612110"	"unprognostic (1.90e-2)"	"unprognostic (1.37e-1)"	"unprognostic (2.07e-2)"	"unprognostic (8.60e-2)"	"unprognostic (1.95e-2)"	"unprognostic (1.24e-2)"	"unprognostic (2.01e-1)"	"unprognostic (1.58e-1)"	"unprognostic (5.44e-2)"	"unprognostic (6.06e-2)"	"unprognostic (2.37e-1)"	"unprognostic (4.07e-1)"	"prognostic unfavorable (4.23e-8)"	"unprognostic (1.29e-1)"	"unprognostic (3.01e-2)"	"unprognostic (3.46e-2)"	"unprognostic (2.16e-1)"	8.6	3.8	10.7	29.7	9.6	107.4	7.5	8.1	16.1	4.6	5.2	4.2	0.8	5.8	2.6	5.8	4.5	6.1	9.1	5.8	13.4	6.0	4.2	3.6	22.2	38.1	6.1	6.4	3.1	3.6	3.6	7.4	7.4	7.2	4.3	4.1	3.3	8.4	2.3	2.5	4.2	14.9	4.3	6.2	45.9	6.6	2.7	3.3	56.6	3.9	4.1	22.8	11.3	4.6	3.5	4.3	22.3	5.6	5.4	7.6	3.5	4.2	8.3	0.0	0.4	0.0	1.9	0.4	0.5	1.1	3.1	2.3	0.4	1.9	13.1	4.3	0.1	3.3	0.7	0.0	0.1	1.0	22.9	1.1	7.6	12.3	0.6	8.9	19.7	26.8	1.4	0.3	4.1	1.8	4.3	0.0	14.6	0.6	50.4	2.3	2.7	34.6	20.4	0.4	0.5	0.2	21.9	2.9	23.4	0.8	0.5	2.6	1.2	2.5	0.4	1.0	0.7	2.4	16.1	1.0	0.2	3.0	0.5	18.5	42.1	18.5	13.4	0.3	16.1	0.6	6.8	5.1	8.2	7.0	5.6	4.7	3.5	5.5	7.6	4.3	3.3	3.6	4.8	22.3	5.4	4.2	2.5	6.0	3.5	10.7	9.6	8.1	16.1	13.4	6.0	6.1	6.4	7.2	3.3	3.0	4.8	52.5	2.8	5.5	4.0	1.9	2.5	1.4	1.2	1.8	0.0	0.4	0.0	1.1	2.0	2.9	0.0	0.0	0.8	1.0	10.7	1.9	23.0	0.5	43.3	3.2	1.2	8.6	54.4	0.7	4.9	116.9	42.2	95.6	0.1	0.9	0.4	0.0	0.0	0.6	1.2	6.5	3.8	0.5	1.7	5.4	2.1	97.0	0.2	1.4
FPR1	"FMLP, FPR"	ENSG00000171051	"Formyl peptide receptor 1"	P21462	19	51745172-51804110	"G-protein coupled receptors, Predicted membrane proteins"	Chemotaxis	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 213.3;lymphoid tissue: 64.4"	"Cell type enhanced"	"Detected in many"	21	"Hofbauer cells: 97.2;Kupffer cells: 262.0;Macrophages: 111.7"	"Cancer enhanced"	"Detected in all"		"glioma: 23.0"	"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in many"	6	"neutrophil: 213.3"	"Lineage enriched"	"Detected in many"	6	"granulocytes: 213.3"	"Cell line enriched"	"Detected in some"	5	"U-87 MG: 35.0"	"Not detected"	"Not detected"							"HPA046550, HPA061744"	Approved		Approved	"Nucleoplasm,Nucleoli,Golgi apparatus"		NA	NA			"Golgi apparatus"	"Nucleoplasm, Nucleoli"	"HPA046550: AB_2679694, HPA061744: AB_2684600"	"unprognostic (5.54e-2)"	"unprognostic (4.16e-2)"	"unprognostic (1.88e-1)"	"unprognostic (1.22e-1)"	"unprognostic (8.50e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.96e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.15e-1)"	"unprognostic (5.48e-3)"	"unprognostic (4.59e-2)"	"unprognostic (8.34e-2)"	"prognostic unfavorable (2.21e-4)"	"unprognostic (6.03e-2)"	"unprognostic (4.52e-3)"	"unprognostic (1.54e-2)"	"unprognostic (1.70e-3)"	22.6	3.7	5.2	52.2	12.4	54.5	2.9	1.1	6.3	2.6	2.4	5.9	0.0	1.1	2.3	2.3	3.3	8.4	9.6	11.2	15.7	4.3	6.0	7.5	28.8	58.4	15.5	0.8	1.9	3.5	0.8	2.3	13.0	9.7	1.8	1.2	2.4	2.4	0.9	3.2	1.1	2.2	12.8	14.3	64.4	3.2	2.9	10.1	0.9	2.7	0.7	3.2	7.9	4.6	0.0	8.9	213.3	36.3	0.0	0.0	16.9	0.3	0.5	0.2	0.3	0.4	1.1	0.3	0.2	0.0	0.3	1.0	0.2	0.3	0.6	0.3	0.0	1.9	0.2	0.0	0.0	0.0	0.0	0.0	0.5	0.5	0.6	2.8	0.2	0.4	2.4	0.1	0.9	0.8	4.2	0.0	0.2	0.1	0.4	7.1	0.5	0.1	0.2	0.2	0.2	0.4	0.2	0.4	0.0	0.6	0.3	0.1	0.2	0.4	0.1	0.3	0.1	0.6	0.6	0.5	1.2	0.3	0.0	1.7	0.1	0.0	0.3	35.0	0.9	0.1	13.0	36.3	10.0	0.0	15.9	0.0	0.0	0.0	0.0	8.9	0.0	0.0	0.0	213.3	0.0	9.5	0.3	0.0	16.9	5.2	12.4	1.1	6.3	15.7	4.3	15.5	0.8	9.7	10.1	14.9	40.8	6.2	0.2	0.6	0.4	0.2	0.0	16.0	28.4	0.0	0.0	0.9	0.0	0.0	1.2	0.4	0.0	0.0	0.0	1.2	0.9	0.2	24.4	1.7	97.2	0.0	0.0	4.3	262.0	1.3	0.3	111.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	6.5	1.0	0.5	0.6	0.0	2.5	0.0	0.0	0.0
FPR3	"FMLPY, FPRH1, FPRL2, RMLP-R-I"	ENSG00000187474	"Formyl peptide receptor 3"	P25089	19	51795163-51826189	"G-protein coupled receptors, Predicted membrane proteins"	Chemotaxis	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 35.9"	"Group enriched"	"Detected in some"	10	"Hofbauer cells: 59.4;Kupffer cells: 71.5;Macrophages: 66.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	20	"classical monocyte: 3.2;intermediate monocyte: 9.6;myeloid DC: 3.4"	"Group enriched"	"Detected in many"	43	"dendritic cells: 3.4;monocytes: 9.6"	"Group enriched"	"Detected in some"	4	"HEL: 14.7;hTERT-RPE1: 4.2"															NA	NA						"unprognostic (3.77e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.79e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.84e-1)"	"unprognostic (8.41e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.37e-2)"	"unprognostic (7.14e-2)"	"unprognostic (3.17e-1)"	"unprognostic (9.37e-2)"	"unprognostic (1.02e-3)"	"unprognostic (1.59e-1)"	"prognostic unfavorable (9.13e-4)"	"unprognostic (1.96e-1)"	"unprognostic (4.28e-2)"	35.9	10.0	1.5	12.9	2.1	0.0	6.2	0.6	1.8	3.2	6.6	1.8	0.5	5.9	3.1	7.0	3.4	3.0	10.7	6.3	1.7	1.2	6.8	13.0	25.9	15.1	2.8	0.9	5.4	3.2	0.7	2.2	5.2	2.4	5.0	10.3	4.9	5.1	1.3	4.6	2.3	10.9	4.6	5.2	10.8	3.4	3.3	1.1	8.0	2.7	6.4	10.1	9.3	2.6	0.0	3.4	0.1	9.6	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	14.7	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	4.2	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.6	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.7	0.0	0.1	0.0	2.1	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.1	0.0	3.2	0.0	0.0	9.6	0.0	0.0	0.0	0.0	3.4	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.6	1.5	2.1	0.6	1.8	1.7	1.2	2.8	0.9	2.4	1.1	0.0	1.7	2.4	0.0	4.9	0.0	0.3	0.0	2.7	4.5	0.0	0.0	0.1	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.2	1.0	0.2	0.0	0.5	59.4	0.0	0.0	1.8	71.5	0.0	0.3	66.8	6.8	4.6	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.2	0.0	0.0	4.0	0.7	0.0	0.0	0.0
FXYD5	OIT2	ENSG00000089327	"FXYD domain containing ion transport regulator 5"	Q96DB9	19	35154730-35169883	"Plasma proteins, Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Ion channel"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Hofbauer cells: 407.2;Kupffer cells: 403.3;Macrophages: 433.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											HPA010817	Uncertain		Approved	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"HPA010817: AB_1849214"	"unprognostic (3.97e-3)"	"unprognostic (5.49e-2)"	"unprognostic (6.37e-3)"	"unprognostic (3.01e-1)"	"unprognostic (2.50e-3)"	"unprognostic (4.39e-3)"	"unprognostic (4.68e-2)"	"unprognostic (1.56e-3)"	"unprognostic (3.85e-1)"	"unprognostic (5.66e-3)"	"unprognostic (4.78e-2)"	"unprognostic (4.75e-2)"	"prognostic unfavorable (3.71e-9)"	"unprognostic (6.07e-2)"	"unprognostic (7.88e-2)"	"unprognostic (3.61e-2)"	"unprognostic (1.74e-1)"	58.8	10.6	6.0	47.4	9.0	72.4	66.9	2.7	7.1	44.3	15.6	14.4	10.4	8.8	33.6	25.9	31.3	26.0	28.6	29.1	7.0	7.9	13.7	13.2	39.5	110.7	12.0	7.6	18.9	8.0	3.4	11.7	56.9	11.8	27.3	14.0	19.8	19.7	16.7	17.0	22.7	27.0	18.7	18.2	80.3	20.8	10.8	9.3	33.9	16.0	26.9	97.4	36.6	59.8	73.3	91.4	66.5	76.9	99.6	109.0	94.6	98.9	23.7	0.0	0.1	35.4	44.9	23.8	56.9	75.9	40.7	30.4	6.7	29.1	22.8	15.6	68.7	14.6	23.3	14.6	35.1	26.3	28.1	9.6	42.6	13.1	0.0	27.9	24.2	42.5	26.6	15.7	29.5	51.1	24.0	38.3	6.3	39.9	110.3	25.3	0.1	2.8	10.1	7.3	92.0	13.8	13.6	5.0	28.8	14.9	0.5	4.3	0.0	31.4	16.5	33.2	13.5	8.6	19.5	54.0	50.3	19.1	54.5	4.3	0.1	1.6	5.8	76.6	56.4	76.7	66.5	73.5	13.4	60.3	76.9	56.8	73.3	102.5	62.8	91.4	66.7	68.0	55.0	18.1	99.6	74.5	41.9	109.0	94.6	6.0	9.0	2.7	7.1	7.0	7.9	12.0	7.6	11.8	9.3	3.0	14.9	263.7	53.6	95.1	0.3	2.4	22.9	1.4	7.9	94.2	0.0	9.5	0.0	153.7	1.1	336.6	0.8	0.0	176.3	377.4	156.4	26.1	356.4	4.3	407.2	0.0	10.3	249.2	403.3	2.7	6.1	433.0	199.1	27.9	5.1	0.0	365.9	7.0	0.7	2.5	0.2	64.7	75.9	1.1	7.0	60.5	42.6	318.2	5.2	88.0
FYB1	"ADAP, FYB, FYB-120/130, SLAP-130"	ENSG00000082074	"FYN binding protein 1"	O15117	5	39105255-39274528	"Disease related genes, Predicted intracellular proteins"			"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 153.7;lymphoid tissue: 63.5"	"Cell type enhanced"	"Detected in some"	17	"Extravillous trophoblasts: 65.7;Hofbauer cells: 145.5;Macrophages: 50.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 153.7"	"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in some"	5	"HEL: 16.3;JURKAT: 58.0;MOLT-4: 55.5;REH: 16.2;U-937: 21.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB025336, HPA026796, HPA067427"	Enhanced		Approved	"Nucleoplasm,Plasma membrane"		NA	NA		6600000	"Plasma membrane"	Nucleoplasm	"CAB025336: , HPA026796: AB_10964126, HPA067427: "	"unprognostic (5.65e-2)"	"unprognostic (2.92e-2)"	"unprognostic (1.56e-2)"	"unprognostic (6.26e-2)"	"unprognostic (4.08e-1)"	"unprognostic (3.29e-2)"	"unprognostic (2.60e-1)"	"unprognostic (1.97e-1)"	"unprognostic (1.24e-1)"	"unprognostic (5.63e-2)"	"unprognostic (5.35e-2)"	"unprognostic (3.21e-1)"	"prognostic unfavorable (2.24e-4)"	"unprognostic (2.40e-1)"	"unprognostic (4.14e-2)"	"unprognostic (8.99e-2)"	"unprognostic (1.51e-1)"	7.0	3.5	6.3	36.0	18.3	22.1	3.9	1.8	10.1	3.5	4.4	8.3	0.3	4.1	2.7	6.5	4.9	4.2	7.9	3.5	6.8	6.6	5.7	6.2	13.8	35.5	15.5	2.7	2.6	2.5	1.3	3.5	8.7	11.7	3.8	5.3	3.0	5.4	1.5	1.9	2.4	11.7	5.6	29.4	41.5	5.2	3.5	12.2	63.5	4.1	1.8	28.0	10.1	3.6	0.1	11.9	153.7	41.3	8.6	28.7	30.8	0.0	1.1	0.0	0.0	0.1	0.0	6.2	0.0	0.3	0.0	0.1	0.1	0.0	0.0	0.0	0.0	2.2	4.5	0.0	0.1	0.0	0.0	0.0	16.3	0.0	0.0	0.0	6.1	5.2	0.0	0.1	0.0	0.1	0.0	0.0	58.0	0.0	0.0	0.0	0.0	55.5	3.5	0.0	0.0	0.0	16.2	0.0	0.0	0.2	1.1	0.0	0.0	0.0	0.1	1.6	0.4	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.2	0.0	21.5	0.0	11.9	33.8	32.3	7.9	38.6	5.5	0.1	22.5	13.8	11.9	0.1	28.7	17.3	153.7	8.6	41.3	3.0	21.7	30.8	6.3	18.3	1.8	10.1	6.8	6.6	15.5	2.7	11.7	12.2	14.9	34.3	0.0	0.0	0.0	0.0	0.0	0.0	6.7	10.3	14.0	0.0	25.9	8.3	0.0	0.0	0.0	0.0	0.0	0.0	65.7	0.0	0.0	14.0	0.0	145.5	0.0	0.0	0.0	0.0	0.0	0.0	50.3	0.0	10.0	0.0	0.0	0.0	0.0	0.0	11.5	0.0	0.0	0.0	0.0	0.0	0.0	33.6	0.0	0.0	0.0
GAB3		ENSG00000160219	"GRB2 associated binding protein 3"	Q8WWW8	X	154675249-154751583	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	7	"Cardiomyocytes: 17.5;granulocytes: 19.7;Kupffer cells: 21.8;Macrophages: 12.4;T-cells: 12.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HEL: 18.2;HMC-1: 20.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA010090	Approved					NA	NA					"HPA010090: AB_1849362"	"unprognostic (2.67e-2)"	"unprognostic (1.04e-2)"	"unprognostic (4.10e-2)"	"unprognostic (1.15e-1)"	"unprognostic (2.57e-1)"	"unprognostic (3.63e-3)"	"unprognostic (1.20e-1)"	"unprognostic (5.90e-3)"	"unprognostic (1.87e-1)"	"unprognostic (1.43e-1)"	"unprognostic (2.04e-2)"	"unprognostic (2.92e-1)"	"prognostic unfavorable (5.07e-4)"	"unprognostic (1.22e-1)"	"unprognostic (2.84e-2)"	"unprognostic (5.87e-2)"	"unprognostic (2.19e-1)"	10.3	3.5	3.7	11.5	6.6	12.4	5.9	1.3	4.9	4.1	4.2	4.3	0.5	3.5	6.7	5.5	2.7	4.3	6.6	10.3	3.2	2.4	3.5	2.4	8.6	9.4	5.6	0.7	2.3	4.0	4.2	3.2	5.4	4.0	3.0	3.8	4.3	3.4	2.2	2.6	4.6	8.8	3.9	7.4	19.6	4.0	5.3	4.7	7.6	5.3	2.4	8.7	4.4	3.1	1.3	4.3	18.2	4.5	1.8	11.1	3.7	0.6	0.0	0.7	1.0	0.6	1.9	0.4	0.5	0.5	0.1	0.2	0.0	0.6	2.1	0.5	0.0	1.2	0.3	0.4	0.3	0.0	2.7	0.8	18.2	2.0	1.8	1.0	5.3	20.6	0.5	0.2	1.3	0.7	0.5	4.1	1.4	4.4	6.0	0.7	0.2	2.0	4.9	0.1	0.1	0.1	2.7	0.1	0.2	1.1	0.0	2.7	0.4	0.3	0.2	0.3	0.5	1.1	3.3	3.5	1.1	1.6	0.7	0.4	6.5	5.7	2.2	1.6	6.8	0.7	18.2	4.4	7.6	11.1	4.5	7.5	0.8	2.8	7.6	4.3	1.3	1.0	5.4	9.2	1.8	2.4	2.4	0.8	3.7	3.7	6.6	1.3	4.9	3.2	2.4	5.6	0.7	4.0	4.7	0.0	7.0	7.5	0.0	0.6	0.0	17.5	0.0	2.7	2.3	0.0	0.0	0.0	0.0	0.7	0.3	4.9	0.0	0.0	0.4	0.4	0.8	0.1	19.7	0.0	11.8	0.0	0.0	6.2	21.8	0.5	1.7	12.4	0.0	3.6	0.0	3.4	0.2	0.0	4.2	0.0	0.3	6.5	2.1	0.0	0.9	0.9	0.1	12.1	0.0	0.1
GBGT1	"A3GALNT, FS, MGC44848, UDP-GalNAc"	ENSG00000148288	"Globoside alpha-1,3-N-acetylgalactosaminyltransferase 1 (FORS blood group)"	Q8N5D6	9	133152948-133163945	"Predicted intracellular proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	9	"granulocytes: 11.5;Hofbauer cells: 19.5;Kupffer cells: 23.4;Macrophages: 13.6;monocytes: 11.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HEL: 30.7;HMC-1: 28.7;HUVEC TERT2: 11.9;NB-4: 13.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051298	Approved				"Intracellular and membrane"	NA	NA					"HPA051298: AB_2681428"	"unprognostic (4.63e-3)"	"unprognostic (8.03e-2)"	"prognostic unfavorable (6.22e-4)"	"unprognostic (2.70e-1)"	"unprognostic (8.87e-2)"	"unprognostic (4.38e-1)"	"unprognostic (2.97e-2)"	"unprognostic (7.43e-2)"	"unprognostic (9.04e-2)"	"unprognostic (2.27e-3)"	"unprognostic (2.35e-1)"	"unprognostic (9.50e-2)"	"prognostic unfavorable (3.46e-5)"	"unprognostic (2.92e-2)"	"unprognostic (1.01e-1)"	"unprognostic (3.41e-2)"	"unprognostic (6.35e-2)"	10.2	12.9	6.7	13.7	5.7	10.3	15.5	8.1	7.8	5.8	5.6	6.3	4.7	4.1	8.5	5.7	6.7	7.8	9.0	7.2	7.0	4.6	7.7	2.0	11.2	20.4	6.7	4.3	15.8	4.4	5.6	5.6	19.7	8.8	8.4	3.9	16.7	6.3	8.2	2.9	4.2	7.3	8.2	7.2	11.2	21.7	4.3	5.7	1.7	8.1	3.2	11.5	8.3	9.0	3.4	3.2	5.2	11.2	0.9	0.5	2.5	0.0	0.8	0.8	0.0	0.5	0.6	0.2	2.3	1.8	1.3	0.0	0.0	0.4	0.6	7.8	2.3	0.9	8.6	5.1	0.5	0.0	0.0	0.2	30.7	0.5	0.0	6.3	1.1	28.7	2.7	0.8	0.3	0.0	5.4	11.9	0.4	8.9	0.1	0.4	0.1	0.1	13.8	2.5	0.2	0.2	2.2	0.2	0.8	0.8	0.1	0.2	0.9	0.0	1.2	0.0	1.0	0.0	6.8	7.4	0.0	1.0	0.9	0.0	0.0	0.0	0.0	0.1	4.9	0.4	4.7	11.2	5.2	0.2	7.7	0.5	1.7	0.4	0.0	3.2	3.4	0.1	0.1	2.0	0.9	6.4	2.3	0.2	2.5	6.7	5.7	8.1	7.8	7.0	4.6	6.7	4.3	8.8	5.7	0.0	1.7	0.9	2.6	0.7	0.1	2.0	0.0	0.0	1.2	1.8	0.0	2.0	0.0	3.6	0.0	1.1	0.0	0.0	0.5	0.8	3.7	1.2	11.5	0.0	19.5	0.0	0.0	0.6	23.4	0.0	6.9	13.6	0.0	11.8	0.0	2.4	1.2	10.4	1.8	1.4	0.3	0.0	3.5	0.0	0.1	1.0	3.0	1.0	1.2	1.0
GBP5		ENSG00000154451	"Guanylate binding protein 5"	Q96PP8	1	89258950-89272804	"Predicted intracellular proteins"	"Immunity, Inflammatory response"	"Antimicrobial, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 54.6;lymphoid tissue: 29.1"	"Cell type enhanced"	"Detected in some"	13	"granulocytes: 10.4;Kupffer cells: 15.1;Macrophages: 11.7;T-cells: 33.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"T-reg: 54.6"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"EFO-21: 5.1;NB-4: 7.5;U-266/70: 16.3;U-937: 23.9"	"Low region specificity"	"Detected in all"							HPA028656	Supported					NA	NA					"HPA028656: AB_10601471"	"unprognostic (2.72e-2)"	"unprognostic (1.82e-2)"	"prognostic favorable (9.54e-4)"	"prognostic favorable (3.73e-6)"	"unprognostic (8.33e-2)"	"unprognostic (8.68e-3)"	"unprognostic (3.71e-2)"	"unprognostic (6.43e-3)"	"unprognostic (2.37e-3)"	"prognostic favorable (1.24e-4)"	"unprognostic (3.47e-2)"	"unprognostic (4.16e-1)"	"prognostic unfavorable (5.53e-8)"	"unprognostic (2.75e-2)"	"unprognostic (3.68e-2)"	"unprognostic (1.66e-1)"	"unprognostic (4.11e-2)"	3.3	1.5	1.0	29.1	1.5	12.1	1.7	0.7	0.8	2.3	4.4	0.7	0.2	2.0	2.4	3.0	2.6	3.3	4.5	1.5	1.0	1.0	2.6	4.0	14.0	26.2	2.8	0.8	3.4	1.3	0.0	1.5	2.6	1.9	3.8	3.0	3.3	2.4	1.2	0.9	1.2	7.6	2.0	2.9	27.6	3.2	4.5	1.0	7.8	3.6	1.3	24.9	6.8	1.7	1.5	1.5	23.0	9.4	11.6	54.6	7.3	0.1	0.0	0.0	0.4	0.0	0.0	0.2	0.0	0.5	0.9	1.0	0.0	0.1	0.1	5.1	4.1	2.0	0.1	0.0	0.0	0.1	0.1	0.1	0.2	0.3	0.0	0.0	0.0	0.4	0.0	0.0	0.2	0.0	0.2	0.0	0.7	0.4	2.4	0.2	0.0	0.0	7.5	1.3	0.0	0.0	0.3	0.2	0.0	0.0	0.1	0.0	0.1	0.5	1.5	0.1	0.0	0.0	3.0	0.1	0.4	0.4	0.0	1.7	16.3	0.3	0.1	0.2	23.9	0.0	0.1	3.5	0.2	23.5	8.7	36.8	1.1	15.5	21.4	1.5	1.5	5.8	9.0	23.0	11.6	9.4	0.1	54.6	7.3	1.0	1.5	0.7	0.8	1.0	1.0	2.8	0.8	1.9	1.0	6.0	6.1	3.7	0.1	0.0	0.0	0.6	2.5	8.1	6.8	0.0	3.9	0.0	0.0	0.0	0.2	1.0	0.0	0.0	1.0	0.0	0.4	0.2	10.4	0.6	4.2	0.0	0.0	4.3	15.1	0.0	0.0	11.7	0.0	0.0	0.0	2.3	0.9	0.0	0.0	0.0	0.3	0.0	0.2	0.1	1.5	0.0	0.1	33.2	0.0	0.1
GIMAP4	"FLJ11110, HIMAP4, IAN1, IMAP4"	ENSG00000133574	"GTPase, IMAP family member 4"	Q9NUV9	7	150567277-150573955	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 78.6"	"Group enriched"	"Detected in many"	6	"Endothelial cells: 177.9;Hofbauer cells: 83.4;Ito cells: 198.2;Kupffer cells: 164.1;Macrophages: 61.9;T-cells: 207.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enriched"	"Detected in some"	26	"HUVEC TERT2: 83.7"	"Not detected"	"Not detected"							"HPA019135, HPA019137, HPA027198"	Enhanced					NA	NA					"HPA019135: AB_1849670, HPA019137: AB_1849672, HPA027198: AB_10602599"	"unprognostic (5.03e-2)"	"unprognostic (3.30e-3)"	"unprognostic (4.08e-2)"	"prognostic favorable (7.63e-4)"	"unprognostic (1.72e-1)"	"unprognostic (1.73e-2)"	"unprognostic (7.00e-2)"	"unprognostic (2.40e-2)"	"unprognostic (1.87e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.45e-1)"	"unprognostic (1.21e-1)"	"prognostic unfavorable (1.13e-4)"	"unprognostic (1.65e-1)"	"unprognostic (3.32e-2)"	"unprognostic (1.39e-1)"	"unprognostic (2.29e-1)"	26.7	7.7	9.2	27.2	12.2	1.5	19.5	2.6	8.8	11.5	10.2	6.8	4.0	6.2	12.5	9.1	8.7	10.0	9.7	14.0	9.7	6.6	11.0	11.5	30.5	47.3	11.3	4.1	5.8	4.8	3.1	4.8	19.2	10.8	11.2	9.1	6.8	6.4	5.6	13.6	5.2	15.0	15.2	13.7	43.4	7.6	5.9	11.6	10.4	14.5	8.2	32.5	14.1	9.2	0.3	15.4	43.1	48.7	31.3	58.3	78.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	83.7	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	3.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	45.0	0.6	44.1	48.7	54.4	0.3	55.2	53.8	15.4	0.1	58.3	48.7	43.1	31.3	37.2	0.6	37.8	78.6	9.2	12.2	2.6	8.8	9.7	6.6	11.3	4.1	10.8	11.6	3.0	18.0	4.1	0.1	6.1	0.0	4.1	0.0	1.4	3.4	10.4	0.0	0.5	0.0	0.1	0.4	177.9	0.0	0.0	0.2	0.5	3.9	0.3	5.8	2.5	83.4	0.0	0.0	198.2	164.1	0.5	4.6	61.9	10.1	24.4	0.0	0.2	0.1	0.0	0.0	1.4	0.0	12.9	2.2	0.0	0.5	5.4	0.7	207.5	0.0	0.3
GK	"GK1, GKD"	ENSG00000198814	"Glycerol kinase"	P32189	X	30653359-30731456	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Glycerol metabolism"	"Kinase, Transferase"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 51.4;intestine: 37.9;kidney: 35.4;liver: 40.7"	"Cell type enhanced"	"Detected in many"	7	"Enterocytes: 80.4;Macrophages: 98.4;Proximal tubular cells: 143.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	8	"neutrophil: 51.4"	"Lineage enriched"	"Detected in all"	8	"granulocytes: 51.4"	"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 22.5;Hep G2: 27.3"									HPA060687	Supported					NA	NA					"HPA060687: AB_2684343"	"unprognostic (8.78e-3)"	"unprognostic (8.41e-3)"	"unprognostic (1.28e-2)"	"unprognostic (3.77e-2)"	"unprognostic (3.15e-1)"	"unprognostic (4.15e-3)"	"unprognostic (5.52e-2)"	"unprognostic (1.42e-2)"	"unprognostic (3.85e-1)"	"unprognostic (8.56e-3)"	"unprognostic (1.30e-2)"	"unprognostic (1.58e-2)"	"prognostic favorable (3.24e-9)"	"unprognostic (1.59e-1)"	"unprognostic (9.35e-2)"	"unprognostic (4.57e-3)"	"unprognostic (4.11e-3)"	2.8	4.9	2.4	17.0	7.6	1.6	1.8	2.5	4.7	3.0	7.5	2.7	1.5	28.4	2.5	4.0	4.9	2.7	7.9	4.9	4.6	2.6	35.4	40.7	11.7	8.1	3.8	2.5	2.0	1.9	3.2	5.3	2.3	4.1	1.9	3.4	2.9	6.6	0.6	1.4	3.1	37.9	1.9	6.0	6.4	2.0	2.0	2.2	5.4	2.2	3.8	4.5	4.3	1.7	1.7	4.0	51.4	6.6	1.2	3.2	1.6	2.6	2.1	2.7	4.8	1.7	6.6	1.1	6.4	22.5	4.7	5.3	3.4	2.4	7.5	1.0	2.4	4.2	0.1	5.1	2.1	6.2	4.8	5.7	4.4	4.2	27.3	10.8	8.2	9.6	4.0	3.2	14.8	14.0	1.2	3.6	5.9	2.3	10.7	1.2	3.8	6.3	8.8	4.6	2.9	2.4	8.8	4.3	7.7	3.5	8.8	2.9	3.7	5.6	5.7	12.5	2.9	6.5	5.9	1.4	3.4	1.4	0.1	2.9	5.6	6.0	7.3	5.9	5.4	3.4	1.3	6.6	2.2	0.5	2.0	0.4	0.8	0.9	0.6	4.0	1.7	0.5	0.6	51.4	1.2	2.4	1.2	3.2	1.6	2.4	7.6	2.5	4.7	4.6	2.6	3.8	2.5	4.1	2.2	14.9	24.3	9.1	8.9	6.2	4.1	3.9	10.2	56.2	20.5	7.0	15.7	1.0	29.9	19.8	39.8	3.6	80.4	0.0	9.5	1.0	3.8	12.9	13.9	33.1	30.8	4.8	11.6	4.3	33.0	23.1	1.1	98.4	13.5	44.1	11.5	36.9	13.5	17.5	2.1	143.3	17.9	0.0	4.7	9.9	1.5	14.8	0.7	17.3	7.8	22.6
GLIPR1	"GliPR, RTVP1"	ENSG00000139278	"GLI pathogenesis related 1"	P48060	12	75480680-75503853	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 76.8"	"Cell type enhanced"	"Detected in many"	8	"Extravillous trophoblasts: 303.3;Hofbauer cells: 220.1;Kupffer cells: 261.5;Macrophages: 237.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"hTEC/SVTERT24-B: 40.8;U-138 MG: 79.5;U-87 MG: 31.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA011014	Approved				"Intracellular and membrane"	NA	NA					"HPA011014: AB_1849714"	"unprognostic (2.32e-3)"	"unprognostic (1.25e-2)"	"unprognostic (1.88e-1)"	"unprognostic (1.41e-2)"	"unprognostic (2.19e-1)"	"unprognostic (3.31e-1)"	"unprognostic (2.32e-3)"	"unprognostic (4.09e-1)"	"unprognostic (7.58e-2)"	"unprognostic (3.10e-1)"	"unprognostic (7.23e-2)"	"unprognostic (1.54e-1)"	"prognostic unfavorable (8.69e-9)"	"unprognostic (9.06e-3)"	"unprognostic (5.08e-2)"	"unprognostic (2.07e-2)"	"unprognostic (1.24e-1)"	32.0	12.5	6.7	30.4	7.5	10.9	11.8	2.5	10.2	14.7	13.1	5.2	6.0	4.5	28.8	19.2	8.0	20.2	23.1	12.7	6.3	5.4	10.3	8.2	18.6	45.4	9.3	6.6	18.3	4.5	1.4	5.6	24.2	11.1	12.3	9.0	7.2	13.7	12.5	3.3	3.7	16.2	27.0	19.6	32.0	15.4	7.2	8.1	8.9	7.3	4.3	20.9	20.6	8.9	15.2	39.7	76.8	55.1	3.0	20.0	34.7	1.4	1.5	1.2	0.1	4.8	10.3	0.2	19.7	20.8	16.6	12.1	0.8	0.6	4.9	4.1	21.3	14.7	0.2	0.0	8.1	27.2	7.9	0.3	0.2	1.8	1.2	5.5	1.7	0.2	9.5	3.0	40.8	9.0	26.8	13.4	0.3	0.3	6.2	31.0	0.0	0.8	4.1	0.1	0.0	0.6	0.2	0.9	0.1	1.7	0.3	0.0	0.0	8.1	0.0	0.0	2.8	0.2	1.4	21.6	79.5	7.5	8.4	30.0	1.1	0.1	0.4	31.5	2.0	1.1	2.8	55.1	6.3	20.0	38.0	13.5	12.0	14.3	15.7	39.7	15.2	4.3	9.1	76.8	3.0	40.6	33.4	14.6	34.7	6.7	7.5	2.5	10.2	6.3	5.4	9.3	6.6	11.1	8.1	11.9	16.5	78.6	66.6	12.0	2.5	0.7	7.6	12.0	4.5	3.5	3.9	3.6	0.0	94.4	10.2	6.3	0.0	0.0	71.1	303.3	25.7	70.6	9.3	3.4	220.1	6.4	3.4	13.5	261.5	4.5	13.3	237.2	15.1	13.6	0.3	2.0	65.0	2.9	50.5	1.4	2.8	12.9	27.4	1.9	1.1	8.5	14.1	117.9	0.1	23.7
GLIPR2	"C9orf19, GAPR-1"	ENSG00000122694	"GLI pathogenesis related 2"	Q9H4G4	9	36136536-36163913	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 92.9"	"Cell type enhanced"	"Detected in many"	8	"Hofbauer cells: 191.0;Macrophages: 162.9;monocytes: 200.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC diff: 26.8;HDLM-2: 25.6;TIME: 45.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029478	Approved		Uncertain	Vesicles,Microtubules		NA	NA		18000000	Vesicles	Microtubules	"HPA029478: AB_10670038"	"unprognostic (1.57e-2)"	"unprognostic (5.70e-3)"	"unprognostic (1.54e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.46e-2)"	"unprognostic (1.33e-2)"	"unprognostic (9.90e-2)"	"unprognostic (2.50e-1)"	"unprognostic (1.84e-2)"	"unprognostic (4.26e-2)"	"unprognostic (3.21e-1)"	"unprognostic (5.87e-2)"	"prognostic unfavorable (6.54e-7)"	"unprognostic (6.57e-3)"	"unprognostic (4.94e-1)"	"unprognostic (1.02e-1)"	"unprognostic (2.43e-2)"	28.5	10.8	8.1	25.5	12.1	32.5	15.6	5.7	11.2	19.9	32.4	23.3	9.1	7.5	40.3	16.8	16.3	18.7	13.0	11.7	9.4	7.1	4.9	3.5	31.2	26.5	14.7	6.5	13.4	2.8	0.4	2.9	4.7	12.3	20.1	17.1	11.6	7.9	21.3	4.8	6.1	14.9	35.5	21.8	21.1	13.8	5.0	13.2	10.1	10.6	7.4	9.4	19.2	14.2	3.3	28.8	92.9	48.6	15.8	24.8	45.5	1.2	1.0	7.6	8.0	26.8	12.8	0.8	12.2	7.4	2.8	5.2	0.4	0.1	0.0	3.8	10.9	7.2	0.0	2.8	0.4	1.7	25.6	2.4	3.0	2.4	0.1	10.6	1.9	10.5	8.6	0.3	16.4	2.8	5.2	22.5	8.2	0.1	1.8	6.5	2.9	9.6	5.2	7.3	0.1	3.9	6.6	16.1	0.3	0.6	0.6	2.0	4.1	1.6	0.8	1.2	16.2	0.8	8.5	45.4	3.9	9.3	3.5	9.8	2.9	0.7	4.4	4.1	12.4	0.9	30.1	48.6	71.9	24.8	22.3	13.1	3.2	17.2	15.8	28.8	3.3	7.3	11.5	92.9	15.8	16.2	2.5	17.6	45.5	8.1	12.1	5.7	9.8	9.4	7.1	14.7	6.5	12.3	13.2	3.0	29.7	14.3	2.0	11.8	0.2	1.6	5.1	40.2	23.9	5.2	0.0	2.7	0.0	16.4	0.6	7.1	4.5	23.3	1.1	2.9	35.5	17.3	51.9	0.4	191.0	0.0	8.1	17.8	102.3	0.9	16.7	162.9	59.1	200.2	27.5	14.0	6.0	10.5	24.4	0.3	0.5	45.3	35.8	1.1	3.2	8.9	2.9	62.3	48.7	2.0
GPR132	G2A	ENSG00000183484	"G protein-coupled receptor 132"	Q9UNW8	14	105049389-105065445	"G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins"	"Stress response"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"blood: 14.0;lymphoid tissue: 20.2"	"Cell type enhanced"	"Detected in some"	11	"B-cells: 8.9;granulocytes: 12.7;Macrophages: 18.8;monocytes: 22.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Group enriched"	"Detected in some"	6	"HDLM-2: 20.3;Karpas-707: 21.0;THP-1: 6.3"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"HPA029694, HPA029695"	Supported					NA	NA					"HPA029694: AB_10600213, HPA029695: AB_10601984"	"unprognostic (2.71e-3)"	"prognostic favorable (3.21e-4)"	"unprognostic (1.68e-2)"	"unprognostic (1.07e-3)"	"unprognostic (1.16e-1)"	"prognostic favorable (6.44e-4)"	"unprognostic (1.82e-1)"	"unprognostic (1.28e-1)"	"unprognostic (3.35e-2)"	"unprognostic (8.54e-2)"	"unprognostic (1.10e-1)"	"unprognostic (4.18e-1)"	"prognostic unfavorable (1.71e-5)"	"unprognostic (6.71e-2)"	"unprognostic (4.60e-2)"	"unprognostic (1.23e-3)"	"unprognostic (2.72e-1)"	2.9	1.2	1.8	11.5	2.7	9.3	1.5	0.7	1.8	1.5	2.4	3.3	0.0	1.3	1.0	1.6	1.4	3.0	2.9	1.4	1.6	1.2	4.5	0.8	5.9	20.2	3.3	1.0	1.1	0.8	0.4	0.9	2.0	2.2	1.4	1.2	1.5	3.0	0.7	0.8	3.5	6.6	1.0	3.7	15.4	2.1	0.6	2.5	4.3	6.5	0.7	17.4	3.1	1.9	8.6	9.1	9.8	14.0	9.3	10.6	6.6	0.0	0.1	0.1	0.1	0.1	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.4	2.7	0.5	0.0	0.0	0.6	0.0	0.0	0.0	20.3	0.3	0.5	0.1	0.0	0.0	1.6	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	21.0	0.0	0.5	0.0	2.0	0.1	0.0	0.0	1.6	0.1	2.3	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	2.3	6.3	0.3	0.0	0.1	0.0	0.2	0.5	1.9	0.2	0.0	1.8	0.0	9.8	9.0	8.6	10.6	12.5	9.9	7.2	8.2	9.2	9.1	8.6	8.6	8.9	7.9	9.3	14.0	5.2	5.8	6.6	1.8	2.7	0.7	1.8	1.6	1.2	3.3	1.0	2.2	2.5	0.0	3.4	8.9	0.1	1.4	0.0	0.6	0.0	0.0	0.0	1.8	0.0	0.0	1.7	0.3	0.0	0.0	0.0	0.0	0.6	0.2	0.4	0.1	12.7	0.0	3.8	0.0	0.0	0.0	7.9	0.0	0.0	18.8	5.0	22.6	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.4	0.0	7.5	0.0	1.0
GPR141	PGR13	ENSG00000187037	"G protein-coupled receptor 141"	Q7Z602	7	37683796-37833788	"G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"bone marrow: 27.6;brain: 18.1"	"Cell type enhanced"	"Detected in some"	23	"Alveolar cells type 2: 4.8;granulocytes: 22.0;Kupffer cells: 8.5;Macrophages: 4.0"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	6	"classical monocyte: 11.4;eosinophil: 8.1;gdT-cell: 4.8;memory CD8 T-cell: 4.5;myeloid DC: 5.8;naive CD8 T-cell: 3.3;neutrophil: 10.7"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"HEL: 7.8;HMC-1: 30.8;NTERA-2: 16.6;THP-1: 4.9;U-937: 13.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (4.91e-2)"	"unprognostic (3.44e-1)"	"unprognostic (3.26e-4)"	"unprognostic (4.70e-3)"	"unprognostic (8.67e-2)"	"unprognostic (2.00e-2)"	"unprognostic (3.01e-1)"	"unprognostic (2.51e-2)"	"unprognostic (7.93e-3)"	"unprognostic (1.44e-1)"	"unprognostic (1.51e-2)"	"unprognostic (1.05e-1)"	"unprognostic (3.68e-3)"	"unprognostic (1.39e-2)"	"unprognostic (4.14e-2)"	"unprognostic (1.79e-1)"	"unprognostic (1.60e-1)"	1.7	0.9	2.5	4.4	3.3	27.6	0.9	1.0	3.2	1.9	1.4	0.6	0.0	1.0	1.9	2.0	1.8	1.5	3.7	1.7	3.2	1.4	1.2	1.3	4.3	10.0	5.3	0.7	0.6	1.5	0.3	1.0	2.8	5.8	2.0	2.0	2.7	1.7	0.5	0.6	1.2	1.8	1.8	18.1	10.0	1.2	1.5	5.1	2.9	1.1	1.0	2.1	4.8	2.3	0.0	5.8	10.7	11.4	0.6	4.8	3.4	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	7.8	0.6	0.0	0.0	0.1	30.8	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.7	16.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	4.9	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	13.0	0.0	0.0	11.4	8.1	4.8	0.9	0.0	0.0	1.2	4.5	5.8	0.0	0.5	3.3	10.7	0.6	0.1	0.2	0.0	3.4	2.5	3.3	1.0	3.2	3.2	1.4	5.3	0.7	5.8	5.1	3.0	4.8	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	22.0	0.0	0.8	0.0	0.0	0.0	8.5	0.6	0.0	4.0	0.0	1.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.2	0.3	0.1	0.2	0.5	0.0	0.0
GPR183	EBI2	ENSG00000169508	"G protein-coupled receptor 183"	P32249	13	99294530-99307405	"G-protein coupled receptors, Predicted membrane proteins"	"Adaptive immunity, Immunity"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 101.7"	"Cell type enhanced"	"Detected in many"	15	"B-cells: 189.0;Macrophages: 550.4;monocytes: 424.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Group enriched"	"Detected in some"	22	"HDLM-2: 53.8;HL-60: 36.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA028847, CAB033690, HPA075590"	Approved		Approved	"Nuclear membrane,Vesicles"		NA	NA			"Nuclear membrane, Vesicles"		"CAB033690: AB_2114269, HPA028847: AB_10603672, HPA075590: "	"unprognostic (3.28e-3)"	"prognostic favorable (9.77e-4)"	"unprognostic (6.03e-2)"	"unprognostic (4.61e-3)"	"unprognostic (3.45e-1)"	"unprognostic (7.11e-2)"	"unprognostic (1.71e-1)"	"unprognostic (6.29e-2)"	"unprognostic (2.12e-1)"	"unprognostic (1.23e-1)"	"unprognostic (5.75e-2)"	"unprognostic (2.33e-1)"	"unprognostic (4.50e-3)"	"unprognostic (4.49e-3)"	"unprognostic (1.97e-3)"	"unprognostic (9.31e-3)"	"unprognostic (9.86e-3)"	27.0	5.5	3.1	33.8	5.0	40.8	7.6	1.1	2.9	5.9	11.2	7.5	4.5	3.2	3.8	9.2	9.3	6.4	17.3	11.7	4.8	6.1	5.4	7.2	26.5	53.7	7.5	2.6	4.4	2.1	2.1	4.8	11.1	9.3	7.4	9.2	4.8	6.6	2.0	4.1	5.3	19.2	9.0	31.3	46.5	6.0	3.7	7.4	13.2	6.5	8.3	38.9	34.9	5.2	46.8	30.6	101.7	1.2	55.0	60.2	27.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.1	53.8	0.0	0.4	0.1	0.0	0.0	36.8	0.1	0.0	0.0	0.5	0.0	0.0	0.0	2.0	0.8	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.1	0.2	0.0	101.7	1.2	46.1	5.7	0.4	34.0	46.8	60.2	30.9	9.3	19.1	38.1	5.2	1.2	55.0	0.4	30.6	47.3	27.8	3.1	5.0	1.1	2.9	4.8	6.1	7.5	2.6	9.3	7.4	14.9	41.9	189.0	0.4	54.7	0.2	1.8	0.0	6.7	10.3	0.0	5.9	0.9	1.7	0.1	0.6	2.3	0.0	0.0	2.5	1.3	21.6	0.4	60.0	0.5	114.3	0.0	0.0	0.6	92.9	1.3	0.3	550.4	138.3	424.8	0.0	0.1	0.7	0.0	0.0	0.3	0.8	6.5	3.6	0.5	0.2	46.7	1.5	126.8	0.0	0.3
GPR34		ENSG00000171659	"G protein-coupled receptor 34"	Q9UPC5	X	41688973-41697277	"G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"blood: 60.8"	"Cell type enhanced"	"Detected in some"	23	"granulocytes: 35.9;Hofbauer cells: 198.9;Kupffer cells: 113.1;Macrophages: 46.2"	"Cancer enhanced"	"Detected in all"		"glioma: 26.1"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	14	"basophil: 60.8;eosinophil: 25.3"	"Lineage enriched"	"Detected in many"	20	"granulocytes: 60.8"	"Cell line enhanced"	"Detected in some"		"HMC-1: 5.0;JURKAT: 2.6;U-937: 1.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA010668, CAB025490"	Uncertain		Uncertain	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"CAB025490: , HPA010668: AB_1849294"	"unprognostic (1.26e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.43e-2)"	"unprognostic (1.44e-2)"	"unprognostic (1.20e-1)"	"unprognostic (3.74e-2)"	"unprognostic (5.83e-3)"	"unprognostic (5.13e-2)"	"unprognostic (1.59e-2)"	"unprognostic (9.81e-3)"	"unprognostic (7.19e-2)"	"unprognostic (1.74e-1)"	"unprognostic (3.96e-1)"	"unprognostic (2.72e-3)"	"unprognostic (1.14e-1)"	"unprognostic (1.88e-3)"	"unprognostic (3.18e-2)"	25.1	12.4	15.1	9.7	16.6	0.4	15.0	2.1	11.7	10.5	9.1	13.5	1.0	4.4	4.9	6.6	5.8	5.5	12.2	5.9	16.0	9.5	11.7	5.3	11.4	26.8	22.4	7.5	5.4	4.4	2.8	3.3	29.3	15.4	5.7	9.3	4.9	7.1	6.4	2.1	2.4	11.4	11.5	34.0	22.3	5.1	5.0	21.4	1.9	3.4	1.5	11.1	12.5	3.7	0.3	0.4	60.8	2.8	3.0	0.1	0.5	0.2	0.2	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.4	1.0	0.4	0.0	0.2	0.0	0.1	5.0	0.3	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.3	0.0	0.0	0.2	0.7	0.3	0.0	0.4	0.1	1.1	0.0	0.3	0.1	0.3	0.2	0.0	0.0	0.0	0.5	0.0	0.3	0.0	0.4	0.1	0.8	0.1	0.0	0.0	0.1	0.6	1.3	0.0	60.8	2.2	25.3	0.0	2.8	0.0	0.3	0.1	0.0	0.4	0.1	0.0	0.0	0.2	3.0	1.5	0.0	0.1	0.5	15.1	16.6	2.1	11.7	16.0	9.5	22.4	7.5	15.4	21.4	0.0	3.2	2.7	0.2	0.6	0.0	0.8	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.3	0.3	0.0	0.0	0.0	1.3	1.7	0.1	35.9	0.0	198.9	0.0	1.2	3.1	113.1	0.6	0.9	46.2	1.7	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.7	19.4	0.0	0.0	0.1	0.9	2.1	1.7	0.0	0.0
GPR82		ENSG00000171657	"G protein-coupled receptor 82"	Q96P67	X	41724155-41730135	"G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"blood: 23.2;lymphoid tissue: 12.0"	"Cell type enhanced"	"Detected in many"	5	"Cone photoreceptor cells: 19.6;Kupffer cells: 18.0;Macrophages: 18.7;T-cells: 20.2"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	9	"eosinophil: 23.2;NK-cell: 6.6"	"Group enriched"	"Detected in many"	9	"granulocytes: 23.2;NK-cells: 6.6"	"Cell line enriched"	"Detected in single"	16	"HMC-1: 9.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA035914	Approved					NA	NA					"HPA035914: AB_10670671"	"unprognostic (5.62e-3)"	"unprognostic (1.81e-2)"	"unprognostic (4.65e-2)"	"unprognostic (3.88e-3)"	"unprognostic (1.15e-2)"	"unprognostic (3.28e-2)"	"unprognostic (4.62e-4)"	"unprognostic (1.41e-3)"	"unprognostic (2.12e-2)"	"unprognostic (5.00e-2)"	"unprognostic (1.39e-1)"	"unprognostic (3.01e-1)"	"unprognostic (7.45e-2)"	"unprognostic (2.37e-2)"	"unprognostic (2.26e-1)"	"unprognostic (8.00e-3)"	"unprognostic (1.18e-1)"	1.2	2.2	1.6	3.9	5.9	0.2	1.1	0.6	1.5	0.9	2.7	0.3	0.0	3.0	0.8	1.1	1.1	1.1	1.1	0.7	2.5	1.1	4.7	5.0	10.0	9.0	2.5	0.1	0.7	1.5	0.1	1.1	0.3	3.2	1.1	2.1	0.8	0.8	0.7	0.4	0.7	5.2	0.6	7.3	3.6	1.6	0.4	2.3	1.6	0.8	0.6	12.0	2.4	0.9	0.1	0.2	23.2	1.6	6.6	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.6	0.0	0.0	0.0	0.1	0.2	0.0	0.1	0.0	0.0	0.1	0.2	0.2	0.0	0.0	0.3	9.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.1	0.2	0.0	0.0	0.1	0.1	0.0	0.1	0.1	0.0	0.1	0.2	0.0	0.0	0.1	0.2	23.2	0.0	1.6	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.2	6.6	1.4	0.0	0.0	0.1	1.6	5.9	0.6	1.5	2.5	1.1	2.5	0.1	3.2	2.3	0.0	11.1	5.2	4.1	4.1	14.7	0.3	0.0	1.4	9.1	1.8	19.6	0.7	0.0	1.8	0.2	2.2	3.9	0.0	1.0	0.2	5.1	2.7	0.0	0.8	1.3	12.7	1.2	4.3	18.0	0.0	3.7	18.7	3.3	1.8	1.3	0.9	1.7	4.2	2.8	0.0	16.7	0.0	3.8	1.0	1.1	2.4	0.6	20.2	3.2	3.1
GPR84	EX33	ENSG00000139572	"G protein-coupled receptor 84"	Q9NQS5	12	54362445-54364487	"G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 27.2"	"Group enriched"	"Detected in some"	5	"Hofbauer cells: 20.5;Macrophages: 17.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	23	"basophil: 6.0;classical monocyte: 8.7;myeloid DC: 12.9;neutrophil: 5.3"	"Group enriched"	"Detected in many"	53	"dendritic cells: 12.9;granulocytes: 6.0;monocytes: 8.7"	"Group enriched"	"Detected in some"	5	"HL-60: 9.4;NB-4: 29.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA027603	Enhanced					NA	NA					"HPA027603: AB_10612115"	"unprognostic (5.40e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.19e-1)"	"unprognostic (3.92e-2)"	"unprognostic (2.36e-2)"	"unprognostic (4.54e-2)"	"unprognostic (6.16e-3)"	"unprognostic (7.43e-2)"	"unprognostic (9.29e-2)"	"unprognostic (1.37e-1)"	"unprognostic (2.34e-2)"	"unprognostic (2.92e-1)"	"unprognostic (1.36e-9)"	"unprognostic (1.27e-1)"	"unprognostic (4.42e-2)"	"unprognostic (1.40e-1)"	"unprognostic (9.44e-2)"	7.2	2.3	2.7	11.2	6.8	27.2	0.7	0.4	3.3	1.0	0.9	5.0	0.0	0.8	0.6	0.9	1.1	1.7	1.8	3.2	1.6	2.1	2.4	0.8	5.3	2.7	4.4	0.0	2.7	1.0	0.7	2.3	6.7	5.0	1.2	1.3	0.7	1.2	0.7	1.1	1.4	0.8	2.8	6.7	8.0	1.2	2.1	7.5	0.9	2.1	0.0	2.8	3.0	2.1	0.0	12.9	6.0	8.7	0.0	0.1	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	9.4	1.6	0.1	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	29.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	2.3	3.7	0.0	6.0	8.7	0.0	0.0	0.3	0.0	0.0	0.0	0.1	12.9	0.0	0.0	0.0	5.3	0.0	0.0	0.0	0.0	1.8	2.7	6.8	0.4	3.3	1.6	2.1	4.4	0.0	5.0	7.5	0.0	0.3	0.0	0.1	0.8	2.9	0.1	0.0	0.0	1.2	0.0	3.9	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.4	0.1	0.0	0.0	20.5	0.0	0.0	0.0	2.7	0.0	0.0	17.9	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.6	0.0	0.2	0.4	0.0	0.4	0.7	0.0	0.0	0.0
GPSM3	"AGS4, C6orf9, G18, G18.1a, G18.1b, G18.2, NG1"	ENSG00000213654	"G protein signaling modulator 3"	Q9Y4H4	6	32190766-32195523	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 29.9;lymphoid tissue: 66.2"	"Group enriched"	"Detected in many"	5	"B-cells: 274.2;Hofbauer cells: 247.8;Kupffer cells: 319.4;Macrophages: 253.8;monocytes: 287.7;T-cells: 292.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Lineage enriched"	"Detected in all"	4	"granulocytes: 29.9"	"Cell line enhanced"	"Detected in many"		"HMC-1: 26.4;NB-4: 14.6;THP-1: 15.3;U-937: 9.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"									NA	NA		160000				"unprognostic (2.93e-2)"	"unprognostic (2.51e-2)"	"unprognostic (2.02e-2)"	"prognostic favorable (5.98e-4)"	"unprognostic (3.55e-1)"	"unprognostic (3.07e-2)"	"unprognostic (3.66e-1)"	"unprognostic (6.61e-2)"	"unprognostic (4.48e-2)"	"unprognostic (1.29e-1)"	"unprognostic (3.34e-2)"	"unprognostic (1.12e-1)"	"prognostic unfavorable (6.92e-9)"	"unprognostic (2.01e-2)"	"unprognostic (1.69e-2)"	"unprognostic (5.47e-2)"	"unprognostic (5.87e-2)"	7.1	3.3	3.4	28.8	5.3	20.6	4.4	1.3	3.6	2.3	3.9	5.2	0.4	3.4	2.2	4.2	4.1	4.2	5.5	4.7	3.6	3.0	5.2	5.1	17.3	32.2	5.3	1.0	2.1	1.9	0.8	2.5	6.1	4.7	4.0	4.0	4.7	7.2	1.8	1.2	2.5	18.4	2.2	9.1	66.2	4.8	2.0	4.6	53.0	3.4	1.5	33.3	8.1	3.4	5.7	6.3	29.9	6.6	3.4	7.4	4.6	0.1	0.0	0.4	0.3	0.0	0.0	0.1	0.4	1.6	0.7	0.9	0.1	0.6	4.4	2.1	0.7	0.0	0.1	0.0	1.1	0.7	5.5	0.1	6.2	0.0	0.2	1.8	0.0	26.4	0.5	0.0	0.2	0.9	0.3	3.0	4.8	2.9	7.4	0.1	0.0	3.1	14.6	0.0	0.0	0.0	2.5	0.3	6.7	0.3	0.0	0.0	0.2	0.0	0.0	0.9	1.0	0.2	15.3	2.9	0.4	1.2	0.0	0.3	0.3	0.3	4.8	0.1	9.0	1.6	4.6	6.5	19.2	5.2	6.6	4.8	5.7	6.9	6.0	6.3	5.3	7.4	5.6	29.9	3.4	6.4	4.4	4.7	4.6	3.4	5.3	1.3	3.6	3.6	3.0	5.3	1.0	4.7	4.6	0.0	2.1	274.2	11.5	10.0	0.0	0.3	2.5	0.0	2.3	3.5	0.0	2.9	0.0	8.2	3.9	21.7	0.5	0.0	4.6	4.3	7.7	4.9	58.6	2.8	247.8	0.0	1.2	23.4	319.4	9.5	1.1	253.8	42.2	287.7	5.7	0.4	12.5	14.4	0.0	2.0	0.3	6.5	8.5	0.6	2.5	7.4	5.3	292.4	4.0	20.7
HACD4	"Em:AL662879.1, PTPLAD2"	ENSG00000188921	"3-hydroxyacyl-CoA dehydratase 4"	Q5VWC8	9	20999515-21031636	"Enzymes, Predicted membrane proteins"	"Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism"	Lyase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	8	"Alveolar cells type 1: 44.7;Ciliated cells: 89.7;Hofbauer cells: 50.9;Kupffer cells: 90.6;Macrophages: 52.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 15.8;HDLM-2: 9.6;TIME: 7.9;U-937: 12.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA058666	Uncertain					NA	NA					"HPA058666: AB_2683793"	"unprognostic (1.71e-1)"	"unprognostic (2.58e-2)"	"unprognostic (5.47e-2)"	"unprognostic (1.70e-2)"	"unprognostic (7.66e-2)"	"unprognostic (1.87e-2)"	"unprognostic (2.21e-1)"	"unprognostic (1.28e-2)"	"unprognostic (1.11e-4)"	"prognostic favorable (3.14e-4)"	"unprognostic (8.72e-2)"	"unprognostic (1.63e-1)"	"prognostic unfavorable (6.77e-4)"	"unprognostic (3.89e-3)"	"unprognostic (7.33e-2)"	"unprognostic (1.77e-2)"	"unprognostic (2.00e-3)"	4.3	7.9	4.9	9.2	7.1	16.3	10.3	3.3	3.1	8.9	10.1	2.6	1.2	3.2	6.9	5.6	10.7	6.5	7.6	7.5	4.1	3.2	3.3	1.8	24.1	18.2	5.2	1.8	6.5	1.9	4.0	2.3	9.9	3.7	5.9	5.0	6.3	3.6	3.8	1.5	4.7	7.5	11.5	9.6	10.1	5.4	1.8	5.5	19.9	4.1	6.2	7.9	5.1	5.6	1.2	8.4	13.6	8.8	3.0	3.0	3.9	3.7	1.1	0.4	0.1	0.0	0.1	0.1	3.4	15.8	2.8	3.2	0.0	0.0	3.4	1.9	6.7	0.0	1.0	0.2	1.4	3.5	9.6	0.1	0.0	1.2	0.0	2.2	2.8	3.0	6.4	6.2	2.5	0.0	0.0	0.9	3.9	0.0	2.0	0.5	0.1	0.0	3.9	0.8	0.0	0.0	0.0	0.0	0.1	0.1	0.5	0.6	0.0	0.8	0.3	0.0	2.3	2.8	5.3	7.9	0.0	0.0	0.2	0.1	0.1	0.1	0.1	0.0	12.1	0.1	13.6	7.1	11.4	2.2	8.8	2.0	1.2	2.4	2.5	8.4	1.2	1.7	2.4	10.2	3.0	8.5	0.9	3.0	3.9	4.9	7.1	3.3	3.1	4.1	3.2	5.2	1.8	3.7	5.5	44.7	6.7	16.7	9.5	0.0	1.4	1.6	0.0	89.7	20.5	12.2	0.0	10.0	5.0	0.5	0.4	3.3	0.0	0.0	0.4	30.5	7.8	3.2	3.5	1.3	50.9	0.0	0.0	9.8	90.6	0.0	3.4	52.2	0.0	14.4	0.0	6.7	0.1	0.0	1.1	5.1	1.5	12.9	7.3	0.3	1.3	0.0	4.2	28.8	0.1	3.8
HAVCR2	"CD366, FLJ14428, Tim-3, TIM3, TIMD3"	ENSG00000135077	"Hepatitis A virus cellular receptor 2"	Q8TDQ0	5	157085832-157142869	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Adaptive immunity, Immunity, Inflammatory response, Innate immunity"		"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 34.6"	"Cell type enhanced"	"Detected in many"	12	"granulocytes: 80.6;Hofbauer cells: 135.6;Kupffer cells: 75.1;Macrophages: 74.2;monocytes: 60.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"classical monocyte: 13.2;intermediate monocyte: 14.5;myeloid DC: 34.6;NK-cell: 24.1;non-classical monocyte: 8.6"	"Group enriched"	"Detected in many"	6	"dendritic cells: 34.6;monocytes: 14.5;NK-cells: 24.1"	"Cell line enhanced"	"Detected in some"		"ASC diff: 5.9;Daudi: 3.9;HDLM-2: 17.4;HMC-1: 4.3;RPMI-8226: 14.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			CAB026003	Enhanced					NA	NA		2900000			"CAB026003: "	"unprognostic (2.50e-2)"	"unprognostic (1.11e-2)"	"unprognostic (5.18e-2)"	"unprognostic (2.04e-3)"	"unprognostic (3.79e-2)"	"unprognostic (1.14e-1)"	"unprognostic (6.69e-2)"	"unprognostic (2.54e-1)"	"unprognostic (9.18e-2)"	"unprognostic (1.42e-1)"	"unprognostic (8.48e-2)"	"unprognostic (5.13e-2)"	"unprognostic (7.83e-2)"	"unprognostic (1.89e-1)"	"unprognostic (1.83e-2)"	"unprognostic (2.13e-1)"	"unprognostic (1.34e-1)"	16.8	8.6	9.3	16.0	12.3	10.3	6.5	8.4	10.7	5.1	5.3	15.5	1.8	4.1	3.9	5.9	4.2	5.3	11.4	4.8	9.8	9.3	23.3	8.9	19.8	21.7	15.5	7.5	4.4	3.8	2.4	5.5	14.3	11.3	4.2	6.5	4.1	6.2	3.1	3.3	3.1	6.0	7.2	24.8	23.1	4.2	5.8	12.1	4.7	3.8	2.9	11.1	10.3	2.9	0.3	34.6	3.1	14.5	24.1	3.8	9.7	0.0	0.1	0.1	0.1	5.9	0.1	0.6	0.0	0.1	0.0	0.0	0.0	0.1	3.9	0.3	0.0	0.1	0.1	0.0	0.0	0.0	17.4	0.0	0.8	0.0	0.0	0.0	0.0	4.3	0.2	0.3	0.0	0.1	0.0	0.0	0.4	0.1	2.1	0.0	0.0	0.1	2.8	0.2	0.0	0.0	0.1	2.2	14.2	0.2	0.0	0.1	0.1	0.0	0.1	0.2	0.5	0.1	0.2	0.0	0.7	0.3	0.2	0.0	0.3	1.2	0.2	0.1	0.4	0.1	3.1	13.2	0.0	3.8	14.5	0.8	0.3	1.6	2.0	34.6	0.1	2.0	2.9	0.7	24.1	8.6	4.1	3.1	9.7	9.3	12.3	8.4	10.7	9.8	9.3	15.5	7.5	11.3	12.1	6.0	9.2	10.3	0.1	0.9	1.0	0.8	0.0	0.0	3.4	0.0	0.0	0.6	6.6	0.0	10.7	0.9	0.0	0.0	0.0	0.7	1.3	0.5	80.6	0.0	135.6	0.0	0.0	1.3	75.1	6.0	0.3	74.2	3.3	60.5	0.0	0.1	0.1	0.0	0.0	38.9	0.0	6.5	0.7	0.2	0.5	1.1	0.9	28.7	0.1	0.4
HCLS1	"CTTNL, HS1"	ENSG00000180353	"Hematopoietic cell-specific Lyn substrate 1"	P14317	3	121631399-121660927	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 149.7;lymphoid tissue: 110.1"	"Cell type enhanced"	"Detected in many"	15	"Kupffer cells: 535.9;Macrophages: 194.3;monocytes: 183.1;T-cells: 152.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Daudi: 43.1;HMC-1: 61.2;Karpas-707: 39.8;RPMI-8226: 40.9;THP-1: 42.7;U-266/70: 60.6;U-698: 60.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA019143	Enhanced		Supported	"Plasma membrane,Cytosol"		NA	NA		200000	"Plasma membrane, Cytosol"		"HPA019143: AB_1850532"	"unprognostic (2.27e-2)"	"unprognostic (1.79e-3)"	"unprognostic (5.38e-3)"	"unprognostic (6.29e-2)"	"unprognostic (1.01e-2)"	"unprognostic (4.02e-3)"	"unprognostic (2.35e-1)"	"unprognostic (4.88e-3)"	"unprognostic (1.70e-2)"	"unprognostic (1.19e-1)"	"unprognostic (6.76e-2)"	"unprognostic (2.28e-1)"	"unprognostic (1.03e-3)"	"unprognostic (2.93e-1)"	"unprognostic (3.46e-2)"	"unprognostic (2.60e-2)"	"unprognostic (2.01e-1)"	24.7	10.7	7.8	44.9	14.7	35.5	9.1	1.3	7.4	6.3	10.4	8.5	2.2	5.5	5.6	8.2	4.8	9.1	10.1	7.5	6.7	5.0	10.5	10.1	18.7	59.4	12.9	3.2	4.6	5.1	1.4	6.1	15.4	10.9	6.1	8.6	4.9	7.4	3.1	7.0	4.6	23.0	8.9	15.1	110.1	7.1	3.6	11.6	41.0	6.1	4.4	61.5	12.5	5.6	33.4	59.6	149.7	84.9	24.3	44.1	103.5	0.1	0.0	0.0	0.0	3.6	2.0	0.9	0.6	0.6	0.1	0.2	0.0	0.0	43.1	21.0	0.0	0.0	0.0	1.1	1.6	0.1	19.2	0.0	27.9	0.0	0.0	2.0	30.6	61.2	0.3	0.0	0.0	0.3	0.0	25.4	17.6	5.5	39.8	0.0	0.0	21.7	25.9	0.0	0.0	0.7	22.0	0.0	40.9	0.0	11.2	0.0	0.0	0.0	0.0	0.1	0.1	0.0	42.7	33.1	0.0	0.3	0.0	0.1	60.6	18.4	60.6	0.3	29.5	0.0	26.6	64.1	104.2	40.2	80.6	32.9	33.4	33.3	36.8	59.6	29.4	28.5	33.0	149.7	24.3	84.9	18.5	44.1	103.5	7.8	14.7	1.3	7.4	6.7	5.0	12.9	3.2	10.9	11.6	8.9	51.2	119.0	0.8	2.9	0.4	1.7	7.6	18.7	12.5	0.0	0.0	96.0	0.0	0.3	0.8	14.6	0.1	23.3	0.2	50.7	6.0	0.3	70.6	2.1	117.6	0.0	0.0	33.2	535.9	0.9	3.1	194.3	18.6	183.1	0.3	0.6	0.3	0.0	1.1	0.6	0.7	12.9	6.6	0.3	0.6	3.9	121.6	152.2	0.2	1.8
HCST	"DAP10, DKFZP586C1522, KAP10, PIK3AP"	ENSG00000126264	"Hematopoietic cell signal transducer"	Q9UBK5	19	35902480-35904377	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"blood: 134.0;bone marrow: 84.0;lymphoid tissue: 79.1"	"Group enriched"	"Detected in many"	5	"granulocytes: 237.5;Hofbauer cells: 491.9;Kupffer cells: 329.9;Macrophages: 424.4;T-cells: 835.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"HEL: 52.9;HL-60: 30.5;HMC-1: 35.3;THP-1: 40.0;U-937: 60.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB034435, HPA063026"	Enhanced		Supported	"Golgi apparatus,Vesicles,Plasma membrane"		NA	NA			"Golgi apparatus, Plasma membrane"	Vesicles	"CAB034435: AB_2117803, HPA063026: "	"unprognostic (1.40e-3)"	"unprognostic (3.07e-2)"	"unprognostic (3.04e-2)"	"unprognostic (7.27e-3)"	"unprognostic (1.23e-1)"	"unprognostic (8.23e-3)"	"unprognostic (1.85e-1)"	"unprognostic (2.54e-1)"	"prognostic favorable (6.70e-4)"	"unprognostic (5.97e-2)"	"unprognostic (1.94e-3)"	"unprognostic (1.02e-1)"	"prognostic unfavorable (1.59e-10)"	"unprognostic (3.78e-1)"	"unprognostic (3.25e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.56e-1)"	29.4	4.0	6.5	19.9	5.2	84.0	5.9	1.4	3.1	3.9	4.9	4.8	0.5	4.5	5.4	6.0	3.0	4.5	6.3	7.3	5.7	5.9	5.6	6.9	38.4	79.1	7.7	2.2	3.4	2.9	0.7	4.3	10.6	4.9	5.5	3.6	7.1	6.2	3.7	2.4	2.8	10.9	4.5	12.7	49.5	5.6	1.7	4.4	56.8	3.4	3.3	26.7	5.2	3.6	6.1	66.6	15.9	57.0	96.4	134.0	89.5	0.2	0.0	0.0	0.1	0.2	0.0	0.0	0.4	0.2	0.0	0.1	0.2	0.2	5.7	0.3	0.4	0.1	0.2	0.0	0.0	0.0	0.1	0.0	52.9	0.1	0.1	0.1	30.5	35.3	0.3	0.0	0.0	0.0	0.1	0.0	3.2	0.4	7.6	0.1	0.0	3.5	11.9	0.0	0.0	0.1	0.1	0.1	0.4	0.1	0.0	0.2	0.0	0.2	0.1	0.1	0.0	0.1	40.0	0.1	0.3	0.4	0.0	0.0	0.3	0.2	8.7	0.3	60.0	0.0	7.3	57.0	7.9	134.0	42.0	99.3	6.1	57.4	108.5	32.6	3.7	48.3	96.4	15.9	96.4	23.0	66.6	48.5	89.5	6.5	5.2	1.4	3.1	5.7	5.9	7.7	2.2	4.9	4.4	6.0	65.6	87.2	1.1	25.3	0.2	0.8	5.1	8.1	11.4	8.7	0.0	3.2	0.0	2.1	0.3	9.0	1.4	0.0	1.0	3.2	13.1	0.6	237.5	11.3	491.9	1.6	0.0	19.6	329.9	1.8	2.0	424.4	42.2	31.5	0.7	0.2	1.1	0.9	0.0	4.4	1.9	19.4	1.9	1.7	2.8	18.3	5.0	835.8	1.7	0.8
HK3		ENSG00000160883	"Hexokinase 3"	P52790	5	176880869-176899332	"Enzymes, Plasma proteins, Predicted intracellular proteins"	Glycolysis	"Allosteric enzyme, Kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 76.2;bone marrow: 55.0;lymphoid tissue: 40.6"	"Group enriched"	"Detected in some"	13	"Hofbauer cells: 32.3;Kupffer cells: 47.9;Macrophages: 21.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Cell type enhanced"	"Detected in many"		"basophil: 76.2"	"Group enriched"	"Detected in many"	11	"granulocytes: 76.2;monocytes: 31.4"	"Cell line enriched"	"Detected in some"	4	"U-937: 21.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA056743	Enhanced					NA	NA		1700000			"HPA056743: AB_2683222"	"unprognostic (4.22e-2)"	"unprognostic (4.07e-2)"	"unprognostic (1.23e-1)"	"unprognostic (8.63e-2)"	"unprognostic (2.02e-2)"	"unprognostic (1.39e-1)"	"unprognostic (8.69e-2)"	"unprognostic (2.11e-1)"	"unprognostic (5.37e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.96e-2)"	"unprognostic (3.82e-1)"	"prognostic unfavorable (3.84e-8)"	"unprognostic (7.02e-2)"	"unprognostic (6.01e-3)"	"unprognostic (1.46e-1)"	"unprognostic (5.42e-2)"	9.2	2.6	0.6	8.5	1.0	55.0	1.3	0.3	1.2	0.4	1.7	0.3	0.0	0.9	0.8	2.6	1.9	3.0	0.9	5.4	0.6	0.3	1.6	4.1	16.3	24.1	1.2	0.5	1.2	1.0	0.0	0.4	2.9	0.5	0.9	0.6	0.9	0.9	0.1	0.8	0.3	1.6	3.4	0.6	40.6	1.2	0.6	0.2	1.3	1.5	0.2	1.2	1.8	5.3	0.0	5.1	76.2	31.4	0.0	0.0	6.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	4.8	0.1	0.3	0.0	0.0	0.0	0.0	3.8	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	21.3	0.0	76.2	15.4	32.9	0.0	29.5	0.0	0.0	0.0	0.0	5.1	0.0	0.0	0.0	5.4	0.0	31.4	0.2	0.0	6.0	0.6	1.0	0.3	1.2	0.6	0.3	1.2	0.5	0.5	0.2	0.0	1.4	0.9	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.1	0.2	32.3	0.0	0.0	0.6	47.9	0.0	0.0	21.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.2	0.1	0.1	0.2	0.0	0.0	0.0
HLA-DMA	"D6S222E, RING6"	ENSG00000204257	"Major histocompatibility complex, class II, DM alpha"	P28067	6	32948613-32969094	"Predicted intracellular proteins, Predicted membrane proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	10	"B-cells: 394.3;Hofbauer cells: 370.5;Kupffer cells: 264.8;Macrophages: 648.8;monocytes: 269.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"classical monocyte: 4.1;intermediate monocyte: 4.0;memory B-cell: 6.8;myeloid DC: 7.9;naive B-cell: 7.0;plasmacytoid DC: 5.7"	"Group enriched"	"Detected in many"	12	"B-cells: 7.0;dendritic cells: 7.9;monocytes: 4.1"	"Group enriched"	"Detected in some"	4	"U-266/70: 15.7;U-698: 40.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA012750, HPA017295"	Enhanced		Approved	Vesicles		NA	NA			Vesicles		"HPA012750: AB_1853926, HPA017295: AB_2669575"	"unprognostic (1.69e-3)"	"unprognostic (3.52e-2)"	"unprognostic (8.03e-2)"	"prognostic favorable (4.64e-5)"	"unprognostic (3.99e-1)"	"unprognostic (3.90e-2)"	"unprognostic (1.60e-1)"	"prognostic favorable (4.59e-4)"	"unprognostic (7.01e-2)"	"unprognostic (9.69e-2)"	"unprognostic (6.66e-2)"	"unprognostic (1.89e-1)"	"unprognostic (2.12e-3)"	"unprognostic (1.41e-1)"	"unprognostic (4.95e-2)"	"unprognostic (3.80e-1)"	"unprognostic (2.14e-2)"	22.9	20.5	5.1	27.2	7.9	18.9	17.4	1.0	5.0	11.3	18.4	9.8	5.7	3.2	8.0	25.3	6.7	32.1	11.1	13.1	4.6	5.2	19.3	12.4	50.7	24.5	10.1	2.0	14.9	20.2	2.1	5.0	3.2	9.7	7.6	14.3	8.4	17.3	10.1	4.3	7.3	28.4	4.3	15.2	38.5	23.1	3.5	7.9	17.3	10.0	11.9	42.1	5.9	6.0	7.0	7.9	0.5	4.1	0.3	0.4	3.1	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.3	0.8	0.0	0.0	0.2	0.1	0.0	1.3	0.2	0.0	0.0	0.2	1.9	0.2	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	15.7	6.9	40.0	0.3	0.0	0.0	0.0	4.1	0.4	0.2	4.0	0.0	6.8	0.1	0.3	7.9	7.0	0.1	0.2	0.5	0.3	1.1	5.7	0.4	3.1	5.1	7.9	1.0	5.0	4.6	5.2	10.1	2.0	9.7	7.9	68.5	147.1	394.3	13.3	42.8	1.6	3.6	50.9	37.5	51.2	50.6	2.0	3.8	14.9	38.3	2.8	85.6	22.0	23.3	46.1	3.5	19.8	18.9	40.4	2.9	370.5	0.0	2.9	32.5	264.8	4.3	15.0	648.8	75.9	269.7	18.9	4.1	34.9	15.3	17.7	36.3	0.8	19.4	18.6	3.6	4.4	36.6	3.3	44.0	22.6	27.6
HLA-DMB	"D6S221E, RING7"	ENSG00000242574	"Major histocompatibility complex, class II, DM beta"	P28068	6	32934629-32941070	"Predicted intracellular proteins, Predicted membrane proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"B-cells: 222.5;Hofbauer cells: 281.2;Kupffer cells: 131.2;Macrophages: 353.4;monocytes: 112.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in all"	6	"B-cells: 19.9;dendritic cells: 11.5;monocytes: 11.9"	"Group enriched"	"Detected in some"	13	"CAPAN-2: 7.3;Daudi: 10.3;EFO-21: 4.9;U-266/70: 3.9;U-698: 12.6"									"HPA012298, HPA077524"	Supported		Supported	Vesicles		NA	NA			Vesicles		"HPA012298: AB_1853927, HPA077524: "	"unprognostic (5.34e-2)"	"unprognostic (1.63e-2)"	"unprognostic (2.45e-2)"	"prognostic favorable (3.89e-5)"	"unprognostic (3.07e-1)"	"unprognostic (7.64e-3)"	"unprognostic (4.00e-1)"	"unprognostic (3.46e-3)"	"unprognostic (6.99e-2)"	"unprognostic (8.76e-2)"	"unprognostic (8.93e-2)"	"unprognostic (2.73e-1)"	"unprognostic (6.82e-3)"	"unprognostic (2.03e-1)"	"unprognostic (4.14e-2)"	"unprognostic (8.35e-2)"	"unprognostic (5.60e-2)"	12.0	13.0	5.9	20.2	7.5	4.3	7.9	0.4	4.9	8.1	9.7	8.8	2.1	1.2	6.2	10.2	3.3	12.6	6.0	8.0	5.7	4.2	13.1	5.4	20.8	24.0	10.2	2.3	7.4	5.0	1.2	3.2	6.2	8.1	6.3	10.5	6.3	7.8	3.2	2.9	4.5	31.8	1.9	14.5	35.6	6.1	2.1	7.3	10.5	33.7	3.8	34.5	10.6	3.2	19.9	11.5	2.2	11.9	2.2	1.0	10.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.3	10.3	4.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	3.9	0.3	12.6	0.0	0.0	0.0	0.0	11.9	2.2	0.3	10.1	0.4	15.1	0.2	0.5	11.1	19.9	0.1	0.5	0.5	2.2	3.5	11.5	1.0	10.3	5.9	7.5	0.4	4.9	5.7	4.2	10.2	2.3	8.1	7.3	8.9	53.6	222.5	0.9	10.6	0.1	2.2	7.6	10.7	6.8	15.7	0.0	1.4	10.0	10.4	0.5	31.8	3.1	0.0	4.0	1.2	4.7	1.4	14.0	0.6	281.2	0.0	4.1	3.7	131.2	0.7	3.1	353.4	15.1	112.8	1.5	0.5	3.9	0.9	1.8	6.0	1.2	6.5	4.1	0.4	0.5	9.5	2.3	15.0	1.7	2.4
HLA-DOA	"HLA-D0-alpha, HLA-DNA, HLA-DZA"	ENSG00000204252	"Major histocompatibility complex, class II, DO alpha"	P06340	6	33004178-33009612	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 30.6"	"Cell type enhanced"	"Detected in many"	14	"Alveolar cells type 2: 31.2;B-cells: 33.8;Macrophages: 41.0;monocytes: 64.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"myeloid DC: 9.1;naive B-cell: 11.2"	"Group enriched"	"Detected in many"	9	"B-cells: 11.2;dendritic cells: 9.1;monocytes: 4.4"	"Cell line enhanced"	"Detected in some"		"Daudi: 6.5;HDLM-2: 4.6;REH: 20.7;U-698: 5.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA045038	Enhanced					NA	NA					"HPA045038: AB_10959457"	"unprognostic (8.02e-2)"	"unprognostic (2.30e-2)"	"unprognostic (2.60e-2)"	"unprognostic (1.19e-1)"	"unprognostic (3.01e-1)"	"unprognostic (3.83e-2)"	"unprognostic (2.60e-1)"	"unprognostic (9.86e-3)"	"unprognostic (1.31e-1)"	"unprognostic (1.50e-1)"	"unprognostic (3.68e-1)"	"unprognostic (4.39e-2)"	"unprognostic (1.91e-1)"	"unprognostic (9.95e-2)"	"unprognostic (3.65e-2)"	"unprognostic (8.70e-2)"	"unprognostic (5.94e-2)"	5.7	5.7	2.2	18.4	3.9	2.0	5.1	1.5	2.1	4.5	4.0	8.3	2.2	5.1	4.6	6.0	2.7	4.6	4.8	9.3	2.8	3.1	10.0	3.4	18.1	24.7	5.5	2.0	5.7	2.9	3.3	3.3	1.0	5.4	5.4	4.7	4.0	4.5	3.2	1.2	2.5	12.3	2.4	9.6	25.5	4.5	1.2	3.9	14.7	3.8	3.2	30.6	3.4	3.1	11.2	9.1	0.3	4.4	0.1	0.9	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.6	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	20.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	5.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	4.4	0.0	7.4	0.0	0.3	9.1	11.2	0.1	0.9	0.3	0.1	2.0	2.8	0.7	1.4	2.2	3.9	1.5	2.1	2.8	3.1	5.5	2.0	5.4	3.9	3.0	31.2	33.8	0.5	1.6	0.0	1.1	0.0	0.0	3.4	3.5	0.0	0.1	0.0	1.6	0.0	4.6	0.0	0.0	0.2	0.0	0.9	0.5	4.7	0.0	14.2	0.0	0.0	0.6	16.4	0.0	0.3	41.0	0.0	64.1	0.0	0.9	0.5	0.0	0.0	2.6	0.2	0.0	0.2	0.0	0.2	1.0	0.1	1.3	0.0	0.1
HLA-DPA1	HLA-DP1A	ENSG00000231389	"Major histocompatibility complex, class II, DP alpha 1"	P20036	6	33064569-33080775	"Predicted intracellular proteins, Predicted membrane proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 59.5"	"Cell type enhanced"	"Detected in many"	18	"B-cells: 1100.8;Hofbauer cells: 1218.6;Kupffer cells: 965.1;Macrophages: 2476.0;monocytes: 4193.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"classical monocyte: 16.3;intermediate monocyte: 37.8;memory B-cell: 30.0;myeloid DC: 59.5;naive B-cell: 26.7;non-classical monocyte: 23.2;plasmacytoid DC: 17.1"	"Group enriched"	"Detected in all"	8	"B-cells: 30.0;dendritic cells: 59.5;monocytes: 37.8"	"Cell line enhanced"	"Detected in some"		"Daudi: 15.8;HDLM-2: 48.6;REH: 12.4;U-698: 11.4"									HPA017967	Enhanced		Supported	Vesicles		NA	NA		92000	Vesicles		"HPA017967: AB_1853929"	"unprognostic (8.93e-3)"	"unprognostic (3.15e-2)"	"unprognostic (3.64e-2)"	"unprognostic (9.40e-3)"	"unprognostic (9.07e-2)"	"unprognostic (2.80e-2)"	"unprognostic (5.69e-2)"	"unprognostic (1.82e-2)"	"unprognostic (7.28e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.93e-1)"	"unprognostic (1.80e-1)"	"unprognostic (8.38e-2)"	"unprognostic (1.17e-1)"	"unprognostic (4.69e-2)"	"unprognostic (8.11e-2)"	"unprognostic (1.06e-1)"	25.2	12.8	3.3	13.3	3.6	4.7	16.3	3.5	3.3	11.8	6.8	3.1	4.3	8.6	8.5	15.9	8.5	5.7	14.7	11.1	4.2	6.2	12.4	9.7	35.9	20.2	6.2	3.8	3.8	5.4	3.8	5.2	6.5	4.8	7.4	7.3	7.5	7.4	15.7	4.1	5.8	14.7	6.4	20.4	37.6	5.6	8.6	4.1	10.9	14.2	9.5	21.5	8.5	17.8	30.0	59.5	1.3	37.8	4.0	5.6	20.3	0.0	0.0	0.0	0.0	0.3	0.6	0.5	0.2	0.1	0.2	0.0	0.0	2.1	15.8	2.2	0.3	3.1	0.0	0.0	0.0	0.0	48.6	1.0	2.6	0.0	0.0	0.0	0.0	5.1	0.7	0.0	1.0	0.0	0.0	0.2	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.3	0.0	0.0	12.4	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.5	1.1	3.5	0.0	0.0	0.0	2.4	0.3	11.4	5.5	0.1	1.9	0.3	16.3	1.3	4.6	37.8	1.2	30.0	2.1	5.0	59.5	26.7	0.7	3.4	0.6	4.0	23.2	17.1	5.6	20.3	3.3	3.6	3.5	3.3	4.2	6.2	6.2	3.8	4.8	4.1	77.4	317.2	1100.8	5.1	183.6	2.5	10.5	76.5	80.3	113.7	22.7	0.0	4.2	8.3	15.4	2.1	188.1	6.1	0.0	15.8	5.3	55.4	10.4	62.4	4.5	1218.6	4.8	9.8	60.2	965.1	4.3	16.7	2476.0	286.8	4193.1	9.2	4.8	4.8	4.5	25.8	32.7	3.1	51.8	21.8	0.9	2.9	153.2	5.7	100.5	4.1	8.9
HLA-DPB1	HLA-DP1B	ENSG00000223865	"Major histocompatibility complex, class II, DP beta 1"	P04440	6	33075926-33087201	"Predicted membrane proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 99.4"	"Cell type enhanced"	"Detected in many"	19	"B-cells: 1312.2;Hofbauer cells: 1159.7;Kupffer cells: 1265.6;Macrophages: 2334.4;monocytes: 5192.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"myeloid DC: 90.1"	"Group enriched"	"Detected in all"	8	"B-cells: 57.8;dendritic cells: 90.1;monocytes: 40.6"	"Group enriched"	"Detected in some"	6	"HDLM-2: 47.2;REH: 22.5"									"HPA011078, HPA058509"	Enhanced		Approved	"Nucleoplasm,Cell Junctions"		NA	NA		730000	"Cell Junctions"	Nucleoplasm	"HPA011078: AB_1079378, HPA058509: AB_2683737"	"unprognostic (5.44e-3)"	"unprognostic (7.03e-3)"	"unprognostic (9.84e-2)"	"prognostic favorable (3.38e-4)"	"unprognostic (9.43e-2)"	"unprognostic (1.80e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.51e-3)"	"unprognostic (1.77e-2)"	"unprognostic (5.64e-2)"	"unprognostic (1.57e-1)"	"unprognostic (4.34e-1)"	"unprognostic (4.35e-2)"	"unprognostic (1.80e-1)"	"unprognostic (4.17e-2)"	"unprognostic (3.58e-2)"	"unprognostic (1.85e-1)"	29.6	31.9	9.8	52.8	15.1	6.9	22.0	6.1	7.7	15.5	11.8	14.9	6.9	14.4	15.3	23.4	9.8	11.0	26.6	29.6	9.7	10.4	25.5	12.4	79.9	99.4	23.5	6.0	10.8	10.5	4.3	11.5	6.2	19.6	19.4	6.6	22.2	25.0	15.4	6.1	14.8	33.7	8.9	35.3	88.8	15.8	4.3	16.2	51.9	14.2	20.7	69.3	35.5	11.9	57.8	90.1	1.1	40.6	2.8	7.6	23.5	0.0	0.0	0.0	0.0	0.0	0.2	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	4.4	0.2	0.1	0.0	0.0	0.0	0.0	47.2	2.2	1.3	0.0	0.0	0.0	0.0	0.1	1.2	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	3.6	0.0	0.0	22.5	0.0	0.1	0.1	0.0	0.5	0.0	0.0	0.1	0.0	0.5	0.0	0.0	0.7	0.0	0.2	0.0	0.0	6.0	0.1	3.9	0.0	0.0	0.0	0.2	18.7	1.1	5.3	40.6	0.7	57.8	1.9	7.6	90.1	56.9	0.7	4.2	0.4	2.8	17.0	25.7	7.2	23.5	9.8	15.1	6.1	7.7	9.7	10.4	23.5	6.0	19.6	16.2	62.5	286.9	1312.2	21.4	267.0	12.2	9.3	73.9	46.8	77.3	27.9	15.7	5.1	3.3	33.6	3.2	238.9	10.6	0.0	13.0	4.7	50.0	41.9	61.1	5.5	1159.7	7.9	9.2	88.4	1265.6	4.0	25.3	2334.4	307.1	5192.2	12.2	24.1	8.0	4.0	19.8	36.3	19.2	45.3	33.2	1.2	5.9	203.9	7.6	173.0	6.5	13.9
HLA-DQA1	"CELIAC1, HLA-DQA"	ENSG00000196735	"Major histocompatibility complex, class II, DQ alpha 1"	P01909	6	32628179-32647062	"Predicted intracellular proteins, Predicted membrane proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 91.5;lymphoid tissue: 113.3"	"Cell type enhanced"	"Detected in many"	18	"B-cells: 621.2;Hofbauer cells: 402.6;Macrophages: 675.1;monocytes: 1355.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"myeloid DC: 91.5"	"Group enriched"	"Detected in many"	19	"B-cells: 43.3;dendritic cells: 91.5;monocytes: 32.1"	"Cell line enriched"	"Detected in some"	7	"HDLM-2: 176.7"									HPA012315	Enhanced					NA	NA					"HPA012315: AB_1853930"	"unprognostic (4.24e-3)"	"unprognostic (1.47e-2)"	"unprognostic (1.43e-2)"	"unprognostic (7.94e-3)"	"unprognostic (1.72e-1)"	"unprognostic (6.07e-2)"	"unprognostic (3.26e-1)"	"unprognostic (5.81e-3)"	"unprognostic (2.84e-2)"	"unprognostic (1.17e-1)"	"unprognostic (4.65e-2)"	"unprognostic (1.15e-1)"	"unprognostic (5.36e-2)"	"unprognostic (6.74e-2)"	"unprognostic (2.27e-1)"	"unprognostic (7.43e-2)"	"unprognostic (1.57e-1)"	44.6	8.9	3.9	63.5	6.9	0.7	14.8	1.2	3.1	11.4	13.6	7.4	6.1	0.0	10.6	45.5	8.1	6.1	23.7	4.4	3.8	4.9	23.8	17.2	69.0	48.2	8.7	2.6	16.4	5.1	0.0	6.5	3.7	8.9	5.8	22.1	14.8	11.4	1.2	7.6	11.3	26.1	4.2	19.5	97.0	17.3	2.1	6.7	113.3	8.5	0.5	63.6	42.3	6.6	43.3	91.5	0.4	32.1	1.0	2.9	15.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	26.8	0.1	0.0	0.0	0.0	0.0	0.0	0.0	176.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	8.2	0.1	19.5	3.2	0.0	0.0	0.1	14.8	0.0	0.3	32.1	0.1	42.8	0.4	2.3	91.5	43.3	0.0	0.6	0.4	1.0	8.1	22.7	2.9	15.8	3.9	6.9	1.2	3.1	3.8	4.9	8.7	2.6	8.9	6.7	11.9	132.6	621.2	0.4	44.6	0.0	2.0	12.7	10.7	21.6	0.0	2.0	0.7	1.7	1.4	0.4	35.0	0.3	0.0	3.8	1.1	13.6	1.2	46.5	0.4	402.6	0.0	0.0	9.8	236.5	0.2	2.8	675.1	67.4	1355.3	0.3	0.5	2.1	0.0	0.0	5.1	1.8	6.5	2.0	0.0	0.8	36.4	1.7	27.7	0.4	0.4
HLA-DQA2	HLA-DXA	ENSG00000237541	"Major histocompatibility complex, class II, DQ alpha 2"	P01906	6	32741342-32747215	"Predicted membrane proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 37.7;lymphoid tissue: 51.1"	"Cell type enhanced"	"Detected in many"	22	"B-cells: 96.0;Hofbauer cells: 116.5;Kupffer cells: 86.7;Macrophages: 348.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"																	NA	NA						"unprognostic (4.06e-3)"	"unprognostic (2.46e-3)"	"unprognostic (1.21e-1)"	"unprognostic (1.07e-2)"	"unprognostic (2.69e-1)"	"unprognostic (5.44e-2)"	"unprognostic (2.64e-1)"	"unprognostic (2.57e-2)"	"unprognostic (8.85e-2)"	"unprognostic (4.40e-1)"	"unprognostic (1.04e-1)"	"unprognostic (7.67e-2)"	"unprognostic (1.18e-1)"	"unprognostic (2.19e-2)"	"unprognostic (3.83e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.48e-2)"	6.1	2.7	0.5	1.5	0.5	1.5	3.6	0.0	1.5	6.3	1.8	2.1	0.0	1.5	3.8	1.5	2.5	1.9	27.2	16.5	1.0	0.9	12.5	3.5	37.7	43.6	1.3	0.6	1.5	1.5	1.5	1.5	1.9	3.0	7.9	1.5	6.5	19.9	2.5	1.5	4.7	11.7	1.5	5.9	35.5	2.3	1.5	0.0	40.5	3.5	6.7	51.1	1.5	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.5	0.0	0.2	1.0	0.9	1.3	0.6	3.0	0.0	3.0	2.2	96.0	0.2	20.8	0.0	0.4	0.0	5.3	5.7	3.5	0.0	0.2	0.0	0.0	0.5	8.7	0.0	0.0	0.0	0.5	0.3	0.0	0.0	0.0	116.5	0.0	2.4	3.1	86.7	0.5	1.1	348.8	23.6	35.1	0.0	0.0	0.3	0.0	0.0	1.5	0.0	6.5	0.2	0.0	0.0	20.5	0.3	21.5	0.0	0.7
HLA-DQB1	"CELIAC1, HLA-DQB, IDDM1"	ENSG00000179344	"Major histocompatibility complex, class II, DQ beta 1"		6	32659467-32668383	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"				"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 74.6"	"Group enriched"	"Detected in many"	4	"B-cells: 690.1;Hofbauer cells: 446.2;Macrophages: 1016.1;monocytes: 1484.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"classical monocyte: 27.8;intermediate monocyte: 24.1;memory B-cell: 30.9;myeloid DC: 68.2;naive B-cell: 35.6;plasmacytoid DC: 21.4"	"Group enriched"	"Detected in all"	6	"B-cells: 35.6;dendritic cells: 68.2;monocytes: 27.8"	"Cell line enriched"	"Detected in some"	6	"HDLM-2: 114.5"									HPA013667	Enhanced		Supported	"Golgi apparatus,Rods & Rings"		NA	NA			"Rods & Rings"	"Golgi apparatus"	"HPA013667: AB_1853932"	"unprognostic (8.60e-3)"	"unprognostic (1.91e-2)"	"unprognostic (5.91e-2)"	"unprognostic (9.85e-3)"	"unprognostic (4.48e-1)"	"unprognostic (5.30e-2)"	"unprognostic (4.75e-2)"	"unprognostic (1.06e-2)"	"unprognostic (2.51e-2)"	"unprognostic (1.48e-1)"	"unprognostic (3.48e-2)"	"unprognostic (3.94e-1)"	"unprognostic (1.34e-2)"	"unprognostic (3.13e-1)"	"unprognostic (4.16e-1)"	"unprognostic (2.43e-1)"	"unprognostic (1.40e-1)"	23.9	10.0	3.5	40.4	3.0	9.0	17.0	1.0	4.9	11.0	18.8	8.8	4.5	0.0	9.9	42.6	9.6	8.0	21.7	12.7	4.1	5.3	35.4	9.9	61.2	61.1	6.1	4.2	6.3	4.0	0.0	9.2	4.0	7.9	11.3	10.7	13.5	11.8	5.6	7.8	12.4	27.6	4.6	15.5	74.5	32.7	4.6	2.9	63.5	13.3	7.9	74.6	37.9	7.4	35.6	68.2	4.6	27.8	1.5	7.1	31.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	18.1	0.4	0.0	0.0	3.7	0.0	3.7	0.0	114.5	2.6	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.6	0.0	0.0	0.0	0.0	0.5	0.0	0.3	0.0	1.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.3	0.2	0.2	0.0	0.6	2.1	0.0	0.0	0.1	0.1	0.0	13.7	0.3	12.6	9.5	0.0	0.0	0.0	27.8	4.6	2.4	24.1	1.1	30.9	1.2	3.7	68.2	35.6	0.0	1.1	1.9	1.5	6.6	21.4	7.1	31.9	3.5	3.0	1.0	4.9	4.1	5.3	6.1	4.2	7.9	2.9	38.7	182.5	690.1	8.0	79.8	4.8	2.5	22.9	21.4	40.9	17.4	9.8	1.7	6.6	16.1	13.8	55.5	8.1	0.0	17.6	1.9	15.3	7.5	36.0	0.9	446.2	0.0	21.9	12.3	206.1	4.7	6.1	1016.1	92.8	1484.2	9.0	1.0	19.0	5.8	9.2	15.4	1.7	6.5	4.2	2.1	2.1	58.1	2.5	41.5	4.1	32.4
HLA-DQB2	HLA-DXB	ENSG00000232629	"Major histocompatibility complex, class II, DQ beta 2"	P05538	6	32756098-32763534	"Predicted intracellular proteins, Predicted membrane proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 25.6;skin 1: 25.8"	"Group enriched"	"Detected in some"	4	"Basal keratinocytes: 25.2;Macrophages: 78.8;Melanocytes: 25.3;Suprabasal keratinocytes: 24.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Cell type enhanced"	"Detected in some"		"myeloid DC: 3.1"	"Group enriched"	"Detected in many"	7	"B-cells: 3.0;dendritic cells: 3.1;monocytes: 1.2"	"Group enriched"	"Detected in some"	4	"Daudi: 1.0;HDLM-2: 3.6;U-266/70: 1.0"									HPA073187	Enhanced					NA	NA					"HPA073187: "	"prognostic favorable (5.55e-4)"	"unprognostic (3.75e-3)"	"unprognostic (2.16e-1)"	"unprognostic (2.50e-2)"	"unprognostic (2.10e-1)"	"unprognostic (6.60e-2)"	"unprognostic (8.15e-2)"	"unprognostic (3.73e-3)"	"unprognostic (6.48e-2)"	"unprognostic (1.25e-1)"	"unprognostic (3.74e-1)"	"unprognostic (1.94e-1)"	"unprognostic (6.66e-2)"	"unprognostic (1.23e-1)"	"unprognostic (4.10e-2)"	"unprognostic (1.16e-1)"	"unprognostic (6.92e-2)"	2.1	0.9	0.4	3.5	0.4	0.3	2.0	0.4	0.3	2.1	0.5	0.6	0.2	0.4	0.3	1.8	5.5	0.6	0.8	0.3	0.3	0.2	1.2	0.4	9.7	3.0	1.3	0.2	0.9	0.2	0.0	0.8	0.2	0.8	0.6	1.1	0.8	2.7	0.8	0.5	25.8	3.1	0.2	1.4	7.2	2.2	0.5	0.3	25.6	1.0	11.3	17.8	1.1	2.3	3.0	3.1	0.3	1.2	0.3	0.2	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.0	0.0	0.0	0.0	0.2	0.0	0.3	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	1.0	0.0	0.2	0.4	0.2	0.1	0.2	0.8	0.1	0.1	1.2	0.0	2.8	0.0	0.1	3.1	3.0	0.1	0.1	0.3	0.3	0.4	0.5	0.2	1.2	0.4	0.4	0.4	0.3	0.3	0.2	1.3	0.2	0.8	0.3	3.0	8.8	6.7	0.0	25.2	0.0	0.3	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.3	3.1	0.0	0.0	0.0	0.0	0.1	0.0	2.3	0.0	2.5	0.0	0.0	0.0	8.2	0.0	0.9	78.8	25.3	8.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	24.1	0.1	0.0	0.0	0.1
HLA-DRA	HLA-DRA1	ENSG00000204287	"Major histocompatibility complex, class II, DR alpha"	P01903	6	32439842-32445046	"Plasma proteins, Predicted membrane proteins"	"Adaptive immunity, Host-virus interaction, Immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 211.6"	"Group enriched"	"Detected in many"	5	"B-cells: 2551.2;Hofbauer cells: 2965.8;Kupffer cells: 2919.1;Macrophages: 6482.8;monocytes: 9158.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"classical monocyte: 29.8;intermediate monocyte: 46.8;memory B-cell: 59.4;naive B-cell: 61.7;non-classical monocyte: 28.0;plasmacytoid DC: 29.6"	"Group enriched"	"Detected in all"	5	"B-cells: 61.7;dendritic cells: 29.6;monocytes: 46.8"	"Cell line enhanced"	"Detected in some"		"Daudi: 56.6;HDLM-2: 101.0;REH: 41.1;U-266/70: 24.9;U-698: 58.2;U-87 MG: 40.5"					"Low region specificity"	"Detected in all"			"CAB002798, CAB015402, HPA050162, HPA053176"	Enhanced					NA	NA		1600000			"CAB002798: , CAB015402: AB_629980, HPA050162: AB_2681037, HPA053176: AB_2682070"	"unprognostic (1.20e-3)"	"unprognostic (4.70e-3)"	"prognostic favorable (5.30e-4)"	"unprognostic (3.13e-3)"	"unprognostic (1.30e-1)"	"unprognostic (2.72e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.11e-2)"	"unprognostic (2.77e-2)"	"unprognostic (3.05e-2)"	"unprognostic (3.92e-2)"	"unprognostic (1.89e-1)"	"unprognostic (1.35e-1)"	"unprognostic (1.98e-1)"	"unprognostic (4.42e-2)"	"unprognostic (5.67e-2)"	"unprognostic (2.52e-2)"	51.8	33.5	14.1	79.1	20.2	1.8	37.3	2.3	10.1	21.1	38.9	21.5	10.9	30.8	16.5	76.8	15.9	33.9	21.8	34.7	13.1	16.2	60.9	17.8	147.2	211.6	27.3	7.4	14.7	10.0	1.7	14.7	9.7	23.5	21.9	33.8	23.5	21.6	12.6	12.9	27.6	86.2	9.0	52.8	127.3	68.7	7.2	21.6	53.7	18.6	25.9	151.6	53.5	15.1	61.7	29.6	9.3	46.8	1.8	2.7	29.9	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	56.6	0.4	0.0	0.0	0.0	0.0	0.0	0.0	101.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	41.1	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	1.4	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	24.9	0.0	58.2	40.5	0.0	0.0	0.6	29.8	9.3	0.3	46.8	0.1	59.4	0.3	1.7	0.5	61.7	0.2	0.3	2.2	1.8	28.0	29.6	2.7	29.9	14.1	20.2	2.3	10.1	13.1	16.2	27.3	7.4	23.5	21.6	271.0	1055.7	2551.2	15.4	664.8	2.8	17.1	140.1	283.7	312.8	143.1	0.0	12.6	24.9	102.1	5.1	500.2	61.2	70.0	51.5	11.7	106.8	41.9	162.6	8.5	2965.8	1.6	62.4	159.6	2919.1	12.4	27.9	6482.8	733.9	9158.9	74.1	8.3	54.7	48.9	4.2	202.9	18.7	71.1	73.3	3.5	5.0	503.6	21.6	91.4	51.9	59.2
HLA-DRB1	HLA-DR1B	ENSG00000196126	"Major histocompatibility complex, class II, DR beta 1"	"P01911, P04229, Q29974, Q9GIY3"	6	32578769-32589848	"Disease related genes, Plasma proteins, Predicted membrane proteins"	"Adaptive immunity, Host-virus interaction, Immunity"	"Host cell receptor for virus entry, Receptor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 95.6;lung: 95.9"	"Cell type enhanced"	"Detected in many"	15	"Hofbauer cells: 1496.4;Macrophages: 3257.5;monocytes: 4435.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"myeloid DC: 95.6"	"Group enriched"	"Detected in all"	10	"B-cells: 41.3;dendritic cells: 95.6;monocytes: 52.5"	"Cell line enhanced"	"Detected in some"		"HDLM-2: 157.6;HMC-1: 22.4;THP-1: 18.9;U-266/70: 21.0;U-698: 27.1;U-87 MG: 43.5"									"CAB015400, CAB034021, HPA043151"	Enhanced					NA	NA					"CAB015400: AB_784538, CAB034021: AB_1124844, HPA043151: AB_2678342"	"unprognostic (3.69e-3)"	"unprognostic (3.66e-3)"	"unprognostic (1.80e-2)"	"unprognostic (2.40e-3)"	"unprognostic (2.21e-1)"	"unprognostic (5.45e-2)"	"unprognostic (5.28e-2)"	"unprognostic (1.22e-3)"	"unprognostic (8.56e-2)"	"unprognostic (3.00e-2)"	"unprognostic (1.23e-1)"	"unprognostic (2.08e-1)"	"unprognostic (2.28e-3)"	"unprognostic (6.16e-2)"	"unprognostic (1.19e-1)"	"unprognostic (5.10e-2)"	"unprognostic (1.53e-1)"	36.8	18.7	9.7	32.2	15.9	8.7	24.9	3.6	10.0	14.2	18.2	11.5	11.2	0.2	10.5	27.2	12.1	13.3	12.0	11.9	8.5	6.9	50.0	15.6	95.9	80.8	18.9	5.4	6.9	8.0	0.0	9.4	5.7	14.8	9.5	23.7	16.1	11.3	2.4	8.2	13.3	42.1	3.8	19.7	62.1	38.1	5.6	13.2	33.6	14.1	3.8	44.7	29.7	17.0	41.3	95.6	6.3	52.5	2.7	4.7	37.7	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	2.3	0.0	0.0	0.2	0.0	0.6	0.0	157.6	1.7	0.0	0.0	0.0	0.0	0.0	22.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	3.7	0.0	0.3	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	3.5	0.2	0.6	18.9	0.0	0.0	0.1	0.3	0.0	21.0	0.5	27.1	43.5	0.7	0.0	0.2	34.6	6.3	1.8	52.5	0.3	32.7	1.2	3.7	95.6	41.3	0.1	1.6	1.2	2.7	26.9	20.4	4.7	37.7	9.7	15.9	3.6	10.0	8.5	6.9	18.9	5.4	14.8	13.2	137.0	520.2	984.8	8.4	154.2	1.7	28.0	109.5	140.5	174.0	134.3	0.0	2.5	21.6	104.5	3.5	441.7	148.8	0.0	65.2	4.6	54.7	18.7	119.2	3.4	1496.4	0.0	34.5	186.6	1186.4	7.6	13.8	3257.5	205.8	4435.6	52.0	8.3	76.3	364.7	25.1	169.2	9.4	25.8	72.3	1.8	3.4	129.4	5.7	137.1	73.6	61.3
HLA-DRB5		ENSG00000198502	"Major histocompatibility complex, class II, DR beta 5"	Q30154	6	32517343-32530287	"Predicted membrane proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 71.8;lymphoid tissue: 64.8"	"Cell type enhanced"	"Detected in many"	11	"B-cells: 354.6;Hofbauer cells: 502.6;Kupffer cells: 564.1;Macrophages: 808.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"myeloid DC: 26.4"	"Group enriched"	"Detected in many"	10	"B-cells: 13.3;dendritic cells: 26.4;monocytes: 16.0"	"Group enriched"	"Detected in some"	5	"HDLM-2: 112.0;HMC-1: 28.3;U-698: 33.5;U-87 MG: 44.2"									HPA043151	Supported					NA	NA					"HPA043151: AB_2678342"	"unprognostic (1.97e-3)"	"unprognostic (4.74e-2)"	"unprognostic (3.30e-2)"	"prognostic favorable (7.89e-4)"	"unprognostic (2.28e-2)"	"unprognostic (4.68e-3)"	"unprognostic (9.09e-3)"	"unprognostic (2.08e-3)"	"unprognostic (1.06e-2)"	"unprognostic (5.40e-2)"	"unprognostic (4.31e-2)"	"unprognostic (2.87e-1)"	"unprognostic (2.89e-2)"	"unprognostic (1.45e-1)"	"unprognostic (7.60e-3)"	"unprognostic (9.72e-2)"	"unprognostic (5.48e-2)"	21.8	14.2	2.9	22.1	3.9	3.7	16.2	2.0	3.2	16.7	21.7	7.0	6.4	2.3	8.7	22.1	9.5	12.6	6.6	9.1	4.3	4.0	32.2	9.3	71.8	60.4	7.3	0.8	4.9	4.9	0.0	6.0	4.9	5.4	9.5	10.2	11.2	9.0	2.7	7.4	8.8	34.7	4.7	12.2	64.8	40.3	4.6	4.5	15.3	9.5	11.2	27.6	21.8	6.5	13.3	26.4	1.5	16.0	0.9	1.8	15.4	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.1	0.0	0.0	0.0	112.0	1.1	0.0	0.0	0.0	0.0	0.1	28.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	9.9	0.0	0.6	0.1	0.3	0.0	7.6	0.1	33.5	44.2	0.3	0.0	0.0	10.1	1.5	0.4	16.0	0.0	10.5	0.4	1.1	26.4	13.3	0.0	0.5	0.3	0.9	8.1	5.9	1.8	15.4	2.9	3.9	2.0	3.2	4.3	4.0	7.3	0.8	5.4	4.5	14.9	139.1	354.6	2.3	92.6	0.6	6.9	137.6	5.3	7.9	14.0	3.9	1.1	1.7	1.1	2.3	236.0	13.4	0.0	6.9	2.7	11.4	6.5	57.8	3.4	502.6	0.0	1.7	114.2	564.1	3.7	14.7	808.2	114.7	129.0	14.9	0.0	18.4	51.8	32.2	19.6	1.4	19.4	37.4	0.7	0.2	79.3	2.6	71.0	3.5	18.2
HPSE	"HPA, HPSE1, HSE1"	ENSG00000173083	Heparanase	Q9Y251	4	83292461-83335153	"Enzymes, Predicted secreted proteins"	"Cell adhesion"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	11	"Hofbauer cells: 15.9;Kupffer cells: 27.7;Macrophages: 10.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"classical monocyte: 17.8;neutrophil: 12.8"	"Group enriched"	"Detected in many"	5	"granulocytes: 12.8;monocytes: 17.8"	"Cell line enhanced"	"Detected in many"		"Karpas-707: 23.3;OE19: 20.5"	"Region enhanced"	"Detected in some"		"olfactory region: 4.5"	"Low region specificity"	"Detected in all"			"CAB009813, HPA055344"			Supported	Nucleoplasm,Vesicles	"Secreted to extracellular matrix"	No	No		9700000	Nucleoplasm	Vesicles	"CAB009813: AB_2120854, HPA055344: "	"unprognostic (6.57e-2)"	"unprognostic (1.22e-2)"	"unprognostic (9.13e-2)"	"unprognostic (5.92e-3)"	"unprognostic (1.12e-1)"	"unprognostic (1.25e-1)"	"unprognostic (1.24e-2)"	"unprognostic (5.65e-2)"	"unprognostic (7.06e-2)"	"unprognostic (1.90e-1)"	"unprognostic (1.50e-1)"	"unprognostic (9.62e-3)"	"unprognostic (3.27e-1)"	"unprognostic (2.78e-1)"	"unprognostic (3.04e-3)"	"unprognostic (4.15e-2)"	"unprognostic (3.70e-3)"	4.9	5.1	3.0	6.8	3.5	2.2	1.2	0.8	2.4	3.6	6.2	7.1	0.0	2.3	2.9	2.8	14.5	5.7	3.0	5.8	3.2	1.5	3.0	5.6	8.2	16.1	7.1	1.4	7.5	1.1	15.5	2.3	11.3	3.4	1.1	7.0	0.7	12.5	2.1	0.7	6.9	3.6	2.1	7.0	19.0	2.4	6.0	2.8	1.6	1.4	16.9	9.7	2.4	4.9	0.3	1.9	12.8	17.8	1.4	3.4	4.8	7.6	0.3	0.0	1.0	1.8	0.5	0.0	0.9	4.2	1.9	8.1	0.2	5.7	0.2	1.4	2.1	13.0	7.4	9.7	1.3	3.4	0.7	0.9	2.0	5.5	0.1	1.0	1.3	4.6	0.8	2.9	1.3	9.2	0.8	10.2	1.3	0.0	23.3	0.8	1.6	0.1	0.1	0.4	20.5	1.4	0.0	0.3	0.3	5.3	0.2	5.5	0.0	10.6	5.9	0.8	1.5	0.8	1.8	11.8	0.8	2.7	0.8	0.9	0.3	3.6	0.1	6.1	6.2	1.4	0.2	17.8	0.0	1.0	6.7	0.7	0.2	1.9	0.7	1.9	0.3	1.4	1.2	12.8	1.4	0.9	0.1	3.4	4.8	3.0	3.5	0.8	2.4	3.2	1.5	7.1	1.4	3.4	2.8	6.0	4.1	0.0	2.6	3.1	0.0	0.4	0.0	2.7	3.4	1.8	0.0	0.5	0.0	1.3	0.6	0.6	5.1	0.0	1.2	2.3	0.6	1.5	0.0	0.2	15.9	0.0	6.3	3.1	27.7	0.0	0.6	10.2	0.0	0.0	2.9	0.0	0.8	8.0	0.0	0.0	0.0	0.0	0.6	0.0	0.5	3.1	1.3	3.2	4.6	3.7
HRH2		ENSG00000113749	"Histamine receptor H2"	P25021	5	175658030-175710756	"FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"blood: 45.7;bone marrow: 30.1"	"Cell type enhanced"	"Detected in some"	15	"Cardiomyocytes: 21.0;Kupffer cells: 24.0;Macrophages: 14.4;Smooth muscle cells: 45.1"	"Cancer enhanced"	"Detected in many"		"renal cancer: 4.6"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 45.7"	"Group enriched"	"Detected in many"	5	"granulocytes: 45.7;monocytes: 13.1"	"Group enriched"	"Detected in some"	4	"RPMI-8226: 36.2;SK-MEL-30: 10.8;THP-1: 10.0;U-937: 12.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA013770	Approved					NA	NA					"HPA013770: AB_1851086"	"unprognostic (8.56e-3)"	"unprognostic (1.62e-1)"	"unprognostic (6.66e-2)"	"unprognostic (5.96e-2)"	"unprognostic (3.49e-2)"	"unprognostic (1.80e-1)"	"unprognostic (1.20e-1)"	"unprognostic (4.77e-2)"	"unprognostic (9.93e-2)"	"unprognostic (5.76e-2)"	"unprognostic (1.52e-1)"	"unprognostic (2.35e-1)"	"unprognostic (3.71e-3)"	"unprognostic (2.01e-2)"	"unprognostic (1.97e-2)"	"unprognostic (1.97e-3)"	"unprognostic (1.77e-2)"	7.9	1.5	5.9	11.1	11.6	30.1	2.8	1.0	12.1	3.9	2.8	0.9	0.5	5.9	2.3	1.3	1.6	2.7	2.6	18.6	3.4	1.7	2.4	1.2	5.4	12.3	2.3	4.9	1.6	1.6	0.3	1.3	9.5	2.4	3.0	1.3	0.6	1.7	4.8	1.2	2.1	7.2	3.5	4.4	9.9	10.3	1.2	5.6	9.9	1.8	0.2	3.0	2.8	2.0	0.0	6.4	45.7	13.1	0.6	2.3	3.7	0.0	0.8	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	1.2	0.0	0.5	0.0	0.0	0.1	0.0	0.0	0.0	1.0	0.0	0.1	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	2.8	1.7	0.0	0.0	3.9	0.0	36.2	0.0	0.2	0.2	0.0	0.0	0.0	10.8	1.0	0.0	10.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	12.1	2.4	28.9	12.9	13.6	0.0	12.0	0.1	0.0	1.1	0.2	6.4	0.0	2.3	1.4	45.7	0.6	13.1	5.0	0.8	3.7	5.9	11.6	1.0	12.1	3.4	1.7	2.3	4.9	2.4	5.6	0.0	4.5	0.5	0.1	0.7	4.5	21.0	0.0	1.4	4.5	0.0	0.0	0.0	0.0	0.0	0.6	0.7	0.0	0.0	2.2	0.1	5.2	0.1	2.3	0.0	10.1	1.6	0.0	0.0	24.0	0.7	0.0	14.4	0.0	0.0	0.0	0.0	0.3	0.0	0.4	0.1	0.0	0.0	45.1	0.2	1.1	0.3	0.0	2.5	0.0	0.0
HVCN1	"Hv1, MGC15619, VSOP"	ENSG00000122986	"Hydrogen voltage gated channel 1"	Q96D96	12	110627841-110704950	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Hydrogen ion transport, Ion transport, Transport"	"Ion channel, Voltage-gated channel"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 99.8;lymphoid tissue: 40.6"	"Cell type enhanced"	"Detected in many"	7	"B-cells: 65.1;Early spermatids: 69.1;Hofbauer cells: 51.3;Late spermatids: 55.1;Macrophages: 42.5;Spermatocytes: 72.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"naive B-cell: 99.8"	"Low lineage specificity"	"Detected in all"			"Group enriched"	"Detected in some"	4	"NB-4: 78.2;U-698: 24.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA039329	Enhanced					NA	NA					"HPA039329: AB_10674284"	"unprognostic (3.43e-2)"	"unprognostic (6.32e-3)"	"unprognostic (7.05e-2)"	"unprognostic (1.54e-2)"	"unprognostic (4.62e-3)"	"unprognostic (3.89e-2)"	"unprognostic (1.96e-1)"	"unprognostic (5.85e-3)"	"unprognostic (2.40e-1)"	"unprognostic (3.09e-2)"	"unprognostic (1.54e-2)"	"unprognostic (5.67e-2)"	"unprognostic (3.35e-3)"	"unprognostic (4.82e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.79e-1)"	"unprognostic (1.68e-1)"	4.8	3.3	7.6	17.6	12.2	3.8	3.3	4.7	7.4	5.6	3.9	20.4	3.2	3.0	6.4	7.0	2.9	5.8	5.0	13.8	9.7	11.3	2.6	2.6	8.0	34.6	26.9	5.0	8.6	1.5	1.5	2.0	4.8	36.7	5.9	4.1	14.2	2.6	5.5	4.6	1.9	10.8	6.1	9.4	25.6	4.3	24.5	8.2	5.0	2.5	2.8	40.6	7.5	5.3	99.8	15.4	75.6	24.2	19.8	3.3	18.8	0.0	0.2	0.8	0.0	1.3	1.3	0.4	0.2	0.3	0.7	0.4	0.1	0.0	0.7	0.7	1.4	0.0	0.1	0.9	0.0	1.0	0.0	0.2	0.0	0.0	0.2	1.1	11.9	0.8	1.8	0.1	0.6	0.0	0.1	1.8	3.8	0.5	0.7	1.3	0.0	1.7	78.2	0.9	0.0	0.9	1.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.9	0.0	11.9	0.5	0.0	0.0	0.1	0.0	7.7	0.9	24.4	0.0	0.6	0.0	39.8	24.2	75.6	1.7	23.0	0.9	63.0	1.6	2.8	10.4	99.8	3.2	2.1	38.4	19.8	19.9	15.4	3.3	18.8	7.6	12.2	4.7	7.4	9.7	11.3	26.9	5.0	36.7	8.2	3.0	7.7	65.1	2.0	0.7	0.4	6.3	0.0	2.7	3.4	1.8	0.0	0.3	0.0	0.4	69.1	10.6	0.0	0.0	0.2	1.2	3.5	0.5	8.1	0.2	51.3	0.0	0.0	9.8	31.3	55.1	12.4	42.5	11.8	1.8	0.1	16.0	0.2	0.0	13.1	0.4	1.5	12.9	9.8	72.9	2.5	0.4	1.0	4.9	0.0	1.0
IFI30	"GILT, IFI-30, IP-30, IP30, MGC32056"	ENSG00000216490	"IFI30, lysosomal thiol reductase"	P13284	19	18173162-18178117	"Predicted intracellular proteins, Predicted membrane proteins"	Immunity	Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 348.5"	"Cell type enhanced"	"Detected in many"	12	"Hofbauer cells: 159.4;Kupffer cells: 201.6;Macrophages: 219.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"intermediate monocyte: 348.5"	"Group enriched"	"Detected in all"	8	"dendritic cells: 145.5;granulocytes: 95.4;monocytes: 348.5"	"Cell line enhanced"	"Detected in many"		"Daudi: 76.0;RPMI-8226: 82.4;SK-BR-3: 55.7;U-266/84: 91.1"					"Low region specificity"	"Detected in many"			HPA026650	Enhanced		Supported	Vesicles,Cytosol	"Intracellular and membrane"	NA	NA		89000	"Vesicles, Cytosol"		"HPA026650: AB_10602237"	"unprognostic (4.66e-2)"	"unprognostic (1.25e-4)"	"unprognostic (2.35e-3)"	"unprognostic (7.40e-2)"	"unprognostic (1.76e-2)"	"unprognostic (3.11e-2)"	"unprognostic (8.10e-3)"	"unprognostic (2.40e-1)"	"unprognostic (4.01e-2)"	"unprognostic (9.19e-3)"	"unprognostic (3.04e-1)"	"unprognostic (1.19e-1)"	"unprognostic (7.29e-11)"	"unprognostic (3.50e-1)"	"unprognostic (1.62e-2)"	"unprognostic (3.39e-2)"	"unprognostic (9.59e-3)"	104.2	31.0	5.8	85.5	10.8	28.3	13.9	1.2	5.2	5.3	17.4	6.5	3.2	23.3	5.0	13.7	9.3	15.9	13.1	16.2	5.0	4.0	37.5	60.4	109.7	139.5	12.0	0.8	15.0	14.6	2.0	7.6	123.2	11.0	8.6	18.2	9.2	18.7	4.3	7.2	10.1	28.5	18.9	13.3	140.6	19.4	5.7	7.9	20.6	15.6	9.6	41.2	24.5	8.2	24.3	145.5	95.4	348.5	1.7	1.0	213.4	12.8	6.8	0.0	4.5	1.3	1.8	12.2	1.4	1.9	3.9	10.2	15.3	23.0	76.0	11.7	4.4	20.2	10.1	8.1	3.0	0.4	20.2	5.8	0.9	12.6	21.7	13.0	2.2	5.9	7.9	6.9	6.4	2.3	0.5	0.2	2.3	10.7	47.8	1.9	25.2	1.0	0.2	2.5	44.2	6.8	7.4	0.5	82.4	11.7	0.4	0.6	0.8	23.6	55.7	1.3	0.9	3.8	0.9	0.3	6.8	4.1	13.9	1.4	1.6	91.1	43.3	18.8	15.0	1.0	2.0	228.9	95.4	1.0	348.5	1.0	24.3	0.7	0.8	145.5	16.8	0.5	0.6	52.5	1.7	230.0	4.3	1.0	213.4	5.8	10.8	1.2	5.2	5.0	4.0	12.0	0.8	11.0	7.9	8.9	51.2	68.0	1.9	3.2	0.1	0.6	7.6	13.4	31.8	12.2	0.0	4.4	1.7	1.2	0.2	2.2	3.8	0.0	1.0	12.3	1.9	3.5	12.8	1.5	159.4	0.0	0.0	4.9	201.6	0.0	0.3	219.1	5.0	58.7	4.6	0.6	1.7	2.5	0.0	4.8	0.4	0.0	0.9	0.0	0.7	2.9	10.1	3.8	5.1	1.3
IKZF1	"hIk-1, Hs.54452, IKAROS, LyF-1, PPP1R92, ZNFN1A1"	ENSG00000185811	"IKAROS family zinc finger 1"	Q13422	7	50304068-50405101	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Transcription factors"	"Cell cycle, Transcription, Transcription regulation"	"Activator, Chromatin regulator, Developmental protein, DNA-binding, Repressor"	"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 28.7;bone marrow: 55.2;lymphoid tissue: 86.7"	"Cell type enhanced"	"Detected in many"	11	"B-cells: 46.7;Kupffer cells: 47.2;Macrophages: 43.8;monocytes: 70.3;T-cells: 103.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"Daudi: 26.9;HDLM-2: 45.8;HMC-1: 42.9;JURKAT: 26.3;MOLT-4: 33.5;REH: 36.3;U-698: 68.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"CAB009247, HPA035221, HPA035222"	Enhanced		Supported	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"CAB009247: AB_2124699, HPA035221: AB_2674524, HPA035222: AB_2674525"	"prognostic favorable (4.28e-4)"	"prognostic favorable (2.02e-4)"	"unprognostic (2.49e-3)"	"unprognostic (2.41e-3)"	"unprognostic (5.59e-1)"	"prognostic favorable (8.63e-4)"	"unprognostic (1.45e-2)"	"unprognostic (1.37e-2)"	"unprognostic (1.15e-2)"	"unprognostic (2.43e-1)"	"unprognostic (6.63e-2)"	"unprognostic (2.95e-1)"	"unprognostic (1.69e-3)"	"unprognostic (1.71e-1)"	"unprognostic (2.84e-2)"	"unprognostic (6.77e-2)"	"unprognostic (4.67e-2)"	3.5	1.5	2.9	25.5	3.8	55.2	2.3	0.7	1.8	1.6	3.6	2.8	0.8	2.4	1.6	2.1	2.2	2.4	2.9	1.6	3.4	1.8	2.5	2.3	8.3	44.4	5.9	1.1	1.1	1.3	0.2	1.2	1.2	3.4	2.2	2.5	1.5	5.2	0.7	0.9	1.9	14.5	1.4	5.1	31.0	3.7	1.1	4.1	86.7	2.4	1.2	26.3	4.5	2.9	24.0	12.6	12.8	23.6	12.8	28.7	12.7	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	26.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	45.8	0.0	9.2	0.0	0.0	0.0	16.3	42.9	0.0	0.0	0.0	0.0	0.0	0.0	26.3	11.9	3.2	0.0	0.0	33.5	16.2	0.4	0.0	0.0	36.3	0.0	7.6	0.0	0.0	0.3	0.3	0.1	0.2	0.1	0.0	0.0	22.5	0.0	0.0	0.3	0.0	0.0	14.6	7.5	68.8	0.1	17.7	0.1	10.2	7.7	12.8	20.4	23.6	17.0	24.0	21.2	19.9	8.2	21.3	28.7	20.7	11.2	12.8	22.3	12.6	17.1	12.7	2.9	3.8	0.7	1.8	3.4	1.8	5.9	1.1	3.4	4.1	3.0	16.4	46.7	0.1	2.5	0.0	1.1	5.1	2.7	3.4	1.8	0.0	0.3	0.0	0.1	3.0	2.9	0.0	23.3	0.0	0.2	3.4	0.1	22.0	1.0	27.1	0.0	0.0	4.3	47.2	4.5	0.0	43.8	18.6	70.3	0.0	0.0	0.1	0.0	0.0	0.7	0.0	0.0	2.1	0.0	0.7	2.4	0.6	103.3	0.0	0.1
IL10	"CSIF, IL-10, IL10A, TGIF"	ENSG00000136634	"Interleukin 10"	P22301	1	206767602-206772494	"Cancer-related genes, Candidate cardiovascular disease genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"		Cytokine	"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 28.3"	"Group enriched"	"Detected in some"	5	"Hofbauer cells: 25.9;Kupffer cells: 36.4;Macrophages: 43.8"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"classical monocyte: 5.4;intermediate monocyte: 4.0"	"Lineage enriched"	"Detected in many"	5	"monocytes: 5.4"	"Group enriched"	"Detected in some"	8	"HMC-1: 18.6;U-266/70: 9.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"CAB013120, HPA071391"	Approved				"Secreted to blood"	NA	NA	5670				"CAB013120: , HPA071391: "	"unprognostic (3.65e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.03e-2)"	"unprognostic (8.71e-2)"	"unprognostic (2.20e-1)"	"unprognostic (2.63e-3)"	"unprognostic (2.58e-1)"	"unprognostic (1.54e-1)"	"unprognostic (9.59e-2)"	"unprognostic (4.26e-1)"	"unprognostic (8.01e-2)"	"unprognostic (4.00e-1)"	"unprognostic (4.66e-4)"	"unprognostic (7.11e-2)"	"unprognostic (1.93e-2)"	"unprognostic (2.73e-1)"	"unprognostic (1.96e-2)"	10.9	3.1	1.1	10.7	1.2	4.1	2.1	0.3	1.3	1.6	1.8	2.1	0.5	0.8	1.0	1.9	1.7	4.0	5.2	3.9	0.8	0.9	1.3	3.1	4.3	9.2	1.8	0.9	1.5	1.2	0.4	2.3	3.6	2.3	1.7	1.8	2.1	1.6	0.8	0.9	0.7	2.1	4.6	2.2	28.3	2.0	1.6	1.4	2.2	2.4	0.9	3.5	4.1	1.0	0.2	0.5	0.5	5.4	0.1	1.0	1.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	18.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.4	0.1	0.1	0.0	0.0	0.0	1.8	0.0	0.0	0.3	0.2	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.1	0.1	0.2	0.0	9.6	0.3	0.3	0.0	0.1	0.0	0.5	5.4	0.1	0.2	4.0	0.0	0.1	0.2	1.0	0.5	0.2	0.1	0.1	0.3	0.1	1.4	0.1	0.9	1.0	1.1	1.2	0.3	1.3	0.8	0.9	1.8	0.9	2.3	1.4	0.0	3.4	1.4	0.3	0.9	0.0	0.3	0.0	0.0	2.3	0.0	0.0	0.1	0.0	0.0	6.9	0.3	0.0	0.0	0.0	0.1	0.6	0.3	1.1	0.0	25.9	0.0	0.0	0.6	36.4	2.2	0.0	43.8	1.7	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.9	0.0	0.1	1.0	0.1	1.3	0.0	0.4
IL10RA	"CD210, CD210a, CDW210A, HIL-10R, IL10R"	ENSG00000110324	"Interleukin 10 receptor subunit alpha"	Q13651	11	117986348-118003037	"CD markers, Disease related genes, Predicted membrane proteins"		Receptor	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 56.2"	"Cell type enhanced"	"Detected in many"	11	"Extravillous trophoblasts: 88.9;Kupffer cells: 162.4;Macrophages: 88.5;monocytes: 146.1;T-cells: 102.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"Daudi: 14.9;HDLM-2: 37.1;Karpas-707: 13.9;RPMI-8226: 16.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA065647, HPA069086"			Supported	"Plasma membrane,Cytosol"		NA	NA			"Plasma membrane"	Cytosol	"HPA065647: , HPA069086: "	"unprognostic (1.01e-2)"	"unprognostic (2.07e-3)"	"unprognostic (1.58e-2)"	"unprognostic (7.08e-2)"	"unprognostic (8.27e-2)"	"prognostic favorable (4.47e-4)"	"unprognostic (5.27e-2)"	"unprognostic (4.84e-2)"	"unprognostic (7.70e-3)"	"unprognostic (5.94e-2)"	"unprognostic (2.14e-2)"	"unprognostic (3.83e-1)"	"prognostic unfavorable (1.45e-5)"	"unprognostic (1.82e-1)"	"unprognostic (8.43e-3)"	"unprognostic (2.19e-1)"	"unprognostic (1.27e-1)"	11.3	6.5	2.9	29.6	3.5	27.2	7.2	1.1	3.0	3.4	7.9	4.7	0.5	3.8	5.5	11.0	4.3	4.9	9.7	7.6	3.0	3.6	5.0	6.4	13.6	49.8	4.7	1.4	3.4	3.6	1.3	3.4	6.9	4.5	5.8	7.5	6.4	7.9	1.9	2.6	3.0	17.6	5.0	8.0	56.2	4.9	3.1	3.5	9.6	3.6	3.9	32.2	9.5	3.4	4.6	15.4	1.2	23.9	23.7	30.7	22.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.9	0.1	0.0	0.3	0.0	0.2	0.0	0.0	37.1	0.0	0.1	0.0	0.0	0.0	0.0	4.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	2.7	13.9	0.0	0.0	0.2	2.9	0.0	0.0	0.0	0.0	0.0	16.9	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	1.0	0.0	0.0	0.0	0.0	0.0	2.9	0.4	3.9	0.0	5.6	0.0	1.1	15.8	0.8	19.7	23.9	14.2	4.6	19.0	22.7	15.4	2.3	6.9	12.3	1.2	23.7	18.8	6.0	30.7	22.8	2.9	3.5	1.1	3.0	3.0	3.6	4.7	1.4	4.5	3.5	6.0	26.0	27.4	0.5	5.0	0.0	2.0	0.0	2.7	2.3	0.0	0.0	1.2	0.0	0.1	0.0	1.2	0.0	0.0	0.7	88.9	2.8	0.0	11.6	0.5	54.1	0.0	0.0	4.3	162.4	0.0	0.3	88.5	16.9	146.1	0.0	0.5	0.1	0.0	0.0	0.6	0.0	0.0	1.0	0.1	0.2	3.6	2.7	102.0	0.0	0.4
IL17RA	"CD217, CDw217, hIL-17R, IL-17RA, IL17R"	ENSG00000177663	"Interleukin 17 receptor A"	Q96F46	22	17084954-17115694	"CD markers, Disease related genes, Predicted membrane proteins, Predicted secreted proteins"		Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 50.0"	"Cell type enhanced"	"Detected in many"	8	"Kupffer cells: 84.8;Macrophages: 43.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 15.6"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HL-60: 27.6;NB-4: 24.3;THP-1: 35.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			CAB024996	Enhanced		Approved	Nucleoplasm,Cytosol	"Secreted - unknown location"	NA	NA		20000	"Nucleoplasm, Cytosol"		"CAB024996: "	"unprognostic (1.92e-1)"	"unprognostic (3.15e-1)"	"unprognostic (1.65e-2)"	"unprognostic (9.83e-2)"	"unprognostic (7.66e-2)"	"unprognostic (5.15e-2)"	"unprognostic (3.56e-2)"	"unprognostic (1.22e-2)"	"unprognostic (1.41e-2)"	"unprognostic (8.52e-2)"	"unprognostic (1.91e-1)"	"unprognostic (3.04e-1)"	"unprognostic (1.96e-2)"	"prognostic favorable (8.35e-4)"	"unprognostic (2.16e-2)"	"unprognostic (1.27e-1)"	"unprognostic (6.51e-3)"	17.7	7.6	6.5	13.6	13.8	40.5	24.7	4.0	6.7	8.6	8.1	7.7	4.6	6.2	7.4	9.4	6.8	7.8	7.4	8.8	6.1	4.9	8.3	11.6	16.8	39.2	10.3	2.0	7.7	7.7	6.9	5.4	6.2	8.3	6.9	5.7	5.3	7.0	5.3	5.3	8.6	9.1	8.3	11.2	23.4	7.3	5.3	9.7	50.0	7.9	3.2	11.0	6.3	12.8	0.5	3.6	15.6	6.9	1.4	2.4	2.0	3.6	2.1	1.9	2.5	3.9	2.3	2.5	5.5	3.6	2.6	3.3	2.0	2.4	3.3	2.3	5.5	3.4	6.0	2.7	2.6	1.8	5.4	3.2	0.0	1.2	1.3	4.5	27.6	8.6	3.4	3.8	2.3	1.8	2.5	2.7	2.7	1.4	3.5	2.6	3.1	3.3	24.3	1.1	4.7	2.1	0.7	0.4	0.6	2.4	2.7	1.3	0.0	3.8	3.3	2.7	2.3	2.5	35.0	7.5	2.0	2.9	3.0	2.0	2.8	1.5	1.6	2.9	13.4	2.1	6.7	6.9	6.1	1.1	3.2	0.9	0.4	1.5	1.1	3.6	0.5	2.4	1.8	15.6	1.4	2.9	1.7	0.9	2.0	6.5	13.8	4.0	6.7	6.1	4.9	10.3	2.0	8.3	9.7	11.9	13.1	6.7	5.5	7.8	2.0	4.5	15.3	5.3	3.4	5.2	7.9	5.4	0.0	8.0	2.5	9.3	15.1	0.0	10.8	10.6	8.2	8.5	7.0	9.6	29.2	3.2	12.7	20.9	84.8	1.4	8.3	43.1	8.5	3.6	13.1	3.8	10.5	11.8	4.2	3.1	3.2	12.9	9.0	1.4	14.7	5.9	5.4	20.0	10.6	9.3
IL18BP	IL18BPa	ENSG00000137496	"Interleukin 18 binding protein"	O95998	11	71998541-72005715	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 54.3;lymphoid tissue: 71.5"	"Cell type enhanced"	"Detected in many"	5	"Exocrine glandular cells: 11.8;Hofbauer cells: 10.7;Macrophages: 11.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in single"							"CAB025980, HPA041061"	Enhanced		Approved	"Endoplasmic reticulum"	"Secreted to blood"	NA	NA	3070000	14000000	"Endoplasmic reticulum"		"CAB025980: , HPA041061: AB_2677280"	"unprognostic (2.66e-3)"	"unprognostic (2.04e-3)"	"unprognostic (9.14e-3)"	"unprognostic (1.70e-2)"	"unprognostic (5.58e-3)"	"unprognostic (7.75e-2)"	"unprognostic (1.41e-1)"	"unprognostic (6.20e-2)"	"unprognostic (1.19e-2)"	"unprognostic (1.75e-3)"	"unprognostic (1.74e-1)"	"unprognostic (1.51e-1)"	"prognostic unfavorable (2.93e-6)"	"unprognostic (1.19e-1)"	"unprognostic (4.14e-2)"	"unprognostic (6.76e-2)"	"unprognostic (1.93e-2)"	23.7	10.6	6.5	19.7	7.7	6.0	7.2	6.2	5.7	6.3	6.7	6.7	1.0	7.1	6.1	4.1	4.1	5.8	7.2	4.7	3.8	4.1	37.0	54.3	20.8	20.2	7.0	1.9	10.1	4.9	2.8	6.4	28.4	9.0	8.9	9.8	5.3	6.4	4.0	6.2	5.1	9.2	11.4	6.1	71.5	6.1	3.0	6.3	6.1	17.3	3.6	15.6	8.6	6.2	13.6	22.3	22.2	30.5	1.9	23.4	13.9	2.0	2.7	6.2	3.6	1.3	1.9	7.0	3.4	2.0	3.3	4.5	13.2	2.6	1.2	2.7	1.7	3.8	5.1	3.7	2.8	2.6	3.0	4.4	5.2	7.0	3.7	1.4	3.0	12.6	2.9	3.2	3.0	1.6	4.5	6.4	8.1	8.9	2.3	1.8	3.4	3.8	6.5	4.5	2.4	2.5	5.8	6.4	2.1	2.2	5.5	3.3	6.4	3.8	4.3	5.0	6.6	4.3	2.8	13.8	5.4	4.2	6.2	2.1	3.7	2.2	2.5	2.3	11.0	2.6	2.3	8.5	22.2	23.4	30.5	10.5	13.6	12.4	13.8	15.5	7.0	10.4	15.0	3.6	1.9	23.7	22.3	6.1	13.9	6.5	7.7	6.2	5.7	3.8	4.1	7.0	1.9	9.0	6.3	6.0	3.5	5.7	0.4	1.8	3.1	0.8	0.0	2.7	1.2	0.0	9.8	0.7	0.0	1.9	0.0	7.9	0.7	0.0	11.8	0.9	2.3	0.9	7.0	0.5	10.7	3.2	0.0	8.0	7.2	0.0	0.9	11.1	0.0	0.0	0.7	1.6	7.3	0.0	0.7	0.7	3.0	0.0	1.2	0.5	0.4	1.8	0.7	3.2	0.6	0.1
IL1A	"IL-1A, IL1, IL1-ALPHA, IL1F1"	ENSG00000115008	"Interleukin 1 alpha"	P01583	2	112773915-112784590	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins, Transporters"	"Inflammatory response"	"Cytokine, Mitogen, Pyrogen"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 17.6;lymphoid tissue: 22.2;tongue: 17.9"	"Cell type enhanced"	"Detected in some"	10	"Alveolar cells type 1: 6.0;Early spermatids: 6.2;Late spermatids: 3.2;Macrophages: 4.8;Pancreatic endocrine cells: 2.8"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 22.3;urothelial cancer: 17.0"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"HBEC3-KT: 86.6;hTCEpi: 42.9;hTERT-HME1: 56.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"								"Secreted to blood"	NA	NA	10800					"unprognostic (3.41e-2)"	"prognostic unfavorable (9.52e-4)"	"unprognostic (1.99e-2)"	"unprognostic (4.28e-2)"	"unprognostic (2.08e-1)"	"unprognostic (8.03e-3)"	"unprognostic (4.42e-3)"	"prognostic unfavorable (1.54e-4)"	"unprognostic (1.62e-1)"	"unprognostic (2.45e-1)"	"unprognostic (4.57e-3)"	"unprognostic (1.22e-1)"	"unprognostic (4.30e-3)"	"prognostic unfavorable (4.03e-4)"	"unprognostic (1.66e-1)"	"unprognostic (2.44e-1)"	"unprognostic (8.62e-2)"	0.7	0.3	0.7	1.2	1.4	0.8	0.3	0.2	1.2	5.8	0.3	2.3	0.5	0.0	2.6	0.7	17.6	0.3	2.4	0.3	3.1	0.8	0.2	0.2	3.7	0.2	1.2	0.1	0.3	0.2	0.3	0.4	3.1	2.1	0.3	0.1	0.0	1.9	1.2	0.2	1.2	0.3	0.0	1.8	0.5	0.2	10.9	1.2	0.0	0.2	17.9	22.2	5.4	1.6	0.0	0.0	0.0	0.0	0.0	0.3	0.0	2.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.1	0.1	0.0	10.4	0.0	13.1	0.7	0.0	86.6	0.3	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	42.9	0.7	56.7	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.1	0.0	0.0	0.0	0.0	10.5	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.3	0.2	0.1	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	1.4	0.2	0.9	3.1	0.8	1.2	0.1	2.1	1.2	6.0	1.4	0.0	0.7	1.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.6	6.2	0.0	0.0	0.0	0.7	0.1	0.0	0.2	1.1	0.0	0.3	0.0	0.0	0.0	0.0	3.2	0.0	4.8	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.9	0.0	0.0	0.0	0.3
IL1B	"IL-1B, IL1-BETA, IL1F2"	ENSG00000125538	"Interleukin 1 beta"	P01584	2	112829751-112836903	"Cancer-related genes, Candidate cardiovascular disease genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins, Transporters"	"Inflammatory response"	"Cytokine, Mitogen, Pyrogen"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 62.3;lymphoid tissue: 35.4"	"Cell type enriched"	"Detected in many"	7	"Macrophages: 764.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in many"	5	"neutrophil: 34.4"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 34.4"	"Cell line enhanced"	"Detected in some"		"BJ hTERT+: 93.2;HBEC3-KT: 42.4;HMC-1: 34.6;hTEC/SVTERT24-B: 46.6;hTERT-RPE1: 40.3;U-87 MG: 85.2"	"Low region specificity"	"Detected in some"												"Secreted to blood"	NA	NA	2330					"unprognostic (1.55e-3)"	"prognostic unfavorable (1.31e-4)"	"unprognostic (2.75e-2)"	"unprognostic (5.71e-2)"	"unprognostic (1.34e-1)"	"unprognostic (7.12e-2)"	"unprognostic (2.63e-2)"	"unprognostic (1.61e-2)"	"unprognostic (1.07e-1)"	"unprognostic (3.63e-3)"	"unprognostic (3.72e-2)"	"unprognostic (5.57e-2)"	"prognostic unfavorable (7.49e-5)"	"unprognostic (1.29e-2)"	"unprognostic (4.42e-2)"	"unprognostic (5.09e-2)"	"unprognostic (4.01e-2)"	19.6	3.3	4.2	20.4	15.3	62.3	0.8	1.1	10.8	1.6	3.2	12.7	0.2	1.2	3.0	1.5	3.5	3.4	7.5	3.7	19.0	3.6	1.7	4.0	17.3	5.0	5.9	0.3	3.4	2.4	2.4	3.0	10.3	24.9	2.6	2.6	1.0	2.2	0.8	0.4	0.9	3.7	3.5	29.7	35.4	20.9	1.6	5.8	0.8	1.1	13.5	14.0	10.4	1.2	0.0	6.9	34.4	7.0	0.0	0.0	1.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.3	93.2	0.4	1.0	0.0	0.0	0.0	2.6	0.0	1.6	2.1	0.0	42.4	5.8	0.0	0.0	4.1	0.0	0.0	0.3	0.0	34.6	0.1	1.3	46.6	15.7	40.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.1	3.5	0.1	0.0	0.0	0.0	5.6	0.0	0.0	0.2	0.0	0.3	0.0	0.0	0.4	0.0	2.2	0.0	0.1	0.0	0.0	0.0	0.0	85.2	1.9	3.2	0.5	4.2	1.5	0.0	7.0	0.0	0.0	0.0	0.0	6.9	0.0	0.0	0.0	34.4	0.0	2.7	0.0	0.0	1.0	4.2	15.3	1.1	10.8	19.0	3.6	5.9	0.3	24.9	5.8	8.9	45.3	1.4	4.6	27.4	0.0	4.3	0.0	13.4	7.9	1.8	0.0	1.2	0.0	12.2	0.1	2.2	0.3	0.0	0.5	2.1	9.9	2.3	39.4	0.0	109.6	0.0	0.0	1.3	54.0	0.0	0.0	764.6	21.9	0.0	2.2	0.0	3.6	6.2	0.0	0.5	0.2	0.0	4.3	0.0	0.2	17.8	3.7	2.2	0.0	4.6
IL1R2	"CD121b, IL1RB"	ENSG00000115590	"Interleukin 1 receptor type 2"	P27930	2	101991844-102028544	"Cancer-related genes, CD markers, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins"		Receptor	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 73.2;lymphoid tissue: 74.1"	"Group enriched"	"Detected in many"	5	"Basal keratinocytes: 131.3;Kupffer cells: 197.6;Macrophages: 236.7;Mucus-secreting cells: 105.1;Pancreatic endocrine cells: 123.7;Suprabasal keratinocytes: 73.4"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in many"	4	"midbrain: 9.2"	"Cell type enriched"	"Detected in some"	25	"neutrophil: 73.2"	"Lineage enriched"	"Detected in many"	25	"granulocytes: 73.2"	"Cell line enriched"	"Detected in some"	8	"HDLM-2: 102.2"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"HPA027597, HPA027598"	Uncertain				"Secreted to blood"	NA	NA	7130000	21000000			"HPA027597: AB_10600768, HPA027598: AB_10601229"	"unprognostic (3.54e-2)"	"unprognostic (1.87e-1)"	"unprognostic (1.21e-1)"	"unprognostic (3.83e-2)"	"unprognostic (6.59e-2)"	"unprognostic (1.42e-1)"	"unprognostic (6.36e-2)"	"unprognostic (4.82e-3)"	"unprognostic (1.62e-2)"	"unprognostic (7.15e-2)"	"unprognostic (8.20e-3)"	"unprognostic (1.07e-1)"	"prognostic unfavorable (5.58e-12)"	"unprognostic (1.92e-1)"	"unprognostic (7.51e-2)"	"unprognostic (1.77e-1)"	"unprognostic (6.62e-2)"	9.1	3.2	1.2	16.4	1.9	22.3	1.6	1.2	1.9	6.4	13.4	0.4	0.1	0.1	1.3	1.3	20.4	9.7	3.4	15.1	1.2	0.5	5.8	8.2	25.5	74.1	9.2	0.2	2.5	1.4	0.0	2.4	24.9	2.2	1.1	20.0	1.8	4.3	0.8	2.8	14.1	2.2	1.3	4.4	47.5	14.6	1.6	1.1	1.6	1.8	8.5	25.1	3.2	9.1	0.0	2.8	73.2	0.8	0.0	1.1	0.2	1.5	0.2	0.0	0.0	0.2	0.2	0.1	0.0	0.0	0.0	0.0	1.6	0.0	0.0	3.3	0.0	0.0	0.6	0.0	0.1	0.0	102.2	0.1	0.0	0.0	0.8	0.5	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.2	0.0	0.0	0.0	0.0	5.3	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	1.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.8	0.0	0.0	0.4	0.0	0.0	0.1	0.0	2.8	0.0	0.0	0.0	73.2	0.0	0.0	0.0	1.1	0.2	1.2	1.9	1.2	1.9	1.2	0.5	9.2	0.2	2.2	1.1	6.0	0.6	5.4	8.6	131.3	0.0	0.4	17.8	4.0	0.0	1.8	0.0	0.4	5.0	8.0	2.6	1.9	8.6	0.0	7.3	28.9	9.3	2.5	2.3	14.4	5.9	0.0	6.4	4.3	197.6	1.5	0.3	236.7	30.4	1.0	105.1	0.0	123.7	31.7	0.0	0.4	0.0	6.5	8.9	0.0	1.4	73.4	23.2	1.0	20.4	7.1
IRAK3	IRAK-M	ENSG00000090376	"Interleukin 1 receptor associated kinase 3"	Q9Y616	12	66188879-66254622	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"	Asthma	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 58.0"	"Cell type enhanced"	"Detected in many"	14	"Ito cells: 36.2;Kupffer cells: 118.3;Macrophages: 66.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"basophil: 5.6;classical monocyte: 13.1;intermediate monocyte: 13.2;myeloid DC: 6.2;neutrophil: 7.2;non-classical monocyte: 20.6"	"Group enriched"	"Detected in many"	12	"dendritic cells: 6.2;granulocytes: 7.2;monocytes: 20.6"	"Cell line enhanced"	"Detected in some"		"ASC diff: 15.0;ASC TERT1: 12.4;HEL: 12.8;HL-60: 17.0;NB-4: 13.6;THP-1: 20.6;U-937: 14.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA043097	Approved		Approved	Vesicles	"Intracellular and membrane"	NA	NA			Vesicles		"HPA043097: AB_10795612"	"unprognostic (7.12e-2)"	"unprognostic (1.06e-1)"	"unprognostic (2.90e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.90e-1)"	"unprognostic (7.56e-3)"	"unprognostic (1.49e-1)"	"unprognostic (2.46e-1)"	"unprognostic (7.82e-2)"	"unprognostic (1.33e-1)"	"unprognostic (2.95e-2)"	"unprognostic (8.52e-2)"	"prognostic unfavorable (6.23e-4)"	"unprognostic (5.58e-2)"	"unprognostic (4.64e-2)"	"unprognostic (3.41e-2)"	"unprognostic (3.23e-2)"	21.8	3.7	2.1	10.6	3.6	58.0	13.4	1.0	2.4	8.7	6.5	2.3	5.5	1.7	6.2	8.6	4.9	7.0	7.6	16.0	2.9	2.1	3.6	2.9	22.1	25.6	4.6	0.3	5.9	2.7	1.3	17.9	6.1	3.7	7.0	3.0	5.5	6.0	5.5	5.5	3.3	4.9	6.4	5.9	25.3	6.2	5.1	2.8	1.0	4.9	4.5	5.4	9.5	11.4	0.4	6.2	7.2	20.6	0.9	0.3	3.6	0.0	0.0	0.2	0.0	15.0	12.4	0.0	1.6	0.0	0.9	1.3	0.0	1.2	0.0	0.8	3.0	0.0	0.0	1.8	0.0	0.7	0.0	0.0	12.8	0.7	0.0	7.8	17.0	2.4	7.8	0.0	0.7	0.0	0.0	4.4	0.0	0.0	0.0	0.5	0.0	0.0	13.6	0.7	0.0	0.0	0.0	3.7	0.0	0.1	1.9	0.1	0.0	6.7	0.0	0.7	0.0	0.0	20.6	4.7	0.0	0.0	0.0	0.0	0.5	0.1	1.2	0.0	14.9	0.0	5.6	13.1	2.2	0.0	13.2	0.0	0.0	0.0	0.0	6.2	0.4	0.0	0.0	7.2	0.9	20.6	0.0	0.3	3.6	2.1	3.6	1.0	2.4	2.9	2.1	4.6	0.3	3.7	2.8	8.9	20.8	0.8	4.1	1.3	0.3	2.2	0.0	6.7	20.5	3.5	0.0	0.2	0.0	0.6	3.6	29.3	0.0	0.0	1.0	0.1	17.3	1.4	26.5	0.0	8.9	0.0	0.0	36.2	118.3	3.0	6.6	66.9	5.0	2.8	1.0	0.2	2.8	0.0	10.6	0.2	0.0	0.0	7.2	0.7	0.9	1.1	0.2	2.5	0.2	2.2
IRF5		ENSG00000128604	"Interferon regulatory factor 5"	Q13568	7	128937612-128950035	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Antiviral defense, Immunity, Innate immunity, Transcription, Transcription regulation"	DNA-binding	"Systemic lupus erythematosus"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"ductus deferens: 40.1"	"Cell type enhanced"	"Detected in many"	17	"Hofbauer cells: 34.3;Kupffer cells: 30.3;Macrophages: 27.6;monocytes: 91.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in all"	7	"B-cells: 8.9;dendritic cells: 20.6;monocytes: 24.2"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 46.0;RPMI-8226: 33.4;THP-1: 18.6;U-937: 22.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA046700, HPA076024"	Enhanced					NA	NA					"HPA046700: AB_2679761, HPA076024: "	"unprognostic (4.01e-2)"	"unprognostic (2.73e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.92e-2)"	"unprognostic (3.45e-1)"	"unprognostic (1.57e-2)"	"unprognostic (5.69e-3)"	"unprognostic (1.49e-1)"	"unprognostic (2.74e-1)"	"unprognostic (4.84e-2)"	"unprognostic (1.51e-1)"	"unprognostic (6.85e-2)"	"unprognostic (1.53e-3)"	"unprognostic (2.66e-1)"	"unprognostic (4.89e-2)"	"unprognostic (6.58e-2)"	"unprognostic (3.20e-3)"	5.4	3.6	6.2	10.1	8.4	16.8	8.8	2.0	5.0	2.7	3.5	5.6	40.1	8.0	1.6	2.5	12.0	4.1	5.3	12.3	7.3	5.2	12.6	5.1	15.8	18.9	12.3	2.2	1.4	7.0	10.2	5.7	3.4	7.5	3.3	2.9	2.0	6.3	24.0	1.1	7.1	10.0	2.5	7.0	25.5	3.6	1.6	8.4	3.9	2.2	1.6	9.9	6.8	5.1	8.9	20.6	1.8	24.2	2.0	2.7	8.5	5.8	1.7	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.4	0.4	0.1	2.3	4.1	2.1	0.0	5.5	5.1	1.3	0.9	0.1	46.0	1.2	6.4	0.0	0.7	0.0	0.9	9.3	0.0	6.0	0.2	0.6	0.4	0.0	0.0	0.0	12.5	0.0	1.8	0.0	1.9	0.1	0.6	1.1	0.3	0.0	33.4	1.7	2.9	0.1	0.7	1.0	1.0	0.5	0.0	1.8	18.6	0.0	0.0	0.1	0.1	0.4	7.3	4.8	1.6	0.2	22.9	0.1	0.8	19.0	1.8	0.5	24.2	1.9	8.9	1.1	0.4	20.6	6.8	0.0	0.0	1.3	2.0	17.1	4.9	2.7	8.5	6.2	8.4	2.0	5.0	7.3	5.2	12.3	2.2	7.5	8.4	0.0	5.1	9.5	0.9	0.7	0.1	0.6	5.1	2.7	0.0	19.2	0.0	0.3	3.3	2.9	0.1	0.7	1.3	0.0	2.1	0.2	0.6	0.4	8.1	0.5	34.3	0.0	0.0	0.0	30.3	0.0	0.0	27.6	0.0	91.0	1.2	0.0	2.0	1.7	0.0	3.7	0.2	0.0	0.4	0.0	0.2	1.8	1.3	4.9	1.5	1.4
IRF8	"ICSBP, ICSBP1, IRF-8"	ENSG00000140968	"Interferon regulatory factor 8"	Q02556	16	85898803-85922609	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Autophagy, Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 197.4;lymphoid tissue: 64.4"	"Cell type enhanced"	"Detected in many"	13	"B-cells: 159.1;Hofbauer cells: 61.3;Kupffer cells: 76.1;Macrophages: 82.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	6	"plasmacytoid DC: 197.4"	"Lineage enriched"	"Detected in many"	6	"dendritic cells: 197.4"	"Cell line enhanced"	"Detected in some"		"Daudi: 35.6;THP-1: 60.1;U-698: 140.9;U-937: 19.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002267, HPA002531, CAB013480"	Enhanced		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"CAB013480: AB_2533439, HPA002267: AB_1079143, HPA002531: AB_1851904"	"unprognostic (2.09e-3)"	"unprognostic (7.51e-2)"	"unprognostic (5.16e-2)"	"unprognostic (1.19e-1)"	"unprognostic (7.54e-2)"	"unprognostic (3.46e-3)"	"unprognostic (3.19e-2)"	"unprognostic (5.31e-3)"	"unprognostic (1.23e-1)"	"unprognostic (1.20e-1)"	"unprognostic (1.66e-1)"	"unprognostic (5.31e-2)"	"unprognostic (3.14e-3)"	"unprognostic (3.97e-2)"	"unprognostic (9.66e-3)"	"unprognostic (4.04e-1)"	"unprognostic (1.10e-2)"	12.4	4.0	6.8	36.1	8.8	19.2	6.7	2.6	5.3	2.3	7.8	8.3	6.8	12.3	2.3	3.0	3.7	2.9	5.6	2.9	5.8	3.3	5.6	9.9	11.7	60.4	9.3	3.1	2.1	3.1	0.2	2.2	2.7	6.7	3.3	10.0	2.2	6.1	8.9	1.5	2.6	36.4	3.6	10.9	64.4	6.5	2.2	8.8	18.4	3.6	2.3	63.3	8.3	2.1	31.8	197.4	0.7	10.8	8.9	0.3	9.8	0.1	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	3.8	0.0	35.6	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	2.8	0.0	3.2	0.0	1.1	0.1	4.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	60.1	0.0	0.0	1.6	0.0	0.1	0.0	0.0	140.9	0.0	19.9	0.0	0.5	10.7	0.2	0.2	10.8	0.3	29.3	0.1	0.1	23.7	31.8	0.3	0.2	0.7	8.9	7.2	197.4	0.0	9.8	6.8	8.8	2.6	5.3	5.8	3.3	9.3	3.1	6.7	8.8	0.0	6.2	159.1	1.1	9.3	0.0	1.2	2.5	0.0	2.3	0.0	0.0	0.5	1.7	0.4	1.4	3.9	16.1	0.0	1.2	4.7	6.4	0.9	2.3	5.6	61.3	0.0	27.5	3.1	76.1	3.7	0.3	82.3	42.2	7.2	5.8	0.4	0.2	11.9	0.0	2.2	0.0	6.5	4.4	0.5	5.5	8.2	0.9	13.8	19.3	2.5
ITGAM	"CD11b, CR3A, MAC-1"	ENSG00000169896	"Integrin subunit alpha M"	P11215	16	31259990-31332892	"Cancer-related genes, CD markers, Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion, Immunity, Innate immunity"	"Integrin, Receptor"	"Cancer-related genes, Systemic lupus erythematosus"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 93.7"	"Cell type enhanced"	"Detected in many"	22	"granulocytes: 34.6;Hofbauer cells: 42.4;Kupffer cells: 152.2;Macrophages: 53.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"basophil: 29.4;classical monocyte: 19.1;eosinophil: 23.8;gdT-cell: 12.2;intermediate monocyte: 7.6;neutrophil: 21.0;NK-cell: 18.8"	"Low lineage specificity"	"Detected in all"			"Group enriched"	"Detected in some"	4	"HMC-1: 33.5;NB-4: 11.8;U-937: 14.3"									"HPA002274, CAB025091, CAB072870"	Enhanced					NA	NA		900000			"CAB025091: , CAB072870: AB_2665722, HPA002274: AB_1078435"	"unprognostic (1.82e-2)"	"unprognostic (1.70e-2)"	"unprognostic (8.78e-2)"	"unprognostic (2.54e-2)"	"unprognostic (2.40e-2)"	"unprognostic (4.20e-2)"	"prognostic unfavorable (3.43e-4)"	"unprognostic (1.86e-1)"	"unprognostic (1.73e-1)"	"unprognostic (3.29e-3)"	"unprognostic (1.27e-1)"	"unprognostic (1.80e-1)"	"prognostic unfavorable (6.93e-5)"	"unprognostic (9.89e-2)"	"prognostic unfavorable (6.93e-4)"	"unprognostic (3.99e-2)"	"unprognostic (5.03e-2)"	19.7	5.0	6.0	14.0	7.2	93.7	6.0	2.0	4.5	2.9	3.2	9.4	0.5	1.8	2.5	3.5	2.2	4.8	4.0	6.5	4.3	3.9	3.0	3.3	14.6	22.8	10.5	1.6	2.5	2.9	1.6	1.8	4.9	5.3	3.6	2.7	3.3	3.2	2.0	1.6	1.5	4.4	6.9	8.6	29.9	2.8	1.5	7.4	2.3	2.1	1.7	6.6	4.9	4.5	1.9	3.4	29.4	19.1	18.8	12.2	8.0	0.5	1.1	0.0	0.0	0.0	0.0	1.0	0.1	0.0	0.0	0.0	0.3	0.5	0.9	0.6	0.0	0.2	0.1	0.0	0.2	0.0	4.8	0.0	0.6	0.0	0.0	0.0	1.2	33.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.1	0.1	0.0	0.0	0.0	11.8	0.0	0.0	0.0	0.2	0.0	0.6	0.0	1.3	0.0	0.0	0.0	0.3	0.2	0.0	0.1	2.7	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	14.3	0.0	29.4	19.1	23.8	12.2	7.6	0.7	1.9	1.3	3.6	3.4	0.3	0.3	3.0	21.0	18.8	1.1	0.2	0.5	8.0	6.0	7.2	2.0	4.5	4.3	3.9	10.5	1.6	5.3	7.4	3.0	15.6	5.1	0.1	1.0	0.0	1.5	2.5	0.0	2.3	0.0	0.0	0.3	0.0	1.1	0.3	0.6	0.0	0.0	0.0	0.4	1.0	0.5	34.6	0.8	42.4	0.0	3.5	1.8	152.2	1.5	0.3	53.9	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	12.9	0.0	0.4	0.7	0.9	0.7	5.4	0.0	0.1
ITGAX	CD11c	ENSG00000140678	"Integrin subunit alpha X"	P20702	16	31355134-31382997	"CD markers, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"	"Integrin, Receptor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 47.9;blood: 31.7;lung: 33.2;lymphoid tissue: 46.3"	"Cell type enhanced"	"Detected in many"	12	"Alveolar cells type 2: 80.7;granulocytes: 70.6;Hofbauer cells: 46.3;Kupffer cells: 28.3;Macrophages: 71.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"classical monocyte: 10.1;eosinophil: 9.2;intermediate monocyte: 18.1;myeloid DC: 12.4;neutrophil: 31.7;NK-cell: 14.9;non-classical monocyte: 20.3"	"Low lineage specificity"	"Detected in many"			"Cell line enriched"	"Detected in some"	6	"HMC-1: 49.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB004458, HPA004723, CAB072871"	Enhanced					NA	NA					"CAB004458: AB_626859, CAB072871: AB_2665723, HPA004723: AB_1846231"	"unprognostic (9.75e-3)"	"unprognostic (2.49e-2)"	"unprognostic (1.75e-1)"	"unprognostic (1.99e-2)"	"unprognostic (1.89e-1)"	"unprognostic (2.29e-2)"	"unprognostic (1.27e-1)"	"unprognostic (9.59e-2)"	"unprognostic (8.06e-3)"	"unprognostic (3.20e-1)"	"unprognostic (7.75e-2)"	"unprognostic (3.34e-1)"	"prognostic unfavorable (1.37e-4)"	"unprognostic (3.92e-2)"	"unprognostic (3.04e-2)"	"unprognostic (2.82e-1)"	"unprognostic (2.95e-2)"	47.9	1.9	4.4	28.1	5.7	28.6	2.9	1.4	4.4	1.8	2.1	17.1	0.6	1.7	2.1	2.5	1.9	4.3	7.7	2.5	5.3	4.6	2.3	4.6	33.2	24.4	13.6	3.8	3.0	2.1	0.8	2.4	3.3	8.1	2.5	3.2	2.5	4.3	1.3	1.1	1.6	3.8	3.3	15.6	46.3	3.3	0.9	7.5	3.8	2.2	0.9	9.7	5.1	1.9	0.8	12.4	31.7	20.3	14.9	1.8	3.2	0.0	0.3	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	4.2	0.0	0.1	0.0	0.0	0.1	0.0	8.3	0.0	0.0	0.1	0.1	0.0	0.5	49.2	0.0	0.0	0.8	0.1	0.3	0.4	0.0	0.0	0.1	0.0	0.0	0.0	3.9	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	1.5	0.3	0.0	0.7	0.0	0.0	0.0	0.0	0.0	2.3	0.8	0.1	3.9	10.1	9.2	1.8	18.1	0.1	0.8	0.0	0.3	12.4	0.4	0.0	0.2	31.7	14.9	20.3	0.2	0.0	3.2	4.4	5.7	1.4	4.4	5.3	4.6	13.6	3.8	8.1	7.5	11.9	80.7	2.9	0.2	2.5	0.0	1.4	0.0	2.7	19.4	0.0	0.0	0.3	0.0	0.2	0.0	1.6	0.0	0.0	0.0	0.2	2.1	0.2	70.6	0.0	46.3	0.0	0.0	0.0	28.3	0.0	0.0	71.4	1.7	2.8	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	2.0	0.0	0.1	1.0	0.3	5.0	0.0	0.0
ITGB2	"CD18, LFA-1, MAC-1, MFI7"	ENSG00000160255	"Integrin subunit beta 2"	P05107	21	44885953-44931989	"CD markers, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion, Phagocytosis"	"Integrin, Receptor"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 159.7;bone marrow: 91.4;lymphoid tissue: 75.6"	"Group enriched"	"Detected in many"	4	"Hofbauer cells: 620.8;Kupffer cells: 458.1;Macrophages: 428.6;T-cells: 303.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"THP-1: 117.5;U-937: 87.3"					"Low region specificity"	"Detected in all"			"HPA008877, HPA016894"	Enhanced		Supported	"Plasma membrane,Rods & Rings"		NA	NA		2500000	"Plasma membrane"	"Rods & Rings"	"HPA008877: AB_1846256, HPA016894: AB_1846257"	"unprognostic (1.94e-2)"	"unprognostic (7.66e-3)"	"unprognostic (1.23e-1)"	"unprognostic (6.21e-3)"	"unprognostic (2.95e-2)"	"unprognostic (9.73e-3)"	"unprognostic (2.53e-2)"	"unprognostic (1.82e-1)"	"unprognostic (1.18e-2)"	"unprognostic (1.36e-1)"	"unprognostic (1.20e-1)"	"unprognostic (6.34e-2)"	"unprognostic (1.87e-3)"	"unprognostic (1.42e-1)"	"unprognostic (4.42e-2)"	"unprognostic (2.65e-2)"	"unprognostic (4.83e-2)"	59.1	9.8	9.0	47.5	16.8	91.4	8.4	1.7	8.0	5.6	7.4	12.2	1.2	6.3	4.9	9.0	4.8	10.7	10.3	9.7	7.2	6.4	8.1	7.0	32.9	73.8	14.3	2.9	6.6	5.1	1.1	3.3	12.7	12.1	6.9	4.2	5.2	8.8	2.7	3.0	4.1	13.2	12.3	18.3	75.6	7.6	4.2	12.2	53.5	4.5	2.2	29.0	15.7	4.2	9.5	76.0	104.6	122.9	41.0	57.4	159.7	0.2	0.7	0.0	0.0	0.0	0.0	0.2	0.0	0.4	0.0	0.0	0.0	0.0	2.5	20.3	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.2	2.4	0.0	0.4	0.0	15.3	4.0	0.2	0.0	0.0	0.0	0.0	0.0	8.1	0.1	0.2	1.0	0.5	17.4	18.5	0.0	0.0	0.3	0.2	3.6	9.5	0.7	0.0	0.1	0.2	0.5	0.3	0.3	0.0	0.0	117.5	0.3	0.0	1.0	0.0	0.5	0.1	0.8	0.4	0.0	87.3	0.1	10.5	122.9	85.7	57.4	84.1	25.8	6.7	28.4	39.5	76.0	9.5	19.1	32.0	104.6	41.0	81.0	11.6	20.7	159.7	9.0	16.8	1.7	8.0	7.2	6.4	14.3	2.9	12.1	12.2	14.9	42.5	86.5	0.5	4.8	0.0	3.5	15.3	5.3	19.4	5.2	0.0	3.4	0.0	2.7	0.5	5.2	0.0	0.0	0.3	3.3	5.7	0.5	23.1	4.3	620.8	0.0	0.0	11.6	458.1	2.1	0.6	428.6	5.0	109.2	0.1	0.3	0.4	0.0	1.4	3.4	0.6	6.5	3.1	0.2	1.1	4.4	4.7	303.6	0.2	0.6
KCNAB2	"AKR6A5, HKvbeta2.1, HKvbeta2.2, KCNA2B"	ENSG00000069424	"Potassium voltage-gated channel subfamily A regulatory beta subunit 2"	Q13303	1	5991466-6101193	"Plasma proteins, Predicted intracellular proteins"	"Ion transport, Potassium transport, Transport"	"Ion channel, Oxidoreductase, Voltage-gated channel"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 57.5;brain: 54.3"	"Cell type enhanced"	"Detected in many"	7	"Hofbauer cells: 58.5;Kupffer cells: 65.2;Macrophages: 36.4;Melanocytes: 60.8"	"Cancer enriched"	"Detected in all"	7	"melanoma: 29.3"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HL-60: 67.4;JURKAT: 36.3;U-937: 71.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB001975	Enhanced					NA	NA					"CAB001975: "	"unprognostic (6.60e-2)"	"unprognostic (2.33e-2)"	"unprognostic (3.97e-3)"	"unprognostic (2.30e-2)"	"unprognostic (1.76e-2)"	"unprognostic (8.18e-3)"	"unprognostic (4.30e-2)"	"unprognostic (1.05e-1)"	"unprognostic (4.85e-2)"	"unprognostic (1.58e-2)"	"unprognostic (7.71e-3)"	"unprognostic (8.83e-3)"	"prognostic unfavorable (3.50e-5)"	"unprognostic (2.88e-2)"	"unprognostic (3.10e-2)"	"unprognostic (2.35e-1)"	"unprognostic (5.24e-2)"	6.9	4.8	37.8	21.5	34.7	57.5	2.7	13.5	54.3	2.7	4.2	4.2	0.5	3.7	3.4	2.1	4.1	6.2	8.1	8.1	44.6	13.1	10.9	3.8	13.9	31.2	16.1	24.7	3.2	2.2	1.3	6.1	4.5	28.7	2.7	4.1	10.8	3.1	2.5	4.0	9.0	7.4	5.0	5.8	21.9	5.3	3.1	4.7	13.9	2.4	0.5	17.0	9.0	1.7	6.8	19.6	11.4	21.1	9.2	19.8	22.8	2.5	7.0	0.6	0.8	0.3	1.2	2.4	1.3	8.5	1.4	1.7	2.5	1.2	14.9	4.3	0.9	1.3	0.9	0.5	0.1	0.8	17.4	2.4	18.3	7.1	4.2	1.3	67.4	0.5	1.3	0.3	0.9	1.7	1.2	1.1	36.3	0.5	28.4	0.7	2.2	12.9	29.0	0.4	1.1	3.1	2.6	2.1	17.6	0.2	0.0	4.3	1.5	1.0	1.2	22.2	0.6	1.0	26.0	0.2	0.3	2.5	2.6	1.5	21.5	25.1	21.2	2.6	71.8	0.5	2.1	21.1	11.4	19.8	17.6	18.7	6.0	13.0	19.1	19.6	6.8	13.8	14.5	9.0	9.2	15.4	8.1	13.6	22.8	37.8	34.7	13.5	54.3	44.6	13.1	16.1	24.7	28.7	4.7	0.0	10.0	20.6	1.6	4.2	16.5	12.6	7.6	9.4	2.3	1.8	5.9	0.5	0.0	0.3	4.5	3.4	0.0	0.0	1.2	1.7	3.5	0.3	8.1	0.8	58.5	6.4	0.0	4.3	65.2	3.1	3.4	36.4	60.8	5.4	0.2	4.3	0.5	0.0	2.5	35.2	11.0	0.0	3.1	3.8	3.2	2.5	0.7	34.8	0.0	0.8
KCNE1	"ISK, JLNS2, LQT5, minK"	ENSG00000180509	"Potassium voltage-gated channel subfamily E regulatory subunit 1"	P15382	21	34446688-34512275	"Disease related genes, FDA approved drug targets, Predicted membrane proteins"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel, Voltage-gated channel"	"Deafness, Disease mutation, FDA approved drug targets, Long QT syndrome"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"fallopian tube: 17.6"	"Group enriched"	"Detected in many"	7	"Ciliated cells: 32.1;Cone photoreceptor cells: 23.6;Kupffer cells: 26.3;Macrophages: 15.3"	"Not detected"	"Not detected"			"Region enriched"	"Detected in some"	6	"pons and medulla: 10.6"	"Cell type enhanced"	"Detected in some"		"eosinophil: 6.8"	"Lineage enriched"	"Detected in many"	4	"granulocytes: 6.8"	"Cell line enhanced"	"Detected in some"		"BJ hTERT+ SV40 Large T+: 3.0;CACO-2: 9.2;HBF TERT88: 2.3"															NA	NA						"unprognostic (8.24e-3)"	"unprognostic (9.14e-3)"	"unprognostic (1.26e-1)"	"unprognostic (2.71e-3)"	"unprognostic (1.01e-3)"	"unprognostic (2.98e-2)"	"unprognostic (2.45e-2)"	"unprognostic (1.47e-2)"	"unprognostic (2.58e-1)"	"unprognostic (2.06e-1)"	"unprognostic (9.30e-2)"	"unprognostic (7.90e-3)"	"unprognostic (1.41e-2)"	"unprognostic (3.27e-2)"	"unprognostic (2.34e-2)"	"unprognostic (1.30e-1)"	"unprognostic (4.40e-2)"	9.3	0.4	0.7	1.3	0.9	1.6	4.8	0.1	0.5	1.8	3.2	2.7	0.0	0.4	0.8	4.0	0.7	17.6	0.4	9.2	1.3	0.8	3.4	4.3	12.0	10.6	1.7	0.0	2.9	0.2	1.0	1.3	3.5	10.6	1.0	0.4	0.5	0.8	0.3	0.2	0.4	0.6	0.7	0.5	7.3	0.5	4.8	0.3	0.2	0.7	0.1	0.3	1.6	14.8	0.0	0.5	6.8	1.5	0.0	0.0	0.4	0.1	0.0	0.0	0.1	0.2	0.0	0.0	0.5	1.1	3.0	1.0	9.2	0.1	0.0	0.0	0.3	0.0	0.1	0.1	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.3	0.0	0.0	0.2	0.0	0.0	0.4	0.2	0.0	0.1	0.1	0.0	0.1	0.3	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	1.3	0.6	0.1	0.2	0.0	0.0	0.0	0.0	0.3	0.3	0.0	0.0	0.0	0.3	0.1	0.1	1.3	6.8	0.0	1.3	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	3.0	0.0	1.5	0.0	0.0	0.4	0.7	0.9	0.1	0.5	1.3	0.8	1.7	0.0	10.6	0.3	3.0	2.6	0.0	0.6	0.7	1.4	3.1	0.0	32.1	1.2	0.0	23.6	0.0	0.0	0.6	3.1	1.8	0.0	0.0	0.3	0.3	0.6	0.3	0.0	3.4	3.7	0.0	0.0	1.8	26.3	1.8	0.3	15.3	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	1.6	0.0	0.6	0.9	0.0	0.3	0.0	0.0	0.0	0.8
KCNK13	"K2p13.1, THIK-1, THIK1"	ENSG00000152315	"Potassium two pore domain channel subfamily K member 13"	Q9HB14	14	90061765-90185857	"Predicted membrane proteins, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel, Voltage-gated channel"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 8.3;parathyroid gland: 14.3;testis: 13.2"	"Cell type enhanced"	"Detected in some"	24	"Hofbauer cells: 5.6;Kupffer cells: 2.5;Macrophages: 5.3;monocytes: 14.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	6	"classical monocyte: 1.5;intermediate monocyte: 1.3;myeloid DC: 3.8"	"Group enriched"	"Detected in many"	7	"dendritic cells: 3.8;monocytes: 1.5"	"Cell line enhanced"	"Detected in some"		"GAMG: 2.4;RT4: 4.2;SuSa: 7.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA003514	Approved		Approved	"Nuclear speckles,Cell Junctions"		NA	NA			"Nuclear speckles, Cell Junctions"		"HPA003514: AB_2666978"	"unprognostic (1.40e-1)"	"unprognostic (1.73e-1)"	"unprognostic (6.17e-2)"	"unprognostic (6.31e-2)"	"unprognostic (2.56e-1)"	"unprognostic (5.55e-2)"	"unprognostic (3.56e-2)"	"unprognostic (3.98e-2)"	"unprognostic (2.40e-1)"	"unprognostic (2.34e-1)"	"unprognostic (1.85e-1)"	"unprognostic (3.45e-2)"	"unprognostic (1.97e-1)"	"unprognostic (2.04e-2)"	"unprognostic (6.32e-2)"	"unprognostic (1.46e-1)"	"unprognostic (5.65e-2)"	0.8	1.1	2.9	2.2	3.5	0.1	0.4	0.2	4.2	0.4	0.6	4.0	0.0	0.6	0.3	1.5	0.3	0.4	0.5	2.7	2.9	2.4	4.8	0.7	0.7	1.6	6.3	1.4	0.4	2.7	14.3	0.6	1.2	3.6	0.4	0.7	0.1	1.1	0.7	0.1	0.1	0.7	0.4	8.3	1.1	0.5	13.2	5.4	0.7	2.7	0.0	0.6	0.8	0.1	0.0	3.8	0.0	1.5	0.0	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	2.4	0.0	0.9	0.0	0.0	0.8	1.0	0.0	0.0	1.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.6	0.0	0.2	0.0	0.0	0.0	1.9	0.0	0.0	0.7	0.0	1.0	0.0	0.0	0.0	0.4	4.2	1.8	0.5	0.0	1.8	1.2	7.1	0.0	1.6	0.0	0.0	2.1	0.0	0.6	0.6	1.8	0.0	0.2	0.0	0.1	0.0	1.5	0.0	0.0	1.3	0.0	0.0	0.0	0.0	3.8	0.0	0.0	0.3	0.0	0.0	0.3	0.0	0.0	0.3	2.9	3.5	0.2	4.2	2.9	2.4	6.3	1.4	3.6	5.4	0.0	0.0	0.0	0.0	0.1	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.6	0.0	0.0	0.0	2.5	0.6	0.0	5.3	0.0	14.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.5	0.3	0.1	0.0	0.0	0.1
KLHL6	FLJ00029	ENSG00000172578	"Kelch like family member 6"	Q8WZ60	3	183487531-183555689	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 43.2"	"Cell type enhanced"	"Detected in many"	12	"B-cells: 16.2;Ciliated cells: 18.7;granulocytes: 47.6;Hofbauer cells: 22.0;Kupffer cells: 16.7;Macrophages: 17.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"Daudi: 15.4;HEL: 9.8;HMC-1: 10.3;U-266/70: 31.6;U-266/84: 16.4;U-698: 46.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA024512	Uncertain		Approved	"Plasma membrane,Microtubules,Mitotic spindle,Centriolar satellite"		Yes	NA			"Centriolar satellite"	"Plasma membrane, Microtubules, Mitotic spindle"	"HPA024512: AB_2131015"	"unprognostic (8.46e-2)"	"unprognostic (3.67e-4)"	"unprognostic (1.48e-2)"	"unprognostic (6.03e-4)"	"unprognostic (5.15e-2)"	"unprognostic (1.30e-3)"	"unprognostic (1.39e-1)"	"unprognostic (5.05e-2)"	"unprognostic (7.43e-2)"	"unprognostic (9.62e-2)"	"unprognostic (8.24e-2)"	"unprognostic (2.68e-1)"	"prognostic unfavorable (3.53e-4)"	"unprognostic (1.81e-1)"	"unprognostic (3.68e-2)"	"unprognostic (2.42e-1)"	"unprognostic (5.73e-2)"	4.4	1.2	1.4	43.2	3.3	2.9	2.2	0.5	1.8	1.7	4.1	2.4	0.5	2.3	1.1	0.3	1.7	4.2	2.3	1.9	1.8	1.3	1.4	1.4	8.0	23.8	4.4	0.0	0.7	0.8	0.2	1.0	1.8	2.8	1.4	2.2	0.8	4.6	0.6	0.7	0.8	9.9	0.7	8.8	15.1	3.5	0.7	2.3	21.4	1.6	0.5	34.5	2.8	2.7	4.4	5.2	13.3	3.3	2.8	4.8	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.0	0.0	9.8	0.0	0.0	0.0	2.6	10.3	0.0	0.0	0.0	0.0	0.0	1.7	0.2	0.1	7.0	0.0	0.0	3.2	1.5	0.0	0.0	0.0	5.4	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.9	0.0	0.0	0.0	0.0	31.6	16.4	46.4	0.0	2.9	0.0	7.1	3.3	13.3	0.8	2.7	0.9	4.4	3.0	1.3	2.3	3.3	3.6	2.2	3.1	2.8	3.0	5.2	4.8	2.7	1.4	3.3	0.5	1.8	1.8	1.3	4.4	0.0	2.8	2.3	6.0	9.2	16.2	1.5	1.0	0.6	3.2	0.0	18.7	9.1	0.0	2.0	0.2	0.0	0.0	1.5	2.9	0.0	0.0	0.0	0.2	1.1	1.1	47.6	0.0	22.0	0.0	0.0	1.8	16.7	0.0	0.3	17.0	8.5	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.2	0.4	0.5	0.5	10.8	0.0	1.0
KYNU		ENSG00000115919	Kynureninase	Q16719	2	142877498-143055832	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Pyridine nucleotide biosynthesis"	Hydrolase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 35.9;liver: 41.1;placenta: 34.3"	"Cell type enhanced"	"Detected in many"	18	"Macrophages: 94.5;monocytes: 360.7;Syncytiotrophoblasts: 87.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	18	"classical monocyte: 28.7;intermediate monocyte: 35.9;memory B-cell: 19.7;myeloid DC: 28.4;naive B-cell: 12.7;non-classical monocyte: 29.2;plasmacytoid DC: 19.9"	"Group enriched"	"Detected in many"	21	"B-cells: 19.7;dendritic cells: 28.4;monocytes: 35.9"	"Cell line enhanced"	"Detected in some"		"A549: 37.9;GAMG: 62.8;HeLa: 42.3;Hep G2: 25.7;hTEC/SVTERT24-B: 22.2;U-87 MG: 66.4"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			HPA031686	Enhanced		Supported	Nucleoplasm,Cytosol		NA	NA		360000	Cytosol	Nucleoplasm	"HPA031686: AB_2673995"	"unprognostic (2.58e-2)"	"unprognostic (3.39e-3)"	"unprognostic (1.21e-2)"	"unprognostic (5.94e-2)"	"unprognostic (1.65e-2)"	"unprognostic (9.04e-2)"	"unprognostic (5.36e-3)"	"unprognostic (3.58e-3)"	"unprognostic (4.88e-2)"	"unprognostic (3.35e-2)"	"unprognostic (2.87e-3)"	"unprognostic (1.51e-1)"	"unprognostic (1.40e-3)"	"unprognostic (3.33e-3)"	"unprognostic (3.65e-2)"	"unprognostic (5.24e-2)"	"unprognostic (1.64e-1)"	9.0	3.7	2.2	11.0	3.7	3.9	15.4	0.6	1.7	3.0	1.2	1.3	0.8	0.2	1.1	2.6	5.6	1.5	4.4	3.8	1.4	1.1	8.4	41.1	12.7	13.7	2.9	0.4	1.7	1.0	0.2	1.6	34.3	2.7	1.9	1.2	1.5	3.0	0.8	0.7	1.5	2.7	2.0	6.3	16.0	2.4	7.0	2.6	2.7	2.2	1.7	13.0	12.4	2.6	19.7	28.4	1.3	35.9	0.4	0.1	11.1	0.0	37.9	0.1	0.1	0.0	0.1	0.1	0.0	1.0	0.0	0.0	0.6	0.5	2.2	0.1	0.0	62.8	0.1	0.0	0.0	0.0	0.1	0.0	0.8	42.3	25.7	0.5	0.1	0.2	3.6	3.1	22.2	0.1	0.0	0.0	0.0	0.1	0.2	0.3	19.3	0.0	2.3	0.1	0.0	0.1	0.0	0.2	0.1	0.6	19.6	0.1	0.0	21.0	3.1	0.2	0.2	10.5	5.4	0.3	1.2	0.1	18.5	0.0	0.1	0.0	0.0	66.4	4.4	0.1	0.1	28.7	0.5	0.1	35.9	0.1	19.7	0.1	0.1	28.4	12.7	0.1	0.0	1.3	0.4	29.2	19.9	0.1	11.1	2.2	3.7	0.6	1.7	1.4	1.1	2.9	0.4	2.7	2.6	3.0	2.4	22.6	0.5	3.5	0.1	1.2	5.1	2.7	10.3	3.5	3.9	2.8	5.0	12.1	34.6	2.9	0.0	0.0	7.8	1.5	3.3	0.8	0.0	44.8	38.5	9.5	0.0	3.1	59.7	39.6	1.7	94.5	1.7	360.7	0.0	0.2	37.4	0.0	0.4	23.0	0.5	6.5	1.3	40.0	8.0	2.8	87.5	0.0	0.0	4.2
LAIR1	CD305	ENSG00000167613	"Leukocyte associated immunoglobulin like receptor 1"	Q6GTX8	19	54351384-54370558	"CD markers, Predicted intracellular proteins, Predicted membrane proteins"	"Adaptive immunity, Immunity"	Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 39.0"	"Cell type enhanced"	"Detected in many"	12	"granulocytes: 103.2;Hofbauer cells: 178.5;Kupffer cells: 84.4;Macrophages: 142.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"HMC-1: 6.6;Karpas-707: 17.1;THP-1: 19.4"									HPA011155	Enhanced		Supported	"Plasma membrane"		NA	NA		130000	"Plasma membrane"		"HPA011155: AB_1852685"	"unprognostic (1.91e-1)"	"unprognostic (1.12e-2)"	"unprognostic (2.81e-2)"	"unprognostic (1.25e-2)"	"unprognostic (2.03e-2)"	"unprognostic (4.38e-2)"	"unprognostic (2.16e-2)"	"unprognostic (1.74e-1)"	"unprognostic (5.00e-2)"	"unprognostic (2.24e-1)"	"unprognostic (2.21e-1)"	"unprognostic (7.11e-2)"	"prognostic unfavorable (5.01e-5)"	"unprognostic (1.72e-1)"	"unprognostic (2.72e-3)"	"unprognostic (3.52e-2)"	"unprognostic (5.22e-2)"	12.7	7.0	4.5	10.9	9.9	13.5	6.9	0.5	4.5	2.7	5.1	6.7	0.2	2.7	2.2	6.8	2.5	3.6	4.4	3.9	5.2	4.2	3.8	2.9	16.5	33.1	10.2	1.9	2.0	2.4	1.4	2.8	7.0	7.0	3.0	2.0	3.1	3.9	2.2	2.3	2.3	7.6	7.8	11.9	28.6	2.9	3.1	7.4	39.0	2.0	0.5	6.1	3.7	1.7	6.0	10.3	12.4	8.8	5.8	8.0	5.7	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.2	0.0	0.0	0.0	2.8	6.6	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	17.1	0.0	0.0	2.2	1.5	0.0	0.0	0.0	2.2	0.1	2.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	19.4	0.1	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.2	2.7	0.2	12.4	4.2	10.0	8.0	8.3	4.6	2.3	2.4	4.3	0.1	6.0	3.8	4.9	0.6	5.8	8.8	10.3	1.6	5.7	4.5	9.9	0.5	4.5	5.2	4.2	10.2	1.9	7.0	7.4	14.9	34.1	29.8	0.5	0.6	5.5	1.3	0.0	20.1	20.5	0.0	35.3	4.4	0.0	0.0	15.9	0.7	0.0	0.0	0.0	4.1	1.9	0.5	103.2	0.8	178.5	1.6	0.0	4.3	84.4	20.4	0.3	142.0	0.0	1.0	0.0	1.1	0.1	0.0	0.0	0.1	14.8	0.0	0.9	1.4	1.0	1.0	8.4	33.0	0.0	0.8
LAPTM5		ENSG00000162511	"Lysosomal protein transmembrane 5"	Q13571	1	30732469-30757820	"Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 166.6;bone marrow: 157.5;lymphoid tissue: 144.5"	"Group enriched"	"Detected in many"	5	"B-cells: 749.7;granulocytes: 621.6;Hofbauer cells: 1099.3;Kupffer cells: 831.6;Macrophages: 787.9;T-cells: 409.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"Daudi: 47.1;HEL: 89.3;HL-60: 56.6;HMC-1: 211.5;REH: 66.3;U-698: 76.8;U-937: 46.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051293	Approved		Approved	Cytosol		NA	NA			Cytosol		"HPA051293: AB_2681424"	"unprognostic (3.12e-2)"	"prognostic favorable (3.40e-4)"	"unprognostic (6.86e-2)"	"unprognostic (4.05e-3)"	"unprognostic (1.63e-1)"	"unprognostic (8.45e-2)"	"unprognostic (1.43e-1)"	"unprognostic (3.76e-1)"	"unprognostic (1.22e-3)"	"unprognostic (2.30e-1)"	"unprognostic (6.75e-2)"	"unprognostic (1.60e-1)"	"prognostic unfavorable (5.89e-5)"	"unprognostic (9.47e-2)"	"unprognostic (8.18e-3)"	"unprognostic (5.98e-2)"	"unprognostic (3.94e-2)"	56.0	15.5	11.5	59.1	17.8	157.5	15.0	2.2	10.4	8.2	11.2	20.7	1.8	9.5	7.5	6.8	8.3	13.7	19.9	9.2	11.2	12.7	14.0	18.2	60.8	144.5	19.0	3.3	7.7	6.3	2.0	6.8	20.1	14.6	8.2	13.2	7.4	11.7	4.7	4.0	5.5	37.1	12.9	33.8	130.9	9.5	6.7	15.8	75.2	10.1	5.2	91.2	21.4	6.4	98.2	69.1	145.1	109.3	26.0	55.4	166.6	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	47.1	4.9	0.1	0.1	0.1	0.0	0.0	0.0	5.2	0.0	89.3	0.0	0.1	0.0	56.6	211.5	0.0	0.1	0.0	0.3	0.0	10.8	6.1	1.1	2.9	0.7	0.0	9.7	11.9	0.0	0.0	0.0	66.3	8.7	32.9	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.0	36.0	12.5	0.0	0.2	0.0	0.2	0.2	0.0	76.8	0.2	46.2	0.1	73.5	109.3	115.3	47.7	87.9	55.4	70.2	43.7	44.6	69.1	98.2	44.2	43.1	145.1	26.0	83.9	33.2	53.7	166.6	11.5	17.8	2.2	10.1	11.2	12.7	19.0	3.3	14.6	15.8	23.8	148.6	749.7	1.1	21.2	0.0	5.6	10.2	18.7	25.0	3.5	0.0	5.6	0.0	0.4	1.5	31.3	0.7	0.0	0.6	5.1	16.6	0.8	621.6	4.2	1099.3	0.0	1.2	36.2	831.6	1.7	1.4	787.9	47.2	70.3	0.6	0.2	0.9	0.0	0.4	2.2	1.3	0.0	6.8	0.3	0.3	17.6	7.4	409.7	0.3	1.6
LAT2	"HSPC046, LAB, NTAL, WBSCR15, WBSCR5, WSCR5"	ENSG00000086730	"Linker for activation of T cells family member 2"	Q9GZY6	7	74199652-74229834	"Disease related genes, Predicted intracellular proteins"	"Adaptive immunity, Immunity, Mast cell degranulation"		"Williams-Beuren syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 98.4;lymphoid tissue: 36.7"	"Cell type enhanced"	"Detected in many"	12	"B-cells: 89.1;granulocytes: 165.4;Hofbauer cells: 75.1;Kupffer cells: 75.9;Macrophages: 83.0;monocytes: 54.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"basophil: 98.4"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"NB-4: 46.6;REH: 53.0;RPMI-8226: 19.0;THP-1: 48.0;U-937: 46.8"					"Low region specificity"	"Detected in all"			HPA003462	Enhanced		Supported	"Plasma membrane"	"Intracellular and membrane"	NA	NA			"Plasma membrane"		"HPA003462: AB_1079238"	"unprognostic (1.24e-2)"	"unprognostic (1.14e-2)"	"unprognostic (1.32e-2)"	"unprognostic (3.55e-3)"	"unprognostic (1.09e-1)"	"unprognostic (3.30e-3)"	"unprognostic (2.79e-2)"	"unprognostic (1.33e-1)"	"unprognostic (9.27e-2)"	"unprognostic (1.19e-1)"	"unprognostic (6.34e-3)"	"unprognostic (6.91e-2)"	"prognostic unfavorable (4.10e-4)"	"unprognostic (1.80e-1)"	"prognostic unfavorable (6.10e-4)"	"unprognostic (7.44e-2)"	"unprognostic (2.03e-1)"	4.6	3.7	10.3	21.4	19.3	32.8	2.5	2.7	9.6	2.8	3.9	11.6	0.5	3.3	2.5	2.4	2.5	3.8	5.9	2.4	8.8	6.5	3.0	3.8	11.6	29.3	21.9	2.5	1.4	2.8	1.0	2.8	4.4	15.7	4.5	4.7	2.3	3.6	2.2	2.7	1.8	9.9	5.0	19.3	36.7	3.6	1.6	17.6	3.2	2.4	1.0	32.7	5.8	4.6	26.8	32.5	98.4	39.5	10.0	1.3	24.7	0.4	0.2	0.2	0.8	0.0	0.0	0.3	0.3	0.3	0.2	0.2	0.5	8.1	5.3	0.1	0.1	1.6	0.2	0.0	0.3	0.1	8.5	0.3	2.1	0.3	0.3	0.0	15.5	15.6	0.1	0.2	0.5	0.1	0.3	0.0	0.2	0.3	2.4	0.2	0.3	0.3	46.6	0.2	1.3	0.5	53.0	0.2	19.0	0.0	0.4	0.2	0.2	0.1	0.3	0.2	0.2	0.2	48.0	0.6	0.6	5.6	0.2	0.4	0.2	1.5	8.3	2.7	46.8	0.3	98.4	39.5	5.9	1.3	22.3	0.1	24.4	0.3	0.1	32.5	26.8	0.1	0.4	69.1	10.0	12.4	1.2	0.6	24.7	10.3	19.3	2.7	9.6	8.8	6.5	21.9	2.5	15.7	17.6	3.0	23.9	89.1	0.6	3.1	0.0	0.8	7.6	10.7	5.7	3.5	0.0	0.5	0.0	0.0	2.3	1.0	0.0	0.0	0.2	0.9	1.4	1.0	165.4	3.2	75.1	0.0	7.5	4.9	75.9	1.9	0.0	83.0	1.7	54.1	0.2	0.3	0.6	0.0	0.7	0.0	1.3	0.0	0.7	0.4	1.1	2.3	1.0	51.6	0.4	0.5
LCP1	"CP64, L-PLASTIN, LC64P, PLS2"	ENSG00000136167	"Lymphocyte cytosolic protein 1"	P13796	13	46125920-46211871	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"		Actin-binding	"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 188.6;lymphoid tissue: 118.2"	"Group enriched"	"Detected in many"	4	"Alveolar cells type 2: 106.9;B-cells: 102.2;Early spermatids: 108.1;granulocytes: 292.1;Hofbauer cells: 246.0;Kupffer cells: 369.7;Late spermatids: 220.3;Macrophages: 303.2;monocytes: 275.9;T-cells: 260.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Daudi: 82.8;HDLM-2: 75.7;HL-60: 80.4;HMC-1: 85.3;JURKAT: 76.6;THP-1: 75.0;U-698: 106.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019493, CAB020673"	Enhanced		Approved	"Plasma membrane,Actin filaments,Cytosol"		NA	NA		2200000000	"Plasma membrane, Cytosol"	"Actin filaments"	"CAB020673: , HPA019493: AB_1855457"	"unprognostic (2.79e-2)"	"unprognostic (8.20e-3)"	"unprognostic (1.19e-2)"	"unprognostic (3.95e-3)"	"unprognostic (1.19e-1)"	"unprognostic (2.84e-2)"	"unprognostic (2.70e-1)"	"unprognostic (4.99e-2)"	"unprognostic (6.70e-3)"	"unprognostic (2.54e-1)"	"unprognostic (5.47e-2)"	"unprognostic (3.63e-1)"	"unprognostic (3.32e-3)"	"unprognostic (2.51e-1)"	"unprognostic (1.02e-1)"	"unprognostic (7.50e-2)"	"unprognostic (2.92e-1)"	57.1	10.0	5.6	44.3	9.4	71.2	8.7	3.9	4.6	3.6	6.2	4.5	5.0	4.5	5.3	43.1	6.2	8.3	8.9	5.5	4.3	3.8	7.2	12.2	33.7	59.1	12.0	1.0	5.7	3.9	0.1	2.8	24.7	7.7	21.5	8.1	5.5	9.5	2.5	3.5	6.8	21.7	6.5	11.9	112.9	6.1	8.2	9.2	118.2	4.5	4.1	68.7	14.0	7.1	25.4	79.3	133.5	127.6	43.2	67.2	188.6	3.3	0.0	0.1	0.0	0.0	0.0	40.2	0.0	0.1	0.3	0.2	22.2	0.1	82.8	17.6	0.0	24.6	0.1	0.0	0.0	0.3	75.7	19.7	17.9	0.0	0.0	0.0	80.4	85.3	0.2	0.0	0.1	0.1	0.0	0.0	76.6	9.3	55.1	0.0	0.1	56.9	55.7	0.0	0.0	0.8	42.4	0.1	59.2	0.0	22.9	0.1	0.7	0.1	8.8	0.6	2.5	0.4	75.0	0.2	2.1	1.3	0.1	2.4	13.2	27.4	106.5	1.6	49.0	0.3	57.1	96.6	54.3	67.2	127.6	60.8	25.4	40.4	55.5	79.3	18.3	25.2	42.3	133.5	43.2	118.1	20.8	40.5	188.6	5.6	9.4	3.9	4.6	4.3	3.8	12.0	1.0	7.7	9.2	29.8	106.9	102.2	0.8	10.6	0.4	3.1	2.5	25.4	33.0	3.5	0.0	8.6	0.0	19.4	108.1	6.6	0.0	23.3	14.4	53.7	6.6	52.4	292.1	26.8	246.0	0.0	1.2	14.1	369.7	220.3	1.1	303.2	21.9	275.9	0.0	19.2	4.7	0.6	1.8	1.4	0.9	0.0	7.9	1.8	1.7	10.3	11.3	260.3	0.1	2.2
LCP2	"SLP-76, SLP76"	ENSG00000043462	"Lymphocyte cytosolic protein 2"	Q13094	5	170246237-170298227	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 51.1;lymphoid tissue: 95.2"	"Cell type enhanced"	"Detected in many"	10	"granulocytes: 122.8;Hofbauer cells: 51.0;Kupffer cells: 121.6;Macrophages: 65.3;T-cells: 60.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"HEL: 34.3;HL-60: 35.3;HMC-1: 91.1;Karpas-707: 19.5;MOLT-4: 21.2;THP-1: 18.8;U-937: 23.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"CAB004574, HPA036396, HPA036397"	Enhanced					NA	NA		3600000			"CAB004574: AB_628259, HPA036396: AB_10671840, HPA036397: AB_10670436"	"unprognostic (1.33e-2)"	"unprognostic (3.88e-2)"	"unprognostic (7.52e-3)"	"prognostic favorable (5.08e-4)"	"unprognostic (1.43e-1)"	"unprognostic (1.30e-2)"	"unprognostic (2.03e-1)"	"unprognostic (8.84e-2)"	"unprognostic (1.44e-1)"	"unprognostic (4.87e-2)"	"unprognostic (1.37e-1)"	"unprognostic (3.10e-1)"	"prognostic unfavorable (6.22e-5)"	"unprognostic (1.87e-1)"	"unprognostic (3.56e-2)"	"unprognostic (1.71e-2)"	"unprognostic (1.07e-1)"	18.9	5.8	4.6	26.6	5.8	51.1	6.8	1.2	6.3	5.4	7.5	5.2	0.7	5.7	4.2	5.0	3.6	5.4	10.8	4.3	3.7	3.6	5.4	9.4	22.0	25.3	8.4	1.7	3.6	3.0	0.9	3.3	8.0	5.6	7.3	6.1	4.6	5.3	2.3	2.7	4.0	14.3	5.9	7.9	46.8	6.1	4.0	6.7	95.2	4.6	2.4	25.8	9.7	4.3	1.3	11.3	31.1	26.1	18.0	18.4	8.7	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	34.3	0.0	0.0	0.0	35.3	91.1	0.0	0.0	0.0	0.0	0.0	0.0	12.0	0.2	19.5	0.0	0.0	21.2	12.0	0.1	0.0	0.0	3.2	0.0	10.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	18.8	0.0	0.0	0.0	0.0	0.0	0.3	3.2	0.0	0.0	23.2	0.4	23.2	8.6	31.1	18.3	18.4	18.4	1.3	15.0	17.5	11.3	0.4	14.2	14.5	30.6	18.0	26.1	2.3	16.8	8.7	4.6	5.8	1.2	6.3	3.7	3.6	8.4	1.7	5.6	6.7	14.9	43.0	14.1	0.2	2.9	0.0	2.0	2.5	5.3	10.3	1.8	0.0	0.4	0.0	0.1	1.3	10.5	0.0	0.0	0.0	0.6	4.5	0.4	122.8	1.3	51.0	0.0	0.0	22.1	121.6	0.2	2.3	65.3	1.7	0.0	0.0	0.0	0.0	0.0	2.8	0.2	0.0	25.8	2.5	0.0	0.1	1.6	0.7	60.9	0.0	0.3
LILRA5	"CD85, CD85f, ILT11, LILRB7, LIR9"	ENSG00000187116	"Leukocyte immunoglobulin like receptor A5"	A6NI73	19	54307070-54313139	"CD markers, Predicted membrane proteins, Predicted secreted proteins"	"Immunity, Innate immunity"	Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 30.2;lymphoid tissue: 67.3"	"Group enriched"	"Detected in some"	4	"Kupffer cells: 84.9;Macrophages: 23.1"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	8	"classical monocyte: 10.6;intermediate monocyte: 27.0;neutrophil: 14.5;non-classical monocyte: 30.2"	"Group enriched"	"Detected in many"	8	"granulocytes: 14.5;monocytes: 30.2"	"Cell line enriched"	"Detected in single"	11	"RPMI-8226: 4.1"														"Secreted to blood"	NA	NA		370000				"unprognostic (8.52e-2)"	"unprognostic (3.61e-1)"	"unprognostic (2.23e-1)"	"unprognostic (1.77e-1)"	"unprognostic (1.57e-2)"	"unprognostic (6.56e-2)"	"unprognostic (2.90e-1)"	"unprognostic (1.86e-1)"	"unprognostic (3.11e-1)"	"unprognostic (6.61e-3)"	"unprognostic (2.01e-1)"	"unprognostic (1.50e-1)"	"prognostic unfavorable (7.78e-4)"	"unprognostic (3.61e-2)"	"unprognostic (6.51e-3)"	"unprognostic (4.68e-2)"	"unprognostic (6.21e-2)"	3.4	0.6	0.3	9.9	0.3	19.1	0.7	0.1	0.3	0.4	0.6	0.1	0.0	0.8	0.4	2.0	0.6	2.0	0.9	7.0	0.2	0.2	1.7	10.8	14.4	24.2	0.5	0.0	1.5	0.4	0.1	0.4	1.3	0.6	0.6	0.7	0.6	0.5	0.3	0.9	0.1	1.8	1.3	0.7	67.3	1.0	0.6	0.0	0.1	1.4	0.4	0.4	2.7	2.8	0.0	2.6	14.5	30.2	0.0	0.0	5.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.1	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	10.6	0.0	0.0	27.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	14.5	0.0	30.2	2.1	0.0	5.1	0.3	0.3	0.1	0.3	0.2	0.2	0.5	0.0	0.6	0.0	0.0	13.3	1.4	0.1	0.1	0.0	0.0	0.0	4.0	5.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.1	10.5	0.2	6.5	0.0	0.0	0.6	84.9	0.0	0.0	23.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
LILRA6	"CD85b, ILT8, LILRB6"	ENSG00000244482	"Leukocyte immunoglobulin like receptor A6"	Q6PI73	19	54236592-54242791	"Predicted membrane proteins"	"Adaptive immunity, Immunity"	Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 9.4;lymphoid tissue: 16.0"	"Cell type enhanced"	"Detected in some"	22	"Alveolar cells type 2: 6.2;Hofbauer cells: 12.4;Kupffer cells: 34.4;Macrophages: 12.0"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"classical monocyte: 4.5;intermediate monocyte: 4.5;neutrophil: 9.4"	"Group enriched"	"Detected in many"	23	"granulocytes: 9.4;monocytes: 4.5"	"Cell line enhanced"	"Detected in single"		"PC-3: 1.5"															NA	NA		18000000				"unprognostic (1.00e-1)"	"unprognostic (8.38e-2)"	"unprognostic (5.60e-2)"	"unprognostic (3.31e-1)"	"unprognostic (2.95e-2)"	"unprognostic (1.14e-1)"	"unprognostic (4.16e-2)"	"unprognostic (2.51e-1)"	"unprognostic (1.86e-1)"	"unprognostic (1.75e-1)"	"unprognostic (9.11e-2)"	"unprognostic (1.51e-1)"	"unprognostic (7.47e-5)"	"unprognostic (7.76e-2)"	"unprognostic (4.01e-3)"	"unprognostic (1.90e-1)"	"unprognostic (4.33e-2)"	4.9	1.1	0.2	4.0	0.2	4.4	0.8	0.2	0.6	0.2	0.5	0.2	0.2	0.3	0.2	2.2	1.9	1.3	1.4	0.8	0.2	0.0	0.4	5.5	6.0	0.2	0.2	0.2	1.1	0.2	0.0	0.2	1.9	0.7	1.1	0.0	0.2	0.8	0.2	0.8	0.1	1.1	4.0	0.2	16.0	0.5	0.8	0.2	0.2	0.6	0.2	0.2	1.3	0.2	0.0	0.3	9.4	4.5	0.0	0.0	1.2	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.5	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	4.5	0.0	0.0	4.5	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	9.4	0.0	1.0	0.0	0.0	1.2	0.2	0.2	0.2	0.6	0.2	0.0	0.2	0.2	0.7	0.2	0.0	6.2	0.0	0.0	0.2	0.0	0.4	5.1	1.4	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	3.5	0.2	12.4	0.0	0.0	1.3	34.4	0.0	0.0	12.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0
LILRB2	"CD85d, ILT4, LIR-2, LIR2, MIR-10, MIR10"	ENSG00000131042	"Leukocyte immunoglobulin like receptor B2"	Q8N423	19	54273821-54281184	"CD markers, Predicted membrane proteins"	"Adaptive immunity, Immunity"	Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 37.9;bone marrow: 30.3;lymphoid tissue: 31.9"	"Cell type enhanced"	"Detected in some"	24	"Hofbauer cells: 26.7;Kupffer cells: 133.7;Macrophages: 59.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"classical monocyte: 15.9;intermediate monocyte: 33.8;neutrophil: 16.7;non-classical monocyte: 37.9"	"Group enriched"	"Detected in many"	5	"granulocytes: 16.7;monocytes: 37.9"	"Cell line enhanced"	"Detected in single"		"THP-1: 1.2"															NA	NA		52000000				"unprognostic (1.23e-1)"	"unprognostic (1.12e-2)"	"unprognostic (3.21e-2)"	"unprognostic (3.51e-2)"	"unprognostic (6.21e-3)"	"unprognostic (1.70e-2)"	"unprognostic (1.44e-2)"	"unprognostic (2.94e-1)"	"unprognostic (1.08e-2)"	"unprognostic (2.98e-2)"	"unprognostic (2.64e-1)"	"unprognostic (2.15e-1)"	"prognostic unfavorable (5.45e-7)"	"unprognostic (1.90e-2)"	"unprognostic (4.68e-3)"	"unprognostic (3.72e-1)"	"unprognostic (9.73e-2)"	3.2	1.4	0.4	6.8	0.6	30.3	1.0	0.3	1.9	0.5	1.1	0.6	0.4	3.3	0.6	0.9	0.5	2.3	6.6	1.5	1.6	0.4	1.5	3.6	18.4	4.9	2.6	0.0	0.4	0.7	0.2	0.7	0.7	1.8	0.9	1.0	1.1	7.4	2.6	0.5	0.4	1.5	0.6	3.4	31.9	1.0	0.3	0.8	0.8	0.6	5.0	0.7	0.6	1.9	0.0	5.3	16.7	37.9	0.0	0.1	8.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	15.9	4.2	0.0	33.8	0.1	0.0	0.0	0.0	5.3	0.0	0.0	0.0	16.7	0.0	37.9	2.2	0.1	8.1	0.4	0.6	0.3	1.9	1.6	0.4	2.6	0.0	1.8	0.8	3.0	17.0	3.4	0.0	1.3	0.0	0.6	2.5	4.0	5.7	0.0	0.0	0.1	0.0	0.0	0.1	0.5	0.0	0.0	0.0	0.2	0.8	0.0	4.7	0.8	26.7	0.0	0.0	3.1	133.7	0.0	0.0	59.3	3.3	5.4	0.0	0.0	0.0	0.0	0.0	0.2	0.0	6.5	0.2	0.0	0.0	0.5	0.1	0.0	0.0	0.0
LILRB3	"CD85a, HL9, ILT5, LIR-3, LIR3, PIR-B, PIRB"	ENSG00000204577	"Leukocyte immunoglobulin like receptor B3"	O75022	19	54216278-54223506	"CD markers, Predicted intracellular proteins, Predicted membrane proteins"	"Adaptive immunity, Immunity"	Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 24.4;bone marrow: 15.3;lymphoid tissue: 23.4"	"Cell type enhanced"	"Detected in many"	14	"Hofbauer cells: 57.4;Kupffer cells: 90.9;Macrophages: 66.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Cell type enhanced"	"Detected in some"		"neutrophil: 24.4"	"Group enriched"	"Detected in many"	4	"granulocytes: 24.4;monocytes: 9.4"	"Cell line enhanced"	"Detected in some"		"BJ: 1.7;HaCaT: 1.9;HEK 293: 2.6"															NA	NA						"unprognostic (7.51e-2)"	"unprognostic (3.52e-2)"	"unprognostic (9.59e-2)"	"unprognostic (4.53e-1)"	"unprognostic (1.83e-3)"	"unprognostic (5.28e-3)"	"unprognostic (2.91e-2)"	"unprognostic (2.55e-1)"	"unprognostic (5.58e-2)"	"unprognostic (2.35e-1)"	"unprognostic (1.43e-1)"	"unprognostic (1.63e-1)"	"unprognostic (1.92e-8)"	"unprognostic (2.18e-1)"	"unprognostic (2.19e-3)"	"unprognostic (1.84e-1)"	"unprognostic (1.75e-1)"	5.1	0.8	0.4	8.9	1.0	15.3	0.8	0.4	0.5	0.7	1.6	0.0	0.2	0.2	0.6	2.5	0.7	1.3	1.1	7.8	1.5	0.6	0.7	1.5	10.9	19.7	0.5	0.0	3.0	1.7	0.0	0.5	2.0	0.6	0.9	0.0	1.0	0.8	0.0	1.7	0.6	0.9	0.9	2.2	23.4	0.8	0.7	0.0	0.3	1.5	0.0	0.1	6.4	1.1	0.1	4.0	24.4	9.4	0.0	0.1	4.5	1.5	0.6	0.4	0.8	0.0	0.0	0.5	1.7	0.0	0.0	0.0	1.0	0.0	0.0	0.4	0.0	0.4	1.9	0.0	0.0	0.0	0.4	2.6	1.0	0.6	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.2	0.0	0.0	0.0	1.4	0.0	1.1	0.2	0.5	0.6	0.2	0.0	0.0	1.0	1.7	0.0	0.0	0.6	0.1	0.0	1.6	0.0	0.0	0.7	0.8	0.0	0.0	0.5	0.3	0.0	0.3	1.0	0.0	0.4	9.4	0.3	0.0	7.5	0.1	0.1	0.1	0.0	4.0	0.1	0.0	0.0	24.4	0.0	3.3	0.4	0.0	4.5	0.4	1.0	0.4	0.5	1.5	0.6	0.5	0.0	0.6	0.0	8.9	18.3	3.0	1.2	2.2	0.7	0.4	5.1	8.1	11.4	1.8	0.0	1.4	0.0	0.3	0.9	0.6	0.0	0.0	0.5	2.6	1.3	0.8	7.0	2.1	57.4	0.0	0.0	2.5	90.9	2.6	0.3	66.5	1.7	2.8	0.7	0.9	0.2	0.6	0.7	0.3	3.0	6.5	1.2	0.5	1.6	2.6	1.0	1.8	1.2	0.3
LILRB4	"CD85k, HM18, ILT3, LIR-5, LIR5"	ENSG00000186818	"Leukocyte immunoglobulin like receptor B4"	Q8NHJ6	19	54643889-54670359	"CD markers, Predicted intracellular proteins, Predicted membrane proteins"	"Adaptive immunity, Immunity"	Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 22.8;lymphoid tissue: 33.1"	"Group enriched"	"Detected in some"	6	"Hofbauer cells: 134.1;Kupffer cells: 95.5;Macrophages: 56.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"plasmacytoid DC: 22.8"	"Group enriched"	"Detected in many"	69	"dendritic cells: 22.8;monocytes: 6.2"	"Cell line enriched"	"Detected in some"	35	"Karpas-707: 97.2"									HPA052807	Approved					NA	NA		9900			"HPA052807: AB_2681958"	"unprognostic (4.09e-2)"	"unprognostic (5.75e-3)"	"unprognostic (6.06e-2)"	"unprognostic (1.91e-2)"	"unprognostic (1.82e-1)"	"unprognostic (1.55e-1)"	"unprognostic (5.03e-2)"	"unprognostic (3.53e-1)"	"unprognostic (4.13e-2)"	"unprognostic (1.52e-1)"	"unprognostic (5.43e-1)"	"unprognostic (2.79e-1)"	"unprognostic (1.91e-2)"	"unprognostic (1.08e-1)"	"unprognostic (4.42e-2)"	"unprognostic (4.51e-2)"	"unprognostic (4.52e-2)"	15.4	4.3	5.1	20.1	7.4	4.5	3.1	0.8	5.9	1.6	3.6	12.8	0.0	4.0	1.0	4.7	2.1	4.2	4.4	3.9	5.3	5.3	3.1	3.9	12.3	33.1	10.8	1.9	1.7	1.6	1.5	2.4	4.2	6.6	1.7	5.5	2.9	3.8	1.4	0.8	0.9	5.4	2.1	15.1	18.0	2.8	1.3	6.9	3.1	2.3	0.7	6.1	13.8	0.8	0.2	22.8	0.1	6.2	0.1	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	97.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.3	2.8	0.0	0.0	0.0	0.0	0.0	4.5	0.0	0.0	6.2	0.0	0.1	0.0	0.0	7.0	0.2	0.0	0.0	0.1	0.1	4.8	22.8	0.0	1.8	5.1	7.4	0.8	4.5	5.3	5.3	10.8	1.9	6.6	6.9	0.0	5.5	16.7	0.0	0.3	0.0	0.6	0.0	0.0	2.3	0.0	0.0	0.3	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.6	0.5	0.0	1.1	0.2	134.1	0.0	0.0	2.5	95.5	0.0	0.0	56.7	1.7	12.6	0.0	0.0	0.1	0.0	0.0	0.0	0.1	6.5	0.3	0.0	0.4	0.1	0.7	0.0	0.0	0.0
LIPA	"CESD, LAL"	ENSG00000107798	"Lipase A, lysosomal acid type"	P38571	10	89213569-89414557	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Lipid degradation, Lipid metabolism"	Hydrolase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adipose tissue: 139.0"	"Group enriched"	"Detected in many"	7	"Hofbauer cells: 503.3;Kupffer cells: 514.1;Macrophages: 167.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"classical monocyte: 31.8;intermediate monocyte: 68.4;myeloid DC: 23.3;non-classical monocyte: 35.6"	"Group enriched"	"Detected in all"	5	"dendritic cells: 23.3;monocytes: 68.4"	"Cell line enhanced"	"Detected in many"		"AN3-CA: 61.6;ASC TERT1: 77.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB034892, HPA057052"	Enhanced		Supported	"Nucleoplasm,Nucleoli fibrillar center,Vesicles,Cytosol"	"Intracellular and membrane"	NA	NA		150000	"Vesicles, Cytosol"	"Nucleoplasm, Nucleoli fibrillar center"	"CAB034892: AB_784329, HPA057052: AB_2683322"	"unprognostic (1.27e-1)"	"unprognostic (3.23e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.61e-1)"	"unprognostic (2.55e-2)"	"unprognostic (7.14e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.19e-1)"	"unprognostic (4.28e-2)"	"unprognostic (1.08e-1)"	"unprognostic (7.30e-3)"	"unprognostic (1.39e-2)"	"unprognostic (1.40e-1)"	"unprognostic (4.42e-2)"	"unprognostic (3.42e-2)"	"unprognostic (5.71e-2)"	139.0	16.3	15.8	14.4	22.7	7.8	19.9	8.8	21.4	13.4	28.1	61.3	3.4	37.4	10.2	5.2	9.5	9.0	19.4	8.7	22.5	13.8	10.8	49.3	38.5	45.7	41.6	13.4	10.4	9.5	17.5	6.3	17.8	28.4	7.4	16.7	5.7	11.0	8.8	4.1	6.8	65.8	11.3	55.1	87.3	7.9	3.1	37.2	7.0	8.3	4.7	10.0	15.1	8.6	7.0	23.3	3.2	68.4	5.5	8.3	25.5	55.0	8.5	5.6	61.6	58.1	77.3	1.6	29.2	34.2	12.2	21.9	3.2	29.7	10.2	5.7	45.7	13.1	55.2	2.4	15.8	9.1	14.3	5.7	4.2	3.6	13.1	15.3	8.1	8.4	34.3	11.4	13.0	7.0	14.8	2.4	7.7	0.0	19.0	9.5	4.6	7.0	5.5	3.6	9.8	9.6	4.6	6.6	9.4	11.3	8.7	1.9	3.9	7.1	9.2	21.5	3.9	10.5	10.5	4.4	10.4	2.7	22.2	7.1	9.9	10.5	4.2	12.4	18.0	13.0	0.8	31.8	3.2	8.2	68.4	8.2	6.5	7.3	7.8	23.3	7.0	7.7	8.3	1.4	5.5	35.6	4.7	7.1	25.5	15.8	22.7	8.8	21.4	22.5	13.8	41.6	13.4	28.4	37.2	38.7	42.2	50.6	22.0	15.8	5.2	8.5	45.9	14.7	13.6	31.4	0.0	28.4	18.3	29.7	4.4	53.1	3.9	23.3	31.7	28.0	34.8	15.2	27.7	46.5	503.3	15.9	20.9	52.8	514.1	1.8	10.6	167.0	45.5	27.9	9.4	29.4	17.5	5.9	20.5	14.6	1.3	6.5	21.8	4.8	10.9	10.9	16.7	33.0	8.7	20.1
LPAR6	"P2RY5, P2Y5"	ENSG00000139679	"Lysophosphatidic acid receptor 6"	P43657	13	48389567-48444704	"Disease related genes, G-protein coupled receptors, Potential drug targets, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"	"Disease mutation, Hypotrichosis"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"testis: 54.2"	"Cell type enhanced"	"Detected in many"	7	"Early spermatids: 329.7;Late spermatids: 239.9;Macrophages: 212.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"AF22: 13.4;HUVEC TERT2: 21.7;MOLT-4: 11.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA028934	Approved					NA	NA					"HPA028934: AB_2672833"	"unprognostic (1.19e-1)"	"unprognostic (4.10e-1)"	"unprognostic (8.82e-2)"	"unprognostic (9.30e-3)"	"unprognostic (2.31e-1)"	"unprognostic (5.57e-2)"	"unprognostic (7.40e-2)"	"prognostic favorable (6.22e-4)"	"unprognostic (1.07e-2)"	"unprognostic (8.00e-2)"	"unprognostic (2.63e-1)"	"unprognostic (2.46e-1)"	"prognostic unfavorable (3.60e-4)"	"unprognostic (6.54e-2)"	"unprognostic (3.81e-2)"	"unprognostic (2.09e-2)"	"unprognostic (1.94e-2)"	10.9	6.0	7.6	5.3	10.0	0.3	11.0	5.4	10.6	8.7	4.5	11.1	2.9	2.7	6.5	9.7	25.6	4.9	8.0	5.6	8.4	4.1	7.6	4.7	9.6	9.4	7.9	10.9	3.7	2.9	2.0	4.8	18.7	14.1	17.7	6.3	5.9	18.3	7.8	3.4	7.5	5.5	6.0	17.4	9.4	4.4	54.2	12.6	2.9	7.3	2.9	9.1	9.6	21.3	0.3	7.3	1.6	31.0	1.8	23.0	16.3	0.0	1.2	13.4	0.0	4.4	5.5	0.1	2.7	7.8	0.5	1.6	0.0	4.0	0.0	0.0	2.9	0.0	7.8	0.4	4.3	0.2	0.0	2.6	0.1	0.1	9.6	3.0	0.0	0.1	7.3	7.8	0.4	4.4	0.0	21.7	4.2	0.0	0.2	2.6	0.0	11.8	3.7	5.3	0.2	3.6	10.2	0.0	0.1	3.7	8.0	0.0	0.0	0.0	0.0	2.6	8.6	1.4	0.1	5.6	1.5	0.0	0.1	0.7	0.0	0.0	0.0	0.4	0.6	4.8	0.3	20.8	0.0	7.6	31.0	4.1	0.3	21.5	9.0	7.3	0.1	15.5	4.8	1.6	1.8	26.6	0.3	23.0	16.3	7.6	10.0	5.4	10.6	8.4	4.1	7.9	10.9	14.1	12.6	3.0	11.9	12.6	163.9	107.2	1.5	3.6	17.8	32.1	33.0	5.2	0.0	0.9	0.0	7.7	329.7	100.6	4.1	0.0	3.6	0.9	17.8	82.2	7.0	2.4	67.9	0.0	20.5	130.8	61.7	239.9	21.0	212.7	47.2	78.5	4.5	8.8	4.9	0.0	14.9	21.8	1.1	12.9	15.6	2.7	1.7	125.0	0.7	58.9	7.3	144.8
LPCAT2	"AGPAT11, AYTL1, FLJ20481, LysoPAFAT"	ENSG00000087253	"Lysophosphatidylcholine acyltransferase 2"	Q7L5N7	16	55508998-55586670	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism"	"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	10	"Collecting duct cells: 64.6;granulocytes: 165.5;Kupffer cells: 68.0;Macrophages: 64.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"basophil: 28.8;eosinophil: 49.4"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 49.4"	"Cell line enhanced"	"Detected in many"		"CAPAN-2: 32.0;HaCaT: 24.5;HL-60: 27.3;HMC-1: 45.6;hTERT-RPE1: 45.8;WM-115: 32.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007891, HPA008433"	Enhanced	Supported	Supported	"Endoplasmic reticulum,Lipid droplets"		NA	NA			"Endoplasmic reticulum"	"Lipid droplets"	"HPA007891: AB_1845223, HPA008433: "	"unprognostic (1.43e-1)"	"unprognostic (2.44e-2)"	"prognostic favorable (3.43e-4)"	"prognostic favorable (8.03e-6)"	"unprognostic (2.91e-1)"	"unprognostic (9.65e-3)"	"unprognostic (8.12e-3)"	"unprognostic (3.26e-3)"	"unprognostic (1.67e-1)"	"unprognostic (7.97e-2)"	"unprognostic (3.18e-3)"	"unprognostic (9.16e-2)"	"unprognostic (1.93e-1)"	"unprognostic (2.33e-1)"	"unprognostic (4.15e-2)"	"unprognostic (1.96e-1)"	"unprognostic (3.53e-2)"	10.5	7.5	10.5	8.0	16.2	43.5	9.9	1.7	7.5	11.0	5.2	18.2	36.5	4.3	17.0	21.5	7.2	8.5	6.2	5.7	9.6	6.3	6.7	2.4	7.4	10.3	18.6	3.1	11.0	3.8	12.7	1.9	9.0	16.1	8.2	5.5	5.1	7.7	33.2	3.0	10.2	5.4	8.9	30.7	8.9	5.3	4.6	14.9	0.9	49.0	5.2	2.6	8.5	8.5	0.0	5.4	49.4	9.3	0.0	0.0	1.4	8.9	1.1	0.9	0.0	3.1	1.2	1.6	3.8	3.7	1.9	1.9	2.0	32.0	0.0	13.2	5.4	1.5	24.5	0.6	5.3	3.1	2.4	2.6	9.2	2.9	4.6	1.1	27.3	45.6	0.6	5.3	2.1	1.7	45.8	14.7	0.5	0.4	0.1	3.2	0.5	0.0	11.0	1.4	2.5	0.1	2.8	1.0	1.3	1.8	3.5	0.6	7.1	7.4	3.0	5.3	4.6	1.3	6.9	16.5	0.3	0.0	1.9	2.6	0.1	0.0	0.0	0.7	13.3	32.5	28.8	4.5	49.4	0.0	6.9	0.0	0.0	0.0	0.0	5.4	0.0	0.0	0.0	12.1	0.0	9.3	0.1	0.0	1.4	10.5	16.2	1.7	7.5	9.6	6.3	18.6	3.1	16.1	14.9	6.0	31.3	1.7	29.9	13.7	1.6	1.6	5.1	2.7	23.9	64.6	9.8	0.7	1.7	7.2	1.3	22.7	4.1	0.0	8.5	6.9	13.8	6.0	165.5	1.7	33.6	0.0	1.2	4.3	68.0	1.7	15.3	64.1	16.9	7.2	11.9	26.1	20.5	31.6	12.0	4.4	5.2	0.0	2.4	11.6	3.8	13.4	1.6	1.3	9.8	15.9
LPXN	LDPL	ENSG00000110031	Leupaxin	O60711	11	58526871-58578220	"Predicted intracellular proteins"	"Cell adhesion, Transcription, Transcription regulation"	Activator		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 42.0;lymphoid tissue: 75.1"	"Cell type enhanced"	"Detected in many"	6	"granulocytes: 51.8;Kupffer cells: 53.4;Macrophages: 67.3;T-cells: 74.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 40.0;HMC-1: 67.0;Karpas-707: 57.4;U-2197: 40.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043741, CAB046478, HPA061441"	Enhanced		Supported	"Nuclear speckles,Focal adhesion sites,Cytosol"		No	No			"Focal adhesion sites"	"Nuclear speckles, Cytosol"	"CAB046478: AB_10603113, HPA043741: AB_2678647, HPA061441: AB_2684518"	"unprognostic (1.61e-3)"	"unprognostic (6.91e-2)"	"unprognostic (6.54e-2)"	"prognostic favorable (8.81e-4)"	"unprognostic (5.16e-2)"	"unprognostic (2.07e-3)"	"unprognostic (2.16e-2)"	"unprognostic (8.87e-3)"	"unprognostic (5.18e-2)"	"unprognostic (3.96e-2)"	"unprognostic (2.39e-2)"	"unprognostic (3.05e-1)"	"unprognostic (3.60e-3)"	"unprognostic (1.91e-1)"	"unprognostic (5.25e-2)"	"unprognostic (2.55e-1)"	"unprognostic (2.41e-3)"	16.3	5.6	5.1	34.2	4.7	4.2	5.1	3.5	4.9	4.4	6.7	9.0	4.1	5.1	6.5	5.9	3.8	4.7	7.2	3.9	5.2	5.1	6.3	7.1	19.7	37.2	6.3	2.5	6.6	5.6	3.9	4.8	2.6	5.0	5.7	9.6	6.2	7.6	5.1	2.1	3.7	16.0	4.7	11.4	32.2	5.7	5.9	4.9	75.1	6.8	4.4	52.9	11.2	3.9	19.9	36.5	3.8	19.1	20.1	42.0	20.9	0.3	0.4	0.4	0.7	1.5	1.9	0.2	10.0	40.0	2.5	4.5	0.0	1.0	29.2	0.4	12.1	1.8	0.3	0.3	27.2	10.5	12.7	0.1	1.3	0.2	0.1	2.6	7.9	67.0	1.5	0.6	34.5	4.5	2.4	16.1	17.9	0.3	57.4	20.2	0.2	27.6	9.9	0.3	0.4	9.1	0.4	0.5	25.1	1.6	14.0	0.2	0.3	0.4	0.6	3.9	0.6	0.5	2.3	15.7	6.3	1.8	40.3	8.9	3.7	3.5	28.7	14.6	7.1	14.2	1.7	19.1	3.1	28.2	11.0	42.0	19.9	29.0	32.4	36.5	11.5	22.6	26.8	3.8	20.1	5.6	33.1	38.7	20.9	5.1	4.7	3.5	4.9	5.2	5.1	6.3	2.5	5.0	4.9	0.0	7.0	47.0	4.0	8.7	3.4	1.6	0.0	4.0	2.3	0.0	3.9	2.3	3.3	2.2	22.9	8.0	4.7	0.0	4.9	1.1	4.5	3.3	51.8	6.7	46.1	1.6	5.8	2.5	53.4	6.2	1.7	67.3	18.6	36.9	2.9	4.1	2.8	4.9	3.5	4.2	4.7	6.5	4.1	7.4	4.1	8.4	2.1	74.6	5.2	26.4
LRRC25	"FLJ38116, MAPA"	ENSG00000175489	"Leucine rich repeat containing 25"	Q8N386	19	18391144-18397617	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 79.9;lymphoid tissue: 50.7"	"Group enriched"	"Detected in some"	6	"Hofbauer cells: 45.4;Kupffer cells: 107.3;Macrophages: 46.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	9	"classical monocyte: 37.6;eosinophil: 41.2;intermediate monocyte: 61.8;myeloid DC: 27.9;neutrophil: 70.3;non-classical monocyte: 79.9"	"Group enriched"	"Detected in many"	50	"dendritic cells: 27.9;granulocytes: 70.3;monocytes: 79.9"	"Cell line enhanced"	"Detected in some"		"HMC-1: 5.2;THP-1: 4.8;U-937: 3.9"					"Low region specificity"	"Detected in all"			HPA029459	Approved					NA	NA		250000			"HPA029459: AB_10610005"	"unprognostic (2.72e-2)"	"unprognostic (6.08e-2)"	"unprognostic (1.76e-2)"	"unprognostic (2.07e-1)"	"unprognostic (3.77e-2)"	"unprognostic (9.15e-2)"	"unprognostic (5.80e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.20e-2)"	"unprognostic (4.63e-2)"	"unprognostic (2.02e-1)"	"unprognostic (1.73e-1)"	"unprognostic (1.19e-3)"	"unprognostic (5.77e-2)"	"prognostic unfavorable (6.93e-4)"	"unprognostic (1.74e-1)"	"unprognostic (1.14e-1)"	12.7	7.0	2.1	14.6	3.0	19.5	5.2	0.6	1.2	1.6	3.4	2.7	0.4	2.3	1.6	5.4	1.5	3.4	3.5	6.4	1.6	1.3	4.1	10.0	10.5	30.7	2.6	0.4	3.2	1.7	0.1	1.3	5.5	2.5	3.5	1.7	2.7	2.5	0.6	2.0	1.1	3.9	4.3	2.7	50.7	2.1	2.2	1.7	2.5	1.4	0.6	3.0	4.5	2.8	1.1	27.9	70.3	79.9	0.6	0.2	21.2	0.2	0.0	0.3	0.4	0.1	0.2	0.7	0.3	0.3	0.1	0.3	0.4	0.5	0.5	0.2	0.1	0.1	0.3	0.3	0.1	0.2	0.1	0.2	2.0	0.8	2.6	2.6	1.1	5.2	1.5	0.1	0.0	0.1	0.7	0.0	0.2	0.2	1.4	0.0	0.5	0.1	1.2	0.7	0.2	0.1	0.2	0.1	1.3	0.3	0.1	0.2	0.2	0.0	0.1	0.3	0.2	0.5	4.8	1.1	0.6	0.4	0.4	0.3	0.3	0.2	0.2	0.6	3.9	0.2	5.8	37.6	41.2	0.1	61.8	0.2	0.9	0.0	0.1	27.9	1.1	0.0	0.0	70.3	0.6	79.9	3.9	0.1	21.2	2.1	3.0	0.6	1.2	1.6	1.3	2.6	0.4	2.5	1.7	0.0	2.2	9.7	0.0	0.0	0.0	0.2	0.0	0.0	1.2	0.0	0.0	0.1	5.0	0.0	1.6	0.0	0.0	0.0	0.0	0.3	0.4	0.0	10.3	0.4	45.4	0.0	0.0	2.5	107.3	0.0	0.0	46.0	1.7	2.8	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.2	0.1	0.3	0.0	0.0	0.1
LTB4R	"BLTR, CMKRL1, GPR16, LTB4R1, P2RY7, P2Y7"	ENSG00000213903	"Leukotriene B4 receptor"	Q15722	14	24311450-24318036	"G-protein coupled receptors, Predicted membrane proteins, Transporters"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 36.8;skin 1: 47.0"	"Cell type enhanced"	"Detected in many"	8	"Basal keratinocytes: 21.3;Kupffer cells: 41.4;Macrophages: 20.5;Suprabasal keratinocytes: 41.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"classical monocyte: 13.8;eosinophil: 13.9;neutrophil: 36.8"	"Group enriched"	"Detected in many"	6	"granulocytes: 36.8;monocytes: 13.8"	"Cell line enhanced"	"Detected in many"		"HaCaT: 17.6;Karpas-707: 14.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA003873	Approved					NA	NA					"HPA003873: AB_1078288"	"unprognostic (4.07e-2)"	"unprognostic (7.67e-2)"	"unprognostic (3.67e-3)"	"unprognostic (2.40e-3)"	"unprognostic (4.90e-2)"	"unprognostic (9.00e-3)"	"unprognostic (1.15e-2)"	"unprognostic (8.63e-2)"	"unprognostic (3.68e-1)"	"unprognostic (2.06e-1)"	"prognostic favorable (1.85e-4)"	"unprognostic (7.25e-2)"	"prognostic unfavorable (3.44e-15)"	"unprognostic (2.88e-1)"	"unprognostic (2.97e-1)"	"unprognostic (6.59e-2)"	"unprognostic (7.45e-2)"	7.8	2.7	0.4	3.5	1.7	9.8	2.9	1.7	2.2	8.4	2.8	0.9	0.4	3.0	2.4	4.0	27.0	2.5	2.6	6.5	1.0	0.2	3.1	10.8	9.2	27.7	1.4	0.4	3.6	3.5	0.6	2.5	2.3	1.2	3.9	1.3	2.9	5.9	2.0	2.6	47.0	2.6	1.3	2.1	23.9	1.6	1.7	1.0	2.4	2.3	14.3	7.2	2.5	11.6	0.1	4.0	36.8	13.8	0.7	1.2	4.3	2.1	4.9	1.7	1.4	1.1	1.1	7.4	1.0	0.7	1.1	1.3	3.6	2.6	3.6	1.6	0.9	1.9	17.6	1.5	2.8	1.5	9.4	5.5	3.8	5.9	2.3	0.6	5.1	5.0	0.6	5.0	2.2	2.6	1.5	2.0	6.0	3.0	14.9	0.5	4.8	2.1	8.7	1.3	0.2	3.8	7.7	1.6	6.1	0.6	3.5	3.9	1.4	5.2	2.5	2.3	3.2	4.1	5.2	1.1	3.6	3.6	3.7	1.3	8.4	1.9	5.8	0.7	13.6	2.4	4.9	13.8	13.9	1.2	1.7	0.9	0.0	0.9	1.0	4.0	0.1	0.4	0.3	36.8	0.7	0.3	0.4	0.2	4.3	0.4	1.7	1.7	2.2	1.0	0.2	1.4	0.4	1.2	1.0	0.0	1.1	0.9	8.4	21.3	3.0	1.2	5.1	2.7	3.4	0.0	5.9	0.7	0.0	2.1	0.2	3.6	2.6	0.0	5.5	0.6	2.6	2.1	1.1	3.6	12.9	0.0	0.0	8.0	41.4	0.4	3.1	20.5	3.3	0.0	2.3	0.6	3.6	2.9	1.4	0.5	11.0	6.5	1.7	1.2	1.3	41.0	0.7	10.1	2.6	2.4
LY86	"dJ80N2.1, MD-1"	ENSG00000112799	"Lymphocyte antigen 86"	O95711	6	6588108-6654983	"Predicted secreted proteins"	"Immunity, Inflammatory response, Innate immunity"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 58.7;lymphoid tissue: 44.6"	"Group enriched"	"Detected in many"	8	"B-cells: 109.7;Hofbauer cells: 173.4;Kupffer cells: 183.5;Macrophages: 157.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"classical monocyte: 58.2;myeloid DC: 58.7"	"Group enriched"	"Detected in many"	43	"B-cells: 47.7;dendritic cells: 58.7;monocytes: 58.2"	"Cell line enhanced"	"Detected in some"		"Daudi: 20.9;NB-4: 11.3;RPMI-8226: 67.8;THP-1: 27.2;U-698: 9.4;U-937: 12.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"CAB025000, HPA044895"	Approved				"Secreted to blood"	NA	NA		83000			"CAB025000: , HPA044895: AB_2679138"	"unprognostic (1.82e-1)"	"unprognostic (2.49e-3)"	"unprognostic (2.01e-2)"	"unprognostic (7.88e-2)"	"unprognostic (2.15e-1)"	"unprognostic (1.93e-1)"	"unprognostic (2.53e-1)"	"unprognostic (1.46e-3)"	"unprognostic (3.52e-2)"	"unprognostic (3.17e-1)"	"unprognostic (1.69e-1)"	"unprognostic (1.16e-1)"	"unprognostic (5.82e-2)"	"unprognostic (1.17e-1)"	"prognostic unfavorable (5.61e-4)"	"unprognostic (1.11e-1)"	"unprognostic (4.20e-2)"	10.2	5.0	9.9	18.2	12.9	11.5	2.9	1.6	5.3	3.9	3.2	15.4	0.0	1.5	1.8	1.5	2.0	2.8	7.4	2.5	8.9	7.0	2.8	5.2	13.3	31.2	16.5	4.1	2.1	2.0	0.8	2.8	6.3	9.3	2.5	4.3	2.3	4.5	3.0	0.9	1.5	13.0	4.6	19.9	44.6	2.5	1.1	12.7	2.9	1.7	0.3	32.7	8.4	1.7	47.7	58.7	1.2	58.2	0.7	0.7	25.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	20.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	11.3	0.0	0.0	0.0	2.4	0.0	67.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	27.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	9.4	0.0	12.7	0.0	0.5	58.2	0.4	0.1	32.1	0.1	47.7	0.1	0.1	58.7	35.6	0.7	0.4	1.2	0.7	11.6	2.3	0.2	25.7	9.9	12.9	1.6	5.3	8.9	7.0	16.5	4.1	9.3	12.7	0.0	19.6	109.7	0.0	1.8	0.0	0.5	2.5	1.4	2.3	0.0	0.0	1.2	0.0	0.0	2.9	0.6	0.0	0.0	0.0	1.6	2.8	0.0	1.1	0.8	173.4	0.0	0.0	5.5	183.5	12.8	0.3	157.3	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	6.5	0.3	0.9	0.0	2.0	1.6	1.3	0.0	0.1
LY96	MD-2	ENSG00000154589	"Lymphocyte antigen 96"	Q9Y6Y9	8	73991352-74029087	"Predicted secreted proteins"	"Immunity, Inflammatory response, Innate immunity"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 92.6"	"Cell type enhanced"	"Detected in many"	15	"Hofbauer cells: 473.5;Kupffer cells: 449.9;Macrophages: 173.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	6	"neutrophil: 92.6"	"Lineage enriched"	"Detected in many"	6	"granulocytes: 92.6"	"Cell line enhanced"	"Detected in many"		"ASC TERT1: 21.0;GAMG: 21.8;Karpas-707: 52.3;RPMI-8226: 25.2;U-87 MG: 27.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA053060			Approved	Vesicles	"Secreted to blood"	NA	NA		95000	Vesicles		"HPA053060: AB_2682029"	"unprognostic (2.96e-1)"	"unprognostic (2.64e-2)"	"unprognostic (2.11e-1)"	"unprognostic (1.85e-1)"	"unprognostic (1.64e-2)"	"unprognostic (2.87e-1)"	"unprognostic (2.12e-3)"	"unprognostic (1.42e-1)"	"unprognostic (8.29e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.24e-1)"	"unprognostic (2.43e-1)"	"prognostic unfavorable (6.38e-11)"	"unprognostic (2.87e-2)"	"unprognostic (1.29e-2)"	"unprognostic (1.60e-2)"	"unprognostic (5.90e-2)"	23.4	9.6	5.7	20.9	9.6	7.3	12.6	1.6	7.8	7.5	10.3	2.5	2.7	6.0	6.2	12.3	9.6	7.6	17.1	18.8	11.2	5.8	7.4	10.9	17.3	36.3	11.6	1.9	12.7	3.2	0.7	7.2	21.8	9.2	9.6	7.4	3.9	9.0	3.4	6.0	3.5	7.0	10.0	19.6	47.3	4.9	7.2	6.6	5.3	6.5	5.2	18.4	15.3	16.1	4.0	6.8	92.6	14.2	0.0	3.1	4.6	0.4	0.0	0.1	0.0	10.1	21.0	0.0	14.0	17.0	3.7	8.8	0.0	0.1	4.3	4.8	8.9	21.8	0.1	0.0	0.2	9.8	4.6	0.1	0.1	0.0	0.5	5.0	0.7	0.2	6.1	0.1	6.1	1.2	0.6	18.6	2.7	0.0	52.3	13.4	0.0	1.7	0.6	0.0	0.0	0.3	1.7	0.0	25.2	0.7	0.0	0.1	0.0	0.0	0.0	1.7	0.1	0.0	0.9	14.4	9.7	0.7	5.1	3.3	13.8	6.4	2.6	27.0	0.2	4.1	1.6	14.2	0.0	0.0	12.3	0.2	4.0	2.0	0.3	6.8	1.8	1.3	0.4	92.6	0.0	9.8	5.6	3.1	4.6	5.7	9.6	1.6	7.8	11.2	5.8	11.6	1.9	9.2	6.6	14.9	15.4	42.6	1.0	12.2	0.1	0.7	0.0	4.0	13.6	3.5	0.0	2.4	0.0	3.2	22.0	45.8	0.0	0.0	6.3	2.6	16.0	0.6	3.5	2.0	473.5	0.0	0.0	102.5	449.9	2.0	13.3	173.5	72.6	46.9	0.0	0.0	13.2	0.0	6.3	0.6	0.1	6.5	14.7	0.5	0.1	10.2	5.4	15.9	0.0	1.0
LYN	JTK8	ENSG00000254087	"LYN proto-oncogene, Src family tyrosine kinase"	P07948	8	55879813-56014168	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Adaptive immunity, Host-virus interaction, Immunity, Inflammatory response, Innate immunity"	"Kinase, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 70.9"	"Cell type enhanced"	"Detected in many"	6	"Hofbauer cells: 110.4;Kupffer cells: 161.3;Macrophages: 122.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 36.8"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HEL: 57.7;HMC-1: 58.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001231, CAB004492"	Enhanced		Supported	"Golgi apparatus,Vesicles,Plasma membrane"		NA	NA		11000000	"Golgi apparatus, Plasma membrane"	Vesicles	"CAB004492: AB_627897, HPA001231: AB_1079286"	"unprognostic (7.87e-2)"	"unprognostic (4.89e-2)"	"unprognostic (9.04e-2)"	"unprognostic (3.74e-1)"	"unprognostic (8.12e-2)"	"unprognostic (2.17e-1)"	"unprognostic (5.70e-2)"	"unprognostic (1.11e-1)"	"unprognostic (2.79e-1)"	"unprognostic (8.80e-2)"	"unprognostic (3.68e-2)"	"unprognostic (7.15e-2)"	"prognostic unfavorable (3.43e-4)"	"unprognostic (2.13e-1)"	"unprognostic (2.72e-3)"	"unprognostic (1.21e-1)"	"unprognostic (7.39e-2)"	8.8	6.8	4.5	34.0	6.3	33.6	11.1	9.5	4.1	5.3	10.5	5.8	7.2	15.6	3.4	7.8	7.2	6.7	13.7	8.9	4.8	3.6	6.1	13.8	34.6	70.9	7.7	2.1	5.3	9.8	3.1	4.9	19.1	5.6	5.7	6.6	6.3	14.9	8.5	2.7	3.4	16.2	6.6	8.5	69.4	7.4	3.6	5.1	3.8	9.4	5.3	25.8	10.7	7.5	8.4	9.2	36.8	26.5	1.9	0.9	2.7	12.8	7.7	1.8	0.3	0.1	0.0	13.9	9.8	14.5	6.2	4.4	5.3	4.4	12.4	4.4	3.9	4.8	6.0	7.2	7.3	5.3	20.1	7.2	57.7	2.3	1.9	1.9	5.8	58.6	0.3	2.5	0.1	4.5	3.6	8.3	0.0	30.5	26.9	0.9	0.7	0.0	6.1	11.1	20.2	0.9	0.9	2.8	1.5	4.0	6.1	1.2	22.3	4.9	0.0	2.0	13.8	1.1	13.6	9.7	0.0	2.9	0.0	4.4	9.0	3.3	28.1	0.6	11.5	0.4	2.1	7.2	12.3	0.9	16.8	0.7	8.2	0.2	0.3	6.4	8.4	0.1	0.4	36.8	1.9	26.5	9.2	0.0	2.7	4.5	6.3	9.5	4.1	4.8	3.6	7.7	2.1	5.6	5.1	32.8	35.7	89.3	18.6	4.7	2.1	1.4	17.8	22.7	31.8	8.7	2.0	2.5	0.0	18.6	0.6	18.5	14.9	0.0	44.9	61.3	8.4	36.9	70.5	10.9	110.4	0.0	5.8	25.8	161.3	1.7	3.1	122.4	5.0	73.1	13.5	61.7	37.6	13.5	1.1	1.3	1.5	19.4	4.3	0.2	1.2	5.1	32.4	24.5	12.3	92.1
LYZ		ENSG00000090382	Lysozyme	P61626	12	69348341-69354234	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted secreted proteins"		"Antimicrobial, Bacteriolytic enzyme, Glycosidase, Hydrolase"	"Amyloidosis, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 490.0;salivary gland: 1017.8"	"Cell type enhanced"	"Detected in many"	16	"Kupffer cells: 3040.5;Macrophages: 4386.3;Pancreatic endocrine cells: 1930.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"classical monocyte: 490.0;myeloid DC: 308.1"	"Group enriched"	"Detected in all"	18	"dendritic cells: 308.1;monocytes: 490.0"	"Cell line enriched"	"Detected in some"	13	"OE19: 521.4"					"Not detected"	"Not detected"			"CAB000055, HPA048284, HPA066182"	Enhanced		Approved	"Nucleoplasm,Golgi apparatus,Actin filaments"	"Secreted to blood"	NA	NA	1500000000	2600000000	"Golgi apparatus, Actin filaments"	Nucleoplasm	"CAB000055: AB_2341230, HPA048284: AB_2680339, HPA066182: AB_2732741"	"unprognostic (8.52e-2)"	"unprognostic (6.12e-3)"	"unprognostic (2.83e-1)"	"unprognostic (7.29e-2)"	"unprognostic (7.91e-2)"	"prognostic favorable (7.45e-4)"	"unprognostic (1.21e-1)"	"unprognostic (7.40e-2)"	"unprognostic (1.41e-1)"	"unprognostic (2.08e-2)"	"unprognostic (1.44e-1)"	"unprognostic (3.13e-1)"	"unprognostic (2.50e-1)"	"unprognostic (2.37e-1)"	"unprognostic (3.65e-2)"	"unprognostic (5.78e-2)"	"unprognostic (3.62e-2)"	19.1	2.4	1.7	42.1	1.8	187.0	2.9	1.6	1.6	2.9	52.5	2.0	0.1	72.4	2.3	6.9	3.9	3.4	105.0	15.4	1.8	1.8	4.8	4.8	81.0	57.2	2.1	0.0	4.5	5.0	0.0	1.8	8.3	0.9	2.4	5.0	2.7	1017.8	2.8	1.8	2.1	95.0	1.8	2.5	34.2	212.1	1.6	0.5	24.5	2.4	207.7	75.7	6.6	2.4	1.6	308.1	21.9	490.0	2.3	1.1	407.9	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.4	0.2	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	39.8	0.0	4.6	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	4.5	0.1	521.4	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	20.5	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.0	22.3	0.0	7.5	490.0	5.9	0.7	102.3	1.1	1.6	0.4	0.5	308.1	0.4	0.4	0.4	21.9	2.3	17.6	6.5	0.6	407.9	1.7	1.8	1.6	1.6	1.8	1.8	2.1	0.0	0.9	0.5	80.4	424.7	79.8	2.3	50.8	0.1	0.0	815.3	52.2	87.6	26.2	0.0	4.1	0.0	46.7	1.4	10.8	19.6	0.0	484.8	7.4	19.7	4.1	113.9	7.3	924.7	0.0	12.0	37.4	3040.5	3.7	3.7	4386.3	50.6	757.4	61.5	0.0	1930.3	401.2	2.1	5.0	1.1	38.8	3.9	0.6	2.3	33.4	7.1	13.8	38.3	2.2
MAFB	KRML	ENSG00000204103	"MAF bZIP transcription factor B"	Q9Y5Q3	20	40685848-40689240	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor"	"Cancer-related genes, Disease mutation, Proto-oncogene, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 87.6;parathyroid gland: 154.1"	"Cell type enhanced"	"Detected in many"	12	"Hofbauer cells: 322.7;Kupffer cells: 488.8;Macrophages: 252.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	4	"intermediate monocyte: 27.4;non-classical monocyte: 36.7"	"Lineage enriched"	"Detected in many"	14	"monocytes: 36.7"	"Cell line enhanced"	"Detected in some"		"HSkMC: 16.2;hTCEpi: 34.0;SCLC-21H: 9.3;SiHa: 8.4;U-138 MG: 9.2;U-2197: 13.4;U-87 MG: 8.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA005653	Approved		Approved	"Nucleoplasm,Nucleoli,Golgi apparatus,Cytosol"		Yes	NA			Nucleoplasm	"Nucleoli, Golgi apparatus, Cytosol"	"HPA005653: AB_1079293"	"unprognostic (1.55e-1)"	"unprognostic (1.17e-2)"	"unprognostic (1.16e-3)"	"prognostic unfavorable (5.64e-4)"	"unprognostic (9.16e-2)"	"unprognostic (3.92e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.10e-1)"	"unprognostic (2.57e-2)"	"unprognostic (6.09e-2)"	"unprognostic (5.45e-3)"	"unprognostic (9.92e-2)"	"unprognostic (3.95e-2)"	"unprognostic (1.05e-1)"	"unprognostic (3.21e-3)"	"unprognostic (3.49e-2)"	"unprognostic (2.30e-2)"	38.3	7.9	3.2	13.0	4.0	17.0	19.5	1.0	9.7	10.6	6.9	3.0	1.2	3.3	5.6	8.9	16.8	7.0	9.2	12.4	3.6	2.3	10.9	14.0	21.9	28.9	4.7	3.4	7.0	6.1	154.1	2.3	9.4	5.0	7.6	3.3	5.6	10.4	2.7	11.0	41.6	7.6	5.5	7.7	87.6	4.7	7.5	3.8	6.9	18.2	20.5	11.4	8.2	10.9	0.0	2.5	0.7	36.7	0.0	0.0	2.5	0.0	0.0	0.0	1.4	0.8	0.1	0.2	0.2	0.0	0.1	0.0	0.2	0.1	0.0	1.1	0.2	0.0	2.0	0.0	0.0	0.0	0.0	0.7	0.0	0.6	0.1	0.5	0.0	0.1	16.2	34.0	0.1	1.1	0.0	0.2	0.0	0.0	0.0	0.0	0.5	0.1	3.9	1.4	3.3	0.0	0.0	0.0	0.0	0.3	0.2	9.3	0.7	8.4	0.8	2.0	3.1	0.8	0.1	0.2	9.2	0.1	13.4	0.0	0.0	0.0	0.0	8.9	0.3	0.0	0.1	7.3	0.0	0.0	27.4	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.7	0.0	36.7	0.0	0.0	2.5	3.2	4.0	1.0	9.7	3.6	2.3	4.7	3.4	5.0	3.8	20.8	32.3	6.7	25.3	60.9	14.6	153.6	7.6	0.0	13.6	48.8	23.6	7.5	1.7	2.0	0.6	19.9	50.9	0.0	3.0	2.1	61.9	37.1	10.4	32.6	322.7	3.2	55.5	34.4	488.8	0.7	27.3	252.1	20.3	0.0	13.7	25.8	5.4	24.6	23.0	0.8	8.2	12.9	44.3	0.5	0.9	77.0	10.4	4.4	8.1	17.7
MAN2B1	"LAMAN, MANB"	ENSG00000104774	"Mannosidase alpha class 2B member 1"	O00754	19	12646511-12666742	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"Glycosidase, Hydrolase"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Erythroid cells: 23.3;Macrophages: 18.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"classical monocyte: 42.1;intermediate monocyte: 39.4;myeloid DC: 35.2;non-classical monocyte: 28.4;plasmacytoid DC: 41.9"	"Group enriched"	"Detected in all"	5	"dendritic cells: 41.9;monocytes: 42.1"	"Low cell line specificity"	"Detected in all"											"HPA041530, HPA053404"	Supported		Approved	Nucleoplasm,Vesicles	"Intracellular and membrane"	NA	NA		3400000	"Nucleoplasm, Vesicles"		"HPA041530: AB_10795639, HPA053404: "	"unprognostic (6.63e-2)"	"unprognostic (3.61e-1)"	"unprognostic (2.20e-2)"	"unprognostic (5.48e-2)"	"unprognostic (3.81e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.61e-1)"	"unprognostic (1.84e-2)"	"unprognostic (9.55e-2)"	"unprognostic (1.95e-1)"	"unprognostic (2.79e-2)"	"unprognostic (1.50e-1)"	"prognostic unfavorable (1.94e-5)"	"unprognostic (4.00e-1)"	"unprognostic (4.17e-2)"	"unprognostic (2.22e-1)"	"unprognostic (1.51e-1)"	25.2	15.6	7.9	26.7	11.0	33.4	24.4	4.4	7.0	10.5	15.0	14.0	8.6	14.2	15.3	16.5	12.2	13.4	16.4	19.4	6.4	4.4	13.6	16.3	30.2	68.6	10.0	4.7	12.2	21.7	9.1	7.2	15.8	8.6	13.7	10.6	12.0	22.0	8.1	7.7	18.0	20.0	10.2	11.7	51.3	19.5	6.3	8.2	22.1	11.3	7.8	30.0	18.7	11.2	7.7	41.9	6.5	42.1	2.7	8.4	26.0	16.5	8.5	8.7	10.2	29.0	19.5	24.6	12.3	26.0	11.0	10.8	6.8	7.0	18.2	15.0	9.7	3.1	13.0	4.4	8.2	5.3	9.0	13.5	6.3	4.2	11.0	14.8	41.5	43.3	23.2	16.2	6.1	7.8	11.9	10.4	6.9	8.0	13.8	5.8	12.9	5.6	23.4	7.2	8.3	10.8	13.0	11.9	9.0	13.0	19.2	2.7	8.5	12.2	10.5	20.0	5.5	16.2	25.7	13.6	15.0	6.2	14.5	11.5	18.4	20.2	9.0	10.1	40.9	16.7	2.2	42.1	6.2	7.5	39.4	8.4	7.7	6.9	6.7	35.2	6.5	3.8	3.8	6.5	2.7	28.4	41.9	6.8	26.0	7.9	11.0	4.4	7.0	6.4	4.4	10.0	4.7	8.6	8.2	6.0	6.9	14.4	1.6	3.2	2.6	0.7	2.5	5.3	1.2	1.8	0.0	2.0	1.7	1.6	2.0	1.0	2.5	23.3	2.0	2.3	2.8	2.2	1.1	0.8	7.9	0.0	1.7	2.5	10.2	8.1	3.4	18.6	1.7	5.4	0.9	1.3	1.0	2.9	4.2	1.1	3.0	12.9	1.2	0.5	1.5	2.9	2.3	5.4	1.7	1.6
MARCH1	"FLJ20668, MARCH-I, RNF171"	ENSG00000145416	"Membrane associated ring-CH-type finger 1"	Q8TCQ1	4	163524298-164384050	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Immunity, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 24.4;lymphoid tissue: 32.4"	"Cell type enhanced"	"Detected in many"	11	"B-cells: 128.6;Cone photoreceptor cells: 184.6;Kupffer cells: 192.5;Macrophages: 105.3;Rod photoreceptor cells: 172.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	95	"classical monocyte: 16.8;eosinophil: 9.9;intermediate monocyte: 17.0;memory B-cell: 18.5;myeloid DC: 18.1;naive B-cell: 15.7;non-classical monocyte: 17.2;plasmacytoid DC: 6.8"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"Daudi: 9.6;U-266/70: 9.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA014600	Uncertain					NA	NA					"HPA014600: AB_1853573"	"unprognostic (7.29e-2)"	"unprognostic (5.82e-2)"	"unprognostic (1.48e-1)"	"unprognostic (9.09e-2)"	"unprognostic (8.25e-2)"	"unprognostic (2.98e-2)"	"unprognostic (4.79e-3)"	"unprognostic (9.00e-2)"	"unprognostic (3.00e-2)"	"unprognostic (2.18e-1)"	"unprognostic (1.13e-1)"	"unprognostic (2.20e-1)"	"unprognostic (1.24e-1)"	"unprognostic (7.00e-2)"	"unprognostic (2.48e-2)"	"unprognostic (2.70e-1)"	"unprognostic (2.91e-2)"	7.7	4.2	11.6	20.5	19.7	3.9	4.0	3.1	14.5	3.7	3.9	8.5	0.1	4.4	3.9	4.6	3.6	4.2	5.9	2.6	12.6	10.1	3.0	4.5	8.3	28.5	17.3	6.3	4.2	4.1	1.5	4.1	10.2	13.5	3.5	5.1	2.4	4.6	1.8	1.6	4.9	9.0	6.5	24.4	32.4	4.1	2.3	17.9	2.6	3.2	1.4	24.6	9.0	4.2	18.5	18.1	9.9	17.2	0.1	0.0	6.6	0.8	0.7	2.9	1.7	0.0	0.0	1.9	1.2	0.1	0.0	0.0	1.6	3.3	9.6	3.6	0.0	0.4	1.4	0.0	0.0	0.0	1.0	1.0	6.8	3.7	0.6	0.0	4.1	2.2	0.0	0.0	0.0	0.2	4.0	0.0	1.9	2.5	5.0	3.3	1.0	2.3	2.6	3.6	0.3	1.3	2.7	0.5	0.7	0.1	1.6	1.5	1.3	0.9	1.5	0.5	2.2	4.0	0.7	3.1	1.1	2.0	0.7	2.3	9.8	3.3	2.7	1.4	2.1	1.5	0.0	16.8	9.9	0.0	17.0	0.0	18.5	0.0	0.0	18.1	15.7	0.0	0.0	0.1	0.1	17.2	6.8	0.0	6.6	11.6	19.7	3.1	12.5	12.6	10.1	17.3	6.3	13.5	17.9	0.0	2.7	128.6	0.0	1.5	24.7	2.4	0.0	1.4	4.5	3.5	184.6	0.3	0.0	0.0	4.6	1.1	0.0	0.0	0.0	0.2	0.8	0.0	0.0	0.9	43.0	11.1	0.0	3.1	192.5	1.7	0.0	105.3	0.0	0.0	0.0	5.1	0.0	0.0	0.0	0.1	172.3	12.9	0.0	0.6	1.5	0.9	0.7	0.8	0.0	0.0
MCOLN2	"FLJ36691, TRP-ML2, TRPML2"	ENSG00000153898	"Mucolipin 2"	Q8IZK6	1	84925583-84997113	"Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Adaptive immunity, Calcium transport, Immunity, Innate immunity, Ion transport, Protein transport, Transport"	"Calcium channel, Ion channel"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 18.9;epididymis: 18.4;lymphoid tissue: 31.9"	"Cell type enhanced"	"Detected in many"	14	"Early spermatids: 34.6;Macrophages: 15.1;monocytes: 53.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Cell type enhanced"	"Detected in many"		"plasmacytoid DC: 18.9"	"Group enriched"	"Detected in many"	12	"B-cells: 6.6;dendritic cells: 18.9;T-cells: 5.9"	"Cell line enhanced"	"Detected in many"		"Daudi: 14.1;HAP1: 10.1;HDLM-2: 16.8;THP-1: 20.1;U-698: 12.5"	"Region enriched"	"Detected in single"	5	"amygdala: 0.4"	"Low region specificity"	"Detected in all"			HPA019114	Uncertain					NA	NA					"HPA019114: AB_1853645"	"unprognostic (3.02e-2)"	"unprognostic (5.67e-2)"	"unprognostic (3.07e-1)"	"unprognostic (1.44e-1)"	"unprognostic (2.47e-1)"	"unprognostic (5.66e-3)"	"unprognostic (2.38e-1)"	"prognostic favorable (2.56e-4)"	"unprognostic (8.92e-2)"	"unprognostic (1.48e-2)"	"unprognostic (6.84e-2)"	"unprognostic (2.21e-2)"	"unprognostic (3.12e-4)"	"unprognostic (3.68e-2)"	"unprognostic (4.69e-2)"	"unprognostic (1.24e-1)"	"unprognostic (4.23e-2)"	1.3	12.5	0.4	31.9	0.4	2.2	1.1	0.2	0.4	1.7	8.5	0.5	1.6	1.2	1.4	18.4	1.3	2.9	3.8	2.0	0.6	0.4	1.4	0.6	7.5	18.4	0.6	0.0	1.0	1.8	0.0	1.2	2.1	1.5	1.5	14.0	1.6	3.2	0.9	0.6	1.8	7.5	0.5	1.7	9.7	1.7	2.7	0.4	4.1	1.0	2.8	27.5	2.3	1.3	6.6	18.9	0.2	0.8	0.4	5.9	1.4	1.0	1.1	0.1	3.0	0.6	0.2	0.4	0.7	3.8	0.9	1.2	0.0	0.1	14.1	0.4	0.0	1.8	0.1	10.1	1.2	1.1	16.8	7.5	1.4	0.4	0.0	0.8	0.3	1.3	0.2	0.0	0.9	0.8	0.1	0.1	3.7	0.0	0.3	0.2	0.4	0.2	0.1	1.1	0.0	1.9	0.1	2.3	0.0	0.1	0.3	0.7	0.0	0.1	0.2	6.2	0.2	1.8	20.1	0.1	1.0	1.6	0.1	2.6	0.1	0.0	12.5	0.9	0.1	2.4	0.1	0.2	0.0	4.1	0.8	1.3	6.6	3.3	5.9	4.5	1.9	0.5	3.4	0.2	0.4	0.1	18.9	0.2	1.4	0.4	0.4	0.2	0.4	0.6	0.4	0.6	0.0	1.5	0.4	0.0	1.1	9.8	0.5	3.9	0.0	0.5	0.0	2.7	2.3	1.8	0.0	0.1	0.0	0.0	34.6	0.1	6.0	0.0	1.2	0.1	2.1	0.7	0.0	0.0	0.7	0.0	2.4	1.3	0.6	14.2	0.0	15.1	8.5	53.3	4.1	0.0	0.4	5.8	0.0	0.3	0.0	0.0	0.1	0.2	3.7	2.9	0.2	8.2	2.3	0.1
MCTP1	FLJ22344	ENSG00000175471	"Multiple C2 and transmembrane domain containing 1"	Q6DN14	5	94703741-95284575	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adipose tissue: 49.2;brain: 42.4"	"Cell type enhanced"	"Detected in many"	10	"Endothelial cells: 29.9;granulocytes: 61.2;Kupffer cells: 33.5;Macrophages: 35.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	41	"basophil: 11.5;classical monocyte: 12.9;eosinophil: 5.8;intermediate monocyte: 19.2;myeloid DC: 10.1;neutrophil: 18.7;non-classical monocyte: 17.6;plasmacytoid DC: 5.3"	"Group enriched"	"Detected in many"	52	"dendritic cells: 10.1;granulocytes: 18.7;monocytes: 19.2"	"Cell line enhanced"	"Detected in many"		"Karpas-707: 28.3;RPMI-8226: 28.0;RPTEC TERT1: 21.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA019018			Approved	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA019018: AB_1853665"	"unprognostic (1.20e-2)"	"unprognostic (6.70e-4)"	"unprognostic (1.77e-2)"	"unprognostic (1.03e-2)"	"unprognostic (1.16e-4)"	"unprognostic (1.88e-1)"	"unprognostic (1.16e-2)"	"unprognostic (2.47e-2)"	"unprognostic (1.86e-1)"	"unprognostic (6.99e-2)"	"unprognostic (5.31e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.91e-6)"	"unprognostic (5.38e-2)"	"unprognostic (3.65e-2)"	"unprognostic (2.89e-3)"	"unprognostic (4.43e-2)"	49.2	2.7	6.5	11.4	42.4	36.9	18.3	18.3	16.5	6.9	7.2	0.3	4.4	5.0	11.1	9.2	6.5	4.1	16.7	4.6	8.5	7.4	3.0	3.8	11.3	5.5	4.1	3.8	3.3	3.4	3.1	5.2	7.1	3.9	5.9	7.3	1.0	4.3	2.7	5.1	4.5	4.8	10.9	5.7	8.2	5.3	4.0	8.1	5.5	5.0	21.2	4.3	17.3	12.6	0.3	10.1	18.7	19.2	0.2	0.2	3.3	0.1	2.0	1.3	0.0	20.0	8.0	0.0	0.1	9.8	0.9	3.2	0.0	5.2	7.2	7.7	0.0	20.5	0.0	0.1	0.1	1.1	0.0	1.4	4.3	4.9	0.0	2.6	8.9	5.8	2.9	0.0	3.6	13.1	8.5	20.7	3.0	0.1	28.3	7.4	0.2	0.5	6.8	1.6	0.1	8.2	0.3	0.0	28.0	21.3	11.3	4.0	0.2	0.6	0.0	14.6	0.6	0.0	8.4	0.1	3.6	5.6	0.1	1.6	2.0	0.0	0.0	16.9	14.9	3.6	11.5	12.9	5.8	0.0	19.2	0.0	0.3	0.0	0.1	10.1	0.1	0.2	0.0	18.7	0.2	17.6	5.3	0.0	3.3	6.5	42.4	18.3	12.2	8.5	7.4	4.1	3.8	3.9	8.1	3.0	9.6	0.0	0.1	16.1	2.0	2.5	0.0	4.0	6.8	3.5	0.0	0.3	0.0	0.0	20.6	29.9	0.0	0.0	0.2	0.1	3.0	0.6	61.2	0.5	10.7	3.2	0.0	1.8	33.5	12.2	0.6	35.3	11.8	0.0	0.0	3.6	0.8	0.0	0.0	0.0	3.7	0.0	2.2	1.4	1.4	11.7	0.2	2.2	0.0	0.4
MEFV	"FMF, MEF, TRIM20"	ENSG00000103313	"MEFV, pyrin innate immunity regulator"	O15553	16	3242028-3256627	"Disease related genes, Predicted intracellular proteins"	"Immunity, Inflammatory response, Innate immunity"	Actin-binding	"Amyloidosis, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 23.3"	"Group enriched"	"Detected in some"	4	"Cardiomyocytes: 7.0;Kupffer cells: 14.8;Macrophages: 7.8"	"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in some"			"Cell type enhanced"	"Detected in many"		"neutrophil: 10.0"	"Low lineage specificity"	"Detected in many"			"Cell line enriched"	"Detected in some"	6	"THP-1: 12.1"									HPA077497			Supported	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA077497: "	"unprognostic (2.67e-1)"	"unprognostic (1.06e-1)"	"unprognostic (4.96e-2)"	"unprognostic (2.01e-1)"	"unprognostic (2.49e-2)"	"unprognostic (3.10e-1)"	"unprognostic (7.06e-2)"	"unprognostic (3.35e-2)"	"unprognostic (2.97e-2)"	"unprognostic (1.09e-1)"	"unprognostic (8.89e-2)"	"unprognostic (3.27e-1)"	"unprognostic (7.58e-7)"	"unprognostic (1.08e-1)"	"unprognostic (7.16e-4)"	"unprognostic (1.73e-3)"	"unprognostic (1.48e-1)"	4.2	1.2	0.5	9.8	1.0	9.7	0.9	0.4	0.9	1.1	1.4	0.3	0.0	1.0	0.6	2.7	1.2	1.6	1.8	4.2	0.5	0.5	1.3	1.5	11.4	14.8	2.8	0.1	1.2	1.8	0.2	0.7	1.8	0.8	0.9	0.6	1.7	0.8	0.7	1.7	0.6	1.3	1.6	2.2	23.3	1.0	2.2	1.3	1.2	1.7	0.2	1.4	2.7	4.1	0.4	2.1	10.0	6.5	0.5	0.3	1.3	0.1	0.1	0.1	0.3	0.2	0.0	0.3	0.1	0.0	0.0	0.0	0.1	0.2	0.2	1.1	0.0	0.9	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.5	0.1	0.0	0.5	0.3	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.7	0.1	0.2	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.1	0.0	0.2	0.2	0.0	0.2	0.2	0.2	0.3	0.1	12.1	0.1	0.3	0.1	0.1	0.1	0.5	0.4	0.2	0.4	2.1	0.0	2.5	3.8	0.2	0.1	4.2	0.1	0.2	0.2	0.1	2.1	0.4	0.1	0.3	10.0	0.5	6.5	0.3	0.1	1.3	0.5	1.0	0.4	0.9	0.5	0.5	2.8	0.1	0.8	1.3	0.0	2.2	0.0	0.0	0.2	0.0	7.0	0.0	1.4	1.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.9	0.0	0.0	0.6	14.8	0.0	0.0	7.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.7	0.1	0.0	0.0	0.0	0.0
MFNG		ENSG00000100060	"MFNG O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase"	O00587	22	37469063-37486401	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Developmental protein, Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 72.7;lymphoid tissue: 42.1"	"Group enriched"	"Detected in many"	5	"B-cells: 44.1;Endothelial cells: 25.5;granulocytes: 30.1;Hofbauer cells: 28.8;Ito cells: 45.4;Kupffer cells: 36.8;Macrophages: 23.4;monocytes: 20.8;T-cells: 53.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Daudi: 32.8;HEL: 25.3;HL-60: 41.3;HMC-1: 54.8;HUVEC TERT2: 44.2;U-698: 31.7;U-937: 37.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA048936, HPA056479"	Approved		Approved	Vesicles	"Intracellular and membrane"	NA	NA		28000	Vesicles		"HPA048936: AB_2680564, HPA056479: "	"unprognostic (1.21e-1)"	"unprognostic (4.17e-3)"	"prognostic unfavorable (5.12e-4)"	"prognostic favorable (1.65e-4)"	"unprognostic (6.41e-3)"	"unprognostic (1.00e-2)"	"unprognostic (2.64e-1)"	"unprognostic (2.36e-2)"	"unprognostic (4.64e-2)"	"unprognostic (2.91e-2)"	"unprognostic (5.44e-2)"	"unprognostic (1.42e-1)"	"prognostic unfavorable (3.31e-5)"	"unprognostic (2.67e-1)"	"unprognostic (4.03e-2)"	"unprognostic (3.86e-2)"	"unprognostic (1.43e-1)"	10.0	4.5	2.6	16.6	5.1	14.4	13.4	1.0	3.3	6.0	6.5	3.0	2.0	3.7	6.5	3.5	4.4	7.1	6.3	6.7	2.8	2.6	6.1	5.6	14.9	42.1	5.6	1.2	3.6	3.7	0.8	2.2	14.0	8.3	5.6	3.7	4.4	5.7	2.5	3.4	3.0	14.1	5.1	4.4	37.6	4.1	2.6	3.6	33.9	6.3	4.5	19.3	8.8	4.2	24.1	40.5	72.7	40.8	40.9	53.3	53.2	1.2	0.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.3	0.6	32.8	0.1	0.0	0.1	2.3	9.6	1.9	0.0	12.9	0.2	25.3	0.1	0.3	0.1	41.3	54.8	0.0	0.5	0.3	0.7	0.2	44.2	11.4	0.1	15.7	0.0	0.1	4.7	0.5	0.1	1.2	0.1	12.1	0.4	24.7	0.1	0.0	19.8	0.2	0.1	0.0	0.0	0.2	0.3	2.8	24.6	0.0	1.2	4.9	0.1	0.0	0.1	31.7	0.2	37.2	0.5	36.8	40.1	72.7	41.3	38.8	45.1	21.8	48.0	43.3	40.5	24.1	52.9	45.5	25.5	40.9	40.8	10.1	53.3	53.2	2.6	5.1	1.0	3.3	2.8	2.6	5.6	1.2	8.3	3.6	0.0	6.7	44.1	0.2	3.3	0.6	1.4	5.1	0.0	5.7	0.0	0.0	0.3	0.0	3.0	0.1	25.5	1.1	0.0	0.8	0.2	1.1	0.4	30.1	1.0	28.8	0.0	1.2	45.4	36.8	0.0	0.0	23.4	3.3	20.8	2.2	0.0	2.1	0.6	0.0	0.3	0.3	0.0	1.0	0.0	0.5	2.0	0.6	53.8	0.6	0.3
MFSD1	"FLJ14153, UG0581B09"	ENSG00000118855	"Major facilitator superfamily domain containing 1"	Q9H3U5	3	158732198-158829719	"Predicted intracellular proteins, Predicted membrane proteins"	Transport			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"Hofbauer cells: 192.2;Kupffer cells: 259.8;Macrophages: 135.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"dendritic cells: 45.3;granulocytes: 42.6;monocytes: 49.6"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA065858	Approved		Approved	"Plasma membrane,Cytosol"		NA	NA		14000	"Plasma membrane"	Cytosol	"HPA065858: AB_2685569"	"unprognostic (9.94e-2)"	"unprognostic (3.12e-3)"	"unprognostic (3.54e-2)"	"unprognostic (1.00e-1)"	"unprognostic (2.16e-2)"	"unprognostic (7.37e-2)"	"unprognostic (1.28e-2)"	"unprognostic (2.61e-2)"	"unprognostic (2.52e-1)"	"unprognostic (1.15e-1)"	"unprognostic (6.48e-2)"	"unprognostic (2.92e-1)"	"prognostic favorable (5.60e-5)"	"unprognostic (1.62e-1)"	"unprognostic (6.33e-3)"	"unprognostic (4.66e-2)"	"unprognostic (2.57e-1)"	26.2	29.5	11.4	22.0	11.8	17.2	24.2	9.1	14.0	18.7	15.7	13.4	18.9	13.2	18.3	20.6	37.0	18.4	17.5	17.7	10.8	10.3	20.7	24.8	24.9	39.8	15.7	11.7	15.3	16.8	16.5	16.8	18.3	13.6	14.7	11.5	14.5	34.5	17.9	9.2	18.6	16.8	15.0	14.5	29.1	19.9	15.0	14.3	11.3	18.7	16.3	16.7	23.8	24.1	10.5	45.3	42.6	49.6	5.4	7.3	35.3	14.9	6.4	1.6	5.0	8.7	8.2	10.3	23.4	10.5	8.3	8.2	2.6	14.8	4.2	17.2	14.9	5.0	7.8	4.0	5.1	7.8	16.6	10.9	11.2	4.9	1.1	9.4	41.3	28.1	12.2	6.7	7.5	2.1	3.3	6.5	2.8	8.7	8.6	14.7	3.4	2.5	12.2	1.6	6.3	16.4	5.6	2.4	36.6	3.0	3.9	4.8	7.2	17.2	13.3	4.1	2.0	10.5	16.2	21.3	11.9	4.6	17.6	11.5	27.4	19.2	2.3	15.0	30.0	8.3	14.0	49.6	42.6	7.3	38.5	6.6	10.5	5.8	6.5	45.3	8.5	6.4	7.0	17.6	5.4	31.6	14.7	6.8	35.3	11.4	11.8	9.1	14.0	10.8	10.3	15.7	11.7	13.6	14.3	17.9	31.3	39.5	33.3	19.1	11.9	17.1	12.7	40.2	29.6	21.0	5.9	23.7	16.6	28.2	3.5	25.1	25.5	23.3	24.8	27.2	23.6	39.9	47.4	30.1	192.2	17.5	21.9	39.3	259.8	5.3	11.2	135.3	30.4	15.4	26.6	23.4	26.7	20.1	10.6	25.9	10.0	12.9	15.5	8.8	7.0	22.7	46.8	15.4	24.0	47.5
MILR1	"Allergin-1, C17orf60, MCA-32"	ENSG00000271605	"Mast cell immunoglobulin like receptor 1"	Q7Z6M3	17	64449037-64468643	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 28.0"	"Group enriched"	"Detected in many"	8	"granulocytes: 33.5;Hofbauer cells: 64.4;Kupffer cells: 28.0;Macrophages: 28.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 17.9;CAPAN-2: 46.9;Daudi: 23.0;REH: 18.3;U-698: 24.6"					"Low region specificity"	"Detected in all"			HPA014347	Enhanced					NA	NA		130000			"HPA014347: AB_2732408"	"unprognostic (8.40e-2)"	"unprognostic (9.77e-2)"	"unprognostic (9.28e-3)"	"unprognostic (3.27e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.21e-2)"	"unprognostic (1.27e-2)"	"unprognostic (1.22e-1)"	"unprognostic (3.25e-1)"	"unprognostic (3.31e-2)"	"unprognostic (5.99e-3)"	"unprognostic (4.78e-2)"	"prognostic unfavorable (5.07e-6)"	"unprognostic (2.51e-2)"	"unprognostic (7.12e-3)"	"unprognostic (1.09e-1)"	"unprognostic (5.99e-2)"	8.4	6.7	6.6	22.3	12.6	13.1	5.0	1.5	6.7	6.8	3.9	11.8	0.6	3.7	3.0	6.9	3.4	4.2	7.3	6.2	7.4	5.4	4.3	3.2	11.4	24.6	13.9	2.3	3.9	2.9	2.5	3.1	13.6	9.8	4.4	7.7	5.6	5.0	2.0	1.6	1.9	7.1	6.7	18.6	24.2	3.1	2.2	11.2	2.2	3.8	3.1	17.7	7.1	3.4	9.4	21.5	28.0	18.7	0.6	0.4	5.2	2.8	0.6	0.0	0.1	1.7	17.9	0.3	0.0	1.9	0.3	3.9	0.1	46.9	23.0	1.0	0.2	9.1	0.5	0.0	0.8	1.1	0.1	0.0	0.5	0.3	0.0	0.3	1.5	15.3	1.7	0.1	5.7	0.7	2.2	1.7	0.2	1.6	2.8	11.1	0.0	0.2	3.0	0.1	0.2	3.2	18.3	3.1	9.5	0.6	0.3	0.1	0.0	1.5	0.2	3.0	0.0	0.1	12.8	6.0	0.2	0.6	0.1	1.1	0.2	0.0	24.6	12.4	2.6	0.0	28.0	18.7	1.0	0.4	15.4	0.3	9.4	0.2	0.3	11.9	6.5	0.3	0.4	5.7	0.6	9.6	21.5	0.2	5.2	6.6	12.6	1.5	6.7	7.4	5.4	13.9	2.3	9.8	11.2	0.0	0.3	4.2	2.3	0.5	0.1	0.4	2.5	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.3	1.6	0.0	0.0	0.0	2.1	1.9	2.0	33.5	0.0	64.4	0.0	4.7	1.8	28.0	0.0	3.7	28.9	0.0	1.0	0.2	0.5	0.0	0.3	1.4	0.0	0.6	0.0	2.0	0.2	0.2	1.5	1.0	0.5	1.5	2.2
MLKL	FLJ34389	ENSG00000168404	"Mixed lineage kinase domain like pseudokinase"	Q8NB16	16	74671855-74700960	"Enzymes, Predicted intracellular proteins, Transporters"	Necrosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"vagina: 50.4"	"Cell type enhanced"	"Detected in many"	6	"granulocytes: 27.8;Macrophages: 24.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA078638			Supported	"Plasma membrane,Cell Junctions,Cytosol"		NA	NA			"Plasma membrane"	"Cell Junctions, Cytosol"	"HPA078638: "	"unprognostic (7.53e-2)"	"unprognostic (1.74e-2)"	"unprognostic (2.57e-1)"	"prognostic favorable (2.16e-4)"	"unprognostic (1.23e-1)"	"unprognostic (3.07e-1)"	"unprognostic (5.69e-2)"	"unprognostic (3.67e-3)"	"unprognostic (1.90e-1)"	"unprognostic (6.64e-3)"	"unprognostic (1.37e-1)"	"unprognostic (2.74e-1)"	"unprognostic (1.60e-3)"	"unprognostic (5.30e-2)"	"unprognostic (1.26e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.53e-3)"	18.5	4.7	5.2	15.1	8.9	21.6	13.2	2.9	7.9	6.4	8.0	3.2	5.3	8.5	7.5	3.8	11.5	5.2	9.1	6.8	6.4	3.5	7.4	6.7	17.3	14.8	10.5	1.8	2.8	8.2	1.6	3.0	7.1	8.1	6.3	9.2	6.5	12.6	4.3	2.3	3.6	10.0	6.0	11.2	26.2	8.2	1.9	8.4	4.3	6.5	4.9	10.4	9.2	50.4	4.2	9.2	25.2	17.7	1.7	8.1	7.1	6.5	12.2	0.1	0.1	3.2	6.7	0.1	8.5	7.4	8.0	11.9	7.0	13.2	0.1	9.8	7.2	6.9	10.5	2.2	12.2	3.0	4.1	0.3	9.2	9.1	8.0	2.3	6.0	9.6	4.5	1.2	8.5	3.0	4.7	19.3	10.7	1.3	1.3	6.2	10.9	3.4	12.0	1.1	14.3	15.0	6.7	0.9	11.7	11.4	4.8	0.5	0.4	6.7	4.5	3.7	0.0	3.2	6.3	21.0	4.0	2.4	3.6	5.8	5.7	19.2	1.6	7.3	21.2	1.9	8.3	17.7	21.7	5.8	10.6	7.9	4.2	6.5	6.0	9.2	2.8	3.6	5.5	25.2	1.7	10.2	0.5	8.1	7.1	5.2	8.9	2.9	7.9	6.4	3.5	10.5	1.8	8.1	8.4	3.0	15.4	8.1	4.8	3.1	0.0	1.6	2.5	2.7	7.9	1.8	0.0	0.2	1.7	4.0	2.6	17.9	5.8	0.0	4.6	0.5	3.8	2.0	27.8	0.9	14.2	1.6	1.2	14.7	15.5	3.8	0.9	24.1	6.8	1.0	5.6	0.0	4.1	9.1	0.4	0.3	0.4	0.0	3.3	0.0	0.2	2.5	0.2	10.0	6.4	5.1
MMP19	"MMP18, RASI-1"	ENSG00000123342	"Matrix metallopeptidase 19"	Q99542	12	55835433-55842966	"Disease related genes, Enzymes, FDA approved drug targets, Predicted secreted proteins"	"Angiogenesis, Collagen degradation, Differentiation"	"Developmental protein, Hydrolase, Metalloprotease, Protease"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 60.7"	"Cell type enhanced"	"Detected in many"	8	"Extravillous trophoblasts: 42.0;Hofbauer cells: 31.2;Kupffer cells: 30.5;Macrophages: 48.2;monocytes: 38.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Group enriched"	"Detected in some"	16	"classical monocyte: 3.2;myeloid DC: 1.0"	"Group enriched"	"Detected in many"	16	"dendritic cells: 1.0;monocytes: 3.2"	"Cell line enriched"	"Detected in many"	6	"BEWO: 57.2"	"Region enriched"	"Detected in single"	6	"olfactory region: 8.8"	"Low region specificity"	"Detected in all"			HPA070804			Approved	"Endoplasmic reticulum,Vesicles"	"Secreted to extracellular matrix"	NA	NA		800000	"Endoplasmic reticulum, Vesicles"		"HPA070804: AB_2686315"	"unprognostic (2.61e-1)"	"unprognostic (6.56e-2)"	"unprognostic (2.28e-2)"	"unprognostic (2.42e-1)"	"unprognostic (4.77e-3)"	"unprognostic (4.77e-3)"	"unprognostic (2.01e-2)"	"unprognostic (4.03e-2)"	"unprognostic (2.85e-2)"	"unprognostic (4.30e-2)"	"unprognostic (2.37e-1)"	"unprognostic (2.09e-1)"	"prognostic unfavorable (8.56e-9)"	"unprognostic (5.06e-3)"	"unprognostic (1.28e-3)"	"unprognostic (2.73e-2)"	"unprognostic (4.00e-2)"	60.7	1.9	0.2	10.9	0.7	0.0	9.9	0.2	0.5	7.6	3.9	0.4	1.4	0.8	12.7	6.0	3.6	11.8	30.3	4.7	0.6	0.1	4.1	3.0	14.0	15.5	0.5	0.2	7.4	8.1	0.0	0.5	24.5	1.0	2.9	2.8	3.1	2.0	3.5	2.1	2.7	4.1	7.7	0.8	27.4	5.0	2.9	0.2	2.7	3.3	1.8	7.1	5.9	3.5	0.0	1.0	0.1	3.2	0.0	0.0	0.6	0.8	0.0	0.0	0.0	6.3	8.1	57.2	6.0	7.1	2.5	2.9	0.3	0.2	0.0	0.0	8.4	0.1	0.0	0.0	1.8	3.4	0.3	0.0	0.0	0.0	0.1	5.2	0.0	0.2	8.4	0.2	1.5	1.6	3.0	0.4	0.0	0.1	0.0	8.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	1.4	0.0	1.1	2.9	0.0	0.0	0.1	0.0	0.0	0.6	0.0	0.1	9.7	1.5	3.3	0.0	0.2	0.0	0.0	0.0	4.5	0.0	0.0	0.0	3.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.6	0.2	0.7	0.2	0.5	0.6	0.1	0.5	0.2	1.0	0.2	0.0	5.8	0.9	0.2	6.4	0.5	0.6	5.1	2.7	5.7	0.0	3.9	14.4	0.0	0.3	0.4	2.1	0.0	0.0	0.4	42.0	24.0	0.4	2.3	0.5	31.2	0.0	0.0	4.9	30.5	0.4	5.5	48.2	11.8	38.7	0.0	0.3	0.1	0.0	4.9	0.0	1.7	0.0	9.6	0.0	0.2	3.8	15.7	0.0	0.0	0.1
MNDA	PYHIN3	ENSG00000163563	"Myeloid cell nuclear differentiation antigen"	P41218	1	158831317-158849506	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 289.8;bone marrow: 83.3"	"Group enriched"	"Detected in many"	4	"Hofbauer cells: 203.8;Kupffer cells: 493.3;Macrophages: 520.9;Muller glia cells: 130.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	5	"neutrophil: 289.8"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 289.8"	"Group enriched"	"Detected in some"	15	"NB-4: 36.7;THP-1: 69.4;U-937: 45.4"					"Low region specificity"	"Detected in all"			"HPA034532, HPA073215"	Enhanced		Supported	"Nucleoplasm,Nucleoli,Nucleoli rim,Vesicles,Cytosol"		NA	NA		110000	Nucleoplasm	"Nucleoli, Nucleoli rim, Vesicles, Cytosol"	"HPA034532: AB_10669677, HPA073215: AB_2686582"	"unprognostic (1.53e-2)"	"unprognostic (7.84e-3)"	"unprognostic (2.45e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.42e-1)"	"unprognostic (1.41e-2)"	"unprognostic (2.02e-2)"	"unprognostic (7.99e-3)"	"unprognostic (1.58e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.65e-1)"	"unprognostic (9.89e-2)"	"unprognostic (1.96e-2)"	"unprognostic (1.07e-1)"	"unprognostic (4.95e-2)"	"unprognostic (2.81e-2)"	"unprognostic (1.02e-1)"	17.6	6.3	5.4	24.4	7.9	83.3	3.0	1.4	5.8	2.1	2.1	3.2	0.2	1.1	1.7	3.4	2.3	4.7	8.4	6.3	4.9	3.2	3.9	4.2	31.3	32.2	10.7	2.6	3.4	2.4	1.1	2.2	9.9	6.8	2.6	2.5	5.0	3.6	1.2	2.0	1.9	3.6	6.2	18.6	57.3	2.6	4.0	6.3	5.5	2.1	1.4	4.2	9.1	4.9	1.6	29.7	289.8	60.9	0.1	0.1	40.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	36.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	69.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	45.4	0.0	7.1	60.9	11.1	0.1	25.4	0.1	1.6	0.0	0.1	29.7	0.6	0.0	0.0	289.8	0.1	12.0	0.4	0.0	40.2	5.4	7.9	1.4	5.8	4.9	3.2	10.7	2.6	6.8	6.3	32.8	82.3	20.5	0.0	2.2	0.6	0.7	10.2	14.7	17.0	0.0	0.0	0.8	0.0	0.0	0.2	2.1	0.0	0.0	0.3	0.9	2.3	0.0	40.7	1.3	203.8	0.0	0.0	6.2	493.3	0.9	1.1	520.9	1.7	25.2	0.0	130.5	0.0	0.0	0.0	1.1	4.7	12.9	9.2	0.3	0.2	1.9	0.8	1.0	0.0	0.0
MRC1	"bA541I19.1, CD206, CLEC13D, CLEC13DL, MRC1L1"	ENSG00000260314	"Mannose receptor C-type 1"	P22897	10	17809344-17911170	"CD markers, FDA approved drug targets, Plasma proteins, Predicted membrane proteins"	"Endocytosis, Host-virus interaction"	"Host cell receptor for virus entry, Receptor"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 44.8;lymphoid tissue: 37.8"	"Group enriched"	"Detected in many"	6	"Hofbauer cells: 135.5;Ito cells: 511.3;Kupffer cells: 324.4;Macrophages: 182.8"	"Low cancer specificity"	"Detected in all"							"Cell type enriched"	"Detected in single"	15	"myeloid DC: 8.2"	"Lineage enriched"	"Detected in single"	15	"dendritic cells: 8.2"	"Group enriched"	"Detected in some"	19	"MOLT-4: 17.7;TIME: 16.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA004114, HPA045134, CAB068203"	Enhanced					NA	NA		130000000			"CAB068203: AB_2665652, HPA004114: AB_1846270, HPA045134: AB_2679228"	"unprognostic (2.20e-1)"	"unprognostic (2.07e-1)"	"unprognostic (1.03e-2)"	"unprognostic (2.58e-1)"	"unprognostic (5.62e-2)"	"unprognostic (4.30e-1)"	"unprognostic (6.36e-3)"	"unprognostic (1.35e-1)"	"unprognostic (1.05e-2)"	"unprognostic (6.05e-2)"	"unprognostic (5.61e-2)"	"unprognostic (4.12e-1)"	"unprognostic (2.94e-2)"	"unprognostic (4.97e-2)"	"unprognostic (3.05e-2)"	"unprognostic (1.74e-2)"	"unprognostic (7.02e-2)"	34.8	8.3	0.3	6.2	1.2	0.0	19.8	0.7	0.6	5.2	11.2	0.6	0.9	2.2	4.5	10.4	4.2	1.3	7.9	13.4	0.9		12.4	16.4	44.8	37.8	1.0	0.0	3.6	5.1	1.8	2.4	15.4	3.1	5.5	5.1	7.0	0.7	1.9	5.1	0.0	6.5	8.2	1.4	30.6	2.2	7.1	0.8	0.8	6.5	3.5	0.7	7.5	5.1	0.0	8.2	0.1	0.5	0.0	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	17.7	0.0	0.2	0.0	0.0	0.1	0.3	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	16.4	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.1	0.0	0.0	0.1	0.0	8.2	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.4	0.2											29.8	47.4	11.5	0.0	0.3	0.0	3.6	5.1	10.7	13.6	0.0	0.0	0.8	0.0	0.0	26.7	4.8	1.3	0.0	0.3	1.1	1.0	0.0	12.8	2.5	135.5	0.0	0.0	511.3	324.4	7.9	1.4	182.8	0.0	0.0	0.4	0.0	0.1	1.1	0.0	0.0	0.0	32.3	0.0	0.3	1.2	0.4	1.7	4.9	0.8	0.0
MS4A4A	"CD20L1, MS4A4, MS4A7"	ENSG00000110079	"Membrane spanning 4-domains A4A"	Q96JQ5	11	60280541-60308972	"Predicted membrane proteins"		Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in all"		"adipose tissue: 47.2"	"Cell type enhanced"	"Detected in many"	19	"Hofbauer cells: 321.0;Kupffer cells: 359.4;Macrophages: 124.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"intermediate monocyte: 26.4;myeloid DC: 11.9;non-classical monocyte: 31.6;plasmacytoid DC: 11.7"	"Group enriched"	"Detected in many"	27	"dendritic cells: 11.9;monocytes: 31.6"	"Cell line enriched"	"Detected in some"	18	"K-562: 54.8"									HPA029323	Approved					NA	NA					"HPA029323: AB_10601866"	"unprognostic (7.93e-2)"	"unprognostic (2.05e-2)"	"unprognostic (1.37e-3)"	"unprognostic (1.98e-1)"	"unprognostic (4.46e-2)"	"unprognostic (2.31e-1)"	"unprognostic (9.66e-2)"	"unprognostic (1.59e-1)"	"unprognostic (4.56e-1)"	"unprognostic (6.65e-2)"	"unprognostic (8.10e-2)"	"unprognostic (2.11e-1)"	"unprognostic (5.02e-3)"	"unprognostic (3.32e-2)"	"unprognostic (4.66e-2)"	"unprognostic (4.89e-2)"	"unprognostic (4.21e-2)"	47.2	13.9	3.8	10.2	5.3	1.3	18.8	1.4	3.1	8.5	9.8	2.8	2.5	2.6	4.4	18.9	6.2	10.6	14.8	13.7	4.1	3.0	12.6	9.9	20.4	28.2	4.9	1.5	4.4	3.1	1.6	5.0	32.7	6.7	8.3	9.5	8.7	7.7	2.7	3.9	2.6	9.9	12.1	7.4	30.7	5.7	5.6	3.6	2.8	5.0	3.4	4.0	13.1	3.1	0.2	11.9	0.3	31.6	0.8	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	54.8	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	3.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	4.2	0.0	0.0	26.4	0.0	0.2	0.0	0.0	11.9	0.0	0.0	0.0	0.3	0.8	31.6	11.7	0.0	2.3	3.8	5.3	1.4	3.1	4.1	3.0	4.9	1.5	6.7	3.6	0.0	9.3	9.5	0.1	1.5	0.0	3.6	5.1	0.0	4.5	0.0	0.0	1.5	0.0	0.0	0.6	2.1	0.0	0.0	0.0	1.3	2.6	0.0	7.0	2.6	321.0	0.0	0.0	74.9	359.4	0.8	0.9	124.2	3.3	3.6	0.0	0.0	0.3	0.0	0.0	0.0	0.0	12.9	0.9	0.0	0.1	1.6	3.0	4.1	0.0	0.0
MS4A6A	"CD20L3, MS4A6"	ENSG00000110077	"Membrane spanning 4-domains A6A"	Q9H2W1	11	60172014-60184666	"Predicted intracellular proteins, Predicted membrane proteins"		Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 112.4;lymphoid tissue: 89.5"	"Group enriched"	"Detected in many"	14	"Hofbauer cells: 335.3;Ito cells: 767.3;Kupffer cells: 1329.9;Macrophages: 569.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	8	"basophil: 32.4;classical monocyte: 112.4;intermediate monocyte: 35.6;myeloid DC: 65.3;plasmacytoid DC: 46.3"	"Group enriched"	"Detected in many"	96	"dendritic cells: 65.3;granulocytes: 32.4;monocytes: 112.4"	"Cell line enriched"	"Detected in some"	9	"THP-1: 32.6"									"HPA011391, HPA076623"	Approved		Approved	Vesicles		NA	NA			Vesicles		"HPA011391: AB_10603876, HPA076623: AB_2686809"	"unprognostic (1.17e-1)"	"prognostic favorable (6.33e-4)"	"unprognostic (2.35e-2)"	"unprognostic (1.21e-2)"	"unprognostic (1.00e-1)"	"unprognostic (8.51e-2)"	"unprognostic (2.33e-1)"	"unprognostic (3.75e-2)"	"unprognostic (3.61e-1)"	"unprognostic (1.76e-1)"	"unprognostic (1.91e-1)"	"unprognostic (3.20e-1)"	"unprognostic (4.75e-3)"	"unprognostic (1.06e-1)"	"unprognostic (4.66e-2)"	"unprognostic (3.94e-2)"	"unprognostic (2.97e-2)"	29.3	17.8	12.3	18.3	26.7	9.1	18.1	2.8	14.6	10.2	14.9	4.7	4.0	9.0	7.0	28.3	8.7	11.3	21.0	23.1	10.7	6.9	18.0	35.6	23.0	89.5	22.2	2.4	7.7	6.0	2.4	8.8	21.5	20.5	9.6	19.0	10.2	11.8	6.3	6.0	5.1	20.4	17.2	32.0	78.1	8.5	8.3	19.4	8.5	7.0	6.7	15.4	21.5	6.3	0.7	65.3	32.4	112.4	0.2	0.3	61.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.9	0.1	0.0	0.0	0.0	0.0	0.0	2.8	0.0	3.8	0.0	0.0	0.0	0.0	2.9	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	32.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	2.8	0.0	32.4	112.4	0.7	0.1	35.6	0.3	0.7	0.2	0.1	65.3	0.1	0.1	0.1	7.4	0.2	2.3	46.3	0.1	61.3	12.3	26.7	2.8	14.6	10.7	6.9	22.2	2.4	20.5	19.4	6.0	31.7	53.0	0.4	8.2	0.0	2.4	30.6	2.7	4.5	3.5	0.0	1.6	0.0	0.0	2.0	8.5	0.0	0.0	0.0	1.7	7.3	0.2	12.8	6.0	335.3	0.0	0.0	767.3	1329.9	1.1	1.4	569.3	13.5	0.0	0.0	0.0	0.0	0.2	0.0	0.5	0.4	45.3	7.2	0.3	1.0	6.9	1.7	27.7	0.0	0.1
MX2	MXB	ENSG00000183486	"MX dynamin like GTPase 2"	P20592	21	41361943-41409390	"Plasma proteins, Predicted intracellular proteins, Transporters"	"Antiviral defense, Immunity, Innate immunity, mRNA transport, Protein transport, Translocation, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 61.2;lymphoid tissue: 35.9"	"Cell type enhanced"	"Detected in many"	5	"Kupffer cells: 26.3;Macrophages: 27.1;Sertoli cells: 25.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in all"	5	"neutrophil: 61.2"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 61.2"	"Cell line enhanced"	"Detected in many"		"BJ hTERT+ SV40 Large T+: 43.1;BJ hTERT+ SV40 Large T+ RasG12V: 42.1;MOLT-4: 26.9;U-266/84: 44.7;U-937: 46.2"					"Low region specificity"	"Detected in all"			HPA030235	Uncertain					NA	NA					"HPA030235: AB_10601970"	"unprognostic (1.88e-1)"	"unprognostic (2.26e-1)"	"unprognostic (7.90e-3)"	"prognostic unfavorable (3.71e-5)"	"unprognostic (2.50e-1)"	"unprognostic (2.30e-1)"	"unprognostic (7.77e-2)"	"unprognostic (3.36e-1)"	"unprognostic (2.63e-1)"	"unprognostic (6.64e-2)"	"unprognostic (2.01e-2)"	"unprognostic (9.48e-2)"	"unprognostic (3.38e-14)"	"unprognostic (6.31e-2)"	"unprognostic (1.59e-3)"	"unprognostic (5.61e-2)"	"unprognostic (1.16e-2)"	21.6	1.4	1.6	14.3	7.6	12.5	11.5	0.7	2.3	9.2	4.7	3.0	2.5	5.5	9.2	7.4	5.7	5.6	12.4	7.1	2.3	2.2	4.9	3.0	6.1	34.7	2.2	2.8	3.9	2.8	0.2	1.7	5.7	6.1	4.4	2.8	5.7	6.7	1.8	4.5	4.8	8.9	4.9	5.5	24.3	11.2	3.9	2.1	35.9	4.6	2.4	14.9	12.3	6.7	5.2	7.4	61.2	11.7	2.5	8.3	6.3	0.2	0.0	0.0	0.0	1.0	2.3	0.0	0.0	5.9	43.1	42.1	0.0	14.7	0.0	0.0	0.7	8.4	0.0	0.0	0.0	1.4	0.5	0.0	17.7	0.0	7.7	0.3	0.3	0.0	3.5	0.0	0.8	0.0	0.0	0.0	0.4	0.7	9.1	0.0	0.0	26.9	10.7	16.8	2.3	0.2	3.8	0.0	1.4	0.0	1.1	0.0	0.0	0.9	0.0	1.2	0.0	0.0	10.4	0.0	0.0	0.0	0.0	0.0	0.0	44.7	0.6	1.3	46.2	4.6	2.3	10.5	9.0	4.4	11.7	5.7	5.2	7.1	5.2	7.4	4.7	8.3	5.4	61.2	2.5	10.3	4.2	4.8	6.3	1.6	7.6	0.7	2.3	2.3	2.2	2.2	2.8	6.1	2.1	6.0	10.3	18.5	2.2	3.7	0.0	2.8	0.0	10.7	15.9	1.8	0.0	0.3	1.7	0.9	0.3	9.7	2.6	0.0	2.6	0.9	8.0	2.7	11.6	0.0	15.0	0.0	2.9	4.3	26.3	1.2	6.4	27.1	10.1	0.0	1.0	0.3	3.9	0.0	3.9	0.1	0.2	25.8	9.5	1.4	6.4	1.3	0.2	13.1	0.0	4.9
NAIP	"BIRC1, NLRB1"	ENSG00000249437	"NLR family apoptosis inhibitory protein"	Q13075	5	70968483-71025114	"Cancer-related genes, Predicted intracellular proteins"	"Apoptosis, Immunity, Inflammatory response, Innate immunity"	"Protease inhibitor, Thiol protease inhibitor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 8.1;lymphoid tissue: 17.5"	"Cell type enhanced"	"Detected in many"	10	"Hofbauer cells: 56.4;Kupffer cells: 123.5;Macrophages: 49.1"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in some"		"pons and medulla: 6.4"	"Group enriched"	"Detected in some"	10	"classical monocyte: 8.1;intermediate monocyte: 2.9;myeloid DC: 6.9;neutrophil: 5.9"	"Group enriched"	"Detected in many"	14	"dendritic cells: 6.9;granulocytes: 5.9;monocytes: 8.1"	"Cell line enhanced"	"Detected in some"		"MOLT-4: 8.0;SiHa: 4.6;T-47d: 5.0"									HPA042438	Approved					NA	NA					"HPA042438: AB_10796578"	"unprognostic (9.03e-2)"	"unprognostic (6.03e-2)"	"unprognostic (1.31e-1)"	"unprognostic (7.50e-2)"	"unprognostic (3.33e-1)"	"unprognostic (1.12e-3)"	"unprognostic (1.12e-1)"	"unprognostic (2.23e-2)"	"unprognostic (4.36e-2)"	"unprognostic (1.86e-1)"	"unprognostic (2.54e-2)"	"unprognostic (5.13e-1)"	"unprognostic (1.69e-3)"	"unprognostic (1.17e-1)"	"unprognostic (1.18e-2)"	"unprognostic (1.38e-1)"	"unprognostic (9.96e-2)"	2.4	1.0	0.8	4.7	0.8	2.4	0.8	0.8	2.6	0.8	0.8	0.8	0.8	0.1	0.9	1.2	0.8	1.6	1.6	0.8	0.8	0.6	0.8	0.8	3.9	3.4	1.2	0.8	0.8	0.8	0.2	0.8	0.8	6.4	0.8	0.7	0.8	0.8	0.8	1.0	0.4	2.3	1.1	2.3	17.5	3.0	0.8	0.8	0.8	0.9	0.8	0.8	3.6	0.8	0.3	6.9	5.9	8.1	0.4	0.2	2.0	0.0	0.0	1.1	0.5	0.4	0.0	0.3	0.0	0.0	0.3	0.0	0.8	0.8	0.0	0.1	0.0	0.2	0.1	0.0	0.0	0.0	0.1	0.7	0.8	0.7	1.6	0.2	1.5	0.5	0.0	0.0	0.0	0.2	0.4	0.0	0.3	0.3	0.6	0.2	0.0	8.0	0.0	0.1	0.0	0.0	0.1	0.0	1.7	0.3	0.1	0.3	0.0	4.6	0.0	0.3	0.9	5.0	0.0	0.0	1.2	0.3	0.2	0.0	0.9	0.0	0.6	0.2	0.1	0.9	0.2	8.1	0.0	0.2	2.9	0.1	0.1	0.0	0.1	6.9	0.3	0.2	0.1	5.9	0.4	0.5	0.3	0.1	2.0	0.8	0.8	0.8	2.6	0.8	0.6	1.2	0.8	6.4	0.8	17.9	8.9	0.8	2.3	3.2	15.4	2.7	17.8	9.4	12.5	5.2	21.6	2.9	0.0	1.6	40.1	7.1	2.0	23.3	1.9	1.7	4.3	2.3	4.7	4.5	56.4	15.9	10.3	9.8	123.5	10.1	10.0	49.1	1.7	1.0	6.0	6.5	1.6	0.0	6.7	0.6	35.7	6.5	2.6	15.2	4.3	3.3	2.4	3.1	3.4	1.4
NAMPT	"PBEF, PBEF1"	ENSG00000105835	"Nicotinamide phosphoribosyltransferase"	P43490	7	106248285-106286326	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Biological rhythms, Pyridine nucleotide biosynthesis"	"Cytokine, Glycosyltransferase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Hepatocytes: 597.4;Macrophages: 479.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	18	"neutrophil: 143.5"	"Lineage enriched"	"Detected in many"	20	"granulocytes: 143.5"	"Cell line enhanced"	"Detected in all"		"U-87 MG: 110.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB034349, HPA047776, HPA057722"	Approved		Approved	"Nuclear speckles,Cell Junctions"	"Secreted to blood"	NA	NA	2140000	410000	"Nuclear speckles"	"Cell Junctions"	"CAB034349: AB_2251220, HPA047776: AB_2680151, HPA057722: "	"unprognostic (2.87e-1)"	"prognostic unfavorable (4.78e-4)"	"unprognostic (5.90e-3)"	"unprognostic (1.63e-2)"	"unprognostic (1.50e-2)"	"prognostic unfavorable (8.81e-4)"	"unprognostic (2.15e-1)"	"unprognostic (2.74e-2)"	"unprognostic (2.74e-1)"	"unprognostic (3.30e-1)"	"prognostic unfavorable (1.51e-4)"	"unprognostic (3.02e-1)"	"prognostic unfavorable (2.49e-6)"	"unprognostic (6.83e-2)"	"unprognostic (6.96e-2)"	"unprognostic (7.76e-2)"	"unprognostic (6.44e-3)"	67.3	22.2	8.1	113.6	18.1	110.4	52.6	7.8	12.9	11.6	18.2	2.9	9.5	9.3	9.9	13.5	53.4	27.8	28.1	84.4	13.4	6.3	13.5	92.9	48.9	117.5	10.3	5.2	27.3	18.3	5.5	10.0	23.9	29.2	17.4	10.5	8.2	32.9	14.3	41.0	12.9	14.1	44.9	59.1	41.1	26.4	11.9	7.1	6.2	13.5	40.7	13.2	48.8	26.4	0.8	2.0	143.5	7.3	1.0	1.5	1.3	19.2	12.9	4.6	7.8	19.7	23.0	7.6	6.1	34.6	12.4	21.9	7.6	11.7	16.1	14.7	6.8	37.2	15.2	8.6	18.4	27.2	9.5	9.2	6.5	5.5	5.9	73.7	12.6	12.1	21.9	21.1	22.2	26.0	18.6	39.5	8.0	13.6	62.0	14.8	10.1	12.6	5.3	9.0	12.2	10.4	6.0	6.6	35.5	11.8	18.2	9.5	5.2	8.6	18.8	21.8	13.4	6.0	3.6	33.6	18.5	14.3	26.5	11.2	42.7	24.2	23.3	110.0	14.3	27.4	8.1	2.3	3.5	0.4	5.6	0.7	0.8	0.5	0.6	2.0	0.7	0.8	0.4	143.5	1.0	7.3	0.8	1.5	1.3	8.1	18.1	7.8	12.9	13.4	6.3	10.3	5.2	29.2	7.1	122.1	246.8	48.1	258.1	184.4	22.1	87.9	163.1	104.4	177.5	40.1	11.8	23.8	39.7	250.8	6.3	173.0	92.2	0.0	120.5	44.2	117.9	276.9	178.5	597.4	98.8	38.1	24.1	141.8	340.8	4.5	37.4	479.6	153.5	65.9	46.4	19.5	161.8	35.1	29.4	36.0	28.4	25.8	234.9	14.9	57.9	181.7	21.2	41.5	63.9	273.8
NCKAP1L	HEM1	ENSG00000123338	"NCK associated protein 1 like"	P55160	12	54497711-54548238	"Plasma proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 39.1;lymphoid tissue: 56.7"	"Group enriched"	"Detected in many"	5	"B-cells: 52.5;granulocytes: 53.3;Hofbauer cells: 98.9;Kupffer cells: 144.7;Macrophages: 81.9;monocytes: 90.2;T-cells: 53.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"HL-60: 33.5;HMC-1: 35.4;NB-4: 24.7;REH: 17.7;THP-1: 36.7;U-937: 21.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA039490, HPA040772"	Approved		Uncertain	"Plasma membrane,Cytosol"		NA	NA		52000	Cytosol	"Plasma membrane"	"HPA039490: AB_2676540, HPA040772: AB_2677129"	"unprognostic (4.54e-2)"	"unprognostic (5.20e-3)"	"unprognostic (1.61e-2)"	"unprognostic (1.22e-3)"	"unprognostic (9.29e-2)"	"unprognostic (1.01e-2)"	"unprognostic (3.69e-1)"	"unprognostic (2.95e-2)"	"unprognostic (6.53e-3)"	"unprognostic (4.80e-1)"	"unprognostic (1.76e-1)"	"unprognostic (2.08e-1)"	"unprognostic (1.54e-3)"	"unprognostic (2.57e-1)"	"unprognostic (2.76e-2)"	"unprognostic (3.63e-2)"	"unprognostic (4.74e-2)"	18.1	5.0	5.9	22.0	10.5	16.9	7.2	1.2	5.8	3.1	15.0	8.1	0.6	4.0	3.1	4.3	4.8	4.0	5.1	6.5	4.1	3.5	3.9	6.5	19.7	56.7	9.3	2.5	2.2	2.4	4.4	2.3	7.3	6.6	4.8	6.9	3.0	4.3	4.0	1.5	2.8	15.4	7.0	13.9	44.7	4.7	1.7	7.9	47.2	2.8	1.8	30.0	22.2	3.3	11.2	25.4	18.4	39.1	12.3	15.2	19.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	12.1	0.1	14.4	0.0	0.0	0.0	33.5	35.4	0.0	0.0	0.0	0.0	0.0	0.2	12.4	2.3	13.6	0.0	0.0	14.1	24.7	0.0	0.0	0.0	17.7	0.0	14.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	36.7	0.0	0.0	0.0	0.0	0.0	0.7	0.8	11.8	0.0	21.5	0.0	8.6	23.3	18.4	11.9	36.4	9.8	11.2	10.7	12.1	25.4	11.0	6.9	10.0	5.9	12.3	39.1	14.4	15.2	19.2	5.9	10.5	1.2	5.8	4.1	3.5	9.3	2.5	6.6	7.9	0.0	15.2	52.5	0.4	1.1	0.9	1.3	7.6	1.4	3.4	0.0	0.0	0.6	0.0	0.0	0.6	2.0	0.0	0.0	0.3	0.7	1.7	0.1	53.3	0.9	98.9	0.0	0.0	9.2	144.7	1.5	1.1	81.9	5.0	90.2	0.0	0.2	0.0	0.0	0.0	0.3	0.8	0.0	1.4	0.5	1.0	0.5	1.1	53.6	0.0	0.3
NFAM1	CNAIP	ENSG00000235568	"NFAT activating protein with ITAM motif 1"	Q8NET5	22	42380410-42432395	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 34.0;bone marrow: 28.0;lymphoid tissue: 35.2"	"Cell type enhanced"	"Detected in some"	20	"granulocytes: 11.5;Hofbauer cells: 15.6;Kupffer cells: 46.1;Macrophages: 14.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"neutrophil: 34.0"	"Group enriched"	"Detected in many"	4	"granulocytes: 34.0;monocytes: 17.5"	"Cell line enriched"	"Detected in some"	4	"THP-1: 28.6"					"Group enriched"	"Detected in many"	4	"basal ganglia: 2.9;hypothalamus: 3.7;midbrain: 7.4;pons and medulla: 7.8;thalamus: 8.3"	HPA031812	Uncertain					NA	NA					"HPA031812: AB_10603121"	"unprognostic (9.77e-3)"	"unprognostic (2.77e-3)"	"unprognostic (8.21e-2)"	"prognostic favorable (6.16e-4)"	"unprognostic (4.83e-2)"	"unprognostic (8.76e-3)"	"unprognostic (2.34e-1)"	"unprognostic (1.08e-1)"	"unprognostic (9.12e-3)"	"unprognostic (9.97e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.00e-1)"	"unprognostic (8.12e-3)"	"unprognostic (1.75e-1)"	"unprognostic (4.42e-2)"	"unprognostic (2.71e-2)"	"unprognostic (1.91e-1)"	10.9	3.1	1.7	12.3	3.1	28.0	2.0	0.9	1.9	2.2	1.8	4.0	0.7	1.5	1.4	4.2	2.0	3.3	2.8	4.8	1.8	2.2	2.5	9.9	12.1	35.2	2.4	0.6	1.5	1.7	0.4	1.3	4.4	2.7	2.5	1.4	2.4	2.0	1.8	1.1	1.6	3.3	3.0	4.8	27.7	1.7	1.4	2.5	2.8	1.5	1.2	3.7	3.1	1.5	0.0	6.1	34.0	17.5	0.0	0.1	7.3	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.4	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.2	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	6.6	0.2	0.0	0.0	0.1	0.0	0.0	0.3	0.1	4.6	0.0	0.0	0.1	0.0	0.3	0.0	28.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	3.4	0.0	0.1	17.5	0.9	0.0	12.2	0.1	0.0	0.0	0.0	6.1	0.0	0.0	0.0	34.0	0.0	10.6	0.1	0.0	7.3	1.7	3.1	0.9	1.9	1.8	2.2	2.4	0.6	2.7	2.5	0.0	5.9	0.5	0.6	0.8	0.1	0.6	2.5	0.0	0.0	0.0	0.0	0.1	0.0	0.1	2.6	0.2	0.0	0.0	0.2	0.1	0.8	0.2	11.5	0.2	15.6	0.0	1.2	0.6	46.1	3.6	0.3	14.9	0.0	2.8	0.0	0.0	0.0	0.0	0.4	0.0	0.3	0.0	0.3	0.2	0.6	0.9	0.2	0.0	0.0	0.4
NFKBID	"IkappaBNS, TA-NFKBH"	ENSG00000167604	"NFKB inhibitor delta"	Q8NI38	19	35887653-35902303	"Predicted intracellular proteins, Transcription factors"	"Inflammatory response"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"bone marrow: 21.0"	"Cell type enhanced"	"Detected in many"	9	"granulocytes: 91.9;Macrophages: 54.1;monocytes: 51.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HMC-1: 10.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA054778			Uncertain	"Nuclear bodies,Plasma membrane,Cytosol"		NA	NA			Cytosol	"Nuclear bodies, Plasma membrane"	"HPA054778: "	"prognostic favorable (6.01e-4)"	"unprognostic (9.60e-2)"	"unprognostic (1.00e-1)"	"unprognostic (3.28e-2)"	"unprognostic (1.51e-2)"	"prognostic favorable (5.43e-4)"	"unprognostic (4.21e-2)"	"unprognostic (7.68e-2)"	"unprognostic (3.83e-1)"	"unprognostic (4.10e-2)"	"unprognostic (1.47e-3)"	"unprognostic (5.64e-2)"	"unprognostic (6.83e-2)"	"unprognostic (1.04e-1)"	"unprognostic (5.21e-2)"	"unprognostic (2.71e-2)"	"prognostic favorable (8.34e-6)"	4.1	2.8	0.9	13.5	2.5	21.0	7.0	4.5	2.4	1.9	2.1	4.4	0.9	1.9	2.3	2.7	3.0	3.7	6.9	2.1	0.7	1.1	3.4	1.8	11.4	9.1	2.3	0.4	4.3	3.5	1.9	5.5	1.6	2.0	2.6	1.5	2.7	2.3	3.4	0.9	3.6	4.8	5.1	2.4	6.8	2.8	1.5	1.1	14.4	5.1	1.0	14.7	2.8	7.4	9.4	1.9	4.8	1.6	2.0	2.3	0.6	4.7	4.4	0.9	3.0	0.6	0.7	2.1	3.0	3.5	3.2	2.3	1.0	3.9	5.8	2.3	3.1	2.8	2.5	3.1	2.3	1.3	3.3	0.6	3.5	6.2	1.1	0.8	3.0	10.5	1.0	1.6	5.9	1.5	0.8	1.1	2.7	0.7	3.6	0.7	3.7	2.5	3.6	1.3	0.9	0.9	1.3	0.7	1.2	2.8	2.0	1.6	1.2	4.0	3.1	0.3	0.8	1.4	3.0	1.2	5.0	4.5	2.2	2.0	2.5	0.9	6.8	2.7	7.1	0.7	0.0	1.4	2.5	2.3	0.9	1.7	5.4	1.0	1.8	1.4	9.4	1.7	1.0	4.8	2.0	1.6	1.9	2.2	0.6	0.9	2.5	4.5	2.4	0.7	1.1	2.3	0.4	2.0	1.1	0.0	13.7	34.0	7.1	26.4	8.1	0.8	5.1	4.0	2.3	1.8	19.6	1.1	0.0	2.3	0.0	8.7	2.9	0.0	0.9	2.2	15.4	12.3	91.9	0.0	32.9	0.0	2.9	2.5	30.8	0.0	1.1	54.1	18.6	51.3	2.6	1.1	2.7	2.5	1.8	0.9	9.7	0.0	9.5	0.5	0.5	29.2	0.8	15.2	4.8	7.9
NLRC4	"CARD12, CLAN, CLAN1, CLANA, CLANB, CLANC, CLAND, CLR2.1, ipaf"	ENSG00000091106	"NLR family CARD domain containing 4"	Q9NPP4	2	32224453-32265854	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Apoptosis, Immunity, Inflammatory response, Innate immunity"		"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 23.8;lymphoid tissue: 22.4"	"Group enriched"	"Detected in some"	4	"Hofbauer cells: 10.7;Kupffer cells: 20.0;Macrophages: 11.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	7	"classical monocyte: 19.8;intermediate monocyte: 23.8;myeloid DC: 13.3;neutrophil: 9.7;non-classical monocyte: 17.6"	"Group enriched"	"Detected in many"	35	"dendritic cells: 13.3;granulocytes: 9.7;monocytes: 23.8"	"Cell line enhanced"	"Detected in many"		"HL-60: 7.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			HPA006592	Uncertain					NA	NA					"HPA006592: AB_2667620"	"unprognostic (7.59e-2)"	"unprognostic (1.08e-1)"	"unprognostic (6.25e-2)"	"unprognostic (1.97e-1)"	"unprognostic (8.88e-2)"	"unprognostic (2.45e-2)"	"unprognostic (1.17e-2)"	"unprognostic (2.09e-2)"	"unprognostic (1.48e-1)"	"unprognostic (2.26e-1)"	"unprognostic (6.33e-2)"	"unprognostic (6.33e-2)"	"unprognostic (6.03e-6)"	"unprognostic (7.42e-2)"	"unprognostic (2.06e-3)"	"unprognostic (2.02e-2)"	"unprognostic (1.63e-1)"	8.4	2.4	2.2	11.7	5.2	11.2	1.3	1.3	3.7	0.8	1.1	2.0	0.3	1.1	0.9	1.4	0.8	1.7	2.0	2.7	2.1	1.4	1.7	2.2	8.3	16.2	5.4	0.8	1.0	1.5	0.0	1.2	2.8	3.0	0.9	1.1	1.2	1.1	0.2	1.5	0.6	1.7	2.9	5.5	22.4	1.2	1.0	3.6	1.7	0.9	0.0	1.5	2.7	2.3	0.4	13.3	9.7	23.8	0.1	0.1	6.5	0.6	0.6	0.9	1.8	0.2	0.0	1.1	0.9	0.0	0.0	0.0	0.7	0.9	0.9	0.7	0.0	0.5	0.8	0.0	0.0	0.0	2.0	0.7	1.3	0.3	1.0	0.0	7.0	1.3	0.0	1.0	0.0	3.6	1.1	0.0	0.4	0.7	1.1	0.0	0.1	0.5	3.3	0.5	0.5	0.5	0.3	1.1	1.1	0.0	0.9	0.8	1.7	0.5	0.6	2.9	1.3	0.3	3.4	0.2	0.8	0.8	0.7	1.0	1.4	1.9	3.1	1.4	3.1	1.0	0.1	19.8	2.3	0.0	23.8	0.1	0.2	0.0	0.0	13.3	0.4	0.0	0.0	9.7	0.1	17.6	0.1	0.0	6.5	2.2	5.2	1.3	3.7	2.1	1.4	5.4	0.8	3.0	3.6	0.0	2.6	0.0	0.0	0.0	0.4	0.4	0.0	0.0	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.1	0.0	10.7	0.0	0.0	0.6	20.0	0.0	0.0	11.3	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.1	0.1	0.2	0.0	0.0	0.0
NOD2	"BLAU, CARD15, CD, CLR16.3, IBD1, NLRC2, PSORAS1"	ENSG00000167207	"Nucleotide binding oligomerization domain containing 2"	Q9HC29	16	50693588-50734041	"Disease related genes, FDA approved drug targets, Predicted intracellular proteins"	"Immunity, Innate immunity"		"Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in some"	4	"Alveolar cells type 2: 5.9;Basal keratinocytes: 5.3;Kupffer cells: 9.7;Macrophages: 13.7;Suprabasal keratinocytes: 13.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"classical monocyte: 15.3;eosinophil: 3.9;intermediate monocyte: 9.1;myeloid DC: 15.5;neutrophil: 6.3;non-classical monocyte: 5.8"	"Group enriched"	"Detected in many"	6	"dendritic cells: 15.5;granulocytes: 6.3;monocytes: 15.3"	"Cell line enhanced"	"Detected in some"		"HMC-1: 11.9;T-47d: 5.7;THP-1: 6.8;U-266/70: 15.7;U-266/84: 6.7"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"HPA041985, HPA054494"	Enhanced		Approved	"Golgi apparatus,Cytosol"		No	NA			"Golgi apparatus, Cytosol"		"HPA041985: AB_2677780, HPA054494: AB_2682505"	"unprognostic (1.01e-1)"	"unprognostic (4.38e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.02e-3)"	"unprognostic (9.91e-3)"	"unprognostic (5.84e-2)"	"unprognostic (5.90e-3)"	"unprognostic (1.23e-1)"	"unprognostic (4.17e-1)"	"unprognostic (3.88e-2)"	"unprognostic (6.94e-3)"	"unprognostic (1.48e-2)"	"unprognostic (2.31e-9)"	"unprognostic (4.38e-2)"	"unprognostic (1.08e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.13e-1)"	2.6	0.6	0.9	6.2	0.5	13.2	1.7	0.5	1.5	5.7	1.0	0.7	0.9	1.5	1.8	2.6	12.6	1.1	3.7	3.2	1.2	0.5	0.8	1.9	7.6	8.0	1.6	0.0	1.4	0.4	0.0	1.0	2.6	1.4	1.8	1.0	1.2	5.5	0.4	1.4	14.2	1.3	1.9	3.2	4.7	1.4	2.2	0.9	1.0	0.9	12.1	8.3	4.0	10.6	0.0	15.5	6.3	15.3	1.9	1.0	6.8	0.5	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.2	0.0	11.9	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	2.1	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.1	0.1	0.0	1.4	0.0	0.0	5.7	6.8	0.0	0.0	0.0	0.0	0.0	15.7	6.7	0.0	0.2	0.1	0.0	2.0	15.3	3.9	0.2	9.1	0.5	0.0	1.0	0.9	15.5	0.0	0.1	0.3	6.3	1.9	5.8	0.6	0.6	6.8	0.9	0.5	0.5	1.5	1.2	0.5	1.6	0.0	1.4	0.9	0.0	5.9	0.0	0.3	5.3	0.0	0.4	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.5	0.3	1.1	0.0	2.4	0.0	1.2	0.0	9.7	0.0	0.0	13.7	1.7	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	13.6	0.2	0.7	0.0	0.3
NRROS	"ELLP3030, GARPL1, LRRC33, MGC50789, UNQ3030"	ENSG00000174004	"Negative regulator of reactive oxygen species"	Q86YC3	3	196639686-196662004	"Predicted membrane proteins"		"Growth factor binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 30.4"	"Cell type enhanced"	"Detected in some"	14	"Hofbauer cells: 61.8;Ito cells: 18.4;Kupffer cells: 33.8;Macrophages: 36.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"basophil: 7.4;classical monocyte: 1.9;eosinophil: 3.3;intermediate monocyte: 2.0;myeloid DC: 2.5;non-classical monocyte: 1.9"	"Group enriched"	"Detected in many"	5	"dendritic cells: 2.5;granulocytes: 7.4;monocytes: 2.0"	"Cell line enhanced"	"Detected in some"		"HEL: 16.4;HMC-1: 34.6;Karpas-707: 21.4;MOLT-4: 18.2;NB-4: 42.6;RPMI-8226: 21.2;THP-1: 18.8;U-937: 23.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA031586	Uncertain					NA	NA					"HPA031586: AB_10601543"	"unprognostic (5.28e-2)"	"unprognostic (8.92e-3)"	"unprognostic (1.02e-1)"	"unprognostic (3.05e-2)"	"unprognostic (2.23e-1)"	"unprognostic (1.41e-3)"	"unprognostic (1.05e-1)"	"unprognostic (9.67e-2)"	"unprognostic (3.20e-2)"	"prognostic unfavorable (9.63e-4)"	"unprognostic (2.32e-2)"	"unprognostic (2.81e-1)"	"unprognostic (6.73e-3)"	"unprognostic (1.47e-1)"	"unprognostic (7.13e-2)"	"unprognostic (1.27e-1)"	"unprognostic (2.31e-1)"	17.0	3.6	3.8	9.3	4.4	30.4	12.4	1.6	3.1	4.7	3.3	4.0	1.0	3.0	7.6	7.1	2.7	4.2	5.8	8.5	3.1	2.7	4.3	3.4	13.4	23.0	4.3	1.3	2.6	2.6	1.2	2.3	12.4	3.4	4.5	2.2	5.7	3.8	2.2	3.1	3.1	6.9	4.9	5.2	22.5	3.4	2.8	4.8	15.6	3.5	2.4	8.8	6.3	3.5	0.6	2.5	7.4	2.0	0.6	0.7	1.2	0.0	0.0	0.1	0.0	0.1	0.3	0.0	0.1	0.6	0.1	0.1	0.0	0.0	0.0	2.2	0.1	0.1	0.0	0.3	0.0	0.0	1.2	0.0	16.4	0.0	0.0	0.1	13.4	34.6	0.1	0.0	0.5	0.2	0.6	1.3	15.5	1.6	21.4	0.4	0.0	18.2	42.6	1.4	0.0	0.0	4.9	0.0	21.2	0.0	0.1	0.1	0.0	0.0	0.0	8.6	0.3	0.0	18.8	0.1	0.1	0.0	0.6	0.0	8.6	12.9	3.8	1.1	23.7	0.2	7.4	1.9	3.3	0.7	2.0	0.2	0.6	0.5	0.4	2.5	0.5	0.2	0.4	0.0	0.6	1.9	0.3	0.5	1.2	3.8	4.4	1.6	3.1	3.1	2.7	4.3	1.3	3.4	4.8	0.0	0.3	15.9	0.0	1.3	0.0	0.1	0.0	0.0	1.2	0.0	3.9	0.3	0.0	0.0	0.9	3.8	0.0	0.0	0.0	0.5	0.8	0.0	13.9	0.0	61.8	0.0	0.0	18.4	33.8	0.0	0.6	36.2	8.5	3.6	0.0	0.0	0.0	0.0	0.7	0.0	0.4	6.5	0.5	0.5	0.2	0.6	0.5	13.1	0.0	0.0
OAS2		ENSG00000111335	"2'-5'-oligoadenylate synthetase 2"	P29728	12	112978395-113011723	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Antiviral defense, Immunity, Innate immunity"	"Nucleotidyltransferase, RNA-binding, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"B-cells: 14.9;Endothelial cells: 14.3;Hofbauer cells: 15.1;Kupffer cells: 16.2;Macrophages: 15.1;T-cells: 13.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+ SV40 Large T+: 72.2;BJ hTERT+ SV40 Large T+ RasG12V: 58.9;SK-MEL-30: 28.2;U-266/70: 26.3;U-266/84: 22.6"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"HPA003320, CAB024984"	Approved		Approved	Centrosome		NA	NA			Centrosome		"CAB024984: , HPA003320: "	"unprognostic (2.39e-1)"	"unprognostic (9.51e-2)"	"unprognostic (2.13e-2)"	"unprognostic (1.15e-2)"	"unprognostic (1.34e-1)"	"unprognostic (7.94e-2)"	"unprognostic (4.79e-2)"	"unprognostic (2.05e-2)"	"unprognostic (1.31e-1)"	"unprognostic (7.64e-3)"	"prognostic unfavorable (4.63e-4)"	"unprognostic (4.20e-1)"	"prognostic unfavorable (4.31e-6)"	"unprognostic (1.12e-1)"	"unprognostic (4.17e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.94e-2)"	37.9	3.8	4.0	13.9	5.1	9.0	7.2	1.8	4.9	8.5	4.3	7.5	1.2	4.6	9.0	6.9	13.2	3.9	9.6	6.9	3.8	4.4	8.8	9.9	15.6	24.1	5.0	3.7	3.9	1.9	1.2	2.9	22.2	7.3	6.6	4.7	6.9	32.9	1.8	2.2	2.9	8.8	6.4	7.1	36.6	9.7	2.2	3.0	32.4	9.8	8.2	27.4	13.7	5.4	12.0	12.7	2.0	26.8	15.1	17.4	13.2	0.7	0.1	0.0	0.0	0.4	2.6	0.0	0.1	8.2	72.2	58.9	0.1	1.2	18.2	1.8	1.5	16.2	0.8	0.1	0.2	2.5	4.5	0.0	0.0	0.1	0.1	0.5	0.0	0.0	0.2	1.3	4.1	0.0	0.0	1.1	0.9	0.0	9.5	0.0	0.3	0.5	1.0	0.0	0.1	2.6	3.9	0.0	2.7	0.0	6.5	0.0	0.0	0.7	0.2	28.2	0.0	0.6	1.1	1.8	0.1	0.0	0.3	0.0	26.3	22.6	2.8	0.6	0.9	0.7	2.0	15.9	1.2	13.4	26.8	16.8	12.0	15.4	15.2	12.7	8.9	15.2	11.2	1.8	15.1	26.0	5.3	17.4	13.2	4.0	5.1	1.8	4.9	3.8	4.4	5.0	3.7	7.3	3.0	3.0	8.9	14.9	1.5	1.8	0.0	1.4	0.0	8.1	3.4	1.8	0.0	0.1	0.0	1.0	0.6	14.3	0.3	0.0	1.0	2.1	2.1	2.4	1.1	1.8	15.1	0.0	0.0	11.1	16.2	0.7	0.6	15.1	5.0	3.6	3.1	0.5	2.3	0.2	3.2	0.0	0.1	0.0	1.0	0.0	0.1	1.0	0.1	13.8	0.1	7.7
OGFRL1	dJ331H24.1	ENSG00000119900	"Opioid growth factor receptor like 1"	Q5TC84	6	71288803-71308950	"Predicted intracellular proteins"		Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 52.2"	"Cell type enhanced"	"Detected in many"	5	"Kupffer cells: 79.5;Macrophages: 93.2;Muller glia cells: 83.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	4	"neutrophil: 12.8"	"Lineage enriched"	"Detected in many"	4	"granulocytes: 12.8"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA027122			Approved	"Nucleoplasm,Golgi apparatus"		NA	NA			"Golgi apparatus"	Nucleoplasm	"HPA027122: AB_2156775"	"unprognostic (8.44e-3)"	"unprognostic (1.41e-2)"	"unprognostic (2.48e-1)"	"unprognostic (1.95e-1)"	"unprognostic (2.52e-1)"	"unprognostic (4.24e-3)"	"prognostic unfavorable (3.62e-4)"	"unprognostic (9.62e-3)"	"unprognostic (2.30e-2)"	"unprognostic (2.49e-1)"	"unprognostic (4.22e-2)"	"unprognostic (2.11e-1)"	"unprognostic (1.39e-2)"	"unprognostic (1.27e-1)"	"unprognostic (1.37e-1)"	"unprognostic (3.25e-2)"	"unprognostic (5.58e-3)"	16.9	8.7	20.2	11.3	26.8	16.9	36.0	22.3	33.3	6.7	7.2	29.1	2.8	2.9	8.3	10.7	24.5	5.2	8.3	5.8	30.2	17.6	5.7	4.8	8.5	9.6	27.7	18.3	5.4	6.0	5.8	10.0	9.9	37.8	6.7	4.3	3.3	31.8	10.3	4.1	14.6	5.7	24.1	52.2	11.7	5.4	2.4	29.1	3.2	4.8	4.3	17.8	5.4	9.4	0.7	2.4	12.8	3.0	0.5	0.5	0.6	3.8	1.1	4.1	0.0	11.2	10.3	1.5	17.4	10.8	7.0	7.2	1.4	0.7	23.7	24.0	7.5	6.5	1.9	3.1	12.0	25.0	5.0	2.5	5.2	4.2	0.6	9.1	2.4	1.8	10.3	10.3	5.2	16.4	5.9	5.6	0.0	0.3	1.9	24.1	3.2	0.0	3.8	1.7	1.5	1.0	1.6	12.6	5.4	16.3	0.3	14.1	6.4	5.1	3.2	1.1	6.2	5.5	19.2	8.6	17.3	8.7	1.8	5.7	2.5	0.1	3.1	5.8	16.5	3.0	3.1	3.0	0.1	0.5	2.0	0.5	0.4	0.4	0.5	2.4	0.7	0.1	0.3	12.8	0.5	1.4	0.9	0.2	0.6	20.2	26.8	22.3	27.4	30.2	17.6	27.7	18.3	37.8	29.1	6.0	21.8	14.3	18.0	34.6	15.3	7.8	5.1	1.4	11.4	10.4	23.6	19.2	1.7	12.9	0.4	21.0	0.0	0.0	27.8	10.1	31.4	13.9	5.8	4.0	53.5	36.5	13.8	8.6	79.5	1.1	15.3	93.2	30.4	27.9	2.4	83.6	18.3	0.0	31.1	3.1	5.0	25.8	18.6	0.4	1.1	40.7	15.9	12.1	4.3	14.9
OLR1	"CLEC8A, LOX-1, SCARE1"	ENSG00000173391	"Oxidized low density lipoprotein receptor 1"	P78380	12	10158301-10172138	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion, Immunity, Inflammatory response"	Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 28.5;lung: 46.8;placenta: 53.4"	"Group enriched"	"Detected in many"	7	"Cytotrophoblasts: 386.0;Hofbauer cells: 209.3;Macrophages: 102.1;Syncytiotrophoblasts: 387.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"myeloid DC: 5.9"	"Group enriched"	"Detected in many"	6	"dendritic cells: 5.9;granulocytes: 3.3;monocytes: 1.5"	"Cell line enhanced"	"Detected in some"		"CACO-2: 32.7;HaCaT: 17.2;HHSteC: 34.6;hTCEpi: 15.9;SiHa: 65.9;SK-BR-3: 26.2"					"Low region specificity"	"Detected in all"			HPA050798			Approved	"Nucleoplasm,Vesicles,Plasma membrane"	"Intracellular and membrane"	NA	NA	1060000		"Nucleoplasm, Plasma membrane"	Vesicles	"HPA050798: AB_2756318"	"unprognostic (2.30e-1)"	"unprognostic (3.16e-2)"	"unprognostic (1.58e-2)"	"unprognostic (1.32e-1)"	"unprognostic (7.81e-2)"	"prognostic unfavorable (8.24e-5)"	"unprognostic (6.34e-2)"	"unprognostic (6.07e-3)"	"unprognostic (5.40e-2)"	"unprognostic (2.64e-1)"	"unprognostic (1.97e-2)"	"unprognostic (3.51e-1)"	"unprognostic (1.08e-1)"	"unprognostic (4.94e-3)"	"unprognostic (3.47e-2)"	"unprognostic (1.48e-2)"	"unprognostic (1.42e-1)"	2.0	1.9	6.0	14.1	10.3	10.6	2.0	1.3	10.2	1.9	0.5	21.3	0.0	0.8	1.0	0.9	0.5	1.2	3.9	1.1	8.5	6.7	6.9	1.8	46.8	0.5	16.4	4.4	0.4	1.6	2.8	1.9	53.4	12.3	1.4	0.7	0.2	2.0	0.7	0.4	0.5	0.8	1.2	28.5	0.6	1.4	2.8	10.5	0.0	1.5	0.0	0.6	4.3	0.4	0.5	5.9	3.3	1.5	0.3	0.3	1.1	1.8	0.1	0.0	0.1	0.0	0.0	4.5	3.1	0.5	2.0	0.7	32.7	0.0	0.4	0.0	4.2	0.1	17.2	0.0	0.1	1.3	0.0	0.0	0.0	1.6	0.0	34.6	0.0	0.0	0.2	15.9	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.5	0.1	0.0	65.9	26.2	0.0	4.9	7.3	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	1.0	1.5	2.7	0.2	0.2	0.3	0.3	0.3	0.2	5.9	0.5	0.3	0.3	3.3	0.3	0.4	0.8	0.2	1.1	6.0	10.3	1.3	7.4	8.5	6.7	16.4	4.4	12.3	10.5	26.8	30.9	0.0	0.2	1.3	0.4	0.0	2.5	12.0	7.9	0.0	0.0	386.0	0.0	0.0	9.4	1.2	0.0	0.0	0.0	8.5	1.3	0.0	14.0	0.8	209.3	0.0	0.0	0.0	21.9	7.6	0.3	102.1	0.0	36.9	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.5	387.3	0.0	0.0	0.0
OSM	MGC20461	ENSG00000099985	"Oncostatin M"	P13725	22	30262829-30266840	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Growth regulation"	"Cytokine, Mitogen"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"blood: 24.9;bone marrow: 63.0"	"Cell type enhanced"	"Detected in some"	22	"Alveolar cells type 2: 18.3;granulocytes: 14.0;Hofbauer cells: 72.9;Macrophages: 23.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	6	"basophil: 24.9;neutrophil: 17.5"	"Lineage enriched"	"Detected in many"	7	"granulocytes: 24.9"	"Cell line enhanced"	"Detected in some"		"HDLM-2: 16.2;HL-60: 3.9;HMC-1: 12.0;Karpas-707: 3.7;NB-4: 6.9"					"Low region specificity"	"Detected in some"								"Secreted to blood"	NA	NA	39700					"unprognostic (5.15e-2)"	"unprognostic (8.80e-3)"	"unprognostic (1.01e-1)"	"unprognostic (6.02e-2)"	"unprognostic (7.37e-2)"	"unprognostic (2.61e-2)"	"unprognostic (6.78e-2)"	"unprognostic (3.77e-2)"	"unprognostic (2.81e-2)"	"unprognostic (4.60e-2)"	"unprognostic (1.58e-2)"	"unprognostic (1.25e-1)"	"prognostic unfavorable (1.03e-5)"	"unprognostic (4.00e-2)"	"unprognostic (7.72e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.82e-1)"	5.3	2.6	0.9	8.5	2.5	63.0	3.7	0.7	1.7	1.6	1.0	5.3	0.4	0.6	1.2	1.9	0.8	3.8	4.1	2.2	3.8	1.7	1.9	1.8	11.4	9.4	2.0	0.0	3.0	1.0	1.0	2.5	6.4	5.9	1.2	0.7	1.8	1.4	0.5	1.7	0.4	1.0	2.1	7.8	6.9	1.4	2.3	1.2	0.6	1.1	0.5	2.2	6.8	0.9	0.1	0.4	24.9	0.2	1.9	3.4	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.7	0.0	0.0	0.1	0.0	0.0	0.0	0.0	16.2	0.0	0.3	0.0	0.0	0.0	3.9	12.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.1	3.7	0.0	0.0	0.5	6.9	0.0	0.0	0.0	0.6	0.1	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	2.4	0.0	24.9	0.2	0.9	1.0	0.1	3.4	0.0	2.5	1.3	0.4	0.1	0.5	1.2	17.5	1.9	0.0	0.1	0.7	0.8	0.9	2.5	0.7	1.7	3.8	1.7	2.0	0.0	5.9	1.2	8.9	18.3	0.0	0.1	0.7	0.0	0.4	0.0	1.4	6.8	0.0	0.0	0.6	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.6	0.6	0.1	14.0	0.0	72.9	0.0	0.0	0.0	6.2	0.0	0.0	23.5	0.0	1.8	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.7	7.0	0.0	0.0
P2RX7	"MGC20089, P2X7"	ENSG00000089041	"Purinergic receptor P2X 7"	Q99572	12	121132819-121188032	"Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Ion channel, Ligand-gated ion channel, Receptor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 30.5"	"Cell type enhanced"	"Detected in many"	8	"Hofbauer cells: 22.5;Kupffer cells: 18.7;Macrophages: 34.0"	"Cancer enhanced"	"Detected in all"		"melanoma: 19.5"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"dendritic cells: 4.2;monocytes: 7.5;T-cells: 2.3"	"Cell line enhanced"	"Detected in some"		"Karpas-707: 23.5;RPMI-8226: 13.8;SK-MEL-30: 23.3;U-266/70: 12.9;U-266/84: 11.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA034968, HPA042013, HPA044141"	Approved					NA	NA					"HPA034968: AB_10673105, HPA042013: AB_2677797, HPA044141: AB_2678830"	"unprognostic (1.05e-1)"	"unprognostic (4.90e-2)"	"unprognostic (8.87e-2)"	"unprognostic (6.54e-3)"	"unprognostic (4.49e-2)"	"unprognostic (1.55e-2)"	"unprognostic (8.82e-2)"	"unprognostic (9.11e-2)"	"unprognostic (1.05e-2)"	"unprognostic (1.08e-1)"	"unprognostic (2.42e-1)"	"unprognostic (6.62e-2)"	"prognostic unfavorable (2.92e-4)"	"unprognostic (1.91e-1)"	"unprognostic (3.59e-2)"	"unprognostic (5.55e-2)"	"unprognostic (1.65e-1)"	2.4	3.1	13.7	5.7	25.2	2.9	2.4	7.8	23.3	4.6	3.0	26.5	0.1	1.7	4.8	1.8	1.7	2.9	4.1	1.5	14.8	5.9	1.2	5.3	7.4	6.0	30.5	9.4	10.2	1.2	2.4	2.0	3.4	14.5	2.3	2.8	3.1	2.8	2.2	0.8	15.1	1.7	5.1	16.3	6.5	1.8	1.6	26.1	0.4	1.4	0.5	4.0	3.1	3.3	0.6	4.2	0.5	7.5	1.0	2.3	1.3	0.0	0.0	0.0	0.6	0.7	0.3	0.5	0.0	1.1	0.4	1.0	0.0	0.0	0.0	0.0	0.4	2.5	0.1	0.0	0.0	0.3	1.0	0.1	0.4	0.0	0.0	0.5	0.9	6.9	0.6	0.0	1.1	0.0	0.0	1.1	0.2	0.0	23.5	0.0	0.0	0.1	2.5	0.0	0.0	0.2	2.1	5.2	13.8	0.0	0.0	0.3	1.4	0.1	0.0	23.3	0.0	0.3	4.5	0.0	0.4	0.1	0.0	0.1	12.9	11.2	0.1	1.4	6.7	3.6	0.4	4.8	0.0	2.3	7.5	0.8	0.6	1.1	1.0	4.2	0.4	1.0	1.0	0.5	1.0	5.1	0.8	2.3	1.3	13.7	25.2	7.8	23.3	14.8	5.9	30.5	9.4	14.5	26.1	3.0	4.5	2.0	3.1	6.2	2.0	2.2	7.6	6.7	6.8	0.0	2.0	2.5	0.0	0.8	0.6	3.4	0.0	0.0	0.0	0.8	2.3	0.9	5.8	2.9	22.5	1.6	0.0	5.5	18.7	0.4	10.3	34.0	15.1	3.6	0.0	1.4	0.3	0.0	9.9	0.0	0.7	6.5	2.3	1.1	0.7	3.1	3.3	4.6	0.0	0.7
P2RY14	"GPR105, KIAA0001"	ENSG00000174944	"Purinergic receptor P2Y14"	Q15391	3	151212117-151278467	"G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"blood: 54.9"	"Group enriched"	"Detected in some"	4	"granulocytes: 45.0;Macrophages: 18.5;Sertoli cells: 25.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	8	"eosinophil: 54.9;plasmacytoid DC: 24.4"	"Group enriched"	"Detected in many"	8	"dendritic cells: 24.4;granulocytes: 54.9"	"Cell line enriched"	"Detected in single"	73	"HMC-1: 39.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB022646	Uncertain					NA	NA					"CAB022646: "	"unprognostic (9.78e-2)"	"unprognostic (7.47e-4)"	"unprognostic (3.89e-2)"	"unprognostic (4.52e-4)"	"unprognostic (1.69e-2)"	"unprognostic (2.57e-5)"	"unprognostic (2.68e-2)"	"unprognostic (1.55e-2)"	"unprognostic (2.65e-1)"	"unprognostic (1.64e-3)"	"unprognostic (6.30e-2)"	"unprognostic (2.45e-1)"	"prognostic unfavorable (1.72e-5)"	"unprognostic (3.79e-2)"	"unprognostic (6.89e-2)"	"unprognostic (1.58e-1)"	"unprognostic (2.58e-2)"	14.3	0.9	3.9	9.0	6.9	0.5	6.1	1.9	3.8	5.2	17.6	1.3	1.3	5.7	7.2	9.4	17.6	1.2	4.4	4.4	4.3	3.0	2.1	0.7	8.5	7.1	5.0	2.8	1.8	0.9	2.2	4.7	25.9	3.7	10.4	8.3	11.2	2.1	1.1	4.2	2.8	16.3	15.8	2.3	4.4	17.2	2.1	4.2	4.7	3.6	8.9	5.3	21.4	1.7	4.9	24.4	54.9	0.1	2.8	5.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.5	39.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	2.4	0.1	54.9	0.2	0.0	5.0	0.8	0.1	0.5	3.3	4.9	0.0	0.0	2.2	2.8	0.0	24.4	0.2	0.5	3.9	6.9	1.9	3.8	4.3	3.0	5.0	2.8	3.7	4.2	3.0	0.3	6.7	0.0	2.1	1.7	1.1	0.0	1.4	0.0	0.0	0.0	0.1	0.0	0.0	0.3	1.1	0.0	0.0	0.0	0.3	2.8	0.0	45.0	0.0	0.6	0.0	0.0	0.0	0.8	0.0	0.0	18.5	3.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.3	25.8	2.7	0.0	0.1	1.5	0.2	2.9	0.0	0.1
PARVG		ENSG00000138964	"Parvin gamma"	Q9HBI0	22	44172956-44219533	"Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"	Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 27.4;bone marrow: 31.2;lymphoid tissue: 27.7"	"Group enriched"	"Detected in many"	9	"Alveolar cells type 2: 21.8;B-cells: 64.9;granulocytes: 57.8;Hofbauer cells: 62.1;Kupffer cells: 83.7;Macrophages: 73.9;monocytes: 28.9;T-cells: 38.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Group enriched"	"Detected in some"	4	"HL-60: 44.8;NB-4: 17.3;THP-1: 25.4;U-937: 21.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA031833, HPA031834"	Uncertain					NA	NA					"HPA031833: AB_2674063, HPA031834: AB_10601242"	"unprognostic (9.83e-3)"	"unprognostic (2.30e-2)"	"unprognostic (2.06e-1)"	"prognostic favorable (4.44e-6)"	"unprognostic (2.79e-1)"	"unprognostic (1.57e-2)"	"unprognostic (2.14e-1)"	"unprognostic (3.19e-2)"	"unprognostic (7.02e-2)"	"unprognostic (2.17e-1)"	"unprognostic (3.87e-2)"	"unprognostic (3.36e-1)"	"prognostic unfavorable (3.43e-6)"	"unprognostic (3.73e-1)"	"unprognostic (1.35e-2)"	"unprognostic (1.09e-1)"	"unprognostic (9.89e-2)"	8.0	2.9	3.5	22.2	6.9	31.2	2.7	1.2	3.1	3.5	3.5	4.9	0.8	2.7	1.9	2.7	1.9	3.1	4.5	3.5	4.2	3.3	3.1	3.1	13.1	20.3	8.9	1.5	1.6	2.0	0.5	2.1	2.3	5.4	2.6	2.7	2.5	5.2	1.0	1.0	1.7	10.1	2.2	10.8	27.7	3.1	1.7	5.6	19.7	2.4	0.0	18.8	4.5	5.9	8.4	18.5	27.4	23.6	4.8	6.0	14.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.8	0.0	0.0	0.0	44.8	0.3	0.0	0.0	0.0	0.0	0.0	0.0	5.0	0.0	0.0	0.0	0.0	6.4	17.3	0.0	0.0	0.0	3.6	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	25.4	0.0	0.0	4.8	0.1	0.0	0.1	0.0	0.1	0.0	21.1	0.7	3.6	23.6	25.3	5.5	21.3	5.5	8.3	3.3	6.0	18.5	8.4	3.7	4.2	27.4	4.8	22.6	12.6	4.4	14.2	3.5	6.9	1.2	3.1	4.2	3.3	8.9	1.5	5.4	5.6	6.0	21.8	64.9	0.0	2.2	0.0	0.9	0.0	2.7	5.7	0.0	0.0	0.5	0.0	0.0	3.6	1.4	0.0	0.0	0.2	0.6	0.7	0.0	57.8	0.8	62.1	0.0	0.0	4.9	83.7	1.8	0.0	73.9	5.0	28.9	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.7	0.9	1.6	0.8	38.9	0.0	0.0
PHACTR1	"dJ257A7.2, KIAA1733, RPEL1"	ENSG00000112137	"Phosphatase and actin regulator 1"	Q9C0D0	6	12716805-13290484	"Predicted intracellular proteins"		"Actin-binding, Protein phosphatase inhibitor"	Epilepsy	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 25.9;brain: 80.3"	"Cell type enhanced"	"Detected in many"	7	"B-cells: 134.6;Horizontal cells: 170.0;Kupffer cells: 97.1;Macrophages: 102.6"	"Cancer enhanced"	"Detected in many"		"melanoma: 10.2"	"Region enhanced"	"Detected in all"		"basal ganglia: 80.3"	"Group enriched"	"Detected in many"	13	"memory B-cell: 7.2;myeloid DC: 7.7;naive B-cell: 20.9;neutrophil: 10.1;plasmacytoid DC: 25.9"	"Group enriched"	"Detected in many"	17	"B-cells: 20.9;dendritic cells: 25.9;granulocytes: 10.1"	"Cell line enhanced"	"Detected in many"		"HMC-1: 16.7;SK-MEL-30: 15.7;U-266/70: 41.2;U-266/84: 26.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029755, HPA029756, HPA029757"	Enhanced		Uncertain	"Plasma membrane"		NA	NA			"Plasma membrane"		"HPA029755: AB_10600089, HPA029756: AB_10601852, HPA029757: AB_10669870"	"unprognostic (7.86e-2)"	"unprognostic (7.49e-2)"	"unprognostic (2.74e-2)"	"unprognostic (2.80e-1)"	"unprognostic (1.59e-1)"	"unprognostic (1.29e-1)"	"unprognostic (7.72e-2)"	"unprognostic (4.80e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.22e-1)"	"unprognostic (3.67e-4)"	"unprognostic (1.53e-1)"	"prognostic unfavorable (5.48e-6)"	"unprognostic (1.31e-1)"	"unprognostic (1.43e-1)"	"unprognostic (5.00e-2)"	"unprognostic (1.16e-1)"	3.5	1.6	11.6	7.2	80.3	22.6	1.6	4.9	31.4	1.4	1.4	1.3	0.3	2.0	1.3	2.6	1.5	1.9	4.2	9.2	10.9	4.4	3.9	1.9	9.0	8.7	2.7	16.6	1.8	4.2	0.5	6.0	1.7	2.2	1.4	1.5	0.6	1.4	0.7	1.2	2.6	2.9	1.7	2.6	6.5	2.0	2.2	7.2	0.4	1.3	0.0	13.4	3.4	1.4	20.9	25.9	10.1	1.1	0.4	0.2	1.1	0.0	0.1	1.1	0.2	0.0	0.0	3.2	0.3	1.2	1.2	2.1	0.1	0.0	0.2	0.4	0.1	1.6	0.1	0.0	0.0	1.5	4.2	0.3	8.4	0.1	0.1	0.1	7.9	16.7	0.4	0.0	0.0	0.1	0.1	1.5	0.5	3.9	7.1	1.2	0.0	0.1	6.1	1.1	0.0	0.0	4.0	2.2	0.7	1.0	0.1	5.0	1.5	0.0	3.2	15.7	1.6	9.6	1.9	1.7	0.1	0.3	0.0	0.0	41.2	26.8	7.0	0.6	2.3	6.4	0.1	1.1	0.6	0.1	0.9	0.0	7.2	0.1	0.0	7.7	20.9	0.1	0.2	10.1	0.4	0.3	25.9	0.0	1.1	11.6	80.3	4.9	31.4	10.9	4.4	2.7	16.6	2.2	7.2	62.5	37.4	134.6	1.5	3.3	35.3	9.1	2.5	9.4	14.8	59.3	3.9	1.2	26.6	0.6	54.5	8.3	0.4	0.0	2.5	2.0	6.2	0.8	80.7	0.8	76.1	170.0	1.7	15.4	97.1	44.3	4.4	102.6	45.5	18.0	0.1	21.8	1.0	0.0	6.0	0.6	13.0	0.0	4.0	1.2	2.7	2.8	1.6	2.5	0.4	0.7
PIK3AP1	"BCAP, FLJ35564"	ENSG00000155629	"Phosphoinositide-3-kinase adaptor protein 1"	Q6ZUJ8	10	96593312-96720514	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 38.9;liver: 38.4;lymphoid tissue: 32.0;salivary gland: 29.7"	"Cell type enhanced"	"Detected in many"	11	"Hepatocytes: 66.5;Kupffer cells: 114.3;Macrophages: 53.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"intermediate monocyte: 15.5;memory B-cell: 17.5;naive B-cell: 16.2;non-classical monocyte: 38.9"	"Group enriched"	"Detected in all"	6	"B-cells: 17.5;monocytes: 38.9"	"Cell line enhanced"	"Detected in some"		"Daudi: 24.7;NB-4: 17.8;REH: 52.8;THP-1: 26.9;U-698: 33.7;U-937: 27.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB026136, HPA038452"	Enhanced		Approved	"Nucleoplasm,Plasma membrane,Cytosol"	"Intracellular and membrane"	No	No			Cytosol	"Nucleoplasm, Plasma membrane"	"CAB026136: , HPA038452: AB_2676019"	"unprognostic (2.83e-2)"	"unprognostic (4.61e-3)"	"unprognostic (7.32e-2)"	"unprognostic (1.70e-1)"	"unprognostic (1.79e-1)"	"unprognostic (1.49e-1)"	"unprognostic (4.60e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.33e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.96e-1)"	"unprognostic (2.10e-1)"	"unprognostic (5.11e-2)"	"unprognostic (1.28e-1)"	"unprognostic (4.69e-2)"	"unprognostic (5.45e-1)"	"unprognostic (1.13e-1)"	5.8	2.2	2.9	16.8	7.1	14.7	4.8	1.0	3.0	1.4	2.2	3.2	0.0	1.9	1.3	2.3	1.3	2.0	8.5	3.3	3.1	2.4	6.2	38.4	6.0	19.5	5.3	0.5	3.3	16.1	0.3	3.0	10.9	5.1	1.8	2.7	1.6	29.7	0.8	1.1	1.5	6.6	2.4	7.3	32.0	1.9	1.7	4.3	2.0	2.4	0.6	19.2	4.1	2.2	17.5	4.4	4.7	38.9	4.5	4.8	4.2	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.8	0.4	24.7	2.5	0.0	0.4	0.0	5.2	0.0	0.2	13.7	0.9	3.7	0.0	0.4	0.0	10.3	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.2	0.0	0.0	0.1	0.3	17.8	0.2	7.0	0.3	52.8	1.2	5.8	0.0	0.0	1.1	0.6	0.0	0.0	0.3	0.1	0.0	26.9	0.0	0.0	0.8	0.0	0.2	0.2	0.0	33.7	0.0	27.7	0.0	1.7	5.4	3.3	4.8	15.5	1.7	17.5	0.1	1.5	4.4	16.2	0.0	1.2	4.7	4.5	38.9	3.9	0.1	4.2	2.9	7.1	1.0	3.0	3.1	2.4	5.3	0.5	5.1	4.3	3.0	3.8	29.6	0.0	1.3	0.2	2.2	28.1	1.4	3.4	1.8	2.0	0.4	1.7	26.1	3.3	1.4	2.6	0.0	25.2	0.7	1.0	0.5	13.9	66.5	41.2	0.0	1.7	8.0	114.3	0.4	1.1	53.7	5.0	2.8	2.5	0.2	22.8	18.4	2.1	12.8	3.3	0.0	1.7	0.2	0.2	1.0	1.9	27.7	2.9	0.1
PIK3R5	"p101, P101-PI3K"	ENSG00000141506	"Phosphoinositide-3-kinase regulatory subunit 5"	Q8WYR1	17	8878911-8965712	"Disease related genes, Predicted intracellular proteins"			"Disease mutation, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 51.0"	"Cell type enhanced"	"Detected in some"	9	"B-cells: 14.4;Hofbauer cells: 16.8;Kupffer cells: 22.6;Macrophages: 26.2;monocytes: 12.6;T-cells: 17.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"HDLM-2: 28.0;HMC-1: 4.2;JURKAT: 10.1;U-937: 8.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA044505, HPA052247, HPA052412"	Uncertain		Supported	"Centriolar satellite,Cytosol"		No	NA			Cytosol	"Centriolar satellite"	"HPA044505: AB_2678964, HPA052247: AB_2681772, HPA052412: AB_2681823"	"unprognostic (2.81e-1)"	"unprognostic (1.31e-2)"	"unprognostic (3.10e-2)"	"unprognostic (2.37e-2)"	"unprognostic (3.44e-2)"	"unprognostic (9.89e-3)"	"unprognostic (1.42e-1)"	"unprognostic (5.70e-2)"	"unprognostic (1.38e-1)"	"unprognostic (7.95e-2)"	"unprognostic (1.33e-2)"	"unprognostic (2.66e-1)"	"unprognostic (7.59e-3)"	"unprognostic (6.89e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.94e-1)"	"unprognostic (1.24e-1)"	13.8	4.1	2.0	13.0	3.4	51.0	7.2	0.6	1.8	2.1	5.6	3.6	0.0	2.5	1.9	3.1	3.1	3.8	5.7	3.1	3.4	1.6	2.7	2.4	16.4	22.9	5.0	0.6	2.5	1.8	0.7	1.3	2.3	3.0	2.7	2.1	2.4	3.1	1.0	1.0	1.8	10.4	2.9	5.3	23.8	2.6	4.0	2.5	17.6	2.2	1.9	12.4	4.5	2.8	3.6	8.0	23.8	12.1	5.7	13.6	9.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	28.0	0.3	1.0	0.0	0.0	0.0	0.4	4.2	0.0	0.0	0.0	0.0	0.0	0.0	10.1	0.0	0.0	0.0	0.2	1.0	1.8	0.4	0.0	0.0	3.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.1	0.0	4.9	10.6	3.7	13.6	10.0	8.8	3.2	7.5	11.4	8.0	3.6	5.8	8.9	23.8	5.7	12.1	6.4	9.2	9.5	2.0	3.4	0.6	1.8	3.4	1.6	5.0	0.6	3.0	2.5	0.0	9.6	14.4	0.0	0.9	0.0	2.0	2.5	0.0	0.0	0.0	0.0	0.1	0.0	0.1	3.9	0.0	0.0	0.0	0.0	0.2	1.1	0.1	4.7	0.2	16.8	0.0	0.0	1.8	22.6	6.3	0.3	26.2	1.7	12.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.3	0.4	0.6	0.3	17.9	0.0	0.0
PLAUR	"CD87, UPAR, URKR"	ENSG00000011422	"Plasminogen activator, urokinase receptor"	Q03405	19	43646095-43670547	"Cancer-related genes, CD markers, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins"		Receptor	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 118.0;bone marrow: 165.0"	"Cell type enhanced"	"Detected in many"	17	"Basal glandular cells: 664.4;Macrophages: 801.6;Urothelial cells: 2343.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 118.0"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"hTEC/SVTERT24-B: 50.2;U-251 MG: 71.3;U-87 MG: 62.2;WM-115: 60.6"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"HPA050843, CAB073533"	Uncertain		Supported	"Plasma membrane"	"Intracellular and membrane"	NA	NA		760000	"Plasma membrane"		"CAB073533: , HPA050843: AB_2681255"	"unprognostic (9.28e-2)"	"unprognostic (9.65e-3)"	"unprognostic (1.39e-1)"	"unprognostic (1.29e-3)"	"unprognostic (3.59e-3)"	"unprognostic (1.50e-2)"	"unprognostic (2.18e-3)"	"prognostic unfavorable (2.33e-5)"	"unprognostic (8.08e-3)"	"unprognostic (4.30e-2)"	"unprognostic (2.29e-3)"	"unprognostic (5.30e-2)"	"prognostic unfavorable (7.83e-9)"	"unprognostic (4.99e-2)"	"unprognostic (1.66e-1)"	"unprognostic (5.45e-2)"	"unprognostic (9.33e-2)"	25.2	3.6	3.0	23.6	4.8	165.0	6.3	2.2	6.1	10.7	7.5	4.4	1.8	3.3	9.5	6.0	8.6	10.6	23.0	11.5	4.5	3.2	5.1	6.1	39.4	8.1	6.0	1.1	11.9	4.3	2.5	4.4	12.2	6.9	6.1	6.0	4.6	11.0	3.7	7.9	3.5	7.3	7.2	7.1	12.6	12.0	6.3	6.3	2.5	4.4	7.7	7.0	22.7	14.9	0.2	21.3	118.0	50.5	0.6	0.9	21.0	14.3	5.0	4.5	0.3	4.1	14.6	2.8	30.0	30.5	19.0	23.8	0.4	16.9	0.5	7.6	18.5	11.0	6.1	1.2	7.4	21.2	0.9	0.9	2.7	7.5	0.6	5.2	3.2	34.9	15.0	1.5	50.2	7.5	27.8	20.9	3.3	2.7	0.6	18.2	1.0	3.4	8.6	1.5	25.7	10.8	4.0	3.0	1.0	5.9	0.7	0.2	3.9	13.4	3.1	3.9	2.3	0.6	10.0	21.4	41.9	21.5	19.1	71.3	0.6	1.4	0.1	62.2	5.8	60.6	7.2	48.9	72.4	0.7	41.5	0.8	0.2	0.9	0.6	21.3	0.1	0.3	0.4	118.0	0.6	50.5	6.8	0.3	21.0	3.0	4.8	2.2	6.1	4.5	3.2	6.0	1.1	6.9	6.3	68.5	114.1	4.7	664.4	93.4	0.4	3.5	15.3	20.1	44.3	19.2	0.0	4.1	1.7	219.5	0.8	49.2	68.8	0.0	94.2	28.2	110.9	445.0	294.8	1.3	440.8	9.5	14.3	18.4	142.0	0.9	6.4	801.6	69.2	13.6	15.1	1.2	350.1	4.9	3.9	2.4	0.6	6.5	151.4	0.9	3.2	55.2	11.0	9.6	5.0	2343.3
PLCB2	FLJ38135	ENSG00000137841	"Phospholipase C beta 2"	Q00722	15	40278176-40307935	"Enzymes, Predicted intracellular proteins"	"Lipid degradation, Lipid metabolism"	"Hydrolase, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 30.5;lymphoid tissue: 36.3"	"Group enriched"	"Detected in many"	4	"Alveolar cells type 2: 25.1;granulocytes: 25.5;Hofbauer cells: 26.0;Kupffer cells: 49.0;Macrophages: 28.1;T-cells: 15.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"HEL: 31.5;HMC-1: 39.3;THP-1: 11.4;U-937: 21.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"CAB009443, HPA041298, HPA068595, HPA069308"	Enhanced		Approved	"Plasma membrane,Cytosol"		NA	NA			"Plasma membrane, Cytosol"		"CAB009443: AB_632197, HPA041298: AB_2677395, HPA068595: , HPA069308: "	"unprognostic (5.52e-2)"	"unprognostic (4.96e-3)"	"unprognostic (6.09e-3)"	"unprognostic (1.88e-2)"	"unprognostic (1.31e-1)"	"prognostic favorable (3.00e-4)"	"unprognostic (1.66e-1)"	"unprognostic (3.08e-2)"	"unprognostic (1.28e-1)"	"unprognostic (2.34e-1)"	"unprognostic (1.42e-1)"	"unprognostic (2.75e-1)"	"prognostic unfavorable (7.20e-5)"	"unprognostic (9.89e-2)"	"unprognostic (2.06e-3)"	"unprognostic (5.81e-2)"	"unprognostic (1.13e-1)"	6.3	3.6	8.1	17.6	11.6	30.5	2.9	1.1	7.5	2.9	3.3	16.2	1.7	4.0	2.8	3.2	2.4	4.6	6.5	3.3	6.9	5.1	3.3	4.2	12.5	17.2	12.7	2.4	1.6	2.0	1.3	2.9	4.6	9.3	3.2	5.5	4.1	5.2	2.9	1.3	1.5	10.2	4.8	17.9	36.3	3.6	1.4	10.9	12.2	2.8	1.8	17.6	6.9	2.5	1.0	4.5	8.5	4.3	1.8	3.1	2.0	0.1	0.0	0.2	0.0	0.0	0.0	4.4	0.0	0.0	0.0	0.0	0.0	7.8	0.6	7.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	31.5	0.0	0.0	0.0	6.7	39.3	0.0	0.0	0.0	0.0	0.0	0.0	4.1	0.3	1.7	0.0	0.0	1.8	3.6	0.4	0.0	0.1	5.5	0.8	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	2.3	0.0	11.4	4.1	0.0	3.8	0.0	0.0	0.0	0.0	1.5	0.0	21.6	0.0	2.7	4.2	8.5	3.1	4.3	2.0	0.7	1.6	1.6	4.5	1.0	1.6	1.8	6.9	1.8	4.2	1.6	2.9	2.0	8.1	11.6	1.1	7.5	6.9	5.1	12.7	2.4	9.3	10.9	6.0	25.1	3.4	0.1	0.8	0.0	2.8	2.5	6.7	5.7	1.8	0.0	0.4	0.0	0.1	1.0	0.4	0.0	0.0	0.0	0.4	1.0	0.0	25.5	0.2	26.0	0.0	0.0	1.8	49.0	0.4	0.3	28.1	3.3	0.0	0.8	0.0	0.2	0.0	0.0	0.7	0.2	0.0	0.3	0.2	2.1	0.5	0.3	15.9	1.2	0.0
PLEK	P47	ENSG00000115956	Pleckstrin	P08567	2	68365173-68397453	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 80.4;bone marrow: 120.1;lymphoid tissue: 51.0"	"Group enriched"	"Detected in many"	5	"B-cells: 62.6;granulocytes: 59.1;Hofbauer cells: 195.0;Kupffer cells: 185.4;Macrophages: 211.6;monocytes: 179.5;T-cells: 116.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"HEL: 93.6;HL-60: 21.1;HMC-1: 35.8;NB-4: 31.4;THP-1: 36.6;U-266/84: 24.3;U-698: 24.9;U-937: 58.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA031838, HPA057341"	Enhanced		Approved	Nucleoli		NA	NA		970000000	Nucleoli		"HPA031838: AB_10602146, HPA057341: AB_2732609"	"unprognostic (2.57e-2)"	"unprognostic (5.18e-2)"	"unprognostic (1.87e-3)"	"unprognostic (4.52e-3)"	"unprognostic (3.52e-1)"	"unprognostic (3.08e-2)"	"unprognostic (4.67e-2)"	"unprognostic (3.40e-2)"	"unprognostic (4.00e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.22e-1)"	"prognostic unfavorable (1.95e-4)"	"unprognostic (3.57e-1)"	"unprognostic (4.42e-2)"	"unprognostic (2.03e-1)"	"unprognostic (1.56e-1)"	27.8	3.6	3.0	21.7	7.7	120.1	4.6	1.0	3.0	1.8	4.2	7.0	0.4	2.4	2.4	7.5	3.5	5.5	4.9	4.9	2.6	2.4	3.8	6.5	17.0	36.6	6.4	0.8	4.3	2.8	0.7	2.0	8.5	5.0	4.0	4.5	2.7	3.5	0.8	2.3	1.7	8.0	5.0	8.6	51.0	3.2	5.7	3.7	8.2	3.8	2.7	25.7	7.3	2.0	22.9	66.9	80.4	50.8	33.2	44.7	65.9	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	93.6	0.0	0.0	0.0	21.1	35.8	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	10.3	0.0	0.0	0.0	31.4	0.0	0.0	0.0	0.2	0.0	4.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	36.6	0.0	0.0	0.0	0.0	0.0	1.4	24.3	24.9	0.0	58.0	0.0	24.8	39.7	57.2	44.7	49.2	23.5	22.9	8.2	32.2	32.1	13.5	2.3	25.3	80.4	33.2	50.8	66.9	0.8	65.9	3.0	7.7	1.0	3.0	2.6	2.4	6.4	0.8	5.0	3.7	17.9	30.6	62.6	0.1	5.8	0.0	1.7	0.0	24.1	28.4	1.8	0.0	1.0	0.0	0.1	1.4	3.1	0.0	0.0	0.5	1.3	6.1	0.1	59.1	0.9	195.0	0.0	0.0	4.9	185.4	4.5	0.6	211.6	16.9	179.5	0.0	0.0	0.1	0.0	0.4	0.6	0.0	12.9	2.6	0.9	0.7	5.8	2.2	116.7	0.0	0.1
PLXDC2	"FLJ14623, TEM7R"	ENSG00000120594	"Plexin domain containing 2"	Q6UX71	10	19816239-20289856	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Hofbauer cells: 92.7;Ito cells: 94.5;Kupffer cells: 87.5;Macrophages: 96.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"classical monocyte: 21.2;intermediate monocyte: 12.6;myeloid DC: 13.3;neutrophil: 31.4;non-classical monocyte: 12.7"	"Group enriched"	"Detected in many"	14	"dendritic cells: 13.3;granulocytes: 31.4;monocytes: 21.2"	"Cell line enhanced"	"Detected in some"		"HHSteC: 12.7;U-2197: 29.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA017268, HPA070793"	Approved		Supported	"Nuclear bodies"		No	No		560000000	"Nuclear bodies"		"HPA017268: AB_10965928, HPA070793: AB_2686313"	"unprognostic (1.75e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.15e-1)"	"unprognostic (3.05e-1)"	"unprognostic (3.31e-2)"	"unprognostic (2.99e-1)"	"unprognostic (1.94e-2)"	"unprognostic (1.57e-1)"	"unprognostic (5.32e-2)"	"unprognostic (7.52e-2)"	"unprognostic (1.89e-1)"	"unprognostic (1.35e-1)"	"unprognostic (5.44e-2)"	"unprognostic (3.91e-3)"	"unprognostic (8.71e-2)"	"unprognostic (3.35e-1)"	"unprognostic (2.66e-2)"	31.7	13.1	15.9	8.2	20.6	5.5	25.5	3.8	12.4	14.5	9.1	17.9	11.5	4.9	14.2	9.2	11.1	11.5	20.4	14.5	16.8	8.3	12.9	3.9	21.9	5.4	26.1	9.6	11.3	4.2	17.0	5.6	5.5	16.7	10.3	5.7	8.7	9.8	9.7	6.1	21.1	8.0	18.0	27.7	10.5	6.0	7.8	22.7	0.4	10.5	12.3	3.6	11.9	17.7	0.0	13.3	31.4	21.2	1.5	1.1	5.4	0.0	0.0	3.4	0.0	0.0	0.0	4.5	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	5.0	1.4	1.1	0.0	0.0	0.5	1.8	5.4	0.3	12.7	0.0	0.0	4.3	0.3	0.0	1.5	5.6	0.0	0.0	0.1	1.2	0.6	0.7	0.3	0.1	2.2	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.2	0.1	1.4	0.2	0.0	1.2	0.5	0.6	0.0	5.0	2.7	29.9	0.0	0.0	0.0	0.0	2.3	0.0	0.0	3.0	21.2	4.1	0.5	12.6	1.1	0.0	0.0	0.1	13.3	0.0	0.0	0.0	31.4	1.5	12.7	0.6	0.0	5.4	15.9	20.6	3.8	12.4	16.8	8.3	26.1	9.6	16.7	22.7	14.9	9.9	11.0	20.8	32.6	32.3	8.5	20.4	4.0	13.6	5.2	7.9	1.0	0.0	5.5	2.0	30.8	6.6	0.0	0.0	7.7	34.8	7.3	30.1	2.5	92.7	1.6	2.9	94.5	87.5	0.7	17.8	96.7	6.8	34.3	22.7	23.8	1.1	15.8	53.7	21.6	65.0	19.4	3.9	1.4	0.9	33.2	1.0	3.2	7.1	13.2
PLXNC1	"CD232, VESPR"	ENSG00000136040	"Plexin C1"	O60486	12	94148723-94307675	"CD markers, Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 43.5;retina: 40.6"	"Cell type enhanced"	"Detected in many"	14	"Kupffer cells: 41.4;Macrophages: 32.1;Melanocytes: 91.1"	"Cancer enhanced"	"Detected in all"		"melanoma: 24.8"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 14.2"	"Group enriched"	"Detected in many"	4	"granulocytes: 14.2;monocytes: 6.7"	"Cell line enhanced"	"Detected in many"		"HAP1: 15.3;Karpas-707: 11.9;SK-MEL-30: 19.0;U-266/70: 30.1;U-266/84: 31.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA066899			Approved	Mitochondria		NA	NA		82000	Mitochondria		"HPA066899: AB_2685743"	"unprognostic (1.49e-1)"	"unprognostic (4.01e-2)"	"unprognostic (5.60e-2)"	"unprognostic (1.99e-1)"	"unprognostic (2.33e-1)"	"unprognostic (3.24e-2)"	"unprognostic (4.67e-3)"	"unprognostic (2.80e-2)"	"unprognostic (3.49e-1)"	"unprognostic (4.64e-2)"	"unprognostic (1.78e-2)"	"unprognostic (2.38e-1)"	"unprognostic (4.02e-2)"	"unprognostic (5.33e-3)"	"unprognostic (3.19e-2)"	"unprognostic (6.85e-3)"	"unprognostic (5.48e-2)"	6.6	7.5	7.1	16.1	6.9	12.6	3.9	16.8	8.6	8.0	5.1	3.1	0.8	3.1	7.3	2.2	4.9	4.3	8.3	4.1	6.3	15.2	3.2	2.0	15.2	43.5	4.5	7.7	13.0	2.3	0.5	6.3	7.5	5.2	4.3	5.4	40.6	3.7	3.7	2.9	6.6	5.0	5.7	4.9	28.6	3.4	12.1	3.3	8.6	3.3	2.7	10.2	9.6	6.5	2.4	2.5	14.2	6.7	0.9	1.7	1.5	0.4	0.2	1.2	0.2	0.7	0.5	0.1	0.6	0.8	0.8	2.4	4.1	0.0	9.8	0.0	0.9	0.7	0.0	15.3	0.6	0.5	6.8	0.3	0.5	0.2	2.7	8.5	2.0	3.4	8.4	0.0	0.9	0.4	1.0	0.0	0.9	0.2	11.9	0.2	0.1	0.4	1.0	2.5	0.1	0.5	1.6	0.4	5.3	0.0	0.7	1.0	0.7	0.1	0.1	19.0	3.1	0.0	1.6	0.3	0.2	1.1	0.1	0.3	30.1	31.3	0.6	0.1	5.3	0.6	0.0	3.0	12.2	1.4	5.2	1.6	2.4	1.6	1.7	2.5	1.4	1.4	1.5	14.2	0.9	6.7	0.9	1.0	1.5	7.1	6.9	16.8	8.6	6.3	15.2	4.5	7.7	5.2	3.3	3.0	3.7	11.2	0.2	5.5	2.1	3.7	2.5	4.0	0.0	0.0	0.0	0.1	1.7	0.2	6.7	1.8	0.2	0.0	0.5	0.1	2.6	0.2	16.1	0.8	19.6	0.0	19.0	9.8	41.4	5.9	1.4	32.1	91.1	19.8	1.6	0.0	0.4	0.0	3.2	3.1	0.6	6.5	1.4	1.5	1.2	1.4	0.1	3.2	1.0	0.1
PPT1	"CLN1, INCL, PPT"	ENSG00000131238	"Palmitoyl-protein thioesterase 1"	P50897	1	40071461-40097727	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Sensory transduction, Vision"	Hydrolase	"Disease mutation, Neurodegeneration, Neuronal ceroid lipofuscinosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	6	"Hofbauer cells: 247.2;Kupffer cells: 246.8;Macrophages: 282.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"SK-BR-3: 88.0;THP-1: 163.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA021546	Supported		Supported	"Golgi apparatus,Vesicles"	"Intracellular and membrane"	NA	NA		130000	"Golgi apparatus, Vesicles"		"HPA021546: AB_1855667"	"unprognostic (5.02e-2)"	"unprognostic (2.73e-1)"	"unprognostic (1.64e-1)"	"unprognostic (2.06e-3)"	"unprognostic (6.68e-2)"	"unprognostic (2.83e-2)"	"prognostic unfavorable (6.98e-8)"	"unprognostic (1.39e-1)"	"unprognostic (1.78e-1)"	"unprognostic (1.23e-1)"	"unprognostic (8.16e-2)"	"unprognostic (2.39e-1)"	"unprognostic (5.20e-3)"	"unprognostic (1.75e-1)"	"unprognostic (2.30e-1)"	"unprognostic (2.93e-2)"	"unprognostic (2.08e-2)"	33.3	27.1	37.6	31.0	41.5	33.3	39.7	35.2	41.0	30.3	21.0	31.5	17.2	12.9	31.3	19.4	18.5	20.7	23.2	18.1	32.7	35.8	29.4	18.4	47.3	48.5	35.3	29.1	24.7	17.4	30.4	21.2	25.9	34.6	28.0	26.0	26.3	22.1	23.6	8.3	13.8	16.6	36.5	33.6	61.3	17.9	13.8	29.1	19.8	18.7	14.4	30.0	23.0	19.8	9.3	77.4	59.9	90.0	7.2	19.1	91.6	10.3	7.0	11.3	6.3	13.6	11.6	22.1	5.8	10.4	13.9	17.2	40.1	17.3	11.8	11.3	6.0	11.5	18.1	17.5	10.3	19.1	14.8	18.0	6.2	17.2	19.8	15.4	13.8	14.9	10.9	11.3	11.1	10.3	7.8	18.7	10.1	14.3	17.1	7.8	20.6	7.9	10.3	21.2	15.8	10.8	8.9	15.2	20.5	9.7	18.4	9.0	9.6	11.3	88.0	35.0	11.1	12.7	163.5	6.6	6.8	14.6	6.3	17.1	15.4	32.3	11.3	8.7	33.8	12.3	6.2	90.0	48.2	9.9	77.6	11.8	9.3	14.7	11.5	77.4	9.2	19.1	14.7	59.9	7.2	58.3	7.6	16.8	91.6	37.6	41.5	35.2	41.0	32.7	35.8	35.3	29.1	34.6	29.1	26.8	50.8	34.5	72.3	35.1	45.4	13.0	38.2	38.8	47.8	36.6	15.7	48.8	5.0	52.1	40.9	45.0	3.0	23.3	36.9	52.5	46.0	47.6	82.1	8.3	247.2	23.8	19.1	48.5	246.8	54.3	29.1	282.7	64.1	155.1	8.2	108.8	23.0	7.0	37.1	15.4	24.1	19.4	53.3	13.7	37.9	23.8	34.4	40.8	10.3	29.4
PRAM1	PML-RAR	ENSG00000133246	"PML-RARA regulated adaptor molecule 1"	Q96QH2	19	8490056-8503112	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 30.8;bone marrow: 70.7;brain: 25.1"	"Group enriched"	"Detected in some"	8	"Hofbauer cells: 29.1;Kupffer cells: 73.2;Macrophages: 49.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	7	"classical monocyte: 23.6;intermediate monocyte: 28.1;myeloid DC: 16.1;neutrophil: 14.9;non-classical monocyte: 30.8"	"Group enriched"	"Detected in many"	7	"dendritic cells: 16.1;granulocytes: 14.9;monocytes: 30.8"	"Cell line enhanced"	"Detected in some"		"HL-60: 9.3;NB-4: 7.3;THP-1: 16.2;U-937: 51.8"					"Low region specificity"	"Detected in all"			"HPA045236, HPA050161"	Approved		Approved	"Golgi apparatus"		NA	NA			"Golgi apparatus"		"HPA045236: AB_2679267, HPA050161: AB_2681036"	"unprognostic (1.68e-2)"	"unprognostic (3.79e-3)"	"unprognostic (1.15e-2)"	"unprognostic (3.91e-3)"	"unprognostic (1.25e-1)"	"unprognostic (6.54e-3)"	"unprognostic (3.36e-1)"	"unprognostic (1.74e-3)"	"unprognostic (1.48e-2)"	"unprognostic (1.26e-1)"	"unprognostic (1.28e-2)"	"unprognostic (1.28e-1)"	"prognostic unfavorable (8.08e-4)"	"unprognostic (1.73e-1)"	"unprognostic (2.15e-3)"	"unprognostic (2.72e-1)"	"unprognostic (6.12e-3)"	4.0	1.5	7.1	9.2	15.5	70.7	1.3	2.7	8.3	2.7	1.2	14.4	0.0	3.0	1.7	1.2	1.4	2.3	2.4	1.5	6.8	3.7	1.3	2.4	12.3	10.2	10.9	3.5	1.7	1.5	1.2	2.1	1.6	10.1	3.7	1.3	1.5	1.5	1.2	1.2	1.9	3.1	2.5	25.1	12.8	1.7	1.3	12.0	1.8	2.0	0.0	1.2	2.3	1.4	0.0	16.1	14.9	30.8	3.1	0.1	8.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	9.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	7.3	0.1	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.2	0.1	0.0	0.0	0.0	0.0	0.3	0.3	0.1	0.0	51.8	0.0	0.8	23.6	0.8	0.0	28.1	0.1	0.0	0.0	0.0	16.1	0.0	0.0	0.1	14.9	3.1	30.8	0.9	0.0	8.9	7.1	15.5	2.7	8.3	6.8	3.7	10.9	3.5	10.1	12.0	6.0	5.3	0.9	0.9	0.3	2.7	0.6	2.5	0.0	5.7	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.4	2.3	0.0	29.1	1.6	0.0	3.1	73.2	0.0	0.6	49.9	0.0	0.0	0.0	0.6	0.0	0.0	1.4	0.1	1.4	0.0	0.0	0.2	1.3	0.1	0.2	0.0	0.0	0.7
PREX1	"KIAA1415, P-REX1"	ENSG00000124126	"Phosphatidylinositol-3,4,5-trisphosphate dependent Rac exchange factor 1"	Q8TCU6	20	48624252-48827883	"Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 32.7;brain: 35.5"	"Cell type enhanced"	"Detected in many"	11	"Kupffer cells: 81.5;Macrophages: 39.6;T-cells: 41.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"MCF7: 44.2;SK-BR-3: 46.4;T-47d: 41.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001927	Supported		Supported	Vesicles,Cytosol		NA	NA			"Vesicles, Cytosol"		"HPA001927: AB_1079674"	"unprognostic (8.07e-2)"	"unprognostic (3.16e-2)"	"unprognostic (2.15e-2)"	"unprognostic (2.55e-1)"	"unprognostic (7.47e-2)"	"prognostic favorable (8.56e-4)"	"unprognostic (2.16e-1)"	"unprognostic (1.85e-1)"	"unprognostic (1.31e-1)"	"unprognostic (5.21e-2)"	"unprognostic (1.13e-2)"	"unprognostic (2.70e-2)"	"unprognostic (5.86e-3)"	"unprognostic (6.84e-2)"	"unprognostic (2.31e-1)"	"unprognostic (1.50e-1)"	"unprognostic (1.01e-2)"	10.8	8.1	20.5	25.1	24.9	32.7	12.4	11.4	25.0	9.6	5.1	35.5	0.2	4.6	3.2	2.7	4.8	3.7	9.5	4.9	21.8	15.5	4.1	4.0	17.7	28.3	26.2	12.1	2.2	3.9	5.2	5.8	8.4	17.4	3.9	4.6	7.7	4.0	2.8	4.6	2.7	8.6	5.6	27.6	28.7	6.1	4.5	23.9	2.8	6.7	1.0	15.1	10.3	2.5	2.0	2.1	11.7	2.7	2.1	9.3	2.2	0.6	1.7	22.5	0.0	0.3	1.7	7.8	0.7	1.0	3.2	0.8	0.1	0.0	4.5	14.3	2.0	6.1	0.2	1.1	0.0	2.1	1.0	0.5	0.6	2.5	0.0	1.3	2.4	14.7	1.8	0.0	7.4	0.0	2.2	19.4	2.0	0.0	0.1	4.2	44.2	0.0	6.9	0.9	2.2	1.8	6.6	6.5	2.7	0.1	0.0	4.7	0.7	4.1	46.4	5.1	1.3	41.4	18.9	21.6	1.3	4.6	0.0	1.2	0.2	0.9	5.5	21.0	4.9	6.9	5.2	2.3	2.5	5.0	2.7	3.0	2.0	2.7	4.2	2.1	1.7	0.4	1.5	11.7	2.1	2.3	1.7	9.3	2.2	20.5	24.9	11.4	17.7	21.8	15.5	26.2	12.1	17.4	23.9	3.0	10.0	24.1	0.2	2.3	0.2	2.5	2.5	8.1	4.5	1.8	7.9	0.6	0.0	0.1	2.8	13.4	0.2	0.0	1.1	2.7	6.0	0.8	1.1	1.5	28.2	0.0	1.2	20.3	81.5	2.3	0.9	39.6	8.5	16.2	1.0	17.2	0.2	0.0	0.4	0.0	0.6	0.0	4.7	1.9	10.2	2.0	7.8	41.5	2.9	0.4
PSTPIP1	"CD2BP1, CD2BP1L, CD2BP1S, H-PIP, PAPAS, PSTPIP"	ENSG00000140368	"Proline-serine-threonine phosphatase interacting protein 1"	O43586	15	76993359-77037332	"Disease related genes, Predicted intracellular proteins"	"Cell adhesion, Endocytosis, Immunity, Inflammatory response, Innate immunity"		"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 34.2;bone marrow: 41.0;lymphoid tissue: 29.3"	"Cell type enhanced"	"Detected in many"	9	"Hofbauer cells: 36.9;Intestinal endocrine cells: 57.6;Kupffer cells: 54.2;Macrophages: 31.2;T-cells: 51.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"HDLM-2: 29.5;HL-60: 7.0;NB-4: 11.8;THP-1: 7.9;U-937: 31.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA010600	Enhanced					NA	NA					"HPA010600: AB_1855870"	"unprognostic (4.42e-3)"	"unprognostic (1.31e-3)"	"unprognostic (3.56e-2)"	"prognostic favorable (4.74e-5)"	"unprognostic (3.79e-2)"	"unprognostic (1.12e-3)"	"unprognostic (2.16e-2)"	"unprognostic (1.23e-2)"	"unprognostic (1.16e-1)"	"unprognostic (9.85e-2)"	"unprognostic (2.96e-2)"	"unprognostic (3.18e-1)"	"prognostic unfavorable (7.36e-9)"	"unprognostic (1.39e-1)"	"unprognostic (1.84e-1)"	"unprognostic (1.91e-1)"	"unprognostic (5.42e-2)"	6.0	1.9	1.7	29.3	1.7	41.0	2.7	0.4	0.9	2.4	3.8	0.6	0.1	2.0	3.6	4.1	3.3	2.2	7.2	3.8	2.0	1.4	2.8	2.2	10.6	28.1	1.8	0.0	1.8	1.2	0.4	1.1	2.3	1.0	2.5	0.9	2.1	7.6	2.6	2.3	1.2	6.6	1.9	2.4	24.5	2.5	2.3	0.9	15.7	2.1	2.4	18.6	2.8	2.0	6.4	23.0	34.2	27.9	15.4	17.3	14.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	29.5	0.0	0.0	0.0	1.8	0.0	7.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	1.3	11.8	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	2.1	0.4	0.0	0.0	0.0	0.0	0.0	7.9	0.0	0.0	0.0	0.0	0.0	0.0	0.6	1.3	0.0	31.9	0.0	1.8	27.9	26.7	17.3	12.7	13.3	5.5	11.6	14.2	23.0	6.4	6.4	9.9	34.2	15.4	13.0	1.9	10.3	14.8	1.7	1.7	0.4	0.9	2.0	1.4	1.8	0.0	1.0	0.9	0.0	9.0	17.1	1.0	8.2	0.0	1.6	0.0	0.0	4.5	0.0	0.0	0.3	0.0	0.0	8.3	0.7	0.3	0.0	0.2	0.6	1.1	0.1	2.3	0.8	36.9	0.0	57.6	1.8	54.2	13.7	0.9	31.2	6.8	15.4	3.4	0.2	0.1	0.8	2.5	0.1	0.4	0.0	1.6	0.2	1.2	4.3	0.5	51.7	0.2	0.8
PSTPIP2		ENSG00000152229	"Proline-serine-threonine phosphatase interacting protein 2"	Q9H939	18	45983536-46072272	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 38.1;bone marrow: 36.9;lymphoid tissue: 46.7"	"Cell type enhanced"	"Detected in many"	5	"granulocytes: 41.7;Kupffer cells: 40.3;Macrophages: 35.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"eosinophil: 38.1"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HEL: 37.7;HMC-1: 41.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040923, HPA040944"	Enhanced		Approved	"Nucleoplasm,Plasma membrane,Mitochondria"		No	No		7100000	"Plasma membrane, Mitochondria"	Nucleoplasm	"HPA040923: AB_10794429, HPA040944: AB_10795485"	"unprognostic (1.61e-1)"	"unprognostic (9.08e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.53e-2)"	"unprognostic (2.57e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.17e-2)"	"unprognostic (4.80e-3)"	"unprognostic (1.87e-1)"	"unprognostic (1.33e-1)"	"unprognostic (5.83e-2)"	"unprognostic (3.06e-1)"	"prognostic unfavorable (2.39e-7)"	"unprognostic (5.21e-2)"	"unprognostic (3.55e-1)"	"unprognostic (1.61e-1)"	"unprognostic (1.93e-1)"	4.6	3.3	1.8	6.1	3.1	36.9	4.9	0.6	2.1	3.4	3.4	0.9	2.7	2.0	2.7	2.8	4.4	2.9	4.4	4.0	4.5	1.2	3.3	8.6	7.4	11.5	3.4	0.4	3.1	3.9	2.2	3.9	11.6	3.5	5.8	3.0	3.5	4.5	8.8	16.6	5.9	3.1	4.1	4.6	46.7	4.3	1.9	3.2	3.0	1.8	6.5	5.6	4.6	3.0	0.0	8.9	38.1	12.4	0.9	3.9	6.3	1.0	0.0	1.4	0.0	0.3	2.6	7.9	5.6	2.8	2.0	1.7	4.3	1.5	0.0	0.3	1.8	0.0	13.7	7.7	10.6	2.5	0.0	1.2	37.7	1.9	0.0	2.3	2.2	41.9	1.9	13.2	1.9	6.3	1.8	4.0	0.0	9.0	0.0	8.8	1.3	0.3	0.0	0.9	0.0	0.0	0.0	2.9	1.8	4.2	13.8	0.1	0.8	0.9	3.9	0.1	11.4	12.4	4.4	2.9	0.2	3.2	0.3	0.0	0.0	0.1	0.0	0.5	0.0	0.1	20.7	9.0	38.1	3.9	12.4	1.3	0.0	2.3	2.8	8.9	0.0	2.8	3.3	4.9	0.9	11.9	0.3	1.4	6.3	1.8	3.1	0.6	2.1	4.5	1.2	3.4	0.4	3.5	3.2	11.9	15.2	6.9	15.7	12.2	0.6	2.8	2.5	2.7	13.6	0.0	0.0	21.1	3.3	8.8	1.9	2.2	0.4	0.0	3.3	2.5	3.8	21.9	41.7	16.3	12.6	0.0	1.2	10.4	40.3	5.0	2.6	35.6	6.8	6.4	2.6	9.5	20.5	0.0	2.1	2.9	0.2	6.5	6.2	0.5	1.1	8.9	7.3	12.5	2.2	17.0
PTGER4	EP4	ENSG00000171522	"Prostaglandin E receptor 4"	P35408	5	40679498-40693735	"FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pancreas: 57.2"	"Cell type enhanced"	"Detected in many"	6	"Basal keratinocytes: 54.4;Macrophages: 56.4;monocytes: 52.3;T-cells: 69.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 19.1;HUVEC TERT2: 13.5;LHCN-M2: 13.2;RT4: 19.2;THP-1: 12.8;TIME: 24.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"HPA011226, HPA012756"	Approved					NA	NA					"HPA011226: AB_1855885, HPA012756: AB_1855884"	"unprognostic (1.79e-2)"	"unprognostic (6.53e-3)"	"unprognostic (9.43e-3)"	"unprognostic (6.77e-3)"	"unprognostic (1.44e-1)"	"unprognostic (7.16e-2)"	"unprognostic (7.28e-3)"	"unprognostic (1.86e-2)"	"unprognostic (2.19e-1)"	"unprognostic (2.83e-1)"	"unprognostic (1.02e-1)"	"unprognostic (2.76e-1)"	"unprognostic (3.61e-2)"	"unprognostic (2.17e-1)"	"unprognostic (2.48e-2)"	"unprognostic (1.44e-1)"	"prognostic favorable (2.48e-4)"	10.3	5.1	1.4	12.8	1.2	34.7	6.9	0.4	0.8	8.5	24.8	1.7	1.1	9.4	4.8	2.8	6.0	6.1	14.5	9.0	1.1	1.3	8.4	3.7	16.5	16.6	2.2	0.1	4.3	57.2	0.3	1.6	2.3	2.1	7.0	7.9	4.1	3.6	1.0	7.4	4.0	28.7	6.6	4.5	18.2	8.9	2.1	1.2	23.3	3.3	5.7	9.5	11.6	6.2	1.3	5.4	9.3	15.6	2.5	11.4	4.1	1.6	0.3	0.0	0.0	8.2	9.8	0.0	0.1	0.6	0.5	0.3	0.0	0.5	0.2	0.1	0.0	8.6	1.2	0.1	3.0	0.8	19.1	0.4	0.0	0.6	0.0	7.5	7.0	1.4	1.0	0.5	4.9	2.0	1.1	13.5	6.8	0.0	4.6	13.2	0.0	7.0	3.2	0.0	0.3	2.9	4.8	1.3	0.6	1.8	19.2	0.0	0.0	0.3	0.6	0.0	0.3	3.0	12.8	24.3	2.6	0.0	0.0	0.6	0.0	0.1	0.9	1.1	5.3	0.6	3.5	4.5	9.3	11.4	12.8	6.6	1.3	6.9	7.1	5.4	1.3	4.2	6.1	8.7	2.5	15.6	0.8	5.5	4.1	1.4	1.2	0.4	0.8	1.1	1.3	2.2	0.1	2.1	1.2	11.9	13.6	11.5	5.6	54.4	0.0	3.6	0.0	8.1	7.9	7.0	0.0	0.2	0.0	0.9	2.4	8.6	18.8	0.0	6.7	0.6	8.2	9.2	9.3	0.2	30.8	0.0	12.5	3.7	32.1	1.1	0.9	56.4	18.6	52.3	35.0	0.0	2.8	23.2	0.4	0.0	0.2	0.0	10.6	3.6	1.3	26.6	0.2	69.2	16.6	0.8
PTPN22	"Lyp, Lyp1, Lyp2, PTPN8"	ENSG00000134242	"Protein tyrosine phosphatase, non-receptor type 22"	Q9Y2R2	1	113813811-113871759	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Autophagy, Immunity"	"Hydrolase, Protein phosphatase"	"Diabetes mellitus, Disease mutation, Systemic lupus erythematosus"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 23.6;lymphoid tissue: 46.0"	"Cell type enhanced"	"Detected in many"	15	"B-cells: 29.6;granulocytes: 26.6;Kupffer cells: 19.2;Macrophages: 20.5;T-cells: 65.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Daudi: 33.5;HL-60: 13.3;U-266/70: 14.4;U-698: 18.0;U-937: 13.6"	"Region enriched"	"Detected in single"	10	"cerebellum: 5.9"	"Not detected"	"Not detected"			"HPA004912, CAB012209, HPA013350"	Approved		Uncertain	"Nucleoplasm,Vesicles,Plasma membrane"		NA	NA			Nucleoplasm	"Vesicles, Plasma membrane"	"CAB012209: , HPA004912: AB_10602069, HPA013350: AB_10601570"	"unprognostic (2.25e-2)"	"unprognostic (5.31e-3)"	"unprognostic (3.48e-1)"	"unprognostic (3.33e-4)"	"unprognostic (9.14e-2)"	"unprognostic (2.47e-3)"	"unprognostic (9.60e-2)"	"unprognostic (8.14e-2)"	"unprognostic (3.71e-1)"	"unprognostic (1.82e-1)"	"unprognostic (1.62e-1)"	"unprognostic (3.02e-1)"	"unprognostic (2.75e-6)"	"unprognostic (3.19e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.61e-1)"	"unprognostic (3.22e-2)"	4.2	1.4	0.5	17.1	0.8	23.6	1.9	1.0	0.5	2.4	3.3	0.3	1.0	4.1	2.0	2.2	2.0	1.7	3.2	2.5	0.6	0.7	3.4	1.8	9.0	14.9	0.7	0.4	1.5	2.4	0.0	0.9	0.9	1.0	1.7	2.8	1.3	2.7	3.0	0.6	1.0	9.9	0.9	2.1	19.0	3.1	1.1	0.4	46.0	1.5	2.4	12.8	4.8	1.7	7.2	6.2	17.2	3.5	7.5	14.9	4.6	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.4	0.2	0.0	0.3	0.0	0.2	33.5	0.0	0.1	0.0	0.0	0.0	0.0	0.2	3.1	0.0	4.7	0.0	0.0	0.1	13.3	10.5	3.0	0.0	1.4	0.1	2.7	5.2	8.4	0.0	7.7	5.1	0.1	9.4	7.5	0.0	0.0	0.0	0.5	3.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	4.8	2.4	8.0	0.1	0.1	0.2	14.4	3.0	18.0	5.5	13.6	0.0	10.2	3.5	17.2	12.8	0.9	14.9	7.2	6.5	10.1	6.2	4.7	3.9	9.4	1.7	7.5	0.4	3.7	10.0	4.6	0.5	0.8	1.0	0.5	0.6	0.7	0.7	0.4	1.0	0.4	0.0	9.2	29.6	0.2	2.3	0.4	0.5	0.0	4.0	0.0	1.8	2.0	0.0	0.0	0.0	0.3	0.0	2.3	0.0	0.5	0.2	0.9	0.2	26.6	0.6	7.1	0.0	0.0	0.6	19.2	0.6	0.0	20.5	3.3	1.8	1.0	0.0	0.6	0.0	0.0	0.0	0.4	12.9	0.9	0.3	0.2	2.4	0.1	65.4	1.7	0.2
PTPN6	"HCP, HCPH, PTP-1C, SHP-1, SHP1"	ENSG00000111679	"Protein tyrosine phosphatase, non-receptor type 6"	P29350	12	6946468-6961316	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 107.1;lymphoid tissue: 69.0"	"Group enriched"	"Detected in many"	5	"B-cells: 106.2;Early spermatids: 45.6;granulocytes: 130.8;Hofbauer cells: 168.2;Kupffer cells: 145.1;Macrophages: 118.2;T-cells: 105.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HEL: 28.7;HL-60: 25.5;HMC-1: 112.6;THP-1: 43.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA001466, CAB004572, CAB072845"	Enhanced		Supported	Nucleoplasm,Nucleoli		NA	NA		7400000	Nucleoplasm	Nucleoli	"CAB004572: AB_628251, CAB072845: , HPA001466: AB_1855930"	"unprognostic (4.28e-3)"	"prognostic favorable (1.87e-4)"	"prognostic unfavorable (5.42e-4)"	"prognostic favorable (6.65e-4)"	"unprognostic (6.54e-2)"	"unprognostic (7.92e-2)"	"unprognostic (2.36e-1)"	"unprognostic (1.44e-2)"	"unprognostic (6.93e-3)"	"unprognostic (3.57e-1)"	"unprognostic (1.41e-2)"	"unprognostic (2.61e-1)"	"unprognostic (1.60e-3)"	"unprognostic (1.98e-3)"	"unprognostic (2.60e-2)"	"unprognostic (5.91e-2)"	"prognostic favorable (2.64e-8)"	6.6	8.8	2.4	42.9	4.4	27.7	4.6	1.2	2.7	2.8	7.0	5.1	4.7	7.5	3.7	8.8	7.0	5.0	9.8	2.9	3.1	2.3	7.0	6.8	25.4	58.1	5.2	1.8	2.3	6.7	2.7	5.6	7.7	3.9	5.6	5.2	3.6	10.6	7.0	1.3	6.1	21.0	2.6	4.9	69.0	6.6	1.5	3.3	31.4	6.3	4.1	50.7	8.5	4.2	63.9	38.0	107.1	103.2	22.2	28.2	63.2	2.9	5.6	0.0	0.0	0.0	0.0	5.3	0.0	0.0	0.0	0.0	3.0	6.6	2.0	1.5	0.0	0.0	3.4	0.0	3.9	0.0	1.2	1.2	28.7	0.6	2.4	0.0	25.5	112.6	0.0	2.8	0.0	1.2	0.0	0.0	10.3	0.0	0.2	0.0	6.1	9.2	14.9	1.5	6.8	0.9	8.4	0.0	14.5	3.1	5.5	0.5	0.0	0.9	4.6	0.0	4.1	1.4	43.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	11.2	0.1	54.4	35.9	107.1	28.2	71.3	18.2	62.3	13.7	21.0	38.0	63.9	15.8	19.9	66.7	22.2	103.2	10.0	14.4	63.2	2.4	4.4	1.2	2.7	3.1	2.3	5.2	1.8	3.9	3.3	6.0	18.1	106.2	8.1	8.0	0.0	1.6	12.7	12.0	11.4	5.2	0.0	21.7	13.3	12.3	45.6	4.1	15.8	23.3	13.5	15.5	3.5	4.1	130.8	10.2	168.2	0.0	23.7	9.8	145.1	8.7	0.9	118.2	13.5	6.4	12.0	0.4	11.8	17.3	0.0	10.5	0.6	6.5	2.3	0.3	1.1	7.5	15.4	105.5	15.6	5.6
PTPRE	PTPE	ENSG00000132334	"Protein tyrosine phosphatase, receptor type E"	P23469	10	127907061-128085855	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 91.0"	"Cell type enhanced"	"Detected in many"	10	"Kupffer cells: 141.1;Macrophages: 249.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 91.0;plasmacytoid DC: 65.7"	"Group enriched"	"Detected in all"	11	"dendritic cells: 65.7;granulocytes: 91.0;monocytes: 25.5"	"Cell line enhanced"	"Detected in many"		"hTERT-RPE1: 18.8;HUVEC TERT2: 19.8;NB-4: 14.9;TIME: 37.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015870, HPA021872"	Supported		Approved	"Intermediate filaments"		NA	NA			"Intermediate filaments"		"HPA015870: AB_1855759, HPA021872: AB_1855760"	"unprognostic (5.23e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.99e-1)"	"unprognostic (7.11e-2)"	"unprognostic (3.19e-1)"	"unprognostic (9.67e-2)"	"unprognostic (6.50e-2)"	"unprognostic (4.49e-2)"	"unprognostic (2.11e-1)"	"unprognostic (2.56e-2)"	"unprognostic (8.71e-3)"	"unprognostic (2.00e-1)"	"prognostic unfavorable (4.08e-5)"	"unprognostic (1.52e-1)"	"unprognostic (6.71e-3)"	"unprognostic (2.49e-2)"	"unprognostic (5.59e-2)"	16.8	18.5	12.5	24.0	12.5	39.5	11.0	7.4	15.3	4.8	9.2	14.5	1.6	9.6	5.1	8.1	8.8	6.2	10.7	12.3	15.0	12.2	4.4	4.8	22.5	20.0	12.5	6.5	4.3	3.1	3.4	6.5	8.0	9.8	4.5	9.8	4.8	7.0	3.1	1.9	4.9	12.7	7.7	14.3	26.4	7.7	4.3	10.9	11.4	6.6	6.1	12.2	10.0	5.0	1.2	65.7	91.0	25.5	4.0	5.4	4.9	1.9	0.4	0.2	0.0	1.2	0.2	3.6	0.0	0.0	0.8	1.7	0.8	12.0	1.5	1.3	1.0	2.6	1.1	1.0	5.7	0.3	1.8	0.9	0.1	0.7	0.0	2.0	7.4	5.6	0.4	3.3	2.9	5.9	18.8	19.8	4.9	0.0	0.9	1.2	1.8	2.2	14.9	0.1	2.1	0.7	8.8	1.2	2.9	3.3	8.5	0.0	1.2	3.4	0.6	0.1	0.9	0.3	9.4	37.4	0.8	0.8	3.7	4.1	0.4	0.6	2.1	5.5	5.8	0.0	17.4	25.5	19.3	5.4	9.0	3.2	0.9	2.4	3.6	13.3	1.2	1.7	2.9	91.0	4.0	6.8	65.7	3.5	4.9	12.5	12.5	7.4	12.7	15.0	12.2	12.5	6.5	9.8	10.9	77.4	67.6	24.7	47.2	52.9	2.6	15.1	5.1	9.4	33.0	3.5	0.0	33.6	0.0	4.3	1.6	49.4	12.3	0.0	4.0	40.5	9.9	8.3	30.1	1.3	53.6	0.0	6.4	46.1	141.1	1.7	0.6	249.1	23.6	4.6	14.4	0.0	28.7	11.5	0.4	1.9	0.8	0.0	8.1	0.5	1.4	56.6	14.2	52.4	10.2	34.4
PTX3	"TNFAIP5, TSG-14"	ENSG00000163661	"Pentraxin 3"	P26022	3	157436789-157443628	"Plasma proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 61.7;skeletal muscle: 67.7;urinary bladder: 77.0"	"Cell type enhanced"	"Detected in some"	10	"Ductal cells: 6.0;Fibroblasts: 10.1;Macrophages: 5.9;Melanocytes: 13.5"	"Cancer enhanced"	"Detected in many"		"glioma: 22.5"	"Group enriched"	"Detected in some"	6	"hippocampal formation: 1.1;pons and medulla: 3.6"	"Cell type enhanced"	"Detected in some"		"eosinophil: 3.2"	"Group enriched"	"Detected in many"	20	"dendritic cells: 1.3;granulocytes: 3.2;monocytes: 1.2"	"Cell line enhanced"	"Detected in many"		"ASC diff: 86.4;ASC TERT1: 125.2;BJ hTERT+: 82.2;HHSteC: 160.8;HSkMC: 167.5;hTEC/SVTERT24-B: 88.5;TIME: 119.2;U-2197: 111.1"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in single"			HPA069320	Approved		Approved	"Plasma membrane"	"Secreted to blood"	NA	NA	1090000	310000	"Plasma membrane"		"HPA069320: AB_2686118"	"unprognostic (1.93e-2)"	"unprognostic (4.96e-3)"	"unprognostic (1.35e-1)"	"prognostic unfavorable (8.35e-9)"	"unprognostic (5.79e-3)"	"prognostic unfavorable (6.36e-4)"	"unprognostic (6.03e-3)"	"prognostic unfavorable (8.75e-6)"	"unprognostic (2.45e-1)"	"unprognostic (6.69e-2)"	"unprognostic (7.60e-2)"	"unprognostic (2.63e-1)"	"unprognostic (2.76e-9)"	"unprognostic (6.03e-3)"	"unprognostic (5.98e-2)"	"unprognostic (2.15e-4)"	"unprognostic (1.92e-3)"	61.7	3.4	0.3	16.7	0.2	31.6	35.3	0.2	0.7	0.8	13.2	0.3	0.6	0.5	0.5	0.8	2.0	6.5	3.5	14.7	1.1	0.0	3.0	0.6	22.5	7.0	0.3	0.1	6.8	18.0	0.3	1.0	4.9	3.6	2.5	1.2	5.2	1.8	0.4	67.7	6.0	1.9	6.4	0.9	9.6	4.9	0.9	0.2	0.3	2.7	0.4	0.4	77.0	2.5	0.0	1.3	3.2	1.2	0.0	0.0	0.1	0.0	0.0	52.1	0.0	86.4	125.2	0.0	9.0	82.2	3.9	4.2	0.0	0.5	0.0	32.1	10.6	6.1	0.0	0.0	0.0	7.7	0.0	0.0	0.1	0.0	0.0	160.8	0.1	0.0	167.5	0.0	88.5	30.1	7.7	18.2	0.0	0.0	0.0	26.0	0.0	0.0	0.1	0.7	0.0	0.3	0.0	0.0	0.0	0.3	3.5	0.4	0.0	0.5	0.0	0.0	0.0	0.0	0.1	119.2	17.7	0.8	111.1	1.5	0.0	0.0	0.0	3.7	0.4	5.0	0.0	1.2	3.2	0.0	1.2	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.1	0.3	0.2	0.2	0.2	1.1	0.0	0.3	0.1	3.6	0.2	0.0	1.7	0.0	1.1	1.4	0.8	0.4	0.0	0.0	2.3	0.0	0.0	0.1	0.0	6.0	1.9	2.0	0.0	0.0	0.0	0.0	10.1	0.4	0.0	0.0	2.6	0.0	0.0	3.1	4.6	0.8	0.3	5.9	13.5	0.0	0.0	0.5	0.4	0.0	0.0	0.0	0.4	0.0	4.2	0.0	0.4	0.9	0.2	0.0	0.0	0.1
PYCARD	"ASC, CARD5, TMS-1"	ENSG00000103490	"PYD and CARD domain containing"	Q9ULZ3	16	31201485-31203450	"Predicted intracellular proteins"	"Apoptosis, Immunity, Inflammatory response, Innate immunity"		"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 130.8"	"Cell type enhanced"	"Detected in many"	7	"Enterocytes: 312.0;Hofbauer cells: 375.8;Kupffer cells: 516.6;Macrophages: 364.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"basophil: 37.8;classical monocyte: 90.4;eosinophil: 71.4;intermediate monocyte: 87.5;myeloid DC: 66.8;neutrophil: 130.8;non-classical monocyte: 85.0;plasmacytoid DC: 61.0"	"Group enriched"	"Detected in all"	6	"dendritic cells: 66.8;granulocytes: 130.8;monocytes: 90.4"	"Cell line enhanced"	"Detected in many"		"MCF7: 34.5;NB-4: 54.4;THP-1: 40.1;U-937: 24.9"									"CAB006853, CAB015948, HPA049074, HPA054496"	Enhanced		Supported	Nucleoplasm,Nucleoli,Cytosol		NA	NA		1100000	Nucleoplasm	"Nucleoli, Cytosol"	"CAB006853: , CAB015948: , HPA049074: AB_2680621, HPA054496: AB_2682506"	"unprognostic (1.00e-3)"	"unprognostic (2.62e-2)"	"unprognostic (2.40e-1)"	"unprognostic (4.67e-3)"	"unprognostic (3.34e-1)"	"unprognostic (1.87e-1)"	"unprognostic (5.29e-2)"	"unprognostic (2.88e-2)"	"unprognostic (3.12e-1)"	"unprognostic (2.33e-1)"	"unprognostic (6.52e-3)"	"unprognostic (3.88e-2)"	"prognostic unfavorable (6.09e-7)"	"unprognostic (4.45e-3)"	"unprognostic (2.51e-1)"	"unprognostic (3.61e-2)"	"unprognostic (6.97e-2)"	11.6	4.4	3.6	16.7	4.6	22.4	8.6	3.6	3.3	8.2	26.8	6.8	4.1	38.7	5.4	7.9	20.7	6.8	8.5	6.6	2.4	2.6	5.6	6.8	15.0	32.8	6.4	1.8	6.6	6.1	1.3	3.2	6.6	4.0	9.7	4.4	4.7	9.6	5.6	3.5	31.2	29.9	3.5	6.4	34.1	13.3	3.7	3.3	20.6	5.5	22.3	26.3	7.9	11.8	17.1	66.8	130.8	90.4	16.0	16.0	53.1	5.7	13.5	0.1	0.0	1.3	3.0	0.1	2.8	4.0	1.8	1.2	0.0	7.2	2.4	0.0	2.7	0.0	16.0	0.7	10.7	0.0	17.3	0.0	2.2	1.6	4.4	4.6	20.1	16.0	4.0	5.6	0.8	0.1	0.0	3.9	0.0	9.9	3.7	0.5	34.5	0.0	54.4	3.7	2.3	0.0	17.5	0.0	7.6	0.1	5.6	0.1	0.0	2.4	0.0	2.7	0.0	3.3	40.1	2.6	0.1	0.2	2.4	0.0	0.1	0.0	0.0	1.4	24.9	0.0	37.8	90.4	71.4	15.1	87.5	9.5	17.1	12.7	15.5	66.8	15.2	8.9	12.3	130.8	16.0	85.0	61.0	16.0	53.1	3.6	4.6	3.6	3.3	2.4	2.6	6.4	1.8	4.0	3.3	20.8	28.2	73.7	67.5	65.8	0.1	2.8	28.1	36.1	29.6	24.4	0.0	46.3	5.0	83.5	0.3	38.6	312.0	23.3	50.3	8.9	26.7	26.8	108.5	3.0	375.8	0.0	56.6	41.7	516.6	1.5	43.7	364.0	92.8	16.2	110.6	0.0	56.2	271.9	21.2	1.4	0.6	25.8	23.3	0.3	1.1	143.2	14.9	75.0	247.3	42.2
RAB31	Rab22B	ENSG00000168461	"RAB31, member RAS oncogene family"	Q13636	18	9708165-9862551	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Alveolar cells type 1: 163.8;Kupffer cells: 229.6;Macrophages: 199.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"basophil: 36.9"	"Group enriched"	"Detected in many"	7	"dendritic cells: 13.7;granulocytes: 36.9;monocytes: 16.5"	"Cell line enhanced"	"Detected in many"		"GAMG: 43.4;HHSteC: 40.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA019717	Approved					NA	NA					"HPA019717: AB_10601493"	"unprognostic (4.61e-2)"	"unprognostic (1.65e-2)"	"unprognostic (8.53e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.23e-2)"	"unprognostic (5.70e-2)"	"unprognostic (3.07e-2)"	"unprognostic (5.99e-2)"	"unprognostic (4.42e-2)"	"unprognostic (3.42e-2)"	"unprognostic (1.71e-2)"	"unprognostic (1.75e-1)"	"unprognostic (6.26e-2)"	"unprognostic (3.98e-3)"	"unprognostic (8.71e-3)"	"unprognostic (1.61e-1)"	"unprognostic (6.34e-2)"	17.5	52.5	35.1	19.9	33.2	25.6	11.5	10.1	53.9	45.2	16.7	19.8	6.2	5.7	28.7	11.3	16.1	11.6	22.7	9.9	27.1	24.3	7.6	5.4	28.1	17.5	31.0	17.8	22.6	3.8	2.3	4.2	27.1	25.0	10.2	9.2	8.0	5.9	25.0	3.4	5.2	8.7	41.5	39.2	16.0	15.1	20.4	23.0	2.6	12.5	7.2	10.9	25.0	15.1	3.1	13.7	36.9	16.5	1.3	0.0	5.3	0.6	3.4	25.9	0.0	34.5	17.9	18.5	6.1	17.3	4.5	3.9	0.9	3.5	0.0	4.2	23.9	43.4	2.4	6.3	7.8	5.2	1.5	3.7	21.3	26.7	0.4	40.0	1.7	23.5	19.3	1.6	10.3	8.1	19.4	11.5	0.0	5.2	0.1	10.3	2.8	0.0	2.7	5.5	0.2	1.6	0.0	2.8	0.8	3.4	0.0	0.5	1.7	23.3	14.9	8.2	22.6	1.6	11.5	12.6	28.2	14.3	19.3	9.0	4.8	1.3	0.0	38.3	0.0	11.4	36.9	16.5	6.2	0.0	14.2	0.0	3.1	0.0	0.0	13.7	1.7	0.0	0.0	23.1	1.3	14.5	1.6	0.0	5.3	35.1	33.2	10.1	25.1	27.1	24.3	31.0	17.8	25.0	23.0	163.8	29.5	12.3	11.5	14.1	3.7	9.2	12.7	45.5	72.8	10.4	0.0	152.5	6.6	6.2	5.1	32.2	0.0	0.0	17.5	10.3	56.4	11.3	7.0	2.4	142.0	143.0	0.0	29.4	229.6	7.3	16.4	199.5	6.8	111.0	0.0	12.0	14.2	0.9	110.3	1.9	3.6	38.8	101.9	0.9	0.9	14.1	156.1	3.2	0.1	30.2
RAB39A	RAB39	ENSG00000179331	"RAB39A, member RAS oncogene family"	Q14964	11	107928503-107963482	"Predicted intracellular proteins"	"Autophagy, Protein transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 16.3;pituitary gland: 10.0"	"Cell type enhanced"	"Detected in some"	8	"Cone photoreceptor cells: 3.9;Hofbauer cells: 3.2;Kupffer cells: 4.3;Macrophages: 2.6;Spermatocytes: 3.4;Spermatogonia: 3.0"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	7	"classical monocyte: 3.3;intermediate monocyte: 5.0;memory B-cell: 1.4;myeloid DC: 2.4;naive B-cell: 1.3;non-classical monocyte: 3.5"	"Group enriched"	"Detected in many"	7	"B-cells: 1.4;dendritic cells: 2.4;monocytes: 5.0"	"Cell line enhanced"	"Detected in some"		"GAMG: 9.2;NTERA-2: 6.7;RPMI-8226: 11.9;SCLC-21H: 22.0;SH-SY5Y: 13.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042505	Uncertain					NA	NA					"HPA042505: AB_2678030"	"unprognostic (1.45e-1)"	"unprognostic (1.48e-2)"	"unprognostic (1.83e-1)"	"unprognostic (3.40e-2)"	"unprognostic (4.99e-1)"	"unprognostic (4.30e-2)"	"unprognostic (4.26e-3)"	"unprognostic (1.20e-1)"	"unprognostic (5.55e-2)"	"unprognostic (7.36e-2)"	"unprognostic (4.22e-3)"	"unprognostic (2.24e-2)"	"unprognostic (1.41e-3)"	"unprognostic (1.11e-1)"	"unprognostic (1.36e-1)"	"unprognostic (5.02e-2)"	"unprognostic (2.43e-1)"	2.3	2.8	5.3	7.3	5.1	1.7	1.2	16.3	11.0	1.0	1.6	4.1	0.0	1.5	0.8	0.5	1.0	1.3	2.3	1.1	5.9	5.2	1.7	1.9	2.5	5.0	3.7	3.0	0.9	1.1	0.5	10.0	3.4	10.2	1.0	2.3	0.9	1.3	0.6	0.8	1.0	2.1	2.0	4.1	7.3	1.8	2.3	4.9	3.3	1.0	0.0	3.7	3.5	0.9	1.4	2.4	0.4	5.0	0.1	0.2	0.9	0.0	1.4	5.7	0.1	0.0	0.0	0.7	0.0	0.0	0.6	0.5	0.0	0.0	0.3	0.1	0.0	9.2	0.0	5.7	0.0	0.1	0.0	0.7	0.0	0.1	0.0	0.0	0.3	5.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	6.7	0.0	0.2	0.0	3.1	11.9	0.0	0.0	22.0	13.6	0.0	0.0	0.3	1.4	0.3	2.3	0.0	0.1	1.6	0.0	1.0	0.1	3.1	0.0	0.3	1.3	3.2	0.2	3.3	0.1	0.1	5.0	0.1	1.4	0.1	0.0	2.4	1.3	0.2	0.2	0.4	0.1	3.5	0.3	0.0	0.9	5.3	5.1	16.3	7.1	5.9	5.2	3.7	3.0	10.2	4.9	0.0	0.6	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	3.9	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	3.2	0.0	1.7	0.0	4.3	0.0	0.0	2.6	0.0	1.0	0.0	0.0	0.1	0.0	0.0	0.5	0.2	0.0	0.0	3.4	3.0	0.1	0.0	0.0	0.0	0.0
RASGRP4		ENSG00000171777	"RAS guanyl releasing protein 4"	Q8TDF6	19	38409051-38426305	"Predicted intracellular proteins, RAS pathway related proteins"	Differentiation	"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 22.4;bone marrow: 23.3;lymphoid tissue: 23.1"	"Group enriched"	"Detected in some"	8	"Cardiomyocytes: 10.9;granulocytes: 26.5;Hofbauer cells: 12.0;Kupffer cells: 34.4;Macrophages: 11.0"	"Cancer enhanced"	"Detected in many"		"testis cancer: 3.2"	"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"neutrophil: 22.4"	"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in some"	5	"HEL: 19.4;HMC-1: 19.4;U-937: 5.0"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			HPA041929			Supported	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Nucleoplasm, Cytosol"	"Plasma membrane"	"HPA041929: AB_10961405"	"unprognostic (1.22e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.58e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.39e-2)"	"unprognostic (1.39e-2)"	"unprognostic (2.10e-1)"	"unprognostic (2.00e-1)"	"unprognostic (5.23e-4)"	"unprognostic (6.54e-2)"	"unprognostic (1.27e-1)"	"unprognostic (2.30e-3)"	"unprognostic (2.19e-2)"	"unprognostic (1.05e-1)"	"unprognostic (4.56e-1)"	"unprognostic (2.66e-2)"	4.5	1.8	2.4	8.0	3.3	23.3	5.4	0.7	1.8	1.8	1.7	2.8	0.1	1.4	1.6	2.9	1.6	2.6	3.4	6.2	2.0	1.3	1.5	1.8	11.8	23.1	3.4	0.2	1.1	1.6	0.5	0.9	3.0	1.8	1.7	1.2	1.7	1.6	0.8	1.5	1.4	2.4	2.7	4.2	19.2	1.9	0.8	2.4	0.5	1.0	0.2	1.0	2.6	3.1	0.1	5.2	22.4	9.5	0.0	0.7	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	19.4	0.0	0.0	0.0	0.1	19.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.0	0.0	6.0	7.1	10.6	0.0	8.5	0.0	0.0	0.2	0.0	5.2	0.1	0.0	0.0	22.4	0.0	9.5	0.4	0.7	2.1	2.4	3.3	0.7	1.8	2.0	1.3	3.4	0.2	1.8	2.4	0.0	1.1	0.0	0.0	0.7	0.0	10.9	0.0	0.0	2.3	0.0	0.0	0.2	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.1	0.2	0.0	26.5	0.0	12.0	0.0	0.0	1.8	34.4	0.0	0.0	11.0	1.7	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.2	0.5	0.0	0.1
RETN	"ADSF, FIZZ3, RETN1"	ENSG00000104918	Resistin	Q9HD89	19	7669044-7670454	"Candidate cardiovascular disease genes, Plasma proteins, Predicted secreted proteins"		Hormone	"Diabetes mellitus, Obesity"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 45.5;bone marrow: 79.5;lymphoid tissue: 27.6"	"Group enriched"	"Detected in some"	6	"Hofbauer cells: 97.8;Kupffer cells: 67.2;Macrophages: 72.2"	"Cancer enhanced"	"Detected in many"		"pancreatic cancer: 4.8"	"Low region specificity"	"Detected in single"			"Cell type enhanced"	"Detected in many"		"classical monocyte: 45.5;myeloid DC: 30.3"	"Group enriched"	"Detected in many"	11	"dendritic cells: 30.3;monocytes: 45.5"	"Group enriched"	"Detected in some"	11	"NB-4: 102.5;U-937: 47.9"	"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"								"Secreted to blood"	NA	NA	5120000	350000				"unprognostic (5.61e-2)"	"unprognostic (6.20e-3)"	"unprognostic (1.32e-2)"	"unprognostic (3.04e-1)"	"unprognostic (5.19e-4)"	"unprognostic (1.53e-4)"	"unprognostic (7.34e-2)"	"unprognostic (3.35e-2)"	"unprognostic (9.30e-2)"	"unprognostic (1.35e-2)"	"unprognostic (1.20e-1)"	"unprognostic (4.02e-1)"	"unprognostic (7.16e-5)"	"unprognostic (4.23e-2)"	"unprognostic (2.26e-1)"	"unprognostic (8.91e-2)"	"unprognostic (1.20e-1)"	1.3	0.4	0.0	1.9	0.6	79.5	0.6	0.4	0.9	0.1	0.2	0.1	0.7	2.3	0.3	0.1	0.2	1.3	0.2	21.9	0.0	0.0	0.9	1.6	17.3	7.5	1.3	0.0	0.8	1.6	0.1	0.4	1.1	0.2	0.2	0.1	0.7	0.7	0.1	0.6	0.2	0.3	1.5	0.4	27.6	0.4	0.4	0.5	2.7	0.8	0.0	0.4	0.2	2.3	0.0	30.3	3.4	45.5	0.0	2.4	14.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.8	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.3	102.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	47.9	0.0	0.0	45.5	0.0	0.1	21.7	0.3	0.0	0.5	0.4	30.3	0.0	1.1	2.4	3.4	0.0	11.1	1.2	0.0	14.0	0.0	0.6	0.4	0.9	0.0	0.0	1.3	0.0	0.2	0.5	11.9	13.5	2.7	0.0	0.2	0.0	0.0	0.0	2.7	7.9	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.2	0.0	3.5	0.0	97.8	0.0	0.0	0.6	67.2	0.0	0.0	72.2	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.9	0.0	0.0	0.0
RGS1	"1R20, BL34, IER1, IR20"	ENSG00000090104	"Regulator of G protein signaling 1"	Q08116	1	192575727-192580031	"Predicted intracellular proteins"		"GTPase activation, Signal transduction inhibitor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 124.8"	"Cell type enhanced"	"Detected in many"	16	"granulocytes: 1329.7;Hofbauer cells: 403.4;Macrophages: 726.1;monocytes: 582.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"eosinophil: 16.7;T-reg: 14.5"	"Group enriched"	"Detected in many"	5	"granulocytes: 16.7;T-cells: 14.5"	"Cell line enriched"	"Detected in some"	4	"U-266/70: 145.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA074572	Approved					NA	NA					"HPA074572: "	"unprognostic (3.68e-3)"	"unprognostic (1.14e-3)"	"unprognostic (3.17e-1)"	"unprognostic (1.76e-1)"	"unprognostic (4.37e-1)"	"unprognostic (3.87e-3)"	"unprognostic (6.61e-2)"	"unprognostic (1.38e-1)"	"unprognostic (3.23e-1)"	"unprognostic (1.18e-1)"	"unprognostic (1.22e-2)"	"unprognostic (2.70e-1)"	"prognostic unfavorable (4.91e-5)"	"prognostic unfavorable (9.57e-4)"	"unprognostic (4.01e-2)"	"unprognostic (9.90e-2)"	"unprognostic (4.56e-2)"	46.1	25.9	8.9	46.3	12.0	37.9	19.3	1.9	11.0	15.8	17.5	12.2	2.6	6.8	5.5	5.0	19.0	6.2	32.5	8.4	16.2	19.4	5.9	16.4	39.8	36.5	32.9	4.9	5.1	5.1	2.7	11.4	5.9	43.7	12.8	33.3	5.9	15.6	4.1	4.5	4.6	22.5	23.7	124.8	20.1	9.8	7.9	20.0	24.8	6.3	12.6	24.0	40.3	10.5	0.0	3.3	16.7	0.1	0.5	14.5	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.6	0.0	0.0	0.4	0.6	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	33.1	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	145.0	0.5	0.5	0.0	0.0	0.0	0.0	0.0	16.7	0.6	0.1	1.3	0.0	3.7	3.2	0.4	0.0	0.3	2.9	0.1	0.5	0.0	3.3	14.5	0.4	8.9	12.0	1.9	11.0	16.2	19.4	32.9	4.9	43.7	20.0	11.9	168.0	115.1	5.1	43.7	0.7	1.2	7.6	18.7	23.9	0.0	0.0	2.0	0.0	0.0	1.4	2.7	1.4	70.0	2.4	1.7	15.5	2.9	1329.7	0.8	403.4	0.0	4.6	3.1	135.8	6.5	2.8	726.1	237.8	582.5	0.4	1.0	0.2	3.5	0.7	1.0	1.5	19.4	9.8	0.4	1.1	35.1	5.0	265.3	0.4	6.4
RGS10		ENSG00000148908	"Regulator of G protein signaling 10"	O43665	10	119499828-119542708	"Predicted intracellular proteins"		"GTPase activation, Signal transduction inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 77.9;lymphoid tissue: 96.9"	"Cell type enhanced"	"Detected in many"	9	"Erythroid cells: 256.9;granulocytes: 281.0;Hofbauer cells: 444.1;Macrophages: 293.8;monocytes: 273.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HMC-1: 94.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004559, HPA021305, HPA058485"	Enhanced	Supported	Supported	"Nucleoplasm,Plasma membrane"		NA	NA		1400000	"Nucleoplasm, Plasma membrane"		"CAB004559: AB_628216, HPA021305: AB_1856225, HPA058485: AB_2683732"	"unprognostic (1.64e-2)"	"prognostic favorable (6.81e-4)"	"unprognostic (7.98e-2)"	"prognostic favorable (6.32e-4)"	"unprognostic (5.21e-2)"	"unprognostic (6.19e-2)"	"unprognostic (4.32e-3)"	"unprognostic (6.35e-2)"	"unprognostic (9.90e-3)"	"unprognostic (1.10e-1)"	"unprognostic (1.42e-2)"	"unprognostic (1.30e-1)"	"prognostic unfavorable (4.20e-10)"	"unprognostic (2.50e-1)"	"unprognostic (9.20e-2)"	"unprognostic (7.70e-2)"	"unprognostic (7.92e-3)"	9.6	7.7	11.9	28.2	12.1	23.6	15.4	2.8	12.4	25.8	44.0	17.0	5.3	12.5	15.3	13.1	21.9	10.8	18.8	11.7	12.0	10.5	8.3	3.9	13.5	47.6	17.4	6.7	10.3	3.9	0.8	6.6	16.9	10.5	17.8	18.9	6.4	18.1	8.2	13.2	9.3	23.1	19.1	28.5	18.7	12.8	3.7	11.1	96.9	14.7	11.1	34.3	17.9	20.0	6.9	40.2	20.5	26.3	7.6	77.9	63.0	30.1	5.6	0.4	53.0	7.6	49.0	5.0	14.1	21.4	8.5	13.7	1.7	7.2	12.9	7.5	10.9	8.3	6.7	7.9	8.5	22.6	6.3	9.1	34.6	1.6	4.1	12.3	7.0	94.1	19.0	11.4	16.5	15.4	29.1	16.1	12.7	8.8	10.5	9.8	13.7	40.9	24.5	2.4	3.7	15.3	8.0	0.0	4.8	4.3	7.1	2.1	1.7	2.7	34.7	49.6	6.8	6.6	12.5	21.3	4.9	4.2	7.0	12.0	0.5	8.1	4.7	1.5	30.7	2.1	20.5	21.5	0.2	15.0	26.3	15.7	6.9	32.5	25.8	40.2	3.6	77.9	58.5	9.9	7.6	21.6	23.9	35.0	63.0	11.9	12.1	2.8	12.4	12.0	10.5	17.4	6.7	10.5	11.1	0.0	19.1	64.8	23.8	32.6	0.0	1.2	0.0	2.7	11.4	1.8	0.0	10.7	51.4	0.7	1.8	5.3	4.2	256.9	5.6	30.7	57.9	75.3	281.0	0.4	444.1	0.0	18.0	14.7	196.4	3.9	46.3	293.8	89.4	273.3	63.2	1.4	8.0	5.8	8.9	3.8	0.8	12.9	31.9	0.2	1.7	24.6	8.5	117.2	14.2	34.9
RGS18	RGS13	ENSG00000150681	"Regulator of G protein signaling 18"	Q9NS28	1	192158457-192185815	"Predicted intracellular proteins"		"Signal transduction inhibitor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 66.0;lymphoid tissue: 37.3"	"Cell type enhanced"	"Detected in some"	26	"granulocytes: 24.3;Kupffer cells: 118.0;Macrophages: 42.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"eosinophil: 66.0"	"Lineage enriched"	"Detected in many"	4	"granulocytes: 66.0"	"Group enriched"	"Detected in some"	5	"HEL: 29.3;HL-60: 22.4;NB-4: 21.1;U-937: 19.5"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"HPA028727, HPA045780"	Uncertain		Approved	"Golgi apparatus"		NA	NA		380000	"Golgi apparatus"		"HPA028727: AB_2797219, HPA045780: AB_10962728"	"unprognostic (3.09e-2)"	"unprognostic (4.32e-2)"	"unprognostic (8.66e-2)"	"unprognostic (1.70e-1)"	"unprognostic (2.28e-1)"	"unprognostic (1.52e-2)"	"unprognostic (1.48e-1)"	"unprognostic (2.18e-2)"	"unprognostic (2.58e-1)"	"unprognostic (1.87e-1)"	"unprognostic (3.07e-1)"	"unprognostic (2.36e-1)"	"unprognostic (1.30e-3)"	"unprognostic (8.21e-3)"	"unprognostic (2.81e-4)"	"unprognostic (1.73e-2)"	"unprognostic (9.91e-2)"	3.9	1.9	4.8	11.4	4.6	9.9	1.8	0.9	3.1	2.0	2.2	1.0	0.0	2.3	1.1	2.3	2.0	2.2	4.5	7.5	3.6	2.5	2.7	4.2	16.1	23.0	4.9	0.8	1.6	1.2	0.0	1.2	3.8	4.2	1.8	2.3	0.6	1.6	0.8	0.9	0.9	4.8	2.3	9.2	37.3	1.4	1.3	4.4	3.0	1.3	0.4	3.5	4.6	1.3	0.0	9.8	66.0	14.9	0.1	1.3	16.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	29.3	0.0	0.0	0.0	22.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	1.3	0.0	0.0	0.0	21.1	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.5	0.0	27.4	9.8	66.0	0.1	12.9	1.3	0.0	0.1	0.2	9.8	0.0	0.0	0.0	32.4	0.1	14.9	2.3	0.0	16.4	4.8	4.6	0.9	3.1	3.6	2.5	4.9	0.8	4.2	4.4	6.0	0.0	2.2	0.0	0.2	0.0	0.4	0.0	2.7	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	24.3	0.4	7.6	0.0	0.0	0.6	118.0	0.2	0.3	42.4	0.0	1.0	0.0	0.0	0.0	0.0	0.4	0.2	0.3	12.9	0.0	0.1	0.2	0.1	0.1	7.1	0.0	0.0
RGS2	G0S8	ENSG00000116741	"Regulator of G protein signaling 2"	P41220	1	192809039-192812283	"Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Translation regulation"	"GTPase activation, Signal transduction inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 234.2"	"Cell type enhanced"	"Detected in many"	16	"granulocytes: 1743.9;Macrophages: 609.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"basophil: 135.8;neutrophil: 234.2"	"Lineage enriched"	"Detected in many"	9	"granulocytes: 234.2"	"Cell line enhanced"	"Detected in many"		"hTCEpi: 39.9;hTERT-HME1: 27.6;Karpas-707: 26.2;PC-3: 63.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA013385			Supported	Cytosol		NA	NA			Cytosol		"HPA013385: AB_2668827"	"prognostic favorable (2.43e-4)"	"unprognostic (9.75e-2)"	"unprognostic (1.28e-3)"	"unprognostic (4.43e-2)"	"unprognostic (1.79e-1)"	"unprognostic (1.93e-1)"	"unprognostic (2.09e-3)"	"unprognostic (1.29e-2)"	"unprognostic (2.59e-1)"	"unprognostic (2.79e-2)"	"unprognostic (1.36e-1)"	"unprognostic (6.49e-2)"	"prognostic unfavorable (2.90e-5)"	"prognostic unfavorable (3.56e-4)"	"unprognostic (1.16e-1)"	"unprognostic (4.34e-3)"	"unprognostic (1.01e-3)"	22.7	62.0	8.1	39.2	20.1	84.9	23.3	6.0	10.0	20.7	57.5	4.5	50.6	23.2	43.3	34.2	45.5	27.4	35.0	14.2	8.2	13.2	9.4	10.8	24.3	32.6	8.9	6.6	25.1	84.3	1.9	52.6	16.7	16.9	99.8	19.1	44.0	5.0	54.5	4.4	6.4	33.9	135.0	19.0	50.6	22.5	13.0	7.9	3.9	4.2	5.7	6.2	72.1	28.5	0.3	6.2	234.2	26.6	0.1	1.8	12.2	0.0	5.5	7.1	0.6	14.1	2.2	0.4	2.7	3.4	0.9	0.9	4.8	3.2	0.4	0.7	2.5	0.7	2.6	4.6	4.8	0.8	0.7	3.4	1.3	3.6	0.1	6.2	3.2	0.8	2.3	39.9	1.8	27.6	5.1	6.6	2.4	1.1	26.2	2.7	0.0	1.7	4.5	9.5	0.5	63.1	1.7	1.6	1.4	4.6	4.4	2.6	13.4	1.9	0.1	3.0	7.6	0.2	1.6	1.8	1.3	1.2	1.4	1.4	15.6	0.4	1.4	19.2	0.6	4.8	135.8	26.6	38.0	0.8	10.5	1.8	0.3	0.5	0.5	6.2	0.1	0.3	0.3	234.2	0.1	17.7	0.8	0.3	12.2	8.1	20.1	6.0	10.0	8.2	13.2	8.9	6.6	16.9	7.9	47.6	315.5	133.6	46.1	37.5	21.4	56.8	2.5	30.8	62.6	129.1	17.7	168.7	0.0	22.6	22.0	24.3	61.9	23.3	26.0	21.8	64.8	43.7	1743.9	2.1	326.0	20.6	335.5	23.9	383.7	13.9	15.3	609.2	84.4	77.5	43.4	36.4	13.0	20.1	59.1	2.2	35.7	0.0	69.0	5.0	9.4	27.1	103.9	144.7	17.8	7.5
RHOG	"ARHG, MGC125835, MGC125836, RhoG"	ENSG00000177105	"Ras homolog family member G"	P84095	11	3826978-3840983	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 112.3;bone marrow: 109.5"	"Cell type enhanced"	"Detected in many"	7	"Kupffer cells: 257.1;Macrophages: 301.6;monocytes: 429.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HMC-1: 120.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039871	Enhanced					NA	NA		2300000			"HPA039871: AB_10673428"	"unprognostic (2.39e-2)"	"unprognostic (1.02e-2)"	"prognostic unfavorable (1.81e-4)"	"unprognostic (2.26e-2)"	"unprognostic (1.35e-1)"	"unprognostic (4.21e-2)"	"unprognostic (4.27e-3)"	"unprognostic (7.28e-2)"	"unprognostic (1.71e-2)"	"unprognostic (3.28e-1)"	"unprognostic (1.96e-1)"	"unprognostic (3.53e-1)"	"prognostic unfavorable (9.49e-8)"	"unprognostic (9.38e-2)"	"unprognostic (8.98e-2)"	"unprognostic (1.11e-1)"	"unprognostic (2.48e-1)"	22.9	14.0	14.5	36.6	24.4	109.5	22.0	4.9	21.4	14.6	15.9	49.7	9.2	21.0	17.8	10.1	28.2	15.8	16.5	12.6	19.8	13.5	13.7	17.3	30.2	65.1	34.8	11.6	15.6	12.2	8.8	9.9	22.3	23.3	13.2	14.0	9.3	14.4	14.9	17.9	17.3	27.0	18.6	44.5	63.8	15.1	9.4	26.5	38.6	11.0	15.9	30.4	19.6	18.6	9.6	35.3	112.3	58.4	10.3	22.6	31.4	13.4	18.4	3.7	6.4	14.5	16.5	4.1	8.9	11.2	14.1	15.0	11.3	14.7	13.7	4.8	16.5	14.3	15.9	5.8	12.6	9.1	12.1	14.1	31.2	8.9	10.4	14.7	27.1	120.1	15.9	11.6	8.8	8.5	8.1	16.1	18.7	18.2	15.3	11.4	15.8	22.7	37.6	5.9	9.8	14.8	11.6	4.0	8.1	10.0	9.4	2.0	5.1	6.3	14.7	7.2	4.5	7.7	20.5	12.5	17.1	8.6	18.1	10.4	8.6	11.7	7.7	15.6	24.8	9.5	40.8	38.9	80.1	14.0	51.7	12.2	9.6	15.3	15.4	35.3	9.2	10.9	12.5	112.3	10.3	58.4	8.8	22.6	31.4	14.5	24.4	4.9	21.4	19.8	13.5	34.8	11.6	23.3	26.5	17.9	28.7	63.7	52.7	61.0	0.8	4.6	12.7	8.1	21.6	19.2	0.0	94.3	13.3	58.1	1.5	58.5	96.4	0.0	49.1	70.0	45.9	49.5	199.3	16.2	223.5	3.2	15.5	33.7	257.1	2.5	35.6	301.6	50.6	429.2	25.4	14.9	63.3	105.2	33.9	20.7	3.1	19.4	42.4	8.4	23.6	51.9	103.9	119.9	24.7	76.6
RILPL2	"FLJ30380, FLJ32372, MGC7036"	ENSG00000150977	"Rab interacting lysosomal protein like 2"	Q969X0	12	123410683-123436717	"Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Macrophages: 123.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HEL: 16.5;NB-4: 35.7;THP-1: 22.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA028958	Uncertain		Supported	Cytosol		NA	NA			Cytosol		"HPA028958: AB_10602124"	"unprognostic (1.94e-3)"	"unprognostic (3.29e-3)"	"unprognostic (1.02e-1)"	"prognostic favorable (5.24e-7)"	"unprognostic (2.62e-2)"	"unprognostic (8.89e-2)"	"unprognostic (2.18e-1)"	"unprognostic (2.69e-2)"	"unprognostic (4.08e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.97e-1)"	"unprognostic (2.10e-2)"	"unprognostic (5.90e-3)"	"unprognostic (1.11e-1)"	"unprognostic (8.57e-2)"	"unprognostic (2.10e-1)"	"unprognostic (4.74e-2)"	14.8	5.6	5.8	13.2	7.1	42.9	13.6	3.8	5.7	25.1	7.7	5.3	12.8	4.1	17.8	10.6	10.2	14.2	13.4	7.4	6.3	5.1	12.8	7.8	21.6	15.3	6.3	4.7	12.2	5.0	6.0	7.0	7.7	7.2	18.2	3.8	8.2	21.4	15.6	4.4	6.5	9.8	9.6	7.6	29.9	7.6	7.8	5.8	8.6	25.7	7.4	14.3	14.0	22.0	8.5	13.6	26.2	19.0	3.1	9.0	7.8	2.5	2.5	1.2	4.6	5.2	4.2	2.9	3.1	6.4	2.4	2.1	2.7	1.4	1.6	2.6	4.3	1.7	2.1	1.9	2.1	2.5	5.1	2.0	16.5	2.6	3.9	5.5	12.5	9.7	3.4	1.6	2.6	1.9	3.8	2.5	3.6	2.3	2.0	2.1	1.7	4.5	35.7	1.1	0.9	2.6	3.7	2.6	2.9	2.6	4.3	0.6	1.6	3.6	0.8	2.8	1.8	3.5	22.8	3.1	2.5	2.8	4.3	1.9	2.2	1.7	3.2	2.5	8.9	1.2	12.5	19.0	21.5	3.8	14.4	3.5	8.5	7.8	6.5	13.6	5.7	3.4	3.7	26.2	3.1	15.7	6.9	9.0	7.8	5.8	7.1	3.8	5.7	6.3	5.1	6.3	4.7	7.2	5.8	32.8	66.4	47.4	59.9	21.8	1.0	3.7	28.1	50.9	42.1	21.0	2.0	8.6	21.6	16.7	1.7	50.1	1.1	0.0	18.6	6.2	24.9	47.9	60.2	11.9	67.8	1.6	4.1	49.1	107.3	0.9	46.6	123.1	35.4	92.0	7.5	12.2	16.2	3.7	62.2	44.4	1.6	6.5	38.1	0.7	14.0	13.4	6.8	70.5	3.7	63.3
RIN3	FLJ22439	ENSG00000100599	"Ras and Rab interactor 3"	Q8TB24	14	92513774-92688994	"Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	10	"granulocytes: 50.7;Kupffer cells: 114.2;Macrophages: 50.3;monocytes: 94.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enriched"	"Detected in many"	5	"HMC-1: 49.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA039836	Uncertain					NA	NA					"HPA039836: AB_10795257"	"unprognostic (1.06e-1)"	"unprognostic (1.33e-1)"	"unprognostic (1.93e-1)"	"unprognostic (1.87e-1)"	"unprognostic (7.18e-2)"	"unprognostic (6.40e-2)"	"unprognostic (2.44e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.32e-1)"	"unprognostic (3.07e-3)"	"unprognostic (5.69e-3)"	"unprognostic (5.13e-2)"	"unprognostic (5.90e-3)"	"unprognostic (2.88e-2)"	"unprognostic (6.95e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.33e-1)"	20.3	14.5	5.9	9.5	7.5	39.8	8.0	2.2	5.0	6.7	16.7	7.5	1.7	6.7	16.0	9.4	7.1	9.0	10.8	7.0	6.5	3.3	5.4	14.9	17.4	23.5	9.9	1.3	9.1	2.5	7.3	3.1	7.5	8.0	8.4	5.2	7.4	5.2	5.7	3.8	5.1	9.2	10.2	11.0	32.7	7.4	6.1	9.3	21.6	5.3	2.1	10.6	12.5	10.9	4.1	17.8	21.7	20.3	8.5	4.6	8.4	4.4	8.8	1.9	0.7	0.8	6.7	6.7	5.7	6.2	5.4	3.7	3.3	7.8	0.0	5.5	8.4	3.8	9.8	1.4	0.0	2.5	4.6	1.7	9.4	0.6	3.8	4.1	3.0	49.1	4.0	3.5	5.2	2.2	2.1	3.2	1.1	1.3	0.2	2.2	2.8	1.4	7.0	1.2	0.5	2.7	1.2	0.9	0.1	2.2	3.0	0.4	0.0	2.7	0.9	4.0	2.0	0.0	1.1	5.5	6.4	5.0	9.1	4.8	1.4	0.0	0.0	6.3	0.1	8.1	15.2	18.2	21.7	4.6	17.0	1.5	3.3	2.1	2.2	17.8	4.1	3.2	3.5	17.4	8.5	20.3	0.7	1.2	8.4	5.9	7.5	2.2	5.0	6.5	3.3	9.9	1.3	8.0	9.3	0.0	12.8	13.7	1.7	3.4	1.2	4.0	0.0	0.0	0.0	0.0	0.0	4.3	0.0	1.4	8.2	10.5	9.2	0.0	1.2	2.9	3.5	3.6	50.7	12.4	44.8	0.0	0.0	8.0	114.2	4.1	4.9	50.3	11.8	94.6	5.9	0.0	6.3	3.5	17.7	4.7	0.3	12.9	4.2	17.3	3.7	2.4	10.6	30.5	8.8	3.1
RNASE6	"RAD1, RNaseK6, RNS6"	ENSG00000169413	"Ribonuclease A family member k6"	Q93091	14	20781051-20782467	"Predicted secreted proteins"		"Antibiotic, Antimicrobial, Endonuclease, Hydrolase, Nuclease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 117.6"	"Cell type enhanced"	"Detected in many"	23	"B-cells: 117.8;Hofbauer cells: 181.1;Kupffer cells: 514.5;Macrophages: 188.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"plasmacytoid DC: 117.6"	"Low lineage specificity"	"Detected in all"			"Cell line enriched"	"Detected in some"	7	"RPMI-8226: 33.8"	"Low region specificity"	"Detected in many"							HPA000698	Approved				"Secreted to blood"	NA	NA		2300000			"HPA000698: AB_2181340"	"unprognostic (5.04e-2)"	"unprognostic (5.21e-3)"	"unprognostic (3.59e-2)"	"unprognostic (4.05e-2)"	"unprognostic (1.74e-1)"	"unprognostic (7.31e-2)"	"unprognostic (7.91e-2)"	"unprognostic (2.29e-1)"	"unprognostic (4.45e-1)"	"unprognostic (1.65e-1)"	"unprognostic (2.04e-1)"	"unprognostic (2.73e-1)"	"unprognostic (2.85e-3)"	"unprognostic (9.62e-2)"	"unprognostic (5.60e-3)"	"unprognostic (3.46e-2)"	"unprognostic (5.54e-2)"	25.0	10.8	7.8	19.3	10.3	7.3	11.9	1.8	7.7	10.7	9.1	7.9	4.6	5.7	5.5	25.9	4.7	7.2	14.6	11.2	7.0	6.5	10.6	8.2	16.4	51.0	10.9	3.3	4.3	4.9	1.3	4.1	13.9	9.8	6.0	10.8	6.9	9.5	5.6	2.7	4.9	23.4	7.2	24.0	49.3	5.8	5.7	10.3	12.8	4.2	3.3	25.5	14.7	4.5	42.2	117.6	33.8	52.0	3.6	1.4	26.8	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	1.1	1.2	0.0	0.0	0.0	0.0	0.0	0.8	2.5	0.3	0.1	0.0	0.0	1.0	2.2	0.0	0.0	0.0	0.1	0.0	33.8	0.5	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	4.4	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.0	0.0	33.8	52.0	1.1	0.5	12.2	1.2	28.9	1.4	0.6	49.4	42.2	0.6	0.1	19.0	3.6	0.1	117.6	0.1	26.8	7.8	10.3	1.8	7.7	7.0	6.5	10.9	3.3	9.8	10.3	6.0	12.7	117.8	0.1	3.9	0.0	0.4	22.9	0.0	1.2	0.0	0.0	1.0	0.0	0.0	0.6	2.2	0.8	23.3	0.0	1.5	2.7	0.3	0.0	2.1	181.1	0.0	0.0	11.1	514.5	0.7	2.6	188.7	20.3	1.8	0.3	0.0	0.0	10.5	0.7	0.4	0.4	12.9	0.7	0.0	0.8	3.3	1.8	8.9	2.8	0.8
RNASET2	"bA514O12.3, FLJ10907, RNASE6PL"	ENSG00000026297	"Ribonuclease T2"	O00584	6	166929504-166957191	"Disease related genes, Predicted intracellular proteins, Predicted secreted proteins"	"Immunity, Innate immunity"	"Endonuclease, Hydrolase, Lyase, Nuclease"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 105.7"	"Cell type enhanced"	"Detected in many"	6	"Hofbauer cells: 343.2;Kupffer cells: 367.0;Macrophages: 275.2;Paneth cells: 280.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"EFO-21: 40.0;THP-1: 99.3"									"HPA029013, HPA066509"	Approved				"Secreted to blood"	NA	NA		16000000			"HPA029013: AB_10602922, HPA066509: AB_2685682"	"unprognostic (4.18e-2)"	"unprognostic (2.57e-1)"	"unprognostic (1.44e-1)"	"unprognostic (1.06e-1)"	"unprognostic (4.13e-2)"	"unprognostic (9.33e-2)"	"unprognostic (1.76e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.15e-2)"	"unprognostic (8.11e-2)"	"unprognostic (1.79e-1)"	"unprognostic (5.06e-2)"	"prognostic unfavorable (1.70e-14)"	"unprognostic (5.03e-2)"	"unprognostic (7.34e-2)"	"unprognostic (6.29e-2)"	"unprognostic (1.01e-2)"	13.0	9.9	27.8	21.9	23.7	29.4	13.9	3.7	18.6	46.0	21.0	26.3	35.5	15.4	13.8	40.5	10.6	37.6	22.9	8.8	24.9	18.7	12.3	14.3	15.1	45.7	36.0	9.2	13.4	39.5	11.6	12.1	12.9	24.9	18.0	25.0	9.1	30.7	53.1	2.9	10.1	24.6	7.5	43.2	84.7	25.7	5.7	34.5	16.7	22.2	6.3	25.0	13.2	13.9	20.9	56.6	105.7	57.0	4.5	28.0	22.3	3.2	2.7	2.5	7.5	11.7	8.3	2.3	3.3	4.1	1.4	1.4	6.5	4.0	2.4	40.0	8.0	3.3	8.9	4.1	3.6	0.8	4.1	8.0	1.9	4.1	15.9	3.9	31.8	8.9	4.8	6.7	0.8	0.5	6.1	1.9	4.3	5.0	18.6	2.1	8.4	2.7	24.7	1.4	26.9	2.9	6.0	3.4	29.8	26.9	1.9	1.0	7.0	6.9	20.1	1.6	4.7	2.5	99.3	3.9	3.0	2.2	9.6	3.2	4.0	4.5	0.2	6.6	30.6	2.0	16.6	28.7	105.7	5.0	44.5	9.2	20.9	28.0	12.5	36.7	17.6	21.5	6.8	78.7	4.5	57.0	56.6	13.9	22.3	27.8	23.7	3.7	18.6	24.9	18.7	36.0	9.2	24.9	34.5	17.9	34.3	199.1	101.2	38.5	10.0	8.7	48.4	20.1	19.4	36.6	0.0	45.4	19.9	56.6	8.7	19.9	139.7	0.0	24.1	40.5	36.8	50.6	70.4	20.7	343.2	12.7	72.4	20.9	367.0	8.0	32.8	275.2	55.6	38.7	135.0	25.1	53.1	280.5	27.6	13.9	6.8	25.8	14.1	7.1	12.2	30.2	23.2	107.8	184.1	89.4
RNF130	"G1RZFP, GOLIATH, GP"	ENSG00000113269	"Ring finger protein 130"	Q86XS8	5	179911651-180072118	"Enzymes, Predicted membrane proteins"	"Apoptosis, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Hofbauer cells: 270.4;Kupffer cells: 303.4;Macrophages: 212.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	8	"basophil: 17.0;classical monocyte: 38.1;eosinophil: 24.6;intermediate monocyte: 27.5;myeloid DC: 31.1;neutrophil: 68.1;non-classical monocyte: 23.8;plasmacytoid DC: 22.9"	"Group enriched"	"Detected in all"	11	"dendritic cells: 31.1;granulocytes: 68.1;monocytes: 38.1"	"Cell line enhanced"	"Detected in many"		"HMC-1: 41.5"	"Low region specificity"	"Detected in all"							HPA014499	Approved					NA	NA					"HPA014499: AB_1856328"	"unprognostic (2.01e-1)"	"prognostic favorable (6.32e-4)"	"unprognostic (2.43e-1)"	"unprognostic (1.37e-1)"	"unprognostic (2.24e-1)"	"unprognostic (1.62e-2)"	"unprognostic (2.83e-1)"	"unprognostic (2.02e-3)"	"unprognostic (2.93e-2)"	"unprognostic (1.78e-1)"	"unprognostic (4.00e-2)"	"unprognostic (2.81e-1)"	"unprognostic (1.14e-1)"	"unprognostic (8.41e-2)"	"unprognostic (4.17e-2)"	"unprognostic (4.32e-1)"	"unprognostic (1.38e-2)"	36.3	16.3	23.5	16.3	32.5	29.5	24.0	19.0	25.3	26.0	16.7	56.0	19.0	10.6	18.5	12.0	10.6	19.5	21.9	17.0	27.8	21.1	20.7	64.4	25.5	19.1	50.2	20.3	21.7	28.6	11.0	16.7	19.8	30.3	16.3	16.1	15.8	30.6	28.3	17.3	7.9	12.1	22.2	58.2	20.4	20.5	7.3	38.8	2.5	14.3	6.3	10.3	20.7	13.3	1.2	31.1	68.1	38.1	4.0	2.0	20.3	8.0	5.9	29.0	21.2	28.3	15.4	5.5	6.3	7.9	6.9	7.5	1.9	6.9	0.0	19.5	11.0	12.3	0.8	20.1	12.8	7.6	0.1	17.9	15.9	3.2	4.1	7.2	3.8	41.5	14.5	6.8	0.5	3.9	17.4	11.2	16.4	3.2	0.1	6.9	12.2	7.2	12.3	7.9	1.5	9.0	16.2	6.7	0.0	8.7	1.4	17.6	7.9	11.7	6.4	24.3	12.3	9.2	9.1	8.7	11.7	4.7	8.2	6.7	0.0	6.2	1.6	1.5	30.5	9.1	17.0	38.1	24.6	2.0	27.5	1.9	1.2	0.9	1.0	31.1	1.2	1.0	1.2	68.1	4.0	23.8	22.9	0.1	20.3	23.5	32.5	19.0	25.3	27.8	21.1	50.2	20.3	30.3	38.8	17.9	25.0	20.3	17.8	12.6	26.9	27.4	73.9	65.6	22.7	40.1	49.1	10.0	19.9	43.4	9.6	42.9	21.0	0.0	67.5	13.5	39.8	43.3	79.8	129.2	270.4	6.4	15.6	43.0	303.4	14.4	33.9	212.8	30.4	45.1	37.0	18.1	46.5	35.1	45.3	34.2	17.7	45.3	40.1	8.6	27.9	11.3	7.3	17.3	61.0	17.1
RNF166	"MGC14381, MGC2647"	ENSG00000158717	"Ring finger protein 166"	Q96A37	16	88696495-88706421	"Predicted intracellular proteins"	"Autophagy, Immunity, Innate immunity, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 63.9"	"Cell type enhanced"	"Detected in many"	7	"Kupffer cells: 37.7;Macrophages: 37.5;T-cells: 66.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"NB-4: 44.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042970			Approved	"Nucleoplasm,Plasma membrane,Cytosol"		No	No			Nucleoplasm	"Plasma membrane, Cytosol"	"HPA042970: AB_10796682"	"unprognostic (3.01e-2)"	"unprognostic (6.98e-3)"	"unprognostic (3.96e-2)"	"unprognostic (5.36e-3)"	"unprognostic (1.23e-1)"	"unprognostic (2.71e-2)"	"unprognostic (6.52e-2)"	"unprognostic (5.86e-2)"	"unprognostic (4.88e-2)"	"unprognostic (2.38e-2)"	"prognostic favorable (1.04e-4)"	"unprognostic (3.22e-2)"	"prognostic unfavorable (9.45e-6)"	"unprognostic (1.54e-1)"	"unprognostic (3.91e-2)"	"unprognostic (1.28e-1)"	"unprognostic (2.69e-2)"	9.2	8.1	9.2	22.8	8.9	63.9	10.5	13.7	15.3	6.7	7.2	11.2	3.7	12.0	8.1	8.3	6.4	9.1	12.3	10.0	8.6	7.3	9.6	9.7	20.8	30.5	8.9	6.5	9.7	11.4	5.3	8.5	7.5	8.4	8.9	4.9	11.0	12.1	6.0	14.8	8.2	16.0	8.3	11.1	47.2	10.9	9.2	9.1	21.6	8.8	7.8	23.8	9.7	6.7	2.0	11.8	28.7	12.5	5.5	17.1	9.7	4.2	6.8	5.3	8.4	2.6	2.2	10.1	4.3	2.8	5.1	2.3	4.6	2.7	5.1	5.6	2.5	2.9	4.7	3.1	2.8	2.0	2.6	9.2	6.9	5.0	7.7	6.9	6.8	8.8	2.6	2.7	4.0	3.3	2.8	5.3	8.7	11.5	3.8	2.1	8.3	15.9	44.6	8.7	1.8	9.1	14.9	3.3	13.2	2.3	1.9	4.9	5.5	9.8	2.0	5.3	2.7	5.8	23.3	7.3	3.8	5.7	5.7	5.1	8.6	5.0	12.4	3.4	25.9	5.3	3.0	12.5	28.7	17.1	9.1	14.8	2.0	10.4	14.8	11.8	1.9	8.7	12.5	20.4	5.5	10.5	7.3	10.5	9.7	9.2	8.9	13.7	15.3	8.6	7.3	8.9	6.5	8.4	9.1	8.9	5.1	15.7	4.7	4.2	10.1	2.4	7.6	1.4	3.4	7.0	5.9	7.4	8.3	5.2	1.1	8.0	2.0	0.0	8.0	7.5	8.2	3.6	20.7	4.0	34.7	7.9	4.7	10.4	37.7	1.8	8.6	37.5	10.1	11.8	2.7	8.9	4.6	0.0	7.4	5.6	8.6	6.5	7.1	9.4	8.6	5.1	3.1	66.8	4.1	1.3
RUFY4	"FLJ46536, ZFYVE31"	ENSG00000188282	"RUN and FYVE domain containing 4"	Q6ZNE9	2	218034960-218090581	"Predicted intracellular proteins"	Autophagy			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"lung: 6.6;lymphoid tissue: 5.1"	"Cell type enhanced"	"Detected in some"	20	"Kupffer cells: 2.2;Macrophages: 1.4"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in some"			"Cell type enhanced"	"Detected in single"		"myeloid DC: 1.9"	"Low lineage specificity"	"Detected in single"			"Cell line enriched"	"Detected in some"	13	"Karpas-707: 15.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA037980	Uncertain					NA	NA					"HPA037980: AB_10672501"	"unprognostic (1.27e-3)"	"unprognostic (4.60e-3)"	"unprognostic (9.39e-3)"	"unprognostic (6.79e-2)"	"unprognostic (5.92e-2)"	"unprognostic (6.57e-3)"	"unprognostic (1.16e-1)"	"unprognostic (2.42e-2)"	"unprognostic (1.31e-3)"	"unprognostic (1.50e-1)"	"unprognostic (6.09e-2)"	"unprognostic (1.55e-1)"	"unprognostic (2.41e-14)"	"unprognostic (1.36e-2)"	"unprognostic (1.13e-3)"	"unprognostic (3.45e-1)"	"unprognostic (1.43e-5)"	0.3	0.4	0.6	2.2	1.9	1.8	0.3	0.3	1.0	0.3	0.4	0.3	0.3	1.9	0.3	0.3	0.9	0.4	1.2	0.3	3.1	0.3	0.5	0.3	6.6	2.8	0.4	0.3	0.3	0.3	0.0	0.4	0.3	0.3	2.6	1.5	0.3	1.4	0.3	0.3	0.7	1.8	0.3	0.3	5.1	1.5	0.3	0.3	1.1	0.3	0.3	2.2	0.6	0.6	0.0	1.9	0.0	0.6	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.9	0.0	0.2	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.4	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.4	0.0	0.0	0.6	0.6	0.0	0.0	0.6	1.9	0.3	1.0	3.1	0.3	0.4	0.3	0.3	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	2.2	0.0	0.0	1.4	0.0	1.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3
RUNX3	"AML2, CBFA3, PEBP2A3"	ENSG00000020633	"Runt related transcription factor 3"	Q13761	1	24899511-24965121	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 31.5;lymphoid tissue: 47.6"	"Cell type enhanced"	"Detected in many"	17	"B-cells: 38.9;granulocytes: 46.0;Macrophages: 35.5;Melanocytes: 43.9;monocytes: 68.5;T-cells: 144.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 39.5;Karpas-707: 53.2;SK-MEL-30: 29.5;U-266/70: 18.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA004195, CAB025416, HPA059006"	Enhanced		Supported	Nucleoplasm,Vesicles,Cytosol		NA	NA			"Nucleoplasm, Vesicles"	Cytosol	"CAB025416: , HPA004195: , HPA059006: AB_2683877"	"unprognostic (7.75e-3)"	"unprognostic (6.51e-3)"	"prognostic unfavorable (8.71e-4)"	"unprognostic (1.42e-1)"	"unprognostic (7.60e-2)"	"unprognostic (1.81e-2)"	"unprognostic (6.51e-2)"	"unprognostic (6.95e-2)"	"unprognostic (3.39e-1)"	"unprognostic (1.28e-2)"	"unprognostic (1.01e-1)"	"unprognostic (4.71e-1)"	"prognostic unfavorable (5.59e-5)"	"unprognostic (1.10e-1)"	"unprognostic (4.42e-2)"	"unprognostic (3.08e-1)"	"unprognostic (1.62e-1)"	3.0	1.1	0.9	25.4	1.1	31.5	3.4	0.5	1.0	11.9	8.0	1.2	0.3	2.5	1.7	1.4	3.5	1.7	6.2	1.3	0.9	1.1	2.2	2.3	11.7	28.8	2.8	0.7	1.3	1.0	0.0	1.0	1.3	1.8	2.3	2.3	2.8	6.5	2.2	2.2	9.5	13.7	1.3	1.8	30.6	2.7	2.1	0.8	14.2	1.8	3.1	47.6	8.9	2.2	4.5	1.0	4.3	4.6	18.1	15.1	3.1	0.1	3.5	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.1	0.0	6.3	6.2	5.4	0.0	0.1	3.7	0.0	0.2	39.5	0.6	0.1	0.6	0.0	0.0	1.4	13.7	0.0	0.0	0.0	0.4	0.0	0.0	1.0	0.0	53.2	0.0	0.0	0.4	12.2	0.2	0.0	1.0	0.0	0.0	7.4	0.0	0.1	1.2	0.0	2.4	0.0	29.5	1.0	0.0	8.5	0.0	0.0	0.6	0.0	0.1	18.4	12.8	6.0	0.0	13.8	1.5	0.4	0.7	4.3	15.1	3.0	8.1	4.5	5.7	13.2	0.9	3.8	2.8	10.3	0.9	18.1	4.6	1.0	5.7	3.1	0.9	1.1	0.5	1.0	0.9	1.1	2.8	0.7	1.8	0.8	0.0	5.1	38.9	0.7	6.8	0.0	2.2	0.0	0.0	1.2	1.8	0.0	0.0	0.0	0.0	0.7	0.6	0.0	0.0	0.2	0.1	1.2	0.7	46.0	0.8	4.9	0.0	0.0	1.8	17.0	0.8	0.0	35.5	43.9	68.5	0.0	0.0	0.1	0.0	0.7	0.0	0.0	0.0	4.7	0.2	2.7	5.1	0.2	144.9	0.0	0.4
S100A4	"18A2, 42A, CAPL, FSP1, MTS1, P9KA, PEL98"	ENSG00000196154	"S100 calcium binding protein A4"	P26447	1	153543613-153550136	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 419.2"	"Cell type enhanced"	"Detected in many"	11	"Hofbauer cells: 1794.8;Kupffer cells: 3413.1;Macrophages: 4385.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"A549: 115.2;ASC diff: 149.4;BJ hTERT+: 287.5;fHDF/TERT166: 205.6;RPMI-8226: 108.6"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"CAB002618, HPA007973, CAB027387, CAB058698, CAB068227, CAB068228"	Enhanced		Enhanced	"Plasma membrane"		NA	NA		13000000	"Plasma membrane"		"CAB002618: , CAB027387: , CAB058698: AB_2665603, CAB068227: AB_2665602, CAB068228: AB_2665601, HPA007973: AB_1079858"	"unprognostic (1.56e-1)"	"unprognostic (6.10e-2)"	"unprognostic (2.84e-2)"	"unprognostic (8.20e-2)"	"unprognostic (6.21e-2)"	"prognostic favorable (4.03e-5)"	"unprognostic (8.35e-2)"	"unprognostic (4.81e-2)"	"unprognostic (1.50e-1)"	"unprognostic (2.20e-1)"	"unprognostic (2.78e-2)"	"unprognostic (3.39e-2)"	"prognostic unfavorable (2.90e-4)"	"unprognostic (1.05e-1)"	"unprognostic (3.05e-1)"	"unprognostic (2.76e-2)"	"unprognostic (3.16e-2)"	125.9	10.1	2.6	29.2	8.3	75.2	171.6	2.2	4.6	52.1	33.9	2.7	25.8	7.3	26.8	52.2	58.6	27.9	34.7	59.9	3.0	1.7	27.8	6.1	80.7	53.2	10.8	3.1	12.7	6.7	0.0	3.0	46.9	6.6	49.5	28.0	19.3	29.8	13.4	25.4	44.5	25.5	38.5	8.9	55.9	17.2	18.2	6.2	8.5	23.7	57.5	26.4	34.9	58.2	18.6	213.1	281.6	293.3	17.3	162.7	419.2	0.5	115.2	0.5	3.3	149.4	103.1	0.1	73.0	287.5	1.4	6.5	0.8	8.1	0.0	13.3	205.6	0.1	2.9	0.4	1.0	1.1	16.4	0.0	49.2	25.6	2.5	0.2	4.3	83.3	16.0	1.1	2.8	0.6	0.2	0.1	0.0	0.4	0.1	104.7	0.4	0.1	51.0	0.3	8.4	44.2	2.6	0.1	108.6	4.5	3.1	4.4	0.5	1.3	55.6	0.4	18.7	3.3	61.7	0.1	0.3	0.6	98.1	0.4	3.6	24.5	0.5	0.2	54.8	5.6	49.5	293.3	30.8	141.2	201.4	147.2	18.6	127.2	112.3	213.1	6.2	22.4	66.5	281.6	17.3	253.9	37.4	162.7	419.2	2.6	8.3	2.2	4.6	3.0	1.7	10.8	3.1	6.6	6.2	455.6	554.5	203.3	20.0	686.7	0.6	8.4	30.6	108.4	174.0	847.9	0.0	45.2	94.5	21.8	4.3	34.1	4.4	116.8	21.4	168.0	716.5	10.9	1330.4	13.0	1794.8	42.9	4.6	120.3	3413.1	10.7	218.3	4385.9	1132.0	911.7	7.1	3.9	22.9	14.4	43.2	14.3	2.7	148.8	785.1	1.6	3.6	606.6	44.6	1190.0	8.0	60.2
S100Z	"Gm625, S100-zeta"	ENSG00000171643	"S100 calcium binding protein Z"	Q8WXG8	5	76850001-76921650	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"blood: 18.7;lymphoid tissue: 9.5"	"Group enriched"	"Detected in some"	5	"B-cells: 3.4;Hofbauer cells: 6.4;Kupffer cells: 13.2;Macrophages: 5.5;Melanocytes: 3.3"	"Cancer enhanced"	"Detected in single"		"testis cancer: 1.1"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"classical monocyte: 17.6;eosinophil: 15.0;intermediate monocyte: 15.9;myeloid DC: 9.5;neutrophil: 5.9;non-classical monocyte: 18.7"	"Group enriched"	"Detected in many"	6	"dendritic cells: 9.5;granulocytes: 15.0;monocytes: 18.7"	"Cell line enriched"	"Detected in some"	6	"U-698: 42.4"	"Region enriched"	"Detected in single"	5	"olfactory region: 1.6"	"Low region specificity"	"Detected in all"			HPA051929	Approved					NA	NA					"HPA051929: AB_2732571"	"unprognostic (4.17e-3)"	"unprognostic (4.10e-2)"	"unprognostic (2.60e-1)"	"unprognostic (1.61e-4)"	"unprognostic (1.86e-1)"	"unprognostic (4.62e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.31e-1)"	"unprognostic (8.89e-2)"	"unprognostic (2.17e-1)"	"unprognostic (3.54e-3)"	"unprognostic (1.32e-1)"	"unprognostic (9.47e-5)"	"unprognostic (3.39e-4)"	"unprognostic (8.94e-2)"	"unprognostic (6.85e-2)"	"unprognostic (1.62e-1)"	1.0	1.0	3.5	5.3	3.3	5.7	1.1	0.6	2.2	0.6	0.9	3.8	0.4	1.0	0.8	0.4	0.8	0.7	1.9	0.7	4.1	1.7	1.0	1.0	5.1	6.2	2.1	2.6	0.6	2.4	0.2	0.7	3.2	3.2	1.0	1.4	0.3	1.1	0.5	0.9	0.6	2.3	1.5	6.2	9.5	1.1	0.7	4.5	2.1	0.7	0.0	6.2	1.8	0.9	2.5	9.5	15.0	18.7	0.3	0.4	4.6	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	1.4	0.0	0.1	0.0	0.0	0.0	0.0	7.4	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.5	0.0	42.4	1.8	0.0	0.0	1.4	17.6	15.0	0.4	15.9	0.1	2.5	0.3	0.0	9.5	0.6	0.0	0.0	5.9	0.3	18.7	0.1	0.3	4.6	3.5	3.3	0.6	2.2	4.1	1.7	2.1	2.6	3.2	4.5	0.0	0.0	3.4	0.1	0.0	0.0	0.1	0.0	1.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	6.4	0.0	0.0	0.6	13.2	0.0	0.0	5.5	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.1	1.0	0.0	0.0
SAMHD1	"AGS5, HDDC1, Mg11, MOP-5, SBBI88"	ENSG00000101347	"SAM and HD domain containing deoxynucleoside triphosphate triphosphohydrolase 1"	Q9Y3Z3	20	36889773-36951901	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Antiviral defense, DNA damage, DNA repair, DNA replication, Host-virus interaction, Immunity, Innate immunity"	"Allosteric enzyme, Hydrolase"	"Aicardi-Goutieres syndrome, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	9	"Hofbauer cells: 131.6;Kupffer cells: 243.3;Macrophages: 175.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"myeloid DC: 46.7"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC diff: 58.1;BJ hTERT+ SV40 Large T+: 24.6;BJ hTERT+ SV40 Large T+ RasG12V: 26.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA047072	Enhanced		Supported	"Nucleoplasm,Plasma membrane"		NA	NA		100000	Nucleoplasm	"Plasma membrane"	"HPA047072: AB_2679921"	"unprognostic (1.09e-1)"	"unprognostic (7.30e-3)"	"unprognostic (1.65e-2)"	"unprognostic (3.85e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.91e-2)"	"unprognostic (2.15e-1)"	"unprognostic (4.07e-2)"	"unprognostic (2.03e-1)"	"unprognostic (3.63e-1)"	"unprognostic (1.88e-1)"	"unprognostic (1.04e-1)"	"prognostic unfavorable (5.12e-4)"	"unprognostic (1.44e-1)"	"unprognostic (9.06e-2)"	"unprognostic (3.18e-2)"	"unprognostic (2.72e-2)"	54.3	18.6	8.7	31.8	13.0	9.9	35.9	4.9	9.7	14.5	21.2	9.0	8.7	15.8	13.5	20.2	24.1	33.4	15.3	25.4	8.7	6.0	12.5	12.4	25.7	48.3	14.5	4.9	22.1	18.1	4.9	22.4	13.7	10.2	14.0	13.2	11.6	14.7	9.7	9.2	11.4	20.6	21.3	13.7	40.7	19.2	15.1	15.0	9.7	14.9	10.7	18.5	23.2	50.2	0.4	46.7	2.8	23.4	6.0	10.9	19.1	3.9	1.5	0.7	1.5	58.1	11.0	0.7	2.3	4.2	24.6	26.4	4.9	1.3	8.3	3.3	1.6	15.0	3.0	6.1	2.9	5.2	2.4	2.0	0.4	2.1	2.6	5.1	4.7	1.5	13.5	0.1	8.6	0.2	1.4	3.2	0.0	1.5	2.0	0.5	1.2	0.0	1.8	0.7	2.4	3.2	0.2	4.0	3.2	0.9	0.6	3.0	0.4	3.0	1.1	2.9	0.2	1.4	7.6	0.8	1.9	2.1	2.0	3.4	1.2	3.0	3.5	1.6	0.4	0.6	0.2	19.4	0.6	6.1	23.4	5.6	0.4	6.9	6.4	46.7	0.4	8.5	6.3	2.8	6.0	20.4	11.0	10.9	19.1	8.7	13.0	4.9	9.7	8.7	6.0	14.5	4.9	10.2	15.0	26.8	30.5	23.8	1.9	5.7	5.3	16.9	25.5	83.0	53.4	1.8	3.9	2.5	0.0	9.3	2.3	36.5	1.1	0.0	8.6	2.8	23.4	2.7	11.6	17.4	131.6	6.4	5.8	47.9	243.3	2.3	76.2	175.7	5.0	16.2	4.3	30.6	11.1	20.1	90.5	1.2	2.6	58.2	29.8	5.1	5.4	5.1	2.4	54.9	4.5	4.7
SELPLG	"CD162, PSGL-1"	ENSG00000110876	"Selectin P ligand"	Q14242	12	108622277-108633959	"Candidate cardiovascular disease genes, CD markers, Plasma proteins, Predicted membrane proteins"	"Cell adhesion, Host-virus interaction"	"Host cell receptor for virus entry, Receptor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 126.9;lymphoid tissue: 60.5"	"Cell type enhanced"	"Detected in many"	12	"Hofbauer cells: 35.0;Kupffer cells: 84.7;Macrophages: 58.3;monocytes: 101.8;T-cells: 37.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"HDLM-2: 28.5;HMC-1: 27.7;JURKAT: 22.6;Karpas-707: 43.3;RPMI-8226: 60.2;U-266/70: 70.7;U-266/84: 44.0"									"CAB002431, HPA069062"	Enhanced					NA	NA					"CAB002431: AB_563509, HPA069062: "	"unprognostic (2.32e-2)"	"prognostic favorable (1.46e-4)"	"unprognostic (3.64e-3)"	"unprognostic (1.02e-2)"	"unprognostic (6.32e-2)"	"prognostic favorable (6.94e-4)"	"unprognostic (2.52e-1)"	"unprognostic (1.29e-1)"	"prognostic favorable (2.92e-4)"	"unprognostic (2.26e-1)"	"unprognostic (2.12e-2)"	"unprognostic (3.24e-1)"	"prognostic unfavorable (5.86e-4)"	"unprognostic (5.88e-2)"	"unprognostic (2.37e-2)"	"prognostic favorable (2.74e-4)"	"unprognostic (5.44e-2)"	10.6	5.5	11.3	25.3	8.9	10.7	4.2	2.2	12.5	5.8	5.4	27.2	0.1	5.0	2.9	4.1	5.0	6.8	9.6	5.9	12.1	9.6	4.6	3.9	23.3	46.8	16.2	5.4	2.1	2.9	1.3	3.1	7.3	11.5	3.0	5.2	3.4	5.2	2.5	1.8	2.7	10.3	6.7	19.6	60.5	6.0	2.1	13.5	26.0	3.1	2.8	18.0	14.8	3.0	2.2	50.9	126.9	68.4	28.1	63.2	77.1	0.1	0.0	0.3	0.1	0.1	0.3	0.1	1.0	1.0	0.4	0.3	0.0	0.4	0.1	0.3	1.5	0.4	0.0	0.0	0.0	0.3	28.5	0.0	10.1	0.0	0.0	0.0	7.1	27.7	0.4	0.1	0.5	0.1	1.1	0.0	22.6	0.1	43.3	1.3	0.0	5.7	4.1	0.0	0.0	0.3	0.0	0.1	60.2	0.6	0.0	0.0	0.0	0.1	0.0	0.4	0.7	0.0	9.1	0.3	0.5	0.1	0.7	0.2	70.7	44.0	1.2	0.3	15.2	0.4	126.9	28.1	88.8	43.8	49.5	35.8	2.0	41.8	37.4	29.4	2.2	32.4	34.1	125.8	28.1	68.4	50.9	63.2	77.1	11.3	8.9	2.2	12.5	12.1	9.6	16.2	5.4	11.5	13.5	3.0	18.0	6.0	0.1	3.1	0.0	2.0	5.1	9.4	4.5	0.0	0.0	0.4	0.0	0.3	6.1	1.1	0.0	0.0	0.2	2.1	3.0	0.1	27.8	0.9	35.0	0.0	0.0	1.8	84.7	7.2	0.3	58.3	6.8	101.8	0.0	0.0	0.3	0.0	0.0	0.5	0.1	0.0	1.4	0.1	0.3	1.6	0.8	37.9	0.0	0.0
SEMA6B	"SEM-SEMA-Y, SEMA-VIB, SEMAN, semaZ"	ENSG00000167680	"Semaphorin 6B"	Q9H3T3	19	4542593-4559808	"Plasma proteins, Predicted membrane proteins"	"Differentiation, Neurogenesis"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 42.9"	"Group enriched"	"Detected in many"	5	"Alveolar cells type 1: 26.8;Alveolar cells type 2: 55.5;Ciliated cells: 32.1;Club cells: 35.2;Endothelial cells: 25.1;granulocytes: 27.8;Horizontal cells: 17.5;Ito cells: 38.1;Macrophages: 22.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"Hep G2: 36.4;HMC-1: 60.2;HUVEC TERT2: 24.6;TIME: 31.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB025157, HPA055778, HPA058523"	Enhanced					NA	NA		180000			"CAB025157: , HPA055778: AB_2682916, HPA058523: AB_2683741"	"unprognostic (4.03e-1)"	"unprognostic (9.69e-3)"	"unprognostic (6.38e-3)"	"unprognostic (2.15e-1)"	"unprognostic (1.15e-1)"	"unprognostic (7.94e-2)"	"unprognostic (2.10e-1)"	"unprognostic (4.34e-3)"	"unprognostic (6.61e-2)"	"unprognostic (1.90e-1)"	"unprognostic (4.21e-2)"	"unprognostic (2.82e-1)"	"prognostic unfavorable (3.29e-5)"	"unprognostic (1.26e-1)"	"unprognostic (1.81e-2)"	"prognostic unfavorable (1.45e-4)"	"unprognostic (9.55e-2)"	23.2	9.3	27.2	12.1	24.2	7.9	9.7	16.9	42.9	3.8	4.7	1.7	0.3	4.8	4.1	3.1	3.6	2.5	7.0	12.8	30.3	11.5	3.7	5.2	13.1	18.6	9.5	0.8	5.1	4.8	1.7	3.1	9.9	11.0	4.3	1.8	2.7	1.4	2.2	9.3	3.3	4.8	7.9	6.4	17.5	2.5	2.5	8.8	0.0	6.0	3.7	2.0	8.3	24.4	0.0	0.0	0.7	0.4	0.0	0.0	0.0	2.0	7.3	0.6	6.3	0.0	0.3	0.1	0.0	0.2	0.7	0.2	0.0	0.6	0.0	7.0	0.0	1.1	1.3	1.8	0.0	0.2	0.0	0.3	0.0	0.1	36.4	0.1	0.0	60.2	2.2	0.0	0.0	0.0	7.5	24.6	0.0	0.4	0.1	0.2	1.8	0.0	0.0	7.9	0.5	0.1	0.1	14.3	0.1	0.5	0.0	5.3	0.5	0.0	0.6	3.8	0.6	0.9	0.3	31.0	0.9	11.6	0.1	5.2	0.4	0.0	0.1	0.2	0.3	1.3	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	27.2	24.2	16.9	27.9	30.3	11.5	9.5	0.8	11.0	8.8	26.8	55.5	1.4	1.0	4.1	4.3	1.5	2.5	32.1	35.2	1.8	3.9	0.6	0.0	0.7	0.9	25.1	0.0	0.0	0.2	0.6	5.7	0.9	27.8	5.8	2.9	17.5	0.0	38.1	5.4	0.0	0.6	22.3	6.8	1.0	0.0	1.7	0.1	0.0	0.7	0.1	4.2	0.0	2.2	0.5	2.2	4.4	0.2	3.2	0.0	0.9
SH2B3	"IDDM20, LNK"	ENSG00000111252	"SH2B adaptor protein 3"	Q9UQQ2	12	111405948-111451623	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"			"Cancer-related genes, Diabetes mellitus"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	10	"Ito cells: 49.7;Kupffer cells: 110.0;Macrophages: 49.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HMC-1: 32.3;hTEC/SVTERT24-B: 37.0;U-87 MG: 56.2;WM-115: 42.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA005483	Approved		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA005483: AB_1079260"	"unprognostic (2.77e-1)"	"unprognostic (1.74e-1)"	"unprognostic (1.20e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.18e-1)"	"unprognostic (9.09e-2)"	"unprognostic (1.23e-1)"	"unprognostic (2.42e-1)"	"unprognostic (1.18e-1)"	"unprognostic (4.65e-2)"	"unprognostic (8.17e-3)"	"unprognostic (9.08e-2)"	"prognostic unfavorable (6.20e-4)"	"unprognostic (2.86e-1)"	"unprognostic (3.89e-3)"	"unprognostic (1.11e-1)"	"unprognostic (2.24e-2)"	17.6	9.0	7.9	13.7	7.9	34.4	19.8	3.8	9.3	8.9	7.5	7.2	3.1	5.3	8.0	7.1	5.6	7.5	12.7	15.3	5.8	5.5	9.2	12.5	17.6	27.8	6.6	4.0	8.2	11.0	4.7	7.6	16.1	5.2	8.4	9.3	8.7	5.0	4.2	10.2	3.6	10.3	9.1	7.8	31.7	5.5	13.3	6.8	9.5	10.2	3.2	11.8	10.0	5.8	1.8	6.1	3.8	10.3	2.3	1.7	1.9	2.3	1.4	1.8	1.9	6.4	9.6	1.2	7.5	20.6	5.7	6.2	2.1	1.3	3.9	5.4	11.4	19.5	0.4	1.4	4.3	9.4	3.3	0.7	13.4	0.6	1.5	6.3	5.8	32.3	5.7	1.0	37.0	3.3	12.8	30.9	3.3	9.6	1.6	20.9	0.8	2.4	11.7	2.8	0.6	5.4	2.4	4.2	2.5	2.7	0.9	1.2	1.3	1.3	0.1	10.7	1.7	0.9	8.4	23.9	5.3	3.0	4.5	12.1	3.6	3.8	4.5	56.2	4.2	42.8	1.1	4.3	1.5	1.6	10.3	1.4	1.8	1.4	1.7	5.9	0.7	1.0	1.3	3.8	2.3	7.6	6.1	0.5	1.9	7.9	7.9	3.8	9.3	5.8	5.5	6.6	4.0	5.2	6.8	3.0	31.9	11.5	1.3	6.1	4.1	14.9	5.1	0.0	2.3	1.8	2.0	0.4	1.7	3.1	9.6	32.1	3.8	0.0	7.5	1.1	9.8	2.4	37.0	9.4	35.5	3.2	3.4	49.7	110.0	4.0	2.6	49.7	15.1	34.3	2.6	0.9	6.9	7.0	3.9	1.4	3.1	0.0	17.6	9.4	4.0	3.6	0.8	11.8	1.7	0.8
SIGLEC9	CD329	ENSG00000129450	"Sialic acid binding Ig like lectin 9"	Q9Y336	19	51124908-51136651	"Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 42.7;lymphoid tissue: 25.1"	"Group enriched"	"Detected in some"	5	"Hofbauer cells: 38.7;Kupffer cells: 36.5;Macrophages: 29.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	11	"classical monocyte: 40.6;intermediate monocyte: 36.5;myeloid DC: 34.1;neutrophil: 42.7;non-classical monocyte: 22.9"	"Group enriched"	"Detected in many"	12	"dendritic cells: 34.1;granulocytes: 42.7;monocytes: 40.6"	"Group enriched"	"Detected in some"	10	"Karpas-707: 21.2;RPMI-8226: 14.4"									HPA010682	Uncertain					NA	NA		220000			"HPA010682: AB_1079968"	"unprognostic (2.31e-1)"	"unprognostic (3.99e-2)"	"unprognostic (1.03e-2)"	"unprognostic (1.36e-1)"	"unprognostic (4.69e-2)"	"unprognostic (6.86e-2)"	"unprognostic (5.10e-2)"	"unprognostic (2.10e-1)"	"unprognostic (1.31e-1)"	"unprognostic (4.73e-2)"	"unprognostic (1.06e-1)"	"unprognostic (7.03e-3)"	"prognostic unfavorable (6.17e-5)"	"unprognostic (6.56e-2)"	"unprognostic (7.38e-3)"	"unprognostic (2.95e-1)"	"unprognostic (1.73e-1)"	8.5	5.7	6.6	17.0	12.6	7.6	7.4	0.9	5.0	1.7	2.5	4.0	0.0	1.6	1.4	2.8	1.1	3.7	4.9	2.9	6.2	2.3	4.5	5.5	9.0	15.8	8.4	0.7	3.2	1.8	5.8	1.5	7.5	8.1	1.6	2.4	1.3	2.3	0.9	0.8	0.9	2.6	6.1	8.8	25.1	2.0	1.9	9.6	0.8	1.4	0.0	2.3	3.7	1.2	0.0	34.1	42.7	40.6	0.5	3.2	14.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	21.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	14.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.3	0.0	0.0	1.3	0.0	0.0	0.0	0.0	1.8	1.3	0.0	2.5	40.6	0.3	3.2	36.5	1.8	0.0	0.5	1.2	34.1	0.0	0.1	0.6	42.7	0.5	22.9	1.8	0.1	14.4	6.6	12.6	0.9	5.0	6.2	2.3	8.4	0.7	8.1	9.6	0.0	0.3	0.9	0.0	0.5	0.0	0.3	0.0	0.0	2.3	0.0	0.0	0.1	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.3	0.4	0.0	0.0	0.8	38.7	0.0	0.0	4.3	36.5	0.0	4.6	29.2	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	6.5	0.0	0.0	0.1	0.1	0.2	1.0	0.0	0.0
SIRPA	"BIT, CD172a, MFR, MYD-1, P84, PTPNS1, SHPS-1, SHPS1, SIRP, SIRP-ALPHA-1, SIRPalpha, SIRPalpha2"	ENSG00000198053	"Signal regulatory protein alpha"	P78324	20	1894167-1940592	"CD markers, Plasma proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 69.2"	"Cell type enhanced"	"Detected in many"	6	"Hofbauer cells: 89.1;Macrophages: 65.8;monocytes: 84.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	6	"classical monocyte: 10.1;eosinophil: 20.9;myeloid DC: 6.3;neutrophil: 23.5"	"Group enriched"	"Detected in many"	134	"dendritic cells: 6.3;granulocytes: 23.5;monocytes: 10.1"	"Cell line enhanced"	"Detected in many"		"fHDF/TERT166: 42.9;RPTEC TERT1: 31.1;SK-MEL-30: 36.1"									"CAB002776, CAB015122, HPA054437, HPA058511"	Enhanced					NA	NA		170000000			"CAB002776: , CAB015122: AB_677430, HPA054437: AB_2682488, HPA058511: AB_2683738"	"unprognostic (9.78e-2)"	"unprognostic (2.67e-1)"	"unprognostic (3.07e-1)"	"unprognostic (1.23e-1)"	"unprognostic (5.56e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.15e-3)"	"unprognostic (4.19e-3)"	"unprognostic (3.48e-2)"	"unprognostic (2.84e-3)"	"unprognostic (3.69e-1)"	"unprognostic (3.33e-2)"	"unprognostic (2.79e-3)"	"unprognostic (1.08e-1)"	"unprognostic (1.55e-2)"	"unprognostic (3.55e-2)"	"unprognostic (2.24e-2)"	23.2	21.7	36.9	24.9	38.8	19.9	14.0	39.1	69.2	9.5	6.7	22.8	3.0	14.1	6.4	11.2	7.2	9.1	14.6	11.9	29.3	18.5	9.6	16.1	22.0	10.3	18.8	50.3	9.7	6.1	2.2	5.5	13.8	14.7	4.9	8.2	9.5	15.0	8.9	5.5	13.6	11.7	11.4	18.0	9.6	5.2	3.9	20.4	1.0	4.1	2.2	8.8	13.2	6.9	0.0	6.3	23.5	10.1	0.0	0.0	3.4	3.4	7.6	3.8	7.1	9.3	8.8	0.5	18.3	15.6	5.0	1.5	4.8	0.1	0.0	4.4	42.9	13.5	3.5	3.0	21.3	2.1	0.0	2.1	0.0	0.9	2.6	11.2	7.1	8.8	7.8	10.1	4.2	5.2	14.4	15.5	0.0	0.4	4.7	6.7	0.2	0.0	10.0	4.2	0.0	3.4	0.0	6.8	4.7	31.1	0.0	0.5	1.1	2.5	0.0	36.1	1.4	1.2	22.9	23.1	22.2	11.5	14.3	9.0	0.0	0.0	0.0	6.9	23.0	2.5	0.1	10.1	20.9	0.0	2.7	0.0	0.0	0.0	0.0	6.3	0.0	0.0	0.0	23.5	0.0	1.0	0.4	0.0	3.4	36.9	38.8	39.1	68.6	29.3	18.5	18.8	50.3	14.7	20.4	3.0	9.2	1.9	10.4	12.7	9.3	9.7	30.6	4.0	5.7	8.7	13.7	16.4	1.7	22.9	0.5	10.8	3.8	0.0	1.8	1.6	22.0	5.7	17.3	23.1	89.1	14.3	9.2	17.8	49.1	0.4	4.6	65.8	21.9	84.8	3.3	21.8	15.8	6.5	1.8	12.8	25.2	6.5	5.2	0.3	7.9	5.8	30.6	1.0	3.0	6.5
SIRPB2	"dJ776F14.2, PTPN1L, PTPNS1L3"	ENSG00000196209	"Signal regulatory protein beta 2"	Q5JXA9	20	1470741-1491587	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 29.5;lymphoid tissue: 21.2"	"Cell type enhanced"	"Detected in some"	24	"Hofbauer cells: 4.4;Kupffer cells: 18.9;Macrophages: 9.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	13	"classical monocyte: 19.8;eosinophil: 12.3;intermediate monocyte: 12.8;myeloid DC: 8.8;neutrophil: 29.5;non-classical monocyte: 9.7"	"Group enriched"	"Detected in many"	194	"dendritic cells: 8.8;granulocytes: 29.5;monocytes: 19.8"	"Cell line enhanced"	"Detected in some"		"A-431: 5.3;HBEC3-KT: 4.5;HMC-1: 9.3;hTCEpi: 10.0;HUVEC TERT2: 5.0;THP-1: 8.8;TIME: 4.4;U-937: 9.4"					"Low region specificity"	"Detected in all"			"HPA011548, HPA048032"	Uncertain		Approved	"Nuclear bodies"		NA	NA		100000	"Nuclear bodies"		"HPA011548: AB_2668514, HPA048032: AB_2680236"	"unprognostic (3.22e-2)"	"unprognostic (5.57e-2)"	"unprognostic (2.29e-2)"	"unprognostic (2.04e-1)"	"unprognostic (1.45e-1)"	"unprognostic (2.21e-2)"	"unprognostic (2.07e-2)"	"unprognostic (3.28e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.75e-1)"	"unprognostic (2.38e-1)"	"unprognostic (2.43e-1)"	"unprognostic (3.50e-5)"	"unprognostic (3.59e-3)"	"unprognostic (9.24e-3)"	"unprognostic (1.37e-1)"	"unprognostic (1.06e-1)"	8.1	4.2	5.8	15.8	11.0	8.1	5.2	0.8	6.5	2.8	2.4	3.3	0.0	1.3	1.9	4.5	2.6	3.1	5.2	2.7	5.9	3.1	2.6	2.5	9.5	17.3	9.2	1.7	1.4	1.6	0.7	1.4	10.0	7.9	1.8	2.5	2.4	2.8	1.0	1.2	1.5	3.3	5.5	13.1	21.2	2.0	1.8	9.1	1.0	1.7	0.3	4.3	6.4	3.9	0.0	8.8	29.5	19.8	0.0	0.0	6.4	5.3	0.0	0.0	0.1	0.0	0.4	0.1	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.9	0.0	0.2	1.3	0.0	4.5	0.1	0.0	0.0	0.1	0.0	0.0	0.0	2.2	9.3	0.0	10.0	0.0	0.2	0.0	5.0	0.0	0.0	0.0	0.0	0.1	0.0	2.9	0.0	0.1	0.0	0.0	0.0	0.0	0.1	1.6	0.0	0.0	0.0	0.0	0.1	0.1	0.1	8.8	4.4	0.1	0.1	0.1	0.0	0.1	0.0	0.0	0.1	9.4	0.1	1.2	19.8	12.3	0.0	12.8	0.0	0.0	0.0	0.0	8.8	0.0	0.0	0.0	29.5	0.0	9.7	0.3	0.0	6.4	5.8	11.0	0.8	6.5	5.9	3.1	9.2	1.7	7.9	9.1	0.0	0.6	0.5	0.7	0.2	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.5	0.6	0.4	1.1	0.0	4.4	0.0	0.0	0.6	18.9	0.0	0.0	9.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.6	0.0	0.0	0.5
SLAMF8	"BLAME, CD353, SBBI42"	ENSG00000158714	"SLAM family member 8"	Q9P0V8	1	159826750-159837249	"CD markers, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 44.1"	"Group enriched"	"Detected in some"	10	"Hofbauer cells: 37.6;Kupffer cells: 13.7;Macrophages: 31.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"myeloid DC: 12.1"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"ASC TERT1: 4.2;HL-60: 3.6;U-138 MG: 5.0;U-87 MG: 2.8;U-937: 2.6"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			HPA067601	Enhanced					NA	NA					"HPA067601: AB_2685870"	"unprognostic (1.04e-1)"	"unprognostic (8.80e-3)"	"unprognostic (5.12e-2)"	"unprognostic (2.14e-3)"	"unprognostic (3.07e-2)"	"unprognostic (3.22e-2)"	"unprognostic (7.87e-2)"	"unprognostic (4.29e-1)"	"unprognostic (2.20e-2)"	"unprognostic (4.56e-2)"	"unprognostic (6.47e-2)"	"unprognostic (1.77e-1)"	"prognostic unfavorable (5.42e-5)"	"unprognostic (3.50e-1)"	"unprognostic (4.42e-2)"	"unprognostic (2.01e-1)"	"unprognostic (1.04e-1)"	16.9	4.6	1.5	20.1	3.4	0.4	5.4	8.2	1.6	3.1	6.0	1.4	0.6	4.6	1.8	4.2	3.1	3.6	6.1	7.1	5.2	1.7	7.8	2.2	19.6	44.1	4.1	0.7	3.8	2.0	0.1	4.2	5.4	5.0	2.7	7.1	3.0	4.2	1.0	2.2	3.1	7.0	5.4	4.1	22.7	3.1	2.4	2.7	9.7	4.8	3.0	12.7	8.6	2.8	0.0	12.1	0.5	6.6	8.1	3.8	2.8	0.0	0.1	0.0	0.0	0.5	4.2	0.0	0.1	0.4	0.0	0.2	0.0	0.0	0.0	0.6	0.3	0.0	0.0	0.0	0.0	0.8	0.0	0.1	1.8	0.0	0.0	0.0	3.6	0.7	1.4	0.0	0.3	0.2	0.0	0.0	0.2	0.0	0.8	0.2	0.0	0.1	1.9	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.2	0.8	0.0	1.7	0.0	5.0	0.2	0.0	0.9	0.0	0.0	0.0	2.8	2.6	0.0	0.0	5.1	0.0	3.2	6.6	0.2	0.0	1.1	3.8	12.1	0.0	0.2	2.6	0.5	8.1	0.4	0.1	0.0	2.8	1.5	3.4	8.2	1.6	5.2	1.7	4.1	0.7	5.0	2.7	0.0	2.9	0.0	0.0	1.5	0.2	0.2	0.0	1.4	1.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.7	0.0	0.0	0.0	37.6	0.0	0.0	0.0	13.7	0.0	0.3	31.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.9	0.5	0.8	0.0	0.0
SLC11A1	"LSH, NRAMP, NRAMP1"	ENSG00000018280	"Solute carrier family 11 member 1"	P49279	2	218382029-218396894	"Predicted membrane proteins, Transporters"	"Ion transport, Iron transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 37.6;lymphoid tissue: 23.8"	"Group enriched"	"Detected in many"	5	"Alveolar cells type 2: 52.4;Hofbauer cells: 110.2;Kupffer cells: 163.4;Macrophages: 201.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	9	"classical monocyte: 7.9;intermediate monocyte: 5.8;myeloid DC: 2.4;neutrophil: 6.0;non-classical monocyte: 7.0"	"Group enriched"	"Detected in many"	11	"dendritic cells: 2.4;granulocytes: 6.0;monocytes: 7.9"	"Cell line enhanced"	"Detected in some"		"HEL: 3.8;HMC-1: 3.7;NB-4: 3.1"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"HPA029590, HPA050378, HPA068540"	Uncertain		Approved	Nucleoli,Mitochondria		NA	NA			Mitochondria	Nucleoli	"HPA029590: AB_10794613, HPA050378: , HPA068540: "	"unprognostic (2.64e-1)"	"unprognostic (3.05e-2)"	"unprognostic (1.46e-2)"	"unprognostic (2.34e-2)"	"unprognostic (1.99e-2)"	"unprognostic (3.83e-2)"	"unprognostic (1.04e-3)"	"unprognostic (2.06e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.58e-2)"	"unprognostic (7.29e-3)"	"unprognostic (2.49e-1)"	"prognostic unfavorable (2.58e-8)"	"unprognostic (9.55e-2)"	"unprognostic (3.50e-2)"	"unprognostic (1.78e-2)"	"unprognostic (1.08e-2)"	13.5	4.7	4.3	14.9	13.3	11.6	2.6	0.6	9.3	1.7	1.8	4.6	0.0	1.3	1.3	2.1	1.4	4.1	3.0	6.5	15.0	2.6	2.1	3.2	37.6	19.9	17.1	0.7	2.4	3.3	1.2	1.9	6.2	11.3	1.7	1.0	1.7	2.0	1.2	2.0	1.0	1.2	4.6	18.1	23.8	1.7	2.4	10.3	0.0	1.8	0.2	1.0	7.1	1.3	0.4	2.4	6.0	7.9	0.2	0.4	2.6	0.3	0.7	0.0	0.4	0.1	0.1	0.9	0.0	0.0	0.1	0.2	1.0	2.1	0.2	0.2	0.0	0.3	0.8	0.0	0.0	0.0	0.7	0.1	3.8	0.6	0.7	0.1	0.0	3.7	0.3	0.1	0.0	0.2	0.3	0.0	1.2	1.0	0.7	0.1	1.3	0.2	3.1	0.0	0.6	0.2	0.2	0.6	0.4	0.1	0.3	0.8	0.2	0.5	0.4	0.4	0.2	0.3	1.1	0.3	0.7	0.4	0.2	0.0	0.3	0.3	0.7	0.2	0.4	0.4	0.3	7.9	0.6	0.4	5.8	0.3	0.1	0.2	0.2	2.4	0.4	0.4	0.3	6.0	0.2	7.0	0.2	0.2	2.6	4.3	13.3	0.6	9.3	15.0	2.6	17.1	0.7	11.3	10.3	20.8	52.4	3.0	3.9	0.8	3.6	6.3	5.1	17.4	22.7	8.7	0.0	1.6	8.3	0.8	1.2	4.7	1.2	0.0	1.8	7.2	2.4	5.7	24.3	4.7	110.2	1.6	1.2	8.6	163.4	0.4	2.0	201.4	1.7	1.0	4.0	7.6	0.6	0.9	0.7	6.8	3.0	19.4	5.0	0.5	1.7	0.9	6.8	1.7	2.2	2.7
SLC31A2	"COPT2, CTR2, hCTR2"	ENSG00000136867	"Solute carrier family 31 member 2"	O15432	9	113150942-113164137	"Predicted membrane proteins, Transporters"	"Copper transport, Ion transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in all"		"blood: 60.2;salivary gland: 125.5"	"Cell type enhanced"	"Detected in many"	5	"Cytotrophoblasts: 80.2;Kupffer cells: 82.1;Macrophages: 93.6;monocytes: 89.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	12	"classical monocyte: 36.6;intermediate monocyte: 50.5;myeloid DC: 21.2;neutrophil: 54.5;non-classical monocyte: 60.2"	"Group enriched"	"Detected in many"	36	"dendritic cells: 21.2;granulocytes: 54.5;monocytes: 60.2"	"Cell line enhanced"	"Detected in many"		"ASC diff: 22.2;hTCEpi: 33.7;hTERT-HME1: 23.1;LHCN-M2: 26.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA014861	Approved		Approved	"Nuclear speckles,Plasma membrane,Intermediate filaments"		NA	NA			"Nuclear speckles"	"Plasma membrane, Intermediate filaments"	"HPA014861: AB_1857098"	"unprognostic (2.26e-1)"	"unprognostic (7.20e-2)"	"unprognostic (3.79e-3)"	"unprognostic (1.09e-1)"	"unprognostic (1.10e-1)"	"unprognostic (4.81e-3)"	"unprognostic (5.63e-2)"	"unprognostic (3.31e-2)"	"unprognostic (2.24e-1)"	"unprognostic (3.44e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.86e-1)"	"unprognostic (6.05e-3)"	"unprognostic (1.76e-1)"	"unprognostic (3.56e-2)"	"unprognostic (1.25e-1)"	"unprognostic (8.89e-2)"	15.7	8.0	10.0	8.1	20.5	7.0	8.5	3.2	15.0	3.0	8.4	45.1	27.1	5.2	2.0	6.0	4.6	3.0	4.5	3.4	18.2	9.4	9.8	11.2	10.0	6.2	34.3	10.5	2.8	7.8	17.9	1.2	10.2	22.3	2.1	4.4	1.0	125.5	21.8	6.7	18.5	9.9	3.8	48.5	14.1	4.5	5.4	26.2	1.2	2.8	2.9	5.8	3.9	4.1	0.3	21.2	54.5	60.2	0.2	1.2	13.4	5.5	2.5	1.4	2.0	22.2	9.1	4.8	4.2	5.4	5.1	4.9	1.8	1.7	0.3	0.8	3.5	8.3	20.6	2.0	12.0	4.8	2.8	0.8	0.3	1.2	2.9	8.5	2.2	1.2	10.2	33.7	11.9	23.1	2.7	2.7	2.7	1.6	3.0	26.6	5.3	2.1	1.3	0.7	2.8	2.3	0.4	20.1	0.4	1.7	3.4	1.3	2.2	5.8	17.8	1.7	1.2	6.4	2.0	2.5	2.8	1.9	9.2	3.6	1.9	3.9	0.2	8.8	2.9	2.8	0.8	36.6	3.6	0.9	50.5	1.2	0.2	1.0	1.0	21.2	0.3	0.8	0.8	54.5	0.2	60.2	0.5	0.6	13.4	10.0	20.5	3.2	15.0	18.2	9.4	34.3	10.5	22.3	26.2	8.9	8.6	18.0	5.3	33.0	6.9	0.4	2.5	10.7	5.7	1.8	33.4	80.2	3.3	10.7	2.3	6.7	17.4	0.0	6.6	5.8	13.3	7.9	0.0	18.7	55.9	6.4	3.4	17.2	82.1	2.0	14.7	93.6	0.0	89.2	3.2	8.2	13.8	7.0	8.9	17.4	9.1	19.4	8.9	30.6	5.1	33.5	36.0	8.3	3.5	4.2
SLC37A2	FLJ00171	ENSG00000134955	"Solute carrier family 37 member 2"	Q8TED4	11	125063067-125090312	"Predicted membrane proteins, Transporters"	"Antiport, Sugar transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 47.2;salivary gland: 85.6"	"Group enriched"	"Detected in many"	7	"Hofbauer cells: 32.3;Kupffer cells: 15.9;Macrophages: 9.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	13	"classical monocyte: 8.0;intermediate monocyte: 9.9;myeloid DC: 3.7;non-classical monocyte: 11.9"	"Group enriched"	"Detected in many"	12	"dendritic cells: 3.7;monocytes: 11.9"	"Cell line enhanced"	"Detected in some"		"A-431: 12.7;CAPAN-2: 27.2;hTCEpi: 12.2;hTERT-HME1: 29.3;U-138 MG: 20.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA014948	Uncertain					NA	NA					"HPA014948: AB_2190374"	"unprognostic (8.47e-2)"	"unprognostic (4.85e-1)"	"unprognostic (9.64e-2)"	"unprognostic (2.91e-2)"	"unprognostic (7.88e-2)"	"unprognostic (2.84e-1)"	"unprognostic (5.47e-2)"	"unprognostic (1.68e-1)"	"unprognostic (2.06e-2)"	"unprognostic (1.30e-1)"	"unprognostic (2.15e-2)"	"unprognostic (3.11e-1)"	"unprognostic (6.61e-2)"	"unprognostic (1.94e-3)"	"unprognostic (1.66e-3)"	"unprognostic (7.01e-2)"	"unprognostic (3.24e-2)"	7.1	26.4	1.0	47.2	1.4	0.0	3.4	0.4	1.0	2.5	3.6	3.5	0.5	3.7	0.7	2.0	7.2	1.0	2.4	2.3	1.3	0.7	1.0	2.7	7.2	6.4	1.5	0.3	1.8	0.7	0.0	0.6	3.2	1.5	2.0	4.6	2.4	85.6	0.6	0.4	16.3	4.6	1.3	1.7	10.2	0.8	0.7	1.2	1.4	0.6	3.3	3.1	6.6	6.5	0.1	3.7	0.6	11.9	0.0	0.0	3.1	12.7	0.0	0.2	0.0	0.3	0.4	0.0	0.4	1.2	0.4	1.2	0.1	27.2	0.0	3.9	0.1	1.0	6.7	0.2	7.2	1.8	0.3	0.2	2.9	0.2	0.6	0.0	0.0	0.1	0.3	12.2	1.2	29.3	0.7	0.7	0.2	0.1	0.1	1.3	0.0	0.0	0.6	0.3	0.0	0.2	0.0	0.9	0.2	0.3	6.6	0.0	0.1	2.3	0.0	0.8	0.2	0.0	0.6	1.5	20.9	0.0	0.2	0.5	0.3	0.4	0.0	0.7	0.7	1.6	0.0	8.0	0.0	0.0	9.9	0.0	0.1	0.0	0.0	3.7	0.0	0.0	0.0	0.6	0.0	11.9	0.0	0.0	3.1	1.0	1.4	0.4	1.0	1.3	0.7	1.5	0.3	1.5	1.2	0.0	1.1	1.4	1.2	0.2	1.4	0.8	0.0	0.0	2.3	0.0	2.0	0.5	0.0	0.1	1.3	0.8	0.0	0.0	0.0	0.6	0.3	0.8	2.3	0.0	32.3	0.0	0.0	1.8	15.9	1.7	0.9	9.3	0.0	0.0	0.0	0.5	0.1	0.0	1.1	0.0	0.7	0.0	0.4	2.2	1.0	0.6	2.9	0.7	0.0	2.6
SLC7A7	"LPI, y+LAT-1"	ENSG00000155465	"Solute carrier family 7 member 7"	Q9UM01	14	22773222-22829820	"Disease related genes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Amino-acid transport, Transport"		"Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 63.8;intestine: 93.5;kidney: 67.3"	"Cell type enhanced"	"Detected in many"	13	"Hofbauer cells: 200.4;Kupffer cells: 312.3;Macrophages: 142.1;Proximal tubular cells: 254.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"intermediate monocyte: 59.5;non-classical monocyte: 63.8"	"Lineage enriched"	"Detected in many"	4	"monocytes: 63.8"	"Cell line enhanced"	"Detected in some"		"BEWO: 44.5;CACO-2: 72.0;EFO-21: 15.6;OE19: 63.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA036227	Enhanced					NA	NA					"HPA036227: AB_10696653"	"unprognostic (1.34e-1)"	"unprognostic (7.65e-2)"	"unprognostic (4.25e-2)"	"unprognostic (2.52e-1)"	"unprognostic (6.12e-2)"	"unprognostic (3.69e-2)"	"unprognostic (7.84e-3)"	"unprognostic (1.47e-1)"	"unprognostic (2.88e-2)"	"unprognostic (1.73e-2)"	"unprognostic (2.60e-3)"	"unprognostic (7.15e-2)"	"prognostic unfavorable (6.28e-6)"	"unprognostic (2.68e-3)"	"unprognostic (1.86e-2)"	"unprognostic (2.61e-1)"	"unprognostic (1.12e-1)"	10.4	2.8	1.9	8.3	3.1	3.6	3.2	0.7	2.7	2.6	48.0	4.1	0.2	24.1	2.7	2.3	2.1	4.6	7.6	3.0	2.2	1.6	67.3	6.5	15.3	20.5	3.7	1.0	2.6	2.7	26.3	1.0	6.5	3.2	2.7	3.4	2.1	3.3	0.9	1.6	1.8	93.5	3.5	4.5	32.4	3.0	13.4	2.7	2.1	2.8	0.8	5.7	4.1	3.6	3.0	14.6	5.4	63.8	0.0	0.1	17.8	0.0	2.4	0.2	0.1	0.4	0.8	44.5	0.5	3.6	0.1	0.3	72.0	7.3	3.5	15.6	0.3	0.2	2.7	0.0	0.0	0.1	0.1	0.0	0.2	0.0	0.7	2.1	0.3	0.3	1.6	0.2	0.2	0.1	0.3	5.5	0.2	0.0	2.8	0.5	0.1	0.0	0.3	0.7	63.3	0.0	0.6	7.8	2.1	0.1	0.2	0.0	0.1	0.1	0.1	0.5	2.1	0.1	1.7	0.3	0.1	0.3	0.1	0.1	0.6	0.1	1.8	0.2	0.1	0.0	0.0	41.2	0.1	0.0	59.5	0.0	3.0	0.0	0.0	14.6	2.3	0.1	0.0	5.4	0.0	63.8	0.5	0.1	17.8	1.9	3.1	0.7	2.7	2.2	1.6	3.7	1.0	3.2	2.7	11.9	10.3	23.7	0.1	0.9	0.0	0.8	58.6	9.4	4.5	3.5	0.0	1.0	10.0	6.7	40.8	4.5	8.6	0.0	5.8	4.5	4.8	0.2	1.1	1.3	200.4	0.0	1.2	22.1	312.3	7.5	3.4	142.1	5.0	34.3	0.4	0.5	7.3	0.0	0.0	254.4	1.2	6.5	2.8	12.2	1.7	0.4	1.5	5.0	0.3	0.0
SLCO2B1	"OATP-B, OATP2B1, SLC21A9"	ENSG00000137491	"Solute carrier organic anion transporter family member 2B1"	O94956	11	75100563-75206549	"FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Transport"		"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 98.1"	"Group enriched"	"Detected in many"	5	"Hepatocytes: 171.3;Hofbauer cells: 103.0;Kupffer cells: 116.2;Macrophages: 55.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CACO-2: 36.0;GAMG: 8.9;Hep G2: 8.1;HMC-1: 10.9;OE19: 43.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA020659	Uncertain					NA	NA					"HPA020659: AB_1857219"	"unprognostic (8.25e-2)"	"unprognostic (5.30e-2)"	"unprognostic (2.02e-2)"	"unprognostic (3.57e-1)"	"unprognostic (3.40e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.58e-2)"	"unprognostic (1.09e-1)"	"unprognostic (2.61e-1)"	"unprognostic (2.00e-3)"	"unprognostic (1.99e-1)"	"unprognostic (2.09e-1)"	"unprognostic (9.75e-3)"	"unprognostic (2.54e-2)"	"unprognostic (4.57e-3)"	"unprognostic (1.04e-1)"	"unprognostic (3.87e-2)"	21.4	15.2	15.0	13.4	23.1	1.4	7.8	4.8	15.8	8.6	12.9	22.8	0.8	18.0	5.8	7.7	8.8	8.3	12.3	7.1	15.6	11.9	9.6	98.1	24.9	21.4	23.9	7.4	4.9	9.6	3.7	4.0	18.3	17.7	4.9	10.4	9.1	6.3	4.7	2.6	3.0	21.2	10.9	24.1	23.6	6.5	4.4	21.3	4.0	6.8	3.6	11.8	12.5	4.8	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.3	1.1	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	36.0	0.0	0.0	0.0	0.0	8.9	0.0	0.0	0.0	0.0	0.4	0.0	5.9	0.3	8.1	0.0	0.4	10.9	0.0	0.0	0.2	0.0	0.0	0.0	0.0	3.1	3.6	0.0	0.0	0.0	0.0	0.0	43.2	0.0	0.0	1.0	3.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.7	0.0	0.0	0.1	0.0	0.6	0.6	0.0	0.6	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.0	23.1	4.8	15.8	15.6	11.9	23.9	7.4	17.7	21.3	0.0	12.8	1.5	0.0	1.6	1.6	2.0	20.4	1.4	3.4	0.0	0.0	0.6	1.7	0.0	2.4	12.9	20.2	0.0	0.2	2.1	1.8	0.0	23.0	171.3	103.0	0.0	0.0	3.1	116.2	1.1	10.0	55.1	0.0	3.6	4.4	0.3	0.1	14.0	9.9	7.0	0.2	0.0	0.3	0.5	0.2	0.4	2.1	0.7	9.3	0.0
SLFN11	FLJ34922	ENSG00000172716	"Schlafen family member 11"	Q7Z7L1	17	35350305-35373701	"Predicted intracellular proteins"	"Antiviral defense, DNA damage, Immunity"	"Helicase, Hydrolase, RNA-binding, tRNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Fibroblasts: 26.8;Hofbauer cells: 27.4;Kupffer cells: 33.5;Macrophages: 35.9;Smooth muscle cells: 27.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"MOLT-4: 32.5"									"HPA023030, HPA062062"	Uncertain		Supported	Nucleoplasm,Cytosol		No	NA			Nucleoplasm	Cytosol	"HPA023030: AB_1856613, HPA062062: AB_2684673"	"unprognostic (1.93e-2)"	"unprognostic (2.56e-1)"	"unprognostic (3.04e-2)"	"unprognostic (1.03e-2)"	"unprognostic (3.48e-3)"	"unprognostic (1.01e-1)"	"unprognostic (5.19e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.34e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.39e-1)"	"unprognostic (2.54e-1)"	"prognostic unfavorable (9.93e-10)"	"unprognostic (1.65e-1)"	"unprognostic (5.71e-3)"	"unprognostic (6.33e-2)"	"unprognostic (8.81e-3)"	20.9	5.3	5.4	10.3	10.0	6.0	24.1	3.2	5.2	15.5	7.3	4.8	10.3	3.0	12.2	24.6	8.1	15.0	9.9	12.6	6.6	2.8	5.5	3.5	20.4	10.4	6.9	2.2	21.3	4.4	2.1	5.0	5.4	8.9	7.8	6.1	8.9	8.3	9.6	6.0	4.1	10.1	10.3	6.7	17.5	6.1	4.2	7.3	18.3	19.0	4.6	12.9	10.9	17.7	3.1	13.0	1.4	18.3	2.0	6.0	5.2	8.1	7.3	0.0	0.0	7.5	21.7	0.1	10.1	7.3	17.5	30.7	0.0	0.0	0.0	0.1	13.2	5.5	4.0	22.7	0.0	21.3	4.6	27.2	17.7	0.0	0.0	9.9	22.8	0.0	8.8	0.2	19.5	0.0	0.0	28.6	13.5	0.0	0.0	2.9	0.0	32.5	18.5	0.1	0.0	0.0	27.6	21.4	0.0	0.2	3.9	0.0	0.0	0.0	3.8	0.0	0.0	6.0	16.5	14.8	4.8	0.1	18.1	15.1	0.7	0.2	0.0	3.6	19.9	10.3	0.4	11.8	1.4	4.3	18.3	6.0	3.1	2.7	3.9	9.2	1.3	2.1	2.9	1.3	2.0	11.4	13.0	3.9	5.2	5.4	10.0	3.2	5.2	6.6	2.8	6.9	2.2	8.9	7.3	0.0	6.9	9.1	0.7	6.6	0.0	2.5	0.0	16.0	3.4	1.8	0.0	0.7	0.0	0.0	1.2	16.1	0.0	0.0	0.5	0.6	26.8	1.1	3.5	0.0	27.4	0.0	0.0	10.4	33.5	1.1	9.5	35.9	11.8	1.0	0.0	0.1	0.1	0.2	2.8	0.0	0.0	6.5	27.9	0.0	0.0	7.4	0.7	20.3	0.0	0.6
SMAP2	SMAP1L	ENSG00000084070	"Small ArfGAP2"	Q8WU79	1	40344850-40423326	"Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 90.9"	"Cell type enhanced"	"Detected in all"	7	"B-cells: 177.5;Kupffer cells: 237.9;Macrophages: 148.9;monocytes: 250.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"THP-1: 74.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021466, HPA024424"	Approved					NA	NA					"HPA021466: AB_2239737, HPA024424: AB_1857259"	"unprognostic (1.65e-1)"	"prognostic favorable (6.55e-4)"	"unprognostic (7.17e-2)"	"unprognostic (1.40e-3)"	"unprognostic (4.32e-1)"	"prognostic favorable (5.34e-5)"	"prognostic unfavorable (2.53e-4)"	"unprognostic (9.05e-2)"	"unprognostic (2.27e-1)"	"unprognostic (2.24e-1)"	"unprognostic (4.00e-3)"	"unprognostic (2.65e-1)"	"unprognostic (1.02e-2)"	"unprognostic (1.88e-2)"	"unprognostic (5.45e-2)"	"unprognostic (6.23e-2)"	"unprognostic (1.24e-1)"	24.3	9.4	21.3	47.3	25.9	26.1	12.7	17.0	35.1	17.8	12.2	12.4	2.7	6.6	6.8	5.8	10.0	11.8	17.7	6.6	20.0	19.1	8.2	26.3	21.6	90.9	15.7	15.6	6.9	8.9	9.5	16.0	13.9	18.2	7.2	12.5	9.1	11.4	7.7	12.0	11.4	34.3	15.0	14.2	79.2	15.0	6.2	13.8	35.1	7.0	4.3	70.0	16.7	6.9	14.4	11.7	47.4	42.7	6.9	8.4	10.5	6.1	2.3	5.6	5.6	8.2	15.8	3.1	9.6	8.7	10.0	9.8	2.9	4.2	22.9	4.7	8.5	4.1	2.5	10.3	7.3	13.8	43.2	8.6	12.7	3.6	6.2	7.4	13.1	39.4	13.5	6.2	12.9	5.6	4.9	5.6	18.0	22.8	24.2	11.8	4.1	19.0	12.5	3.4	6.0	21.0	7.3	5.2	23.4	4.8	7.2	9.4	4.3	4.5	11.7	7.3	4.5	3.7	74.7	3.1	11.0	4.5	10.2	7.3	7.9	8.8	18.8	10.0	13.1	7.1	2.7	21.1	23.2	3.7	36.8	4.6	10.6	5.9	5.5	11.7	14.4	8.4	7.7	47.4	6.9	42.7	2.2	8.1	10.5	21.3	25.9	17.0	35.1	20.0	19.1	15.7	15.6	18.2	13.8	23.8	34.5	177.5	8.3	16.0	30.6	9.0	17.8	87.0	30.7	7.0	21.6	4.7	5.0	9.9	11.7	9.2	9.6	46.7	16.2	8.4	16.8	13.3	26.7	55.0	37.0	25.4	9.1	46.6	237.9	16.5	4.9	148.9	27.0	250.7	9.1	13.0	14.0	3.5	4.6	6.9	23.7	32.3	18.4	11.8	8.7	15.6	3.4	91.2	8.6	10.8
SNAI3	"SMUC, Zfp293, ZNF293"	ENSG00000185669	"Snail family transcriptional repressor 3"	Q3KNW1	16	88677682-88686493	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"blood: 25.5;skeletal muscle: 33.9"	"Cell type enhanced"	"Detected in some"	9	"B-cells: 8.0;granulocytes: 9.2;Hofbauer cells: 7.0;Kupffer cells: 14.2;Macrophages: 10.3;T-cells: 10.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in some"	5	"NB-4: 14.7;RPMI-8226: 23.2"	"Region enhanced"	"Detected in single"		"basal ganglia: 1.3"	"Not detected"	"Not detected"			HPA071127			Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA071127: AB_2686346"	"unprognostic (1.03e-2)"	"prognostic favorable (1.39e-4)"	"unprognostic (2.20e-2)"	"unprognostic (6.19e-4)"	"unprognostic (3.05e-1)"	"unprognostic (2.85e-3)"	"unprognostic (2.60e-1)"	"unprognostic (1.98e-3)"	"unprognostic (3.24e-2)"	"unprognostic (7.79e-2)"	"prognostic favorable (3.58e-4)"	"unprognostic (9.09e-2)"	"unprognostic (1.62e-1)"	"unprognostic (8.46e-2)"	"unprognostic (6.57e-2)"	"unprognostic (1.11e-1)"	"unprognostic (7.47e-2)"	0.9	0.8	2.4	6.3	2.3	2.3	0.8	1.9	2.9	1.3	3.4	2.1	0.2	2.2	0.8	1.3	1.3	1.4	2.6	2.4	2.5	1.7	1.3	1.0	5.3	4.5	3.1	0.8	1.5	6.1	2.1	1.0	0.9	2.2	1.6	0.8	1.4	3.6	0.7	33.9	1.1	4.6	1.1	2.4	9.2	3.5	2.1	2.2	2.1	3.0	9.5	13.0	2.7	2.4	4.6	9.2	25.5	7.7	0.5	11.6	5.4	0.2	0.8	0.2	1.1	0.0	0.0	0.5	0.2	0.0	0.0	0.1	2.9	0.2	1.9	0.5	0.0	0.7	0.6	0.2	0.2	0.0	0.3	1.1	0.9	0.1	0.9	0.0	0.2	0.7	0.0	0.0	0.0	0.0	0.1	0.0	1.2	1.7	3.6	0.0	2.6	0.1	14.7	0.3	0.3	0.3	3.2	0.2	23.2	0.0	0.4	1.4	0.2	0.6	0.0	0.2	0.4	1.0	1.8	0.3	0.1	0.9	0.2	0.0	0.6	3.3	3.3	0.2	4.0	0.4	2.8	7.7	25.5	6.1	2.9	10.9	4.6	9.9	5.7	9.2	3.8	6.1	3.8	17.1	0.5	0.7	6.5	11.6	5.4	2.4	2.3	1.9	2.4	2.5	1.7	3.1	0.8	2.2	2.2	3.0	0.0	8.0	0.1	0.5	0.2	2.0	0.0	0.0	1.2	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.3	0.1	9.2	0.0	7.0	0.0	0.0	0.6	14.2	0.0	0.0	10.3	5.0	0.0	0.0	0.0	0.2	0.0	0.4	0.0	0.4	0.0	0.8	0.0	1.1	0.3	0.1	10.9	0.0	0.0
SNX10		ENSG00000086300	"Sorting nexin 10"	Q9Y5X0	7	26291895-26374329	"Disease related genes, Predicted intracellular proteins"	"Cilium biogenesis/degradation, Protein transport, Transport"		"Disease mutation, Osteopetrosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 67.6;brain: 39.0;liver: 37.4"	"Cell type enhanced"	"Detected in many"	7	"Distal tubular cells: 242.1;Hofbauer cells: 146.8;Kupffer cells: 156.1;Macrophages: 186.4;Muller glia cells: 262.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 67.6"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"RPTEC TERT1: 27.2;U-937: 22.3;WM-115: 77.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015605, HPA064782"	Approved		Supported	Nucleoplasm,Nucleoli,Microtubules		NA	NA			"Nucleoplasm, Microtubules"	Nucleoli	"HPA015605: AB_1857342, HPA064782: AB_2685349"	"unprognostic (6.42e-2)"	"unprognostic (2.72e-3)"	"unprognostic (2.45e-1)"	"unprognostic (7.62e-2)"	"prognostic unfavorable (1.16e-4)"	"unprognostic (6.92e-2)"	"unprognostic (2.48e-3)"	"unprognostic (4.51e-2)"	"unprognostic (4.87e-1)"	"unprognostic (9.36e-2)"	"unprognostic (1.59e-1)"	"unprognostic (2.56e-1)"	"prognostic unfavorable (8.06e-5)"	"unprognostic (1.12e-2)"	"unprognostic (3.21e-1)"	"unprognostic (8.59e-2)"	"unprognostic (1.50e-1)"	17.7	8.7	20.2	18.6	17.9	20.9	6.7	13.2	39.0	2.9	3.3	2.1	0.1	2.5	5.4	0.8	1.8	1.9	5.2	1.3	22.2	32.7	21.3	37.4	22.4	18.0	27.8	20.8	1.0	5.0	0.6	3.0	8.9	36.2	2.2	3.9	1.8	1.4	1.5	0.9	1.0	3.6	5.4	15.4	22.1	2.3	3.0	2.1	3.8	1.9	0.1	13.6	6.3	1.8	16.3	20.1	67.6	30.9	9.0	5.6	11.6	13.9	1.3	0.0	2.6	0.0	0.0	15.2	0.0	1.0	0.0	0.0	0.1	4.7	6.1	11.0	0.0	9.6	0.4	3.5	0.9	0.0	8.4	3.3	0.6	0.1	9.2	0.0	13.0	2.3	0.1	1.4	0.0	1.1	0.0	0.2	7.9	0.3	0.0	0.0	2.4	5.4	13.7	4.0	0.1	1.3	0.0	0.0	0.3	27.2	3.0	6.0	1.8	3.0	2.2	15.8	5.0	4.0	18.6	0.0	0.0	3.3	0.0	3.4	4.7	3.7	4.1	0.1	22.3	77.5	8.2	29.2	0.7	4.0	30.9	3.8	16.3	2.8	3.4	20.1	14.5	1.5	2.6	67.6	9.0	30.1	7.4	5.6	11.6	20.2	17.9	13.2	39.0	22.2	32.7	27.8	20.8	36.2	2.1	3.0	17.1	49.9	1.0	4.7	17.7	1.6	20.4	1.4	7.9	22.7	2.0	11.6	242.1	51.3	0.9	5.6	2.6	23.3	23.5	64.7	3.6	2.8	31.1	90.6	146.8	33.4	9.1	2.5	156.1	0.7	1.1	186.4	8.5	49.5	2.5	262.3	22.1	0.0	0.0	123.2	20.4	0.0	3.3	1.6	28.0	2.6	24.0	38.8	9.7	0.9
SPI1	"OF, PU.1, SFPI1, SPI-1, SPI-A"	ENSG00000066336	"Spi-1 proto-oncogene"	P17947	11	47354860-47378576	"Predicted intracellular proteins, Predicted membrane proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding, RNA-binding"	Proto-oncogene	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 100.3;lymphoid tissue: 70.2"	"Group enriched"	"Detected in many"	5	"Hofbauer cells: 391.4;Kupffer cells: 374.7;Macrophages: 436.5;monocytes: 317.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"eosinophil: 45.4;neutrophil: 24.8"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 45.4"	"Cell line enhanced"	"Detected in some"		"HEL: 19.2;HL-60: 33.6;HMC-1: 62.7;NB-4: 56.7;THP-1: 44.2;U-698: 17.9;U-937: 25.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004079, HPA044653"	Enhanced		Supported	Nucleoplasm		NA	NA			Nucleoplasm		"CAB004079: AB_10692379, HPA044653: AB_2679036"	"unprognostic (4.45e-2)"	"unprognostic (3.31e-3)"	"unprognostic (2.92e-2)"	"unprognostic (1.66e-2)"	"unprognostic (5.97e-2)"	"unprognostic (3.33e-2)"	"unprognostic (5.28e-2)"	"unprognostic (1.07e-1)"	"unprognostic (2.35e-2)"	"unprognostic (2.79e-1)"	"unprognostic (3.36e-1)"	"unprognostic (1.78e-1)"	"prognostic unfavorable (2.07e-5)"	"unprognostic (1.20e-1)"	"unprognostic (4.95e-2)"	"unprognostic (2.40e-1)"	"unprognostic (4.92e-2)"	24.4	8.1	6.7	35.7	15.2	100.3	9.0	1.5	6.6	3.6	5.2	8.6	0.0	7.6	3.2	6.2	4.0	8.5	7.7	15.7	5.6	5.1	5.8	11.9	37.2	51.1	12.6	1.6	6.1	3.5	0.9	3.6	10.1	9.6	4.5	3.9	3.9	6.4	2.6	3.3	5.0	10.5	7.6	12.1	70.2	5.8	5.4	10.5	9.6	3.7	2.7	16.8	9.1	5.7	1.0	4.6	45.4	9.1	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	15.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.2	0.0	0.0	0.0	33.6	62.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.1	0.0	0.0	0.0	56.7	0.0	0.0	0.0	10.3	0.0	10.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	44.2	0.0	0.0	0.1	0.1	0.0	0.0	0.0	17.9	0.0	25.0	0.0	3.6	5.4	45.4	0.0	7.8	0.0	1.0	0.0	0.0	4.6	0.8	0.0	0.0	24.8	0.0	9.1	0.2	0.0	1.5	6.7	15.2	1.5	6.6	5.6	5.1	12.6	1.6	9.6	10.5	3.0	0.6	71.3	0.5	9.3	1.5	2.0	7.6	1.4	1.2	5.2	0.0	1.9	16.6	0.0	5.9	2.2	0.3	0.0	0.3	2.5	5.9	0.4	34.5	1.3	391.4	0.0	4.1	11.1	374.7	20.0	1.7	436.5	10.1	317.4	0.1	4.0	0.0	0.0	0.0	1.3	1.0	12.9	2.1	5.5	2.5	8.7	3.5	2.5	0.4	0.4
SRGN	"PPG, PRG, PRG1"	ENSG00000122862	Serglycin	P10124	10	69088106-69104811	"Plasma proteins, Predicted intracellular proteins"	"Apoptosis, Biomineralization"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 259.2;bone marrow: 657.4"	"Cell type enhanced"	"Detected in many"	14	"granulocytes: 2209.7;Kupffer cells: 1775.9;Macrophages: 2336.3;monocytes: 4414.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"neutrophil: 259.2"	"Lineage enriched"	"Detected in all"	6	"granulocytes: 259.2"	"Cell line enhanced"	"Detected in many"		"HL-60: 234.4;NB-4: 136.2;THP-1: 234.7;TIME: 141.6;U-937: 189.8"					"Low region specificity"	"Detected in many"			HPA000759	Enhanced		Supported	"Golgi apparatus"	"Intracellular and membrane"	NA	NA		50000000	"Golgi apparatus"		"HPA000759: AB_1079675"	"unprognostic (3.61e-2)"	"unprognostic (1.62e-2)"	"unprognostic (2.78e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.37e-1)"	"unprognostic (4.50e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.70e-2)"	"unprognostic (1.63e-1)"	"unprognostic (8.22e-2)"	"unprognostic (5.80e-2)"	"unprognostic (9.82e-2)"	"prognostic unfavorable (3.18e-5)"	"unprognostic (1.65e-1)"	"unprognostic (2.32e-2)"	"unprognostic (4.07e-2)"	"unprognostic (4.08e-2)"	51.3	12.3	11.0	74.4	18.7	657.4	27.0	5.7	11.8	11.6	13.8	9.7	3.4	8.1	11.6	10.5	13.3	19.6	31.6	31.9	21.0	14.0	29.1	23.2	107.8	87.1	18.4	3.0	11.9	7.4	6.5	13.2	33.0	32.9	12.7	12.6	15.7	8.4	6.8	15.1	3.7	16.8	21.1	42.4	129.8	11.7	10.7	12.6	28.2	15.2	6.5	31.1	46.1	16.2	3.3	28.4	259.2	46.1	40.8	22.7	53.1	0.2	2.2	0.0	0.0	43.7	42.8	0.0	5.1	3.4	12.8	15.7	0.0	0.9	0.4	6.4	0.2	7.3	0.0	0.0	1.0	44.6	27.8	0.0	4.5	1.8	0.0	17.9	234.4	51.3	17.4	0.0	35.7	2.2	12.3	66.7	0.6	4.1	23.1	67.7	0.0	0.9	136.2	0.0	0.0	4.4	0.1	0.1	23.5	0.0	0.3	0.0	0.0	0.1	0.0	0.8	0.0	0.1	234.7	141.6	10.6	0.6	0.2	1.0	27.0	26.1	3.0	6.3	189.8	0.0	82.5	46.1	116.7	22.7	34.3	14.8	3.3	11.0	16.9	26.1	1.6	6.2	13.2	259.2	40.8	29.7	28.4	17.1	53.1	11.0	18.7	5.7	11.8	21.0	14.0	18.4	3.0	32.9	12.6	104.2	308.1	287.9	9.6	156.3	0.7	10.0	25.5	83.0	102.4	31.4	0.0	6.4	0.0	1.9	2.9	366.4	0.0	46.7	8.1	6.8	94.4	8.3	2209.7	11.5	808.1	0.0	1.7	496.0	1775.9	3.4	6.9	2336.3	528.1	4414.9	0.4	1.0	1.5	0.3	17.0	3.6	4.8	71.1	133.9	0.7	2.0	124.0	11.9	1091.4	0.2	14.7
ST8SIA4	"PST, PST1, SIAT8D"	ENSG00000113532	"ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 4"	Q92187	5	100806935-100903266	"Predicted intracellular proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 37.1;lymphoid tissue: 34.7"	"Cell type enhanced"	"Detected in many"	11	"Kupffer cells: 79.2;Macrophages: 44.4;monocytes: 119.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"neutrophil: 37.1"	"Lineage enriched"	"Detected in all"	4	"granulocytes: 37.1"	"Cell line enhanced"	"Detected in many"		"AF22: 19.1;HDLM-2: 30.8;Karpas-707: 26.5;NB-4: 12.4;RPMI-8226: 19.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA051126, HPA053995"	Approved		Approved	"Golgi apparatus"	"Intracellular and membrane"	NA	NA		580000	"Golgi apparatus"		"HPA051126: AB_2681352, HPA053995: AB_2682336"	"unprognostic (2.25e-1)"	"unprognostic (2.04e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.98e-2)"	"unprognostic (1.14e-1)"	"unprognostic (6.45e-3)"	"unprognostic (1.91e-1)"	"unprognostic (5.46e-2)"	"unprognostic (2.87e-1)"	"unprognostic (1.49e-2)"	"unprognostic (1.71e-1)"	"unprognostic (1.17e-1)"	"prognostic unfavorable (7.80e-7)"	"unprognostic (6.07e-2)"	"unprognostic (4.38e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.23e-2)"	11.7	2.7	4.3	16.7	4.3	8.2	6.5	1.3	4.2	3.4	5.3	2.6	0.3	4.0	2.3	4.2	4.3	3.5	6.5	4.7	4.0	8.0	2.6	3.3	17.5	27.9	5.1	1.7	2.5	2.1	1.5	2.4	13.7	11.6	3.4	5.6	2.7	4.0	1.3	2.0	2.1	7.7	3.6	8.0	31.6	3.7	1.6	4.3	34.7	4.9	0.8	13.8	7.4	3.5	4.7	4.9	37.1	8.9	4.0	6.9	4.4	0.0	2.8	19.1	0.0	1.2	1.8	0.4	0.0	0.0	0.0	0.1	0.0	0.0	1.5	0.0	0.0	0.4	0.0	0.4	0.0	0.0	30.8	0.0	1.1	0.2	0.0	0.0	5.7	2.3	1.5	0.0	0.0	0.0	2.5	3.5	4.6	0.0	26.5	1.1	0.2	8.1	12.4	0.1	0.0	0.1	4.6	0.3	19.7	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	5.2	1.2	0.2	0.1	0.0	0.3	8.7	8.8	1.7	0.4	7.1	2.3	18.8	7.5	8.9	5.7	8.8	4.3	4.7	3.8	4.7	4.9	3.6	2.4	4.5	37.1	4.0	8.9	1.5	6.9	4.4	4.3	4.3	1.3	4.2	4.0	8.0	5.1	1.7	11.6	4.3	6.0	13.1	25.4	0.2	7.3	0.4	2.0	0.0	26.8	15.9	0.0	0.0	7.7	1.7	0.0	0.2	16.4	0.0	0.0	0.0	31.1	6.1	0.1	23.1	0.0	20.9	0.0	0.0	7.4	79.2	0.0	0.0	44.4	13.5	119.0	0.0	3.9	0.0	0.0	0.4	0.3	0.6	12.9	5.7	0.4	0.7	4.8	16.0	28.0	0.0	0.4
STK17B	DRAK2	ENSG00000081320	"Serine/threonine kinase 17b"	O94768	2	196133566-196176503	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	Apoptosis	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 62.0;bone marrow: 103.4;lymphoid tissue: 72.2"	"Cell type enhanced"	"Detected in many"	5	"B-cells: 158.6;granulocytes: 189.5;Kupffer cells: 142.8;Macrophages: 145.8;T-cells: 178.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Daudi: 36.3;HMC-1: 36.8;Karpas-707: 34.1;U-698: 39.5"	"Region enriched"	"Detected in many"	6	"cerebellum: 71.1"	"Low region specificity"	"Detected in all"			HPA034858	Enhanced		Uncertain	"Plasma membrane,Cytosol"		NA	Yes			"Plasma membrane, Cytosol"		"HPA034858: AB_10670981"	"unprognostic (2.14e-1)"	"unprognostic (2.45e-3)"	"unprognostic (3.68e-2)"	"unprognostic (3.61e-2)"	"unprognostic (3.63e-2)"	"unprognostic (7.43e-3)"	"unprognostic (1.75e-1)"	"unprognostic (7.63e-2)"	"unprognostic (9.15e-2)"	"unprognostic (1.14e-1)"	"unprognostic (9.90e-2)"	"unprognostic (1.52e-1)"	"prognostic unfavorable (5.72e-8)"	"unprognostic (1.88e-1)"	"unprognostic (1.19e-2)"	"unprognostic (2.64e-2)"	"unprognostic (5.80e-2)"	21.0	4.1	3.2	42.8	3.8	103.4	10.1	3.2	3.3	8.2	18.8	1.1	3.8	8.5	3.4	3.9	8.9	6.3	8.6	5.7	3.3	2.2	7.2	2.9	26.2	53.7	2.3	1.8	3.1	5.0	0.7	3.8	6.5	1.7	6.8	5.7	3.5	16.7	6.1	3.4	10.9	31.8	5.3	2.7	59.3	6.0	4.6	1.4	72.2	7.5	7.0	56.2	11.3	6.0	16.9	13.6	62.0	27.0	10.3	28.4	19.0	3.2	2.2	3.4	1.2	15.0	5.7	3.8	7.7	11.6	8.5	8.9	6.8	1.1	36.3	7.1	4.4	2.2	2.2	1.4	3.3	10.4	6.4	3.8	3.4	2.9	0.6	4.5	13.7	36.8	7.2	3.3	10.5	5.5	12.1	3.5	8.6	2.6	34.1	21.1	1.7	17.8	31.0	1.9	5.9	5.2	2.9	20.7	11.0	5.0	7.6	1.3	1.3	1.9	1.9	1.6	5.5	1.3	7.2	4.2	8.3	4.1	5.9	4.3	14.0	22.6	39.5	6.2	4.7	3.6	35.9	19.7	40.2	12.0	20.7	15.3	13.3	21.5	14.5	13.6	16.9	28.4	23.1	62.0	10.3	27.0	9.7	18.5	19.0	3.2	3.8	3.2	3.3	3.3	2.2	2.3	1.8	1.7	1.4	83.4	80.3	158.6	22.9	53.1	0.3	2.2	10.2	34.8	52.4	10.4	0.0	5.9	3.3	5.2	4.6	11.6	59.1	46.7	2.5	20.9	21.2	28.7	189.5	2.4	23.5	0.0	2.9	7.4	142.8	2.0	5.2	145.8	55.6	40.5	11.0	0.9	7.9	38.6	4.2	1.4	0.2	6.5	20.5	28.6	24.9	55.5	4.2	178.5	10.5	39.9
SUCNR1	GPR91	ENSG00000198829	"Succinate receptor 1"	Q9BXA5	3	151873643-151884619	"G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 63.1;lymphoid tissue: 23.3"	"Group enriched"	"Detected in some"	5	"Distal tubular cells: 16.6;Hofbauer cells: 18.9;Kupffer cells: 22.2;Macrophages: 11.8;Proximal tubular cells: 31.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Group enriched"	"Detected in some"	5	"eosinophil: 2.0;intermediate monocyte: 1.0;non-classical monocyte: 1.7;plasmacytoid DC: 2.2"	"Group enriched"	"Detected in many"	20	"dendritic cells: 2.2;granulocytes: 2.0;monocytes: 1.7"	"Group enriched"	"Detected in some"	5	"HEL: 28.0;NB-4: 16.2;U-937: 28.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			CAB022745	Uncertain					NA	NA					"CAB022745: "	"unprognostic (1.54e-1)"	"unprognostic (2.65e-2)"	"unprognostic (3.45e-2)"	"unprognostic (6.94e-2)"	"unprognostic (1.58e-1)"	"unprognostic (6.01e-2)"	"unprognostic (3.17e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.70e-1)"	"unprognostic (1.04e-1)"	"unprognostic (8.92e-2)"	"unprognostic (2.59e-1)"	"unprognostic (1.34e-3)"	"unprognostic (2.14e-1)"	"unprognostic (4.14e-2)"	"unprognostic (7.49e-2)"	"unprognostic (1.58e-1)"	13.7	1.6	0.6	0.7	0.9	4.7	1.6	0.2	1.2	0.3	0.5	0.7	0.0	0.7	0.4	0.6	0.5	0.3	0.2	2.8	0.4	0.4	63.1	3.6	2.2	3.3	0.6	0.1	0.7	0.4	4.2	0.3	0.2	0.8	0.5	0.5	0.1	1.3	0.0	0.3	0.7	0.5	0.3	0.5	23.3	6.7	0.4	0.0	1.3	14.6	0.8	0.3	0.7	0.3	0.0	2.2	2.0	1.7	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	28.0	0.0	0.0	0.0	3.9	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.2	0.0	0.0	0.0	0.0	0.0	4.5	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	28.0	0.0	0.0	0.1	2.0	0.0	1.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.3	0.0	1.7	2.2	0.0	0.2	0.6	0.9	0.2	1.2	0.4	0.4	0.6	0.1	0.8	0.0	0.0	0.6	0.0	0.0	0.2	0.0	0.4	0.0	2.7	0.0	3.5	0.0	0.0	16.6	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	4.2	18.9	0.0	0.0	0.0	22.2	0.0	0.0	11.8	0.0	0.0	0.0	0.0	0.1	0.0	0.0	31.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0
SYK		ENSG00000165025	"Spleen associated tyrosine kinase"	P43405	9	90801787-90898549	"Cancer-related genes, Enzymes, Predicted intracellular proteins"	"Adaptive immunity, Angiogenesis, Host-virus interaction, Immunity, Innate immunity"	"Kinase, Transferase, Tyrosine-protein kinase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 38.5"	"Cell type enhanced"	"Detected in many"	6	"B-cells: 53.8;Hofbauer cells: 63.0;Kupffer cells: 79.3;Macrophages: 66.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	15	"classical monocyte: 21.4;eosinophil: 23.3;intermediate monocyte: 19.0;memory B-cell: 23.1;myeloid DC: 24.9;naive B-cell: 17.5;neutrophil: 32.8;NK-cell: 8.7;non-classical monocyte: 16.4;plasmacytoid DC: 18.5"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"Daudi: 39.4;HEL: 22.7;HL-60: 31.3;HMC-1: 20.9;REH: 26.2;THP-1: 24.1;U-698: 18.6;U-937: 22.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA001384, CAB007773"	Enhanced		Approved	"Vesicles,Plasma membrane,Cytosol"		No	NA		1000000	"Plasma membrane, Cytosol"	Vesicles	"CAB007773: AB_562232, HPA001384: AB_1080144"	"unprognostic (1.01e-1)"	"unprognostic (5.45e-2)"	"unprognostic (2.10e-1)"	"unprognostic (2.69e-2)"	"unprognostic (2.31e-1)"	"unprognostic (7.92e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.34e-1)"	"unprognostic (6.41e-2)"	"unprognostic (1.78e-2)"	"unprognostic (7.20e-2)"	"unprognostic (9.93e-2)"	"unprognostic (2.55e-3)"	"unprognostic (8.77e-2)"	"unprognostic (5.36e-3)"	"unprognostic (3.41e-2)"	"unprognostic (1.06e-2)"	7.2	3.3	6.0	38.1	9.6	18.2	6.7	1.1	4.5	3.7	10.3	6.7	1.5	12.3	2.3	6.7	16.2	6.9	6.6	5.5	7.2	3.2	8.6	2.5	13.7	36.4	9.1	2.5	2.1	8.9	25.9	3.1	5.0	6.1	4.1	8.3	2.8	8.9	1.8	1.4	8.3	22.2	3.5	11.3	38.5	7.4	5.5	7.9	30.5	18.1	7.8	32.2	8.6	7.5	23.1	24.9	32.8	21.4	8.7	0.1	10.2	7.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.6	39.4	1.1	0.0	1.3	6.1	0.8	3.2	0.0	0.0	5.4	22.7	0.0	0.0	0.0	31.3	20.9	0.0	4.5	0.0	0.4	0.0	0.0	4.9	0.6	3.2	0.0	4.8	0.0	13.7	0.2	14.8	0.0	26.2	0.0	10.8	0.8	5.9	2.1	1.8	0.0	2.8	0.0	0.1	2.5	24.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	18.6	0.0	22.1	0.0	1.4	21.4	23.3	0.1	19.0	0.1	23.1	0.0	0.0	24.9	17.5	0.0	0.0	32.8	8.7	16.4	18.5	0.0	10.2	6.0	9.6	1.1	4.5	7.2	3.2	9.1	2.5	6.1	7.9	11.9	22.7	53.8	3.7	3.1	0.9	1.6	12.7	12.0	17.0	14.0	0.0	1.2	13.3	12.6	5.5	1.1	18.4	0.0	10.9	1.3	1.1	1.8	40.6	0.9	63.0	0.0	9.9	4.9	79.3	4.7	0.6	66.0	11.8	24.4	23.8	0.0	15.3	28.1	0.0	0.3	0.1	6.5	1.0	0.7	0.7	5.0	1.1	5.3	24.7	6.5
TAGAP	"ARHGAP47, FLJ32631, IDDM21"	ENSG00000164691	"T cell activation RhoGTPase activating protein"	Q8N103	6	159034468-159045152	"Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 47.9;bone marrow: 55.6;lymphoid tissue: 32.7"	"Cell type enhanced"	"Detected in many"	13	"B-cells: 68.1;Macrophages: 53.7;T-cells: 89.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"Daudi: 14.4;HMC-1: 21.0;Karpas-707: 21.9;U-266/84: 9.8;U-698: 20.2;U-937: 16.1"					"Low region specificity"	"Detected in all"			"HPA031000, HPA039982"	Uncertain		Approved	Cytosol		NA	NA			Cytosol		"HPA031000: AB_10610560, HPA039982: "	"unprognostic (9.86e-3)"	"unprognostic (7.55e-2)"	"unprognostic (2.41e-2)"	"unprognostic (1.56e-2)"	"unprognostic (6.36e-2)"	"unprognostic (3.10e-3)"	"unprognostic (1.04e-1)"	"unprognostic (5.25e-2)"	"unprognostic (3.35e-3)"	"unprognostic (8.39e-2)"	"unprognostic (6.19e-2)"	"unprognostic (2.41e-1)"	"unprognostic (1.49e-1)"	"unprognostic (7.25e-2)"	"unprognostic (1.15e-1)"	"unprognostic (5.24e-2)"	"unprognostic (7.39e-2)"	4.4	2.3	1.5	16.9	2.1	55.6	2.5	0.9	2.0	1.9	2.5	7.9	1.3	1.7	9.7	1.8	2.7	2.1	4.1	2.0	1.9	3.7	2.2	2.4	8.4	32.7	5.0	1.1	1.9	1.0	0.4	1.4	2.8	3.9	1.9	3.6	3.2	3.2	1.8	0.8	1.4	11.8	12.2	9.2	22.1	2.7	1.7	3.0	32.6	2.2	4.0	32.1	6.8	1.9	14.9	7.8	47.9	7.7	12.0	22.0	14.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	3.2	0.0	0.0	0.0	7.4	21.0	0.1	0.0	0.0	0.0	0.0	0.0	4.6	0.0	21.9	0.0	0.0	1.9	3.9	5.9	0.0	0.0	0.7	0.0	0.7	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.6	0.0	3.4	0.1	0.0	0.0	0.0	0.0	2.4	9.8	20.2	0.0	16.1	0.0	38.7	7.7	23.6	16.4	5.5	18.5	13.9	22.0	19.0	7.8	14.9	17.4	12.1	47.9	12.0	7.0	2.6	15.5	14.4	1.5	2.1	0.9	2.0	1.9	3.7	5.0	1.1	3.9	3.0	3.0	10.0	68.1	0.2	2.5	0.1	0.4	0.0	1.4	1.2	0.0	0.0	0.5	0.0	0.0	0.2	0.6	0.0	0.0	0.0	0.4	3.7	0.4	18.5	0.8	23.7	0.0	0.0	1.8	19.5	0.9	1.1	53.7	27.0	0.0	0.0	0.3	0.0	0.0	21.2	0.2	0.1	0.0	0.3	0.0	0.1	2.4	0.7	89.6	0.0	0.3
TBXAS1	"CYP5, CYP5A1, THAS, TS, TXAS, TXS"	ENSG00000059377	"Thromboxane A synthase 1"	P24557	7	139777051-140020325	"Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism, Prostaglandin biosynthesis, Prostaglandin metabolism"	"Isomerase, Monooxygenase, Oxidoreductase"	"Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 67.1;lymphoid tissue: 51.7"	"Group enriched"	"Detected in many"	5	"granulocytes: 69.3;Hofbauer cells: 78.3;Kupffer cells: 159.9;Macrophages: 116.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	13	"basophil: 38.1;classical monocyte: 44.5;eosinophil: 45.2;intermediate monocyte: 67.1;myeloid DC: 18.7;neutrophil: 38.8;non-classical monocyte: 56.4"	"Group enriched"	"Detected in all"	20	"dendritic cells: 18.7;granulocytes: 45.2;monocytes: 67.1"	"Cell line enhanced"	"Detected in some"		"NB-4: 35.3;PC-3: 11.4;RPTEC TERT1: 10.1;U-937: 28.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"HPA031257, HPA031258, HPA031259"	Enhanced					NA	NA		32000000			"HPA031257: AB_2673812, HPA031258: AB_2673813, HPA031259: AB_2673814"	"unprognostic (4.46e-2)"	"unprognostic (3.07e-1)"	"unprognostic (8.80e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.72e-1)"	"unprognostic (9.41e-2)"	"unprognostic (5.10e-2)"	"unprognostic (3.12e-1)"	"unprognostic (2.38e-1)"	"unprognostic (3.07e-2)"	"unprognostic (1.11e-1)"	"unprognostic (3.03e-2)"	"prognostic unfavorable (1.14e-4)"	"unprognostic (1.52e-1)"	"unprognostic (5.00e-3)"	"unprognostic (8.53e-2)"	"unprognostic (5.34e-2)"	13.5	7.7	6.6	17.6	8.9	13.8	5.4	1.5	5.6	3.7	6.3	13.9	0.8	6.5	3.2	4.1	3.4	5.0	13.9	3.7	7.6	5.7	6.1	8.1	20.3	43.9	12.6	2.0	2.5	3.1	1.4	3.5	9.0	9.0	5.2	8.6	4.4	8.2	2.6	1.6	1.9	9.3	7.9	19.3	51.7	7.1	2.0	12.7	7.5	2.4	2.2	6.1	9.3	2.5	1.3	18.7	45.2	67.1	1.5	2.2	25.1	0.1	3.0	0.1	0.0	0.6	1.9	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	5.9	0.0	0.1	0.0	0.0	0.0	0.0	4.6	0.4	8.3	0.0	0.0	0.8	2.8	7.4	1.0	0.0	0.0	0.4	0.5	1.1	0.0	0.2	1.0	0.3	0.0	1.0	35.3	0.1	8.3	11.4	1.3	0.0	0.5	10.1	0.0	0.1	0.5	0.1	0.0	0.3	0.0	0.0	6.7	0.9	0.3	0.1	0.7	0.5	2.4	0.4	0.1	0.2	28.7	0.9	38.1	44.5	45.2	1.1	67.1	1.7	1.3	2.2	0.6	18.7	0.5	0.3	0.2	38.8	1.5	56.4	3.3	2.0	25.1	6.6	8.9	1.5	5.6	7.6	5.7	12.6	2.0	9.0	12.7	3.0	16.2	6.0	0.9	0.3	1.0	0.8	7.6	1.4	2.3	1.8	5.9	0.4	8.3	4.3	0.4	2.9	0.1	0.0	8.4	0.6	0.8	7.4	69.3	4.0	78.3	3.2	1.7	18.4	159.9	0.4	0.3	116.3	3.3	16.2	2.0	3.2	3.9	7.0	0.0	4.6	3.8	19.4	0.9	0.4	0.4	0.5	0.5	14.9	2.7	1.0
TFEC	"bHLHe34, TCFEC, TFECL"	ENSG00000105967	"Transcription factor EC"	O14948	7	115935148-116159896	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 22.6"	"Group enriched"	"Detected in some"	6	"Hofbauer cells: 40.9;Kupffer cells: 42.8;Macrophages: 48.6;Proximal tubular cells: 52.2"	"Cancer enhanced"	"Detected in many"		"renal cancer: 5.2"	"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"classical monocyte: 8.7;myeloid DC: 7.7"	"Group enriched"	"Detected in many"	32	"B-cells: 4.9;dendritic cells: 7.7;monocytes: 8.7"	"Cell line enhanced"	"Detected in some"		"HEL: 12.3;HUVEC TERT2: 8.6;THP-1: 16.3;TIME: 9.6;U-937: 18.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"CAB032260, HPA063577"	Approved		Supported	Nucleoplasm		NA	NA			Nucleoplasm		"CAB032260: AB_2202845, HPA063577: AB_2685047"	"unprognostic (1.36e-1)"	"unprognostic (1.08e-2)"	"unprognostic (8.70e-2)"	"unprognostic (1.91e-2)"	"unprognostic (1.44e-1)"	"unprognostic (2.79e-2)"	"unprognostic (1.13e-1)"	"unprognostic (8.26e-2)"	"unprognostic (2.15e-1)"	"unprognostic (6.54e-2)"	"unprognostic (2.36e-1)"	"unprognostic (1.72e-1)"	"unprognostic (2.05e-3)"	"unprognostic (2.92e-1)"	"unprognostic (4.14e-2)"	"unprognostic (1.51e-1)"	"unprognostic (3.60e-2)"	11.2	3.5	5.8	15.4	9.2	12.3	7.6	0.8	4.6	1.8	3.7	1.4	0.6	3.4	1.6	6.1	2.4	2.6	4.2	2.5	6.0	2.1	22.6	2.8	15.7	17.0	13.0	2.2	1.6	1.8	0.4	1.8	3.9	8.8	1.9	3.6	0.8	3.1	0.7	1.2	1.3	11.6	2.6	15.2	16.4	2.3	1.7	9.4	1.6	2.1	1.1	10.0	3.8	1.7	4.9	7.7	0.2	8.7	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	2.8	0.0	1.3	0.1	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	12.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	8.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	16.3	9.6	1.7	0.1	1.0	0.0	4.3	0.0	0.0	0.0	18.5	0.9	0.0	8.7	0.0	0.0	3.7	0.0	4.9	0.0	0.0	7.7	2.1	0.0	0.0	0.2	0.0	0.5	3.9	0.0	1.7	5.8	9.2	0.8	4.6	6.0	2.1	13.0	2.2	8.8	9.4	0.0	2.1	5.0	0.0	0.5	0.0	0.7	2.5	0.0	0.0	3.5	0.0	0.1	0.0	0.0	1.6	0.1	0.0	0.0	0.0	0.2	0.3	0.0	2.3	0.0	40.9	0.0	0.0	0.0	42.8	2.7	0.0	48.6	0.0	8.2	0.0	0.0	0.1	0.0	0.0	52.2	0.0	0.0	0.0	0.2	0.4	0.4	0.7	0.0	0.0	0.0
TGFBI	"BIGH3, CDB1, CDGG1, CSD1, CSD2, CSD3, LCD1"	ENSG00000120708	"Transforming growth factor beta induced"	Q15582	5	136028895-136063818	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Cell adhesion, Sensory transduction, Vision"		"Amyloidosis, Corneal dystrophy, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	10	"Hofbauer cells: 254.4;Kupffer cells: 259.4;Macrophages: 225.7;Pancreatic endocrine cells: 363.6"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in all"	5	"pons and medulla: 19.7"	"Group enriched"	"Detected in many"	30	"classical monocyte: 41.9;intermediate monocyte: 27.0;myeloid DC: 28.6;non-classical monocyte: 20.6;plasmacytoid DC: 61.2"	"Group enriched"	"Detected in many"	43	"dendritic cells: 61.2;monocytes: 41.9"	"Cell line enhanced"	"Detected in many"		"fHDF/TERT166: 157.9;GAMG: 129.4;HSkMC: 164.8;hTCEpi: 114.6;LHCN-M2: 131.0;U-2197: 114.5;U-87 MG: 219.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA008612, HPA017019"	Enhanced				"Secreted to blood"	NA	NA		1400000000			"HPA008612: AB_1857970, HPA017019: AB_2669511"	"unprognostic (1.05e-1)"	"prognostic unfavorable (1.03e-5)"	"unprognostic (4.38e-3)"	"prognostic favorable (1.17e-4)"	"unprognostic (5.21e-3)"	"unprognostic (5.53e-3)"	"unprognostic (4.60e-2)"	"unprognostic (8.71e-3)"	"unprognostic (5.45e-2)"	"prognostic unfavorable (1.14e-5)"	"unprognostic (1.42e-3)"	"unprognostic (2.26e-1)"	"prognostic unfavorable (7.82e-10)"	"unprognostic (8.81e-3)"	"unprognostic (1.73e-2)"	"unprognostic (3.42e-1)"	"unprognostic (1.70e-3)"	51.3	16.6	1.8	30.4	3.9	4.3	32.2	1.1	6.5	14.1	24.2	5.2	16.2	9.2	30.2	71.9	21.1	15.2	94.9	53.0	4.1	2.9	21.7	47.5	42.5	65.1	3.7	2.4	27.0	10.5	3.3	23.7	90.0	19.7	27.0	16.9	21.8	21.1	13.1	24.1	63.8	22.4	56.5	10.1	41.6	21.2	18.2	2.1	21.2	12.0	40.1	18.8	46.3	24.4	0.2	61.2	0.9	41.9	1.2	0.3	15.1	5.7	23.6	0.0	0.2	66.7	22.0	0.0	17.6	2.2	12.1	7.3	10.6	74.2	0.0	10.8	157.9	129.4	28.5	0.0	56.7	10.8	0.1	0.0	0.0	28.3	28.6	44.6	0.0	0.2	164.8	114.6	4.5	5.1	43.6	10.3	0.0	0.0	0.2	131.0	0.2	0.0	0.0	0.7	0.2	0.0	0.0	1.2	0.1	5.7	0.5	0.0	0.0	27.8	0.9	0.2	24.0	0.2	6.3	43.5	82.5	3.5	114.5	62.9	0.0	0.0	0.0	219.3	0.0	62.9	0.2	41.9	0.1	0.1	27.0	0.2	0.2	0.2	0.3	28.6	0.0	0.0	0.2	0.9	1.2	20.6	61.2	0.1	15.1	1.8	3.9	1.1	3.0	4.1	2.9	3.7	2.4	19.7	2.1	3.0	25.0	13.3	3.2	106.1	0.1	6.4	7.6	4.0	9.1	1.8	0.0	6.6	0.0	39.9	1.8	14.7	0.0	23.3	98.6	5.6	70.4	0.9	4.7	21.2	254.4	1.6	3.4	32.5	259.4	1.3	9.5	225.7	47.2	8.2	2.0	0.0	363.6	0.0	2.1	1.6	0.2	25.8	143.8	0.2	0.8	48.7	16.2	2.5	0.4	2.0
THEMIS2	"C1orf38, ICB-1"	ENSG00000130775	"Thymocyte selection associated family member 2"	Q5TEJ8	1	27872543-27886685	"Predicted intracellular proteins"	"Immunity, Inflammatory response"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 72.0;bone marrow: 72.3;lymphoid tissue: 73.0"	"Cell type enhanced"	"Detected in many"	12	"Hofbauer cells: 60.6;Kupffer cells: 120.5;Macrophages: 117.1;monocytes: 154.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"dendritic cells: 43.6;granulocytes: 72.0;monocytes: 62.6"	"Cell line enhanced"	"Detected in many"		"Karpas-707: 48.2;U-266/70: 37.4;U-937: 21.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA027513, HPA031096"	Uncertain		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA027513: , HPA031096: AB_10599254"	"unprognostic (7.38e-2)"	"unprognostic (6.56e-2)"	"unprognostic (5.07e-2)"	"unprognostic (1.99e-3)"	"unprognostic (4.51e-2)"	"unprognostic (5.56e-3)"	"unprognostic (4.13e-1)"	"unprognostic (8.21e-2)"	"unprognostic (1.77e-2)"	"unprognostic (3.05e-2)"	"unprognostic (1.38e-2)"	"unprognostic (8.96e-2)"	"unprognostic (7.21e-3)"	"unprognostic (5.07e-2)"	"unprognostic (1.42e-2)"	"unprognostic (2.24e-3)"	"unprognostic (4.52e-3)"	13.4	5.2	4.3	27.2	7.2	72.3	5.8	0.9	4.6	3.6	7.2	10.7	0.3	4.1	3.0	6.6	4.6	5.4	9.5	6.5	7.1	4.6	5.9	7.5	22.1	39.0	11.5	2.7	3.8	2.7	1.0	2.7	7.1	7.8	2.8	4.2	6.0	6.0	1.8	2.3	2.3	12.7	6.0	16.4	73.0	4.8	9.9	6.7	12.5	5.3	1.1	25.2	7.8	3.3	6.5	43.6	72.0	62.6	8.5	11.3	40.5	3.2	0.1	1.2	0.2	4.1	5.7	0.5	0.6	7.0	10.3	14.6	0.4	0.8	4.5	0.4	2.2	5.7	0.4	1.8	0.4	1.6	0.6	0.4	6.3	0.1	0.9	8.2	7.8	10.3	2.9	0.1	5.3	0.0	0.5	3.9	0.3	8.8	48.2	0.7	2.1	0.3	6.8	4.1	0.1	0.7	1.4	4.6	7.9	3.0	0.1	0.0	1.8	0.0	0.2	9.0	0.7	0.1	6.9	2.4	0.6	0.0	2.0	0.1	37.4	2.1	0.3	11.6	21.9	0.1	4.4	54.1	47.1	11.3	62.6	10.3	6.5	8.2	9.1	43.6	2.9	7.1	7.3	72.0	8.5	60.9	17.7	7.9	40.5	4.3	7.2	0.9	4.6	7.1	4.6	11.5	2.7	7.8	6.7	3.0	30.7	30.5	1.4	2.9	0.3	0.5	5.1	1.4	5.7	0.0	0.0	0.6	0.0	0.5	0.9	2.2	0.0	0.0	7.5	1.0	1.8	2.2	12.7	0.8	60.6	0.0	10.3	5.5	120.5	3.6	0.6	117.1	16.9	154.1	0.1	0.0	7.4	0.0	0.4	0.3	0.2	0.0	0.5	0.7	1.9	1.0	2.1	49.0	0.0	3.8
TIMP1	"CLGI, EPO, TIMP"	ENSG00000102265	"TIMP metallopeptidase inhibitor 1"	P01033	X	47582313-47586789	"Cancer-related genes, Candidate cardiovascular disease genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"		"Growth factor, Metalloenzyme inhibitor, Metalloprotease inhibitor, Protease inhibitor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 293.3"	"Cell type enhanced"	"Detected in many"	7	"Ito cells: 2535.0;Leydig cells: 1644.5;Macrophages: 2104.1;Peritubular cells: 1468.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC diff: 164.6;ASC TERT1: 220.3;HSkMC: 150.9;U-87 MG: 142.1"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"CAB022360, HPA053417"	Approved		Approved	"Golgi apparatus"	"Secreted to blood"	NA	NA	127000000	750000000	"Golgi apparatus"		"CAB022360: , HPA053417: AB_2682142"	"unprognostic (5.86e-3)"	"unprognostic (1.30e-1)"	"prognostic unfavorable (2.09e-4)"	"unprognostic (4.68e-2)"	"unprognostic (1.81e-2)"	"unprognostic (1.07e-3)"	"unprognostic (4.99e-2)"	"unprognostic (8.24e-3)"	"unprognostic (9.12e-3)"	"unprognostic (9.69e-2)"	"unprognostic (9.10e-2)"	"unprognostic (2.17e-1)"	"prognostic unfavorable (2.90e-11)"	"unprognostic (1.88e-2)"	"unprognostic (1.61e-1)"	"unprognostic (1.92e-2)"	"unprognostic (2.66e-1)"	80.2	82.3	6.3	154.0	12.8	9.2	31.8	3.3	8.4	63.5	29.1	6.5	27.2	6.1	48.9	109.6	34.9	53.5	110.9	105.7	9.2	5.5	71.2	115.9	144.8	293.3	8.4	4.8	149.3	22.2	41.8	48.7	125.5	29.5	62.9	19.0	33.4	45.9	42.0	26.1	11.6	13.2	64.5	14.6	69.3	19.3	71.9	4.6	8.8	98.6	14.6	34.8	121.0	46.8	2.3	56.8	57.1	91.5	9.4	26.4	39.7	9.6	16.1	7.9	93.2	164.6	220.3	1.9	104.6	86.5	32.6	26.4	6.3	18.1	0.1	13.8	134.5	18.9	9.5	4.3	44.4	21.1	19.5	10.2	9.9	11.8	9.8	109.5	6.6	126.8	150.9	11.4	99.4	21.2	38.0	14.6	0.0	15.3	7.3	54.0	18.8	0.1	25.5	8.8	11.5	33.8	0.1	16.2	8.6	52.6	6.7	0.1	0.4	62.0	0.4	13.2	15.3	0.8	12.9	14.1	48.9	51.5	57.6	10.2	3.1	6.5	0.3	142.1	16.0	31.7	29.5	54.6	0.8	16.2	91.5	16.0	2.3	26.4	14.3	56.8	1.2	8.6	7.7	57.1	9.4	83.6	1.6	10.7	39.7	6.3	12.8	3.3	5.3	9.2	5.5	8.4	4.8	29.5	4.6	101.3	235.0	76.3	526.8	205.4	19.6	8.1	374.5	117.8	310.5	125.6	0.0	21.5	0.0	407.2	18.1	600.1	19.3	0.0	372.2	201.1	871.1	751.9	475.1	110.9	305.2	0.0	266.3	2535.0	691.3	38.8	1644.5	2104.1	485.9	250.7	58.9	120.3	535.0	52.1	1468.0	7.0	6.7	679.1	606.7	17.9	10.8	152.7	37.6	115.1	45.8	406.7
TLR1	"CD281, KIAA0012, rsc786"	ENSG00000174125	"Toll like receptor 1"	Q15399	4	38790677-38856817	"CD markers, Predicted intracellular proteins, Predicted membrane proteins"	"Immunity, Inflammatory response, Innate immunity"	"Hydrolase, Receptor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 43.3;lymphoid tissue: 40.4"	"Cell type enhanced"	"Detected in many"	14	"Hofbauer cells: 14.0;Kupffer cells: 33.2;Macrophages: 18.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 43.3"	"Group enriched"	"Detected in all"	6	"granulocytes: 43.3;monocytes: 13.1"	"Cell line enhanced"	"Detected in many"		"Daudi: 9.6;HUVEC TERT2: 11.0;RPMI-8226: 11.9;U-698: 17.8"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"									NA	NA						"unprognostic (7.82e-2)"	"unprognostic (3.35e-3)"	"unprognostic (4.02e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.71e-1)"	"unprognostic (1.85e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.80e-1)"	"unprognostic (3.88e-1)"	"unprognostic (1.04e-1)"	"unprognostic (3.94e-2)"	"unprognostic (1.76e-1)"	"unprognostic (7.25e-3)"	"unprognostic (4.08e-2)"	"unprognostic (1.91e-2)"	"unprognostic (2.08e-1)"	"unprognostic (3.97e-2)"	10.9	4.6	7.1	17.9	11.4	21.0	5.4	2.0	6.0	3.4	3.7	5.9	0.5	4.2	5.8	3.9	3.2	5.3	6.5	4.0	6.5	3.4	4.6	5.8	9.8	26.4	12.9	2.6	7.4	7.7	1.0	4.2	6.6	10.6	3.9	4.6	2.2	11.0	2.5	1.7	3.1	6.7	6.5	19.4	40.4	4.2	1.6	10.9	10.1	2.4	1.7	13.1	6.3	2.8	2.3	4.5	43.3	13.1	1.8	1.1	2.4	0.2	1.7	0.1	0.0	0.2	1.3	0.0	0.0	0.4	0.1	1.0	0.2	4.7	9.6	1.0	0.0	4.7	0.3	0.1	1.2	0.2	1.1	0.5	1.2	0.4	0.0	0.0	1.8	0.5	0.4	0.2	0.4	0.0	0.4	11.0	0.2	1.3	2.9	1.4	0.0	0.4	3.9	0.0	0.0	0.0	6.5	0.1	11.9	1.1	0.0	0.0	1.4	0.0	0.1	0.4	0.1	0.1	2.3	2.8	1.0	0.4	0.1	0.6	1.1	0.1	17.8	2.5	6.6	0.3	0.0	6.8	2.6	1.0	10.4	0.8	2.3	1.1	0.8	4.5	2.0	1.1	0.6	43.3	1.8	13.1	1.5	0.4	2.4	7.1	11.4	2.0	6.0	6.5	3.4	12.9	2.6	10.6	10.9	0.0	1.0	6.4	0.5	0.2	0.2	0.0	0.0	8.1	2.3	1.8	0.0	0.1	1.7	3.9	0.0	2.1	0.2	0.0	3.8	0.2	0.7	1.0	3.5	2.5	14.0	0.0	0.0	0.0	33.2	0.0	0.0	18.2	0.0	2.8	0.3	1.7	1.9	0.0	2.5	1.2	0.2	0.0	0.0	0.1	0.1	0.5	0.1	4.4	1.5	0.9
TLR2	"CD282, TIL4"	ENSG00000137462	"Toll like receptor 2"	O60603	4	153684070-153705702	"CD markers, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Immunity, Inflammatory response, Innate immunity"	"Hydrolase, Receptor"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 72.9"	"Group enriched"	"Detected in many"	5	"Alveolar cells type 2: 64.7;Kupffer cells: 106.5;Macrophages: 52.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"classical monocyte: 29.5;intermediate monocyte: 28.1;myeloid DC: 19.1;neutrophil: 72.9;non-classical monocyte: 18.4"	"Group enriched"	"Detected in many"	46	"dendritic cells: 19.1;granulocytes: 72.9;monocytes: 29.5"	"Cell line enhanced"	"Detected in some"		"HL-60: 6.9;HSkMC: 7.5;hTCEpi: 7.5;RPTEC TERT1: 7.7;RT4: 9.5;THP-1: 36.3;U-937: 6.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA060231, HPA071546"			Supported	Nucleoplasm,Mitochondria		No	NA			"Nucleoplasm, Mitochondria"		"HPA060231: , HPA071546: "	"unprognostic (4.15e-1)"	"unprognostic (3.29e-2)"	"unprognostic (5.32e-2)"	"unprognostic (1.52e-2)"	"unprognostic (3.46e-2)"	"unprognostic (4.88e-2)"	"unprognostic (1.39e-2)"	"unprognostic (4.24e-2)"	"unprognostic (2.48e-1)"	"unprognostic (2.02e-2)"	"unprognostic (2.04e-1)"	"unprognostic (1.33e-1)"	"prognostic unfavorable (1.11e-4)"	"unprognostic (7.87e-2)"	"unprognostic (3.80e-3)"	"unprognostic (1.42e-1)"	"unprognostic (5.93e-3)"	16.3	6.9	6.9	30.0	11.1	34.6	7.3	1.4	5.3	4.7	4.7	3.0	9.3	2.2	3.1	8.0	3.2	7.2	10.0	7.2	6.7	3.3	9.8	7.3	31.1	37.8	12.4	1.4	4.2	5.1	1.1	4.4	6.4	9.9	5.5	1.9	3.3	15.0	9.9	2.5	3.1	4.0	6.6	21.9	29.3	3.9	4.8	9.5	0.9	3.3	1.0	8.5	7.3	3.5	0.2	19.1	72.9	29.5	0.8	0.2	9.3	4.0	0.0	0.2	0.0	0.5	1.6	0.0	0.0	0.3	0.3	0.5	1.9	0.2	0.0	0.4	0.0	0.0	3.6	0.4	0.3	0.2	0.0	0.0	0.1	0.0	0.4	0.0	6.9	0.5	7.5	7.5	0.0	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.4	0.4	0.0	1.6	0.1	0.0	0.0	7.7	9.5	0.0	0.2	0.4	0.0	1.8	0.2	0.0	36.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	6.9	0.9	6.2	29.5	0.2	0.0	28.1	0.0	0.0	0.1	0.0	19.1	0.2	0.2	0.0	72.9	0.8	18.4	0.1	0.0	9.3	6.9	11.1	1.4	5.3	6.7	3.3	12.4	1.4	9.9	9.5	6.0	64.7	0.8	1.1	1.0	0.0	1.2	5.1	2.7	12.5	3.5	0.0	0.1	0.0	4.8	0.3	0.6	0.0	0.0	3.2	0.1	0.9	2.0	3.5	0.9	16.3	0.0	0.0	2.5	106.5	0.0	0.6	52.5	1.7	0.0	0.1	0.0	3.1	0.0	0.4	1.0	0.3	12.9	0.4	0.2	0.4	1.0	0.1	0.7	0.0	1.4
TLR4	"ARMD10, CD284, hToll, TLR-4"	ENSG00000136869	"Toll like receptor 4"	O00206	9	117704175-117724730	"CD markers, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Immunity, Inflammatory response, Innate immunity"	"Hydrolase, Receptor"	"Age-related macular degeneration, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	15	"Hofbauer cells: 31.7;Ito cells: 59.5;Kupffer cells: 88.0;Macrophages: 33.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 30.1"	"Group enriched"	"Detected in many"	30	"dendritic cells: 7.5;granulocytes: 30.1;monocytes: 21.4"	"Cell line enhanced"	"Detected in many"		"Karpas-707: 29.6;TIME: 21.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"CAB004025, HPA049174"	Approved		Supported	"Golgi apparatus,Plasma membrane"	"Intracellular and membrane"	NA	NA			"Plasma membrane"	"Golgi apparatus"	"CAB004025: , HPA049174: AB_2680662"	"unprognostic (1.60e-1)"	"unprognostic (8.34e-2)"	"unprognostic (7.22e-2)"	"prognostic favorable (6.29e-4)"	"unprognostic (3.39e-1)"	"unprognostic (7.48e-2)"	"unprognostic (8.68e-2)"	"unprognostic (1.80e-1)"	"unprognostic (3.38e-1)"	"unprognostic (5.18e-2)"	"unprognostic (8.00e-2)"	"unprognostic (9.42e-2)"	"unprognostic (4.08e-2)"	"unprognostic (8.63e-2)"	"prognostic unfavorable (3.79e-4)"	"unprognostic (1.09e-2)"	"unprognostic (1.96e-2)"	29.2	12.1	15.5	23.5	12.5	17.8	21.9	9.4	10.3	6.9	6.8	10.6	3.0	4.4	5.8	7.7	5.0	6.8	10.6	10.9	19.9	7.5	9.0	16.5	16.0	30.9	12.4	11.4	6.7	3.0	2.9	3.8	22.8	10.5	5.7	7.4	7.2	9.0	3.6	7.4	5.2	6.6	10.4	11.1	41.4	4.5	2.4	13.0	1.1	8.3	5.6	7.5	12.1	16.1	0.6	7.5	30.1	21.4	0.0	0.0	6.9	0.0	0.0	12.7	0.0	5.9	12.0	0.1	5.0	8.8	1.3	0.7	0.0	1.2	1.7	0.2	13.0	3.9	0.0	0.0	1.1	1.9	0.0	0.0	2.7	2.7	0.1	4.4	9.1	0.0	7.4	0.0	2.8	0.3	11.4	15.5	0.0	0.0	29.6	15.4	0.0	0.0	1.8	1.5	1.2	0.6	0.0	14.3	9.3	0.5	14.8	0.0	0.0	3.2	0.0	0.5	1.2	0.0	5.0	21.4	0.7	9.6	0.0	2.4	0.0	0.0	0.0	0.4	9.6	7.6	17.6	21.4	7.2	0.0	19.6	0.0	0.6	0.0	0.0	7.5	0.2	0.0	0.0	30.1	0.0	20.2	0.3	0.0	6.9	15.5	12.5	9.4	10.3	19.9	7.5	12.4	11.4	10.5	13.0	0.0	5.3	1.5	0.1	0.7	0.2	2.5	5.1	2.7	4.5	0.0	0.0	0.2	0.0	0.0	0.0	19.7	0.3	0.0	0.2	0.2	1.9	0.2	15.1	1.8	31.7	0.0	0.0	59.5	88.0	0.0	0.0	33.1	1.7	0.0	0.6	13.8	0.3	1.7	0.0	0.4	0.8	6.5	0.9	0.0	0.2	0.0	0.7	0.0	0.1	2.2
TLR6	CD286	ENSG00000174130	"Toll like receptor 6"	Q9Y2C9	4	38823715-38856817	"CD markers, Predicted membrane proteins"	"Immunity, Inflammatory response, Innate immunity"	"Hydrolase, Receptor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 14.2;brain: 16.0;lymphoid tissue: 16.2"	"Cell type enhanced"	"Detected in some"	12	"B-cells: 5.0;Hofbauer cells: 5.9;Kupffer cells: 11.8;Macrophages: 9.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	5	"neutrophil: 14.2"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 14.2"	"Cell line enhanced"	"Detected in many"		"CAPAN-2: 12.5;GAMG: 12.9;RPMI-8226: 9.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA062733			Approved	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"HPA062733: AB_2684853"	"unprognostic (9.82e-2)"	"unprognostic (4.76e-2)"	"unprognostic (3.30e-2)"	"unprognostic (3.05e-2)"	"unprognostic (1.91e-1)"	"unprognostic (1.87e-2)"	"unprognostic (1.83e-1)"	"unprognostic (4.45e-2)"	"unprognostic (9.26e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.05e-2)"	"unprognostic (2.69e-1)"	"unprognostic (7.62e-7)"	"unprognostic (4.89e-2)"	"unprognostic (1.02e-2)"	"unprognostic (7.78e-2)"	"unprognostic (2.12e-2)"	2.9	2.7	6.1	10.7	7.9	6.4	2.1	2.0	3.9	1.8	1.6	2.6	0.2	1.7	1.4	2.0	1.8	1.9	3.9	1.5	4.5	1.7	1.7	2.1	5.0	11.2	10.6	1.9	1.6	1.2	0.7	1.9	2.8	7.2	1.6	2.4	0.9	4.3	0.5	0.9	1.7	7.8	2.1	16.0	16.2	2.1	0.8	6.8	1.8	1.5	1.1	14.8	5.8	1.9	1.8	1.8	14.2	2.6	0.3	0.4	0.6	1.4	5.7	0.2	0.1	0.3	6.7	0.0	1.6	6.9	0.7	2.3	0.0	12.5	6.9	2.7	0.3	12.9	0.6	0.1	1.2	1.1	0.0	0.5	3.2	6.9	0.2	0.4	3.5	5.2	2.8	1.3	2.8	1.5	0.2	1.4	1.1	3.5	2.2	3.1	0.0	0.0	6.1	0.2	0.0	0.9	3.4	3.1	9.8	0.4	0.1	0.0	0.1	0.2	0.0	0.9	0.3	0.3	1.8	1.9	2.2	7.5	0.9	2.4	0.1	0.0	5.8	5.1	4.1	1.6	0.0	2.6	0.7	0.2	2.4	0.0	1.8	0.1	0.1	1.8	1.2	0.3	0.2	14.2	0.3	1.2	1.3	0.4	0.6	6.1	7.9	2.0	3.9	4.5	1.7	10.6	1.9	7.2	6.8	0.0	0.0	5.0	1.1	0.6	0.7	1.2	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.4	0.0	0.0	0.2	0.2	0.8	0.8	2.3	0.0	5.9	0.0	0.0	0.6	11.8	0.0	0.6	9.5	0.0	1.8	0.0	0.0	0.2	0.0	0.7	0.0	0.1	0.0	0.4	0.2	0.0	0.6	0.2	0.0	0.0	0.9
TLR7		ENSG00000196664	"Toll like receptor 7"	Q9NYK1	X	12867083-12890380	"FDA approved drug targets, Predicted membrane proteins"	"Immunity, Inflammatory response, Innate immunity"	Receptor	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 26.5"	"Cell type enhanced"	"Detected in some"	16	"Hofbauer cells: 20.2;Macrophages: 14.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"plasmacytoid DC: 15.7"	"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in some"	5	"Daudi: 16.0;U-266/70: 16.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA059613	Supported					NA	NA					"HPA059613: AB_2684083"	"unprognostic (1.22e-1)"	"unprognostic (1.09e-2)"	"unprognostic (2.36e-3)"	"unprognostic (9.29e-2)"	"unprognostic (2.06e-1)"	"unprognostic (1.06e-2)"	"unprognostic (8.27e-2)"	"unprognostic (6.20e-3)"	"unprognostic (3.75e-1)"	"unprognostic (6.91e-2)"	"unprognostic (3.55e-1)"	"unprognostic (8.47e-2)"	"unprognostic (2.54e-1)"	"unprognostic (4.17e-3)"	"unprognostic (1.19e-3)"	"unprognostic (1.53e-3)"	"unprognostic (1.34e-1)"	2.9	3.1	7.6	7.2	11.3	1.0	7.6	1.7	7.9	2.5	3.3	10.6	0.0	3.2	1.8	2.9	1.8	1.7	5.3	4.1	8.4	5.1	2.2	1.5	7.7	6.9	17.4	2.6	1.6	1.9	1.5	2.2	11.0	12.9	2.2	4.0	1.5	2.7	2.0	1.4	1.4	4.9	3.5	26.5	6.7	3.0	1.5	17.2	7.7	1.7	0.5	9.4	5.2	1.6	6.9	15.7	3.2	8.9	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	16.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.2	0.0	16.5	0.0	3.1	0.0	0.3	0.0	0.2	7.2	3.2	0.0	8.9	0.0	6.9	0.0	0.0	3.7	5.8	0.0	0.0	0.4	0.0	6.8	15.7	0.0	2.2	7.6	11.3	1.7	7.9	8.4	5.1	17.4	2.6	12.9	17.2	0.0	4.6	2.4	1.1	1.1	0.0	0.5	0.0	4.0	1.2	0.0	2.0	0.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	1.0	0.7	1.1	0.0	20.2	0.0	0.0	0.6	2.4	0.0	0.6	14.8	1.7	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.8	0.0	0.1	0.9	0.2	0.0	0.0	1.4
TLR8	CD288	ENSG00000101916	"Toll like receptor 8"	Q9NR97	X	12906620-12923169	"CD markers, Predicted membrane proteins"	"Immunity, Inflammatory response, Innate immunity"	Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 17.8;lymphoid tissue: 45.6"	"Group enriched"	"Detected in some"	6	"Kupffer cells: 48.1;Macrophages: 13.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	94	"classical monocyte: 10.0;intermediate monocyte: 9.6;myeloid DC: 5.3;neutrophil: 17.8;non-classical monocyte: 9.2"	"Group enriched"	"Detected in many"	100	"dendritic cells: 5.3;granulocytes: 17.8;monocytes: 10.0"	"Cell line enhanced"	"Detected in some"		"HMC-1: 1.2;PC-3: 2.8;THP-1: 1.3"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			HPA001608	Enhanced					NA	NA					"HPA001608: AB_1080295"	"unprognostic (1.32e-1)"	"unprognostic (6.94e-2)"	"unprognostic (3.96e-3)"	"unprognostic (4.43e-2)"	"unprognostic (9.63e-2)"	"unprognostic (2.48e-2)"	"unprognostic (2.59e-1)"	"unprognostic (6.61e-2)"	"unprognostic (1.93e-1)"	"unprognostic (2.23e-1)"	"unprognostic (3.72e-2)"	"unprognostic (2.73e-1)"	"unprognostic (1.74e-2)"	"unprognostic (1.03e-1)"	"unprognostic (4.14e-2)"	"unprognostic (1.52e-1)"	"unprognostic (5.66e-2)"	8.5	1.4	0.9	16.0	1.5	4.7	1.2	0.7	1.1	1.0	1.5	0.4	0.0	0.6	1.0	3.2	1.0	2.0	2.4	3.0	2.0	1.0	2.0	4.0	13.7	33.0	1.7	0.1	1.1	1.0	0.2	1.0	4.0	1.9	1.4	1.7	0.9	1.2	0.0	1.4	0.8	2.0	3.5	3.3	45.6	1.3	1.2	1.6	3.5	1.0	1.1	2.4	4.2	2.4	0.1	5.3	17.8	10.0	0.0	0.0	2.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	2.8	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.3	0.0	0.1	0.2	0.0	0.4	0.2	0.0	0.0	0.3	0.0	0.0	10.0	0.0	0.0	9.6	0.0	0.1	0.0	0.0	5.3	0.0	0.0	0.0	17.8	0.0	9.2	0.0	0.0	2.0	0.9	1.5	0.7	1.1	2.0	1.0	1.7	0.1	1.9	1.6	0.0	4.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	5.0	0.0	0.0	0.6	48.1	0.0	0.0	13.2	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
TM6SF1		ENSG00000136404	"Transmembrane 6 superfamily member 1"	Q9BZW5	15	83107407-83144854	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 44.3;skeletal muscle: 37.8"	"Cell type enhanced"	"Detected in many"	9	"granulocytes: 43.8;Hofbauer cells: 47.4;Kupffer cells: 39.6;Macrophages: 43.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"eosinophil: 44.3;neutrophil: 26.4"	"Lineage enriched"	"Detected in many"	6	"granulocytes: 44.3"	"Cell line enhanced"	"Detected in some"		"HEL: 9.3;HHSteC: 22.1;HUVEC TERT2: 11.7;JURKAT: 15.7;TIME: 30.4;U-698: 7.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA016051, HPA056857"	Uncertain					NA	NA					"HPA016051: AB_2203924, HPA056857: AB_2683259"	"unprognostic (8.09e-2)"	"unprognostic (1.31e-1)"	"unprognostic (2.87e-2)"	"unprognostic (4.67e-1)"	"unprognostic (1.96e-1)"	"unprognostic (1.43e-1)"	"unprognostic (6.46e-2)"	"unprognostic (3.52e-3)"	"unprognostic (1.73e-1)"	"unprognostic (1.70e-2)"	"unprognostic (2.80e-1)"	"unprognostic (2.55e-1)"	"prognostic favorable (6.79e-4)"	"unprognostic (1.15e-2)"	"unprognostic (4.65e-3)"	"unprognostic (2.60e-2)"	"unprognostic (1.70e-1)"	9.6	3.4	4.9	4.9	6.8	4.7	11.2	4.4	13.9	4.0	3.0	6.8	0.9	2.3	3.2	4.1	2.4	3.4	3.9	9.2	7.2	6.7	2.9	2.5	10.6	9.0	8.0	7.1	2.1	1.5	1.8	1.7	7.2	10.0	2.5	2.9	3.4	3.2	1.9	37.8	1.7	2.6	3.8	12.5	5.2	2.1	4.1	3.7	0.6	9.9	3.5	3.0	4.9	2.4	0.2	4.6	44.3	7.8	1.0	1.2	2.8	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.1	2.7	0.0	0.0	0.0	0.1	0.1	0.5	0.0	0.1	0.0	1.7	0.0	0.0	0.0	0.2	9.3	0.0	0.0	22.1	0.5	0.0	0.1	0.0	0.0	0.0	0.1	11.7	15.7	0.4	0.0	0.2	0.0	0.0	0.7	0.2	0.0	0.0	0.0	1.5	0.0	0.0	0.2	0.4	0.2	0.0	0.0	0.8	0.2	0.0	6.5	30.4	0.3	0.4	0.0	0.1	0.9	0.0	7.0	0.0	1.2	0.0	14.1	7.8	44.3	1.2	3.3	0.0	0.0	0.1	0.1	4.6	0.2	0.0	0.1	26.4	1.0	1.4	0.6	0.0	2.8	4.9	6.8	4.4	13.9	7.2	6.7	8.0	7.1	10.0	3.7	0.0	8.9	0.5	0.0	2.2	1.1	1.2	2.5	1.4	1.2	0.0	0.0	0.2	0.0	0.1	9.8	10.5	0.0	0.0	1.8	0.3	0.7	0.0	43.8	0.0	47.4	0.0	0.0	5.5	39.6	6.3	0.9	43.7	3.3	5.4	0.0	0.4	0.3	0.0	0.0	0.0	1.1	0.0	0.4	14.9	2.2	1.5	0.2	5.0	0.0	0.0
TMEM106A	MGC20235	ENSG00000184988	"Transmembrane protein 106A"	Q96A25	17	43211835-43220041	"Predicted membrane proteins"	"Immunity, Innate immunity"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 31.9"	"Cell type enhanced"	"Detected in many"	6	"Hofbauer cells: 36.4;Kupffer cells: 35.3;Macrophages: 31.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"basophil: 17.4"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HMC-1: 15.4"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (9.71e-2)"	"unprognostic (2.61e-1)"	"prognostic unfavorable (9.61e-5)"	"unprognostic (4.95e-3)"	"unprognostic (8.62e-2)"	"unprognostic (1.79e-1)"	"unprognostic (9.11e-2)"	"unprognostic (1.76e-1)"	"unprognostic (5.77e-2)"	"unprognostic (2.01e-1)"	"unprognostic (2.99e-2)"	"unprognostic (6.08e-2)"	"unprognostic (7.89e-3)"	"unprognostic (1.39e-1)"	"unprognostic (5.34e-2)"	"unprognostic (1.24e-1)"	"unprognostic (8.30e-2)"	7.6	4.8	4.7	17.2	5.9	3.5	8.9	1.1	3.6	7.4	4.1	5.0	2.6	4.4	7.3	9.1	2.5	6.2	5.2	5.5	4.1	2.8	24.9	5.5	11.0	31.9	5.7	3.6	9.3	6.2	2.6	3.8	18.7	4.1	5.2	6.3	7.2	5.8	6.0	1.9	2.4	6.2	9.9	7.4	16.5	5.5	5.5	5.4	5.3	7.3	4.1	12.0	5.6	5.2	3.3	5.3	17.4	4.9	1.7	2.2	1.7	2.7	0.9	0.3	0.2	3.5	3.9	2.1	7.0	4.5	6.1	9.6	2.1	5.7	4.0	1.4	10.6	2.4	1.3	0.7	0.9	7.2	6.2	0.0	2.7	2.3	9.4	2.0	0.1	15.4	2.4	0.2	11.3	0.3	2.2	5.3	4.8	0.1	2.9	7.6	1.2	4.7	1.8	0.3	0.0	0.0	3.5	1.2	2.4	2.6	0.2	0.6	0.0	1.3	3.3	1.5	1.6	5.0	4.0	6.1	3.1	0.4	3.1	1.4	4.6	0.4	1.2	2.5	4.8	6.0	17.4	4.3	4.8	1.5	4.9	0.6	1.7	1.0	1.4	3.6	3.3	0.7	1.3	1.3	1.7	1.7	5.3	2.2	1.7	4.7	5.9	1.1	3.6	4.1	2.8	5.7	3.6	4.1	5.4	3.0	5.0	11.5	9.6	2.2	4.7	0.8	0.0	5.3	3.4	7.0	2.0	4.6	3.3	1.9	4.1	3.7	2.1	0.0	3.4	5.5	6.6	9.5	8.1	1.6	36.4	0.0	2.9	3.7	35.3	2.1	13.0	31.1	0.0	9.0	3.1	2.0	4.1	2.5	6.7	13.0	3.4	12.9	3.8	7.7	3.8	1.5	4.3	7.0	2.6	10.5
TMEM170B		ENSG00000205269	"Transmembrane protein 170B"	Q5T4T1	6	11538278-11583524	"Predicted membrane proteins"	"Wnt signaling pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in all"		"bone marrow: 31.1"	"Cell type enhanced"	"Detected in many"	10	"Horizontal cells: 23.8;Kupffer cells: 40.6;Macrophages: 21.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	9	"dendritic cells: 3.2;granulocytes: 2.4;monocytes: 2.9"	"Cell line enhanced"	"Detected in many"		"THP-1: 18.2;U-937: 13.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA055134	Uncertain		Approved	Centrosome		NA	NA			Centrosome		"HPA055134: AB_2682709"	"unprognostic (1.32e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.51e-1)"	"unprognostic (2.71e-4)"	"unprognostic (6.67e-2)"	"unprognostic (2.51e-1)"	"unprognostic (2.43e-1)"	"unprognostic (4.62e-3)"	"unprognostic (8.22e-2)"	"unprognostic (6.82e-2)"	"unprognostic (2.45e-5)"	"unprognostic (3.49e-1)"	"unprognostic (1.26e-1)"	"unprognostic (4.27e-2)"	"unprognostic (1.36e-1)"	"unprognostic (2.56e-4)"	"unprognostic (3.97e-2)"	10.1	4.8	11.7	6.4	9.6	31.1	6.1	13.5	18.6	3.1	3.3	4.9	2.0	1.6	4.1	5.2	2.5	2.8	3.0	4.5	10.1	8.8	5.9	12.8	8.8	3.5	8.3	8.7	3.9	3.3	5.8	4.2	4.0	8.4	3.4	2.2	4.2	2.5	3.7	8.3	1.8	2.0	4.7	8.2	5.7	2.4	5.2	6.0	4.2	4.4	1.2	2.2	2.7	3.1	0.2	3.2	2.4	2.9	0.1	0.3	0.5	0.7	1.2	7.5	6.7	1.4	0.1	1.5	0.6	1.7	1.0	1.2	0.4	0.4	5.9	3.4	0.4	1.9	0.0	8.4	0.5	2.7	1.6	4.3	3.3	0.8	1.0	0.5	5.3	3.5	0.5	0.1	1.1	0.0	1.7	0.7	5.6	0.2	0.1	1.5	1.1	6.3	9.2	2.1	0.7	1.0	3.2	7.2	0.9	0.8	1.5	5.1	4.4	0.4	2.4	2.7	11.2	2.4	18.2	0.1	1.4	1.6	2.8	1.7	5.2	10.4	5.3	1.2	13.6	1.8	2.4	2.9	1.5	0.2	1.6	0.1	0.0	0.1	0.1	1.8	0.2	0.3	0.2	1.1	0.1	0.6	3.2	0.0	0.5	11.7	9.6	13.5	13.5	10.1	8.8	8.3	8.7	8.4	6.0	3.0	1.3	0.5	0.7	1.5	12.0	5.2	2.5	0.0	2.3	0.0	3.9	1.8	5.0	0.6	0.4	1.4	0.0	0.0	1.2	0.3	2.3	1.0	1.1	5.8	6.6	23.8	1.7	1.8	40.6	0.2	0.9	21.8	0.0	1.0	0.5	11.8	0.9	0.0	1.4	4.5	8.4	6.5	1.2	5.4	4.6	0.6	1.6	1.7	0.6	0.4
TMEM71	FLJ33069	ENSG00000165071	"Transmembrane protein 71"	Q6P5X7	8	132685007-132760712	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"blood: 65.7;lymphoid tissue: 31.3"	"Group enriched"	"Detected in many"	5	"Cardiomyocytes: 14.8;Kupffer cells: 23.3;Macrophages: 22.7;T-cells: 41.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"neutrophil: 65.7"	"Lineage enriched"	"Detected in all"	4	"granulocytes: 65.7"	"Cell line enhanced"	"Detected in some"		"BJ hTERT+: 8.2;HDLM-2: 33.0;Karpas-707: 7.0;U-937: 19.5"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"HPA058401, HPA070655"	Uncertain		Enhanced	Mitochondria		NA	NA			Mitochondria		"HPA058401: AB_2683707, HPA070655: AB_2686292"	"unprognostic (1.39e-3)"	"unprognostic (7.27e-2)"	"unprognostic (8.82e-2)"	"unprognostic (3.10e-3)"	"unprognostic (7.94e-2)"	"unprognostic (3.91e-3)"	"unprognostic (4.18e-2)"	"unprognostic (5.06e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.71e-1)"	"unprognostic (1.63e-1)"	"unprognostic (1.62e-1)"	"unprognostic (8.83e-2)"	"unprognostic (1.90e-2)"	"unprognostic (6.29e-3)"	"unprognostic (4.39e-2)"	"unprognostic (2.73e-1)"	4.2	1.1	1.4	8.2	1.5	20.8	5.4	0.7	1.2	2.5	9.9	0.8	0.4	1.2	1.0	2.0	4.8	1.9	4.1	25.5	1.8	1.2	1.9	2.3	8.3	20.9	2.2	0.8	1.9	2.9	0.0	1.4	1.0	1.7	2.2	2.2	5.8	5.8	1.3	1.3	1.3	7.2	2.2	4.2	18.2	2.9	0.9	1.4	31.3	2.2	2.5	10.6	7.0	2.8	1.4	8.2	65.7	13.5	2.9	14.8	8.4	0.2	0.0	3.2	0.0	0.0	0.0	0.0	0.8	8.2	0.3	0.6	0.0	0.0	0.0	0.3	2.5	0.0	0.0	0.0	0.2	0.9	33.0	0.0	0.0	0.0	0.0	0.2	2.2	0.0	0.0	0.0	0.0	1.3	0.9	0.6	4.2	0.0	7.0	1.4	0.0	1.6	1.3	0.7	0.0	0.2	0.1	1.1	0.4	3.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.0	1.2	0.4	0.5	0.7	3.4	0.0	1.6	0.0	5.8	19.5	2.4	12.5	13.5	23.9	8.0	3.9	14.8	1.4	5.9	5.6	8.2	1.3	9.0	6.5	65.7	2.9	3.2	0.2	0.7	8.4	1.4	1.5	0.7	1.2	1.8	1.2	2.2	0.8	1.7	1.4	0.0	4.8	4.2	1.0	0.8	0.0	14.8	0.0	4.0	3.4	0.0	0.0	0.0	0.0	0.0	4.9	0.0	0.0	0.0	0.0	0.0	1.3	0.1	1.1	0.0	3.1	0.0	0.0	1.3	23.3	3.6	0.0	22.7	5.0	0.0	0.0	1.1	0.1	0.0	0.0	0.5	0.0	0.0	0.3	0.0	0.2	0.3	0.2	41.5	0.0	5.1
TNF	"DIF, TNF-alpha, TNFA, TNFSF2"	ENSG00000232810	"Tumor necrosis factor"	P01375	6	31575567-31578336	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"		Cytokine	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 14.6;lymphoid tissue: 28.0"	"Cell type enhanced"	"Detected in many"	10	"Hofbauer cells: 32.8;Macrophages: 42.1;T-cells: 34.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Cell type enhanced"	"Detected in many"		"non-classical monocyte: 10.8"	"Group enriched"	"Detected in many"	5	"granulocytes: 3.5;monocytes: 10.8;T-cells: 6.6"	"Group enriched"	"Detected in some"	5	"HDLM-2: 10.2;HMC-1: 9.8;NB-4: 29.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			CAB078469	Supported				"Secreted to blood"	NA	NA	10100				"CAB078469: AB_908070"	"unprognostic (1.93e-1)"	"unprognostic (1.07e-2)"	"unprognostic (3.85e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.92e-1)"	"unprognostic (2.19e-2)"	"unprognostic (1.67e-1)"	"unprognostic (3.46e-1)"	"unprognostic (1.19e-2)"	"unprognostic (1.94e-1)"	"unprognostic (3.07e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.46e-2)"	"unprognostic (1.82e-1)"	"unprognostic (9.85e-3)"	"unprognostic (1.09e-1)"	"unprognostic (2.04e-1)"	2.3	1.2	0.6	15.6	1.0	14.6	1.2	0.4	1.8	1.7	1.3	3.7	0.3	1.3	1.1	0.4	1.5	0.9	2.3	2.0	0.5	0.3	2.6	1.9	9.5	8.0	0.8	0.0	0.6	0.7	0.5	0.5	3.2	2.0	0.7	0.7	0.4	2.2	0.8	0.4	2.7	4.1	0.7	1.0	28.0	1.0	0.4	0.5	2.1	0.6	5.3	14.7	1.2	0.4	1.3	1.2	3.5	10.8	0.5	6.6	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.2	0.0	0.0	0.0	0.0	10.2	0.0	1.9	0.0	0.0	0.0	0.8	9.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	29.6	0.0	0.0	0.0	1.8	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.3	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	1.7	0.0	4.1	6.5	6.6	1.3	3.1	2.4	1.2	1.3	0.9	1.0	3.5	0.5	10.8	0.7	2.2	2.1	0.6	1.0	0.4	1.8	0.5	0.3	0.8	0.0	2.0	0.5	0.0	4.0	13.4	0.2	7.4	0.1	2.0	5.1	1.4	2.3	0.0	2.0	0.3	0.0	6.7	0.1	2.8	0.0	0.0	2.9	1.5	2.1	0.9	11.6	0.0	32.8	0.0	0.0	1.3	8.7	0.0	0.3	42.1	5.0	1.0	0.1	0.1	10.2	0.0	0.0	0.0	0.1	0.0	2.3	0.0	0.0	3.6	0.9	34.1	0.0	0.3
TNFRSF1B	"CD120b, p75, TNF-R-II, TNF-R75, TNFBR, TNFR2, TNFR80"	ENSG00000028137	"TNF receptor superfamily member 1B"	P20333	1	12167003-12209228	"Cancer-related genes, Candidate cardiovascular disease genes, CD markers, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins"	Apoptosis	Receptor	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 70.1"	"Cell type enhanced"	"Detected in many"	10	"Kupffer cells: 168.8;Macrophages: 143.1;monocytes: 73.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"non-classical monocyte: 70.1"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 17.5;K-562: 21.4;THP-1: 25.1;U-87 MG: 17.2;U-937: 18.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA004796	Approved				"Secreted to blood"	NA	NA	3230000	2500000			"HPA004796: AB_1078436"	"unprognostic (4.45e-2)"	"unprognostic (2.27e-3)"	"unprognostic (7.62e-2)"	"unprognostic (3.82e-3)"	"unprognostic (6.30e-2)"	"unprognostic (4.47e-3)"	"unprognostic (5.28e-3)"	"unprognostic (2.79e-1)"	"unprognostic (1.69e-2)"	"unprognostic (1.73e-2)"	"unprognostic (7.26e-2)"	"unprognostic (2.48e-1)"	"prognostic unfavorable (8.35e-5)"	"unprognostic (2.02e-1)"	"prognostic unfavorable (8.68e-4)"	"unprognostic (3.26e-2)"	"unprognostic (1.10e-1)"	43.4	4.7	4.6	44.3	13.8	29.2	42.3	2.1	6.1	13.3	13.1	6.6	1.9	11.9	9.7	10.2	6.5	11.3	11.6	21.8	8.5	6.2	6.2	22.2	24.5	60.6	9.1	2.2	9.4	4.2	2.3	4.4	24.9	15.0	7.3	8.2	8.3	5.7	3.7	11.5	6.2	17.3	11.5	22.6	48.3	10.5	6.0	6.1	10.9	6.2	5.6	16.2	18.3	8.4	2.7	13.2	25.7	70.1	2.5	12.7	19.9	0.0	0.1	2.1	0.0	5.6	7.7	4.4	0.5	1.0	2.0	2.2	0.8	17.5	0.1	0.3	1.8	2.9	0.0	0.4	0.0	1.1	6.9	0.0	0.0	0.1	0.0	13.2	0.1	1.9	7.6	0.0	7.0	0.0	3.6	10.6	0.1	21.4	3.2	0.9	0.0	0.0	4.0	0.1	2.7	0.6	0.5	0.2	12.3	0.0	0.4	0.0	0.0	0.3	0.1	0.6	3.3	0.0	25.1	3.7	3.0	0.1	13.3	0.0	1.0	0.0	0.0	17.2	18.1	0.7	0.0	20.7	3.0	9.4	49.3	5.4	2.7	6.6	7.7	13.2	1.7	2.0	3.0	25.7	2.5	70.1	2.8	12.7	19.9	4.6	13.8	2.1	6.1	8.5	6.2	9.1	2.2	15.0	6.1	8.9	22.3	30.3	2.5	14.9	0.1	2.8	7.6	2.7	11.4	3.5	0.0	0.7	0.0	0.4	0.3	40.2	11.8	23.3	0.5	4.3	9.7	4.3	2.3	14.0	63.4	0.0	0.0	22.7	168.8	0.4	2.0	143.1	15.1	73.9	3.1	0.3	0.5	1.4	0.4	0.3	1.0	32.3	13.7	0.0	0.9	9.3	25.2	58.9	3.9	9.8
TNFSF8	"CD153, CD30LG"	ENSG00000106952	"TNF superfamily member 8"	P32971	9	114893343-114930595	"Cancer-related genes, CD markers, Predicted membrane proteins"		Cytokine	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 18.6;lymphoid tissue: 48.1"	"Group enriched"	"Detected in some"	4	"B-cells: 4.4;Hofbauer cells: 3.2;Kupffer cells: 6.5;Macrophages: 4.4;T-cells: 9.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Group enriched"	"Detected in some"	7	"Daudi: 34.1;SuSa: 16.1;U-698: 28.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"									NA	NA						"unprognostic (8.82e-2)"	"unprognostic (6.56e-3)"	"unprognostic (7.79e-2)"	"unprognostic (6.05e-2)"	"unprognostic (2.67e-1)"	"unprognostic (5.58e-3)"	"unprognostic (5.26e-3)"	"unprognostic (1.82e-2)"	"unprognostic (2.37e-1)"	"unprognostic (1.24e-1)"	"unprognostic (1.70e-1)"	"unprognostic (2.02e-1)"	"unprognostic (4.75e-2)"	"unprognostic (3.01e-2)"	"unprognostic (2.76e-2)"	"unprognostic (9.61e-2)"	"unprognostic (1.82e-1)"	3.6	1.7	1.1	12.0	1.7	12.7	1.8	0.5	0.9	1.6	2.4	1.4	0.6	0.3	1.1	2.5	1.4	1.5	4.6	2.8	1.1	1.2	1.8	1.4	4.9	48.1	1.6	0.6	0.9	1.1	0.0	0.8	2.2	1.0	1.3	1.9	1.4	3.7	0.9	0.7	1.0	7.0	1.3	2.8	14.9	1.7	1.1	1.0	45.6	1.6	0.8	18.5	3.2	1.3	1.7	7.3	3.9	14.1	1.0	18.6	8.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	34.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.9	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	28.0	0.0	0.0	0.0	0.0	14.1	0.0	4.1	7.3	13.8	1.0	16.4	9.8	7.3	1.7	18.6	13.5	3.9	1.0	0.9	4.0	5.9	8.7	1.1	1.7	0.5	0.9	1.1	1.2	1.6	0.6	1.0	1.0	0.0	0.0	4.4	0.0	0.6	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	3.2	0.0	0.0	1.3	6.5	0.0	0.0	4.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	9.2	0.0	0.0
TREM1	"CD354, TREM-1"	ENSG00000124731	"Triggering receptor expressed on myeloid cells 1"	Q9NP99	6	41267926-41286719	"CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 96.9;bone marrow: 38.5;lung: 34.2"	"Cell type enhanced"	"Detected in some"	15	"Alveolar cells type 2: 31.6;Hofbauer cells: 25.6;Kupffer cells: 32.3;Macrophages: 79.4"	"Cancer enhanced"	"Detected in many"		"lung cancer: 9.6"	"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in some"	8	"neutrophil: 96.9"	"Lineage enriched"	"Detected in many"	8	"granulocytes: 96.9"	"Group enriched"	"Detected in some"	5	"SuSa: 6.5;U-87 MG: 23.8"									"HPA005563, HPA053612"	Approved		Approved	"Golgi apparatus"	"Intracellular and membrane"	NA	NA			"Golgi apparatus"		"HPA005563: AB_1858259, HPA053612: "	"unprognostic (6.41e-2)"	"unprognostic (1.47e-3)"	"unprognostic (1.22e-1)"	"unprognostic (3.39e-2)"	"unprognostic (6.07e-3)"	"unprognostic (2.97e-2)"	"unprognostic (5.73e-5)"	"unprognostic (1.29e-1)"	"unprognostic (1.24e-2)"	"unprognostic (4.13e-3)"	"unprognostic (2.24e-3)"	"unprognostic (7.65e-2)"	"unprognostic (3.18e-7)"	"unprognostic (6.32e-3)"	"unprognostic (4.95e-2)"	"unprognostic (1.08e-1)"	"unprognostic (7.26e-2)"	10.2	0.6	0.7	21.1	1.5	38.5	1.0	0.6	2.1	0.7	0.9	0.7	0.5	0.1	1.0	1.5	0.6	4.2	5.1	3.7	1.2	0.9	1.1	3.7	34.2	8.0	2.7	0.1	2.1	1.8	0.2	2.7	31.2	2.3	0.9	0.0	2.5	1.3	0.1	2.4	0.4	1.1	3.8	3.9	12.1	1.0	2.6	0.6	0.3	2.2	1.9	1.0	3.9	0.7	0.2	5.0	96.9	12.8	0.0	0.0	4.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.3	0.6	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	6.5	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	23.8	1.5	0.0	0.0	12.8	0.3	0.0	3.1	0.0	0.0	0.0	0.0	5.0	0.2	0.0	0.0	96.9	0.0	1.4	0.1	0.0	4.1	0.7	1.5	0.6	2.1	1.2	0.9	2.7	0.1	2.3	0.6	6.0	31.6	2.7	0.1	0.3	0.0	0.3	2.5	13.4	19.4	0.0	0.0	0.3	0.0	0.3	10.6	0.5	0.0	0.0	0.2	0.9	0.7	0.1	5.8	0.2	25.6	0.0	0.0	1.3	32.3	13.1	0.0	79.4	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.1	12.2	0.0	0.0	0.0
TRPM2	"EREG1, KNP3, LTRPC2, NUDT9H, NUDT9L1, TRPC7"	ENSG00000142185	"Transient receptor potential cation channel subfamily M member 2"	O94759	21	44350163-44443081	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Calcium transport, Ion transport, Sodium transport, Transport"	"Calcium channel, Ion channel, Sodium channel"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 29.9"	"Group enriched"	"Detected in some"	5	"Extravillous trophoblasts: 7.0;Hofbauer cells: 15.8;Kupffer cells: 12.5;Macrophages: 9.0;Sertoli cells: 6.5;T-cells: 4.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"classical monocyte: 7.3;plasmacytoid DC: 14.5"	"Group enriched"	"Detected in many"	8	"dendritic cells: 14.5;monocytes: 7.3"	"Cell line enhanced"	"Detected in some"		"HL-60: 16.8;NB-4: 23.8;OE19: 16.9;THP-1: 29.4;U-937: 27.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035260	Enhanced					NA	NA					"HPA035260: AB_2674540"	"unprognostic (3.61e-2)"	"unprognostic (2.18e-1)"	"unprognostic (7.55e-2)"	"prognostic favorable (9.28e-4)"	"unprognostic (6.49e-2)"	"unprognostic (4.54e-2)"	"unprognostic (5.17e-2)"	"unprognostic (2.23e-1)"	"unprognostic (8.13e-2)"	"unprognostic (2.41e-3)"	"unprognostic (1.24e-1)"	"unprognostic (1.03e-1)"	"prognostic unfavorable (4.39e-6)"	"unprognostic (1.40e-1)"	"unprognostic (3.31e-2)"	"unprognostic (8.88e-3)"	"prognostic favorable (7.59e-4)"	5.4	4.5	7.4	8.6	7.8	29.9	3.9	14.5	16.3	2.9	4.5	6.9	0.0	4.4	1.9	1.5	2.1	2.6	5.7	1.8	7.8	8.9	2.1	2.0	3.8	8.2	8.5	10.4	1.5	2.4	2.1	2.1	7.1	11.7	1.9	3.0	2.6	2.9	1.3	1.3	2.3	5.1	3.2	9.7	8.1	3.1	1.9	7.3	2.0	1.7	0.0	4.8	4.9	1.7	1.4	14.5	0.4	7.3	0.5	1.1	1.8	8.3	3.1	0.0	0.0	0.0	0.0	8.9	0.0	0.0	0.2	0.1	0.0	0.0	0.2	10.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	1.5	0.0	0.0	16.8	0.9	0.0	0.0	0.0	0.0	0.0	0.0	4.7	0.0	0.0	0.0	0.0	2.6	23.8	0.0	16.9	9.9	0.9	3.0	3.2	0.0	0.0	6.1	0.0	0.0	9.9	0.0	0.0	11.6	29.4	0.0	0.5	8.9	0.0	0.3	0.1	12.5	0.0	0.0	27.7	0.0	0.0	7.3	0.0	1.0	2.6	0.6	0.3	0.3	0.4	2.5	1.4	0.3	0.4	0.4	0.5	2.0	14.5	1.1	1.8	7.4	7.8	14.5	16.3	7.8	8.9	8.5	10.4	11.7	7.3	0.0	0.3	0.0	0.0	0.3	0.5	1.6	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	2.0	1.0	0.0	0.0	0.2	7.0	0.2	0.0	1.1	0.0	15.8	0.0	0.0	0.6	12.5	1.2	0.6	9.0	0.0	1.0	0.1	0.5	0.8	0.0	0.0	0.1	0.4	6.5	0.0	0.5	0.0	0.3	1.1	4.8	0.0	0.0
TSPAN32	"PHEMX, TSSC6"	ENSG00000064201	"Tetraspanin 32"	Q96QS1	11	2301997-2318200	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 25.3;bone marrow: 17.5;heart muscle: 11.9;lymphoid tissue: 11.5"	"Cell type enhanced"	"Detected in some"	13	"Alveolar cells type 2: 10.7;Cardiomyocytes: 13.4;granulocytes: 29.0;Macrophages: 13.0;T-cells: 23.5"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in some"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Group enriched"	"Detected in some"	8	"HEL: 15.8;HL-60: 6.9;NB-4: 5.7;THP-1: 6.1;U-937: 9.6"	"Low region specificity"	"Detected in many"							HPA024135	Uncertain		Approved	Nucleoplasm		NA	NA		37000	Nucleoplasm		"HPA024135: AB_1858409"	"unprognostic (7.50e-3)"	"unprognostic (4.88e-4)"	"unprognostic (1.58e-2)"	"unprognostic (1.74e-1)"	"unprognostic (4.45e-3)"	"unprognostic (2.10e-4)"	"unprognostic (7.72e-3)"	"unprognostic (8.25e-3)"	"unprognostic (9.74e-2)"	"unprognostic (2.62e-1)"	"unprognostic (2.70e-2)"	"unprognostic (1.02e-1)"	"unprognostic (2.28e-7)"	"unprognostic (1.07e-1)"	"unprognostic (4.20e-1)"	"unprognostic (4.35e-1)"	"unprognostic (8.13e-2)"	1.2	0.4	0.3	6.3	0.5	17.5	0.5	0.4	1.0	1.3	1.3	2.1	0.0	0.2	1.6	1.6	0.9	0.6	1.4	11.9	0.3	0.4	0.9	0.8	3.1	5.1	0.5	0.3	0.8	0.4	0.0	0.4	0.9	0.5	1.2	0.1	1.7	5.6	0.9	0.3	0.5	1.1	1.8	0.8	5.8	1.4	0.4	1.1	7.4	0.5	2.1	11.5	1.0	0.8	1.1	14.9	17.9	19.3	25.3	13.2	9.5	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.1	15.8	0.0	0.1	0.7	6.9	1.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.7	0.2	0.0	0.0	0.0	5.7	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	6.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.0	9.6	0.0	17.9	15.2	2.0	13.0	17.9	8.1	1.1	4.7	11.1	14.9	0.6	3.7	13.2	8.4	25.3	19.3	0.7	5.8	9.5	0.3	0.5	0.4	1.0	0.3	0.4	0.5	0.3	0.5	1.1	0.0	10.7	2.7	0.0	0.8	0.0	13.4	0.0	2.7	1.2	0.0	0.0	0.1	0.0	0.0	0.2	0.6	0.0	0.0	0.0	0.2	0.9	0.0	29.0	0.0	4.4	0.0	0.0	0.0	6.6	3.5	0.9	13.0	1.7	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.5	0.0	23.5	0.0	0.0
TSPAN33	"MGC50844, Penumbra"	ENSG00000158457	"Tetraspanin 33"	Q86UF1	7	129144892-129169697	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"kidney: 56.8"	"Cell type enhanced"	"Detected in many"	11	"Macrophages: 25.0;monocytes: 64.9;Peritubular cells: 30.8;Proximal tubular cells: 50.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"memory B-cell: 5.3;naive B-cell: 6.4"	"Group enriched"	"Detected in many"	5	"B-cells: 6.4;dendritic cells: 2.8;monocytes: 3.2"	"Cell line enhanced"	"Detected in many"		"AN3-CA: 20.9;HEL: 32.6;U-266/70: 38.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA020357	Enhanced		Approved	Microtubules		NA	NA			Microtubules		"HPA020357: AB_1858410"	"unprognostic (3.95e-2)"	"unprognostic (1.27e-2)"	"unprognostic (4.41e-2)"	"unprognostic (1.31e-1)"	"unprognostic (2.16e-2)"	"unprognostic (5.62e-2)"	"unprognostic (2.29e-2)"	"unprognostic (2.29e-1)"	"unprognostic (3.57e-1)"	"unprognostic (2.66e-1)"	"prognostic favorable (8.88e-4)"	"unprognostic (1.67e-1)"	"prognostic favorable (8.74e-5)"	"unprognostic (2.50e-2)"	"unprognostic (2.73e-1)"	"unprognostic (1.55e-2)"	"unprognostic (1.16e-2)"	2.8	3.5	7.4	13.4	7.7	3.8	3.5	7.5	10.0	1.9	4.3	9.9	8.7	3.8	1.5	15.9	3.4	2.6	3.8	5.4	7.2	12.4	56.8	17.2	3.2	15.9	12.1	6.5	1.8	13.0	9.4	13.0	4.6	7.9	8.0	4.8	5.5	20.5	9.5	7.1	4.5	7.1	2.8	8.0	13.7	4.3	6.8	6.0	10.4	8.5	2.9	19.6	6.2	2.4	6.4	2.8	0.2	3.2	0.4	0.9	2.1	1.2	2.7	0.8	20.9	0.0	0.0	1.0	0.0	0.2	0.5	0.2	0.4	1.9	15.8	1.6	0.5	12.2	1.4	10.8	3.3	0.8	13.4	8.3	32.6	0.8	5.9	0.8	4.5	0.6	0.6	3.3	0.1	1.1	0.0	0.5	9.4	0.3	2.0	0.0	3.6	9.5	0.1	6.0	0.9	2.9	2.9	0.4	0.4	1.7	3.9	4.9	5.9	2.0	0.6	11.0	6.2	4.5	1.9	0.0	0.0	1.5	1.7	0.5	38.6	4.5	6.8	0.3	14.5	2.0	0.0	1.1	0.0	0.1	3.2	0.0	5.3	0.1	0.0	2.8	6.4	0.9	0.1	0.2	0.4	0.2	1.1	0.0	2.1	7.4	7.7	7.5	10.0	7.2	12.4	12.1	6.5	7.9	6.0	0.0	1.1	24.2	0.8	2.3	3.8	5.6	0.0	2.7	0.0	5.2	3.9	0.1	11.6	2.0	2.0	0.4	0.8	0.0	7.4	0.2	1.1	2.5	0.0	12.5	7.1	0.0	3.4	0.6	17.8	3.3	2.6	25.0	1.7	64.9	0.3	4.8	3.0	0.0	30.8	50.8	1.4	0.0	0.0	0.5	0.7	2.6	0.1	1.5	0.2	1.0
TYROBP	"DAP12, KARAP, PLO-SL, PLOSL"	ENSG00000011600	"TYRO protein tyrosine kinase binding protein"	O43914	19	35904401-35908295	"Disease related genes, Predicted membrane proteins"	Immunity			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 267.2;bone marrow: 125.7;lymphoid tissue: 123.6"	"Group enriched"	"Detected in many"	4	"Hofbauer cells: 3494.1;Kupffer cells: 3415.8;Macrophages: 2767.6;monocytes: 2409.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 267.2"	"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in some"	10	"HMC-1: 118.8;THP-1: 65.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009493, HPA041899"	Enhanced		Supported	"Plasma membrane"		NA	NA			"Plasma membrane"		"CAB009493: AB_638987, HPA041899: AB_10795266"	"unprognostic (7.09e-2)"	"unprognostic (8.38e-3)"	"unprognostic (7.87e-2)"	"unprognostic (4.76e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.39e-1)"	"unprognostic (5.27e-2)"	"unprognostic (8.04e-2)"	"unprognostic (2.07e-2)"	"unprognostic (2.47e-1)"	"unprognostic (2.91e-1)"	"unprognostic (1.50e-1)"	"prognostic unfavorable (1.05e-4)"	"unprognostic (4.47e-2)"	"unprognostic (1.72e-2)"	"unprognostic (4.27e-2)"	"unprognostic (4.39e-2)"	76.0	21.4	13.3	54.9	20.7	125.7	16.4	2.8	11.3	11.9	14.3	24.0	2.3	17.1	8.1	19.3	7.2	14.0	25.7	17.5	12.9	14.2	17.6	29.8	75.3	80.0	20.8	5.6	11.7	8.7	1.8	9.0	32.0	17.2	14.9	12.3	15.0	12.4	7.2	7.3	6.7	18.9	16.0	36.3	123.6	10.4	7.3	18.6	8.5	6.7	6.6	10.3	22.3	8.4	0.7	79.3	267.2	190.6	62.8	20.3	162.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.6	0.0	0.0	0.1	5.4	118.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	8.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	65.9	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	1.8	0.0	32.8	190.6	100.9	20.3	134.4	10.6	0.7	0.4	2.8	79.3	0.3	0.5	2.3	267.2	62.8	130.3	68.5	0.3	162.3	13.3	20.7	2.8	11.3	12.9	14.2	20.8	5.6	17.2	18.6	53.6	239.1	119.8	2.3	49.0	0.0	5.3	56.0	37.5	79.6	19.2	0.0	18.6	1.7	0.8	2.5	35.9	0.7	0.0	4.8	19.4	38.6	1.2	723.1	19.1	3494.1	0.0	0.0	89.6	3415.8	4.7	8.6	2767.6	54.0	2409.4	0.0	0.5	1.2	0.2	1.1	6.8	1.1	77.6	17.2	0.7	2.8	39.0	32.5	348.1	0.1	1.0
UPP1	"UDRPASE, UP, UPASE, UPP"	ENSG00000183696	"Uridine phosphorylase 1"	Q16831	7	48088628-48108733	"Enzymes, Predicted intracellular proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Extravillous trophoblasts: 206.2;Macrophages: 205.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"GAMG: 26.4;hTERT-HME1: 103.9;SK-MEL-30: 24.1;WM-115: 23.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA054040, HPA055394"	Enhanced		Enhanced	Nucleoplasm		No	No			Nucleoplasm		"HPA054040: AB_2682352, HPA055394: AB_2682805"	"unprognostic (1.16e-1)"	"prognostic unfavorable (1.02e-4)"	"unprognostic (5.96e-2)"	"unprognostic (1.01e-1)"	"unprognostic (3.21e-3)"	"unprognostic (6.36e-2)"	"unprognostic (1.78e-3)"	"prognostic unfavorable (1.97e-4)"	"unprognostic (3.81e-2)"	"unprognostic (1.91e-1)"	"unprognostic (1.53e-1)"	"unprognostic (2.59e-1)"	"unprognostic (1.52e-3)"	"unprognostic (2.95e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.30e-1)"	"unprognostic (1.39e-1)"	16.7	8.4	2.8	12.6	4.2	17.6	7.1	5.7	3.8	10.3	8.0	1.7	2.1	7.5	2.8	4.2	37.7	3.3	8.5	7.0	2.3	3.3	12.4	9.1	18.3	17.4	5.8	1.4	2.9	5.8	2.4	5.0	28.9	5.5	3.0	7.6	2.9	7.5	2.1	5.1	2.0	9.7	5.2	3.9	13.9	2.5	1.8	4.8	1.2	6.2	34.0	19.4	7.9	19.6	0.6	8.2	15.7	22.0	5.7	19.7	16.0	6.5	7.9	0.8	1.6	2.7	1.2	8.1	3.2	4.5	4.1	5.1	3.3	3.2	0.0	1.2	2.6	26.4	4.6	1.5	13.1	2.7	1.3	1.4	0.2	1.9	1.3	2.4	0.2	0.5	1.6	6.4	1.9	103.9	1.9	2.7	0.2	0.4	3.9	2.2	0.7	0.0	1.1	3.1	1.1	6.9	0.0	1.7	1.7	9.5	3.4	0.7	0.7	3.3	0.9	24.1	8.9	0.8	0.2	3.8	9.7	8.3	2.6	8.2	7.5	10.0	1.1	9.8	1.0	23.6	15.7	22.0	15.1	19.7	16.7	12.5	0.2	12.6	13.5	8.2	0.6	13.0	12.0	9.1	5.7	15.9	0.7	11.2	16.0	2.8	4.2	5.7	3.8	2.3	3.3	5.8	1.4	5.5	4.8	17.9	64.1	14.6	17.3	41.6	27.8	10.4	22.9	8.1	13.6	10.4	31.4	6.0	59.7	36.9	0.6	58.5	53.1	0.0	35.8	206.2	39.5	10.1	24.4	15.1	111.9	15.9	12.5	78.5	137.0	1.5	4.9	205.8	82.7	43.3	11.6	13.5	73.7	52.6	2.1	15.4	28.8	6.5	33.0	0.0	3.0	26.1	65.8	46.7	13.3	29.6
VAV1	VAV	ENSG00000141968	"Vav guanine nucleotide exchange factor 1"	P15498	19	6772714-6857366	"Plasma proteins, Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"	Proto-oncogene	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 25.7;bone marrow: 25.7;lymphoid tissue: 43.1"	"Group enriched"	"Detected in many"	5	"B-cells: 26.9;granulocytes: 34.6;Hofbauer cells: 42.9;Kupffer cells: 22.9;Macrophages: 27.7;T-cells: 25.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"HMC-1: 31.3;Karpas-707: 35.7;MOLT-4: 33.9;REH: 22.5;THP-1: 26.3;U-266/70: 21.4;U-266/84: 25.9;U-937: 28.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA001864, HPA005925"	Enhanced		Approved	Cytosol		NA	NA		30000	Cytosol		"HPA001864: AB_1858722, HPA005925: "	"unprognostic (2.93e-1)"	"unprognostic (1.96e-1)"	"unprognostic (1.80e-1)"	"unprognostic (1.01e-1)"	"unprognostic (6.82e-2)"	"unprognostic (1.13e-2)"	"unprognostic (5.62e-1)"	"unprognostic (1.97e-1)"	"unprognostic (1.30e-2)"	"unprognostic (1.90e-2)"	"unprognostic (3.56e-2)"	"unprognostic (8.58e-2)"	"prognostic unfavorable (1.48e-4)"	"unprognostic (9.55e-2)"	"unprognostic (1.78e-1)"	"unprognostic (6.57e-2)"	"unprognostic (3.28e-1)"	5.1	3.0	3.1	19.0	5.6	25.7	2.3	0.7	2.2	1.7	3.5	4.0	0.3	2.8	1.9	2.6	2.6	2.6	3.1	3.3	2.5	3.0	2.7	2.6	8.5	25.1	5.3	1.2	2.0	1.5	5.2	1.8	4.4	3.5	3.2	3.7	2.3	5.8	1.1	0.8	1.4	10.7	2.6	8.7	37.1	2.5	1.5	4.8	43.1	2.0	1.2	20.0	6.1	2.4	9.3	10.5	25.7	22.8	11.5	14.7	10.5	0.4	0.6	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	3.9	15.4	4.7	0.0	0.0	0.0	0.0	0.0	0.0	6.5	0.5	18.6	0.0	0.0	0.0	18.0	31.3	0.0	0.0	0.0	0.0	0.0	0.0	19.6	0.7	35.7	0.0	2.6	33.9	10.3	0.0	0.0	0.0	22.5	0.0	12.1	0.6	0.0	0.0	0.0	0.0	5.1	0.0	0.0	2.2	26.3	0.0	0.0	0.4	0.0	0.0	21.4	25.9	17.5	0.0	28.4	0.0	0.9	11.5	11.9	14.7	18.8	10.5	9.3	10.7	12.7	10.5	9.2	11.8	10.6	25.7	11.5	22.8	9.0	8.5	10.5	3.1	5.6	0.7	2.2	2.5	3.0	5.3	1.2	3.5	4.8	3.0	4.8	26.9	0.5	1.1	0.2	0.7	0.0	5.3	1.2	0.0	0.0	0.4	0.0	5.1	3.2	1.1	0.0	0.0	0.3	0.6	1.2	0.2	34.6	0.0	42.9	0.0	1.2	1.3	22.9	1.3	0.0	27.7	1.7	1.8	0.9	0.0	5.9	5.8	0.0	0.0	0.0	0.0	0.3	1.2	0.9	0.6	1.1	25.5	2.1	0.6
VENTX	"HPX42B, VENTX2"	ENSG00000151650	"VENT homeobox"	O95231	10	133237404-133241929	"Predicted intracellular proteins, Transcription factors"		"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"	20	"Alveolar cells type 2: 1.4;Collecting duct cells: 1.8;Kupffer cells: 6.5;Macrophages: 5.6"	"Cancer enriched"	"Detected in some"	15	"testis cancer: 30.4"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"basophil: 2.4;classical monocyte: 4.6;intermediate monocyte: 5.1;myeloid DC: 3.1;neutrophil: 1.8;non-classical monocyte: 3.9"	"Group enriched"	"Detected in many"	5	"dendritic cells: 3.1;granulocytes: 2.4;monocytes: 5.1"	"Group enriched"	"Detected in some"	10	"NB-4: 18.0;NTERA-2: 10.3"									HPA050955	Uncertain		Uncertain	"Nucleoli fibrillar center,Cytosol"		NA	NA			"Nucleoli fibrillar center"	Cytosol	"HPA050955: AB_2681288"	"unprognostic (9.41e-2)"	"unprognostic (8.89e-2)"	"unprognostic (2.34e-1)"	"unprognostic (4.26e-1)"	"unprognostic (3.22e-2)"	"unprognostic (2.01e-1)"	"unprognostic (2.54e-1)"	"unprognostic (9.62e-3)"	"unprognostic (2.22e-1)"	"unprognostic (3.00e-3)"	"unprognostic (3.70e-4)"	"unprognostic (4.22e-1)"	"unprognostic (2.51e-3)"	"unprognostic (3.43e-2)"	"unprognostic (3.48e-1)"	"unprognostic (7.54e-2)"	"unprognostic (3.14e-1)"	5.6	2.4	1.2	6.6	1.2	4.4	2.0	1.2	1.2	1.7	1.7	1.2	1.2	0.4	1.7	1.2	1.2	2.0	2.5	1.2	1.2	1.5	1.9	1.2	4.4	1.2	1.2	1.2	1.7	2.1	1.0	1.5	1.2	1.2	1.2	0.4	1.2	1.5	1.2	1.2	2.0	1.2	2.1	2.2	7.3	0.9	6.3	1.2	2.9	1.2	1.2	1.2	1.5	1.2	0.5	3.1	2.4	5.1	0.6	0.3	1.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.2	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.2	0.1	0.0	0.0	0.0	18.0	10.3	0.2	0.0	0.0	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.0	1.4	0.0	0.4	0.0	0.0	0.1	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.0	2.4	4.6	0.6	0.3	5.1	0.1	0.5	0.2	0.2	3.1	0.5	0.2	0.3	1.8	0.6	3.9	0.2	0.1	1.0	1.2	1.2	1.2	1.2	1.2	1.5	1.2	1.2	1.2	1.2	0.0	1.4	0.0	0.0	0.2	0.0	0.4	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	6.5	0.0	0.0	5.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
VSIG4	Z39IG	ENSG00000155659	"V-set and immunoglobulin domain containing 4"	Q9Y279	X	66021738-66040125	"Plasma proteins, Predicted membrane proteins"	"Complement alternate pathway, Immunity, Innate immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	31	"Hofbauer cells: 772.9;Kupffer cells: 436.3;Macrophages: 389.0"	"Cancer enhanced"	"Detected in all"		"glioma: 88.6"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	26	"classical monocyte: 13.9;intermediate monocyte: 8.1;myeloid DC: 13.1"	"Group enriched"	"Detected in many"	30	"dendritic cells: 13.1;monocytes: 13.9"	"Cell line enhanced"	"Detected in some"		"BEWO: 1.2;HMC-1: 1.1;NB-4: 3.1;SH-SY5Y: 1.1;U-937: 2.7"					"Low region specificity"	"Detected in many"			"HPA003903, CAB026000"	Enhanced		Uncertain	"Nucleoli,Plasma membrane,Cytosol"		NA	NA		41000000	"Plasma membrane, Cytosol"	Nucleoli	"CAB026000: , HPA003903: AB_1858776"	"unprognostic (6.87e-3)"	"unprognostic (4.79e-2)"	"prognostic unfavorable (1.34e-4)"	"unprognostic (3.19e-1)"	"unprognostic (1.30e-2)"	"unprognostic (1.53e-2)"	"unprognostic (9.37e-3)"	"unprognostic (1.24e-1)"	"unprognostic (3.10e-1)"	"unprognostic (1.37e-3)"	"unprognostic (1.06e-1)"	"unprognostic (2.77e-1)"	"prognostic unfavorable (1.95e-6)"	"unprognostic (3.70e-2)"	"unprognostic (5.45e-2)"	"unprognostic (3.37e-2)"	"unprognostic (3.47e-2)"	67.1	28.1	15.9	17.6	16.6	2.6	19.0	1.8	10.4	6.3	18.0	5.6	1.0	9.2	6.1	14.2	9.3	28.7	15.5	15.9	11.5	3.5	18.5	22.9	61.4	37.0	17.9	3.4	8.2	8.2	3.7	7.9	52.4	12.0	10.9	12.6	8.1	11.3	4.0	10.5	4.0	14.6	39.9	16.7	28.5	9.4	13.5	17.8	0.0	10.7	1.7	1.8	14.4	9.0	0.1	13.1	0.4	13.9	0.0	0.2	3.3	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.8	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.5	0.0	0.0	0.1	3.1	0.2	0.0	0.0	0.4	0.0	0.5	0.0	0.0	0.8	1.1	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.1	0.3	0.1	0.4	0.0	0.0	0.8	2.7	0.0	0.0	13.9	0.0	0.0	8.1	0.0	0.0	0.0	0.2	13.1	0.1	0.0	0.0	0.4	0.0	0.2	0.0	0.0	3.3	15.9	16.6	1.8	10.1	11.5	3.5	17.9	3.4	12.0	17.8	3.0	17.3	3.0	0.1	2.1	0.0	0.8	7.6	8.1	5.7	0.0	0.0	4.4	0.0	0.0	5.8	1.9	0.0	0.0	0.0	3.7	3.8	0.2	3.5	2.4	772.9	0.0	0.0	5.5	436.3	13.2	1.4	389.0	3.3	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	6.5	0.2	0.2	0.9	1.5	10.3	0.0	0.0	0.2
WAS	"IMD2, THC, WASP, WASPA"	ENSG00000015285	"Wiskott-Aldrich syndrome"	P42768	X	48676596-48691427	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"			"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 30.7;lymphoid tissue: 55.9"	"Cell type enhanced"	"Detected in many"	8	"B-cells: 72.2;Hofbauer cells: 95.2;Kupffer cells: 94.9;Macrophages: 70.0;T-cells: 87.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"eosinophil: 20.3"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"Daudi: 21.7;HEL: 19.1;HMC-1: 46.5;MOLT-4: 19.7;NB-4: 21.5;RPMI-8226: 26.5;THP-1: 19.5;U-266/70: 24.6;U-937: 24.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA002022, CAB004290"	Enhanced		Approved	"Plasma membrane,Cytosol"		NA	NA		320000	"Plasma membrane"	Cytosol	"CAB004290: AB_628445, HPA002022: AB_1080581"	"unprognostic (1.43e-3)"	"unprognostic (2.09e-3)"	"unprognostic (2.36e-2)"	"prognostic favorable (4.95e-4)"	"unprognostic (9.89e-2)"	"prognostic favorable (3.78e-4)"	"unprognostic (5.12e-3)"	"unprognostic (7.60e-2)"	"unprognostic (1.54e-2)"	"unprognostic (2.86e-1)"	"unprognostic (7.40e-2)"	"unprognostic (3.60e-1)"	"prognostic unfavorable (5.58e-6)"	"unprognostic (2.24e-1)"	"unprognostic (2.37e-2)"	"unprognostic (3.55e-2)"	"unprognostic (1.71e-1)"	7.6	4.0	4.9	28.9	7.8	30.7	3.3	2.0	5.1	2.7	4.4	5.9	0.5	4.8	2.4	5.6	3.7	4.5	4.4	3.0	4.6	4.1	4.1	5.0	12.6	29.9	7.6	1.3	2.6	2.2	0.7	2.6	5.4	6.0	3.2	3.2	3.5	5.4	1.9	1.4	2.2	14.3	3.7	12.8	55.9	4.1	1.7	7.3	53.2	2.8	1.4	33.2	5.8	2.5	2.1	3.5	20.3	5.3	2.1	3.2	2.0	0.2	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	21.7	0.1	0.0	0.1	0.7	0.0	0.0	0.0	12.5	0.1	19.1	0.2	0.0	0.2	9.8	46.5	0.0	0.0	0.0	0.0	0.0	0.0	11.7	0.2	13.4	0.0	2.2	19.7	21.5	0.1	0.3	0.1	17.3	0.0	26.5	0.0	0.0	0.1	0.2	0.3	0.2	0.2	0.1	0.1	19.5	0.1	0.0	0.1	0.3	0.0	24.6	12.0	15.2	0.1	24.8	0.0	1.8	4.6	20.3	3.0	5.0	2.2	1.8	2.3	2.5	3.5	2.1	2.1	2.3	18.1	2.1	5.3	1.8	3.2	2.0	4.9	7.8	2.0	5.1	4.6	4.1	7.6	1.3	6.0	7.3	3.0	21.3	72.2	0.1	2.2	0.0	0.8	0.0	2.7	0.0	0.0	0.0	0.8	1.7	0.1	0.5	0.5	0.0	23.3	0.3	0.9	1.5	0.2	46.2	0.9	95.2	0.0	1.2	5.5	94.9	0.8	0.0	70.0	3.3	45.9	0.0	0.2	0.1	0.0	0.0	1.5	0.0	0.0	0.6	1.4	1.1	1.3	1.1	87.0	0.0	0.1
WDFY4	"C10orf64, Em:AC060234.3, FLJ45748, KIAA1607"	ENSG00000128815	"WDFY family member 4"	Q6ZS81	10	48684876-48982956	"Predicted intracellular proteins, Predicted membrane proteins"	Autophagy			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 19.7;lymphoid tissue: 31.2"	"Cell type enhanced"	"Detected in some"	10	"B-cells: 20.5;Early spermatids: 25.8;Hofbauer cells: 11.8;Kupffer cells: 11.7;Late spermatids: 11.6;Macrophages: 21.6;monocytes: 17.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	6	"memory B-cell: 8.9;myeloid DC: 6.7;naive B-cell: 12.5;neutrophil: 6.2;plasmacytoid DC: 19.7"	"Group enriched"	"Detected in many"	7	"B-cells: 12.5;dendritic cells: 19.7;granulocytes: 6.2"	"Cell line enhanced"	"Detected in some"		"Daudi: 30.0;HDLM-2: 27.5;HL-60: 10.5;THP-1: 9.3;U-698: 12.8;U-937: 12.4"	"Low region specificity"	"Detected in many"							HPA040634	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA040634: AB_10795491"	"unprognostic (6.20e-2)"	"unprognostic (6.60e-3)"	"unprognostic (1.87e-1)"	"unprognostic (3.31e-2)"	"unprognostic (1.87e-1)"	"unprognostic (9.38e-4)"	"unprognostic (9.41e-2)"	"unprognostic (3.89e-3)"	"unprognostic (2.15e-2)"	"unprognostic (3.74e-1)"	"unprognostic (3.49e-2)"	"unprognostic (9.64e-2)"	"unprognostic (3.21e-1)"	"unprognostic (1.34e-1)"	"unprognostic (1.35e-2)"	"unprognostic (1.97e-1)"	"unprognostic (3.76e-2)"	2.7	1.5	3.6	31.2	5.4	8.6	1.5	0.9	2.7	1.2	1.6	5.2	0.0	1.1	1.2	1.5	1.5	1.5	2.6	1.4	3.1	1.9	1.7	1.2	9.4	20.8	5.3	0.6	1.1	1.1	0.2	1.1	0.8	3.7	1.2	1.5	1.2	5.7	0.4	0.9	2.0	10.2	1.3	7.3	19.1	1.6	1.5	4.4	4.1	1.6	0.9	26.6	3.0	1.2	12.5	19.7	6.2	1.7	0.0	0.1	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	30.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	27.5	0.0	3.2	0.0	0.0	0.0	10.5	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	5.8	0.0	0.0	0.0	3.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.8	0.0	12.4	0.0	0.0	1.7	0.0	0.0	1.6	0.0	8.9	0.0	0.1	6.7	12.5	0.0	0.0	6.2	0.0	0.8	19.7	0.0	0.6	3.6	5.4	0.9	2.7	3.1	1.9	5.3	0.6	3.7	4.4	0.0	0.6	20.5	0.0	0.3	0.0	1.1	0.0	0.0	1.2	1.8	0.0	0.1	1.7	0.0	25.8	0.3	0.0	0.0	0.0	0.1	0.9	0.0	5.7	0.0	11.8	0.0	0.0	0.0	11.7	11.6	0.3	21.6	1.7	17.2	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.4	0.6	0.6	0.3	0.2	0.0	0.0	0.0
ZEB2	"KIAA0569, SIP-1, SIP1, ZFHX1B"	ENSG00000169554	"Zinc finger E-box binding homeobox 2"	O60315	2	144364364-144524583	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"	"Disease mutation, Epilepsy, Hirschsprung disease, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 76.6"	"Cell type enhanced"	"Detected in many"	10	"Horizontal cells: 626.1;Kupffer cells: 357.2;Macrophages: 271.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HEL: 39.1;THP-1: 46.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003456	Approved		Supported	Nucleoplasm,Nucleoli,Cytosol		NA	NA			Nucleoli	"Nucleoplasm, Cytosol"	"HPA003456: AB_10603840"	"unprognostic (1.02e-1)"	"unprognostic (2.08e-1)"	"unprognostic (1.12e-1)"	"unprognostic (2.42e-1)"	"unprognostic (4.12e-1)"	"unprognostic (4.17e-2)"	"unprognostic (3.69e-1)"	"unprognostic (3.77e-2)"	"unprognostic (5.83e-2)"	"unprognostic (7.90e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.62e-1)"	"prognostic unfavorable (6.04e-5)"	"unprognostic (1.11e-2)"	"unprognostic (1.73e-2)"	"unprognostic (7.45e-2)"	"unprognostic (1.32e-2)"	30.2	23.7	48.0	27.8	42.4	55.5	16.6	6.7	36.6	29.4	12.3	72.9	3.4	11.3	15.6	11.1	14.4	11.1	22.6	22.5	52.5	28.8	9.9	11.6	20.7	19.6	54.4	26.4	37.5	3.6	5.0	3.1	31.5	37.6	10.9	16.3	15.7	5.7	12.5	9.6	7.7	12.8	17.2	76.6	32.6	9.3	8.2	38.7	1.9	8.3	7.5	12.4	21.5	14.8	5.0	12.7	9.7	21.6	3.6	10.7	7.4	0.4	0.5	22.5	0.0	26.9	13.7	0.0	9.2	9.4	10.4	10.1	0.0	0.2	1.7	0.0	10.0	2.8	0.1	3.8	0.0	13.0	9.6	2.6	39.1	1.6	0.0	6.1	6.7	31.1	11.2	0.2	12.9	6.2	8.8	7.8	0.0	10.9	1.1	12.2	0.0	0.0	20.5	3.2	0.0	0.5	11.5	15.5	0.0	0.1	0.2	0.2	5.9	1.1	0.0	24.3	7.5	0.0	46.5	12.1	12.0	0.2	23.3	2.9	12.7	0.0	1.9	17.9	20.2	32.2	9.7	21.6	5.7	10.7	20.8	1.0	4.4	1.4	5.3	12.7	5.0	1.1	4.0	7.5	3.6	19.5	10.2	0.3	7.4	48.0	42.4	6.7	35.6	52.5	28.8	54.4	26.4	37.6	38.7	6.0	25.8	45.8	1.2	22.0	178.1	50.1	2.5	6.7	18.2	5.2	3.9	1.3	1.7	0.6	2.0	23.8	0.0	23.3	0.7	1.6	146.0	1.5	150.5	2.1	126.8	626.1	0.0	81.0	357.2	4.0	111.7	271.2	97.8	46.9	0.0	84.2	0.2	0.0	62.6	7.3	8.6	181.1	167.0	2.3	7.0	17.1	3.9	99.2	0.0	2.0
ZGLP1	"GATAD3, GLP-1, GLP1"	ENSG00000220201	"Zinc finger, GATA-like protein 1"	P0C6A0	19	10304803-10309880	"Predicted intracellular proteins, Transcription factors"	"Differentiation, Oogenesis, Spermatogenesis, Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	9	"Hofbauer cells: 12.3;Kupffer cells: 16.8;Macrophages: 7.8;Spermatogonia: 16.8"	"Low cancer specificity"	"Detected in many"							"Cell type enhanced"	"Detected in single"		"gdT-cell: 1.0"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"NB-4: 26.6;U-937: 6.7"	"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			HPA049855	Uncertain		Approved	Nucleoplasm,Vesicles		NA	NA			"Nucleoplasm, Vesicles"		"HPA049855: AB_2680916"	"unprognostic (1.73e-2)"	"unprognostic (3.43e-3)"	"unprognostic (1.42e-3)"	"unprognostic (1.87e-2)"	"unprognostic (1.90e-1)"	"unprognostic (1.46e-4)"	"unprognostic (1.18e-1)"	"unprognostic (1.34e-2)"	"unprognostic (3.04e-2)"	"unprognostic (3.10e-2)"	"unprognostic (1.10e-4)"	"unprognostic (2.82e-2)"	"unprognostic (6.57e-7)"	"unprognostic (6.86e-2)"	"unprognostic (6.21e-2)"	"unprognostic (1.57e-1)"	"unprognostic (2.57e-4)"	0.5	0.9	2.5	2.0	6.5	0.9	1.0	8.0	5.4	1.4	0.9			2.2	2.1	0.7	0.6	2.6	1.8	0.6	2.9	3.4	2.4	3.0	1.0	3.6	1.0		3.9	3.1	1.9	4.8	2.0		3.4	0.3		5.1	2.5	1.4	4.8	1.6	0.2	0.9	2.6	1.4	3.7			5.3		1.4	1.2	0.9	0.3	0.3	0.1	0.3	0.0	1.0	0.1	0.4	1.0	1.4	0.5	0.9	0.4	3.6	0.8	0.2	0.7	1.5	1.0	0.3	1.5	0.8	0.2	0.6	1.5	1.0	0.3	0.2	1.3	4.6	1.4	1.3	0.5	0.6	0.0	0.4	0.8	2.1	0.7	0.4	0.6	0.2	1.2	1.4	1.0	0.9	1.6	0.1	26.6	2.2	0.3	1.7	1.5	0.7	0.7	0.6	0.6	1.2	1.4	0.3	0.3	1.2	0.4	2.1	0.4	0.5	2.1	2.4	2.0	0.2	5.2	6.1	0.6	0.4	6.7	0.9	0.0	0.3	0.0	1.0	0.1	0.6	0.0	0.1	0.1	0.2	0.3	0.1	0.0	0.1	0.0	0.2	0.3	0.0	0.1											0.0	2.6	0.9	0.4	0.8	1.4	0.4	0.0	1.4	1.2	1.8	0.0	0.4	0.0	0.4	0.4	0.8	0.4	0.0	0.0	0.3	0.6	0.8	0.0	1.0	12.3	6.4	0.0	0.6	16.8	0.6	0.9	7.8	3.3	1.8	0.2	1.1	0.3	0.8	0.7	0.3	1.3	0.0	0.4	1.8	16.8	0.6	0.1	0.0	1.1	0.0
